ISSN 1977-0758 |
||
Publicatieblad van de Europese Unie |
L 115 |
|
Uitgave in de Nederlandse taal |
Wetgeving |
61e jaargang |
|
|
|
(1) Voor de EER relevante tekst. |
NL |
Besluiten waarvan de titels mager zijn gedrukt, zijn besluiten van dagelijks beheer die in het kader van het landbouwbeleid zijn genomen en die in het algemeen een beperkte geldigheidsduur hebben. Besluiten waarvan de titels vet zijn gedrukt en die worden voorafgegaan door een sterretje, zijn alle andere besluiten. |
II Niet-wetgevingshandelingen
VERORDENINGEN
4.5.2018 |
NL |
Publicatieblad van de Europese Unie |
L 115/1 |
VERORDENING (EU) 2018/669 VAN DE COMMISSIE
van 16 april 2018
tot wijziging van Verordening (EG) nr. 1272/2008 van het Europees Parlement en de Raad betreffende de indeling, etikettering en verpakking van stoffen en mengsels, met het oog op de aanpassing aan de technische en wetenschappelijke vooruitgang
(Voor de EER relevante tekst)
DE EUROPESE COMMISSIE,
Gezien het Verdrag betreffende de werking van de Europese Unie,
Gezien Verordening (EG) nr. 1272/2008 van het Europees Parlement en de Raad van 16 december 2008 betreffende de indeling, etikettering en verpakking van stoffen en mengsels, tot wijziging en intrekking van de Richtlijnen 67/548/EEG en 1999/45/EG en tot wijziging van Verordening (EG) nr. 1907/2006 (1), en met name artikel 53, lid 1,
Overwegende hetgeen volgt:
(1) |
De tabellen 3.1 en 3.2 van bijlage VI bij Verordening (EG) nr. 1272/2008 bevatten de lijst van geharmoniseerde indelingen en etiketteringen van gevaarlijke stoffen; die lijst is echter in alle taalversies van die verordening uitsluitend in het Engels opgenomen. |
(2) |
Op 2 december 2008 (2) heeft de Commissie zich ertoe verbonden ervoor te zorgen dat de chemische namen die overeenstemmen met de internationale chemische identificatie, in de tabellen 3.1 en 3.2 van bijlage VI bij Verordening (EG) nr. 1272/2008 worden gepubliceerd in de talen die overeenstemmen met de taalversies waarin die verordening is gepubliceerd. |
(3) |
Tabel 3.1 van bijlage VI bij Verordening (EG) nr. 1272/2008 is verscheidene keren gewijzigd om rekening te houden met de technische en wetenschappelijke vooruitgang, door stoffen of de indeling daarvan toe te voegen, te schrappen of te wijzigen. Om rekening te houden met die wijzigingen en om ervoor te zorgen dat alle chemische namen in tabel 3.1 van bijlage VI bij Verordening (EG) nr. 1272/2008 worden opgenomen in de talen die overeenstemmen met de taalversies waarin die verordening is gepubliceerd, moet tabel 3.1 gedeeltelijk worden vervangen. |
(4) |
Met het oog op de afwijking (3) die geldt voor de vertaling in het Iers van handelingen die niet door het Europees Parlement en de Raad gezamenlijk worden vastgesteld, moeten de chemische namen in tabel 3.1 van bijlage VI niet in het Iers worden vertaald. |
(5) |
Tabel 3.2 bevat een lijst van gevaarlijke stoffen met hun geharmoniseerde indeling en etikettering op basis van de criteria in bijlage VI bij Richtlijn 67/548/EEG van de Raad (4), die met ingang van 1 juni 2015 is ingetrokken. Tabel 3.2 moet daarom in overeenstemming met artikel 1, lid 2, van Verordening (EU) 2016/1179 van de Commissie (5) met ingang van 1 juni 2017 worden geschrapt. Die tabel hoeft derhalve niet te worden gewijzigd. Tabel 3.1 is bijgevolg in overeenstemming met artikel 2, lid 2, van Verordening (EU) 2017/776 van de Commissie (6) met ingang van 1 juni 2017 omgenummerd naar tabel 3. |
(6) |
De leveranciers moeten voldoende tijd krijgen om de etikettering en verpakking van stoffen en mengsels aan de nieuwe bepalingen inzake de vertaling aan te passen en om hun bestaande voorraden te verkopen. |
(7) |
De leveranciers moet de mogelijkheid worden geboden deze verordening al vóór de datum van toepassing toe te passen, teneinde een hoog niveau van bescherming van de menselijke gezondheid en het milieu te waarborgen en te voorzien in voldoende flexibiliteit voor de leveranciers. |
(8) |
De in deze verordening vervatte maatregelen zijn in overeenstemming met het advies van het bij artikel 133 van Verordening (EG) nr. 1907/2006 van het Europees Parlement en de Raad (7) ingestelde comité, |
HEEFT DE VOLGENDE VERORDENING VASTGESTELD:
Artikel 1
De vermeldingen in de bijlage bij deze verordening vervangen de dienovereenkomstige vermeldingen in bijlage VI bij Verordening (EG) nr. 1272/2008.
Artikel 2
Deze verordening treedt in werking op de twintigste dag na die van de bekendmaking ervan in het Publicatieblad van de Europese Unie.
Zij is van toepassing met ingang van 1 december 2019.
In afwijking van de tweede alinea mogen stoffen en mengsels vóór 1 december 2019 worden ingedeeld, geëtiketteerd en verpakt overeenkomstig Verordening (EG) nr. 1272/2008, zoals gewijzigd bij deze verordening.
Deze verordening is verbindend in al haar onderdelen en is rechtstreeks toepasselijk in elke lidstaat.
Gedaan te Brussel, 16 april 2018.
Voor de Commissie
De voorzitter
Jean-Claude JUNCKER
(1) PB L 353 van 31.12.2008, blz. 1.
(2) Rectificatie van het standpunt van het Europees Parlement in eerste lezing vastgesteld op 3 september 2008 met het oog op de aanneming van Verordening (EG) nr. 1272/2008 van het Europees Parlement en de Raad betreffende de indeling, etikettering en verpakking van stoffen en mengsels, tot wijziging en intrekking van de Richtlijnen 67/548/EEG en 1999/45/EG en tot wijziging van Verordening (EG) nr. 1907/2006 — P6_TA(2008)0392 (COM(2007)0355 — C6-0197/2007 — 2007/0121 (COD)).
(3) Verordening (EU) nr. 1257/2010 van de Raad van 20 december 2010 houdende verlenging van de tijdelijke afwijkingsmaatregelen met betrekking tot Verordening nr. 1 van 15 april 1958 tot regeling van het taalgebruik in de Europese Economische Gemeenschap en Verordening nr. 1 van 15 april 1958 tot regeling van het taalgebruik in de Europese Gemeenschap voor Atoomenergie, die zijn ingevoerd bij Verordening (EG) nr. 920/2005 (PB L 343 van 29.12.2010, blz. 5).
(4) Richtlijn 67/548/EEG van de Raad van 27 juni 1967 betreffende de aanpassing van de wettelijke en bestuursrechtelijke bepalingen inzake de indeling, de verpakking en het kenmerken van gevaarlijke stoffen (PB 196 van 16.8.1967, blz. 1).
(5) Verordening (EU) 2016/1179 van de Commissie van 19 juli 2016 tot wijziging van Verordening (EG) nr. 1272/2008 van het Europees Parlement en de Raad betreffende de indeling, etikettering en verpakking van stoffen en mengsels, met het oog op de aanpassing aan de technische en wetenschappelijke vooruitgang (PB L 195 van 20.7.2016, blz. 11).
(6) Verordening (EU) 2017/776 van de Commissie van 4 mei 2017 tot wijziging van Verordening (EG) nr. 1272/2008 van het Europees Parlement en de Raad betreffende de indeling, etikettering en verpakking van stoffen en mengsels, met het oog op de aanpassing aan de technische en wetenschappelijke vooruitgang (PB L 116 van 5.5.2017, blz. 1).
(7) Verordening (EG) nr. 1907/2006 van het Europees Parlement en de Raad van 18 december 2006 inzake de registratie en beoordeling van en de autorisatie en beperkingen ten aanzien van chemische stoffen (REACH), tot oprichting van een Europees Agentschap voor chemische stoffen, houdende wijziging van Richtlijn 1999/45/EG en houdende intrekking van Verordening (EEG) nr. 793/93 van de Raad en Verordening (EG) nr. 1488/94 van de Commissie alsmede Richtlijn 76/769/EEG van de Raad en de Richtlijnen 91/155/EEG, 93/67/EEG, 93/105/EG en 2000/21/EG van de Commissie (PB L 396 van 30.12.2006, blz. 1).
BIJLAGE
Catalogusnummer |
Internationale chemische identificatie |
EG-nr. |
CAS-nr. |
Indeling |
Etikettering |
Specifieke concentratiegrenzen, M-factoren |
Opmerkingen |
|||
Gevarenklasse en -categorie |
Gevarenaanduiding |
Pictogram, signaalwoord |
Gevarenaanduiding |
Aanvullende gevarenaanduiding |
||||||
(1) |
(2) |
(3) |
(4) |
(5) |
(6) |
(7) |
(8) |
(9) |
(10) |
(11) |
001-001-00-9 |
waterstof |
215-605-7 |
1333-74-0 |
Flam. Gas 1 Press. Gas |
H220 |
GHS02 GHS04 Dgr |
H220 |
|
|
U |
001-002-00-4 |
lithiumaluminiumhydride |
240-877-9 |
16853-85-3 |
Water-react. 1 Skin Corr. 1A |
H260 H314 |
GHS02 GHS05 Dgr |
H260 H314 |
|
|
|
001-003-00-X |
natriumhydride |
231-587-3 |
7646-69-7 |
Water-react. 1 |
H260 |
GHS02 Dgr |
H260 |
|
|
|
001-004-00-5 |
calciumhydride |
232-189-2 |
7789-78-8 |
Water-react. 1 |
H260 |
GHS02 Dgr |
H260 |
|
|
|
003-001-00-4 |
lithium |
231-102-5 |
7439-93-2 |
Water-react. 1 Skin Corr. 1B |
H260 H314 |
GHS02 GHS05 Dgr |
H260 H314 |
EUH014 |
|
|
003-002-00-X |
n-hexyllithium |
404-950-0 |
21369-64-2 |
Water-react. 1 Pyr. Sol. 1 Skin Corr. 1A |
H260 H250 H314 |
GHS02 GHS05 Dgr |
H260 H250 H314 |
EUH014 |
|
|
003-003-00-5 |
(2-methylpropyl)lithium; isobutyllithium |
440-620-2 |
920-36-5 |
Water-react. 1 Pyr. Liq. 1 Skin Corr. 1A STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 |
H260 H250 H314 H336 H400 H410 |
GHS02 GHS05 GHS07 GHS09 Dgr |
H260 H250 H314 H336 H410 |
EUH014 |
|
|
004-001-00-7 |
beryllium |
231-150-7 |
7440-41-7 |
Carc. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H350i H330 H301 H372 ** H319 H335 H315 H317 |
GHS06 GHS08 Dgr |
H350i H330 H301 H372 ** H319 H335 H315 H317 |
|
|
|
004-002-00-2 |
berylliumverbindingen met uitzondering van berylliumaluminiumsilicaat, tenzij elders in deze bijlage vermeld |
— |
— |
Carc. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H350i H330 H301 H372 ** H319 H335 H315 H317 H411 |
GHS06 GHS08 GHS09 Dgr |
H350i H330 H301 H372 ** H319 H335 H315 H317 H411 |
|
|
A |
004-003-00-8 |
berylliumoxide |
215-133-1 |
1304-56-9 |
Carc. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H350i H330 H301 H372 ** H319 H335 H315 H317 |
GHS06 GHS08 Dgr |
H350i H330 H301 H372 ** H319 H335 H315 H317 |
|
|
|
005-001-00-X |
boortrifluoride |
231-569-5 |
7637-07-2 |
Press. Gas Acute Tox. 2 * Skin Corr. 1A |
H330 H314 |
GHS04 GHS06 GHS05 Dgr |
H330 H314 |
EUH014 |
|
U |
005-002-00-5 |
boortrichloride |
233-658-4 |
10294-34-5 |
Press. Gas Acute Tox. 2 * Acute Tox. 2 * Skin Corr. 1B |
H330 H300 H314 |
GHS04 GHS06 GHS05 Dgr |
H330 H300 H314 |
EUH014 |
|
U |
005-003-00-0 |
boortribromide |
233-657-9 |
10294-33-4 |
Acute Tox. 2 * Acute Tox. 2 * Skin Corr. 1A |
H330 H300 H314 |
GHS06 GHS05 Dgr |
H330 H300 H314 |
EUH014 |
|
|
005-004-00-6 |
trialkylboranen, vast |
— |
— |
Pyr. Sol. 1 Skin Corr. 1B |
H250 H314 |
GHS02 GHS05 Dgr |
H250 H314 |
|
|
A |
005-004-01-3 |
trialkylboranen, vloeibaar |
— |
— |
Pyr. Liq. 1 Skin Corr. 1B |
H250 H314 |
GHS02 GHS05 Dgr |
H250 H314 |
|
|
A |
005-005-00-1 |
trimethylboraat |
204-468-9 |
121-43-7 |
Flam. Liq. 3 Acute Tox. 4 * |
H226 H312 |
GHS02 GHS07 Wng |
H226 H312 |
|
|
|
005-006-00-7 |
dibutyltinwaterstofboraat |
401-040-5 |
75113-37-0 |
Repr. 1B Muta. 2 STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H360FD H341 H372** H312 H302 H318 H317 H400 H410 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H360FD H341 H372** H312 H302 H318 H317 H410 |
|
|
|
005-007-00-2 |
boorzuur; [1] boorzuur; [2] |
233-139-2 [1] 234-343-4 [2] |
10043-35-3 [1] 11113-50-1 [2] |
Repr. 1B |
H360FD |
GHS08 Dgr |
H360FD |
|
Repr.1B; H360FD: C ≥ 5,5 % |
|
005-008-00-8 |
diboortrioxide; booroxide |
215-125-8 |
1303-86-2 |
Repr. 1B |
H360FD |
GHS08 Dgr |
H360FD |
|
Repr.1B; H360FD:C ≥ 3,1 % |
|
005-009-00-3 |
tetrabutylammonium-butyltrifenylboraat |
418-080-4 |
120307-06-4 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
005-010-00-9 |
N, N-dimethylaniliniumtetrakis(pentafluorfenyl)boraat |
422-050-6 |
118612-00-3 |
Carc. 2 Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 |
H351 H302 H315 H318 |
GHS08 GHS05 GHS07 Dgr |
H351 H302 H315 H318 |
|
|
|
005-011-00-4 |
dinatriumtetraboraat, watervrij; boorzuur, dinatriumzout; [1] tetraboordinatriumheptaoxide, hydraat; [2] orthoboorzuur, natriumzout [3] |
215-540-4 [1] 235-541-3 [2] 237-560-2 [3] |
1330-43-4 [1] 12267-73-1 [2] 13840-56-7 [3] |
Repr. 1B |
H360FD |
GHS08 Dgr |
H360FD |
|
Repr. 1B; H360FD: C ≥4,5 % |
|
005-011-01-1 |
dinatriumtetraboraat-decahydraat; borax-decahydraat |
215-540-4 |
1303-96-4 |
Repr. 1B |
H360FD |
GHS08 Dgr |
H360FD |
|
Repr.1B; H360FD: C ≥ 8,5 % |
|
005-011-02-9 |
dinatriumtetraboraat-pentahydraat; borax-pentahydraat |
215-540-4 |
12179-04-3 |
Repr. 1B |
H360FD |
GHS08 Dgr |
H360FD |
|
Repr.B; H360FD: C ≥ 6,5 % |
|
005-012-00-X |
diëthyl{4-[1,5,5-tris(4-diëthylaminofenyl)penta-2,4-diënylideen]cyclohexa-2,5-diënylideen}ammonium-butyltrifenylboraat |
418-070-1 |
141714-54-7 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
005-013-00-5 |
diëthylmethoxyboraan |
425-380-9 |
7397-46-8 |
Pyr. Liq. 1 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 4 |
H250 H332 H312 H302 H373** H314 H317 H413 |
GHS02 GHS05 GHS08 GHS07 Dgr |
H250 H332 H312 H302 H373** H314 H317 H413 |
|
|
|
005-014-00-0 |
4-formylfenylboronzuur |
438-670-5 |
87199-17-5 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
005-015-00-6 |
1-chloormethyl-4-fluor-1,4-diazoniabicyclo[2.2.2]octaanbis(tetrafluorboraat) |
414-380-4 |
140681-55-6 |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H302 H318 H317 H412 |
GHS05 GHS07 Dgr |
H302 H318 H317 H412 |
|
|
|
005-016-00-1 |
tetrabutylammonium-butyl-tris-(4-tert-butylfenyl)boraat |
431-370-5 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
005-017-00-7 |
natriumperboraat; [1] natriumperoxometaboraat; [2] natriumperoxoboraat; [met < 0,1 % (m/m) deeltjes met een aerodynamische diameter van minder dan 50 μm] |
239-172-9 [1] 231-556-4 [2] |
15120-21-5 [1] 7632-04-4 [2] |
Ox. Sol. 2 Repr. 1B Acute Tox. 4 * STOT SE 3 Eye Dam. 1 |
H272 H360Df H302 H335 H318 |
GHS03 GHS05 GHS08 GHS07 Dgr |
H272 H360Df H302 H335 H318 |
|
Repr.1B; H360Df: C ≥9 % Repr.1B; H360 D: 6,5 % ≤ C <9 % Eye Dam. 1; H318: C ≥ 22 % Eye Irrit. 2; H319: 14 % ≤ C < 22 % |
|
005-017-01-4 |
natriumperboraat; [1] natriumperoxometaboraat; [2] natriumperoxoboraat; [met ≥ 0,1 % (m/m) deeltjes met een aerodynamische diameter van minder dan 50 μm] |
239-172-9 [1] 231-556-4 [2] |
15120-21-5 [1] 7632-04-4 [2] |
Ox. Sol. 2 Repr. 1B Acute Tox. 3 * Acute Tox. 4 * STOT SE 3 Eye Dam. 1 |
H272 H360Df H331 H302 H335 H318 |
GHS03 GHS06 GHS05 GHS08 Dgr |
H272 H360Df H331 H302 H335 H318 |
|
Repr. 1B; H360Df: C ≥9 % Repr. 1B; H360D: 6,5 % ≤ C < 9 % Eye Dam. 1; H318: C ≥ 22 % Eye Irrit. 2; H319: 14 % ≤ C < 22 % |
|
005-018-00-2 |
perboorzuur (H3BO2(O2)), mononatriumzout, trihydraat; [1] perboorzuur, natriumzout, tetrahydraat; [2] perboorzuur (HBO(O2)), natriumzout, tetrahydraat; [3] natriumperoxoboraat, hexahydraat; [met < 0,1 % (m/m) deeltjes met een aerodynamische diameter van minder dan 50 μm] |
239-172-9 [1] 234-390-0 [2] 231-556-4 [3] |
13517-20-9 [1] 37244-98-7 [2] 10486-00-7 [3] |
Repr. 1B STOT SE 3 Eye Dam. 1 |
H360Df H335 H318 |
GHS05 GHS08 GHS07 Dgr |
H360Df H335 H318 |
|
Repr. 1B; H360Df: C ≥ 14 % Repr. 1B; H360D: 10 % ≤ C < 14 % Eye Dam. 1; H318: C ≥ 36 % Eye Irrit. 2; H319: 22 % ≤ C < 36 % |
|
005-018-01-X |
perboorzuur (H3BO2(O2)), mononatriumzout, trihydraat; [1] perboorzuur, natriumzout, tetrahydraat; [2] perboorzuur (HBO(O2)), natriumzout, tetrahydraat; [3] natriumperoxoboraat, hexahydraat; [met ≥ 0,1 % (m/m) deeltjes met een aerodynamische diameter van minder dan 50 μm] |
239-172-9 [1] 234-390-0 [2] 231-556-4 [3] |
13517-20-9 [1] 37244-98-7 [2] 10486-00-7 [3] |
Repr. 1B Acute Tox. 4 * STOT SE 3 Eye Dam. 1 |
H360Df H332 H335 H318 |
GHS05 GHS08 GHS07 Dgr |
H360Df H332 H335 H318 |
|
Repr. 1B; H360 Df: C ≥ 14 % Repr. 1B; H360D: 10 % ≤ C < 14 % Eye Dam. 1; H318: C ≥ 36 % Eye Irrit. 2; H319: 22 % ≤ C < 36 % |
|
005-019-00-8 |
perboorzuur, natriumzout; [1] perboorzuur, natriumzout, monohydraat; [2] perboorzuur (HBO(O2)), natriumzout, monohydraat; [3] natriumperoxoboraat; [met < 0,1 % (m/m) deeltjes met een aerodynamische diameter van minder dan 50 μm] |
234-390-0 [1] 234-390-0 [2] 231-556-4 [3] |
11138-47-9 [1] 12040-72-1 [2] 10332-33-9 [3] |
Ox. Sol. 3 Repr. 1B Acute Tox. 4 * STOT SE 3 Eye Dam. 1 |
H272 H360Df H302 H335 H318 |
GHS03 GHS05 GHS08 GHS07 Dgr |
H272 H360Df H302 H335 H318 |
|
Repr. 1B; H360Df: C ≥ 9 % Repr. 1B; H360D: 6,5 % ≤ C < 9 % Eye Dam. 1; H318: C ≥ 22 % Eye Irrit. 2; H319: 14 % ≤ C < 22 % |
|
005-019-01-5 |
perboorzuur, natriumzout; [1] perboorzuur, natriumzout, monohydraat; [2] perboorzuur (HBO(O2)), natriumzout, monohydraat; [3] natriumperoxoboraat; [met ≥ 0,1 % (m/m) deeltjes met een aerodynamische diameter van minder dan 50 μm] |
234-390-0 [1] 234-390-0 [2] 231-556-4 [3] |
11138-47-9 [1] 12040-72-1 [2] 10332-33-9 [3] |
Ox. Sol. 3 Repr. 1B Acute Tox. 3 * Acute Tox. 4 * STOT SE 3 Eye Dam. 1 |
H272 H360Df H331 H302 H335 H318 |
GHS03 GHS06 GHS05 GHS08 Dgr |
H272 H360Df H331 H302 H335 H318 |
|
Repr. 1B; H360Df: C ≥ 9 % Repr. 1B; H360D: 6,5 % ≤ C < 9 % Eye Dam. 1; H318: C ≥ 22 % Eye Irrit. 2; H319: 14 % ≤ C < 22 % |
|
006-001-00-2 |
koolstofmonoxide |
211-128-3 |
630-08-0 |
Flam. Gas 1 Press. Gas Repr. 1A Acute Tox. 3 * STOT RE 1 |
H220 H360D *** H331 H372 ** |
GHS02 GHS04 GHS06 GHS08 Dgr |
H220 H360D *** H331 H372 ** |
|
|
U |
006-002-00-8 |
fosgeen; carbonylchloride |
200-870-3 |
75-44-5 |
Press. Gas Acute Tox. 2 * Skin Corr. 1B |
H330 H314 |
GHS04 GHS06 GHS05 Dgr |
H330 H314 |
|
|
U |
006-003-00-3 |
koolstofdisulfide |
200-843-6 |
75-15-0 |
Flam. Liq. 2 Repr. 2 STOT RE 1 Eye Irrit. 2 Skin Irrit. 2 |
H225 H361fd H372 ** H319 H315 |
GHS02 GHS08 GHS07 Dgr |
H225 H361fd H372 ** H319 H315 |
|
Repr. 2; H361fd: C ≥ 1 % STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,2 % ≤ C < 1 % |
|
006-004-00-9 |
calciumcarbide |
200-848-3 |
75-20-7 |
Water-react. 1 |
H260 |
GHS02 Dgr |
H260 |
|
|
T |
006-005-00-4 |
thiram (ISO); tetramethylthiuramdisulfide |
205-286-2 |
137-26-8 |
Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H332 H302 H373 ** H319 H315 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H332 H302 H373 ** H319 H315 H317 H410 |
|
M = 10 |
|
006-006-00-X |
waterstofcyanide; cyaanwaterstof; blauwzuur |
200-821-6 |
74-90-8 |
Flam. Liq. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H224 H330 H400 H410 |
GHS02 GHS06 GHS09 Dgr |
H224 H330 H410 |
|
|
|
006-006-01-7 |
waterstofcyanide … %; cyaanwaterstof … %; blauwzuur … % |
200-821-6 |
74-90-8 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H330 H310 H300 H410 |
|
|
B |
006-007-00-5 |
zouten van waterstofcyanide met uitzondering van complexe cyaniden zoals hexacyanoferraten(II), hexacyanoferraten(III) en kwikoxycyanide, tenzij elders in deze bijlage vermeld |
— |
— |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H330 H310 H300 H410 |
EUH032 |
|
A |
006-008-00-0 |
antu (ISO); 1-(1-naftyl)-2-thio-ureum |
201-706-3 |
86-88-4 |
Acute Tox. 2 * Carc. 2 |
H300 H351 |
GHS06 GHS08 Dgr |
H300 H351 |
|
|
|
006-009-00-6 |
1-isopropyl-3-methylpyrazool-5-yldimethylcarbamaat; isolan |
204-318-2 |
119-38-0 |
Acute Tox. 1 Acute Tox. 2 * |
H310 H300 |
GHS06 Dgr |
H310 H300 |
|
|
|
006-010-00-1 |
5,5-dimethyl-3-oxocyclohex-1-enyldimethylcarbamaat; 5,5-dimethyldihydroresorcinoldimethylcarbamaat; dimetan |
204-525-8 |
122-15-6 |
Acute Tox. 3 * |
H301 |
GHS06 Dgr |
H301 |
|
|
|
006-011-00-7 |
carbaryl (ISO); 1-naftylmethylcarbamaat |
200-555-0 |
63-25-2 |
Carc. 2 Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 |
H351 H332 H302 H400 |
GHS08 GHS07 GHS09 Wng |
H351 H332 H302 H400 |
|
M=100 |
|
006-012-00-2 |
ziram (ISO); zink-bis(N,N-dimethyldithiocarbamaat) |
205-288-3 |
137-30-4 |
Acute Tox. 2 * Acute Tox. 4 * STOT RE 2 * STOT SE 3 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H302 H373 ** H335 H318 H317 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H330 H302 H373 ** H335 H318 H317 H410 |
|
M = 100 |
|
006-013-00-8 |
metam-natrium (ISO); natrium-N-methyldithiocarbamaat |
205-293-0 |
137-42-8 |
Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H314 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H302 H314 H317 H410 |
EUH031 |
|
|
006-014-00-3 |
nabam (ISO); dinatriumethyleenbisdithiocarbamaat |
205-547-0 |
142-59-6 |
Acute Tox. 4 * STOT SE 3 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H335 H317 H410 |
GHS07 GHS09 Wng |
H302 H335 H317 H410 |
|
|
|
006-015-00-9 |
diuron (ISO); 3-(3,4-dichloorfenyl)-1,1-dimethylureum |
206-354-4 |
330-54-1 |
Carc. 2 Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H302 H373** H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H302 H373** H410 |
|
M = 10 |
|
006-016-00-4 |
propoxur (ISO); 2-isopropyloxyfenyl-N-methylcarbamaat; 2-isopropoxyfenylmethylcarbamaat |
204-043-8 |
114-26-1 |
Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H400 H410 |
GHS06 GHS09 Dgr |
H301 H410 |
|
|
|
006-017-00-X |
aldicarb (ISO); 2-methyl-2-(methylthio)propanal-O-(N-methylcarbamoyl)oxim |
204-123-2 |
116-06-3 |
Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H300 H311 H400 H410 |
GHS06 GHS09 Dgr |
H330 H300 H311 H410 |
|
|
|
006-018-00-5 |
aminocarb (ISO); 4-dimethylamino-3-tolylmethylcarbamaat |
217-990-7 |
2032-59-9 |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H311 H301 H410 |
|
|
|
006-019-00-0 |
diallaat (ISO); S-(2,3-dichloorallyl)-N,N-diisopropylthiocarbamaat |
218-961-1 |
2303-16-4 |
Carc. 2 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H302 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H302 H410 |
|
|
|
006-020-00-6 |
barban (ISO); 4-chloorbut-2-ynyl-N-(3-chloorfenyl)carbamaat |
202-930-4 |
101-27-9 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
|
006-021-00-1 |
linuron (ISO); 3-(3,4-dichloorfenyl)-1-methoxy-1-methylureum |
206-356-5 |
330-55-2 |
Repr. 1B Carc. 2 Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H360Df H351 H302 H373 ** H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H360Df H351 H302 H373 ** H410 |
|
|
|
006-022-00-7 |
decarbofuran (ISO); 2,3-dihydro-2-methylbenzofuran-7-yl-methylcarbamaat |
— |
1563-67-3 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * |
H331 H311 H301 |
GHS06 Dgr |
H331 H311 H301 |
|
|
|
006-023-00-2 |
mercaptodimethur (ISO); methiocarb (ISO); 3,5-dimethyl-4-methylthiofenyl-N-methylcarbamaat |
217-991-2 |
2032-65-7 |
Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H400 H410 |
GHS06 GHS09 Dgr |
H301 H410 |
|
|
|
006-024-00-8 |
proxan-natrium (ISO); natrium-O-isopropyldithiocarbonaat |
205-443-5 |
140-93-2 |
Acute Tox. 4 * Skin Irrit. 2 Aquatic Chronic 2 |
H302 H315 H411 |
GHS07 GHS09 Wng |
H302 H315 H411 |
|
|
|
006-025-00-3 |
allethrin; (RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl-(1RS,3RS;1RS,3SR)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropaancarboxylaat; bioallethrin; (RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl-(1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropaancarboxylaat; [1] S-bioallethrin; [3] (S)-3-allyl-2-methyl-4-oxocyclopent-2-enyl-(1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropaancarboxylaat; [2] esbiothrin; (RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl-(1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropaancarboxylaat [3] |
209-542-4 [1] 249-013-5 [2]-[3] |
584-79-2 [1] 28434-00-6 [2] 84030-86-4 [3] |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H302 H410 |
|
|
C |
006-026-00-9 |
carbofuran (ISO); 2,3-dihydro-2,2-dimethylbenzofuran-7-yl-N-methylcarbamaat |
216-353-0 |
1563-66-2 |
Acute Tox. 2 * Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H300 H400 H410 |
GHS06 GHS09 Dgr |
H330 H300 H410 |
|
|
|
006-028-00-X |
dinobuton (ISO); 2-(1-methylpropyl)-4,6-dinitrofenylisopropylcarbonaat |
213-546-1 |
973-21-7 |
Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H400 H410 |
GHS06 GHS09 Dgr |
H301 H410 |
|
|
|
006-029-00-5 |
dioxacarb (ISO); 2-(1,3-dioxolaan-2-yl)fenyl-N-methylcarbamaat |
230-253-4 |
6988-21-2 |
Acute Tox. 3 * Aquatic Chronic 2 |
H301 H411 |
GHS06 GHS09 Dgr |
H301 H411 |
|
|
|
006-030-00-0 |
EPTC (ISO); S-ethyldipropylthiocarbamaat |
212-073-8 |
759-94-4 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
006-031-00-6 |
formetanaat (ISO); 3-[(EZ)-dimethylaminomethyleenamino]fenylmethylcarbamaat |
244-879-0 |
22259-30-9 |
Acute Tox. 2 * Acute Tox. 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H300 H317 H400 H410 |
GHS06 GHS09 Dgr |
H330 H300 H317 H410 |
|
|
|
006-032-00-1 |
monolinuron (ISO); 3-(4-chloorfenyl)-1-methoxy-1-methylureum |
217-129-5 |
1746-81-2 |
Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373 ** H400 H410 |
GHS08 GHS07 GHS09 Wng |
H302 H373 ** H410 |
|
|
|
006-033-00-7 |
metoxuron (ISO); 3-(3-chloor-4-methoxyfenyl)-1,1-dimethylureum |
243-433-2 |
19937-59-8 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
006-034-00-2 |
pebulaat (ISO); N-butyl-N-ethyl-S-propylthiocarbamaat |
214-215-4 |
1114-71-2 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
006-036-00-3 |
benzthiazuron (ISO); 1-benzothiazool-2-yl-3-methylureum |
217-685-9 |
1929-88-0 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
006-037-00-9 |
promecarb (ISO); 3-isopropyl-5-methylfenyl-N-methylcarbamaat |
220-113-0 |
2631-37-0 |
Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H400 H410 |
GHS06 GHS09 Dgr |
H301 H410 |
|
|
|
006-038-00-4 |
sulfallaat (ISO); 2-chloorallyl-N, N-dimethyldithiocarbamaat |
202-388-9 |
95-06-7 |
Carc. 1B Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H350 H302 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350 H302 H410 |
|
|
|
006-039-00-X |
triallaat (ISO); S-2,3,3-trichloorallyldiisopropylthiocarbamaat |
218-962-7 |
2303-17-5 |
Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373 ** H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H302 H373 ** H317 H410 |
|
|
|
006-040-00-5 |
3-methylpyrazool-5-yl-dimethylcarbamaat; monometilan |
— |
2532-43-6 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * |
H331 H311 H301 |
GHS06 Dgr |
H331 H311 H301 |
|
|
|
006-041-00-0 |
dimethylcarbamoylchloride |
201-208-6 |
79-44-7 |
Carc. 1B Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H350 H331 H302 H319 H335 H315 |
GHS06 GHS08 Dgr |
H350 H331 H302 H319 H335 H315 |
|
Carc. 1B; H350: C ≥ 0,001 % |
|
006-042-00-6 |
monuron (ISO); 3-(4-chloorfenyl)-1,1-dimethylureum |
205-766-1 |
150-68-5 |
Carc. 2 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H302 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H302 H410 |
|
|
|
006-043-00-1 |
3-(4-chloorfenyl)-1,1-dimethyluroniumtrichlooracetaat; monuron-TCA |
— |
140-41-0 |
Carc. 2 Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H319 H315 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H319 H315 H410 |
|
|
|
006-044-00-7 |
isoproturon (ISO); 3-(4-isopropylfenyl)-1,1-dimethylureum |
251-835-4 |
34123-59-6 |
Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H400 H410 |
GHS08 GHS09 Wng |
H351 H410 |
|
M = 10 |
|
006-045-00-2 |
methomyl (ISO); 1-(methylthio)ethylideenamino-N-methylcarbamaat |
240-815-0 |
16752-77-5 |
Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H400 H410 |
GHS06 GHS09 Dgr |
H300 H410 |
|
M=100 |
|
006-047-00-3 |
bufencarb (ISO); reactiemassa van 3-(1-methylbutyl)fenyl-N-methylcarbamaat en 3-(1-ethylpropyl)fenyl-N-methylcarbamaat |
— |
8065-36-9 |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H311 H301 H410 |
|
|
|
006-048-00-9 |
ethiofencarb (ISO); 2-ethylthiomethylfenyl-N-methylcarbamaat |
249-981-9 |
29973-13-5 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
006-049-00-4 |
dixanthogeen; O, O-diëthyldithiobis(thioformiaat) |
207-944-4 |
502-55-6 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
006-050-00-X |
1,1-dimethyl-3-fenyluroniumtrichlooracetaat; fenuron-TCA |
— |
4482-55-7 |
Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Wng |
H315 H410 |
|
|
|
006-051-00-5 |
ferbam (ISO); ijzertris(dimethyldithiocarbamaat) |
238-484-2 |
14484-64-1 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H335 H315 H400 H410 |
GHS07 GHS09 Wng |
H319 H335 H315 H410 |
|
|
|
006-052-00-0 |
formetanaathydrochloride; 3-(N, N-dimethylaminomethyleenamino)fenyl-N-methylcarbamaat |
245-656-0 |
23422-53-9 |
Acute Tox. 2 * Acute Tox. 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H300 H317 H400 H410 |
GHS06 GHS09 Dgr |
H330 H300 H317 H410 |
|
|
|
006-053-00-6 |
isoprocarb (ISO); 2-isopropylfenyl-N-methylcarbamaat |
220-114-6 |
2631-40-5 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
006-054-00-1 |
mexacarbaat (ISO); 3,5-dimethyl-4-dimethylaminofenyl-N-methylcarbamaat |
206-249-3 |
315-18-4 |
Acute Tox. 2 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H312 H400 H410 |
GHS06 GHS09 Dgr |
H300 H312 H410 |
|
|
|
006-055-00-7 |
xylylcarb (ISO); 3,4-dimethylfenyl-N-methylcarbamaat; 3,4-xylylmethylcarbamaat; MPMC |
219-364-9 |
2425-10-7 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
006-056-00-2 |
metolcarb (ISO); m-tolylmethylcarbamaat; MTMC |
214-446-0 |
1129-41-5 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
006-057-00-8 |
nitrapyrin (ISO); 2-chloor-6-trichloormethylpyridine |
217-682-2 |
1929-82-4 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
006-058-00-3 |
noruron (ISO); 1,1-dimethyl-3-(perhydro-4,7-methanoïndeen-5-yl)ureum |
— |
2163-79-3 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
006-059-00-9 |
oxamyl (ISO); N',N'-dimethylcarbamoyl(methylthio)methylenamine-N-methylcarbamaat; |
245-445-3 |
23135-22-0 |
Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 4 * Aquatic Chronic 2 |
H330 H300 H312 H411 |
GHS06 GHS09 Dgr |
H330 H300 H312 H411 |
|
|
|
006-060-00-4 |
oxycarboxin (ISO); 2,3-dihydro-6-methyl-5-(N-fenylcarbamoyl)-1,4-oxothiine-4,4-dioxide |
226-066-2 |
5259-88-1 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
006-061-00-X |
S-ethyl-N-(dimethylaminopropyl)thiocarbamaathydrochloride; prothiocarb-hydrochloride |
243-193-9 |
19622-19-6 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
006-062-00-5 |
methyl-3,4-dichloorfenylcarbamaat; swep |
— |
1918-18-9 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
006-063-00-0 |
thiobencarb (ISO); S-4-chloorbenzyldiëthylthiocarbamaat |
248-924-5 |
28249-77-6 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
006-064-00-6 |
thiofanox (ISO); 3,3-dimethyl-1-(methylthio)butanon-O-(N-methylcarbamoyl)oxim |
254-346-4 |
39196-18-4 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H310 H300 H410 |
|
|
|
006-065-00-1 |
3-chloor-6-cyaan-bicyclo[2.2.1]heptaan-2-on-O(N-methylcarbamoyl)oxim; tranid |
— |
15271-41-7 |
Acute Tox. 2 * Acute Tox. 3 * Aquatic Chronic 2 |
H300 H311 H411 |
GHS06 GHS09 Dgr |
H300 H311 H411 |
|
|
|
006-066-00-7 |
vernolaat (ISO); S-propyldipropylthiocarbamaat; |
217-681-7 |
1929-77-7 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
006-067-00-2 |
XMC; 3,5-xylylmethylcarbamaat |
— |
2655-14-3 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
006-068-00-8 |
diazomethaan |
206-382-7 |
334-88-3 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
006-069-00-3 |
thiofanaat-methyl (ISO); 1,2-di-(3-methoxycarbonyl-2-thio-ureïdo)benzeen |
245-740-7 |
23564-05-8 |
Muta. 2 Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H341 H332 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H341 H332 H317 H410 |
|
|
|
006-070-00-9 |
furmecyclox (ISO); N-cyclohexyl-N-methoxy-2,5-dimethyl-3-furamide |
262-302-0 |
60568-05-0 |
Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H400 H410 |
GHS08 GHS09 Wng |
H351 H410 |
|
|
|
006-071-00-4 |
cycloöct-4-een-1-ylmethylcarbonaat |
401-620-8 |
87731-18-8 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
006-072-00-X |
prosulfocarb (ISO); S-benzyl N, N-dipropylthiocarbamaat |
401-730-6 |
52888-80-9 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H302 H317 H411 |
GHS07 GHS09 Wng |
H302 H317 H411 |
|
|
|
006-073-00-5 |
3-(dimethylamino)propylureum |
401-950-2 |
31506-43-1 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
006-074-00-0 |
2-(3-(prop-1-een-2-yl)fenyl)prop-2-ylisocyanaat |
402-440-2 |
2094-99-7 |
Acute Tox. 2 * Skin Corr. 1B STOT RE 2 * Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H314 H373 ** H334 H317 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H330 H314 H373 ** H334 H317 H410 |
|
|
|
006-076-00-1 |
mancozeb (ISO); mangaanethyleenbis(dithiocarbamaat) (polymeer), complex met zinkzout |
— |
8018-01-7 |
Repr. 2 Skin Sens. 1 Aquatic Acute 1 |
H361d*** H317 H400 |
GHS08 GHS07 GHS09 Wng |
H361d*** H317 H400 |
|
M=10 |
|
006-077-00-7 |
maneb (ISO); mangaanethyleenbis(dithiocarbamaat) (polymeer) |
235-654-8 |
12427-38-2 |
Repr. 2 Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361d*** H332 H319 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H361d*** H332 H319 H317 H410 |
|
M=10 |
|
006-078-00-2 |
zineb (ISO); zinkethyleenbis(dithiocarbamaat) (polymeer) |
235-180-1 |
12122-67-7 |
STOT SE 3 Skin Sens. 1 |
H335 H317 |
GHS07 Wng |
H335 H317 |
|
|
|
006-079-00-8 |
disulfiram; tetraëthylthiuramdisulfide |
202-607-8 |
97-77-8 |
Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373 ** H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H302 H373 ** H317 H410 |
|
|
|
006-080-00-3 |
tetramethylthiurammonosulfide |
202-605-7 |
97-74-5 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H302 H317 H411 |
GHS07 GHS09 Wng |
H302 H317 H411 |
|
|
|
006-081-00-9 |
zinkbis(dibutyldithiocarbamaat) |
205-232-8 |
136-23-2 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H335 H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H319 H335 H315 H317 H410 |
|
|
|
006-082-00-4 |
zinkbis(diëthyldithiocarbamaat) |
238-270-9 |
14324-55-1 |
Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H335 H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H335 H315 H317 H410 |
|
|
|
006-083-00-X |
butocarboxim (ISO); 3-(methylthio)-2-butanon-O-[(methylamino)carbonyl]oxim |
252-139-3 |
34681-10-2 |
Flam. Liq. 3 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H226 H331 H311 H301 H319 H400 H410 |
GHS02 GHS06 GHS09 Dgr |
H226 H331 H311 H301 H319 H410 |
|
|
|
006-084-00-5 |
carbosulfan (ISO); 2,3-dihydro-2,2-dimethyl-7-benzofuryl[(dibutylamino)thio]methylcarbamaat |
259-565-9 |
55285-14-8 |
Acute Tox. 2 * Acute Tox. 3 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H301 H317 H400 H410 |
GHS06 GHS09 Dgr |
H330 H301 H317 H410 |
|
|
|
006-085-00-0 |
fenobucarb (ISO); 2-butylfenylmethylcarbamaat |
223-188-8 |
3766-81-2 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
006-086-00-6 |
fenoxycarb (ISO); ethyl-[2-(4-fenoxyfenoxy)ethyl]carbamaat |
276-696-7 |
72490-01-8 |
Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H400 H410 |
GHS08 GHS09 Wng |
H351 H410 |
|
M = 1 M = 10 000 |
|
006-087-00-1 |
furathiocarb (ISO); 2,3-dihydro-2,2-dimethyl-7-benzofuryl-2,4-dimethyl-6-oxa-5-oxo-3-thia-2,4-diazadecanoaat |
265-974-3 |
65907-30-4 |
Acute Tox. 2 * Acute Tox. 3 * STOT RE 2 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H301 H373** H319 H315 H317 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H330 H301 H373** H319 H315 H317 H410 |
|
M = 100 |
|
006-088-00-7 |
benfuracarb (ISO); ethyl-N-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]-N-isopropyl-β-alaninaat |
— |
82560-54-1 |
Repr. 2 Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H361f*** H331 H302 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H361f*** H331 H302 H410 |
|
|
|
006-090-00-8 |
2-(3-joodprop-2-yn-1-yloxy)ethylfenylcarbamaat |
408-010-0 |
88558-41-2 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 |
H332 H318 H412 |
GHS05 GHS07 Dgr |
H332 H318 H412 |
|
|
|
006-091-00-3 |
propineb (ISO); polymeer zinkpropyleenbis(dithiocarbamaat) |
— |
9016-72-2 |
Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 |
H332 H373** H317 H400 |
GHS08 GHS07 GHS09 Wng |
H332 H373** H317 H400 |
|
|
|
006-092-00-9 |
tert-butyl-(1S)-N-[1-((2S)-2-oxiranyl)-2-fenylethyl]carbamaat |
425-420-5 |
98737-29-2 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
006-093-00-4 |
2,2'-dithiodi(ethylammonium)-bis(dibenzyldithiocarbamaat) |
427-180-7 |
— |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
|
006-094-00-X |
O-isobutyl-N-ethoxycarbonylthiocarbamaat |
434-350-4 |
103122-66-3 |
Flam. Liq. 3 Carc. 1B Muta. 1B Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Chronic 2 |
H226 H350 H340 H302 H373** H317 H411 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H226 H350 H340 H302 H373** H317 H411 |
|
|
|
006-095-00-5 |
fosetyl-aluminium (ISO); aluminiumtriëthyltrifosfonaat |
254-320-2 |
39148-24-8 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
006-096-00-0 |
chloorprofam (ISO); isopropyl-3-chloorcarbanilaat |
202-925-7 |
101-21-3 |
Carc. 2 STOT RE 2 * Aquatic Chronic 2 |
H351 H373** H411 |
GHS08 GHS09 Wng |
H351 H373** H411 |
|
|
|
006-097-00-6 |
1-fenyl-3-(p-tolueensulfonyl)ureum |
424-620-1 |
13909-63-2 |
Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 3 |
H302 H373** H412 |
GHS08 GHS07 Wng |
H302 H373** H412 |
|
|
|
006-098-00-1 |
tert-butyl-(1R,5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamaat |
429-170-8 |
134575-17-0 |
Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 |
H302 H373** H318 H317 |
GHS05 GHS08 GHS07 Dgr |
H302 H373** H318 H317 |
|
|
|
006-099-00-7 |
N-(p-tolueensulfonyl)-N'-(3-(p-tolueensulfonyloxy)fenyl)ureum; 3-({[(4-methylfenyl)sulfonyl]carbamoyl}amino)fenyl-4-methylbenzeensulfonaat |
520-2 |
232938-43-1 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
006-101-00-6 |
reactiemassa van: N, N''-(methyleendi-4,1-fenyleen)bis[N'-fenylureum]; N-(4-[[4-[[(fenylamino)carbonyl]amino]fenylmethyl]fenyl]-N'-cyclohexylureum; N,N''-(methyleendi-4,1-fenyleen)bis[N'-cyclohexylureum] |
423-070-8 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
006-102-00-1 |
O-hexyl-N-ethoxycarbonylthiocarbamaat |
432-750-3 |
— |
Carc. 1B Muta. 1B Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Chronic 2 |
H350 H340 H302 H373** H317 H411 |
GHS08 GHS07 GHS09 Dgr |
H350 H340 H302 H373** H317 H411 |
|
|
|
006-103-00-7 |
N,N''-(methyleendi-4,1-fenyleen)bis[N'-octyl]ureum |
445-760-8 |
— |
Eye Dam. 1 Resp. Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H334 H400 H410 |
GHS05 GHS08 GHS09 Dgr |
H318 H334 H410 |
|
M=100 |
|
007-001-00-5 |
ammoniak, watervrij |
231-635-3 |
7664-41-7 |
Flam. Gas 2 Press. Gas Acute Tox. 3 * Skin Corr. 1B Aquatic Acute 1 |
H221 H331 H314 H400 |
GHS04 GHS06 GHS05 GHS09 Dgr |
H221 H331 H314 H400 |
|
|
U |
007-001-01-2 |
ammoniak …. % |
215-647-6 |
1336-21-6 |
Skin Corr. 1B Aquatic Acute 1 |
H314 H400 |
GHS05 GHS09 Dgr |
H314 H400 |
|
STOT SE 3; H335: C ≥ 5 % |
B |
007-002-00-0 |
stikstofdioxide; [1] distikstoftetraoxide [2] |
233-272-6 [1] 234-126-4 [2] |
10102-44-0 [1] 10544-72-6 [2] |
Press. Gas Ox. Gas 1 Acute Tox. 2 * Skin Corr. 1B |
H270 H330 H314 |
GHS04 GHS03 GHS06 GHS05 Dgr |
H270 H330 H314 |
|
* STOT SE 3; H335: C ≥0,5 % |
5 |
007-003-00-6 |
chloormequat-chloride (ISO); 2-chloorethyltrimethylammoniumchloride |
213-666-4 |
999-81-5 |
Acute Tox. 4 * Acute Tox. 4 * |
H312 H302 |
GHS07 Wng |
H312 H302 |
|
|
|
007-006-00-2 |
ethylnitriet |
203-722-6 |
109-95-5 |
Flam. Gas 1 Press. Gas Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H220 H332 H312 H302 |
GHS02 GHS04 GHS07 Dgr |
H220 H332 H312 H302 |
|
|
U |
007-007-00-8 |
ethylnitraat |
210-903-3 |
625-58-1 |
Unst. Expl. |
H200 |
GHS01 Dgr |
H200 |
|
|
|
007-008-00-3 |
hydrazine |
206-114-9 |
302-01-2 |
Flam. Liq. 3 Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H226 H350 H331 H311 H301 H314 H317 H400 H410 |
GHS02 GHS06 GHS08 GHS05 GHS09 Dgr |
H226 H350 H331 H311 H301 H314 H317 H410 |
|
Skin Corr. 1B; H314: C ≥ 10 % Skin Irrit. 2; H315: 3 % ≤ C < 10 % Eye Irrit. 2; H319: 3 % ≤ C < 10 % |
|
007-009-00-9 |
dicyclohexylammoniumnitriet |
221-515-9 |
3129-91-7 |
Acute Tox. 4 * Acute Tox. 4 * |
H332 H302 |
GHS07 Wng |
H332 H302 |
|
* |
|
007-010-00-4 |
natriumnitriet |
231-555-9 |
7632-00-0 |
Ox. Sol. 3 Acute Tox. 3 * Aquatic Acute 1 |
H272 H301 H400 |
GHS03 GHS06 GHS09 Dgr |
H272 H301 H400 |
|
* |
|
007-011-00-X |
kaliumnitriet |
231-832-4 |
7758-09-0 |
Ox. Sol. 2 Acute Tox. 3 * Aquatic Acute 1 |
H272 H301 H400 |
GHS03 GHS06 GHS09 Dgr |
H272 H301 H400 |
|
* |
|
007-012-00-5 |
N,N-dimethylhydrazine |
200-316-0 |
57-14-7 |
Flam. Liq. 2 Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Aquatic Chronic 2 |
H225 H350 H331 H301 H314 H411 |
GHS02 GHS06 GHS08 GHS05 GHS09 Dgr |
H225 H350 H331 H301 H314 H411 |
|
|
|
007-013-00-0 |
1,2-dimethylhydrazine |
— |
540-73-8 |
Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Chronic 2 |
H350 H331 H311 H301 H411 |
GHS06 GHS08 GHS09 Dgr |
H350 H331 H311 H301 H411 |
|
Carc. 1B; H350: C ≥ 0,01 % |
|
007-014-00-6 |
zouten van hydrazine |
— |
— |
Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H331 H311 H301 H317 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350 H331 H311 H301 H317 H410 |
|
|
A |
007-015-00-1 |
O-ethylhydroxylamine |
402-030-3 |
624-86-2 |
Flam. Liq. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 |
H225 H331 H311 H301 H372 ** H319 H317 H400 |
GHS02 GHS06 GHS08 GHS09 Dgr |
H225 H331 H311 H301 H372 ** H319 H317 H400 |
|
|
|
007-016-00-7 |
butylnitriet |
208-862-1 |
544-16-1 |
Flam. Liq. 2 Acute Tox. 3 * Acute Tox. 3 * |
H225 H331 H301 |
GHS02 GHS06 Dgr |
H225 H331 H301 |
|
|
|
007-017-00-2 |
isobutylnitriet |
208-819-7 |
542-56-3 |
Flam. Liq. 2 Carc. 1B Muta. 2 Acute Tox. 4 * Acute Tox. 4 * |
H225 H350 H341 H332 H302 |
GHS02 GHS08 GHS07 Dgr |
H225 H350 H341 H332 H302 |
|
|
|
007-018-00-8 |
sec-butylnitriet |
213-104-8 |
924-43-6 |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * |
H225 H332 H302 |
GHS02 GHS07 Dgr |
H225 H332 H302 |
|
|
|
007-019-00-3 |
tert-butylnitriet |
208-757-0 |
540-80-7 |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * |
H225 H332 H302 |
GHS02 GHS07 Dgr |
H225 H332 H302 |
|
|
|
007-020-00-9 |
pentylnitriet; [1] „amylnitriet”, mengsel van isomeren [2] |
207-332-7 [1] 203-770-8 [2] |
463-04-7 [1] 110-46-3 [2] |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * |
H225 H332 H302 |
GHS02 GHS07 Dgr |
H225 H332 H302 |
|
|
|
007-021-00-4 |
hydrazobenzeen; 1,2-difenylhydrazine |
204-563-5 |
122-66-7 |
Carc. 1B Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H350 H302 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350 H302 H410 |
|
|
|
007-022-00-X |
hydrazinebis(3-carboxy-4-hydroxybenzeensulfonaat) |
405-030-1 |
— |
Carc. 1B Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 3 |
H350 H302 H314 H317 H412 |
GHS08 GHS05 GHS07 Dgr |
H350 H302 H314 H317 H412 |
|
|
|
007-023-00-5 |
natrium-3,5-bis(3-(2,4-di-tert-pentylfenoxy)propylcarbamoyl)benzeensulfonaat |
405-510-0 |
— |
Skin Irrit. 2 Skin Sens. 1 |
H315 H317 |
GHS07 Wng |
H315 H317 |
|
|
|
007-024-00-0 |
2-(decylthio)ethylammoniumchloride |
405-640-8 |
36362-09-1 |
STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H373 ** H315 H318 H400 H410 |
GHS08 GHS05 GHS09 Dgr |
H373 ** H315 H318 H410 |
|
|
|
007-025-00-6 |
(4-hydrazinofenyl)-N-methylmethaansulfonamidehydrochloride |
406-090-1 |
81880-96-8 |
Muta. 2 Acute Tox. 3 * STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H341 H301 H372 ** H317 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H341 H301 H372 ** H317 H410 |
|
|
|
007-026-00-1 |
oxo-((2,2,6,6-tetramethylpiperidine-4-yl)amino)carbonylacetohydrazide |
413-230-5 |
122035-71-6 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
007-027-00-7 |
1,6-bis(3,3-bis((1-methylpentylidenimino)propyl)ureïdo)hexaan |
420-190-2 |
771478-66-1 |
Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H373 ** H314 H317 H400 H410 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H312 H302 H373 ** H314 H317 H410 |
|
|
|
007-028-00-2 |
hydroxylammoniumnitraat |
236-691-2 |
13465-08-2 |
Expl. 1.1 **** Carc. 2 Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 |
H201 H351 H311 H302 H373** H319 H315 H317 H400 |
GHS01 GHS06 GHS08 GHS09 Dgr |
H201 H351 H311 H302 H373** H319 H315 H317 H400 |
|
|
|
007-029-00-8 |
diëthyldimethylammoniumhydroxide |
419-400-5 |
95500-19-9 |
Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A |
H312 H302 H314 |
GHS05 GHS07 Dgr |
H312 H302 H314 |
|
|
|
008-001-00-8 |
zuurstof |
231-956-9 |
7782-44-7 |
Ox. Gas 1 Press. Gas |
H270 |
GHS03 GHS04 Dgr |
H270 |
|
|
U |
008-003-00-9 |
waterstofperoxide in oplossing … % |
231-765-0 |
7722-84-1 |
Ox. Liq. 1 Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A |
H271 H332 H302 H314 |
GHS03 GHS05 GHS07 Dgr |
H271 H332 H302 H314 |
|
Ox. Liq. 1; H271: C ≥70 %**** Ox. Liq. 2; H272: 50 % ≤ C < 70 % **** * Skin Corr. 1A; H314: C ≥ 70 % Skin Corr. 1B; H314: 50 % ≤ C < 70 % Skin Irrit. 2; H315: 35 % ≤ C < 50 % Eye Dam. 1; H318: 8 % ≤ C < 50 % Eye Irrit. 2; H319: 5 % ≤ C< 8 % STOT SE 3; H335; C ≥ 35 % |
B |
009-001-00-0 |
fluor |
231-954-8 |
7782-41-4 |
Press. Gas Ox. Gas 1 Acute Tox. 2 * Skin Corr. 1A |
H270 H330 H314 |
GHS04 GHS03 GHS06 GHS05 Dgr |
H270 H330 H314 |
|
|
|
009-002-00-6 |
waterstoffluoride |
231-634-8 |
7664-39-3 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Skin Corr. 1A |
H330 H310 H300 H314 |
GHS06 GHS05 Dgr |
H330 H310 H300 H314 |
|
|
|
009-003-00-1 |
waterstoffluorideoplossing … % |
231-634-8 |
7664-39-3 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Skin Corr. 1A |
H330 H310 H300 H314 |
GHS06 GHS05 Dgr |
H330 H310 H300 H314 |
|
Skin Corr. 1A; H314: C ≥ 7 % Skin Corr. 1B; H314: 1 % ≤ C< 7 % Eye Irrit. 2; H319: 0,1 % ≤C < 1 % |
B |
009-004-00-7 |
natriumfluoride |
231-667-8 |
7681-49-4 |
Acute Tox. 3 * Eye Irrit. 2 Skin Irrit. 2 |
H301 H319 H315 |
GHS06 Dgr |
H301 H319 H315 |
EUH032 |
|
|
009-005-00-2 |
kaliumfluoride |
232-151-5 |
7789-23-3 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * |
H331 H311 H301 |
GHS06 Dgr |
H331 H311 H301 |
|
|
|
009-006-00-8 |
ammoniumfluoride |
235-185-9 |
12125-01-8 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * |
H331 H311 H301 |
GHS06 Dgr |
H331 H311 H301 |
|
|
|
009-007-00-3 |
natriumbifluoride; natriumwaterstofdifluoride; |
215-608-3 |
1333-83-1 |
Acute Tox. 3 * Skin Corr. 1B |
H301 H314 |
GHS06 GHS05 Dgr |
H301 H314 |
|
*Skin Corr. 1B; H314: C ≥ 1 % Skin Irrit. 2; H315: 0,1 % ≤ C < % Eye Irrit. 2; H319: 0,1 % ≤ C < 1 % |
|
009-008-00-9 |
natriumbifluoride; kaliumwaterstofdifluoride; |
232-156-2 |
7789-29-9 |
Acute Tox. 3 * Skin Corr. 1B |
H301 H314 |
GHS06 GHS05 Dgr |
H301 H314 |
|
* Skin Corr. 1B; H314: C ≥ 1 % Skin Irrit. 2; H315: 0,1 % ≤ C < 1 % Eye Irrit. 2; H319: 0,1 % ≤ C < 1 % |
|
009-009-00-4 |
ammoniumbifluoride; ammoniumwaterstofdifluoride; |
215-676-4 |
1341-49-7 |
Acute Tox. 3 * Skin Corr. 1B |
H301 H314 |
GHS06 GHS05 Dgr |
H301 H314 |
|
* Skin Corr. 1B; H314: C ≥ 1 % Skin Irrit.2; H315: 0,1 % ≤ C < 1 % Eye Irrit. 2; H319: 0,1 % ≤ C < 1 % |
|
009-010-00-X |
tetrafluorboorzuur … % |
240-898-3 |
16872-11-0 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 % |
B |
009-011-00-5 |
hexafluorkiezelzuur … % |
241-034-8 |
16961-83-4 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
|
B |
009-012-00-0 |
alkalihexafluorosilicaten(Na); [1] alkalihexafluorosilicaten(K); [2] alkalihexafluorosilicaten(NH4) [3] |
240-934-8 [1] 240-896-2 [2] 240-968-3 [3] |
16893-85-9 [1] 16871-90-2 [2] 16919-19-0 [3] |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * |
H331 H311 H301 |
GHS06 Dgr |
H331 H311 H301 |
|
* |
A |
009-013-00-6 |
fluorosilicaten, tenzij elders in deze bijlage vermeld |
— |
— |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
* |
A |
009-014-00-1 |
loodhexafluorosilicaat |
247-278-1 |
25808-74-6 |
Repr. 1A Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H360Df H332 H302 H373 ** H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H360Df H332 H302 H373 ** H410 |
|
|
1 |
009-015-00-7 |
sulfuryldifluoride |
220-281-5 |
2699-79-8 |
Press. Gas Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 |
H331 H373 ** H400 |
GHS04 GHS06 GHS08 GHS09 Dgr |
H331 H373 ** H400 |
|
|
U |
009-016-00-2 |
trinatriumhexafluoraluminaat [1] trinatriumhexafluoraluminaat (kryoliet) [2] |
237-410-6 [1] 239-148-8 [2] |
13775-53-6 [1] 15096-52-3 [2] |
STOT RE 1 Acute Tox. 4 Aquatic Chronic 2 |
H372 H332 H411 |
GHS07 GHS08 GHS09 Dgr |
H372 H332 H411 |
|
|
|
009-017-00-8 |
kalium-μ-fluor-bis(triëthylaluminium) |
400-040-2 |
12091-08-6 |
Flam. Sol. 1 Water-react. 1 Skin Corr. 1A Acute Tox. 4 * |
H228 H270 H314 H332 |
GHS02 GHS05 GHS07 Dgr |
H228 H270 H314 H332 |
EUH014 |
|
T |
009-018-00-3 |
magnesiumhexafluorosilicaat |
241-022-2 |
16949-65-8 |
Acute Tox. 3 * |
H301 |
GHS06 Dgr |
H301 |
|
* |
|
011-001-00-0 |
natrium |
231-132-9 |
7440-23-5 |
Water-react. 1 Skin Corr. 1B |
H260 H314 |
GHS02 GHS05 Dgr |
H260 H314 |
EUH014 |
|
|
011-002-00-6 |
natriumhydroxide; bijtende soda |
215-185-5 |
1310-73-2 |
Skin Corr. 1A |
H314 |
GHS05 Dgr |
H314 |
|
Skin Corr. 1A; H314: C ≥ 5 % Skin Corr. 1B; H314 2 % ≤ C < 5 % Skin Irrit. 2; H315: 0,5 % ≤ C < 2 % Eye Irrit.2; H319: 0,5 % ≤ C < 2 % |
|
011-003-00-1 |
natriumperoxide |
215-209-4 |
1313-60-6 |
Ox. Sol. 1 Skin Corr. 1A |
H271 H314 |
GHS03 GHS05 Dgr |
H271 H314 |
|
|
|
011-004-00-7 |
natriumazide |
247-852-1 |
26628-22-8 |
Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H400 H410 |
GHS06 GHS09 Dgr |
H300 H400 H410 |
EUH032 |
|
|
011-005-00-2 |
natriumcarbonaat |
207-838-8 |
497-19-8 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
011-006-00-8 |
natriumcyanaat |
213-030-6 |
917-61-3 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
011-007-00-3 |
propoxycarbazonnatrium |
— |
181274-15-7 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
M = 10 |
|
012-001-00-3 |
magnesiumpoeder (pyrofoor) |
231-104-6 |
7439-95-4 |
Water-react. 1 Pyr. Sol. 1 |
H260 H250 |
GHS02 Dgr |
H260 H250 |
|
|
T |
012-002-00-9 |
magnesium, poeder of draaisel |
231-104-6 |
— |
Flam. Sol. 1 Water-react. 2 Self-heat. 1 |
H228 H261 H252 |
GHS02 Dgr |
H228 H261 H252 |
|
|
T |
012-003-00-4 |
magnesiumalkylen |
— |
— |
Pyr. Liq. 1 Water-react. 1 Skin Corr. 1B |
H250 H260 H314 |
GHS02 GHS05 Dgr |
H250 H260 H314 |
EUH014 |
|
A |
012-004-00-X |
aluminium-magnesium-carbonaat-hydroxide-perchloraat-hydraat |
422-150-1 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
013-001-00-6 |
aluminiumpoeder (pyrofoor) |
231-072-3 |
7429-90-5 |
Water-react. 2 Pyr. Sol. 1 |
H261 H250 |
GHS02 Dgr |
H261 H250 |
|
|
T |
013-002-00-1 |
aluminiumpoeder (gestabiliseerd) |
231-072-3 |
7429-90-5 |
Water-react. 2 Flam. Sol. 1 |
H261 H228 |
GHS02 Dgr |
H261 H228 |
|
|
T |
013-003-00-7 |
aluminiumchloride, watervrij |
231-208-1 |
7446-70-0 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
|
|
013-004-00-2 |
aluminiumalkylen |
— |
— |
Pyr. Liq. 1 Water-react. 1 Skin Corr. 1B |
H250 H260 H314 |
GHS02 GHS05 Dgr |
H250 H260 H314 |
EUH014 |
|
A |
013-005-00-8 |
diëthyl(ethyldimethylsilanolato)aluminium |
401-160-8 |
55426-95-4 |
Water-react. 1 Pyr. Liq. 1 Skin Corr. 1A |
H260 H250 H314 |
GHS02 GHS05 Dgr |
H260 H250 H314 |
EUH014 |
|
|
013-006-00-3 |
(ethyl-3-oxobutanoato-O'1,O'3)(2-dimethylaminoëthanolato)(1-methoxy-2-propanolato)aluminium(III), gedimeriseerd |
402-370-2 |
— |
Flam. Liq. 3 Eye Dam. 1 |
H226 H318 |
GHS02 GHS05 Dgr |
H226 H318 |
|
|
|
013-007-00-9 |
poly(oxo(2-butoxyethyl-3-oxobutanoato-O'1,O'3)aluminium) |
403-430-0 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
013-008-00-4 |
di-n-octylaluminiumjodide |
408-190-0 |
7585-14-0 |
Pyr. Liq. 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H250 H314 H400 H410 |
GHS02 GHS05 GHS09 Dgr |
H250 H314 H410 |
EUH014 |
|
|
013-009-00-X |
natrium((n-butyl)x(ethyl)y-1,5-dihydro)aluminaat) x = 0,5 y = 1,5 |
418-720-2 |
— |
Flam. Sol. 1 Water-react. 1 Pyr. Sol. 1 Acute Tox. 4 * Skin Corr. 1A |
H228 H260 H250 H332 H314 |
GHS02 GHS05 GHS07 Dgr |
H228 H260 H250 H332 H314 |
EUH014 |
|
T |
013-010-00-5 |
hydroxyaluminiumbis(2,4,8,10-tetra-tert-butyl-6-hydroxy-12H-dibenzo[d,g][1.3.2]dioxafosfocine-6-oxide) |
430-650-4 |
151841-65-5 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
014-001-00-9 |
trichloorsilaan |
233-042-5 |
10025-78-2 |
Flam. Liq. 1 Pyr. Liq. 1 Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A |
H224 H250 H332 H302 H314 |
GHS02 GHS05 GHS07 Dgr |
H224 H250 H332 H302 H314 |
EUH014 EUH029 |
* STOT SE 3; H335: C ≥ 1 % |
T |
014-002-00-4 |
siliciumtetrachloride |
233-054-0 |
10026-04-7 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H319 H335 H315 |
GHS07 Wng |
H319 H335 H315 |
EUH014 |
|
|
014-003-00-X |
dimethyldichloorsilaan |
200-901-0 |
75-78-5 |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H225 H319 H335 H315 |
GHS02 GHS07 Dgr |
H225 H319 H335 H315 |
|
|
|
014-004-00-5 |
methyltrichloorsilaan; methyltrichloorsilaan |
200-902-6 |
75-79-6 |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H225 H319 H335 H315 |
GHS02 GHS07 Dgr |
H225 H319 H335 H315 |
EUH014 |
Skin Irrit.2; H315: C ≥ 1 % Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % |
|
014-005-00-0 |
tetraëthylsilicaat; ethylsilicaat |
201-083-8 |
78-10-4 |
Flam. Liq. 3 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 |
H226 H332 H319 H335 |
GHS02 GHS07 Wng |
H226 H332 H319 H335 |
|
|
|
014-006-00-6 |
bis(4-fluorfenyl)-methyl-(1,2,4-triazool-4-ylmethyl)silaanhydrochloride |
401-380-4 |
— |
Eye Irrit. 2 Aquatic Chronic 2 |
H319 H411 |
GHS07 GHS09 Wng |
H319 H411 |
|
|
|
014-007-00-1 |
triëthoxyisobutylsilaan |
402-810-3 |
17980-47-1 |
Skin Irrit. 2 |
H315 |
GHS07 Wng |
H315 |
|
|
|
014-008-00-7 |
(chloormethyl)bis(4-fluorfenyl)methylsilaan |
401-200-4 |
85491-26-5 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
014-009-00-2 |
isobutylisopropyldimethoxysilaan |
402-580-4 |
111439-76-0 |
Flam. Liq. 3 Acute Tox. 4 * Skin Irrit. 2 |
H226 H332 H315 |
GHS02 GHS07 Wng |
H226 H332 H315 |
|
|
|
014-010-00-8 |
dinatriummetasilicaat |
229-912-9 |
6834-92-0 |
Skin Corr. 1B STOT SE 3 |
H314 H335 |
GHS05 GHS07 Dgr |
H314 H335 |
|
|
|
014-011-00-3 |
cyclohexyldimethoxymethylsilaan |
402-140-1 |
17865-32-6 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
014-012-00-9 |
bis(3-(trimethoxysilyl)propyl)amine |
403-480-3 |
— |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
014-013-00-4 |
α-hydroxypoly(methyl-(3-(2,2,6,6-tetramethylpiperidine-4-yloxy)propyl)siloxaan) |
404-920-7 |
— |
Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 2 |
H312 H302 H314 H411 |
GHS05 GHS07 GHS09 Dgr |
H312 H302 H314 H411 |
|
|
|
014-014-00-X |
etacelasil (ISO); 6-(2-chloorethyl)-6-(2-methoxyethoxy)-2,5,7,10-tetraoxa-6-silaundecaan; |
253-704-7 |
37894-46-5 |
Repr. 1B Acute Tox. 4 * STOT RE 2 * |
H360D *** H302 H373 ** |
GHS08 GHS07 Dgr |
H360D *** H302 H373 ** |
|
|
|
014-015-00-5 |
α-trimethylsilanyl-ω-trimethylsiloxypoly[oxy(methyl-3-(2-(2-methoxypropoxy)propoxy)propylsilaandiyl]-co-oxy(dimethylsilaan)) |
406-420-4 |
69430-40-6 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
014-016-00-0 |
reactiemassa van: 1,3-dihex-5-een-1-yl-1,1,3,3-tetramethyldisiloxaan; 1,3-dihex-n-een-1-yl-1,1,3,3-tetramethyldisiloxaan |
406-490-6 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
014-017-00-6 |
flusilazool (ISO); bis(4-fluorfenyl)(methyl)(1H-1,2,4-triazool-1-ylmethyl)silaan |
— |
85509-19-9 |
Carc. 2 Repr. 1B Acute Tox. 4 * Aquatic Chronic 2 |
H351 H360D *** H302 H411 |
GHS08 GHS07 GHS09 Dgr |
H351 H360D *** H302 H411 |
|
|
|
014-018-00-1 |
octamethylcyclotetrasiloxaan |
209-136-7 |
556-67-2 |
Repr. 2 Aquatic Chronic 4 |
H361f *** H413 |
GHS08 Wng |
H361f *** H413 |
|
|
|
014-019-00-7 |
reactiemassa van: 4-[[bis-(4-fluorfenyl)methylsilyl]methyl]-4H-1,2,4-triazool; 1-[[bis-(4-fluorfenyl)methylsilyl]methyl]-1H-1,2,4-triazool |
403-250-2 |
— |
Carc. 2 Repr. 1B Acute Tox. 4 * Aquatic Chronic 2 |
H351 H360D *** H302 H411 |
GHS08 GHS07 GHS09 Dgr |
H351 H360D *** H302 H411 |
|
|
|
014-020-00-2 |
bis(1,1-dimethyl-2-propynyloxy)dimethylsilaan |
414-960-7 |
53863-99-3 |
Acute Tox. 4 * |
H332 |
GHS07 Wng |
H332 |
|
|
|
014-021-00-8 |
tris(isopropenyloxy)fenylsilaan |
411-340-8 |
52301-18-5 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H400 H410 |
|
|
|
014-022-00-3 |
reactieproduct van: (2-hydroxy-4-(3-propeenoxy)benzofenon en triëthoxysilaan) met (hydrolyseproduct van silica en methyltrimethoxysilaan) |
401-530-9 |
— |
Flam. Sol. 1 STOT SE 1 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H228 H370 ** H332 H312 H302 |
GHS02 GHS08 GHS07 Dgr |
H228 H370 ** H332 H312 H302 |
|
|
T |
014-023-00-9 |
α, ω-dihydroxypoly(hex-5-een-1-ylmethylsiloxaan) |
408-160-7 |
125613-45-8 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
014-024-00-4 |
1-((3-(3-chloor-4-fluorofenyl)propyl)dimethylsilanyl)-4-ethoxybenzeen |
412-620-2 |
121626-74-2 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
014-025-00-X |
4-[3-(diëthoxymethylsilylpropoxy)-2,2,6,6-tetramethyl]-piperidine |
411-400-3 |
102089-33-8 |
Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H302 H373 ** H315 H318 H412 |
GHS08 GHS05 GHS07 Dgr |
H302 H373 ** H315 H318 H412 |
|
|
|
014-026-00-5 |
dichloor-(3-(3-chloor-4-fluorfenyl)propyl)methylsilaan |
407-180-3 |
770722-36-6 |
Skin Corr. 1A |
H314 |
GHS05 Dgr |
H314 |
|
|
|
014-027-00-0 |
chloor(3-(3-chloor-4-fluorfenyl)propyl)dimethylsilaan |
410-270-5 |
770722-46-8 |
Skin Corr. 1A |
H314 |
GHS05 Dgr |
H314 |
|
|
|
014-028-00-6 |
α-[3-(1-oxoprop-2-enyl)-1-oxypropyl]dimethoxysilyloxy-ω-[3-(1-oxoprop-2-enyl)-1-oxypropyl]dimethoxysilylpoly(dimethylsiloxaan) |
415-290-8 |
193159-06-7 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
014-029-00-1 |
O,O'-(ethenylmethylsilyleen)di[(4-methylpentaan-2-on)oxim] |
421-870-1 |
156145-66-3 |
Repr. 2 Acute Tox. 4 * STOT RE 2 * |
H361f *** H302 H373 ** |
GHS08 GHS07 Wng |
H361f *** H302 H373 ** |
|
|
|
014-030-00-7 |
[(dimethylsilyleen)bis((1,2,3,3a,7a-η)-1H-indeen-1-ylideen)dimethyl]hafnium |
422-060-0 |
137390-08-0 |
Acute Tox. 2 * |
H300 |
GHS06 Dgr |
H300 |
|
|
|
014-031-00-2 |
bis(1-methylethyl)-dimethoxysilaan |
421-540-7 |
18230-61-0 |
Flam. Liq. 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H226 H315 H317 H412 |
GHS02 GHS07 Wng |
H226 H315 H317 H412 |
|
|
|
014-032-00-8 |
dicyclopentyldimethoxysilaan |
404-370-8 |
126990-35-0 |
Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H400 H410 |
GHS05 GHS09 Dgr |
H315 H318 H410 |
|
|
|
014-033-00-3 |
reactieproducten van 2-methyl-3-(trimethoxysilyl)propyl-2-propenoaat, gehydrolyseerd, en silica |
419-030-4 |
125804-20-8 |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 |
H225 H319 H336 |
GHS02 GHS07 Dgr |
H225 H319 H336 |
|
|
|
014-034-00-9 |
3-hexylheptamethyltrisiloxaan |
428-700-5 |
1873-90-1 |
Acute Tox. 4 * Aquatic Chronic 4 |
H332 H413 |
GHS07 Wng |
H332 H413 |
|
|
|
014-035-00-4 |
2-(3,4-epoxycyclohexyl)ethyltriëthoxysilaan |
425-050-4 |
10217-34-2 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
014-036-00-X |
(4-ethoxyfenyl)(3-(3-fenoxy-4-fluorfenyl)propyl)dimethylsilaan |
405-020-7 |
105024-66-6 |
Repr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H360F*** H400 H410 |
GHS08 GHS09 Dgr |
H360F*** H410 |
|
M=1000 |
|
014-037-00-5 |
butaan-2-on-O,O',O''-(fenylsilylidyn)trioxim |
433-360-6 |
34036-80-1 |
STOT RE 2 * Skin Sens. 1 Aquatic Chronic 3 |
H373** H317 H412 |
GHS08 GHS07 Wng |
H373** H317 H412 |
|
|
|
014-038-00-0 |
S-(3-(triëthoxysilyl)propyl)octaanthioaat |
436-690-9 |
220727-26-4 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
014-039-00-6 |
(2,3-dimethylbut-2-yl)trimethoxysilaan |
439-360-2 |
142877-45-0 |
Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H315 H318 H412 |
GHS05 Dgr |
H315 H318 H412 |
|
|
|
014-041-00-7 |
N, N-bis(trimethylsilyl)aminopropylmethyldiëthoxysilaan |
445-890-5 |
201290-01-9 |
Acute Tox. 4 * Skin Sens. 1 |
H302 H317 |
GHS07 Wng |
H302 H317 |
|
|
|
014-042-00-2 |
reactiemassa van: O,O',O'',O'''-silaantetrayltetrakis(4-methyl-2-pentanonoxim) (3 stereoisomeren) |
423-010-0 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
014-043-00-8 |
reactieproduct van amorfe silica (50-85 %), butyl(1-methylpropyl)magnesium (3-15 %), tetraëthylorthosilicaat (5-15 %) en titaantetrachloride (5-20 %) |
432-200-2 |
— |
STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H335 H315 H318 H412 |
GHS05 GHS07 Dgr |
H335 H315 H318 H412 |
|
|
|
014-044-00-3 |
3-[(4'-acetoxy-3'-methoxyfenyl)propyl]trimethoxysilaan |
433-050-0 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
014-045-00-9 |
magnesiumnatriumfluoridesilicaat |
442-650-1 |
— |
STOT RE 2 * |
H373** |
GHS08 Wng |
H373** |
|
|
|
015-001-00-1 |
gele of witte fosfor |
231-768-7 |
12185-10-3 |
Pyr. Sol. 1 Acute Tox. 2 * Acute Tox. 2 * Skin Corr. 1A Aquatic Acute 1 |
H250 H330 H300 H314 H400 |
GHS02 GHS06 GHS05 GHS09 Dgr |
H250 H330 H300 H314 H400 |
|
|
|
015-002-00-7 |
rode fosfor |
231-768-7 |
7723-14-0 |
Flam. Sol. 1 Aquatic Chronic 3 |
H228 H412 |
GHS02 Dgr |
H228 H412 |
|
|
|
015-004-00-8 |
aluminiumfosfide |
244-088-0 |
20859-73-8 |
Water-react. 1 Acute Tox. 2 Acute Tox. 3 Acute Tox. 1 Aquatic Acute 1 |
H260 H300 H311 H330 H400 |
GHS02 GHS06 GHS09 Dgr |
H260 H300 H311 H330 H400 |
EUH029 EUH032 |
M = 100 |
|
015-005-00-3 |
magnesiumfosfide; trimagnesiumdifosfide |
235-023-7 |
12057-74-8 |
Water-react. 1 Acute Tox. 2 Acute Tox. 3 Acute Tox. 1 Aquatic Acute 1 |
H260 H300 H311 H330 H400 |
GHS02 GHS06 GHS09 Dgr |
H260 H300 H311 H330 H400 |
EUH029 EUH032 |
M = 100 |
|
015-006-00-9 |
trizinkdifosfide; zinkfosfide |
215-244-5 |
1314-84-7 |
Water-react. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H260 H300 H400 H410 |
GHS02 GHS06 GHS09 Dgr |
H260 H300 H410 |
EUH029 EUH032 |
M=100 |
T |
015-007-00-4 |
fosfortrichloride |
231-749-3 |
7719-12-2 |
Acute Tox. 2 * Acute Tox. 2 * STOT RE 2 * Skin Corr. 1A |
H330 H300 H373 ** H314 |
GHS06 GHS08 GHS05 Dgr |
H330 H300 H373 ** H314 |
EUH014 EUH029 |
|
|
015-008-00-X |
fosforpentachloride |
233-060-3 |
10026-13-8 |
Acute Tox. 2 * Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B |
H330 H302 H373 ** H314 |
GHS06 GHS08 GHS05 Dgr |
H330 H302 H373 ** H314 |
EUH014 EUH029 |
|
|
015-009-00-5 |
fosforyltrichloride |
233-046-7 |
10025-87-3 |
Acute Tox. 2 * STOT RE 1 Acute Tox. 4 * Skin Corr. 1A |
H330 H372 ** H302 H314 |
GHS06 GHS08 GHS05 Dgr |
H330 H372 ** H302 H314 |
EUH014 EUH029 |
|
|
015-010-00-0 |
fosforpentoxide |
215-236-1 |
1314-56-3 |
Skin Corr. 1A |
H314 |
GHS05 Dgr |
H314 |
|
|
|
015-011-00-6 |
fosforzuur . %, orthofosforzuur . % |
231-633-2 |
7664-38-2 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 % |
B |
015-012-00-1 |
tetrafosfortrisulfide; fosforsesquisulfide |
215-245-0 |
1314-85-8 |
Flam. Sol. 2 Water-react. 1 Acute Tox. 4 * Aquatic Acute 1 |
H228 H260 H302 H400 |
GHS02 GHS07 GHS09 Dgr |
H228 H260 H302 H400 |
|
|
T |
015-013-00-7 |
triëthylfosfaat |
201-114-5 |
78-40-0 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
015-014-00-2 |
tributylfosfaat |
204-800-2 |
126-73-8 |
Carc. 2 Acute Tox. 4 * Skin Irrit. 2 |
H351 H302 H315 |
GHS08 GHS07 Wng |
H351 H302 H315 |
|
|
|
015-015-00-8 |
tricresylfosfaat (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-); tritolylfosfaat (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-); |
201-103-5 |
78-30-8 |
STOT SE 1 Aquatic Chronic 2 |
H370 ** H411 |
GHS08 GHS09 Dgr |
H370 ** H411 |
|
STOT SE 1; H370: C ≥ 1 % STOT SE 2; H371: 0,2 % ≤ C < 1 % |
C |
015-016-00-3 |
tricresylfosfaat (m-m-m-, m-m-p-, m-p-p-, p-p-p-); tritolylfosfaat (m-m-m-, m-m-p-, m-p-p-, p-p-p-); |
201-105-6 |
78-32-0 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 2 |
H312 H302 H411 |
GHS07 GHS09 Wng |
H312 H302 H411 |
|
* |
C |
015-019-00-X |
dichloorvos (ISO); 2,2-dichloorvinyldimethylfosfaat |
200-547-7 |
62-73-7 |
Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * Skin Sens. 1 Aquatic Acute 1 |
H330 H311 H301 H317 H400 |
GHS06 GHS09 Dgr |
H330 H311 H301 H317 H400 |
|
M=1000 |
|
015-020-00-5 |
mevinfos (ISO); 2-methoxycarbonyl-1-methylvinyldimethylfosfaat |
232-095-1 |
7786-34-7 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H310 H300 H410 |
|
M = 10000 |
|
015-021-00-0 |
trichloorfon (ISO); dimethyl-2,2,2-trichloor-1-hydroxyethylfosfonaat |
200-149-3 |
52-68-6 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H400 H410 |
|
M = 1000 |
|
015-022-00-6 |
fosfamidon (ISO); 2-chloor-2-diëthylcarbamoyl-1-methylvinyldimethylfosfaat |
236-116-5 |
13171-21-6 |
Muta. 2 Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H341 H300 H311 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H341 H300 H311 H410 |
|
|
|
015-023-00-1 |
pyrazoxon; diëthyl-3-methylpyrazool-5-ylfosfaat |
— |
108-34-9 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * |
H330 H310 H300 |
GHS06 Dgr |
H330 H310 H300 |
|
|
|
015-024-00-7 |
triamifos (ISO); 5-amino-3-fenyl-1,2,4-triazool-1-yl-N,N,N',N'-tetramethylfosfondiamide |
— |
1031-47-6 |
Acute Tox. 1 Acute Tox. 2 * |
H310 H300 |
GHS06 Dgr |
H310 H300 |
|
|
|
015-025-00-2 |
TEPP (ISO); tetraëthylpyrofosfaat |
203-495-3 |
107-49-3 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 |
H310 H300 H400 |
GHS06 GHS09 Dgr |
H310 H300 H400 |
|
|
|
015-026-00-8 |
schradan (ISO); octamethylpyrofosforamide |
205-801-0 |
152-16-9 |
Acute Tox. 1 Acute Tox. 2 * |
H310 H300 |
GHS06 Dgr |
H310 H300 |
|
|
|
015-027-00-3 |
sulfotep (ISO); O,O,O,O-tetraëthyldithiopyrofosfaat |
222-995-2 |
3689-24-5 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H310 H300 H410 |
|
M = 1000 |
|
015-028-00-9 |
demeton-O (ISO); O,O-diëthyl-O-2-ethylthioëthylthiofosfaat |
206-053-8 |
298-03-3 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 |
H310 H300 H400 |
GHS06 GHS09 Dgr |
H310 H300 H400 |
|
|
|
015-029-00-4 |
demeton-S (ISO); diëthyl-S-2-ethylthioëthylthiofosfaat |
204-801-8 |
126-75-0 |
Acute Tox. 1 Acute Tox. 2 * |
H310 H300 |
GHS06 Dgr |
H310 H300 |
|
|
|
015-030-00-X |
demeton-O-methyl (ISO); O-2-ethylthioëthyl-O,O-dimethylthiofosfaat |
212-758-1 |
867-27-6 |
Acute Tox. 3 * |
H301 |
GHS06 Dgr |
H301 |
|
|
|
015-031-00-5 |
demeton-S-methyl (ISO); S-2-ethylthioëthyldimethylthiofosfaat |
213-052-6 |
919-86-8 |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Chronic 2 |
H311 H301 H411 |
GHS06 GHS09 Dgr |
H311 H301 H411 |
|
|
|
015-032-00-0 |
prothoaat (ISO); O,O-diëthylisopropylcarbamoylmethyldithiofosfaat |
218-893-2 |
2275-18-5 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Chronic 3 |
H310 H300 H412 |
GHS06 Dgr |
H310 H300 H412 |
|
|
|
015-033-00-6 |
foraat (ISO); O,O-diëthylethylthiomethyldithiofosfaat |
206-052-2 |
298-02-2 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H310 H300 H410 |
|
M = 1000 |
|
015-034-00-1 |
parathion (ISO); O,O-diëthyl-O-4-nitrofenylthiofosfaat |
200-271-7 |
56-38-2 |
Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H300 H311 H372 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H330 H300 H311 H372 ** H410 |
|
M = 100 |
|
015-035-00-7 |
parathion — methyl (ISO); O,O-dimethyl-O-4-nitrofenylthiofosfaat |
206-050-1 |
298-00-0 |
Flam. Liq. 3 Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H226 H330 H300 H311 H373 ** H400 H410 |
GHS02 GHS06 GHS08 GHS09 Dgr |
H226 H330 H300 H311 H373 ** H410 |
|
M = 100 |
|
015-036-00-2 |
O-ethyl-O-4-nitrofenylfenylthiofosfonaat; EPN |
218-276-8 |
2104-64-5 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H310 H300 H410 |
|
|
|
015-037-00-8 |
fenkapton (ISO); S-(2,5-dichloorfenylthiomethyl)-O, O-diëthyldithiofosfaat |
218-892-7 |
2275-14-1 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H331 H311 H301 H410 |
|
|
|
015-038-00-3 |
cumafos (ISO); O-3-chloor-4-methylcumarine-7-yl-O,O-diëthylthiofosfaat |
200-285-3 |
56-72-4 |
Acute Tox. 2 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H312 H400 H410 |
GHS06 GHS09 Dgr |
H300 H312 H410 |
|
|
|
015-039-00-9 |
azinfos-methyl (ISO); O,O-dimethyl-4-oxobenzotriazine-3-ylmethyldithiofosfaat |
201-676-1 |
86-50-0 |
Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 3 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H300 H311 H317 H400 H410 |
GHS06 GHS09 Dgr |
H330 H300 H311 H317 H410 |
|
|
|
015-040-00-4 |
diazinon (ISO); O,O-diëthyl-O-2-isopropyl-6-methylpyrimidine-4-ylthiofosfaat |
206-373-8 |
333-41-5 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H400 H410 |
|
|
|
015-041-00-X |
malathion (ISO); 1,2-bis(ethoxycarbonyl)ethyl-O,O-dimethyldithiofosfaat; [met ≤ 0,03 % isomalathion] |
204-497-7 |
121-75-5 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
M=1000 |
|
015-042-00-5 |
chloorthion; O-(3-chloor-4-nitrofenyl)-O,O-dimethylthiofosfaat |
207-902-5 |
500-28-7 |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H312 H302 H410 |
|
M = 100 |
|
015-043-00-0 |
fosnichloor (ISO); O-(4-chloor-3-nitrofenyl)-O,O-dimethylthiofosfaat |
— |
5826-76-6 |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H332 H312 H302 |
GHS07 Wng |
H332 H312 H302 |
|
|
|
015-044-00-6 |
carbofenothion (ISO); 4-chloorfenylthiomethyl-O,O-diëthyldithiofosfaat |
212-324-1 |
786-19-6 |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H311 H301 H410 |
|
|
|
015-045-00-1 |
mecarbam (ISO); N-ethoxycarbonyl-N-methylcarbamoylmethyl-O,O-diëthyldithiofosfaat |
219-993-9 |
2595-54-2 |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H311 H301 H400 H410 |
|
|
|
015-046-00-7 |
oxydemeton-methyl; S-2-(ethylsulfinyl)ethyl-O,O-dimethylthiofosfaat |
206-110-7 |
301-12-2 |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 |
H311 H301 H400 |
GHS06 GHS09 Dgr |
H311 H301 H400 |
|
|
|
015-047-00-2 |
ethion (ISO); O,O,O',O'-tetraëthyl-S,S'-methyleendi(dithiofosfaat); diëthion |
209-242-3 |
563-12-2 |
Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H312 H400 H410 |
GHS06 GHS09 Dgr |
H301 H312 H410 |
|
M = 10000 |
|
015-048-00-8 |
fenthion (ISO); O,O-dimethyl-O-(4-methylthio-m-tolyl)thiofosfaat |
200-231-9 |
55-38-9 |
Muta. 2 Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H341 H331 H312 H302 H372** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H341 H331 H312 H302 H372** H410 |
|
M=100 |
|
015-049-00-3 |
endothion (ISO); S-5-methoxy-4-oxopyran-2-ylmethyldimethylthiofosfaat |
220-472-3 |
2778-04-3 |
Acute Tox. 3 * Acute Tox. 3 * |
H311 H301 |
GHS06 Dgr |
H311 H301 |
|
|
|
015-050-00-9 |
thiometon (ISO); S-2-ethylthioëthyl-O,O-dimethyldithiofosfaat |
211-362-6 |
640-15-3 |
Acute Tox. 3 * Acute Tox. 4 * |
H301 H312 |
GHS06 Dgr |
H301 H312 |
|
|
|
015-051-00-4 |
dimethoaat (ISO); O,O-dimethylmethylcarbamoylmethyldithiofosfaat |
200-480-3 |
60-51-5 |
Acute Tox. 4 * Acute Tox. 4 * |
H312 H302 |
GHS07 Wng |
H312 H302 |
|
|
|
015-052-00-X |
fenchloorfos (ISO); O, O-dimethyl-O-2,4,5-trichloorfenylthiofosfaat |
206-082-6 |
299-84-3 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H312 H302 H410 |
|
|
|
015-053-00-5 |
menazon (ISO); S-[(4,6-diamino-1,3,5-triazine-2-yl)methyl]-O, O-dimethyldithiofosfaat |
201-123-4 |
78-57-9 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
015-054-00-0 |
fenitrothion (ISO); O,O-dimethyl-O-4-nitro-m-tolylthiofosfaat |
204-524-2 |
122-14-5 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
015-055-00-6 |
naled (ISO); 1,2-dibroom-2,2-dichloorethyldimethylfosfaat |
206-098-3 |
300-76-5 |
Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 |
H312 H302 H319 H315 H400 |
GHS07 GHS09 Wng |
H312 H302 H319 H315 H400 |
|
M = 1000 |
|
015-056-00-1 |
azinfos-ethyl (ISO); O,O-diëthyl-4-oxobenzotriazine-3-ylmethyldithiofosfaat |
220-147-6 |
2642-71-9 |
Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H311 H400 H410 |
GHS06 GHS09 Dgr |
H300 H311 H410 |
|
M=100 |
|
015-057-00-7 |
formothion (ISO); N-formyl-N-methylcarbamoylmethyl-O,O-dimethyldithiofosfaat |
219-818-6 |
2540-82-1 |
Acute Tox. 4 * Acute Tox. 4 * |
H312 H302 |
GHS07 Wng |
H312 H302 |
|
|
|
015-058-00-2 |
morfothion (ISO); O,O-dimethyl-S-[(morfolino-carbonyl)-methyl]-dithiofosfaat |
205-628-0 |
144-41-2 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H331 H311 H301 H410 |
|
|
|
015-059-00-8 |
vamidothion (ISO); O,O-dimethyl-S-2-(1-methylcarbamoylethylthio)-ethylthiofosfaat |
218-894-8 |
2275-23-2 |
Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 |
H301 H312 H400 |
GHS06 GHS09 Dgr |
H301 H312 H400 |
|
|
|
015-060-00-3 |
disulfoton (ISO); O,O-diëthyl-2-ethylthioëthyldithiofosfaat |
206-054-3 |
298-04-4 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H310 H300 H410 |
|
|
|
015-061-00-9 |
dimefox (ISO); tetramethylfosforodiamidefluoride |
204-076-8 |
115-26-4 |
Acute Tox. 1 Acute Tox. 2 * |
H310 H300 |
GHS06 Dgr |
H310 H300 |
|
|
|
015-062-00-4 |
mipafox (ISO); N,N'-diisopropyldiamidofosforzuur-fluoride |
206-742-3 |
371-86-8 |
STOT SE 1 |
H370 ** |
GHS08 Dgr |
H370 ** |
|
|
|
015-063-00-X |
dioxathion (ISO); 1,4-dioxaan-2,3-diyl-O,O,O',O'-tetraëthyldi(dithiofosfaat) |
201-107-7 |
78-34-2 |
Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H300 H311 H400 H410 |
GHS06 GHS09 Dgr |
H330 H300 H311 H410 |
|
M = 1000 |
|
015-064-00-5 |
bromofos-ethyl (ISO); O-4-broom-2,5-dichloorfenyl-O,O-diëthylthiofosfaat |
225-399-0 |
4824-78-6 |
Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H312 H400 H410 |
GHS06 GHS09 Dgr |
H301 H312 H410 |
|
|
|
015-065-00-0 |
S-[2-(ethylsulfinyl)ethyl]-O,O-dimethyldithiofosfaat |
— |
2703-37-9 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Chronic 2 |
H330 H310 H300 H411 |
GHS06 GHS09 Dgr |
H330 H310 H300 H411 |
|
|
|
015-066-00-6 |
omethoaat (ISO); O,O-dimethyl-S-methylcarbamoylmethylthiofosfaat |
214-197-8 |
1113-02-6 |
Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 |
H301 H312 H400 |
GHS06 GHS09 Dgr |
H301 H312 H400 |
|
|
|
015-067-00-1 |
fosalone (ISO); O,O-diëthyl-S-[(6-chloor-2-oxobenzoxazoline-3-yl)methyl)]-dithiofosfaat |
218-996-2 |
2310-17-0 |
Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H332 H312 H317 H400 H410 |
GHS06 GHS09 Dgr |
H301 H332 H312 H317 H410 |
|
M=1000 |
|
015-068-00-7 |
dichlofenthion (ISO); O-2,4-dichloorfenyl-O,O-diëthylthiofosfaat |
202-564-5 |
97-17-6 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H400 H410 |
|
|
|
015-069-00-2 |
methidathion (ISO); 2,3-dihydro-5-methoxy-2-oxo-1,3,4-thiadiazool-3-ylmethyl-O,O-dimethyldithiofosfaat |
213-449-4 |
950-37-8 |
Acute Tox. 2 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H312 H400 H410 |
GHS06 GHS09 Dgr |
H300 H312 H410 |
|
|
|
015-070-00-8 |
cyaanthoaat (ISO); S-(N-(1-cyaan-1-methylethyl)carbamoylmethyl)-O,O-diëthylthiofosfaat |
223-099-4 |
3734-95-0 |
Acute Tox. 2 * Acute Tox. 3 * |
H300 H311 |
GHS06 Dgr |
H300 H311 |
|
|
|
015-071-00-3 |
chloorfenvinfos (ISO); 2-chloor-1-(2,4-dichloorfenyl)vinyldiëthylfosfaat |
207-432-0 |
470-90-6 |
Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H311 H400 H410 |
GHS06 GHS09 Dgr |
H300 H311 H410 |
|
|
|
015-072-00-9 |
monocrotofos (ISO); dimethyl-1-methyl-2-(methylcarbamoyl)vinylfosfaat |
230-042-7 |
6923-22-4 |
Muta. 2 Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H341 H330 H300 H311 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H341 H330 H300 H311 H410 |
|
|
|
015-073-00-4 |
dicrotofos (ISO); (Z)-2-dimethylcarbamoyl-1-methylvinyldimethylfosfaat |
205-494-3 |
141-66-2 |
Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H311 H400 H410 |
GHS06 GHS09 Dgr |
H300 H311 H410 |
|
|
|
015-074-00-X |
crufomaat (ISO); 4-tert-butyl-2-chloorfenylmethylmethylfosforamidaat |
206-083-1 |
299-86-5 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H312 H302 H410 |
|
|
|
015-075-00-5 |
S-2-ethyl-sulfinylisopropyl-O,O-dimethylthiofosfaat |
— |
2635-50-9 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * |
H331 H311 H301 |
GHS06 Dgr |
H331 H311 H301 |
|
|
|
015-076-00-0 |
potasan; O,O-diëthyl-O-(4-methylcumarine-7-yl)-thiofosfaat |
— |
299-45-6 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H330 H310 H300 H410 |
|
M = 1000 |
|
015-077-00-6 |
O-(2,2-dichloorvinyl)-O-methyl-O-(2-ethylsulfinyl-ethyl)-fosfaat |
— |
7076-53-1 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * |
H331 H311 H301 |
GHS06 Dgr |
H331 H311 H301 |
|
|
|
015-078-00-1 |
demeton-S-methylsulfon (ISO); S-2-ethylsulfonylethyldimethylthiofosfaat |
241-109-5 |
17040-19-6 |
Acute Tox. 3 * Acute Tox. 4 * Aquatic Chronic 2 |
H301 H312 H411 |
GHS06 GHS09 Dgr |
H301 H312 H411 |
|
|
|
015-079-00-7 |
acefaat (ISO); O,S-dimethylacetylthiofosforamidaat |
250-241-2 |
30560-19-1 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
015-080-00-2 |
amidithion (ISO); 2-methoxyethylcarbamoylethyl-O,O-dimethyldithiofosfaat |
— |
919-76-6 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
015-081-00-8 |
O,O,O',O'-tetrapropyl-dithiopyrofosfaat |
221-817-0 |
3244-90-4 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H312 H302 H410 |
|
|
|
015-082-00-3 |
azothoaat (ISO); O-4(4-chloor-fenylazo)fenyl-O,O-dimethylthiofosfaat |
227-419-3 |
5834-96-8 |
Acute Tox. 4 * Acute Tox. 4 * |
H332 H302 |
GHS07 Wng |
H332 H302 |
|
|
|
015-083-00-9 |
bensulide (ISO); 2-fenylsulfonylaminoëthyl-O,O-diisopropyldithiofosfaat |
212-010-4 |
741-58-2 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
015-084-00-4 |
chloorpyrifos (ISO); O,O-diëthyl-O-3,5,6-trichloor-2-pyridylthiofosfaat |
220-864-4 |
2921-88-2 |
Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H400 H410 |
GHS06 GHS09 Dgr |
H301 H400 H410 |
|
M = 10000 |
|
015-085-00-X |
chloorfonium-chloride (ISO); tributyl (2,4-dichloorbenzyl)-fosfoniumchloride |
204-105-4 |
115-78-6 |
Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 |
H301 H312 H319 H315 |
GHS06 Dgr |
H301 H312 H319 H315 |
|
|
|
015-086-00-5 |
cumithoaat (ISO); O,O-diëthyl-O-7,8,9,10-tetrahydro-6-oxo-benzo[c]chromeen-3-ylthiofosfaat |
— |
572-48-5 |
Acute Tox. 3 * |
H301 |
GHS06 Dgr |
H301 |
|
|
|
015-087-00-0 |
cyanofos (ISO); O-4-cyaanfenyl-O,O-dimethylthiofosfaat |
220-130-3 |
2636-26-2 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H312 H302 H410 |
|
|
|
015-088-00-6 |
dialifos (ISO); 2-chloor-1-ftaalimidoëthyl-O,O-diëthyldithiofosfaat |
233-689-3 |
10311-84-9 |
Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H311 H400 H410 |
GHS06 GHS09 Dgr |
H300 H311 H400 H410 |
|
|
|
015-089-00-1 |
ethoaat-methyl (ISO); ethylcarbamoylmethyl-O,O-dimethyldithiofosfaat |
204-121-1 |
116-01-8 |
Acute Tox. 4 * Acute Tox. 4 * |
H312 H302 |
GHS07 Wng |
H312 H302 |
|
|
|
015-090-00-7 |
fensulfothion (ISO); O,O-diëthyl-O-4-methylsulfinylfenylthiofosfaat |
204-114-3 |
115-90-2 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H310 H300 H410 |
|
|
|
015-091-00-2 |
fonofos (ISO); O-ethylfenylethyldithiofosfonaat |
213-408-0 |
944-22-9 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H310 H300 H410 |
|
|
|
015-092-00-8 |
fosacetim (ISO); O,O-bis(4-chloorfenyl)-N-acetimidoylthiofosforamidaat |
223-874-7 |
4104-14-7 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H310 H300 H410 |
|
|
|
015-093-00-3 |
leptofos (ISO); O-4-broom-2,5-dichloorfenyl-O-methylfenylthiofosfonaat |
244-472-8 |
21609-90-5 |
Acute Tox. 3 * STOT SE 1 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H370 ** H312 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H301 H370 ** H312 H410 |
|
|
|
015-094-00-9 |
mefosfolan (ISO); diëthyl-4-methyl-1,3-dithiolaan-2-ylideenfosforamidaat |
213-447-3 |
950-10-7 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Chronic 2 |
H310 H300 H411 |
GHS06 GHS09 Dgr |
H310 H300 H411 |
|
|
|
015-095-00-4 |
methamidofos (ISO); O,S-dimethylthiofosforamidaat |
233-606-0 |
10265-92-6 |
Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 |
H330 H300 H311 H400 |
GHS06 GHS09 Dgr |
H330 H300 H311 H400 |
|
|
|
015-096-00-X |
oxydisulfoton (ISO); O,O-diëthyl-S-[2-(ethylsulfinyl)-ethyl]dithiofosfaat |
219-679-1 |
2497-07-6 |
Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H311 H400 H410 |
GHS06 GHS09 Dgr |
H300 H311 H410 |
|
M = 10 |
|
015-097-00-5 |
fenthoaat (ISO); ethyl-2-(dimethoxyfosfinothioylthio)-2-fenylacetaat |
219-997-0 |
2597-03-7 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H312 H302 H410 |
|
M = 100 |
|
015-098-00-0 |
trichloronaat (ISO); O-ethyl-O-2,4,5-trichloorfenylethylthiofosfonaat |
206-326-1 |
327-98-0 |
Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H311 H400 H410 |
GHS06 GHS09 Dgr |
H300 H311 H410 |
|
|
|
015-099-00-6 |
pirimifos-ethyl (ISO); O,O-diëthyl-O-2-diëthylamino-6-methylpyrimidine-4-ylthiofosfaat |
245-704-0 |
23505-41-1 |
Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H312 H400 H410 |
GHS06 GHS09 Dgr |
H301 H312 H410 |
|
|
|
015-100-00-X |
foxim (ISO); α-(diëthoxyfosfinothioylimino)fenylacetonitril |
238-887-3 |
14816-18-3 |
Repr. 2 Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361f*** H302 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H361f*** H302 H317 H410 |
|
M=1000 |
|
015-101-00-5 |
fosmet (ISO); O,O-dimethylftaalimidomethyldithiofosfaat |
211-987-4 |
732-11-6 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H312 H302 H410 |
|
M = 100 |
|
015-102-00-0 |
tris(2-chloorethyl)fosfaat |
204-118-5 |
115-96-8 |
Carc. 2 Repr. 1B Acute Tox. 4 * Aquatic Chronic 2 |
H351 H360F*** H302 H411 |
GHS08 GHS07 GHS09 Dgr |
H351 H360F*** H302 H411 |
|
|
|
015-103-00-6 |
fosfortribromide |
232-178-2 |
7789-60-8 |
Skin Corr. 1B STOT SE 3 |
H314 H335 |
GHS05 GHS07 Dgr |
H314 H335 |
EUH014 |
|
|
015-104-00-1 |
difosforpentasulfide; fosforpentasulfide |
215-242-4 |
1314-80-3 |
Flam. Sol. 1 Water-react. 1 Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 |
H228 H260 H332 H302 H400 |
GHS02 GHS07 GHS09 Dgr |
H228 H260 H332 H302 H400 |
EUH029 |
|
T |
015-105-00-7 |
trifenylfosfiet |
202-908-4 |
101-02-0 |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H315 H400 H410 |
GHS07 GHS09 Wng |
H319 H315 H410 |
|
Skin Irrit. 2; H315: C ≥ 5 % Eye Irrit. 2; H319: C ≥ 5 % |
|
015-106-00-2 |
hexamethylfosforzuurtriamide; hexamethylfosforamide |
211-653-8 |
680-31-9 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
Carc. 1B; H350: C ≥ 0,01 % |
|
015-107-00-8 |
ethoprofos (ISO); ethyl-S,S-dipropyldithiofosfaat |
236-152-1 |
13194-48-4 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 3 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H301 H317 H400 H410 |
GHS06 GHS09 Dgr |
H330 H310 H301 H317 H410 |
|
|
|
015-108-00-3 |
bromofos (ISO); O-4-broom-2,5-dichloorfenyl-O,O-dimethylthiofosfaat |
218-277-3 |
2104-96-3 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
M = 100 |
|
015-109-00-9 |
crotoxyfos (ISO); 1-fenylethyl-3-(dimethoxyfosfinyloxy)-isocrotonaat |
231-720-5 |
7700-17-6 |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H311 H301 H410 |
|
M = 10 |
|
015-110-00-4 |
cyanofenfos (ISO); O-4-cyaanfenyl-O-ethylfenylthiofosfonaat |
— |
13067-93-1 |
Acute Tox. 3 * STOT SE 1 Acute Tox. 4 * Eye Irrit. 2 Aquatic Chronic 2 |
H301 H370 ** H312 H319 H411 |
GHS06 GHS08 GHS09 Dgr |
H301 H370 ** H312 H319 H411 |
|
|
|
015-111-00-X |
fosfolan (ISO); diëthyl-1,3-dithiolaan-2-ylideenfosforamidaat |
213-423-2 |
947-02-4 |
Acute Tox. 1 Acute Tox. 2 * |
H310 H300 |
GHS06 Dgr |
H310 H300 |
|
|
|
015-112-00-5 |
thionazin (ISO); O,O-diethyl-O-pyrazine-2-ylthiofosfaat; |
206-049-6 |
297-97-2 |
Acute Tox. 1 Acute Tox. 2 * |
H310 H300 |
GHS06 Dgr |
H310 H300 |
|
|
|
015-113-00-0 |
tolclofos-methyl (ISO); O-(2,6-dichloor-p-tolyl)-O,O-dimethylthiofosfaat |
260-515-3 |
57018-04-9 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
015-114-00-6 |
chloormefos (ISO); S-chloormethyl-O,O-diëthyldithiofosfaat |
246-538-1 |
24934-91-6 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H310 H300 H410 |
|
M = 10 |
|
015-115-00-1 |
chloorthiofos (ISO); [isomere reactiemassa met overwegend O-2,5-dichloorfenyl-4-methylthiofenyl-O,O-diëthylthiofosfaat] |
244-663-6 |
21923-23-9 |
Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H311 H400 H410 |
GHS06 GHS09 Dgr |
H300 H311 H410 |
|
M = 1000 |
|
015-116-00-7 |
demefion-O (ISO); O,O-dimethyl-O-2-methylthioëthylthiofosfaat |
211-666-9 |
682-80-4 |
Acute Tox. 2 * Acute Tox. 3 * |
H300 H311 |
GHS06 Dgr |
H300 H311 |
|
|
|
015-117-00-2 |
demefion-S (ISO); O,O-dimethyl-S-2-methylthioëthylthiofosfaat |
219-971-9 |
2587-90-8 |
Acute Tox. 2 * Acute Tox. 3 * |
H300 H311 |
GHS06 Dgr |
H300 H311 |
|
|
|
015-118-00-8 |
demeton |
— |
8065-48-3 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 |
H310 H300 H400 |
GHS06 GHS09 Dgr |
H310 H300 H400 |
|
|
|
015-119-00-3 |
dimethyl-4-(methylthio)fenylfosfaat |
— |
3254-63-5 |
Acute Tox. 1 Acute Tox. 2 * |
H310 H300 |
GHS06 Dgr |
H310 H300 |
|
|
|
015-120-00-9 |
ditalimfos (ISO); O, O-diëthylftaalimidothiofosfonaat; |
225-875-8 |
5131-24-8 |
Skin Irrit. 2 Skin Sens. 1 |
H315 H317 |
GHS07 Wng |
H315 H317 |
|
|
|
015-121-00-4 |
edifenfos (ISO); O-ethyl-S,S-difenyldithiofosfaat |
241-178-1 |
17109-49-8 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H312 H317 H400 H410 |
GHS06 GHS09 Dgr |
H331 H301 H312 H317 H410 |
|
|
|
015-122-00-X |
etrimfos (ISO); O-6-ethoxy-2-ethylpyrimidine-4-yl-O, O-dimethylthiofosfaat |
253-855-9 |
38260-54-7 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
M = 10 |
|
015-123-00-5 |
fenamifos (ISO); ethyl-4-methylthio-m-tolyl-N-isopropylfosforamidaat |
244-848-1 |
22224-92-6 |
Acute Tox. 2 Acute Tox. 2 Acute Tox. 2 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H300 H310 H330 H319 H400 H410 |
GHS06 GHS09 Dgr |
H300 H310 H330 H319 H410 |
|
M = 100 M = 100 |
|
015-124-00-0 |
fosthiëtaan (ISO); diëthyl-1,3-dithiëtaan-2-ylideenfosforamidaat |
244-437-7 |
21548-32-3 |
Acute Tox. 1 Acute Tox. 2 * |
H310 H300 |
GHS06 Dgr |
H310 H300 |
|
|
|
015-125-00-6 |
glyfosine (ISO); N,N-bis(fosfonomethyl)glycine |
219-468-4 |
2439-99-8 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
015-126-00-1 |
heptenofos (ISO); 7-chloorbicyclo[3.2.0]hepta-2,6-dieen-6-yldimethylfosfaat |
245-737-0 |
23560-59-0 |
Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H400 H410 |
GHS06 GHS09 Dgr |
H301 H410 |
|
M = 100 |
|
015-127-00-7 |
iprobenfos (ISO); S-benzyldi-isopropylthiofosfaat |
247-449-0 |
26087-47-8 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
015-128-00-2 |
IPSP; S-ethylsulfinylmethyl-O,O-diisopropyldithiofosfaat |
— |
5827-05-4 |
Acute Tox. 1 Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H301 H400 H410 |
GHS06 GHS09 Dgr |
H310 H301 H410 |
|
M = 100 |
|
015-129-00-8 |
isofenfos (ISO); O-ethyl-O-2-isopropoxycarbonylfenyl-N-isopropylthiofosforamidaat |
246-814-1 |
25311-71-1 |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H311 H301 H410 |
|
M = 100 |
|
015-130-00-3 |
isothioaat (ISO); S-2-isopropylthioëthyl-O,O-dimethyldithiofosfaat; |
— |
36614-38-7 |
Acute Tox. 3 * Acute Tox. 3 * |
H311 H301 |
GHS06 Dgr |
H311 H301 |
|
|
|
015-131-00-9 |
isoxathion (ISO); O,O-diëthyl-O-5-fenylisoxazool-3-ylthiofosfaat |
242-624-8 |
18854-01-8 |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H311 H301 H410 |
|
|
|
015-132-00-4 |
S-(chloorfenylthiomethyl)-O,O-dimethyldithiofosfaat; methylcarbofenothion |
— |
953-17-3 |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H311 H301 H410 |
|
M = 1000 |
|
015-133-00-X |
piperofos (ISO); S-2-methylpiperidinocarbonylmethyl-O,O-dipropyldithiofosfaat |
— |
24151-93-7 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
M = 10 |
|
015-134-00-5 |
pirimifos-methyl (ISO); O-(2-diëthylamino-6-methylpyrimidine-4-yl)-O,O-dimethylthiofosfaat |
249-528-5 |
29232-93-7 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
015-135-00-0 |
profenofos (ISO); O-(4-broom-2-chloorfenyl)-O-ethyl-S-propylthiofosfaat |
255-255-2 |
41198-08-7 |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H312 H302 H410 |
|
M = 1000 |
|
015-136-00-6 |
trans-isopropyl-3-[[(ethylamino)methoxyfosfinothioyl]oxy]crotonaat; isopropyl-3-[[(ethylamino)methoxyfosfinothioyl]oxy]isocrotonaat; propetamfos (ISO) |
250-517-2 |
31218-83-4 |
Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H400 H410 |
GHS06 GHS09 Dgr |
H301 H410 |
|
M = 100 |
|
015-137-00-1 |
pyrazofos (ISO); O,O-diëthyl-O-(6-ethoxycarbonyl-5-methylpyrazolo[2,3-a]pyrimidine-2-yl)thiofosfaat |
236-656-1 |
13457-18-6 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H302 H410 |
|
|
|
015-138-00-7 |
quinalfos (ISO); O,O-diëthyl-O-chinoxaline-2-ylthiofosfaat |
237-031-6 |
13593-03-8 |
Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H312 H400 H410 |
GHS06 GHS09 Dgr |
H301 H312 H410 |
|
M = 1000 |
|
015-139-00-2 |
terbufos (ISO); S-tert-butylthiomethyl-O,O-diëthyldithiofosfaat |
235-963-8 |
13071-79-9 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H310 H300 H410 |
|
M = 1000 |
|
015-140-00-8 |
triazofos (ISO); O,O-diëthyl-O-1-fenyl-1H-1,2,4-triazool-3-ylthiofosfaat |
245-986-5 |
24017-47-8 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H312 H400 H410 |
GHS06 GHS09 Dgr |
H331 H301 H312 H410 |
|
M=100 |
|
015-141-00-3 |
ethyleendiammonium-O,O-bis(octyl)dithiofosfaat, mengsel van isomeren |
400-520-1 |
— |
Skin Corr. 1B Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H314 H302 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H314 H302 H410 |
|
|
|
015-142-00-9 |
butyl(dialkyloxy(dibutoxyfosforyloxy)titaan)(trialkyloxytitaan)fosfaat |
401-100-0 |
— |
Flam. Liq. 2 Eye Irrit. 2 Aquatic Chronic 2 |
H225 H319 H411 |
GHS02 GHS07 GHS09 Dgr |
H225 H319 H411 |
|
|
T |
015-143-00-4 |
reactiemassa van 2-chloorethyl-chloorpropyl-2-chloorethylfosfonaat, reactiemassa van isomeren en 2-chloorethyl-chloorpropyl-2-chloorpropylfosfonaat, reactiemassa van isomeren |
401-740-0 |
— |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
015-144-00-X |
reactiemassa van pentylmethylfosfinaat en 2-methylbutylmethylfosfinaat |
402-090-0 |
87025-52-3 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
|
|
015-145-00-5 |
reactiemassa van koper(I)-O,O-diisopropyldithiofosfaat en koper(I)-O-isopropyl-O-(4-methylpent-2-yl)dithiofosfaat en koper(I)-O,O-bis(4-methylpent-2-yl)dithiofosfaat |
401-520-4 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
015-146-00-0 |
S-(tricyclo(5.2.1.0 2,6)deca-3-een-8(of 9)-yl O-(isopropyl of isobutyl of 2-ethylhexyl) O-(isopropyl of isobutyl of 2-ethylhexyl)dithiofosfaat |
401-850-9 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
015-147-00-6 |
reactiemassa van C12-14-tert-alkylammoniumdifenylthiofosfaat en dinonylsulfide (of -disulfide) |
400-930-0 |
— |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H315 H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H315 H318 H317 H411 |
|
|
|
015-148-00-1 |
2-(difosfonomethyl)barnsteenzuur |
403-070-4 |
51395-42-7 |
Skin Corr. 1B Skin Sens. 1 |
H314 H317 |
GHS05 GHS07 Dgr |
H314 H317 |
|
|
|
015-149-00-7 |
reactiemassa van: hexyldioctylfosfineoxide; dihexyloctylfosfineoxide; trioctylfosfineoxide |
403-470-9 |
— |
Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H314 H400 H410 |
GHS05 GHS09 Dgr |
H314 H410 |
|
|
|
015-150-00-2 |
(2-(1,3-dioxolaan-2-yl)ethyl)trifenylfosfoniumbromide |
404-940-6 |
86608-70-0 |
Acute Tox. 4 * Eye Dam. 1 STOT RE 2 * Aquatic Chronic 3 |
H302 H318 H373 ** H412 |
GHS08 GHS05 GHS07 Dgr |
H302 H318 H373 ** H412 |
|
|
|
015-151-00-8 |
tris(isopropyl/tert-butylfenyl)fosfaat |
405-010-2 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
015-152-00-3 |
dioxabenzofos (ISO); 2-methoxy-4H-1,3,2-benzodioxafosforinine-2-sulfide |
223-292-3 |
3811-49-2 |
Acute Tox. 3 * Acute Tox. 3 * STOT SE 1 Aquatic Chronic 2 |
H311 H301 H370 ** H411 |
GHS06 GHS08 GHS09 Dgr |
H311 H301 H370 ** H411 |
|
|
|
015-153-00-9 |
isazofos (ISO); O-(5-chloor-1-isopropyl-1,2,4-triazool-3-yl)-O, O-diëthylthiofosfaat |
255-863-8 |
42509-80-8 |
Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H311 H301 H373 ** H317 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H330 H311 H301 H373 ** H317 H410 |
|
|
|
015-154-00-4 |
ethefon; 2-chloorethylfosfonzuur |
240-718-3 |
16672-87-0 |
Acute Tox. 3 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1C Aquatic Chronic 2 |
H311 H332 H302 H314 H411 |
GHS06 GHS05 GHS09 Dgr |
H311 H332 H302 H314 H411 |
EUH071 |
|
|
015-155-00-X |
glufosinaat-ammonium (ISO); ammonium-2-amino-4-(hydroxymethylfosfinyl)butyraat |
278-636-5 |
77182-82-2 |
Repr. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * |
H360Fd H332 H312 H302 H373** |
GHS08 GHS07 Dgr |
H360Fd H332 H312 H302 H373** |
|
|
|
015-156-00-5 |
methyl-3-[(dimethoxyfosfinothioyl)oxy]methacrylaat; [1] methacrifos (ISO); methyl (E)-3-[(dimethoxyfosfinothioyl)oxy]methacrylaat; |
250-366-9 [1]-[2] |
30864-28-9 [1] 62610-77-9 [2] |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
|
015-157-00-0 |
fosfonzuur; [1] fosforigzuur [2] |
237-066-7 [1] 233-663-1 [2] |
13598-36-2 [1] 10294-56-1 [2] |
Acute Tox. 4 * Skin Corr. 1A |
H302 H314 |
GHS05 GHS07 Dgr |
H302 H314 |
|
|
|
015-158-00-6 |
(η-cyclopentadiënyl)(η-cumenyl)ijzer(1+)hexafluorofosfaat(1–) |
402-340-9 |
32760-80-8 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
015-159-00-1 |
hydroxyfosfonoazijnzuur |
405-710-8 |
23783-26-8 |
Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B Skin Sens. 1 |
H302 H373 ** H314 H317 |
GHS08 GHS05 GHS07 Dgr |
H302 H373 ** H314 H317 |
|
|
|
015-160-00-7 |
vanadylpyrofosfaat |
406-260-5 |
58834-75-6 |
Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H319 H317 H412 |
GHS07 Wng |
H319 H317 H412 |
|
|
|
015-161-00-2 |
divanadylpyrofosfaat |
407-130-0 |
65232-89-5 |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H302 H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H317 H411 |
|
|
|
015-162-00-8 |
vanadium(IV)oxidewaterstoffosfaat-hemihydraat, gedoopt met lithium, zink, molybdeen, ijzer en chloor |
407-350-7 |
— |
Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Aquatic Chronic 2 |
H332 H373 ** H318 H411 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H332 H373 ** H318 H411 |
|
|
|
015-163-00-3 |
bis(2,6-dimethoxybenzoyl)-2,4,4-trimethylpentylfosfinoxide |
412-010-6 |
145052-34-2 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
015-164-00-9 |
calcium-P,P'-(1-hydroxyethyleen)bis(waterstoffosfonaat)-dihydraat |
400-480-5 |
36669-85-9 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
015-165-00-4 |
reactiemassa van: thiobis(4,1-fenyleen)-S,S,S',S'-tetrafenyldisulfoniumbishexafluorofosfaat; difenyl-(4-fenylthiofenyl)sulfoniumhexafluorofosfaat |
404-986-7 |
— |
Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Dgr |
H318 H410 |
|
|
|
015-166-00-X |
3,9-bis(2,6-di-tert-butyl-4-methylfenoxy)-2,4,8,10-tetraoxa-3,9-difosfaspiro[5.5]undecaan |
410-290-4 |
80693-00-1 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
015-167-00-5 |
3-(hydroxyfenylfosfinyl)propaanzuur |
411-200-6 |
14657-64-8 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
015-168-00-0 |
fosthiazaat (ISO); (RS)-S-sec-butyl-O-ethyl-2-oxo-1,3-thiazolidine-3-ylthiofosfonaat |
— |
98886-44-3 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H312 H317 H400 H410 |
GHS06 GHS09 Dgr |
H331 H301 H312 H317 H410 |
EUH070 |
|
|
015-169-00-6 |
tributyltetradecylfosfonium-tetrafluorboraat |
413-520-1 |
— |
Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373 ** H314 H317 H400 H410 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H302 H373 ** H314 H317 H410 |
|
|
|
015-170-00-1 |
reactiemassa van: di-(1-octaan-N,N,N-trimethylammonium)-octylfosfaat; 1-octaan-N,N,N-trimethylammonium-dioctylfosfaat; 1-octaan-N,N,N-trimethylammonium-octylphosphaat |
407-490-9 |
— |
Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H312 H302 H314 |
GHS05 GHS07 Dgr |
H312 H302 H314 |
|
|
|
015-171-00-7 |
O, O,O-tris(2(of 4)-C9-10-isoalkylfenyl)-thiofosfaat |
406-940-1 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
015-172-00-2 |
reactiemassa van: bis(isotridecylammonium)mono(di-(4-methylpent-2-yloxy)thiofosforothionylisopropyl)fosfaat; isotridecylammonium-bis(di-(4-methylpent-2-yloxy)thiofosforothionylisopropyl)fosfaat |
406-240-6 |
— |
Flam. Liq. 3 Skin Corr. 1B Aquatic Chronic 2 |
H226 H314 H411 |
GHS02 GHS05 GHS09 Dgr |
H226 H314 H411 |
|
|
|
015-173-00-8 |
methyl-[2-(1,1-dimethylethyl)-6-methoxypirimidine-4-yl]ethylthiofosfonaat |
414-080-3 |
117291-73-3 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
015-174-00-3 |
1-chloor-N,N-diëthyl-1,1-difenyl-1-(fenylmethyl)fosforamine |
411-370-1 |
82857-68-9 |
Acute Tox. 3 * Eye Dam. 1 Aquatic Chronic 2 |
H301 H318 H411 |
GHS06 GHS05 GHS09 Dgr |
H301 H318 H411 |
|
|
|
015-175-00-9 |
tert-butyl-(trifenylfosforanylideen)acetaat |
412-880-7 |
35000-38-5 |
Acute Tox. 3 * STOT RE 2 * Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H301 H373 ** H319 H317 H411 |
GHS06 GHS08 GHS09 Dgr |
H301 H373 ** H319 H317 H411 |
|
|
|
015-176-00-4 |
P,P,P',P'-tetrakis-(o-methoxyfenyl)propaan-1,3-difosfine |
413-430-2 |
116163-96-3 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
015-177-00-X |
((4-fenylbutyl)hydroxyfosforyl)azijnzuur |
412-170-7 |
83623-61-4 |
STOT RE 2 * Eye Dam. 1 Skin Sens. 1 |
H373 ** H318 H317 |
GHS08 GHS05 Dgr |
H373 ** H318 H317 |
|
|
|
015-178-00-5 |
(R)-α-fenylethylammonium(–)-(1R, 2S)-(1,2-epoxypropyl)fosfonaat-monohydraat |
418-570-8 |
25383-07-7 |
Repr. 2 Aquatic Chronic 2 |
H361f *** H411 |
GHS08 GHS09 Wng |
H361f *** H411 |
|
|
|
015-179-00-0 |
UVCB-condensatieproduct van: tetrakis-hydroxymethylfosfoniumchloride, ureum en gedestilleerde gehydrogeneerde C16-18-talk-alkylamine |
422-720-8 |
166242-53-1 |
Carc. 2 Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H302 H373 ** H314 H317 H400 H410 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H351 H302 H373 ** H314 H317 H410 |
|
|
|
015-180-00-6 |
[R-(R*,S*)]-[[2-methyl-1-(1-oxopropoxy)propoxy]-(4-fenylbutyl)fosfinyl]-azijnzuur, (–)-cinchonidinezout (1:1) |
415-820-8 |
137590-32-0 |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Dgr |
H318 H317 H412 |
|
|
|
015-181-00-1 |
fosfine |
232-260-8 |
7803-51-2 |
Flam. Gas 1 Press. Gas Acute Tox. 2 * Skin Corr. 1B Aquatic Acute 1 |
H220 H330 H314 H400 |
GHS02 GHS04 GHS06 GHS05 GHS09 Dgr |
H220 H330 H314 H400 |
|
|
U |
015-182-00-7 |
tetrapropaan-2-yl-(dichloormethaandiyl)bis(fosfonaat) |
430-630-5 |
10596-22-2 |
Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 |
H302 H319 H317 |
GHS07 Wng |
H302 H319 H317 |
|
|
|
015-183-00-2 |
(1-hydroxydodecylideen)difosfonzuur |
425-230-2 |
16610-63-2 |
Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H314 H400 H410 |
GHS05 GHS09 Dgr |
H314 H410 |
|
|
|
015-184-00-8 |
zouten van glyfosaat, tenzij elders in deze bijlage vermeld |
— |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
A |
015-186-00-9 |
chloorpyrifos-methyl (ISO); O, O-dimethyl-O-3,5,6-trichloor-2-pyridylthiofosfaat |
227-011-5 |
5598-13-0 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
M = 10000 |
|
015-187-00-4 |
reactiemassa van: tetranatrium(((2-hydroxyethyl)imino)bis(methyleen))bisfosfonaat, N-oxide; trinatrium ((tetrahydro-2-hydroxy-4H-1,4,2-oxazafosforine-4-yl)-methyl)fosfonaat, N-oxide, P-oxide |
417-540-1 |
— |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
015-189-00-5 |
fenylbis(2,4,6-trimethylbenzoyl)-fosfineoxide |
423-340-5 |
162881-26-7 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
015-190-00-0 |
bis(2,4-dicumylfenyl)neopentyldifosfiet; 3,9-bis[2,4-bis(1-fenyl-1-methylethyl)fenoxy]-2,4,8,10-tetraoxa-3,9-difosfaspiro[5.5]undecaan |
421-920-2 |
154862-43-8 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
015-191-00-6 |
dodecyldifenylfosfaat |
431-760-5 |
27460-02-2 |
Skin Irrit. 2 Aquatic Chronic 3 |
H315 H412 |
GHS07 Wng |
H315 H412 |
|
|
|
015-192-00-1 |
tetrakis(2,6-dimethylfenyl)-m-fenyleenbifosfaat |
432-770-2 |
139189-30-3 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
015-193-00-7 |
trifenyl(fenylmethyl)fosfonium-1,1,2,2,3,3,4,4,4-nonafluor-N-methyl-1-butaansulfonamide (1:1) |
442-960-7 |
332350-93-3 |
Acute Tox. 3 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H318 H400 H410 |
GHS05 GHS06 GHS09 Dgr |
H301 H318 H410 |
|
|
|
015-194-00-2 |
tetrabutylfosfoniumnonafluor-1-butaansulfonaat |
444-440-5 |
220689-12-3 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
015-195-00-8 |
reactiemassa van: kalium-o-tolueenfosfonaat; kalium-m-tolueenfosfonaat; kalium-p-tolueenfosfonaat |
433-860-4 |
— |
Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H319 H317 H412 |
GHS07 Wng |
H319 H317 H412 |
|
|
|
015-196-00-3 |
reactiemassa van: dimethyl(2-(hydroxymethylcarbamoyl)ethyl)fosfonaat; diëthyl(2-(hydroxymethylcarbamoyl)ethyl)fosfonaat; methylethyl(2-(hydroxymethylcarbamoyl)ethyl)fosfonaat |
435-960-3 |
— |
Carc. 1B Muta. 1B Skin Sens. 1 |
H350 H340 H317 |
GHS08 GHS07 Dgr |
H350 H340 H317 |
|
|
|
015-197-00-9 |
bis(2,4,4-trimethylpentyl)dithiofosfonzuur |
420-160-9 |
107667-02-7 |
Flam. Liq. 3 Acute Tox. 3 * Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 2 |
H226 H331 H302 H314 H411 |
GHS02 GHS06 GHS05 GHS09 Dgr |
H226 H331 H302 H314 H411 |
|
|
|
015-198-00-4 |
(4-fenylbutyl)fosfinezuur |
420-450-5 |
86552-32-1 |
Carc. 2 Eye Dam. 1 |
H351 H318 |
GHS05 GHS08 Dgr |
H351 H318 |
|
|
|
015-199-00-X |
tris[2-chloor-1-(chloormethyl)ethyl]fosfaat |
237-159-2 |
13674-87-8 |
Carc. 2 |
H351 |
GSH08 Wng |
H351 |
|
|
|
015-200-00-3 |
indiumfosfide |
244-959-5 |
22398-80-7 |
Carc. 1B Repr. 2 STOT RE 1 |
H350 H361f H372 (longen) |
GHS08 Dgr |
H350 H361f H372 (longen) |
|
STOT RE 1; H372: C ≥0,1 % Carc 1B; H350: C ≥0,01 % STOT RE 2; H373: 0,01 % ≤ C < 0,1 % |
|
015-201-00-9 |
trixylylfosfaat |
246-677-8 |
25155-23-1 |
Repr. 1B |
H360F |
GHS08 Dgr |
H360F |
|
|
|
015-202-00-4 |
tris(nonylfenyl)fosfiet |
247-759-6 |
26523-78-4 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
015-203-00-X |
difenyl(2,4,6-trimethylbenzoyl)fosfineoxide |
278-355-8 |
75980-60-8 |
Repr. 2 |
H361f (veroorzaakt testisatrofie) |
GHS08 Wng |
H361f (veroorzaakt testisatrofie) |
|
|
|
016-001-00-4 |
waterstofsulfide |
231-977-3 |
7783-06-4 |
Flam. Gas 1 Press. Gas Acute Tox. 2 * Aquatic Acute 1 |
H220 H330 H400 |
GHS02 GHS04 GHS06 GHS09 Dgr |
H220 H330 H400 |
|
|
U |
016-002-00-X |
bariumsulfide |
244-214-4 |
21109-95-5 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 |
H332 H302 H400 |
GHS07 GHS09 Wng |
H332 H302 H400 |
EUH031 |
|
|
016-003-00-5 |
bariumpolysulfiden |
256-814-3 |
50864-67-0 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 |
H319 H335 H315 H400 |
GHS07 GHS09 Wng |
H319 H335 H315 H400 |
EUH031 |
|
|
016-004-00-0 |
calciumsulfide |
243-873-5 |
20548-54-3 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 |
H319 H335 H315 H400 |
GHS07 GHS09 Wng |
H319 H335 H315 H400 |
EUH031 |
|
|
016-005-00-6 |
calciumpolysulfiden |
215-709-2 |
1344-81-6 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 |
H319 H335 H315 H400 |
GHS07 GHS09 Wng |
H319 H335 H315 H400 |
EUH031 |
|
|
016-006-00-1 |
dikaliumsulfide; kaliumsulfide |
215-197-0 |
1312-73-8 |
Skin Corr. 1B Aquatic Acute 1 |
H314 H400 |
GHS05 GHS09 Dgr |
H314 H400 |
EUH031 |
|
|
016-007-00-7 |
kaliumpolysulfiden |
253-390-1 |
37199-66-9 |
Skin Corr. 1B Aquatic Acute 1 |
H314 H400 |
GHS05 GHS09 Dgr |
H314 H400 |
EUH031 |
|
|
016-008-00-2 |
ammoniumpolysulfiden |
232-989-1 |
9080-17-5 |
Skin Corr. 1B Aquatic Acute 1 |
H314 H400 |
GHS05 GHS09 Dgr |
H314 H400 |
EUH031 |
EUH031: C ≥1 % |
|
016-009-00-8 |
dinatriumsulfide; natriumsulfide |
215-211-5 |
1313-82-2 |
Acute Tox. 3 * Acute Tox. 4 * Skin Corr. 1B Aquatic Acute 1 |
H311 H302 H314 H400 |
GHS06 GHS05 GHS09 Dgr |
H311 H302 H314 H400 |
|
|
|
016-010-00-3 |
natriumpolysulfiden |
215-686-9 |
1344-08-7 |
Acute Tox. 3 * Skin Corr. 1B Aquatic Acute 1 |
H301 H314 H400 |
GHS06 GHS05 GHS09 Dgr |
H301 H314 H400 |
EUH031 |
|
|
016-011-00-9 |
zwaveldioxide |
231-195-2 |
7446-09-5 |
Press. Gas Acute Tox. 3 * Skin Corr. 1B |
H331 H314 |
GHS04 GHS06 GHS05 Dgr |
H331 H314 |
|
* |
U5 |
016-012-00-4 |
dizwaveldichloride; zwavelmonochloride |
233-036-2 |
10025-67-9 |
Acute Tox. 3 * Acute Tox. 4 * Skin Corr. 1A Aquatic Acute 1 |
H301 H332 H314 H400 |
GHS06 GHS05 GHS09 Dgr |
H301 H332 H314 H400 |
EUH014 EUH029 |
STOT SE 3; H335: C ≥ 1 % |
|
016-013-00-X |
zwaveldichloride |
234-129-0 |
10545-99-0 |
Skin Corr. 1B STOT SE 3 Aquatic Acute 1 |
H314 H335 H400 |
GHS05 GHS07 GHS09 Dgr |
H314 H335 H400 |
EUH014 |
STOT SE 3; H335: C ≥ 5 % |
|
016-014-00-5 |
zwaveltetrachloride |
— |
13451-08-6 |
Skin Corr. 1B Aquatic Acute 1 |
H314 H400 |
GHS05 GHS09 Dgr |
H314 H400 |
EUH014 |
STOT SE 3; H335: C ≥ 5 % |
|
016-015-00-0 |
thionyldichloride; thionylchloride |
231-748-8 |
7719-09-7 |
Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A |
H332 H302 H314 |
GHS05 GHS07 Dgr |
H332 H302 H314 |
EUH014 EUH029 |
STOT SE 3; H335: C ≥ 1 % |
|
016-016-00-6 |
sulfurylchloride |
232-245-6 |
7791-25-5 |
Skin Corr. 1B STOT SE 3 |
H314 H335 |
GHS05 GHS07 Dgr |
H314 H335 |
EUH014 |
|
|
016-017-00-1 |
chloorsulfonzuur |
232-234-6 |
7790-94-5 |
Skin Corr. 1A STOT SE 3 |
H314 H335 |
GHS05 GHS07 Dgr |
H314 H335 |
EUH014 |
|
|
016-018-00-7 |
fluorsulfonzuur |
232-149-4 |
7789-21-1 |
Acute Tox. 4 * Skin Corr. 1A |
H332 H314 |
GHS05 GHS07 Dgr |
H332 H314 |
|
|
|
016-019-00-2 |
oleum (rokend zwavelzuur) … % SO3 |
— |
— |
Skin Corr. 1A STOT SE 3 |
H314 H335 |
GHS05 GHS07 Dgr |
H314 H335 |
EUH014 |
|
B |
016-020-00-8 |
zwavelzuur … % |
231-639-5 |
7664-93-9 |
Skin Corr. 1A |
H314 |
GHS05 Dgr |
H314 |
|
Skin Corr. 1A; H314: C ≥ 15 % Skin Irrit. 2; H315: 5 % ≤ C < 15 % Eye Irrit. 2; H319: 5 % ≤ C < 15 % |
B |
016-021-00-3 |
methaanthiol; methylmercaptaan |
200-822-1 |
74-93-1 |
Flam. Gas. 1 Press. Gas Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H220 H331 H400 H410 |
GHS02 GHS04 GHS06 GHS09 Dgr |
H220 H331 H410 |
|
|
U |
016-022-00-9 |
ethaanthiol; ethylmercaptaan |
200-837-3 |
75-08-1 |
Flam. Liq. 2 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H225 H332 H400 H410 |
GHS02 GHS07 GHS09 Dgr |
H225 H332 H410 |
|
|
|
016-023-00-4 |
dimethylsulfaat |
201-058-1 |
77-78-1 |
Carc. 1B Muta. 2 Acute Tox. 2 * Acute Tox. 3 * Skin Corr. 1B Skin Sens. 1 |
H350 H341 H330 H301 H314 H317 |
GHS06 GHS08 GHS05 Dgr |
H350 H341 H330 H301 H314 H317 |
|
Carc. 1B; H350: C ≥ 0,01 % Muta. 2 H341: C ≥ 0,01 % STOT SE 3; H335: C ≥ 5 % |
|
016-024-00-X |
dimexano (ISO); bis(methoxythiocarbonyl)disulfide |
215-993-8 |
1468-37-7 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
016-025-00-5 |
disul (ISO); 2-(2,4-dichloorfenoxy)ethylwaterstofsulfaat; 2,4-DES |
205-259-5 |
149-26-8 |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 |
H302 H315 H318 |
GHS05 GHS07 Dgr |
H302 H315 H318 |
|
|
|
016-026-00-0 |
sulfamidezuur; sulfaminezuur; amidosulfonzuur |
226-218-8 |
5329-14-6 |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 3 |
H319 H315 H412 |
GHS07 Wng |
H319 H315 H412 |
|
|
|
016-027-00-6 |
diëthylsulfaat |
200-589-6 |
64-67-5 |
Carc. 1B Muta. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H350 H340 H332 H312 H302 H314 |
GHS05 GHS08 GHS07 Dgr |
H350 H340 H332 H312 H302 H314 |
|
|
|
016-028-00-1 |
natriumdithioniet; natriumhydrosulfiet |
231-890-0 |
7775-14-6 |
Self-heat. 1 Acute Tox. 4 * |
H251 H302 |
GHS02 GHS07 Dgr |
H251 H302 |
EUH031 |
|
|
016-029-00-7 |
p-tolueensulfonzuur, (met meer dan 5 % H2SO4) |
— |
— |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 % |
|
016-030-00-2 |
p-tolueensulfonzuur (met ten hoogste 5 % H2SO4) |
203-180-0 |
104-15-4 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H319 H335 H315 |
GHS07 Wng |
H319 H335 H315 |
|
STOT SE 3; H335: C ≥ 20 % |
|
016-031-00-8 |
tetrahydrothiofeen-1,1-dioxide; sulfolaan |
204-783-1 |
126-33-0 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
016-032-00-3 |
1,3-propaansulton; 1,2-oxathiolaan-2,2-dioxide |
214-317-9 |
1120-71-4 |
Carc. 1B Acute Tox. 4 * Acute Tox. 4 * |
H350 H312 H302 |
GHS08 GHS07 Dgr |
H350 H312 H302 |
|
Carc. 1B; H350: C ≥ 0,01 % |
|
016-033-00-9 |
dimethylsulfamoylchloride |
236-412-4 |
13360-57-1 |
Carc. 1B Acute Tox. 2 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H350 H330 H312 H302 H314 |
GHS06 GHS05 GHS08 Dgr |
H350 H330 H312 H302 H314 |
|
|
|
016-034-00-4 |
tetranatrium-3,3'-(piperazine-1,4-diylbis((6-chloor-1,3,5-triazine-4,2-diyl)imino(2-aceetamido)-4,1-fenyleenazo))bis(naftaleen-1,5- disulfonaat) |
400-010-9 |
81898-60-4 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
016-035-00-X |
pentanatrium-5-anilino-3-(4-(4-(6-chloor-4-(3-sulfonatoanilino)-1,3,5-triazine-2-ylamino)-2,5-dimethylfenylazo)-2,5-disulfonatofenylazo)-4-hydroxynaftaleen-2,7-disulfonaat |
400-120-7 |
— |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
016-036-00-5 |
tetranatrium-5-(4,6-dichloor-5-cyaanpyrimidine-2-ylamino)-4-hydroxy-2,3-azodinaftaleen-1,2,5,7-disulfonaat |
400-130-1 |
— |
Resp. Sens. 1 Aquatic Chronic 2 |
H334 H411 |
GHS08 GHS09 Dgr |
H334 H411 |
|
|
|
016-037-00-0 |
dinatrium-1-amino-4-(4-benzeensulfonamido-3-sulfonatoanilino)antrachinon-2-sulfonaat |
400-350-8 |
85153-93-1 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
016-038-00-6 |
dinatrium-6-((4-chloor-6-(N-methyl)-2-toluïdino)-1,3,5-triazine-2-ylamino)-1-hydroxy-2-(4-methoxy-2-sulfonatofenylazo)naftaleen-3-sulfonaat |
400-380-1 |
86393-35-3 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
016-039-00-1 |
tetranatrium-2-(6-chloor-4-(4-(2,5-dimethyl-4-(2,5-disulfonatofenylazo)fenylazo)-3-ureïdoanilino)-1,3,5-triazine-2-ylamino)benzeen-1,4-disulfonaat |
400-430-2 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
016-040-00-7 |
reactiemassa van dinatrium-6-(2,4-dihydroxyfenylazo)-3-(4-(4-(2,4-dihydroxyfenylazo)anilino)-3-sulfonatofenylazo)-4-hydroxynaftaleen-2-sulfonaat en dinatrium-6-(2,4-diaminofenylazo)-3-(4-(4-(2,4-diaminofenylazo)anilino)-3-sulfonatofenylazo)-4-hydroxynaftaleen-2-sulfonaat en trinatrium-6-(2,4-dihydroxyfenylazo)-3-(4-(4-(7-(2,4-dihydroxyfenylazo)-1-hydroxy-3-sulfonato-2-naftylazo)anilino)-3-sulfonatofenylazo)-4-hydroxynaftaleen-2-sulfonaat |
400-570-4 |
— |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
016-041-00-2 |
calcium-2,5-dichloor-4-(4-((5-chloor-4-methyl-2-sulfonatofenyl)azo)-5-hydroxy-3-methylpyrazool-1-yl)benzeensulfonaat |
400-710-4 |
— |
Acute Tox. 4 * |
H332 |
GHS07 Wng |
H332 |
|
|
|
016-042-00-8 |
tetranatrium-5-benzamido-3-(5-(4-fluor-6-(1-sulfonato-2-naftylamino)-1,3,5-triazine-2-ylamino)-2-sulfonatofenylazo)-4-hydroxynaftaleen-2,7- disulfonaat |
400-790-0 |
85665-97-0 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Wng |
H319 H315 H317 |
|
|
|
016-043-00-3 |
dilithium-6-aceetamido-4-hydroxy-3-(4-((2-sulfonatoöxy)ethylsulfonyl)fenylazo)naftaleen-2-sulfonaat |
401-010-1 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
016-044-00-9 |
dinatrium-S,S-hexaan-1,6-diyldi(thiosulfaat)-dihydraat |
401-320-7 |
— |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
016-045-00-4 |
lithium-natrium-waterstof-4-amino-6-(5-(5-chloor-2,6-difluorpyrimidine-4-ylamino)-2-sulfonatofenylazo)-5-hydroxy-3-(4-(2-(sulfonatoöxy)ethylsulfonyl)fenylazo)naftaleen-2,7-disulfonaat |
401-560-2 |
108624-00-6 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
016-046-00-X |
natriumwaterstofsulfaat |
231-665-7 |
7681-38-1 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
016-047-00-5 |
hexanatrium-7-(4-(4-(4-(2,5-disulfonatoanilino)-6-fluor-1,3,5-triazine-2-ylamino)-2-methylfenylazo)-7-sulfonatonaftylazo)naftaleen-1,3,5- trisulfonaat |
401-650-1 |
85665-96-9 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
016-048-00-0 |
natrium-3,5-dichloor-2-(5-cyaan-2,6-bis(3-hydroxypropylamino)-4-methylpyridine-3-ylazo)benzeensulfonaat |
401-870-8 |
— |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
016-049-00-6 |
calciumoctadecylxyleensulfonaat |
402-040-8 |
— |
Skin Corr. 1B Aquatic Chronic 2 |
H314 H411 |
GHS05 GHS09 Dgr |
H314 H411 |
|
|
|
016-050-00-1 |
kaliumnatrium-5-(4-chloor-6-(N-(4-(4-chloor-6-(5-hydroxy-2,7-disulfonato-6-(2-sulfonatofenylazo)-4-naftylamino)-1,3,5-triazine-2-ylamino)fenyl-N-methyl)amino)-1,3,5-triazine-2-ylamino)-4-hydroxy-3-(2-sulfonatofenylazo)naftaleen-2,7-disulfonaat |
402-150-6 |
— |
Eye Irrit. 2 Skin Sens. 1 |
H319 H317 |
GHS07 Wng |
H319 H317 |
|
|
|
016-051-00-7 |
trinatrium-7-(4-(6-fluor-4-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazine-2-ylamino)-2-ureïdofenylazo)naftaleen-1,3,6- trisulfonaat |
402-170-5 |
106359-91-5 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
016-052-00-2 |
benzyltributylammonium-4-hydroxynaftaleen-1-sulfonaat |
402-240-5 |
102561-46-6 |
Acute Tox. 4 * Aquatic Chronic 2 |
H332 H411 |
GHS07 GHS09 Wng |
H332 H411 |
|
|
|
016-053-00-8 |
(C16 of C18-n-alkyl)(C16 of C18-n-alkyl)ammonium-2-((C16 of C18-n-alkyl)(C16 of C18-n-alkyl)carbamoyl)benzeensulfonaat |
402-460-1 |
— |
Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 |
H315 H317 H413 |
GHS07 Wng |
H315 H317 H413 |
|
|
|
016-054-00-3 |
natrium-4-(2,4,4-trimethylpentylcarbonyloxy)benzeensulfonaat |
400-030-8 |
— |
Acute Tox. 3 * STOT RE 1 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Sens. 1 |
H331 H372 ** H302 H319 H335 H317 |
GHS06 GHS08 Dgr |
H331 H372 ** H302 H319 H335 H317 |
|
|
|
016-055-00-9 |
tetranatrium-4-amino-3,6-bis(5-(6-chloor-4-(2-hydroxyethylamino)-1,3,5-triazine-2-ylamino)-2-sulfonatofenylazo)-5-hydroxynaftaleen-2,7-sulfonaat (met > 35 % natriumchloride en natriumacetaat) |
400-510-7 |
— |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
016-056-00-4 |
kaliumwaterstofsulfaat |
231-594-1 |
7646-93-7 |
Skin Corr. 1B STOT SE 3 |
H314 H335 |
GHS05 GHS07 Dgr |
H314 H335 |
|
|
|
016-057-00-X |
styreen-4-sulfonylchloride |
404-770-2 |
2633-67-2 |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H315 H318 H317 |
GHS05 GHS07 Dgr |
H315 H318 H317 |
|
|
|
016-058-00-5 |
thionylchloride, reactieprodukten met 1,3,4-thiadiazool-2,5-dithiol, tert-nonaanthiol en C12-14-tert-alkylamine |
404-820-3 |
— |
Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H315 H317 H412 |
GHS07 Wng |
H315 H317 H412 |
|
|
|
016-059-00-0 |
N,N,N',N'-tetramethyldithiobis(ethyleen)diaminedihydrochloride |
405-300-9 |
17339-60-5 |
Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H317 H410 |
|
|
|
016-060-00-6 |
diammoniumperoxodisulfaat; ammoniumpersulfaat |
231-786-5 |
7727-54-0 |
Ox. Sol. 3 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 |
H272 H302 H319 H335 H315 H334 H317 |
GHS03 GHS08 GHS07 Dgr |
H272 H302 H319 H335 H315 H334 H317 |
|
|
|
016-061-00-1 |
dikaliumperoxodisulfaat; kaliumpersulfaat |
231-781-8 |
7727-21-1 |
Ox. Sol. 3 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 |
H272 H302 H319 H335 H315 H334 H317 |
GHS03 GHS08 GHS07 Dgr |
H272 H302 H319 H335 H315 H334 H317 |
|
|
|
016-062-00-7 |
bensultap (ISO); 1,3-bis(fenylsulfonylthio)-2-(N,N-dimethylamino)propaan |
— |
17606-31-4 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
016-063-00-2 |
natriummetabisulfiet |
231-673-0 |
7681-57-4 |
Acute Tox. 4 * Eye Dam. 1 |
H302 H318 |
GHS05 GHS07 Dgr |
H302 H318 |
EUH031 |
|
|
016-064-00-8 |
natriumwaterstofsulfiet … %; natriumbisulfiet . . . % |
231-548-0 |
7631-90-5 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
EUH031 |
|
B |
016-065-00-3 |
natrium-1-amino-4-[2-methyl-5-(4-methylfenylsulfonylamino)fenylamino]antrachinon-2-sulfonaat |
400-100-8 |
84057-97-6 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
016-066-00-9 |
tetranatrium-[5-((4-amino-6-chloor-1,3,5-triazine-2-yl)amino)-2-((2-hydroxy-3,5-disulfonatofenylazo)-2-sulfonatobenzylideenhydrazino)benzoaat]koper(II) |
404-070-7 |
116912-62-0 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
016-067-00-4 |
(4-methylfenyl)mesityleen-sulfonaat |
407-530-5 |
67811-06-7 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
016-068-00-X |
natrium-3,5-bis(tetradecyloxycarbonyl)benzeensulfinaat |
407-720-8 |
155160-86-4 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
016-069-00-5 |
3,5-bis(tetradecyloxycarbonyl)benzeensulfienzuur |
407-990-7 |
141915-64-2 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
016-070-00-0 |
4-benzyloxy-4'-(2,3-epoxy-2-methylprop-1-yloxy)difenylsulfon |
408-220-2 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
016-071-00-6 |
trinatrium-3-amino-6,13-dichloor-10-((3-((4-chloor-6-(2-sulfofenylamino)-1,3,5-triazine-2-yl)amino)propyl)-amino)-4,11-trifenoxydioxazinedisulfonaat |
410-130-3 |
136248-03-8 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
016-072-00-1 |
3-amino-4-hydroxy-N-(2-methoxyethyl)-benzeensulfonamide |
411-520-6 |
112195-27-4 |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H318 H317 H411 |
|
|
|
016-073-00-7 |
tetrakis(fenylmethyl)thioperoxydi(carbothioamide) |
404-310-0 |
10591-85-2 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
016-074-00-2 |
6-fluor-2-methyl-3-(4-methylthiobenzyl)indeen |
405-410-7 |
— |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H315 H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H315 H318 H317 H411 |
|
|
|
016-075-00-8 |
2,2'-diallyl-4,4'-sulfonyldifenol |
411-570-9 |
41481-66-7 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
016-076-00-3 |
2,3-bis((2-mercapto-ethyl)thio)-1-propaanthiol |
411-290-7 |
131538-00-6 |
Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373 ** H400 H410 |
GHS08 GHS07 GHS09 Wng |
H302 H373 ** H410 |
|
|
|
016-077-00-9 |
2-chloor-p-tolueensulfochloride |
412-890-1 |
42413-03-6 |
Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 3 |
H314 H317 H412 |
GHS05 GHS07 Dgr |
H314 H317 H412 |
|
|
|
016-078-00-4 |
4-methyl-N,N-bis(2-(((4-methylfenyl)sulfonyl)amino)ethyl)-benzeensulfonamide |
413-300-5 |
56187-04-3 |
Aquatic Chronic 4 |
H413 |
— |
|
|
|
|
016-079-00-X |
N,N-bis(2-(p-tolueensulfonyloxy)ethyl)-p-tolueensulfonamide |
412-920-3 |
16695-22-0 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
016-080-00-5 |
natrium-2-anilino-5-(2-nitro-4-(N-fenylsulfamoyl))anilinobenzeensulfonaat |
412-320-1 |
31361-99-6 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
016-081-00-0 |
hexahydrocyclopenta[c]pyrrool-1-(1H)-ammonium-N-ethoxycarbonyl-N-(p-tolylsulfonyl)azanide |
418-350-1 |
— |
Muta. 2 Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H341 H302 H319 H317 H411 |
GHS08 GHS07 GHS09 Wng |
H341 H302 H319 H317 H411 |
|
|
|
016-082-00-6 |
ethoxysulfuron (ISO); 1-(4,6-dimethoxypyrimidine-2-yl)-3-(2-ethoxyfenoxysulfonyl)ureum |
— |
126801-58-9 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
016-083-00-1 |
acibenzolar-S-methyl; benzo[1,2,3]thiadiazool-7-carbothioaat, S-methylester |
420-050-0 |
135158-54-2 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H335 H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H319 H335 H315 H317 H410 |
|
|
|
016-084-00-7 |
prosulfuron (ISO); 1-(4-methoxy-6-methyl-1,3,5-triazine-2-yl)-3-[2-(3,3,3-trifluorpropyl)fenylsulfonyl]ureum |
— |
94125-34-5 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
M=100 |
|
016-085-00-2 |
flazasulfuron (ISO); 1-(4,6-dimethoxypyrimidine-2-yl)-3-(3-trifluormethyl-2-pyridylsulfonyl)ureum |
— |
104040-78-0 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
016-086-00-8 |
tetranatrium-10-amino-6,13-dichloor-3-(3-(4-(2,5-disulfonatoanilino)-6-fluor-1,3,5-triazine-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentaceen-4,11-disulfonaat |
402-590-9 |
109125-56-6 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
016-087-00-3 |
reactiemassa van: thiobis(4,1-fenyleen)-S,S,S',S'-tetrafenyldisulfoniumbishexafluorofosfaat; difenyl-(4-fenylthiofenyl)sulfoniumhexafluorofosfaat; propyleencarbonaat |
403-490-8 |
104558-95-4 |
Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H317 H400 H410 |
GHS07 GHS09 Wng |
H319 H317 H410 |
|
|
|
016-088-00-9 |
4-(bis(4-(diëthylamino)fenyl)methyl)benzeen-1,2-dimethaansulfonzuur |
407-280-7 |
71297-11-5 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
016-089-00-4 |
reactiemassa van esters van 5,5',6,6',7,7'-hexahydroxy-3,3,3',3'-tetramethyl-1,1'-spirobiindaan en 2-diazo-1,2-dihydro-1-oxo-5-sulfonaftaleen |
413-840-1 |
— |
Self-react. C **** Aquatic Chronic 4 |
H242 H413 |
GHS02 Dgr |
H242 H413 |
|
|
|
016-090-00-X |
4-methyl-N-(methylsulfonyl)benzeensulfonamide |
415-040-8 |
14653-91-9 |
Acute Tox. 4 * STOT SE 3 Eye Dam. 1 |
H302 H335 H318 |
GHS05 GHS07 Dgr |
H302 H335 H318 |
|
|
|
016-091-00-5 |
C12-14-tert-alkylammonium 1-amino-9,10-dihydro-9,10-dioxo-4-(2,4,6-trimethylanilino)-anthraceen-2-sulfonaat |
414-110-5 |
— |
Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Dgr |
H318 H410 |
|
|
|
016-092-00-0 |
reactiemassa van: 4,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecaandithiol; 4,8-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecaandithiol; 5,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecaandithiol |
427-050-1 |
— |
Repr. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361f H315 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H361f H315 H317 H410 |
|
|
|
016-093-00-6 |
reactiemassa van: 4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinol-4-yl-tris(6-diazo-5,6-dihydro-5-oxonaftaleen-1-sulfonaat); 4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinolbis(6-diazo-5,6-dihydro-5-oxonaftaleen-1-sulfonaat) |
414-770-4 |
140698-96-0 |
Self-react. C **** Carc. 2 |
H242 H351 |
GHS02 GHS08 Dgr |
H242 H351 |
|
|
|
016-094-00-1 |
zwavel |
231-722-6 |
7704-34-9 |
Skin Irrit. 2 |
H315 |
GHS07 Wng |
H315 |
|
|
|
016-095-00-7 |
reactiemassa van: reactieproduct van 4,4'-methyleenbis[2-(4-hydroxybenzyl)-3,6-dimethylfenol] en 6-diazo-5,6-dihydro-5-oxo-naftaleensulfonaat (1:2); reactieproduct van 4,4'-methyleenbis[2-(4-hydroxybenzyl)-3,6-dimethylfenol] en 6-diazo-5,6-dihydro-5-oxo-naftaleensulfonaat (1:3) |
417-980-4 |
— |
Self-react. C **** Carc. 2 |
H242 H351 |
GHS02 GHS08 Dgr |
H242 H351 |
|
|
|
016-096-00-2 |
thifensulfuron-methyl (ISO); methyl-3-(4-methoxy-6-methyl-1,3,5-triazine-2-ylcarbamoylsulfamoyl)thiofeen-2-carboxylaat |
— |
79277-27-3 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
016-097-00-8 |
1-amino-2-methyl-2-propaanthiol-hydrochloride |
434-480-1 |
32047-53-3 |
Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 3 |
H302 H314 H317 H412 |
GHS05 GHS07 Dgr |
H302 H314 H317 H412 |
|
|
|
017-001-00-7 |
chloor |
231-959-5 |
7782-50-5 |
Ox. Gas 1 Press. Gas Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 |
H270 H331 H319 H335 H315 H400 |
GHS03 GHS04 GHS06 GHS09 Dgr |
H270 H331 H319 H335 H315 H400 |
|
M = 100 |
U |
017-002-00-2 |
waterstofchloride |
231-595-7 |
7647-01-0 |
Press. Gas Acute Tox. 3 * Skin Corr. 1A |
H331 H314 |
GHS04 GHS06 GHS05 Dgr |
H331 H314 |
|
|
U5 |
017-002-01-X |
zoutzuur … % |
231-595-7 |
— |
Skin Corr. 1B STOT SE 3 |
H314 H335 |
GHS05 GHS07 Dgr |
H314 H335 |
|
Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % EyeIrrit. 2; H319: 10 % ≤ C < 25 % STOT SE 3; H335: C ≥ 10 % |
B |
017-003-00-8 |
bariumchloraat |
236-760-7 |
13477-00-4 |
Ox. Sol. 1 Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 2 |
H271 H332 H302 H411 |
GHS03 GHS07 GHS09 Dgr |
H271 H332 H302 H411 |
|
|
|
017-004-00-3 |
kaliumchloraat |
223-289-7 |
3811-04-9 |
Ox. Sol. 1 Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 2 |
H271 H332 H302 H411 |
GHS03 GHS07 GHS09 Dgr |
H271 H332 H302 H411 |
|
|
|
017-005-00-9 |
natriumchloraat |
231-887-4 |
7775-09-9 |
Ox. Sol. 1 Acute Tox. 4 * Aquatic Chronic 2 |
H271 H302 H411 |
GHS03 GHS07 GHS09 Dgr |
H271 H302 H411 |
|
|
|
017-006-00-4 |
perchloorzuur … % |
231-512-4 |
7601-90-3 |
Ox. Liq. 1 Skin Corr. 1A |
H271 H314 |
GHS03 GHS05 Dgr |
H271 H314 |
|
Skin Corr. 1A; H314: C ≥ 50 % Skin Corr. 1B; H314: 10 % ≤ C < 50 % Skin Irrit. 2; H315: 1 % ≤ C < 10 % Eye Irrit. 2; H319: 1 % ≤ C < 10 % Ox. Liq. 1; H271: C > 50 %: Ox. Liq. 2; H272: C ≤ 50 %: |
B |
017-007-00-X |
bariumperchloraat |
236-710-4 |
13465-95-7 |
Ox. Sol. 1 Acute Tox. 4 * Acute Tox. 4 * |
H271 H332 H302 |
GHS03 GHS07 Dgr |
H271 H332 H302 |
|
|
|
017-008-00-5 |
kaliumperchloraat |
231-912-9 |
7778-74-7 |
Ox. Sol. 1 Acute Tox. 4 * |
H271 H302 |
GHS03 GHS07 Dgr |
H271 H302 |
|
|
|
017-009-00-0 |
ammoniumperchloraat |
232-235-1 |
7790-98-9 |
Expl. 1.1 Ox. Sol. 1 |
H201 H271 |
GHS01 Dgr |
H201 H271 |
|
|
T |
017-010-00-6 |
natriumperchloraat |
231-511-9 |
7601-89-0 |
Ox. Sol. 1 Acute Tox. 4 * |
H271 H302 |
GHS03 GHS07 Dgr |
H271 H302 |
|
|
|
017-011-00-1 |
natriumhypochloriet, oplossing … % actief Cl |
231-668-3 |
7681-52-9 |
Skin Corr. 1B Aquatic Acute 1 |
H314 H400 |
GHS05 GHS09 Dgr |
H314 H400 |
EUH031 |
EUH031: C ≥5 % |
B |
017-012-00-7 |
calciumhypochloriet |
231-908-7 |
7778-54-3 |
Ox. Sol. 2 Acute Tox. 4 * Skin Corr. 1B Aquatic Acute 1 |
H272 H302 H314 H400 |
GHS03 GHS05 GHS07 GHS09 Dgr |
H272 H302 H314 H400 |
EUH031 |
Skin Corr. 1B; H314: C ≥ 5 % Skin Irrit. 2; H315: 1 % ≤ C < 5 % Eye Dam.1; H318: 3 % ≤ C < 5 % Eye Irrit. 2; H319: 0,5 % ≤ C < 3 % M = 10 |
T |
017-013-00-2 |
calciumchloride |
233-140-8 |
10043-52-4 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
017-014-00-8 |
ammoniumchloride |
235-186-4 |
12125-02-9 |
Acute Tox. 4 * Eye Irrit. 2 |
H302 H319 |
GHS07 Wng |
H302 H319 |
|
|
|
017-015-00-3 |
(2-(aminomethyl)fenyl)acetylchloride-hydrochloride |
417-410-4 |
61807-67-8 |
Acute Tox. 4 * Skin Corr. 1A Skin Sens. 1 |
H302 H314 H317 |
GHS05 GHS07 Dgr |
H302 H314 H317 |
|
|
|
017-016-00-9 |
methyltrifenylfosfoniumchloride |
418-400-2 |
1031-15-8 |
Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 2 |
H312 H302 H315 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H312 H302 H315 H318 H411 |
|
|
|
017-017-00-4 |
(Z)-13-docosenyl-N,N-bis(2-hydroxyethyl)-N-methylammoniumchloride |
426-210-6 |
120086-58-0 |
Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H314 H400 H410 |
GHS05 GHS09 Dgr |
H314 H410 |
|
|
|
017-018-00-X |
N,N,N-trimethyl-2,3-bis(stearoyloxy)propylammoniumchloride |
405-660-7 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
017-019-00-5 |
(R)-1,2,3,4-tetrahydro-6,7-dimethoxy-1-veratrylisochinolinehydrochloride |
415-110-8 |
54417-53-7 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
017-020-00-0 |
ethylpropoxyaluminiumchloride |
421-790-7 |
13014-29-4 |
Water-react. 1 Skin Corr. 1A |
H260 H314 |
GHS02 GHS05 Dgr |
H260 H314 |
EUH014 |
|
|
017-021-00-6 |
beheenamidopropyl-dimethyl-(dihydroxypropyl) ammoniumchloride |
423-420-1 |
136920-10-0 |
Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H318 H317 H410 |
|
|
|
017-023-00-7 |
[fosfinylidyntris(oxy)]-tris[3-aminopropyl-2-hydroxy-N,N-dimethyl-N-(C6-18)-alkyl]-trichloriden |
425-520-9 |
197179-61-6 |
Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Dgr |
H318 H410 |
|
|
|
017-026-00-3 |
chloordioxide |
233-162-8 |
10049-04-4 |
Press. Gas Ox. Gas 1 Acute Tox. 2 * Skin Corr. 1B Aquatic Acute 1 |
H270 H330 H314 H400 |
GHS04 GHS03 GHS06 GHS05 GHS09 Dgr |
H270 H330 H314 H400 |
|
M = 10 |
5 |
017-026-01-0 |
chloordioxide … % |
233-162-8 |
10049-04-4 |
Acute Tox. 3 * Skin Corr. 1B Aquatic Acute 1 |
H301 H314 H400 |
GHS06 GHS05 GHS09 Dgr |
H301 H314 H400 |
|
Skin Corr. 1B; H314: C ≥ 5 % Skin Irrit. 2; H315: 1 % ≤ C < 5 % Eye Dam.1; H318: 3 % ≤ C < 5 % Eye Irrit. 2; H319: 0,3 % ≤ C < 3 % STOT SE 3; H335: C ≥ 3 % M = 10 |
B |
019-001-00-2 |
kalium |
231-119-8 |
7440-09-7 |
Water-react. 1 Skin Corr. 1B |
H260 H314 |
GHS02 GHS05 Dgr |
H260 H314 |
EUH014 |
|
|
019-002-00-8 |
kaliumhydroxide; bijtende potas |
215-181-3 |
1310-58-3 |
Acute Tox. 4 * Skin Corr. 1A |
H302 H314 |
GHS05 GHS07 Dgr |
H302 H314 |
|
Skin Corr. 1A; H314: C ≥ 5 % Skin Corr. 1B; H314: 2 % ≤ C < 5 % Skin Irrit. 2; H315: 0,5 % ≤ C < 2 % Eye Irrit. 2; H319: 0,5 % ≤ C < 2 % |
|
020-001-00-X |
calcium |
231-179-5 |
7440-70-2 |
Water-react. 2 |
H261 |
GHS02 Dgr |
H261 |
|
|
|
020-002-00-5 |
calciumcyanide |
209-740-0 |
592-01-8 |
Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H400 H410 |
GHS06 GHS09 Dgr |
H300 H410 |
EUH032 |
|
|
020-003-00-0 |
reactiemassa van: dicalcium-(bis(2-hydroxy-5-tetrapropenylfenylmethyl)methylamine)dihydroxide; tricalcium-(tris(2-hydroxy-5-tetrapropenylfenylmethyl)methylamine)trihydroxide; poly[calcium-((2-hydroxy-5-tetrapropenylfenylmethyl)methylamine)hydroxide] |
420-470-4 |
— |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Wng |
H319 H315 H317 |
|
|
|
022-001-00-5 |
titaantetrachloride |
231-441-9 |
7550-45-0 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
EUH014 |
|
|
022-002-00-0 |
titaan(4+)oxalaat |
403-260-7 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
022-003-00-6 |
bis(η5-cyclopentadiënyl)-bis(2,6-difluor-3-[pyrrool-1-yl]-phenyl)titaan |
412-000-1 |
125051-32-3 |
Flam. Sol. 1 Repr. 2 STOT RE 2 * Aquatic Chronic 2 |
H228 H361f *** H373 ** H411 |
GHS02 GHS08 GHS09 Dgr |
H228 H361f *** H373 ** H411 |
|
|
T |
022-004-00-1 |
kaliumtitaanoxide (K2Ti6O13) |
432-240-0 |
12056-51-8 |
Carc. 2 |
H351 |
GHS08 Wng |
H351 |
|
|
|
022-005-00-7 |
[N-(1,1-dimethylethyl)-1,1-dimethyl-1-[(1,2,3,4,5-η)-2,3,4,5-tetramethyl-2,4-cyclopentadieen-1-yl]silanaminato(2–)-κN][1,2,3,4-η)-1,3-pentadieen]-titaan |
419-840-8 |
169104-71-6 |
Flam. Sol. 1**** Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 4 |
H228 H314 H317 H413 |
GHS02 GHS05 GHS07 Dgr |
H228 H314 H317 H413 |
|
|
|
023-001-00-8 |
divanadiumpentaoxide; vanadiumpentaoxide |
215-239-8 |
1314-62-1 |
Muta. 2 Repr. 2 STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Aquatic Chronic 2 |
H341 H361d *** H372 ** H332 H302 H335 H411 |
GHS08 GHS07 GHS09 Dgr |
H341 H361d *** H372 ** H332 H302 H335 H411 |
|
|
|
024-001-00-0 |
chroom(VI)oxide |
215-607-8 |
1333-82-0 |
Ox. Sol. 1 Carc. 1A Muta. 1B Repr. 2 Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 Skin Corr. 1A Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H271 H350 H340 H361f *** H330 H311 H301 H372 ** H314 H334 H317 H400 H410 |
GHS03 GHS06 GHS08 GHS05 GHS09 Dgr |
H271 H350 H340 H361f *** H330 H311 H301 H372 ** H314 H334 H317 H410 |
|
STOT SE 3; H335: C ≥ 1 % |
|
024-002-00-6 |
kaliumdichromaat |
231-906-6 |
7778-50-9 |
Ox. Sol. 2 Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Acute Tox. 4 * Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H272 H350 H340 H360FD H330 H301 H372 ** H312 H314 H334 H317 H400 H410 |
GHS03 GHS06 GHS08 GHS05 GHS09 Dgr |
H272 H350 H340 H360FD H330 H301 H372 ** H312 H314 H334 H317 H410 |
|
STOT SE 3; H335: C ≥ 5 % |
3 |
024-003-00-1 |
ammoniumdichromaat |
232-143-1 |
7789-09-5 |
Ox. Sol. 2 **** Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Acute Tox. 4 * Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H272 H350 H340 H360FD H330 H301 H372 ** H312 H314 H334 H317 H400 H410 |
GHS03 GHS06 GHS08 GHS05 GHS09 Dgr |
H272 H350 H340 H360FD H330 H301 H372 ** H312 H314 H334 H317 H410 |
|
STOT SE 3; H335: C ≥ 5 % Resp. Sens.; H334: C ≥0,2 % Skin Sens.; H317:C ≥0,2 % |
G3 |
024-004-00-7 |
natriumdichromaat |
234-190-3 |
10588-01-9 |
Ox. Sol. 2 Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 4 * STOT RE 1 Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H272 H350 H340 H360FD H330 H301 H312 H372** H314 H334 H317 H400 H410 |
GHS03 GHS06 GHS05 GHS08 GHS09 Dgr |
H272 H350 H340 H360FD H330 H301 H312 H372** H314 H334 H317 H410 |
|
Resp. Sens. 1; H334: C ≥ 0,2 % Skin Sens. 1; H317:C ≥0,2 % STOT SE 3; H335: C ≥ 5 % |
3 |
024-005-00-2 |
chromyldichloride; chroomoxychloride |
239-056-8 |
14977-61-8 |
Ox. Liq. 1 Carc. 1B Muta. 1B Skin Corr. 1A Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H271 H350i H340 H314 H317 H400 H410 |
GHS03 GHS08 GHS05 GHS07 GHS09 Dgr |
H271 H350i H340 H314 H317 H410 |
|
Skin Corr. 1A; H314: C ≥ 10 % Skin Corr. 1B; H314: 5 % ≤ C < 10 % Skin Irrit. 2; H315: 0,5 % ≤ C < 5 % Eye Irrit. 2; H319: 0,5 % ≤ C < 5 % STOT SE 3; H335: 0,5 % ≤ C < 5 % Skin Sens. 1; H317: C ≥ 0,5 % |
T3 |
024-006-00-8 |
kaliumchromaat |
232-140-5 |
7789-00-6 |
Carc. 1B Muta. 1B Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H340 H319 H335 H315 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H340 H319 H335 H315 H317 H410 |
|
Skin Sens. 1; H317:C ≥ 0,5 % |
3 |
024-007-00-3 |
zinkchromaat met inbegrip van zinkkaliumchromaat |
— |
— |
Carc. 1A Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H302 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350 H302 H317 H410 |
|
|
A |
024-008-00-9 |
calciumchromaat |
237-366-8 |
13765-19-0 |
Carc. 1B Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H350 H302 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350 H302 H410 |
|
|
|
024-009-00-4 |
strontiumchromaat |
232-142-6 |
7789-06-2 |
Carc. 1B Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H350 H302 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350 H302 H400 H410 |
|
|
|
024-010-00-X |
dichroomtris(chromaat); chroom(III)chromaat; chromichromaat |
246-356-2 |
24613-89-6 |
Ox. Sol. 1 Carc. 1B Skin Corr. 1A Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H271 H350 H314 H317 H400 H410 |
GHS03 GHS08 GHS05 GHS07 GHS09 Dgr |
H271 H350 H314 H317 H410 |
|
|
T |
024-011-00-5 |
ammoniumbis(1-(3,5-dinitro-2-oxidofenylazo)-3-(N-fenylcarbamoyl)-2-naftolato)chromaat(1–) |
400-110-2 |
109125-51-1 |
Self-react. C **** Aquatic Acute 1 Aquatic Chronic 1 |
H242 H400 H410 |
GHS02 GHS09 Dgr |
H242 H410 |
|
|
|
024-012-00-0 |
trinatriumbis(7-aceetamido-2-(4-nitro-2-oxidofenylazo)-3-sulfonato-1-naftolato)chromaat(1–) |
400-810-8 |
— |
Muta. 2 |
H341 |
GHS08 Wng |
H341 |
|
|
|
024-013-00-6 |
trinatrium-(6-anilino-2-(5-nitro-2-oxidofenylazo)-3-sulfonato-1-naftolato)(4-sulfonato-1,1'-azodi-2,2'naftolato)chromaat(1–) |
402-500-8 |
— |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
024-014-00-1 |
trinatriumbis(2-(5-chloor-4-nitro-2-oxidofenylazo)-5-sulfonato-1-naftolato)chromaat(1–) |
402-870-0 |
93952-24-0 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
024-015-00-7 |
dinatrium(3-methyl-4-(5-nitro-2-oxidofenylazo)-1-fenylpyrazololato)(1-(3-nitro-2-oxido-5-sulfonatofenylazo)-2-naftolato)chromaat(1–) |
404-930-1 |
— |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H332 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H332 H318 H411 |
|
|
|
024-016-00-2 |
tetradecylammoniumbis(1-(5-chloor-2-oxidofenylazo)-2-naftolato)chromaat(1–) |
405-110-6 |
88377-66-6 |
STOT RE 2 * Aquatic Chronic 4 |
H373 ** H413 |
GHS08 Wng |
H373 ** H413 |
|
|
|
024-017-00-8 |
chroom(VI)verbindingen met uitzondering van bariumchromaat en van elders in deze bijlage vermelde verbindingen |
— |
— |
Carc. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H317 H410 |
|
|
A |
024-018-00-3 |
natriumchromaat |
231-889-5 |
7775-11-3 |
Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Acute Tox. 4 * Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H340 H360FD H330 H301 H372 ** H312 H314 H334 H317 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H350 H340 H360FD H330 H301 H372 ** H312 H314 H334 H317 H410 |
|
Resp. Sens.; H334: C ≥ 0,2 % Skin Sens.; H317:C ≥ 0,2 % |
3 |
024-019-00-9 |
hoofdbestanddeel: acetoazijnzuuranilide / 3-amino-1-hydroxybenzeen (ATAN-MAP): trinatrium {6-[(2 of 3 of 4)-amino-(4 of 5 of 6)-hydroxyfenylazo]-5'-(fenylsulfamoyl)-3-sulfonatonaftaleen-2-azobenzeen-1,2'-diolato}-{6''-[1-(fenylcarbamoyl)ethylazo]-5'-(fenylsulfamoyl)-3-sulfonatonaftaleen-2-azobenzeen-1'',2'''-diolato}chromaat(III); bijproduct 1: acetoazijnzuuranilide / acetoazijnzuuranilide (ATAN-ATAN): trinatrium-bis{6-[1-(fenylcarbamoyl)ethylazo]-5'''-(fenylsulfonyl)-3''-sulfonatonaftaleen-2-azobenzeen-1,2'-diolato}chromaat(III); bijproduct 2: 3-amino-1-hydroxybenzeen / 3-amino-1-hydroxybenzeen (MAP-MAP): trinatrium-bis{6-[(2 of 3 of 4)-amino-(4 of 5 of 6)-hydroxyfenylazo]-5'-(fenylsulfamoyl)-3-sulfonatonaftaleen-2-azobenzeen-1,2'-diolato}chromaat (III) |
419-230-1 |
— |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
024-020-00-4 |
trinatrium-bis[(3'-nitro-5'-sulfonato(6-amino-2-[4-(2-hydroxy-1-naftylazo)fenylsulfonylamino]pyrimidine-5-azo)benzeen-2',4-diolato)]chromaat(III) |
418-220-4 |
— |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
024-021-00-X |
kaliumtetranatriumbis[(N,N'-n)-1'-(fenylcarbamoyl)-3,5-disulfonatobenzeenazo-1'-prop-1'-een-2,2'-diolato]chromaat(III) |
425-830-4 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
025-001-00-3 |
mangaandioxide |
215-202-6 |
1313-13-9 |
Acute Tox. 4 * Acute Tox. 4 * |
H332 H302 |
GHS07 Wng |
H332 H302 |
|
|
|
025-002-00-9 |
kaliumpermanganaat |
231-760-3 |
7722-64-7 |
Ox. Sol. 2 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H272 H302 H400 H410 |
GHS03 GHS07 GHS09 Dgr |
H272 H302 H410 |
|
|
|
025-003-00-4 |
mangaansulfaat |
232-089-9 |
7785-87-7 |
STOT RE 2 * Aquatic Chronic 2 |
H373 ** H411 |
GHS08 GHS09 Wng |
H373 ** H411 |
|
|
|
025-004-00-X |
bis(N,N',N''-trimethyl-1,4,7-triazacyclononaan)-trioxo-dimangaan(IV)di(hexafluorofosfaat)-monohydraat |
411-760-1 |
116633-53-5 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
025-005-00-5 |
reactiemassa van: trinatrium[29H,31H-ftalocyanine-C, C,C-trisulfonato(6–)-N 29,N 30,N 31,N 32]manganaat(3–); tetranatrium[29H,31H-ftalocyanine-C, C,C, C-tetrasulfonato(6–)-N 29,N 30,N 31,N 32]manganaat(3–); pentanatrium[29H,31H-ftalocyanine-C, C,C, C,C-pentasulfonato(6–)-N 29,N 30,N 31,N 32]manganaat(3–) |
417-660-4 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
026-001-00-6 |
(η-cumeen)-(η-cyclopentadiënyl)ijzer(II)-hexafluorantimonaat |
407-840-0 |
100011-37-8 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 |
H302 H318 H412 |
GHS05 GHS07 Dgr |
H302 H318 H412 |
|
|
|
026-002-00-1 |
(η-cumeen)-(η-cyclopentadiënyl)ijzer(II)-trifluormethaan-sulfonaat |
407-880-9 |
117549-13-0 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
026-003-00-7 |
ijzer(II)sulfaat |
231-753-5 |
7720-78-7 |
Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 |
H302 H319 H315 |
GHS07 Wng |
H302 H319 H315 |
|
|
|
026-003-01-4 |
ijzer(II)sulfaat (1:1)-heptahydraat; zwavelzuur, ijzer(II)zout (1:1), heptahydraat; ijzersulfaat-heptahydraat |
231-753-5 |
7782-63-0 |
Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 |
H302 H319 H315 |
GHS07 Wng |
H302 H319 H315 |
|
Skin Irrit.2; H315: C ≥ 25 % |
|
026-004-00-2 |
kaliumferriet |
430-010-4 |
12160-44-0 |
Skin Corr. 1B Skin Sens. 1 |
H314 H317 |
GHS05 GHS07 Dgr |
H314 H317 |
|
|
|
027-001-00-9 |
kobalt |
231-158-0 |
7440-48-4 |
Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 4 |
H334 H317 H413 |
GHS08 Dgr |
H334 H317 H413 |
|
|
|
027-002-00-4 |
kobaltoxide |
215-154-6 |
1307-96-6 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
M=10 |
|
027-003-00-X |
kobaltsulfide |
215-273-3 |
1317-42-6 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
M=10 |
|
027-004-00-5 |
kobaltdichloride |
231-589-4 |
7646-79-9 |
Carc. 1B Muta. 2 Repr. 1B Acute Tox. 4 * Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360F*** H302 H334 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H341 H360F*** H302 H334 H317 H410 |
|
Carc. 1B; H350i: C ≥ 0,01 % M=10 |
1 |
027-005-00-0 |
kobaltsulfaat |
233-334-2 |
10124-43-3 |
Carc. 1B Muta. 2 Repr. 1B Acute Tox. 4 * Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360F*** H302 H334 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H341 H360F*** H302 H334 H317 H410 |
|
Carc. 1B; H350i: C ≥ 0,01 % M=10 |
1 |
027-006-00-6 |
kobaltdi(acetaat) |
200-755-8 |
71-48-7 |
Carc. 1B Muta. 2 Repr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360F*** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360F*** H334 H317 H410 |
|
Carc. 1B; H350i: C ≥ 0,01 % M = 10 |
1 |
027-007-00-1 |
zinkhexacyaankobaltaat(III), complex met tert-butylalcohol/polypropyleenglycol |
425-240-7 |
— |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
027-008-00-7 |
complex van kobalt(III)-bis(N-fenyl-4-(5-ethylsulfonyl-2-hydroxyfenylazo)-3-hydroxynaftylamide), gehydrateerd (n H2O, 2 <n <3) |
427-390-9 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
027-009-00-2 |
kobaltdinitraat |
233-402-1 |
10141-05-6 |
Carc. 1B Muta. 2 Repr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360F*** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360F*** H334 H317 H410 |
|
Carc. 1B; H350i: C ≥ 0,01 % M = 10 |
1 |
027-010-00-8 |
kobaltcarbonaat |
208-169-4 |
513-79-1 |
Carc. 1B Muta. 2 Repr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360F*** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360F*** H334 H317 H410 |
|
Carc. 1B; H350i: C ≥ 0,01 % M=10 |
1 |
028-001-00-1 |
tetracarbonylnikkel; nikkeltetracarbonyl |
236-669-2 |
13463-39-3 |
Flam. Liq. 2 Carc. 2 Repr. 1B Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H225 H351 H360D *** H330 H400 H410 |
GHS02 GHS06 GHS08 GHS09 Dgr |
H225 H351 H360D *** H330 H410 |
|
|
|
028-002-00-7 |
nikkel |
231-111-4 |
7440-02-0 |
Carc. 2 STOT RE 1 Skin Sens. 1 |
H351 H372** H317 |
GHS08 GHS07 Dgr |
H351 H372** H317 |
|
|
S7 |
028-002-01-4 |
nikkelpoeder; [deeltjes met diameter < 1 mm] |
231-111-4 |
7440-02-0 |
Carc. 2 STOT RE 1 Skin Sens. 1 Aquatic Chronic 3 |
H351 H372** H317 H412 |
GHS08 GHS07 Dgr |
H351 H372** H317 H412 |
|
|
|
028-003-00-2 |
nikkelmonoxide; [1] nikkeloxide; [2] bunseniet [3] |
215-215-7[1] 234-323-5[2]-[3] |
1313-99-1 [1] 11099-02-8 [2] 34492-97-2 [3] |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Chronic 4 |
H350i H372** H317 H413 |
GHS08 GHS07 Dgr |
H350i H372** H317 H413 |
|
|
|
028-004-00-8 |
nikkeldioxide |
234-823-3 |
12035-36-8 |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Chronic 4 |
H350i H372** H317 H413 |
GHS08 GHS07 Dgr |
H350i H372** H317 H413 |
|
|
|
028-005-00-3 |
dinikkeltrioxide |
215-217-8 |
1314-06-3 |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Chronic 4 |
H350i H372** H317 H413 |
GHS08 GHS07 Dgr |
H350i H372** H317 H413 |
|
|
|
028-006-00-9 |
nikkel(II)sulfide; [1] nikkelsulfide; [2] milleriet [3] |
240-841-2[1] 234-349-7[2]-[3] |
16812-54-7 [1] 11113-75-0 [2] 1314-04-1 [3] |
Carc. 1A Muta. 2 STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H341 H372** H317 H410 |
|
|
|
028-007-00-4 |
trinikkeldisulfide; nikkelsubsulfide; [1] heazlewoodiet [2] |
234-829-6[1] -[2] |
12035-72-2 [1] 12035-71-1 [2] |
Carc. 1A Muta. 2 STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H341 H372** H317 H410 |
|
|
|
028-008-00-X |
nikkeldihydroxide; [1] nikkelhydroxide [2] |
235-008-5 [1] 234-348-1 [2] |
12054-48-7 [1] 11113-74-9 [2] |
Carc. 1A Repr. 1B Muta. 2 STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H360D*** H341 H372** H332 H302 H315 H334 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H360D*** H341 H372** H332 H302 H315 H334 H317 H410 |
|
|
|
028-009-00-5 |
nikkelsulfaat |
232-104-9 |
7786-81-4 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H332 H302 H315 H334 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H341 H360D*** H372** H332 H302 H315 H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Irrit. 2; H315: C ≥ 20 % Skin Sens. 1; H317: C ≥ 0,01 % M = 1 |
|
028-010-00-0 |
nikkelcarbonaat; basisch nikkelcarbonaat; koolzuur, nikkel(2+)zout; [1] koolzuur, nikkelzout; [2] [μ-[carbonato(2–)-O:O']]dihydroxytrinikkel; [3] [carbonato(2–)] tetrahydroxytrinikkel [4] |
222-068-2 [1] 240-408-8 [2] 265-748-4 [3] 235-715-9 [4] |
3333-67-3 [1] 16337-84-1 [2] 65405-96-1 [3] 12607-70-4 [4] |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H332 H302 H315 H334 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H341 H360D*** H372** H332 H302 H315 H334 H317 H410 |
|
|
|
028-011-00-6 |
nikkeldichloride |
231-743-0 |
7718-54-9 |
Carc. 1A Muta. 2 Repr. 1B Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H331 H301 H372** H315 H334 H317 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350i H341 H360D*** H331 H301 H372** H315 H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % < C < 1 % Skin Irrit. 2; H315: C ≥ 20 % Skin Sens. 1; H317: C ≥ 0,01 % M = 1 |
|
028-012-00-1 |
nikkeldinitraat; [1] salpeterzuur, nikkelzout [2] |
236-068-5 [1] 238-076-4 [2] |
13138-45-9 [1] 14216-75-2 [2] |
Ox. Sol. 2 Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H272 H350i H341 H360D*** H372** H332 H302 H315 H318 H334 H317 H400 H410 |
GHS03 GHS05 GHS08 GHS07 GHS09 Dgr |
H272 H350i H341 H360D*** H372** H332 H302 H315 H318 H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % < C < 1 % Skin Irrit. 2; H315: C ≥ 20 % Skin Sens. 1; H317 C ≥0,01 % M = 1 |
|
028-013-00-7 |
nikkelmatte |
273-749-6 |
69012-50-6 |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H372** H317 H410 |
|
|
|
028-014-00-2 |
afvalslik en bezinksel, elektrolytische koperzuivering, ontkoperd, nikkelsulfaat |
295-859-3 |
92129-57-2 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H332 H302 H315 H334 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H341 H360D*** H372** H332 H302 H315 H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373:0,1 % ≤ C < % Skin Sens. 1; H317:C ≥ 0,01 % M=1 |
|
028-015-00-8 |
afvalslik en bezinksel, elektrolytische koperzuivering, ontkoperd |
305-433-1 |
94551-87-8 |
Carc. 1A Muta. 2 Repr. 1A STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
|
|
028-016-00-3 |
nikkeldiperchloraat; perchloorzuur, nikkel(II)zout |
237-124-1 |
13637-71-3 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H314 H334 H317 H400 H410 |
GHS05 GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H314 H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 |
|
028-017-00-9 |
dikaliumnikkelbis(sulfaat); [1] diammoniumnikkelbis(sulfaat) [2] |
237-563-9 [1] 239-793-2 [2] |
13842-46-1 [1] 15699-18-0 [2] |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H332 H302 H334 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H341 H360D*** H372** H332 H302 H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373:0,1 % ≤ C < 1 % Skin Sens. 1; H317:C ≥ 0,01 % M=1 |
|
028-018-00-4 |
nikkelbis(sulfamidaat); nikkelsulfamaat |
237-396-1 |
13770-89-3 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317:C ≥ 0,01 % M=1 |
|
028-019-00-X |
nikkelbis(tetrafluorboraat) |
238-753-4 |
14708-14-6 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥0,01 % M=1 |
|
028-021-00-0 |
nikkeldiformiaat; [1] mierenzuur, nikkelzout; [2] mierenzuur, kopernikkelzout [3] |
222-101-0 [1] 239-946-6 [2] 268-755-0 [3] |
3349-06-2 [1] 15843-02-4 [2] 68134-59-8 [3] |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317:C ≥0,01 % M=1 |
|
028-022-00-6 |
nikkeldi(acetaat); [1] nikkelacetaat [2] |
206-761-7 [1] 239-086-1 [2] |
373-02-4 [1] 14998-37-9 [2] |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H332 H302 H334 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H341 H360D*** H372** H332 H302 H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317:C≥ 0,01 % M = 1 |
|
028-024-00-7 |
nikkeldibenzoaat |
209-046-8 |
553-71-9 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317:C≥ 0,01 % M=1 |
|
028-025-00-2 |
nikkelbis(4-cyclohexylbutyraat) |
223-463-2 |
3906-55-6 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317:C ≥0,01 % M=1 |
|
028-026-00-8 |
nikkel(II)stearaat; nikkel(II)octadecanoaat |
218-744-1 |
2223-95-2 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373:0,1 % ≤ C < 1 % Skin Sens. 1; H317:C;≥0,01 % M=1 |
|
028-027-00-3 |
nikkeldilactaat |
— |
16039-61-5 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372:C ≥ 1 % STOT RE 2; H373:0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 |
|
028-028-00-9 |
nikkel(II)octanoaat |
225-656-7 |
4995-91-9 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Skin Corr. 1A Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H314 H334 H317 H400 H410 |
GHS05 GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H314 H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 |
|
028-029-00-4 |
nikkeldifluoride; [1] nikkeldibromide; [2] nikkeldijodide; [3] nikkelkaliumfluoride [4] |
233-071-3 [1] 236-665-0 [2] 236-666-6 [3] -[4] |
10028-18-9 [1] 13462-88-9 [2] 13462-90-3 [3] 11132-10-8 [4] |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥0,01 % M=1 |
|
028-030-00-X |
nikkelhexafluorosilicaat |
247-430-7 |
26043-11-8 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317:C ≥ 0,01 % M=1 |
|
028-031-00-5 |
nikkelselenaat |
239-125-2 |
15060-62-5 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317:C≥0,01 % M=1 |
|
028-032-00-0 |
nikkelwaterstoffosfaat; [1] nikkelbis(diwaterstoffosfaat); [2] trinikkelbis(orthofosfaat); [3] dinikkeldifosfaat; [4] nikkelbis(fosfinaat); [5] nikkelfosfinaat; [6] fosforzuur, calciumnikkelzout; [7] difosforzuur, nikkel(II)zout [8] |
238-278-2 [1] 242-522-3 [2] 233-844-5 [3] 238-426-6 [4] 238-511-8 [5] 252-840-4 [6] -[7] -[8] |
14332-34-4 [1] 18718-11-1 [2] 10381-36-9 [3] 14448-18-1 [4] 14507-36-9 [5] 36026-88-7 [6] 17169-61-8 [7] 19372-20-4 [8] |
Carc. 1A STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H372** H334 H317 H410 |
|
|
|
028-033-00-6 |
diammoniumnikkelhexacyanoferraat |
— |
74195-78-1 |
Carc. 1A STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H372** H334 H317 H410 |
|
|
|
028-034-00-1 |
nikkeldicyanide |
209-160-8 |
557-19-7 |
Carc. 1A STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H372** H334 H317 H410 |
EUH032 |
|
|
028-035-00-7 |
nikkelchromaat |
238-766-5 |
14721-18-7 |
Carc. 1A STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H372** H334 H317 H410 |
|
|
|
028-036-00-2 |
nikkel(II)silicaat; [1] dinikkelorthosilicaat; [2] nikkelsilicaat(3:4); [3] kiezelzuur, nikkelzout; [4] triwaterstofhydroxybis[orthosilicato(4–)]trinikkelaat(3–) [5] |
244-578-4 [1] 237-411-1 [2] 250-788-7 [3] 253-461-7 [4] 235-688-3 [5] |
21784-78-1 [1] 13775-54-7 [2] 31748-25-1 [3] 37321-15-6 [4] 12519-85-6 [5] |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H372** H317 H410 |
|
|
|
028-037-00-8 |
dinikkelhexacyanoferraat |
238-946-3 |
14874-78-3 |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H372** H317 H410 |
|
|
|
028-038-00-3 |
trinikkelbis(arsenaat); nikkel(II)arsenaat |
236-771-7 |
13477-70-8 |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350 H372** H317 H410 |
|
|
|
028-039-00-9 |
nikkeloxalaat; [1] oxaalzuur, nikkelzout [2] |
208-933-7 [1] 243-867-2 [2] |
547-67-1 [1] 20543-06-0 [2] |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H372** H317 H410 |
|
|
|
028-040-00-4 |
nikkeltelluride |
235-260-6 |
12142-88-0 |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H372** H317 H410 |
|
|
|
028-041-00-X |
trinikkeltetrasulfide |
— |
12137-12-1 |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H372** H317 H410 |
|
|
|
028-042-00-5 |
trinikkelbis(arseniet) |
— |
74646-29-0 |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H372** H317 H410 |
|
|
|
028-043-00-0 |
kobaltnikkel grijze periklaas; C.I. Pigment Black 25; C.I. 77332; [1] kobaltnikkeldioxide; [2] kobaltnikkeloxide [3] |
269-051-6 [1] 261-346-8 [2] -[3] |
68186-89-0 [1] 58591-45-0 [2] 12737-30-3 [3] |
Carc. 1A STOT RE 1 Skin Sens. 1 |
H350i H372** H317 |
GHS08 GHS07 Dgr |
H350i H372** H317 |
|
|
|
028-044-00-6 |
nikkeltintrioxide; nikkelstannaat |
234-824-9 |
12035-38-0 |
Carc. 1A STOT RE 1 Skin Sens. 1 |
H350i H372** H317 |
GHS08 GHS07 Dgr |
H350i H372** H317 |
|
|
|
028-045-00-1 |
nikkeltriuraandecaoxide |
239-876-6 |
15780-33-3 |
Carc. 1A STOT RE 1 Skin Sens. 1 |
H350i H372** H317 |
GHS08 GHS07 Dgr |
H350i H372** H317 |
|
|
|
028-046-00-7 |
nikkeldithiocyanaat |
237-205-1 |
13689-92-4 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
EUH032 |
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317:C≥0,01 % M=1 |
|
028-047-00-2 |
nikkeldichromaat |
239-646-5 |
15586-38-6 |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372:C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317:C≥0,01 % M=1 |
|
028-048-00-8 |
nikkel(II)seleniet |
233-263-7 |
10101-96-9 |
Carc. 1A STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H372** H334 H317 H410 |
|
|
|
028-049-00-3 |
nikkelselenide |
215-216-2 |
1314-05-2 |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H372** H317 H410 |
|
|
|
028-050-00-9 |
kiezelzuur, loodnikkelzout |
— |
68130-19-8 |
Carc. 1A Repr. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H360Df H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H360Df H372** H317 H410 |
|
|
|
028-051-00-4 |
nikkeldiarsenide; [1] nikkelarsenide [2] |
235-103-1 [1] 248-169-1 [2] |
12068-61-0 [1] 27016-75-7 [2] |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H372** H317 H410 |
|
|
|
028-052-00-X |
nikkelbariumtitaan lichtgeel prideriet; C.I. Pigment Yellow 157; C.I. 77900 |
271-853-6 |
68610-24-2 |
Carc. 1A STOT RE 1 Skin Sens. 1 |
H350i H372** H317 |
GHS08 GHS07 Dgr |
H350i H372** H317 |
|
|
|
028-053-00-5 |
nikkeldichloraat; [1] nikkeldibromaat; [2] ethylwaterstofsulfaat, nikkel(II)zout [3] |
267-897-0 [1] 238-596-1 [2] 275-897-7 [3] |
67952-43-6 [1] 14550-87-9 [2] 71720-48-4 [3] |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < % Skin Sens. 1; H317:C≥0,01 %1 M=1 |
|
028-054-00-0 |
nikkel(II)trifluoracetaat; [1] nikkel(II)propionaat; [2] nikkelbis(benzeensulfonaat); [3] nikkel(II)hydrogeencitraat; [4] citroenzuur, ammoniumnikkelzout; [5] citroenzuur, nikkelzout; [6] nikkelbis(2-ethylhexanoaat); [7] 2-ethylhexaanzuur, nikkelzout; [8] dimethylhexaanzuur, nikkelzout; [9] nikkel(II)isoöctanoaat; [10] nikkelisoöctanoaat; [11] nikkelbis(isononanoaat); [12] nikkel(II)neononanoaat; [13] nikkel(II)isodecanoaat; [14] nikkel(II)neodecanoaat; [15] neodecaanzuur, nikkelzout; [16] nikkel(II)neoündecanoaat; [17] bis(D-gluconato-O 1,O 2)nikkel; [18] nikkel-3,5-bis(tert-butyl)-4-hydroxybenzoaat (1:2); [19] nikkel(II)palmitaat; [20] (2-ethylhexanoato-O)(isononanoato-O)nikkel; [21] (isononanoato-O)(isoöctanoato-O)nikkel; [22] (isoöctanoato-O)(neodecanoato-O)nikkel; [23] (2-ethylhexanoato-O)(isodecanoato-O)nikkel; [24] 2-ethylhexanoato-O)(neodecanoato-O)nikkel; [25] (isodecanoato-O)(isoöctanoato-O)nikkel; [26] (isodecanoato-O)(isononanoato-O)nikkel; [27] (isononanoato-O)(neodecanoato-O)nikkel; [28] vetzuren, C6-19-vertakte, nikkelzouten; [29] vetzuren, C 8-18- en C18-onverzadigd, nikkelzouten; [30] 2,7-naftaleendisulfonzuur, nikkel(II)zout; [31] |
240-235-8 [1] 222-102-6 [2] 254-642-3 [3] 242-533-3 [4] 242-161-1 [5] 245-119-0 [6] 224-699-9 [7] 231-480-1 [8] 301-323-2 [9] 249-555-2 [10] 248-585-3 [11] 284-349-6 [12] 300-094-6 [13] 287-468-1 [14] 287-469-7 [15] 257-447-1 [16] 300-093-0 [17] 276-205-6 [18] 258-051-1 [19] 294-302-1 [29] 283-972-0 [30] -[31] 237-138-8 [20] 287-470-2 [21] 287-471-8 [22] 284-347-5 [23] 284-351-7 [24] 285-698-7 [25] 285-909-2 [26] 284-348-0 [27] 287-592-6 [28] |
16083-14-0 [1] 3349-08-4 [2] 39819-65-3 [3] 18721-51-2 [4] 18283-82-4 [5] 22605-92-1 [6] 4454-16-4 [7] 7580-31-6 [8] 93983-68-7 [9] 29317-63-3 [10] 27637-46-3 [11] 84852-37-9 [12] 93920-10-6 [13] 85508-43-6 [14] 85508-44-7 [15] 51818-56-5 [16] 93920-09-3 [17] 71957-07-8 [18] 52625-25-9 [19] 13654-40-5 [20] 85508-45-8 [21] 85508-46-9 [22] 84852-35-7 [23] 84852-39-1 [24] 85135-77-9 [25] 85166-19-4 [26] 84852-36-8 [27] 85551-28-6 [28] 91697-41-5 [29] 84776-45-4 [30] 72319-19-8 [31] |
Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H341 H360D*** H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H341 H360D*** H372** H334 H317 H410 |
|
STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M=1 |
|
028-055-00-6 |
nikkel(II)sulfiet; [1] nikkeltelluurtrioxide; [2] nikkeltelluurtetraoxide; [3] molybdeennikkelhydroxideoxidefosfaat [4] |
231-827-7 [1] 239-967-0 [2] 239-974-9 [3] 268-585-7 [4] |
7757-95-1 [1] 15851-52-2 [2] 15852-21-8 [3] 68130-36-9 [4] |
Carc. 1A STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H334 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350i H372** H334 H317 H410 |
|
|
|
028-056-00-1 |
nikkelboride (NiB); [1] dinikkelboride; [2] trinikkelboride; [3] nikkelboride; [4] dinikkelsilicide; [5] nikkeldisilicide; [6] dinikkelfosfide; [7] nikkelboorfosfide [8] |
234-493-0 [1] 234-494-6 [2] 234-495-1 [3] 235-723-2 [4] 235-033-1 [5] 235-379-3 [6] 234-828-0 [7] -[8] |
12007-00-0 [1] 12007-01-1 [2] 12007-02-2 [3] 12619-90-8 [4] 12059-14-2 [5] 12201-89-7 [6] 12035-64-2 [7] 65229-23-4 [8] |
Carc. 1A STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H372** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350i H372** H317 H410 |
|
|
|
028-057-00-7 |
dialuminiumnikkeltetraoxide; [1] nikkeltitaantrioxide; [2] nikkeltitaanoxide; [3] nikkeldivanadiumhexaoxide; [4] kobaltdimolybdeennikkeloctaoxide; [5] nikkelzirkoniumtrioxide; [6] molybdeennikkeltetraoxide; [7] nikkelwolfraamtetraoxide; [8] olivijn, nikkelgroen; [9] lithiumnikkeldioxide; [10] molybdeennikkeloxide; [11] |
234-454-8 [1] 234-825-4 [2] 235-752-0 [3] 257-970-5 [4] 268-169-5 [5] 274-755-1 [6] 238-034-5 [7] 238-032-4 [8] 271-112-7 [9] -[10] -[11] |
12004-35-2 [1] 12035-39-1 [2] 12653-76-8 [3] 52502-12-2 [4] 68016-03-5 [5] 70692-93-2 [6] 14177-55-0 [7] 14177-51-6 [8] 68515-84-4 [9] 12031-65-1 [10] 12673-58-4 [11] |
Carc. 1A STOT RE 1 Skin Sens. 1 |
H350i H372** H317 |
GHS08 GHS07 Dgr |
H350i H372** H317 |
|
|
|
028-058-00-2 |
kobaltlithiumnikkeloxide |
442-750-5 |
— |
Carc. 1A Acute Tox. 2 * STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350i H330 H372** H317 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350i H330 H372** H317 H410 |
|
|
|
029-001-00-4 |
koperchloride; koper(I)chloride; kopermonochloride |
231-842-9 |
7758-89-6 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H400 H410 |
|
|
|
029-003-00-5 |
nafteenzuur, koperzouten; kopernaftenaat |
215-657-0 |
1338-02-9 |
Flam. Liq. 3 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H226 H302 H400 H410 |
GHS02 GHS07 GHS09 Wng |
H226 H302 H410 |
|
|
|
029-004-00-0 |
kopersulfaat |
231-847-6 |
7758-98-7 |
Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H315 H410 |
|
|
|
029-005-00-6 |
(tris(chloormetil)ftalocyaninato)koper(II), reactieprodukten met N-methylpiperazine en methoxyazijnzuur |
401-260-1 |
— |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
029-006-00-1 |
tris(octadec-9-enylammonium)-(trisulfonatoftalocyaninato)koper(II) |
403-210-4 |
— |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
029-007-00-7 |
(trinatrium-(2-((3-(6-(2-chloor-5-sulfonato)anilino-4-(3-carboxypyridinio)-1,3,5-triazine-2-ylamino)-2-oxido-5-sulfonatofenylazo)fenylmethylazo)-4-sulfonatobenzoato)koper(3–))hydroxide |
404-670-9 |
89797-01-3 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
G |
029-008-00-2 |
koper(II)methaansulfonaat |
405-400-2 |
54253-62-2 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H318 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H410 |
|
|
|
029-009-00-8 |
ftalocyanine-N-[3-(diëthylamino)propyl]sulfonamide-kopercomplex |
413-650-9 |
93971-95-0 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
029-010-00-3 |
reactiemassa van verbindingen van (dodecakis(p-tolylthio)ftalocyaninato)koper(II) tot en met (hexadecakis(p-tolylthio)ftalocyaninato)koper(II) |
407-700-9 |
101408-30-4 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
029-011-00-9 |
natrium[29H,31H-ftalocyaninato-(2–)-N 29,N 30,N 31,N 32]-((3-(N-methyl-N-(2-hydroxyethyl)amino)propyl)amino)sulfonyl-sulfonaat, kopercomplex |
412-730-0 |
150522-10-4 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
|
|
029-012-00-4 |
natrium-((N-(3-trimethylammoniopropyl)sulfamoyl)methylsulfonatoftalocyaninato)koper(II) |
407-340-2 |
124719-24-0 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
029-013-00-X |
trinatrium-(2-(α-(3-(4-chloor-6-(2-(2-(vinylsulfonyl)ethoxy)ethylamino)-1,3,5-triazine-2-ylamino)-2-oxido-5-sulfonatofenylazo)benzylideenhydrazino)-4-sulfonatobenzoato)koper(II) |
407-580-8 |
130201-51-3 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
029-014-00-5 |
reactiemassa van: 2,2'-[[cis-1,2-cyclohexaandiylbis(nitrilomethylideen)]bis[fenolaat]](2–)N,N',O,O'-kopercomplex; 2,2'-[[trans-1,2-cyclohexaandiylbis(nitrilomethylidyn)]bis[fenolaat]](2–)N,N',O,O'-kopercomplex |
419-610-7 |
171866-24-3 |
STOT RE 2 * Aquatic Chronic 2 |
H373** H411 |
GHS08 GHS09 Wng |
H373** H411 |
|
|
|
030-001-00-1 |
zinkpoeder — zinkstof (pyrofoor) |
231-175-3 |
7440-66-6 |
Water-react. 1 Pyr. Sol. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H260 H250 H400 H410 |
GHS02 GHS09 Dgr |
H260 H250 H410 |
|
|
T |
030-001-01-9 |
zinkpoeder — zinkstof (gestabiliseerd) |
231-175-3 |
7440-66-6 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
030-003-00-2 |
zinkchloride |
231-592-0 |
7646-85-7 |
Acute Tox. 4 * Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H302 H314 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H302 H314 H410 |
|
STOT SE 3; H335: C ≥ 5 % |
|
030-004-00-8 |
dimethylzink; [1] diëthylzink [2] |
208-884-1 [1] 209-161-3 [2] |
544-97-8 [1] 557-20-0 [2] |
Pyr. Liq. 1 Water-react. 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H250 H260 H314 H400 H410 |
GHS02 GHS05 GHS09 Dgr |
H250 H260 H314 H410 |
EUH014 |
|
|
030-005-00-3 |
diamminediisocyanatozink |
401-610-3 |
— |
Acute Tox. 4 * Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 |
H302 H318 H334 H317 H400 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H302 H318 H334 H317 H400 |
|
|
|
030-006-00-9 |
zinksulfaat (gehydrateerd) (mono-, hexa- en heptahydraat); [1] zinksulfaat (watervrij) [2] |
231-793-3 [1] 231-793-3 [2] |
7446-19-7 [1] 7733-02-0 [2] |
Acute Tox. 4 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H318 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H410 |
|
|
|
030-007-00-4 |
bis(3,5-di-tert-butylsalicylato-O 1,O 2)zink |
403-360-0 |
42405-40-3 |
Flam. Sol. 1 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H228 H302 H400 H410 |
GHS02 GHS07 GHS09 Dgr |
H228 H302 H410 |
|
|
T |
030-008-00-X |
hydroxo(2-(benzeensulfonamido)benzoato)zink(II) |
403-750-0 |
113036-91-2 |
Acute Tox. 4 * Aquatic Chronic 2 |
H332 H411 |
GHS07 GHS09 Wng |
H332 H411 |
|
|
|
030-009-00-5 |
zink-bis(4-(n-octyloxycarbonylamino)salicylaat)-dihydraat |
417-130-2 |
— |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
030-010-00-0 |
2-dodec-1-enylbutaandizuur, 4-methylester zinkzout |
430-740-3 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
030-011-00-6 |
trizinkbis(orthofosfaat) |
231-944-3 |
7779-90-0 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
030-012-00-1 |
aluminium-magnesium-zink-carbonaat-hydroxide |
423-570-6 |
169314-88-9 |
Aquatic Chronic 4 |
H413 |
|
H413 |
|
|
|
030-013-00-7 |
zinkoxide |
215-222-5 |
1314-13-2 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
030-015-00-8 |
tetrazink(2+)bis(hexacyanokobalt(3+))diacetaat |
440-060-9 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
033-001-00-X |
arseen |
231-148-6 |
7440-38-2 |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H400 H410 |
GHS06 GHS09 Dgr |
H331 H301 H410 |
|
|
|
033-002-00-5 |
arseenverbindingen, tenzij elders in deze bijlage vermeld |
— |
— |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H400 H410 |
GHS06 GHS09 Dgr |
H331 H301 H410 |
|
* |
A1 |
033-003-00-0 |
diarseentrioxide; arseentrioxide |
215-481-4 |
1327-53-3 |
Carc. 1A Acute Tox. 2 * Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H300 H314 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H350 H300 H314 H410 |
|
|
|
033-004-00-6 |
diarseenpentaoxide; arseenpentaoxide; arseenoxide |
215-116-9 |
1303-28-2 |
Carc. 1A Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H350 H331 H301 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350 H331 H301 H410 |
|
|
|
033-005-00-1 |
arseenzuur en zouten daarvan, tenzij elders in deze bijlage vermeld |
— |
— |
Carc. 1A Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H350 H331 H301 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350 H331 H301 H410 |
|
|
A |
033-006-00-7 |
arsine |
232-066-3 |
7784-42-1 |
Flam. Gas 1 Press. Gas Acute Tox. 2 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H220 H330 H373 ** H400 H410 |
GHS02 GHS04 GHS06 GHS08 GHS09 Dgr |
H220 H330 H373 ** H410 |
|
|
U |
033-007-00-2 |
tert-butylarsine |
423-320-6 |
4262-43-5 |
Pyr. Liq. 1 Acute Tox. 2 * |
H250 H330 |
GHS02 GHS06 Dgr |
H250 H330 |
|
|
|
034-001-00-2 |
seleen |
231-957-4 |
7782-49-2 |
Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Chronic 4 |
H331 H301 H373 ** H413 |
GHS06 GHS08 Dgr |
H331 H301 H373 ** H413 |
|
|
|
034-002-00-8 |
seleenverbindingen met uitzondering van cadmiumsulfoselenide, tenzij elders in deze bijlage vermeld |
— |
— |
Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H373** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H331 H301 H373** H410 |
|
|
A |
034-003-00-3 |
natriumseleniet |
233-267-9 |
10102-18-8 |
Acute Tox. 2 * Acute Tox. 3 * Skin Sens. 1 Aquatic Chronic 2 |
H300 H331 H317 H411 |
GHS06 GHS09 Dgr |
H300 H331 H317 H411 |
EUH031 |
|
|
035-001-00-5 |
broom |
231-778-1 |
7726-95-6 |
Acute Tox. 2 * Skin Corr. 1A Aquatic Acute 1 |
H330 H314 H400 |
GHS06 GHS05 GHS09 Dgr |
H330 H314 H400 |
|
|
|
035-002-00-0 |
waterstofbromide |
233-113-0 |
10035-10-6 |
Press. Gas Skin Corr. 1A STOT SE 3 |
H314 H335 |
GHS04 GHS05 GHS07 Dgr |
H314 H335 |
|
|
U |
035-002-01-8 |
waterstofbromideoplossing … % |
— |
— |
Skin Corr. 1B STOT SE 3 |
H314 H335 |
GHS05 GHS07 Dgr |
H314 H335 |
|
Skin Corr. 1B; H314: C ≥ 40 % Skin Irrit. 2; H315: 10 % ≤ C < 40 % Eye Irrit. 2; H319: 10 % ≤ C < 40 % STOT SE 3; H335: C ≥ 10 % |
B |
035-003-00-6 |
kaliumbromaat |
231-829-8 |
7758-01-2 |
Ox. Sol. 1 Carc. 1B Acute Tox. 3 * |
H271 H350 H301 |
GHS03 GHS06 GHS08 Dgr |
H271 H350 H301 |
|
|
|
035-004-00-1 |
2-hydroxyethylammoniumperbromide |
407-440-6 |
— |
Ox. Sol. 2 **** Acute Tox. 4 * Skin Corr. 1A Skin Sens. 1 Aquatic Acute 1 |
H272 H302 H314 H317 H400 |
GHS03 GHS05 GHS07 GHS09 Dgr |
H272 H302 H314 H317 H400 |
|
|
|
040-001-00-3 |
zirkoniumpoeder (pyrofoor) |
231-176-9 |
7440-67-7 |
Water-react. 1 Pyr. Sol. 1 |
H260 H250 |
GHS02 Dgr |
H260 H250 |
|
|
T |
040-002-00-9 |
zirkoniumpoeder, droog (niet-pyrofoor) |
— |
— |
Self-heat. 1 |
H251 |
GHS02 Dgr |
H251 |
|
|
T |
040-003-00-4 |
reactieproduct van 3,5-di-tert-butylsalicylzuur en zirkoniumoxychloride, gedehydreerd, basisch Zr: DTBS = 1,0: 1,0 tot en met 1.0: 1,5 |
430-610-6 |
226996-19-6 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
042-001-00-9 |
molybdeentrioxide |
215-204-7 |
1313-27-5 |
Carc. 2 Eye Irrit. 2 STOT SE 3 |
H351 H319 H335 |
GHS08 GHS07 Wng |
H351 H319 H335 |
|
|
|
042-002-00-4 |
tetrakis(dimethylditetradecylammonium)hexa-μ-oxotetra-μ3-oxodi-μ5-oxotetradecaoxoöctamolybdaat(4–) |
404-760-8 |
117342-25-3 |
Acute Tox. 3 * Eye Dam. 1 |
H331 H318 |
GHS06 GHS05 Dgr |
H331 H318 |
|
|
|
042-003-00-X |
tetrakis(trimethylhexadecylammonium)hexa-μ-oxotetra-μ3-oxodi-μ5-oxotetradecaoxoöctamolybdaat(4–) |
404-860-1 |
116810-46-9 |
Flam. Sol. 1 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H228 H318 H400 H410 |
GHS02 GHS05 GHS09 Dgr |
H228 H318 H410 |
|
|
T |
042-004-00-5 |
reactieproduct van ammoniummolybdaat en C12-C24-gediëthoxyleerd alkylamine (1:5-1:3) |
412-780-3 |
— |
Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H315 H317 H411 |
GHS07 GHS09 Wng |
H315 H317 H411 |
|
|
|
042-005-00-0 |
reactiemassa van: mono- en diglycerolen van canolaolie; canolaoliezuuramide van N-[3-(tridecyloxy)propyl]-1,3-propaandiamine, vertakt N,N-diorganodithiocarbamaatmolybdeencomplex |
434-240-6 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
046-001-00-X |
tetraämminepalladium(II)waterstofcarbonaat |
425-270-0 |
134620-00-1 |
Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373** H318 H317 H400 H410 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H302 H373** H318 H317 H410 |
|
|
|
047-001-00-2 |
zilvernitraat |
231-853-9 |
7761-88-8 |
Ox. Sol. 2 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H272 H314 H400 H410 |
GHS03 GHS05 GHS09 Dgr |
H272 H314 H410 |
|
|
|
047-002-00-8 |
polyfosforzuur, koper-, natrium-, magnesium-, calcium-, zilver- en zinkzout |
416-850-4 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
048-001-00-5 |
cadmiumverbindingen met uitzondering van cadmiumsulfoselenide (xCdS.yCdSe), van reactiemassa van cadmiumsulfide met zinksulfide (xCdS.yZnS) en van reactiemassa van cadmiumsulfide met kwiksulfide (xCdS.yHgS), tenzij elders in deze bijlage vermeld |
— |
— |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H312 H302 H410 |
|
* |
A1 |
048-002-00-0 |
cadmium (niet-pyrofoor); [1] cadmiumoxide (niet-pyrofoor) [2] |
231-152-8 [1] 215-146-2 [2] |
7440-43-9 [1] 1306-19-0 [2] |
Carc. 1B Muta. 2 Repr. 2 Acute Tox. 2 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H341 H361fd H330 H372 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350 H341 H361fd H330 H372 ** H410 |
|
|
|
048-003-00-6 |
cadmiumdiformiaat; cadmiumformiaat |
224-729-0 |
4464-23-7 |
Acute Tox. 3 * Acute Tox. 3 * Carc. 2 STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H351 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H331 H301 H351 H373 ** H410 |
|
* STOT RE 2; H373: C ≥0,25 % |
|
048-004-00-1 |
cadmiumcyanide |
208-829-1 |
542-83-6 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Carc. 2 STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H351 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H330 H310 H300 H351 H373 ** H410 |
EUH032 |
STOT RE 2; H373: C ≥0,1 % EUH032:C≥1 % |
|
048-005-00-7 |
cadmiumhexafluorosilicaat(2–); cadmiumfluorosilica |
241-084-0 |
17010-21-8 |
Acute Tox. 3 * Acute Tox. 3 * Carc. 2 STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H351 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H331 H301 H351 H373 ** H410 |
|
* STOT RE 2; H373: C ≥0,1 % |
|
048-006-00-2 |
cadmiumfluoride |
232-222-0 |
7790-79-6 |
Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H340 H360FD H330 H301 H372 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350 H340 H360FD H330 H301 H372 ** H410 |
|
Carc. 1B; H350: C ≥ 0,01 % * oral STOT RE 1; H372: C ≥ 7 % STOT RE 2: 0,1 % ≤ C <7 % |
|
048-007-00-8 |
cadmiumjodide |
232-223-6 |
7790-80-9 |
Acute Tox. 3 * Acute Tox. 3 * Carc. 2 STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H351 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H331 H301 H351 H373 ** H410 |
|
* STOT RE 2; H373: C ≥ 0,1 % |
|
048-008-00-3 |
cadmiumchloride |
233-296-7 |
10108-64-2 |
Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H340 H360FD H330 H301 H372 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350 H340 H360FD H330 H301 H372 ** H410 |
|
Carc. 1B; H350: C ≥ 0,01 % * oral STOT RE 1; H372: C ≥ 7 % STOT RE 2; H373: 0,1 % ≤ C < 7 % |
|
048-009-00-9 |
cadmiumsulfaat |
233-331-6 |
10124-36-4 |
Carc. 1B Muta. 1B Repr. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H340 H360FD H330 H301 H372 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350 H340 H360FD H330 H301 H372 ** H410 |
|
Carc. 1B; H350: C ≥ 0,01 % * oral STOT RE 1; H372: C ≥ 7 % STOT RE 2; H373 0,1 % ≤ C < 7 % |
|
048-010-00-4 |
cadmiumsulfide |
215-147-8 |
1306-23-6 |
Carc. 1B Muta. 2 Repr. 2 STOT RE 1 Acute Tox. 4 * Aquatic Chronic 4 |
H350 H341 H361fd H372 ** H302 H413 |
GHS08 GHS07 Dgr |
H350 H341 H361fd H372 ** H302 H413 |
|
* STOT RE 1; H372: C ≥ 10 % STOT RE 2; H373: 0,1 % ≤ C < 10 % |
1 |
048-011-00-X |
cadmium (pyrofoor) |
231-152-8 |
7440-43-9 |
Pyr. Sol. 1 Carc. 1B Muta. 2 Repr. 2 Acute Tox. 2 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H250 H350 H341 H361fd H330 H372 ** H400 H410 |
GHS02 GHS06 GHS08 GHS09 Dgr |
H250 H350 H341 H361fd H330 H372 ** H410 |
|
|
|
050-001-00-5 |
tintetrachloride; tin(IV)chloride |
231-588-9 |
7646-78-8 |
Skin Corr. 1B Aquatic Chronic 3 |
H314 H412 |
GHS05 Dgr |
H314 H412 |
|
STOT SE 3; H335:C≥5 % |
|
050-002-00-0 |
cyhexatin (ISO); hydroxytricyclohexylstannaan; tri(cyclohexyl)tinhydroxide |
236-049-1 |
13121-70-5 |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H312 H302 H410 |
|
M=1000 |
|
050-003-00-6 |
fentin-acetaat (ISO); trifenyltinacetaat |
212-984-0 |
900-95-8 |
Carc. 2 Repr. 2 Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H361d*** H330 H311 H301 H372** H335 H315 H318 H400 H410 |
GHS06 GHS05 GHS08 GHS09 Dgr |
H351 H361d*** H330 H311 H301 H372** H335 H315 H318 H410 |
|
M=10 |
|
050-004-00-1 |
fentin-hydroxide (ISO); trifenyltinhydroxide |
200-990-6 |
76-87-9 |
Carc. 2 Repr. 2 Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H361d*** H330 H311 H301 H372** H335 H315 H318 H400 H410 |
GHS06 GHS05 GHS08 GHS09 Dgr |
H351 H361d*** H330 H311 H301 H372** H335 H315 H318 H410 |
|
M=10 |
|
050-005-00-7 |
trimethyltinverbindingen, tenzij elders in deze bijlage vermeld |
— |
— |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H330 H310 H300 H410 |
|
* |
A1 |
050-006-00-2 |
triëthyltinverbindingen, tenzij elders in deze bijlage vermeld |
— |
— |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H330 H310 H300 H410 |
|
* |
A1 |
050-007-00-8 |
tripropyltinverbindingen, tenzij elders in deze bijlage vermeld |
— |
— |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H331 H311 H301 H410 |
|
* |
A1 |
050-009-00-9 |
fluortripentylstannaan; [1] hexapentyldistannoxaan [2] |
243-546-7 [1] 247-143-7 [2] |
20153-49-5 [1] 25637-27-8 [2] |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H312 H302 H410 |
|
* |
1 |
050-010-00-4 |
fluortrihexylstannaan |
243-547-2 |
20153-50-8 |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H312 H302 H410 |
|
* |
1 |
050-011-00-X |
trifenyltinverbindingen, tenzij elders in deze bijlage vermeld |
— |
— |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H331 H311 H301 H410 |
|
* M=100 |
A1 |
050-012-00-5 |
tetracyclohexylstannaan; [1] chloortricyclohexylstannaan; [2] butyltricyclohexylstannaan [3] |
215-910-5 [1] 221-437-5 [2] 230-358-5 [3] |
1449-55-4 [1] 3091-32-5 [2] 7067-44-9 [3] |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H312 H302 H410 |
|
* |
A1 |
050-013-00-0 |
trioctyltinverbindingen, tenzij elders in deze bijlage vermeld |
— |
— |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 4 |
H319 H335 H315 H413 |
GHS07 Wng |
H319 H335 H315 H413 |
|
Skin Irrit. 2; H315: C ≥ 1 % Eye Irrit.2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % |
A1 |
050-017-00-2 |
fenbutatin-oxide (ISO); bis(tris(2-fenyl-2-methylpropyl)tin)oxide |
236-407-7 |
13356-08-6 |
Acute Tox. 2 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H319 H315 H400 H410 |
GHS06 GHS09 Dgr |
H330 H319 H315 H410 |
|
|
|
050-018-00-8 |
tin(II)methaansulfonaat |
401-640-7 |
53408-94-9 |
Skin Corr. 1B Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H314 H302 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H314 H302 H317 H411 |
|
|
|
050-019-00-3 |
azocyclotin (ISO); 1-(tricyclohexylstannyl)-1H-1,2,4-triazool; |
255-209-1 |
41083-11-8 |
Acute Tox. 2 * Acute Tox. 3 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H301 H335 H315 H318 H400 H410 |
GHS06 GHS05 GHS09 Dgr |
H330 H301 H335 H315 H318 H410 |
|
|
|
050-020-00-9 |
trioctylstannaan |
413-320-4 |
869-59-0 |
STOT RE 1 Skin Irrit. 2 Aquatic Chronic 4 |
H372 ** H315 H413 |
GHS08 GHS07 Dgr |
H372 ** H315 H413 |
|
|
|
050-021-00-4 |
dichloordioctylstannaan |
222-583-2 |
3542-36-7 |
Acute Tox. 3 * STOT RE 1 Aquatic Chronic 3 |
H331 H372** H412 |
GHS06 GHS08 Dgr |
H331 H372** H412 |
|
|
|
050-022-00-X |
dibutyltindichloride; (DBTC) |
211-670-0 |
683-18-1 |
Muta. 2 Repr. 1B Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 4 * STOT RE 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H341 H360FD H330 H301 H312 H372** H314 H400 H410 |
GHS06 GHS05 GHS08 GHS09 Dgr |
H341 H360FD H330 H301 H312 H372** H314 H410 |
|
Skin Corr. 1B; H314: C ≥ 5 % Skin Irrit. 2; H315: 0,01 % ≤ C < 5 % Eye Dam.1; H318: 3 % ≤ C < 5 % Eye Irrit. 2; H319: 0,01 % ≤ C < 3 % M=10 |
|
050-023-00-5 |
reactiemassa van: bis[(2-ethyl-1-oxohexyl)oxy]dioctylstannaan; bis[((2-ethyl-1-oxohexyl)oxy)dioctylstannyl]oxide; bis(1-fenyl-1,3-decaandionyl)dioctylstannaan; ((2-ethyl-1-oxohexyl)oxy)-(1-fenyl-1,3-decaandionyl)dioctylstannaan |
422-920-5 |
— |
STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H373** H400 H410 |
GHS08 GHS09 Wng |
H373** H410 |
|
M=10 |
|
050-024-00-0 |
reactiemassa van: tri-p-tolyltinhydroxide; hexa-p-tolyldistannoxaan |
432-230-6 |
— |
STOT RE 1 Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H372** H302 H315 H318 H317 H400 H410 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H372** H302 H315 H318 H317 H410 |
|
|
|
050-025-00-6 |
trichloormethylstannaan |
213-608-8 |
993-16-8 |
Repr. 2 |
H361d |
GHS08 Wng |
H361d |
|
|
|
050-026-00-1 |
2-ethylhexyl-10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-methyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoaat |
260-828-5 |
57583-34-3 |
Repr. 2 |
H361d |
GHS08 Wng |
H361d |
|
|
|
050-027-00-7 |
2-ethylhexyl-10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoaat |
239-622-4 |
15571-58-1 |
Repr. 1B |
H360D |
GHS08 Dgr |
H360D |
|
|
|
050-028-00-2 |
2-ethylhexyl-10-ethyl-4,4-dimethyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoaat |
260-829-0 |
57583-35-4 |
Repr. 2 Acute Tox. 4 STOT RE 1 Skin Sens. 1A |
H361d H302 H372 (zenuwstelsel, immuunsysteem) H317 |
GHS08 GHS07 Dgr |
H361d H302 H372 (zenuwstelsel, immuunsysteem) H317 |
|
|
|
050-029-00-8 |
dimethyltindichloride |
212-039-2 |
753-73-1 |
Repr. 2 Acute Tox. 2 Acute Tox. 3 Acute Tox. 3 STOT RE 1 Skin Corr. 1B |
H361d H330 H301 H311 H372 (zenuwstelsel, immuunsysteem) H314 |
GHS08 GHS06 GHS05 Dgr |
H361d H330 H301 H311 H372 (zenuwstelsel, immuunsysteem) H314 |
EUH071 |
|
|
051-001-00-8 |
antimoontrichloride |
233-047-2 |
10025-91-9 |
Skin Corr. 1B Aquatic Chronic 2 |
H314 H411 |
GHS05 GHS09 Dgr |
H314 H411 |
|
STOT SE3; H335: C ≥ 5 % |
|
051-002-00-3 |
antimoonpentachloride |
231-601-8 |
7647-18-9 |
Skin Corr. 1B Aquatic Chronic 2 |
H314 H411 |
GHS05 GHS09 Dgr |
H314 H411 |
|
STOT SE 3; H335: C ≥ 5 % |
|
051-003-00-9 |
antimoonverbindingen met uitzondering van het tetroxide (Sb2O4), van het pentoxide (Sb2O5), van het trisulfide (Sb2S3) en van het pentasulfide (Sb2S5), tenzij elders in deze bijlage vermeld |
— |
— |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 2 |
H332 H302 H411 |
GHS07 GHS09 Wng |
H332 H302 H411 |
|
* |
A1 |
051-004-00-4 |
antimoontrifluoride |
232-009-2 |
7783-56-4 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Chronic 2 |
H331 H311 H301 H411 |
GHS06 GHS09 Dgr |
H331 H311 H301 H411 |
|
|
|
051-005-00-X |
diantimoontrioxide |
215-175-0 |
1309-64-4 |
Carc. 2 |
H351 |
GHS08 Wng |
H351 |
|
|
|
051-006-00-5 |
difenyl(4-fenylthiofenyl)sulfoniumhexafluoroantimonaat |
403-500-0 |
— |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
051-007-00-0 |
bis(4-dodecylfenyl)jodoniumhexafluoroantimonaat |
404-420-9 |
71786-70-4 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
053-001-00-3 |
jood |
231-442-4 |
7553-56-2 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 |
H332 H312 H400 |
GHS07 GHS09 Wng |
H332 H312 H400 |
|
|
|
053-002-00-9 |
waterstofjodide |
233-109-9 |
10034-85-2 |
Press. Gas Skin Corr. 1A |
H314 |
GHS04 GHS05 Dgr |
H314 |
|
Skin Corr. 1A; H314: C ≥ 10 % Skin Corr. 1B; H314: 0,2 % ≤ C < 10 % Skin Irrit. 2; H315: 0,02 % ≤ C < 0,2 % Eye Irrit. 2; H319: 0,02 % ≤ C < 0,2 % STOT SE 3; H335: C ≥0,02 % |
U5 |
053-002-01-6 |
waterstofjodideoplossing … % |
— |
— |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
|
|
Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 % |
B |
053-003-00-4 |
jodylbenzeen |
— |
696-33-3 |
Expl. **** |
**** |
**** |
**** |
|
|
|
053-004-00-X |
calciumjodylbenzoaat |
— |
— |
Expl. **** |
**** |
**** |
**** |
|
|
C |
053-005-00-5 |
(4-(1-methylethyl)fenyl)-(4-methylfenyl)jodonium-tetrakis(pentafluorfenyl)boraat(1–) |
422-960-3 |
178233-72-2 |
Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H373 ** H400 H410 |
GHS08 GHS07 GHS09 Wng |
H312 H302 H373 ** H410 |
|
|
|
056-001-00-1 |
bariumperoxide |
215-128-4 |
1304-29-6 |
Ox. Sol. 2 Acute Tox. 4 * Acute Tox. 4 * |
H272 H332 H302 |
GHS03 GHS07 Dgr |
H272 H332 H302 |
|
|
|
056-002-00-7 |
bariumzouten met uitzondering van bariumsulfaat, van zouten van 1-azo-2-hydroxynaftalenyl-arylsulfonzuur en van elders in deze bijlage vermelde zouten |
— |
— |
Acute Tox. 4 * Acute Tox. 4 * |
H332 H302 |
GHS07 Wng |
H332 H302 |
|
* |
A1 |
056-003-00-2 |
bariumcarbonaat |
208-167-3 |
513-77-9 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
056-004-00-8 |
bariumchloride |
233-788-1 |
10361-37-2 |
Acute Tox. 3 * Acute Tox. 4 * |
H301 H332 |
GHS06 Dgr |
H301 H332 |
|
|
|
064-001-00-8 |
gadolinium(III)sulfiet-trihydraat |
456-900-2 |
51285-81-5 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
072-001-00-4 |
hafnium-tetra-n-butoxide |
411-740-2 |
22411-22-9 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
074-001-00-X |
hexanatrium-diwaterstof-dodecawolframaat |
412-770-9 |
12141-67-2 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 |
H302 H318 H412 |
GHS05 GHS07 Dgr |
H302 H318 H412 |
|
|
|
074-002-00-5 |
reactieproducten van wolfraamhexachloride met 2-methylpropaan-2-ol, nonylfenol en pentaan-2,4-dion |
408-250-6 |
— |
Flam. Liq. 2 Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H225 H332 H314 H317 H400 H410 |
GHS02 GHS05 GHS07 GHS09 Dgr |
H225 H332 H314 H317 H410 |
|
|
|
076-001-00-5 |
osmiumtetraoxide; osmiumzuur |
244-058-7 |
20816-12-0 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Skin Corr. 1B |
H330 H310 H300 H314 |
GHS06 GHS05 Dgr |
H330 H310 H300 H314 |
|
|
|
078-001-00-0 |
tetrachloroplatinaten, tenzij elders in deze bijlage vermeld |
— |
— |
Acute Tox. 3 * Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H301 H318 H334 H317 |
GHS06 GHS05 GHS08 Dgr |
H301 H318 H334 H317 |
|
|
A |
078-002-00-6 |
diammoniumtetrachloroplatinaat |
237-499-1 |
13820-41-2 |
Acute Tox. 3 * Skin Irrit. 2 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H301 H315 H318 H334 H317 |
GHS06 GHS05 GHS08 Dgr |
H301 H315 H318 H334 H317 |
|
|
|
078-003-00-1 |
dinatriumtetrachloroplatinaat |
233-051-4 |
10026-00-3 |
Acute Tox. 3 * Skin Irrit. 2 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H301 H315 H318 H334 H317 |
GHS06 GHS05 GHS08 Dgr |
H301 H315 H318 H334 H317 |
|
|
|
078-004-00-7 |
dikaliumtetrachloroplatinaat |
233-050-9 |
10025-99-7 |
Acute Tox. 3 * Skin Irrit. 2 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H301 H315 H318 H334 H317 |
GHS06 GHS05 GHS08 Dgr |
H301 H315 H318 H334 H317 |
|
|
|
078-005-00-2 |
hexachloroplatinaten, tenzij elders in deze bijlage vermeld |
— |
— |
Acute Tox. 3 * Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H301 H318 H334 H317 |
GHS06 GHS05 GHS08 Dgr |
H301 H318 H334 H317 |
|
|
A |
078-006-00-8 |
dinatriumhexachloroplatinaat |
240-983-5 |
16923-58-3 |
Acute Tox. 3 * Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H301 H318 H334 H317 |
GHS06 GHS05 GHS08 Dgr |
H301 H318 H334 H317 |
|
|
|
078-007-00-3 |
dikaliumhexachloroplatinaat |
240-979-3 |
16921-30-5 |
Acute Tox. 3 * Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H301 H318 H334 H317 |
GHS06 GHS05 GHS08 Dgr |
H301 H318 H334 H317 |
|
|
|
078-008-00-9 |
diammoniumhexachloroplatinaat |
240-973-0 |
16919-58-7 |
Acute Tox. 3 * Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H301 H318 H334 H317 |
GHS06 GHS05 GHS08 Dgr |
H301 H318 H334 H317 |
|
|
|
078-009-00-4 |
hexachloroplatinazuur |
241-010-7 |
16941-12-1 |
Acute Tox. 3 * Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 |
H301 H314 H334 H317 |
GHS06 GHS05 GHS08 Dgr |
H301 H314 H334 H317 |
|
|
|
078-010-00-X |
tetraämmineplatina(II)- waterstofcarbonaat |
426-730-3 |
123439-82-7 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 |
H302 H318 H412 |
GHS05 GHS07 Dgr |
H302 H318 H412 |
|
|
|
078-011-00-5 |
hydroxydisulfitoplatina(II)zuur |
423-310-1 |
61420-92-6 |
Acute Tox. 4 * STOT RE 2 * Skin Corr. 1A Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 3 |
H302 H373 H314 H334 H317 H412 |
GHS05 GHS08 GHS07 Dgr |
H302 H373 H314 H334 H317 H412 |
|
|
|
078-012-00-0 |
platina(IV)nitraat/salpeterzuuroplossing |
432-400-1 |
— |
Skin Corr. 1A Aquatic Acute 1 Aquatic Chronic 1 |
H314 H400 H410 |
GHS05 GHS09 Dgr |
H314 H410 |
|
|
|
080-001-00-0 |
kwik |
231-106-7 |
7439-97-6 |
Repr. 1B Acute Tox. 2 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H360D*** H330 H372** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H360D*** H330 H372** H410 |
|
|
|
080-002-00-6 |
anorganische kwikverbindingen met uitzondering van kwik(II)sulfide, tenzij elders in deze bijlage vermeld |
— |
— |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H330 H310 H300 H373 ** H410 |
|
* STOT RE 2; H373: C ≥ 0,1 % |
A1 |
080-003-00-1 |
dikwikdichloride; kwik(I)chloride; calomel |
233-307-5 |
10112-91-1 |
Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H335 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H335 H315 H410 |
|
|
|
080-004-00-7 |
organische kwikverbindingen, tenzij elders in deze bijlage vermeld |
— |
— |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H330 H310 H300 H373 ** H410 |
|
* STOT RE 2; H373: C ≥0,1 % |
A1 |
080-005-00-2 |
kwikdifulminaat; kwik(II)fulminaat; kwikfulminaat; knalkwik; slagkwik |
211-057-8 |
628-86-4 |
Unst. Expl. Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H200 H331 H311 H301 H373 ** H400 H410 |
GHS01 GHS06 GHS08 GHS09 Dgr |
H200 H331 H311 H301 H373 ** H400 H410 |
|
|
|
080-005-01-X |
kwikdifulminaat; kwik(II)fulminaat; kwikfulminaat; knalkwik; slagkwik [≥ 20 % flegmatisator] |
211-057-8 |
628-86-4 |
Expl. 1.1 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H201 H331 H311 H301 H373 ** H400 H410 |
GHS01 GHS06 GHS08 GHS09 Dgr |
H201 H331 H311 H301 H373 ** H400 H410 |
|
|
|
080-006-00-8 |
dikwikdicyanideoxide; kwikoxycyanide |
215-629-8 |
1335-31-5 |
Expl. 1.1 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H201 H331 H311 H301 H373** H400 H410 |
GHS01 GHS06 GHS08 GHS09 Dgr |
H201 H331 H311 H301 H373** H410 |
|
|
|
080-007-00-3 |
dimethylkwik; [1] diëthylkwik [2] |
209-805-3 [1] 211-000-7 [2] |
593-74-8 [1] 627-44-1 [2] |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H330 H310 H300 H373 ** H410 |
|
* STOT RE 2; H373: C ≥0,05 % |
1 |
080-008-00-9 |
fenylkwiknitraat; [1] fenylkwikhydroxide; [2] basisch fenylkwiknitraat [3] |
200-242-9 [1] 202-866-7 [2] -[3] |
55-68-5 [1] 100-57-2 [2] 8003-05-2 [3] |
Acute Tox. 3 * STOT RE 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H301 H372 ** H314 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H301 H372 ** H314 H410 |
|
|
|
080-009-00-4 |
2-methoxyethylkwikchloride |
204-659-7 |
123-88-6 |
Acute Tox. 3 * STOT RE 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H301 H372 ** H314 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H301 H372 ** H314 H410 |
|
|
|
080-010-00-X |
kwikdichloride; kwik(II)chloride |
231-299-8 |
7487-94-7 |
Muta. 2 Repr. 2 Acute Tox. 2 * STOT RE 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H341 H361f*** H300 H372** H314 H400 H410 |
GHS06 GHS05 GHS08 GHS09 Dgr |
H341 H361f*** H300 H372** H314 H410 |
|
|
|
080-011-00-5 |
fenylkwikacetaat |
200-532-5 |
62-38-4 |
Acute Tox. 3 * STOT RE 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H301 H372 ** H314 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H301 H372 ** H314 H410 |
|
|
|
081-001-00-3 |
thallium |
231-138-1 |
7440-28-0 |
Acute Tox. 2 * Acute Tox. 2 * STOT RE 2 * Aquatic Chronic 4 |
H330 H300 H373 ** H413 |
GHS06 GHS08 Dgr |
H330 H300 H373 ** H413 |
|
|
|
081-002-00-9 |
thalliumverbindingen, tenzij elders in deze bijlage vermeld |
— |
— |
Acute Tox. 2 * Acute Tox. 2 * STOT RE 2 * Aquatic Chronic 2 |
H330 H300 H373 ** H411 |
GHS06 GHS08 GHS09 Dgr |
H330 H300 H373 ** H411 |
|
|
A |
081-003-00-4 |
dithalliumsulfaat; thalliumsulfaat |
231-201-3 |
7446-18-6 |
Acute Tox. 2 * STOT RE 1 Skin Irrit. 2 Aquatic Chronic 2 |
H300 H372 ** H315 H411 |
GHS06 GHS08 GHS09 Dgr |
H300 H372 ** H315 H411 |
|
|
|
082-001-00-6 |
loodverbindingen, tenzij elders in deze bijlage vermeld |
— |
— |
Repr. 1A Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H360Df H332 H302 H373 ** H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H360Df H332 H302 H373 ** H410 |
|
Repr.2 H361f: C ≥ 2,5 % * STOT RE 2; H373: C ≥0,5 % |
A1 |
082-002-00-1 |
loodalkylen |
— |
— |
Repr. 1A Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H360Df H330 H310 H300 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H360Df H330 H310 H300 H373 ** H410 |
|
Repr.1A; H360D: C≥ 0,1 % * STOT RE 2; H373: C ≥0,05 % |
A1 |
082-003-00-7 |
looddiazide; loodazide |
236-542-1 |
13424-46-9 |
Unst. Expl. Repr. 1A Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H200 H360Df H332 H302 H373 ** H400 H410 |
GHS01 GHS08 GHS07 GHS09 Dgr |
H200 H360Df H332 H302 H373 ** H410 |
|
|
1 |
082-003-01-4 |
looddiazide; loodazide [≥ 20 % flegmatisator] |
236-542-1 |
13424-46-9 |
Expl. 1.1 Repr. 1A Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H201 H360Df H332 H302 H373 ** H400 H410 |
GHS01 GHS08 GHS07 GHS09 Dgr |
H201 H360Df H332 H302 H373 ** H410 |
|
|
1 |
082-004-00-2 |
loodchromaat |
231-846-0 |
7758-97-6 |
Carc. 1B Repr. 1A STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H360Df H373** H400 H410 |
GHS08 GHS09 Dgr |
H350 H360Df H373** H410 |
|
|
1 |
082-005-00-8 |
looddi(acetaat) |
206-104-4 |
301-04-2 |
Repr. 1A STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H360Df H373 ** H400 H410 |
GHS08 GHS09 Dgr |
H360Df H373 ** H410 |
|
|
1 |
082-006-00-3 |
triloodbis(orthofosfaat) |
231-205-5 |
7446-27-7 |
Repr. 1A STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H360Df H373 ** H400 H410 |
GHS08 GHS09 Dgr |
H360Df H373 ** H410 |
|
|
1 |
082-007-00-9 |
loodacetaat, basisch |
215-630-3 |
1335-32-6 |
Carc. 2 Repr. 1A STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H360Df H373 ** H400 H410 |
GHS08 GHS09 Dgr |
H351 H360Df H373 ** H410 |
|
|
1 |
082-008-00-4 |
lood(II)methaansulfonaat |
401-750-5 |
17570-76-2 |
Repr. 1A Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 |
H360Df H332 H302 H373 ** H315 H318 |
GHS08 GHS05 GHS07 Dgr |
H360Df H332 H302 H373 ** H315 H318 |
|
|
1 |
082-009-00-X |
loodsulfochromaat geel; C.I. Pigment Yellow 34; [Deze stof staat beschreven in de Colour Index onder het Colour Index Constitution Number, C.I. 77603.] |
215-693-7 |
1344-37-2 |
Carc. 1B Repr. 1A STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H360Df H373** H400 H410 |
GHS08 GHS09 Dgr |
H350 H360Df H373** H410 |
|
|
1 |
082-010-00-5 |
loodchromaatmolybdaatsulfaat rood; C.I. Pigment Red 104; [Deze stof staat beschreven in de Colour Index onder het Colour Index Constitution Number, C.I. 77605.] |
235-759-9 |
12656-85-8 |
Carc. 1B Repr. 1A STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H360Df H373** H400 H410 |
GHS08 GHS09 Dgr |
H350 H360Df H373** H410 |
|
|
1 |
082-011-00-0 |
lood(II)waterstofarsenaat |
232-064-2 |
7784-40-9 |
Carc. 1A Repr. 1A Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H350 H360Df H331 H301 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350 H360Df H331 H301 H373 ** H410 |
|
|
1 |
082-012-00-6 |
bromide/chloride/fluoride/jodide van barium/calcium/cesium/lood/samarium/strontium, europium-gedoteerd |
431-780-4 |
199876-46-5 |
Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 2 |
H302 H373** H411 |
GHS08 GHS07 GHS09 Wng |
H302 H373** H411 |
|
|
|
092-001-00-8 |
uraan |
231-170-6 |
7440-61-1 |
Acute Tox. 2 * Acute Tox. 2 * STOT RE 2 * Aquatic Chronic 4 |
H330 H300 H373 ** H413 |
GHS06 GHS08 Dgr |
H330 H300 H373 ** H413 |
|
|
|
092-002-00-3 |
uraanverbindingen, tenzij elders in deze bijlage vermeld |
— |
— |
Acute Tox. 2 * Acute Tox. 2 * STOT RE 2 Aquatic Chronic 2 |
H330 H300 H373** H411 |
GHS06 GHS08 GHS09 Dgr |
H330 H300 H373** H411 |
|
|
A |
601-001-00-4 |
methaan |
200-812-7 |
74-82-8 |
Flam. Gas 1 Press. Gas |
H220 |
GHS02 GHS04 Dgr |
H220 |
|
|
U |
601-002-00-X |
ethaan |
200-814-8 |
74-84-0 |
Flam. Gas 1 Press. Gas |
H220 |
GHS02 GHS04 Dgr |
H220 |
|
|
U |
601-003-00-5 |
propaan |
200-827-9 |
74-98-6 |
Flam. Gas 1 Press. Gas |
H220 |
GHS02 GHS04 Dgr |
H220 |
|
|
U |
601-004-00-0 |
butaan; [1] en isobutaan [2] |
203-448-7 [1] 200-857-2 [2] |
106-97-8 [1] 75-28-5 [2] |
Flam. Gas 1 Press. Gas |
H220 |
GHS02 GHS04 Dgr |
H220 |
|
|
C U |
601-004-01-8 |
butaan (met ≥ 0,1 % butadieen (203-450-8)); [1] isobutaan (met ≥ 0,1 % butadieen (203-450-8)) [2] |
203-448-7 [1] 200-857-2 [2] |
106-97-8 [1] 75-28-5 [2] |
Flam. Gas 1 Press. Gas Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS02 GHS04 GHS08 Dgr |
H220 H350 H340 |
|
|
C S U |
601-005-00-6 |
2,2-dimethylpropaan; neopentaan |
207-343-7 |
463-82-1 |
Flam. Gas 1 Press. Gas Aquatic Chronic 2 |
H220 H411 |
GHS02 GHS04 GHS09 Dgr |
H220 H411 |
|
|
U |
601-006-00-1 |
pentaan |
203-692-4 |
109-66-0 |
Flam. Liq. 2 Asp. Tox. 1 STOT SE 3 Aquatic Chronic 2 |
H225 H304 H336 H411 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H225 H304 H336 H411 |
EUH066 |
|
C |
601-007-00-7 |
hexaan (met < 5 % n-hexaan (203-777-6)); 2-methylpentaan; [1] 3-methylpentaan; [2] 2,2-dimethylbutaan; [3] 2,3-dimethylbutaan [4] |
203-523-4 [1] 202-481-4 [2] 200-906-8 [3] 201-193-6 [4] |
107-83-5 [1] 96-14-0 [2] 75-83-2 [3] 79-29-8 [4] |
Flam. Liq. 2 Asp. Tox. 1 Skin Irrit. 2 STOT SE 3 Aquatic Chronic 2 |
H225 H304 H315 H336 H411 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H225 H304 H315 H336 H411 |
|
|
C |
601-008-00-2 |
heptaan; n-heptaan; [1] 2,4-dimethylpentaan; [2] 2,2,3-trimethylbutaan; [3] 3,3-dimethylpentaan; [4] 2,3-dimethylpentaan; [5] 3-methylhexaan; [6] 2,2-dimethylpentaan; [7] 2-methylhexaan; [8] 3-ethylpentaan; [9] isoheptaan; [10] |
205-563-8 [1] 203-548-0 [2] 207-346-3 [3] 209-230-8 [4] 209-280-0 [5] 209-643-3 [6] 209-680-5 [7] 209-730-6 [8] 210-529-0 [9] 250-610-8 [10] |
142-82-5 [1] 108-08-7 [2] 464-06-2 [3] 562-49-2 [4] 565-59-3 [5] 589-34-4 [6] 590-35-2 [7] 591-76-4 [8] 617-78-7 [9] 31394-54-4 [10] |
Flam. Liq. 2 Asp. Tox. 1 Skin Irrit. 2 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 |
H225 H304 H315 H336 H400 H410 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H225 H304 H315 H336 H410 |
|
|
C |
601-009-00-8 |
octaan; n-octaan; [1] 2,2,4-trimethylpentaan; [2] 2,3,3-trimethylpentaan; [3] 3,3-dimethylhexaan; [4] 2,2,3-trimethylpentaan; [5] 2,3,4-trimethylpentaan; [6] 3,4-dimethylhexaan; [7] 2,3-dimethylhexaan; [8] 2,4-dimethylhexaan; [9] 4-methylheptaan; [10] 3-methylheptaan; [11] 2,2-dimethylhexaan; [12] 2,5-dimethylhexaan; [13] 2-methylheptaan; [14] 2,2,3,3-tetramethylbutaan; [15] 3-ethyl-2-methylpentaan; [16] 3-ethylhexaan; [17] 3-ethyl-3-methylpentaan; [18] isoöctaan; [19] |
203-892-1 [1] 208-759-1 [2] 209-207-2 [3] 209-243-9 [4] 209-266-4 [5] 209-292-6 [6] 209-504-7 [7] 209-547-1 [8] 209-649-6 [9] 209-650-1 [10] 209-660-6 [11] 209-689-4 [12] 209-745-8 [13] 209-747-9 [14] 209-855-6 [15] 210-187-2 [16] 210-621-0 [17] 213-923-0 [18] 247-861-0 [19] |
111-65-9 [1] 540-84-1 [2] 560-21-4 [3] 563-16-6 [4] 564-02-3 [5] 565-75-3 [6] 583-48-2 [7] 584-94-1 [8] 589-43-5 [9] 589-53-7 [10] 589-81-1 [11] 590-73-8 [12] 592-13-2 [13] 592-27-8 [14] 594-82-1 [15] 609-26-7 [16] 619-99-8 [17] 1067-08-9 [18] 26635-64-3 [19] |
Flam. Liq. 2 Asp. Tox. 1 Skin Irrit. 2 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 |
H225 H304 H315 H336 H400 H410 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H225 H304 H315 H336 H410 |
|
|
C |
601-010-00-3 |
etheen |
200-815-3 |
74-85-1 |
Flam. Gas 1 Press. Gas STOT SE 3 |
H220 H336 |
GHS02 GHS04 GHS07 Dgr |
H220 H336 |
|
|
U |
601-011-00-9 |
propeen; propyleen |
204-062-1 |
115-07-1 |
Flam. Gas 1 Press. Gas |
H220 |
GHS02 GHS04 Dgr |
H220 |
|
|
U |
601-012-00-4 |
but-1-een; [1] buteen, mengsel van 1- en 2-isomeren; [2] 2-methylpropeen; [3] (Z)-but-2-een; [4] (E)-but-2-een [5] |
203-449-2 [1] 203-452-9 [2] 204-066-3 [3] 209-673-7 [4] 210-855-3 [5] |
106-98-9 [1] 107-01-7 [2] 115-11-7 [3] 590-18-1 [4] 624-64-6 [5] |
Flam. Gas 1 Press. Gas |
H220 |
GHS02 GHS04 Dgr |
H220 |
|
|
C U |
601-013-00-X |
1,3-butadieen; buta-1,3-dieen |
203-450-8 |
106-99-0 |
Flam. Gas 1 Press. Gas Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS02 GHS04 GHS08 Dgr |
H220 H350 H340 |
|
|
D U |
601-014-00-5 |
isopreen (gestabiliseerd) 2-methyl-1,3-butadieen |
201-143-3 |
78-79-5 |
Flam. Liq. 1 Carc. 1B Muta. 2 Aquatic Chronic 3 |
H224 H350 H341 H412 |
GHS02 GHS08 Dgr |
H224 H350 H341 H412 |
|
|
D |
601-016-00-6 |
cyclopropaan |
200-847-8 |
75-19-4 |
Flam. Gas 1 Press. Gas |
H220 |
GHS02 GHS04 Dgr |
H220 |
|
|
U |
601-017-00-1 |
cyclohexaan |
203-806-2 |
110-82-7 |
Flam. Liq. 2 Asp. Tox. 1 Skin Irrit. 2 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 |
H225 H304 H315 H336 H400 H410 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H225 H304 H315 H336 H410 |
|
|
|
601-018-00-7 |
methylcyclohexaan |
203-624-3 |
108-87-2 |
Flam. Liq. 2 Asp. Tox. 1 Skin Irrit. 2 STOT SE 3 Aquatic Chronic 2 |
H225 H304 H315 H336 H411 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H225 H304 H315 H336 H411 |
|
|
|
601-019-00-2 |
1,4-dimethylcyclohexaan |
209-663-2 |
589-90-2 |
Flam. Liq. 2 Asp. Tox. 1 Skin Irrit. 2 STOT SE 3 Aquatic Chronic 2 |
H225 H304 H315 H336 H411 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H225 H304 H315 H336 H411 |
|
|
|
601-020-00-8 |
benzeen |
200-753-7 |
71-43-2 |
Flam. Liq. 2 Carc. 1a Muta. 1B STOT RE 1 Asp. Tox. 1 Eye Irrit. 2 Skin Irrit. 2 |
H225 H350 H340 H372 ** H304 H319 H315 |
GHS02 GHS08 GHS07 Dgr |
H225 H350 H340 H372 ** H304 H319 H315 |
|
|
E |
601-021-00-3 |
tolueen |
203-625-9 |
108-88-3 |
Flam. Liq. 2 Repr. 2 Asp. Tox. 1 STOT RE 2 * Skin Irrit. 2 STOT SE 3 |
H225 H361d *** H304 H373 ** H315 H336 |
GHS02 GHS08 GHS07 Dgr |
H225 H361d *** H304 H373 ** H315 H336 |
|
|
|
601-022-00-9 |
o-xyleen; [1] p-xyleen; [2] m-xyleen; [3] xyleen [4] |
202-422-2 [1] 203-396-5 [2] 203-576-3 [3] 215-535-7 [4] |
95-47-6 [1] 106-42-3 [2] 108-38-3 [3] 1330-20-7 [4] |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 |
H226 H332 H312 H315 |
GHS02 GHS07 Wng |
H226 H332 H312 H315 |
|
* |
C |
601-023-00-4 |
ethylbenzeen |
202-849-4 |
100-41-4 |
Flam. Liq. 2 Acute Tox. 4* STOT RE 2 Asp. Tox. 1 |
H225 H332 H373 (gehoororganen) H304 |
GHS02 GHS07 GHS08 Dgr |
H225 H332 H373 (gehoororganen) H304 |
|
|
|
601-024-00-X |
cumeen; [1] propylbenzeen [2] |
202-704-5 [1] 203-132-9 [2] |
98-82-8 [1] 103-65-1 [2] |
Flam. Liq. 3 Asp. Tox. 1 STOT SE 3 Aquatic Chronic 2 |
H226 H304 H335 H411 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H226 H304 H335 H411 |
|
|
C |
601-025-00-5 |
mesityleen; 1,3,5-trimethylbenzeen |
203-604-4 |
108-67-8 |
Flam. Liq. 3 STOT SE 3 Aquatic Chronic 2 |
H226 H335 H411 |
GHS02 GHS07 GHS09 Wng |
H226 H335 H411 |
|
STOT SE 3; H335: C ≥ 25 % |
|
601-026-00-0 |
styreen |
202-851-5 |
100-42-5 |
Flam. Liq. 3 Repr. 2 Acute Tox. 4* STOT RE 1 Skin Irrit. 2 Eye Irrit. 2 |
H226 H361d H332 H372 (gehoororganen) H315 H319 |
GHS02 GHS08 GHS07 Dgr |
H226 H361d H332 H372 (gehoororganen) H315 H319 |
|
* |
D |
601-027-00-6 |
2-fenylpropeen; α-methylstyreen |
202-705-0 |
98-83-9 |
Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 Aquatic Chronic 2 |
H226 H319 H335 H411 |
GHS02 GHS07 GHS09 Wng |
H226 H319 H335 H411 |
|
STOT SE 3; H335: C ≥ 25 % |
|
601-028-00-1 |
2-methylstyreen; 2-vinyltolueen |
210-256-7 |
611-15-4 |
Acute Tox. 4 * Aquatic Chronic 2 |
H332 H411 |
GHS07 GHS09 Wng |
H332 H411 |
|
|
|
601-029-00-7 |
dipenteen; limoneen; [1] (R)-p-mentha-1,8-dieen; d-limoneen; [2] (S)-p-mentha-1,8-dieen; l-limoneen; [3] trans-1-methyl-4-(1-methylvinyl)cyclohexeen; [4] (±)-1-methyl-4-(1-methylvinyl)cyclohexeen [5] |
205-341-0 [1] 227-813-5 [2] 227-815-6 [3] 229-977-3 [4] 231-732-0 [5] |
138-86-3 [1] 5989-27-5 [2] 5989-54-8 [3] 6876-12-6 [4] 7705-14-8 [5] |
Flam. Liq. 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H226 H315 H317 H400 H410 |
GHS02 GHS07 GHS09 Wng |
H226 H315 H317 H410 |
|
|
C |
601-030-00-2 |
cyclopentaan |
206-016-6 |
287-92-3 |
Flam. Liq. 2 Aquatic Chronic 3 |
H225 H412 |
GHS02 Dgr |
H225 H412 |
|
|
|
601-031-00-8 |
2,4,4-trimethylpent-1-een |
203-486-4 |
107-39-1 |
Flam. Liq. 2 Aquatic Chronic 2 |
H225 H411 |
GHS02 GHS09 Dgr |
H225 H411 |
|
|
|
601-032-00-3 |
benzo[a]pyreen; benzo[def]chryseen |
200-028-5 |
50-32-8 |
Carc. 1B Muta. 1B Repr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H340 H360FD H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350 H340 H360FD H317 H410 |
|
Carc. 1B; H350: C ≥ 0,01 % |
|
601-033-00-9 |
benzo[a]antraceen |
200-280-6 |
56-55-3 |
Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H400 H410 |
GHS08 GHS09 Dgr |
H350 H410 |
|
M=100 |
|
601-034-00-4 |
benzo[e]acefenantryleen |
205-911-9 |
205-99-2 |
Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H400 H410 |
GHS08 GHS09 Dgr |
H350 H410 |
|
|
|
601-035-00-X |
benzo[j]fluorantheen |
205-910-3 |
205-82-3 |
Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H400 H410 |
GHS08 GHS09 Dgr |
H350 H410 |
|
|
|
601-036-00-5 |
benzo[k]fluorantheen |
205-916-6 |
207-08-9 |
Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H400 H410 |
GHS08 GHS09 Dgr |
H350 H410 |
|
|
|
601-037-00-0 |
n-hexaan |
203-777-6 |
110-54-3 |
Flam. Liq. 2 Repr. 2 Asp. Tox. 1 STOT RE 2 * Skin Irrit. 2 STOT SE 3 Aquatic Chronic 2 |
H225 H361f *** H304 H373 ** H315 H336 H411 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H225 H361f *** H304 H373 ** H315 H336 H411 |
|
STOT RE 2; H373: C ≥ 5 % |
|
601-041-00-2 |
dibenzo[a,h]antraceen |
200-181-8 |
53-70-3 |
Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H400 H410 |
GHS08 GHS09 Dgr |
H350 H410 |
|
Carc. 1B; H350: C ≥ 0,01 % M=100 |
|
601-042-00-8 |
bifenyl; difenyl |
202-163-5 |
92-52-4 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H335 H315 H400 H410 |
GHS07 GHS09 Wng |
H319 H335 H315 H410 |
|
|
|
601-043-00-3 |
1,2,4-trimethylbenzeen |
202-436-9 |
95-63-6 |
Flam. Liq. 3 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 2 |
H226 H332 H319 H335 H315 H411 |
GHS02 GHS07 GHS09 Wng |
H226 H332 H319 H335 H315 H411 |
|
|
|
601-044-00-9 |
3a,4,7,7a-tetrahydro-4,7-methanoïndeen |
201-052-9 |
77-73-6 |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 2 |
H225 H332 H302 H319 H335 H315 H411 |
GHS02 GHS07 GHS09 Dgr |
H225 H332 H302 H319 H335 H315 H411 |
|
|
|
601-045-00-4 |
1,2,3,4-tetrahydronaftaleen |
204-340-2 |
119-64-2 |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 |
H319 H315 H411 |
GHS07 GHS09 Wng |
H319 H315 H411 |
EUH019 |
|
|
601-046-00-X |
7-methylocta-1,6-dieen |
404-210-7 |
42152-47-6 |
Flam. Liq. 3 Aquatic Acute 1 Aquatic Chronic 1 |
H226 H400 H410 |
GHS02 GHS09 Wng |
H226 H410 |
|
|
|
601-047-00-5 |
m-mentha-1,3(8)-dieen |
404-150-1 |
17092-80-7 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
601-048-00-0 |
chryseen |
205-923-4 |
218-01-9 |
Carc. 1B Muta. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H341 H400 H410 |
GHS08 GHS09 Dgr |
H350 H341 H410 |
|
|
|
601-049-00-6 |
benzo[e]pyreen |
205-892-7 |
192-97-2 |
Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H400 H410 |
GHS08 GHS09 Dgr |
H350 H410 |
|
|
|
601-051-00-7 |
4-fenylbut-1-een |
405-980-7 |
768-56-9 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
601-052-00-2 |
naftaleen |
202-049-5 |
91-20-3 |
Carc. 2 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H302 H400 H410 |
GHS07 GHS08 GHS09 Wng |
H351 H302 H410 |
|
|
|
601-053-00-8 |
nonylfenol; [1] 4-nonylfenol, vertakt [2] |
246-672-0 [1] 284-325-5 [2] |
25154-52-3 [1] 84852-15-3 [2] |
Repr. 2 Acute Tox. 4 * Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H361fd H302 H314 H400 H410 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H361fd H302 H314 H410 |
|
|
|
601-054-00-3 |
reactiemassa van isomeren van: dibenzylbenzeen; dibenzyl(methyl)benzeen; dibenzyl(dimethyl)benzeen; dibenzyl(trimethyl)benzeen |
405-570-8 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
601-055-00-9 |
reactiemassa van isomeren van: mono-(2-tetradecyl)naftalenen; di-(2-tetradecyl)naftalenen; tri-(2-tetradecyl)naftalenen |
410-190-0 |
132983-41-6 |
Eye Irrit. 2 Aquatic Chronic 4 |
H319 H413 |
GHS07 Wng |
H319 H413 |
|
|
|
601-056-00-4 |
reactiemassa van isomeren van: methyldifenylmethaan; dimethyldifenylmethaan |
405-470-4 |
73807-39-3 |
Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Wng |
H315 H410 |
|
|
|
601-057-00-X |
N-dodecyl-[3-(4-dimethylamino)benzamido)-propyl]dimethylammoniumtosylaat |
421-130-8 |
156679-41-3 |
Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H318 H317 H410 |
|
|
|
601-058-00-5 |
di-L-paramentheen |
417-870-6 |
83648-84-4 |
Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H315 H317 H410 |
|
|
|
601-059-00-0 |
methyl-2-benzylideen-3-oxobutyraat |
420-940-9 |
15768-07-7 |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 |
H319 H315 H411 |
GHS07 GHS09 Wng |
H319 H315 H411 |
|
|
|
601-060-00-6 |
1,2-bis[4-fluor-6-{4-sulfo-5-(2-(4-sulfonaftaleen-3-ylazo)-1-hydroxy-3,6-disulfo-8-aminonaftaleen-7-ylazo)fenylamino}-1,3,5-triazine-2-ylamino]ethaan; x-natrium-y-kaliumzouten x = 7,755 y =0,245 |
417-610-1 |
155522-09-1 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
601-061-00-1 |
(ethyl-1,2-ethaandiyl)[-2-[[[(2-hydroxyethyl)methylamino]acetyl]-propyl]ω-(nonylfenoxy)poly]oxy-(methyl-1,2-ethaandiyl) |
418-960-8 |
— |
Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 |
H314 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H314 H317 H411 |
|
|
|
601-062-00-7 |
reactiemassa van: vertakt triacontaan; vertakt dotriacontaan; vertakt tetratriacontaan; vertakt hexatriacontaan |
417-030-9 |
151006-59-6 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
601-063-00-2 |
reactiemassa van isomeren van vertakt tetracosan |
417-060-2 |
151006-61-0 |
Acute Tox. 4 * Aquatic Chronic 4 |
H332 H413 |
GHS07 Wng |
H332 H413 |
|
|
|
601-064-00-8 |
vertakt hexatriacontaan |
417-070-7 |
151006-62-1 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
601-065-00-3 |
reactiemassa van: (1'α,3'α,6'α)-2,2,3',7',7'-pentamethylspiro(1,3-dioxaan-5,2'-norcaraan); (1'α,3'β,6'α)-2,2,3',7',7'-pentamethylspiro(1,3-dioxaan-5,2'-norcaraan) |
416-930-9 |
— |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
601-066-00-9 |
1-(4-(trans-4-heptylcyclohexyl)fenyl)ethanon |
426-820-2 |
78531-60-9 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
601-067-00-4 |
triëthylarsenaat |
427-700-2 |
15606-95-8 |
Carc. 1A Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H350 H331 H301 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350 H331 H301 H410 |
|
|
|
601-068-00-X |
1,2-diacetoxybut-3-een |
421-720-5 |
18085-02-4 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
601-069-00-5 |
2-ethyl-1-(2-(1,3-dioxanyl)ethyl)-pyridiniumbromide |
422-680-1 |
287933-44-2 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
601-070-00-0 |
reactiemassa van: vertakt icosaan; vertakt docosaan; vertakt tetracosaan |
417-050-8 |
151006-58-5 |
Acute Tox. 4 * Aquatic Chronic 4 |
H332 H413 |
GHS07 Wng |
H332 H413 |
|
|
|
601-071-00-6 |
1-dimethoxymethyl-2-nitrobenzeen |
423-830-9 |
20627-73-0 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
601-072-00-1 |
reactiemassa van: 1-(4-isopropylfenyl)-1-fenylethaan; 1-(3-isopropylfenyl)-1-fenylethaan; 1-(2-isopropylfenyl)-1-fenylethaan |
430-690-2 |
52783-21-8 |
Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Wng |
H315 H410 |
|
|
|
601-073-00-7 |
1-broom-3,5-difluorbenzeen |
416-710-2 |
461-96-1 |
Flam. Liq. 3 Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H226 H302 H373 ** H315 H317 H400 H410 |
GHS02 GHS08 GHS07 GHS09 Wng |
H226 H302 H373 ** H315 H317 H410 |
|
|
|
601-074-00-2 |
reactiemassa van: 4-(2,2,3-trimethylcyclopent-3-een-1-yl)-1-methyl-2-oxabicyclo[2.2.2]octaan; 1-(2,2,3-trimethylcyclopent-3-een-1-yl)-5-methyl-6-oxabicyclo[3.2.1]octaan; spiro[cyclohex-3-een-1-yl-[(4,5,6,6a-tetrahydro-3,6',6',6'a-tetramethyl)-1,3'(3'aH)-[2H]cyclopenta[b]furan]; spiro[cyclohex-3-een-1-yl-[4,5,6,6a-tetrahydro-4,6',6',6'a-tetramethyl)-1,3'(3'aH)-[2H]cyclopenta[b]]furan] |
422-040-1 |
— |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 |
H319 H315 H411 |
GHS07 GHS09 Wng |
H319 H315 H411 |
|
|
|
601-075-00-8 |
4,4'-bis(N-carbamoyl-4-methylbenzeensulfonamide)difenylmethaan |
418-770-5 |
151882-81-4 |
Carc. 2 |
H351 |
GHS08 Wng |
H351 |
|
|
|
601-076-00-3 |
ethynylcyclopropaan |
425-430-1 |
6746-94-7 |
Flam. Liq. 2 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H225 H315 H318 H412 |
GHS02 GHS05 Dgr |
H225 H315 H318 H412 |
|
|
|
601-077-00-9 |
reactiemassa van: 1-heptyl-4-ethyl-2,6,7-trioxabicyclo[2.2.2]octaan; 1-nonyl-4-ethyl-2,6,7-trioxabicyclo[2.2.2]octaan |
426-510-7 |
196965-91-0 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
601-078-00-4 |
reactiemassa van: 1,7-dimethyl-2-[(3-methylbicyclo[2.2.1]hept-2-yl)methyl]bicyclo[2.2.1]heptaan; 2,3-dimethyl-2-[(3-methylbicyclo[2.2.1]hept-2-yl)methyl]bicyclo[2.2.1]heptaan |
427-040-5 |
— |
Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H314 H400 H410 |
GHS05 GHS09 Dgr |
H314 H410 |
|
|
|
601-079-00-X |
reactiemassa van: trans-trans-cyclohexadeca-1,9-dieen; cis-trans-cyclohexadeca-1,9-dieen |
429-620-3 |
— |
Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 |
H315 H317 H413 |
GHS07 Wng |
H315 H317 H413 |
|
|
|
601-080-00-5 |
reactiemassa van: sec-butylfenyl(fenyl)methaan, mengsel van isomeren; 1-(sec-butylfenyl(fenyl)-2-fenylethaan, mengsel van isomeren; 1-(sec-butylfenyl-1-fenylethaan, mengsel van isomeren |
431-100-6 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
601-081-00-0 |
cyclohexadeca-1,9-dieen |
431-730-1 |
4277-06-9 |
Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 |
H315 H317 H413 |
GHS07 Wng |
H315 H317 H413 |
|
|
|
601-082-00-6 |
reactiemassa van: endo-2-methyl-exo-3-methyl-exo-2-[(exo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptaan; exo-2-methyl-exo-3-methyl-endo-2-[(endo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptaan |
434-420-4 |
— |
Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H400 H410 |
GHS05 GHS09 Dgr |
H315 H318 H410 |
|
|
|
601-083-00-1 |
5-endo-hexylbicyclo[2.2.1]hept-2-een |
435-000-3 |
22094-83-3 |
Asp. Tox. 1 Skin Irrit. 2 Aquatic Chronic 4 |
H304 H315 H413 |
GHS08 GHS07 Dgr |
H304 H315 H413 |
|
|
|
601-084-00-7 |
reactiemassa van: 5-endo-butylbicyclo[2.2.1]hept-2-een; 5-exo-butylbicyclo[2.2.1]hept-2-een (80:20) |
435-180-3 |
— |
Asp. Tox. 1 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H304 H315 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H304 H315 H410 |
|
|
|
601-085-00-2 |
isopentaan; 2-methylbutaan |
201-142-8 |
78-78-4 |
Flam. Liq. 1 Asp. Tox. 1 STOT SE 3 Aquatic Chronic 2 |
H224 H304 H336 H411 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H224 H304 H336 H411 |
EUH066 |
|
|
601-087-00-3 |
2,4,4-trimethylpenteen |
246-690-9 |
25167-70-8 |
Flam. Liq. 2 Asp. Tox. 1 STOT SE 3 |
H225 H304 H336 |
GHS02 GHS07 GHS08 Dgr |
H225 H304 H336 |
|
|
D |
601-088-00-9 |
4-vinylcyclohexeen |
202-848-9 |
100-40-3 |
Carc. 2 |
H351 |
GHS08 Wng |
H351 |
|
|
|
601-089-00-4 |
muscalure; cis-tricos-9-een |
248-505-7 |
27519-02-4 |
Skin Sens. 1B |
H317 |
GHS07 Wng |
H317 |
|
|
|
602-001-00-7 |
chloormethaan; methylchloride |
200-817-4 |
74-87-3 |
Flam. Gas 1 Press. Gas Carc. 2 STOT RE 2 * |
H220 H351 H373 ** |
GHS02 GHS04 GHS08 Dgr |
H220 H351 H373 ** |
|
|
U |
602-002-00-2 |
broommethaan; methylbromide |
200-813-2 |
74-83-9 |
Press. Gas Muta. 2 Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Ozone 1 |
H341 H331 H301 H373** H319 H335 H315 H400 H420 |
GHS04 GHS06 GHS08 GHS09 Dgr |
H341 H331 H301 H373 ** H319 H335 H315 H400 H420 |
|
|
U |
602-003-00-8 |
dibroommethaan |
200-824-2 |
74-95-3 |
Acute Tox. 4 * Aquatic Chronic 3 |
H332 H412 |
GHS07 Wng |
H332 H412 |
|
* |
|
602-004-00-3 |
dichloormethaan; methyleenchloride |
200-838-9 |
75-09-2 |
Carc. 2 |
H351 |
GHS08 Wng |
H351 |
|
|
|
602-005-00-9 |
methyljodide; joodmethaan |
200-819-5 |
74-88-4 |
Carc. 2 Acute Tox. 4 * Acute Tox. 3 * Acute Tox. 3 * STOT SE 3 Skin Irrit. 2 |
H351 H312 H331 H301 H335 H315 |
GHS06 GHS08 Dgr |
H351 H312 H331 H301 H335 H315 |
|
|
|
602-006-00-4 |
chloroform; trichloormethaan |
200-663-8 |
67-66-3 |
Carc. 2 Repr. 2 Acute Tox. 3 Acute Tox. 4 STOT RE 1 Eye Irrit. 2 Skin Irrit. 2 |
H351 H361d H331 H302 H372 H319 H315 |
GHS06 GHS08 Dgr |
H351 H361d H331 H302 H372 H319 H315 |
|
|
|
602-007-00-X |
bromoform; tribroommethaan |
200-854-6 |
75-25-2 |
Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 |
H331 H302 H319 H315 H411 |
GHS06 GHS09 Dgr |
H331 H302 H319 H315 H411 |
|
|
|
602-008-00-5 |
koolstoftetrachloride; tetrachloormethaan |
200-262-8 |
56-23-5 |
Carc. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 Aquatic Chronic 3 Ozone 1 |
H351 H331 H311 H301 H372** H412 H420 |
GHS06 GHS08 Dgr |
H351 H331 H311 H301 H372 ** H412 H420 |
|
* STOT RE 1; H372:C≥1 % STOT RE 2; H373:0,2 % ≤C < 1 % |
|
602-009-00-0 |
chloorethaan |
200-830-5 |
75-00-3 |
Flam. Gas 1 Press. Gas Carc. 2 Aquatic Chronic 3 |
H220 H351 H412 |
GHS02 GHS04 GHS08 Dgr |
H220 H351 H412 |
|
|
U |
602-010-00-6 |
1,2-dibroomethaan |
203-444-5 |
106-93-4 |
Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 2 |
H350 H331 H311 H301 H319 H335 H315 H411 |
GHS06 GHS08 GHS09 Dgr |
H350 H331 H311 H301 H319 H335 H315 H411 |
|
* |
|
602-011-00-1 |
1,1-dichloorethaan |
200-863-5 |
75-34-3 |
Flam. Liq. 2 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Aquatic Chronic 3 |
H225 H302 H319 H335 H412 |
GHS02 GHS07 Dgr |
H225 H302 H319 H335 H412 |
|
* |
|
602-012-00-7 |
1,2-dichloorethaan; ethyleendichloride |
203-458-1 |
107-06-2 |
Flam. Liq. 2 Carc. 1B Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H225 H350 H302 H319 H335 H315 |
GHS02 GHS08 GHS07 Dgr |
H225 H350 H302 H319 H335 H315 |
|
|
|
602-013-00-2 |
1,1,1-trichloorethaan; methylchloroform |
200-756-3 |
71-55-6 |
Acute Tox. 4 * Ozone 1 |
H332 H420 |
GHS07 Wng |
H332 H420 |
|
|
F |
602-014-00-8 |
1,1,2-trichloorethaan |
201-166-9 |
79-00-5 |
Carc. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H351 H332 H312 H302 |
GHS08 GHS07 Wng |
H351 H332 H312 H302 |
EUH066 |
* |
|
602-015-00-3 |
1,1,2,2-tetrachloorethaan |
201-197-8 |
79-34-5 |
Acute Tox. 2 * Acute Tox. 1 Aquatic Chronic 2 |
H330 H310 H411 |
GHS06 GHS09 Dgr |
H330 H310 H411 |
|
|
|
602-016-00-9 |
1,1,2,2-tetrabroomethaan |
201-191-5 |
79-27-6 |
Acute Tox. 2 * Eye Irrit. 2 Aquatic Chronic 3 |
H330 H319 H412 |
GHS06 Dgr |
H330 H319 H412 |
|
|
|
602-017-00-4 |
pentachloorethaan |
200-925-1 |
76-01-7 |
Carc. 2 STOT RE 1 Aquatic Chronic 2 |
H351 H372 ** H411 |
GHS08 GHS09 Dgr |
H351 H372 ** H411 |
|
STOT RE 1; H372: C≥ 1 % STOT RE 2; H373: 0,2 % ≤ C < 1 % |
|
602-018-00-X |
1-chloorpropaan; [1] 2-chloorpropaan [2] |
208-749-7 [1] 200-858-8 [2] |
540-54-5 [1] 75-29-6 [2] |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H225 H332 H312 H302 |
GHS02 GHS07 Dgr |
H225 H332 H312 H302 |
|
|
C |
602-019-00-5 |
1-broompropaan; n-propylbromide; |
203-445-0 |
106-94-5 |
Flam. Liq. 2 Repr. 1B STOT RE 2 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 STOT SE 3 |
H225 H360FD H373 ** H319 H335 H315 H336 |
GHS02 GHS08 GHS07 Dgr |
H225 H360FD H373 ** H319 H335 H315 H336 |
|
|
|
602-021-00-6 |
1,2-dibroom-3-chloorpropaan |
202-479-3 |
96-12-8 |
Carc. 1B Muta. 1B Repr. 1A Acute Tox. 3 * STOT RE 2 * Aquatic Chronic 3 |
H350 H340 H360F *** H301 H373 ** H412 |
GHS06 GHS08 Dgr |
H350 H340 H360F *** H301 H373 ** H412 |
|
|
|
602-022-00-1 |
1-chloorpentaan; [1] 2-chloorpentaan; [2] 3-chloorpentaan [3] |
208-846-4 [1] 210-885-7 [2] 210-467-4 [3] |
543-59-9 [1] 625-29-6 [2] 616-20-6 [3] |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H225 H332 H312 H302 |
GHS02 GHS07 Dgr |
H225 H332 H312 H302 |
|
|
C |
602-023-00-7 |
vinylchloride; chloorethyleen |
200-831-0 |
75-01-4 |
Press. Gas Flam. Gas 1 Carc. 1A |
H220 H350 |
GHS02 GHS08 Dgr |
H220 H350 |
|
|
D U |
602-024-00-2 |
broomethyleen |
209-800-6 |
593-60-2 |
Press. Gas Flam. Gas 1 Carc. 1B |
H220 H350 |
GHS02 GHS08 Dgr |
H220 H350 |
|
|
U |
602-025-00-8 |
1,1-dichloorethyleen; vinylideenchloride |
200-864-0 |
75-35-4 |
Flam. Liq. 1 Carc. 2 Acute Tox. 4 * |
H224 H351 H332 |
GHS02 GHS08 GHS07 Dgr |
H224 H351 H332 |
|
* |
D |
602-026-00-3 |
1,2-dichloorethyleen; [1] cis-dichloorethyleen; [2] trans-dichloorethyleen [3] |
208-750-2 [1] 205-859-7 [2] 205-860-2 [3] |
540-59-0 [1] 156-59-2 [2] 156-60-5 [3] |
Flam. Liq. 2 Acute Tox. 4 * Aquatic Chronic 3 |
H225 H332 H412 |
GHS02 GHS07 Dgr |
H225 H332 H412 |
|
* |
C |
602-027-00-9 |
trichloorethyleen; trichlooretheen |
201-167-4 |
79-01-6 |
Carc. 1B Muta. 2 Eye Irrit. 2 Skin Irrit. 2 STOT SE 3 Aquatic Chronic 3 |
H350 H341 H319 H315 H336 H412 |
GHS08 GHS07 Dgr |
H350 H341 H319 H315 H336 H412 |
|
|
|
602-028-00-4 |
tetrachloorethyleen |
204-825-9 |
127-18-4 |
Carc. 2 Aquatic Chronic 2 |
H351 H411 |
GHS08 GHS09 Wng |
H351 H411 |
|
|
|
602-029-00-X |
3-chloorpropeen; allylchloride |
203-457-6 |
107-05-1 |
Flam. Liq. 2 Carc. 2 Muta. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 |
H225 H351 H341 H332 H312 H302 H373 ** H319 H335 H315 H400 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H225 H351 H341 H332 H312 H302 H373 ** H319 H335 H315 H400 |
|
|
D |
602-030-00-5 |
1,3-dichloorpropeen; [1] (Z)-1,3-dichloorpropeen [2] |
208-826-5 [1] 233-195-8 [2] |
542-75-6 [1] 10061-01-5 [2] |
Flam. Liq. 3 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * Asp. Tox. 1 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H226 H311 H301 H332 H304 H319 H335 H315 H317 H400 H410 |
GHS02 GHS06 GHS08 GHS09 Dgr |
H226 H311 H301 H332 H304 H319 H335 H315 H317 H410 |
|
|
C D |
602-031-00-0 |
1,1-dichloorpropeen |
209-253-3 |
563-58-6 |
Flam. Liq. 2 Acute Tox. 3 * Aquatic Chronic 3 |
H225 H301 H412 |
GHS02 GHS06 Dgr |
H225 H301 H412 |
|
|
|
602-032-00-6 |
3-chloor-2-methylpropeen |
209-251-2 |
563-47-3 |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 |
H225 H332 H302 H314 H317 H411 |
GHS02 GHS05 GHS07 GHS09 Dgr |
H225 H332 H302 H314 H317 H411 |
|
|
|
602-034-00-7 |
1,2-dichloorbenzeen; o-dichloorbenzeen |
202-425-9 |
95-50-1 |
Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H335 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H335 H315 H410 |
|
* |
|
602-035-00-2 |
1,4-dichloorbenzeen; p-dichloorbenzeen |
203-400-5 |
106-46-7 |
Carc. 2 Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H319 H400 H410 |
GHS08 GHS09 Wng |
H351 H319 H410 |
|
|
|
602-036-00-8 |
chloropreen (gestabiliseerd); 2-chloorbuta-1,3-dieen (gestabiliseerd) |
204-818-0 |
126-99-8 |
Flam. Liq. 2 Carc. 1B Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H225 H350 H332 H302 H373 ** H319 H335 H315 |
GHS02 GHS08 GHS07 Dgr |
H225 H350 H332 H302 H373 ** H319 H335 H315 |
|
|
D |
602-037-00-3 |
α-chloortolueen; benzylchloride |
202-853-6 |
100-44-7 |
Carc. 1B Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 |
H350 H331 H302 H373 ** H335 H315 H318 |
GHS06 GHS08 GHS05 Dgr |
H350 H331 H302 H373 ** H335 H315 H318 |
|
|
|
602-038-00-9 |
α, α,α-trichloortolueen; benzotrichloride |
202-634-5 |
98-07-7 |
Carc. 1B Acute Tox. 3 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 |
H350 H331 H302 H335 H315 H318 |
GHS06 GHS08 GHS05 Dgr |
H350 H331 H302 H335 H315 H318 |
|
|
|
602-039-00-4 |
polychloorbifenylen; pcb |
215-648-1 |
1336-36-3 |
STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H373 ** H400 H410 |
GHS08 GHS09 Wng |
H373 ** H410 |
|
STOT RE 2; H373: C ≥ 0,005 % |
C |
602-040-00-X |
2-chloortolueen; [1] 3-chloortolueen; [2] 4-chloortolueen; [3] chloortolueen [4] |
202-424-3 [1] 203-580-5 [2] 203-397-0 [3] 246-698-2 [4] |
95-49-8 [1] 108-41-8 [2] 106-43-4 [3] 25168-05-2 [4] |
Acute Tox. 4 * Aquatic Chronic 2 |
H332 H411 |
GHS07 GHS09 Wng |
H332 H411 |
|
|
C |
602-041-00-5 |
pentachloornaftaleen |
215-320-8 |
1321-64-8 |
Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H319 H315 H400 H410 |
GHS07 GHS09 Wng |
H312 H302 H319 H315 H410 |
|
|
C |
602-042-00-0 |
1,2,3,4,5,6-hexachloorcyclohexanen, tenzij elders in deze bijlage vermeld |
— |
— |
Carc. 2 Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H301 H312 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H301 H312 H410 |
|
|
A C |
602-043-00-6 |
lindaan (ISO); γ-HCH of γ-BHC; γ-1,2,3,4,5,6-hexachloorcyclohexaan |
200-401-2 |
58-89-9 |
Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Lact. Aquatic Acute 1 Aquatic Chronic 1 |
H301 H332 H312 H373 ** H362 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H301 H332 H312 H373 ** H362 H410 |
|
M=10 |
|
602-044-00-1 |
camfechloor (ISO); toxafeen; |
232-283-3 |
8001-35-2 |
Carc. 2 Acute Tox. 3 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H301 H312 H335 H315 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H301 H312 H335 H315 H410 |
|
|
|
602-045-00-7 |
DDT (ISO); clofenotaan (INN); dicofaan; 1,1,1-trichloor-2,2-bis(4-chloorfenyl)ethaan; dichloordifenyltrichloorethaan |
200-024-3 |
50-29-3 |
Carc. 2 Acute Tox. 3 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H301 H372 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H301 H372 ** H410 |
|
|
|
602-046-00-2 |
heptachloor (ISO); 1,4,5,6,7,8,8-heptachloor-3a,4,7,7a-tetrahydro-4,7-methanoïndeen |
200-962-3 |
76-44-8 |
Carc. 2 Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H311 H301 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H311 H301 H373 ** H410 |
|
|
|
602-047-00-8 |
chloordaan (ISO); 1,2,4,5,6,7,8,8-octachloor-3a,4,7,7a-tetrahydro-4,7-methanoïndaan |
200-349-0 |
57-74-9 |
Carc. 2 Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H312 H302 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H312 H302 H410 |
|
|
|
602-048-00-3 |
aldrin (ISO) |
206-215-8 |
309-00-2 |
Carc. 2 Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H311 H301 H372 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H311 H301 H372 ** H410 |
|
|
|
602-049-00-9 |
dieldrin (ISO) |
200-484-5 |
60-57-1 |
Carc. 2 Acute Tox. 1 Acute Tox. 3 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H310 H301 H372 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H310 H301 H372 ** H410 |
|
|
|
602-050-00-4 |
isodrin; (1α,4α,4aβ,5β,8β,8aβ)-1,2,3,4,10,10-hexachloor-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimethanonaftaleen |
207-366-2 |
465-73-6 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H330 H310 H300 H410 |
|
M=100 |
|
602-051-00-X |
endrin (ISO); 1,2,3,4,10,10-hexachloor-6,7-epoxy-1,4,4a,5,6,7,8,8a-octahydro-1,4:5,8-dimethanonaftaleen |
200-775-7 |
72-20-8 |
Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H311 H400 H410 |
GHS06 GHS09 Dgr |
H300 H311 H410 |
|
|
|
602-052-00-5 |
endosulfan (ISO); 1,2,3,4,7,7-hexachloor-8,9,10-trinorborn-2-een-5,6-yleendimethylsulfiet; (1,4,5,6,7,7-hexachloor-8,9,10-trinorborn-5-een-2,3-yleendimethyleen)sulfiet |
204-079-4 |
115-29-7 |
Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H300 H312 H400 H410 |
GHS06 GHS09 Dgr |
H330 H300 H312 H410 |
|
|
|
602-053-00-0 |
isobenzan (ISO); 1,3,4,5,6,7,8,8-octachloor-1,3,3a,4,7,7a-hexahydro-4,7-methanoïsobenzofuran |
206-045-4 |
297-78-9 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 |
H310 H300 H400 |
GHS06 GHS09 Dgr |
H310 H300 H400 |
|
|
|
602-054-00-6 |
3-joodpropeen; allyljodide |
209-130-4 |
556-56-9 |
Flam. Liq. 2 Skin Corr. 1B |
H225 H314 |
GHS02 GHS05 Dgr |
H225 H314 |
|
|
|
602-055-00-1 |
broomethaan; ethylbromide |
200-825-8 |
74-96-4 |
Flam. Liq. 2 Carc. 2 Acute Tox. 4 * Acute Tox. 4 * |
H225 H351 H332 H302 |
GHS02 GHS08 GHS07 Dgr |
H225 H351 H332 H302 |
|
|
|
602-056-00-7 |
α, α,α-trifluortolueen; benzotrifluoride |
202-635-0 |
98-08-8 |
Flam. Liq. 2 Aquatic Chronic 2 |
H225 H411 |
GHS02 GHS09 Dgr |
H225 H411 |
|
|
|
602-057-00-2 |
α-broomtolueen; benzylbromide |
202-847-3 |
100-39-0 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H319 H335 H315 |
GHS07 Wng |
H319 H335 H315 |
|
|
|
602-058-00-8 |
α, α-dichloortolueen; benzylideenchloride; benzalchloride |
202-709-2 |
98-87-3 |
Carc. 2 Acute Tox. 3 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 |
H351 H331 H302 H335 H315 H318 |
GHS06 GHS08 GHS05 Dgr |
H351 H331 H302 H335 H315 H318 |
|
|
|
602-059-00-3 |
1-chloorbutaan; butylchloride |
203-696-6 |
109-69-3 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
|
|
|
602-060-00-9 |
broombenzeen |
203-623-8 |
108-86-1 |
Flam. Liq. 3 Skin Irrit. 2 Aquatic Chronic 2 |
H226 H315 H411 |
GHS02 GHS07 GHS09 Wng |
H226 H315 H411 |
|
|
|
602-061-00-4 |
perfluorpropeen; hexafluorpropeen |
204-127-4 |
116-15-4 |
Press. Gas Acute Tox. 4 * STOT SE 3 |
H332 H335 |
GHS07 Wng |
H332 H335 |
|
|
U |
602-062-00-X |
1,2,3-trichloorpropaan |
202-486-1 |
96-18-4 |
Carc. 1B Repr. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H350 H360F *** H332 H312 H302 |
GHS08 GHS07 Dgr |
H350 H360F *** H332 H312 H302 |
|
|
D |
602-063-00-5 |
heptachloorepoxide; 2,3-epoxy-1,4,5,6,7,8,8-heptachloor-3a,4,7,7a-tetrahydro-4,7-methanoïndaan |
213-831-0 |
1024-57-3 |
Carc. 2 Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H301 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H301 H373 ** H410 |
|
|
|
602-064-00-0 |
1,3-dichloor-2-propanol |
202-491-9 |
96-23-1 |
Carc. 1B Acute Tox. 3 * Acute Tox. 4 * |
H350 H301 H312 |
GHS06 GHS08 Dgr |
H350 H301 H312 |
|
|
|
602-065-00-6 |
hexachloorbenzeen |
204-273-9 |
118-74-1 |
Carc. 1B STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H372 ** H400 H410 |
GHS08 GHS09 Dgr |
H350 H372 ** H410 |
|
|
|
602-066-00-1 |
tetrachloor-p-benzochinon |
204-274-4 |
118-75-2 |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H315 H400 H410 |
GHS07 GHS09 Wng |
H319 H315 H410 |
|
|
|
602-067-00-7 |
1,3-dichloorbenzeen |
208-792-1 |
541-73-1 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
602-068-00-2 |
ethyleenbis(trichlooracetaat) |
219-732-9 |
2514-53-6 |
Skin Irrit. 2 |
H315 |
GHS07 Wng |
H315 |
|
|
|
602-069-00-8 |
dichloroacetyleen |
— |
7572-29-4 |
Unst. Expl. Carc. 2 STOT RE 2 * |
H200 H351 H373 ** |
GHS01 GHS08 Wng |
H200 H351 H373 ** |
|
|
|
602-070-00-3 |
3-chloor-4,5,α, α,α-pentafluortolueen |
401-930-3 |
77227-99-7 |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 |
H226 H332 H302 H400 |
GHS02 GHS07 GHS09 Wng |
H226 H332 H302 H400 |
|
|
|
602-071-00-9 |
broombenzylbroomtolueen, reactiemassa van isomeren |
402-210-1 |
99688-47-8 |
STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H373 ** H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H373 ** H317 H410 |
|
|
|
602-072-00-4 |
dichloor[(dichloorfenyl)methyl]methylbenzeen, reactiemassa van isomeren; (dichloorfenyl)(dichloortolyl)methaan, reactiemassa van isomeren (IUPAC) |
278-404-3 |
76253-60-6 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
602-073-00-X |
1,4-dichloorbut-2-een |
212-121-8 |
764-41-0 |
Carc. 1B Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H330 H311 H301 H314 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H350 H330 H311 H301 H314 H410 |
|
Carc. 1B; H350: C ≥ 0,01 % STOT SE 3; H335:C≥5 % |
|
602-074-00-5 |
pentachloorbenzeen |
210-172-0 |
608-93-5 |
Flam. Sol. 1 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H228 H302 H400 H410 |
GHS02 GHS07 GHS09 Dgr |
H228 H302 H410 |
|
|
T |
602-075-00-0 |
4,4,5,5-tetrachloor-1,3-dioxolaan-2-on |
404-060-2 |
22432-68-4 |
Acute Tox. 2 * Acute Tox. 4 * Skin Corr. 1B |
H330 H302 H314 |
GHS06 GHS05 Dgr |
H330 H302 H314 |
|
|
|
602-076-00-6 |
2,3,4-trichloorbut-1-een |
219-397-9 |
2431-50-7 |
Carc. 2 Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H331 H302 H319 H335 H315 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H331 H302 H319 H335 H315 H410 |
|
Carc. 2; H351: C ≥ 0,1 % |
|
602-077-00-1 |
dodecachloorpentacyclo[5.2.1.02,6.03,9.05,8]decaan; mirex |
219-196-6 |
2385-85-5 |
Carc. 2 Repr. 2 Lact. Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H361fd H362 H312 H302 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H361fd H362 H312 H302 H410 |
|
|
|
602-078-00-7 |
hexachloorcyclopentadieen |
201-029-3 |
77-47-4 |
Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 4 * Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H330 H311 H302 H314 H400 H410 |
GHS06 GHS05 GHS09 Dgr |
H330 H311 H302 H314 H410 |
|
|
|
602-079-00-2 |
2,3-dichloorpropeen; 2,3-dichloorpropyleen |
201-153-8 |
78-88-6 |
Flam. Liq. 2 Muta. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H225 H341 H332 H312 H302 H335 H315 H318 H412 |
GHS02 GHS08 GHS05 GHS07 Dgr |
H225 H341 H332 H312 H302 H335 H315 H318 H412 |
|
|
|
602-080-00-8 |
alkanen, C10-13, chloor; chloorparaffines, C10-13 |
287-476-5 |
85535-84-8 |
Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H400 H410 |
GHS08 GHS09 Wng |
H351 H410 |
EUH066 |
|
|
602-081-00-3 |
2-chloor-4,5-difluorbenzoëzuur |
405-380-5 |
— |
Acute Tox. 4 * Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 |
H312 H302 H318 H317 |
GHS05 GHS07 Dgr |
H312 H302 H318 H317 |
|
|
|
602-082-00-9 |
2,2,6,6-tetrakis(broommethyl)-4-oxaheptaan-1,7-diol |
408-020-5 |
109678-33-3 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
602-083-00-4 |
difenylether, pentabroomderivaat; pentabroomdifenylether |
251-084-2 |
32534-81-9 |
STOT RE 2 * Lact. Aquatic Acute 1 Aquatic Chronic 1 |
H373 ** H362 H400 H410 |
GHS08 GHS09 Wng |
H373 ** H362 H410 |
|
|
|
602-084-00-X |
1,1-dichloor-1-fluorethaan |
404-080-1 |
1717-00-6 |
Aquatic Chronic 3 Ozone 1 |
H412 H420 |
GHS07 Wng |
H412 H420 |
|
|
|
602-085-00-5 |
2-broompropaan |
200-855-1 |
75-26-3 |
Flam. Liq. 2 Repr. 1a STOT RE 2 * |
H225 H360F *** H373 ** |
GHS02 GHS08 Dgr |
H225 H360F *** H373 ** |
EUH066 |
|
|
602-086-00-0 |
trifluorjoodmethaan; trifluormethyljodide |
219-014-5 |
2314-97-8 |
Muta. 2 |
H341 |
GHS08 Wng |
H341 |
|
|
|
602-087-00-6 |
1,2,4-trichloorbenzeen |
204-428-0 |
120-82-1 |
Acute Tox. 4 * Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H315 H410 |
|
|
|
602-088-00-1 |
2,3-dibroompropaan-1-ol; 2,3-dibroom-1-propanol |
202-480-9 |
96-13-9 |
Carc. 1B Repr. 2 Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 3 |
H350 H361f *** H311 H332 H302 H412 |
GHS08 GHS07 Dgr |
H350 H361f *** H311 H332 H302 H412 |
|
|
|
602-089-00-7 |
4-broom-2-chloorfluorbenzeen |
405-580-2 |
60811-21-4 |
Acute Tox. 4 * Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H315 H410 |
|
|
|
602-090-00-2 |
1-allyl-3-chloor-4-fluorbenzeen |
406-630-6 |
121626-73-1 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
602-091-00-8 |
1,3-dichloor-4-fluorbenzeen |
406-160-1 |
1435-48-9 |
Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 |
H302 H373 ** H315 H411 |
GHS08 GHS07 Wng |
H302 H373 ** H315 H411 |
|
|
|
602-092-00-3 |
1-broom-3,4,5-trifluorbenzeen |
418-480-9 |
138526-69-9 |
Flam. Liq. 3 Carc. 2 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 2 |
H226 H351 H315 H318 H411 |
GHS02 GHS08 GHS05 GHS09 Dgr |
H226 H351 H315 H318 H411 |
|
|
|
602-093-00-9 |
α, α,α,4-tetrachloortolueen; p-chloorbenzotrichloride |
226-009-1 |
5216-25-1 |
Carc. 1B Repr. 2 STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 |
H350 H361f *** H372 ** H312 H302 H335 H315 |
GHS08 GHS07 Dgr |
H350 H361f *** H372 ** H312 H302 H335 H315 |
|
|
|
602-094-00-4 |
difenylether, octabroomderivaat |
251-087-9 |
32536-52-0 |
Repr. 1B |
H360Df |
GHS08 Dgr |
H360Df |
|
|
|
602-095-00-X |
alkanen, C14-17, chloor; chloorparaffines, C14-17 |
287-477-0 |
85535-85-9 |
Lact. Aquatic Acute 1 Aquatic Chronic 1 |
H362 H400 H410 |
GHS09 Wng |
H362 H410 |
EUH066 |
|
|
602-096-00-5 |
malachietgroen, hydrochloride [1]; malachietgroen, oxalaat [2] |
209-322-8 [1] 219-441-7 [2] |
569-64-2 [1] 2437-29-8 [2] |
Repr. 2 Acute Tox. 4 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361d *** H302 H318 H400 H410 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H361d *** H302 H318 H410 |
|
|
|
602-097-00-0 |
1-broom-9-(4,4,5,5,5-pentafluorpentylthio)nonaan |
422-850-5 |
148757-89-5 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
602-098-00-6 |
2-(3-broomfenoxy)tetrahydro-2H-pyran |
429-030-6 |
57999-49-2 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
602-099-00-1 |
3-(4-fluorfenyl)-2-methylpropionylchloride |
426-370-7 |
— |
Skin Corr. 1A Acute Tox. 4 * Aquatic Chronic 3 |
H314 H302 H412 |
GHS05 GHS07 Dgr |
H314 H302 H412 |
EUH014 EUH029 |
|
|
602-100-00-5 |
reactiemassa van: (R,R)-1,1,1,2,2,3,4,5,5,5-decafluorpentaan; (S,S)-1,1,1,2,2,3,4,5,5,5-decafluorpentaan |
420-640-8 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
602-101-00-0 |
2-chloor-4-fluor-5-nitrofenyl(isobutyl)carbonaat |
427-020-6 |
141772-37-4 |
STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H373** H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H373** H317 H410 |
|
|
|
602-102-00-6 |
1,1,1,3,3-pentafluorbutaan |
430-250-1 |
406-58-6 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
|
|
|
602-103-00-1 |
1-(chloorfenylmethyl)-2-methylbenzeen |
431-450-1 |
41870-52-4 |
Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Wng |
H315 H410 |
|
|
|
602-104-00-7 |
1,1,2,2,3,3,4-heptafluorcyclopentaan |
430-710-1 |
15290-77-4 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
602-105-00-2 |
natrium-1,1,2,2,3,3,4,4,4-nonafluor-1-butaansulfinaat |
422-100-7 |
102061-82-5 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
602-106-00-8 |
2-broom-4,6-difluoraniline |
429-430-0 |
444-14-4 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
602-107-00-3 |
3,3,4,4-tetrafluor-4-joodbut-1-een |
439-500-2 |
33831-83-3 |
Acute Tox. 4 * Skin Irrit. 2 Aquatic Chronic 2 |
H302 H315 H411 |
GHS07 GHS09 Wng |
H302 H315 H411 |
|
|
|
602-108-00-9 |
(2,3,5,6-tetrafluorfenyl)methanol |
443-840-7 |
4084-38-2 |
Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 |
H302 H319 H317 |
GHS07 Wng |
H302 H319 H317 |
|
|
|
602-109-00-4 |
hexabroomcyclododecaan [1] 1,2,5,6,9,10-hexabroomcyclododecaan [2] |
247-148-4 [1] 221-695-9[2] |
25637-99-4[1] 3194-55-6[2] |
Repr. 2 Lact. |
H361 H362 |
GHS08 Wng |
H361 H362 |
|
|
|
603-001-00-X |
methanol |
200-659-6 |
67-56-1 |
Flam. Liq. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT SE 1 |
H225 H331 H311 H301 H370 ** |
GHS02 GHS06 GHS08 Dgr |
H225 H331 H311 H301 H370 ** |
|
* STOT SE 1; H370: C≥10 % STOT SE 2; H371: 3 % ≤ C<10 % |
|
603-002-00-5 |
ethanol; ethylalcohol |
200-578-6 |
64-17-5 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
|
|
|
603-003-00-0 |
propaan-1-ol; n-propanol |
200-746-9 |
71-23-8 |
Flam. Liq. 2 Eye Dam. 1 STOT SE 3 |
H225 H318 H336 |
GHS02 GHS05 GHS07 Dgr |
H225 H318 H336 |
|
|
|
603-004-00-6 |
butaan-1-ol; n-butanol |
200-751-6 |
71-36-3 |
Flam. Liq. 3 Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 STOT SE 3 |
H226 H302 H335 H315 H318 H336 |
GHS02 GHS05 GHS07 Dgr |
H226 H302 H335 H315 H318 H336 |
|
|
|
603-005-00-1 |
2-methylpropaan-2-ol; tert-butylalcohol |
200-889-7 |
75-65-0 |
Flam. Liq. 2 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 |
H225 H332 H319 H335 |
GHS02 GHS07 Dgr |
H225 H332 H319 H335 |
|
|
|
603-006-00-7 |
pentanolisomeren, tenzij elders in deze bijlage vermeld |
250-378-8 |
|
Flam. Liq. 3 Acute Tox. 4 * STOT SE 3 |
H226 H332 H335 |
GHS02 GHS07 Wng |
H226 H332 H335 |
EUH066 |
|
C |
603-007-00-2 |
2-methylbutaan-2-ol; tert-pentanol |
200-908-9 |
75-85-4 |
Flam. Liq. 2 Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 |
H225 H332 H335 H315 |
GHS02 GHS07 Dgr |
H225 H332 H335 H315 |
|
|
|
603-008-00-8 |
4-methylpentaan-2-ol; methylisobutylcarbinol |
203-551-7 |
108-11-2 |
Flam. Liq. 3 STOT SE 3 |
H226 H335 |
GHS02 GHS07 Wng |
H226 H335 |
|
STOT SE 3; H335: C ≥ 25 % |
|
603-009-00-3 |
cyclohexanol |
203-630-6 |
108-93-0 |
Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 |
H332 H302 H335 H315 |
GHS07 Wng |
H332 H302 H335 H315 |
|
|
|
603-010-00-9 |
2-methylcyclohexanol, mengsel van isomeren; [1] cis-2-methylcyclohexanol; [2] trans-2-methylcyclohexanol [3] |
209-512-0 [1] 231-187-9 [2] 231-186-3 [3] |
583-59-5 [1] 7443-70-1 [2] 7443-52-9 [3] |
Acute Tox. 4 * |
H332 |
GHS07 Wng |
H332 |
|
|
C |
603-011-00-4 |
2-methoxyethanol; ethyleenglycolmonomethylether |
203-713-7 |
109-86-4 |
Flam. Liq. 3 Repr. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H226 H360FD H332 H312 H302 |
GHS02 GHS08 GHS07 Dgr |
H226 H360FD H332 H312 H302 |
|
|
|
603-012-00-X |
2-ethoxyethanol; ethyleenglycolmonoëthylether |
203-804-1 |
110-80-5 |
Flam. Liq. 3 Repr. 1B Acute Tox. 3 Acute Tox. 4 |
H226 H360FD H331 H302 |
GHS02 GHS08 GHS06 Dgr |
H226 H360FD H331 H302 |
|
|
|
603-013-00-5 |
2-isopropoxyethanol; ethyleenglycolmonoïsopropylether |
203-685-6 |
109-59-1 |
Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 |
H332 H312 H319 |
GHS07 Wng |
H332 H312 H319 |
|
|
|
603-014-00-0 |
2-butoxyethanol; ethyleenglycolmonobutylether; butylglycol |
203-905-0 |
111-76-2 |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 |
H332 H312 H302 H319 H315 |
GHS07 Wng |
H332 H312 H302 H319 H315 |
|
|
|
603-015-00-6 |
allylalcohol |
203-470-7 |
107-18-6 |
Flam. Liq. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 |
H225 H331 H311 H301 H319 H335 H315 H400 |
GHS02 GHS06 GHS09 Dgr |
H225 H331 H311 H301 H319 H335 H315 H400 |
|
|
|
603-016-00-1 |
4-hydroxy-4-methylpentaan-2-on; diacetonalcohol |
204-626-7 |
123-42-2 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
Eye Irrit. 2; H319: C≥ 10 % |
|
603-018-00-2 |
furfurylalcohol |
202-626-1 |
98-00-0 |
Carc. 2 Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 STOT SE 3 |
H351 H331 H312 H302 H373** H319 H335 |
GHS06 GHS08 Dgr |
H351 H331 H312 H302 H373** H319 H335 |
|
|
|
603-019-00-8 |
dimethylether |
204-065-8 |
115-10-6 |
Flam. Gas 1 Press. Gas |
H220 |
GHS02 GHS04 Dgr |
H220 |
|
|
U |
603-020-00-3 |
ethylmethylether |
— |
540-67-0 |
Flam. Gas 1 Press. Gas |
H220 |
GHS02 GHS04 Dgr |
H220 |
|
|
U |
603-021-00-9 |
methylvinylether |
203-475-4 |
107-25-5 |
Flam. Gas 1 Press. Gas |
H220 |
GHS02 GHS04 Dgr |
H220 |
|
|
D U |
603-022-00-4 |
diëthylether; ether |
200-467-2 |
60-29-7 |
Flam. Liq. 1 Acute Tox. 4 * STOT SE 3 |
H224 H302 H336 |
GHS02 GHS07 Dgr |
H224 H302 H336 |
EUH019 EUH066 |
|
|
603-023-00-X |
ethyleenoxide; oxiraan |
200-849-9 |
75-21-8 |
Press. Gas Flam. Gas 1 Carc. 1B Muta. 1B Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H220 H350 H340 H331 H319 H335 H315 |
GHS02 GHS04 GHS06 GHS08 Dgr |
H220 H350 H340 H331 H319 H335 H315 |
|
|
U |
603-024-00-5 |
1,4-dioxaan |
204-661-8 |
123-91-1 |
Flam. Liq. 2 Carc. 2 Eye Irrit. 2 STOT SE 3 |
H225 H351 H319 H335 |
GHS02 GHS08 GHS07 Dgr |
H225 H351 H319 H335 |
EUH019 EUH066 |
|
D |
603-025-00-0 |
tetrahydrofuran |
203-726-8 |
109-99-9 |
Flam. Liq. 2 Carc. 2 Eye Irrit. 2 STOT SE 3 |
H225 H351 H319 H335 |
GHS02 GHS07 GHS08 Dgr |
H225 H351 H319 H335 |
EUH019 |
STOT SE 3; H335: C≥25 % Eye Irrit.2; H319: C ≥ 25 % |
|
603-026-00-6 |
1-chloor-2,3-epoxypropaan; epichloorhydrine |
203-439-8 |
106-89-8 |
Flam. Liq. 3 Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Skin Sens. 1 |
H226 H350 H331 H311 H301 H314 H317 |
GHS02 GHS06 GHS08 GHS05 Dgr |
H226 H350 H331 H311 H301 H314 H317 |
|
* |
|
603-027-00-1 |
ethaandiol; ethyleenglycol |
203-473-3 |
107-21-1 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
603-028-00-7 |
2-chloorethanol; ethyleenchloorhydrine |
203-459-7 |
107-07-3 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * |
H330 H310 H300 |
GHS06 Dgr |
H330 H310 H300 |
|
|
|
603-029-00-2 |
bis(2-chloorethyl)ether |
203-870-1 |
111-44-4 |
Carc. 2 Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * |
H351 H330 H310 H300 |
GHS06 GHS08 Dgr |
H351 H330 H310 H300 |
|
|
|
603-030-00-8 |
2-aminoëthanol; ethanolamine |
205-483-3 |
141-43-5 |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H332 H312 H302 H314 |
GHS05 GHS07 Dgr |
H332 H312 H302 H314 |
|
STOT SE 3; H335: C ≥ 5 % |
|
603-031-00-3 |
1,2-dimethoxyethaan; ethyleenglycoldimethylether; EGDME |
203-794-9 |
110-71-4 |
Flam. Liq. 2 Repr. 1B Acute Tox. 4 * |
H225 H360FD H332 |
GHS02 GHS08 GHS07 Dgr |
H225 H360FD H332 |
EUH019 |
|
|
603-032-00-9 |
ethyleendinitraat; ethyleenglycoldinitraat |
211-063-0 |
628-96-6 |
Unst. Expl. Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 |
H200 H330 H310 H300 H373** |
GHS01 GHS06 GHS08 Dgr |
H200 H330 H310 H300 H373** |
|
|
|
603-033-00-4 |
oxydiëthyleendinitraat; diëthyleenglycoldinitraat; diglycoldinitraat |
211-745-8 |
693-21-0 |
Unst. Expl Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Chronic 3 |
H200 H330 H310 H300 H373 ** H412 |
GHS01 GHS06 GHS08 Dgr |
H200 H330 H310 H300 H373 ** H412 |
|
|
|
603-033-01-1 |
oxydiëthyleendinitraat; diëthyleenglycoldinitraat; diglycoldinitraat [> 25 % flegmatisator] |
211-745-8 |
693-21-0 |
Expl. 1.1 Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Chronic 3 |
H201 H330 H310 H300 H373 ** H412 |
GHS01 GHS06 GHS08 Dgr |
H201 H330 H310 H300 H373 ** H412 |
|
|
|
603-034-00-X |
glyceroltrinitraat; nitroglycerine |
200-240-8 |
55-63-0 |
Unst. Expl. Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Chronic 2 |
H200 H330 H310 H300 H373 ** H411 |
GHS01 GHS06 GHS08 GHS09 Dgr |
H200 H330 H310 H300 H373 ** H411 |
|
|
|
603-034-01-7 |
glyceroltrinitraat; nitroglycerine; [> 40 % flegmatisator] |
200-240-8 |
55-63-0 |
Expl. 1.1 Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Chronic 2 |
H201 H330 H310 H300 H373 ** H411 |
GHS01 GHS06 GHS08 GHS09 Dgr |
H201 H330 H310 H300 H373 ** H411 |
|
|
|
603-035-00-5 |
pentaërytritoltetranitraat; pentaërytriettetranitraat; PETN; pentriet |
201-084-3 |
78-11-5 |
Unst. Expl. |
H200 |
GHS01 Dgr |
H200 |
|
|
|
603-035-01-2 |
pentaërytritoltetranitraat; pentaërytriettetranitraat; PETN; pentriet [> 20 % flegmatisator] |
201-084-3 |
78-11-5 |
Expl. 1.1 |
H201 |
GHS01 Dgr |
H201 |
|
|
T |
603-036-00-0 |
mannitolhexanitraat; nitromanniet |
239-924-6 |
15825-70-4 |
Unst. Expl. |
H200 |
GHS01 Dgr |
H200 |
|
|
|
603-036-01-8 |
mannitolhexanitraat; nitromanniet; [≥ 40 % flegmatisator] |
239-924-6 |
15825-70-4 |
Expl. 1.1 |
H201 |
GHS01 Dgr |
H201 |
|
|
|
603-037-00-6 |
cellulosenitraat; nitrocellulose |
— |
— |
Expl. 1.1 |
H201 |
GHS01 Dgr |
H201 |
|
|
T |
603-038-00-1 |
allylglycidylether; allyl-2,3-epoxypropylether prop-2-een-1-yl-2,3-epoxypropylether |
203-442-4 |
106-92-3 |
Flam. Liq. 3 Carc. 2 Muta. 2 Repr. 2 Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H226 H351 H341 H361f *** H332 H302 H335 H315 H318 H317 H412 |
GHS02 GHS08 GHS05 GHS07 Dgr |
H226 H351 H341 H361f *** H332 H302 H335 H315 H318 H317 H412 |
|
|
|
603-039-00-7 |
n-butylglycidylether; 1-butoxy-2,3-epoxy-propaan; 2,3-epoxypropylbutylether |
219-376-4 |
2426-08-6 |
Flam. Liq. 3 Carc. 2 Muta. 2 Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Sens. 1 Aquatic Chronic 3 |
H226 H351 H341 H332 H302 H335 H317 H412 |
GHS02 GHS08 GHS07 Wng |
H226 H351 H341 H332 H302 H335 H317 H412 |
|
|
|
603-040-00-2 |
natriummethanolaat; natriummethoxide; [1] kaliummethanolaat; kaliummethoxide; [2] lithiummethanolaat; lithiummethoxide [3] |
204-699-5 [1] 212-736-1 [2] 212-737-7 [3] |
124-41-4 [1] 865-33-8 [2] 865-34-9 [3] |
Self-heat 1 Skin Corr. 1B |
H251 H314 |
GHS02 GHS05 Dgr |
H251 H314 |
EUH014 |
|
T |
603-041-00-8 |
kaliumethanolaat; kaliumethoxide; [1] natriumethanolaat; natriumethoxide [2] |
213-029-0 [1] 205-487-5 [2] |
917-58-8 [1] 141-52-6 [2] |
Self-heat 1 Skin Corr. 1B |
H251 H314 |
GHS02 GHS05 Dgr |
H251 H314 |
EUH014 |
|
T |
603-042-00-3 |
aluminiumisopropylaat; aluminiumtriisopropoxide |
209-090-8 |
555-31-7 |
Flam. Sol. 1 |
H228 |
GHS02 Dgr |
H228 |
|
|
T |
603-043-00-9 |
triarimol (ISO); 2,4-dichloor-α-(pyrimidine-5-yl)benzhydrylalcohol |
— |
26766-27-8 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
603-044-00-4 |
dicofol (ISO); 2,2,2-trichloor-1,1-bis(4-chloorfenyl)ethanol |
204-082-0 |
115-32-2 |
Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H312 H302 H315 H317 H410 |
|
|
|
603-045-00-X |
diisopropylether; [1] dipropylether [2] |
203-560-6 [1] 203-869-6 [2] |
108-20-3 [1] 111-43-3 [2] |
Flam. Liq. 2 STOT SE 3 |
H225 H336 |
GHS02 GHS07 Dgr |
H225 H336 |
EUH019 EUH066 |
|
C |
603-046-00-5 |
bis(chloormethyl)ether; oxybis(chloormethaan) |
208-832-8 |
542-88-1 |
Flam. Liq. 2 Carc. 1A Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 4 * |
H225 H350 H330 H311 H302 |
GHS02 GHS06 GHS08 Dgr |
H225 H350 H330 H311 H302 |
|
Carc. 1A; H350: C ≥ 0,001 % |
|
603-047-00-0 |
2-dimethylaminoethanol; N,N-dimethylethanolamine |
203-542-8 |
108-01-0 |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H226 H332 H312 H302 H314 |
GHS02 GHS05 GHS07 Dgr |
H226 H332 H312 H302 H314 |
|
STOT SE 3; H335: C≥5 % |
|
603-048-00-6 |
2-diëthylaminoethanol; N,N-diëthylethanolamine |
202-845-2 |
100-37-8 |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H226 H332 H312 H302 H314 |
GHS02 GHS05 GHS07 GHS09 Dgr |
H226 H332 H312 H302 H314 |
|
STOT SE 3; H335: C≥5 % |
|
603-049-00-1 |
chloorfenethol (ISO); 1,1-bis(4-chloorfenyl)ethanol |
201-246-3 |
80-06-8 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
603-050-00-7 |
1-(2-butoxypropoxy)propaan-2-ol |
246-011-6 |
24083-03-2 |
Acute Tox. 4 * Acute Tox. 4 * |
H312 H302 |
GHS07 Wng |
H312 H302 |
|
|
|
603-051-00-2 |
2-ethylbutaan-1-ol |
202-621-4 |
97-95-0 |
Acute Tox. 4 * Acute Tox. 4 * |
H312 H302 |
GHS07 Wng |
H312 H302 |
|
|
|
603-052-00-8 |
3-butoxypropaan-2-ol; propyleenglycolmonobutylether |
225-878-4 |
5131-66-8 |
Eye Irrit. 2 Skin Irrit. 2 |
H319 H315 |
GHS07 Wng |
H319 H315 |
|
|
|
603-053-00-3 |
2-methylpentaan-2,4-diol |
203-489-0 |
107-41-5 |
Eye Irrit. 2 Skin Irrit. 2 |
H319 H315 |
GHS07 Wng |
H319 H315 |
|
|
|
603-054-00-9 |
di-n-butylether; dibutylether |
205-575-3 |
142-96-1 |
Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 3 |
H226 H319 H335 H315 H412 |
GHS02 GHS07 Wng |
H226 H319 H335 H315 H412 |
|
STOT SE 3; H335: C≥10 % |
|
603-056-00-X |
[(p-tolyloxy)methyl]oxiraan; [1] [(m-tolyloxy)methyl]oxiraan; [2] 2,3-epoxypropyl-o-tolylether; [3] [(tolyloxy)methyl]oxiraan; cresylglycidylether [4] |
218-574-8 [1] 218-575-3 [2] 218-645-3 [3] 247-711-4 [4] |
2186-24-5 [1] 2186-25-6 [2] 2210-79-9 [3] 26447-14-3 [4] |
Muta. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H341 H315 H317 H411 |
GHS08 GHS07 GHS09 Wng |
H341 H315 H317 H411 |
|
|
C |
603-057-00-5 |
benzylalcohol |
202-859-9 |
100-51-6 |
Acute Tox. 4 * Acute Tox. 4 * |
H332 H302 |
GHS07 Wng |
H332 H302 |
|
|
|
603-058-00-0 |
1,3-epoxypropaan; 1,3-propyleenoxide |
207-964-3 |
503-30-0 |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H225 H332 H312 H302 |
GHS02 GHS07 Dgr |
H225 H332 H312 H302 |
|
|
|
603-059-00-6 |
hexaan-1-ol |
203-852-3 |
111-27-3 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
603-060-00-1 |
2,2'-bioxiraan; 1,2:3,4-diëpoxybutaan |
215-979-1 |
1464-53-5 |
Carc. 1B Muta. 1B Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B |
H350 H340 H330 H311 H301 H314 |
GHS06 GHS08 GHS05 Dgr |
H350 H340 H330 H311 H301 H314 |
|
|
|
603-061-00-7 |
tetrahydro-2-furylmethanol; tetrahydrofurfurylalcohol |
202-625-6 |
97-99-4 |
Repr. 1B Eye Irrit. 2 |
H360Df H319 |
GHS08 GHS07 Dgr |
H360Df H319 |
|
|
|
603-062-00-2 |
tetrahydrofuran-2,5-diyldimethanol |
203-239-0 |
104-80-3 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H319 H335 H315 |
GHS07 Wng |
H319 H335 H315 |
|
STOT SE 3; H335: C ≥10 % |
|
603-063-00-8 |
2,3-epoxypropaan-1-ol; glycidol; oxiraanmethanol |
209-128-3 |
556-52-5 |
Carc. 1B Muta. 2 Repr. 1B Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H350 H341 H360F *** H331 H312 H302 H319 H335 H315 |
GHS06 GHS08 Dgr |
H350 H341 H360F *** H331 H312 H302 H319 H335 H315 |
|
|
|
603-064-00-3 |
1-methoxypropaan-2-ol; propyleenglycolmonomethylether |
203-539-1 |
107-98-2 |
Flam. Liq. 3 STOT SE 3 |
H226 H336 |
GHS02 GHS07 Wng |
H226 H336 |
|
|
|
603-065-00-9 |
resorcinol-diglycidylether; 1,3-bis(2,3-epoxypropoxy)benzeen |
202-987-5 |
101-90-6 |
Carc. 2 Muta. 2 Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H351 H341 H312 H302 H319 H315 H317 H412 |
GHS08 GHS07 Wng |
H351 H341 H312 H302 H319 H315 H317 H412 |
|
|
|
603-066-00-4 |
1,2-epoxy-4-epoxyethylcyclohexaan; 4-vinylcyclohexeendiëpoxide |
203-437-7 |
106-87-6 |
Carc. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * |
H351 H331 H311 H301 |
GHS06 GHS08 Dgr |
H351 H331 H311 H301 |
|
* |
|
603-067-00-X |
fenylglycidylether; 2,3-epoxypropylfenylether; 1,2-epoxy-3-fenoxypropaan |
204-557-2 |
122-60-1 |
Carc. 1B Muta. 2 Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H350 H341 H332 H335 H315 H317 H412 |
GHS08 GHS07 Dgr |
H350 H341 H332 H335 H315 H317 H412 |
|
|
|
603-068-00-5 |
2,3-epoxypropyl-2-ethylcyclohexylether; 2-ethylcyclohexyl-glycidylether |
— |
130014-35-6 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Wng |
H319 H315 H317 |
|
|
|
603-069-00-0 |
2,4,6-tris(dimethylaminomethyl)fenol |
202-013-9 |
90-72-2 |
Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 |
H302 H319 H315 |
GHS07 Wng |
H302 H319 H315 |
|
|
|
603-070-00-6 |
2-amino-2-methylpropanol |
204-709-8 |
124-68-5 |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 3 |
H319 H315 H412 |
GHS07 Wng |
H319 H315 H412 |
|
|
|
603-071-00-1 |
2,2'-iminodiëthanol; diëthanolamine |
203-868-0 |
111-42-2 |
Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 |
H302 H373 ** H315 H318 |
GHS08 GHS05 GHS07 Dgr |
H302 H373 ** H315 H318 |
|
|
|
603-072-00-7 |
1,4-bis(2,3-poxypropoxy)butaan; butaandioldiglycidylether |
219-371-7 |
2425-79-8 |
Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H332 H312 H319 H315 H317 |
GHS07 Wng |
H332 H312 H319 H315 H317 |
|
|
|
603-073-00-2 |
bis-[4-(2,3-epoxypropoxy)fenyl]propaan |
216-823-5 |
1675-54-3 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Wng |
H319 H315 H317 |
|
Eye Irrit. 2; H319: C≥ 5 % Skin Irrit. 2; H315: C≥5 % |
|
603-074-00-8 |
reactieproduct: bisfenol-A-epichloorhydrine; epoxyhars (gemiddeld molecuulgewicht ≤ 700) |
500-033-5 |
25068-38-6 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H319 H315 H317 H411 |
GHS07 GHS09 Wng |
H319 H315 H317 H411 |
|
Eye Irrit. 2; H319: C ≥ 5 % Skin Irrit 2; H315: C≥ 5 % |
|
603-075-00-3 |
chloormethyl-methylether; chloordimethylether |
203-480-1 |
107-30-2 |
Flam. Liq. 2 Carc. 1A Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H225 H350 H332 H312 H302 |
GHS02 GHS08 GHS07 Dgr |
H225 H350 H332 H312 H302 |
|
|
|
603-076-00-9 |
but-2-yn-1,4-diol; 2-butyn-1,4-diol |
203-788-6 |
110-65-6 |
Skin Corr. 1B Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 |
H314 H331 H301 H312 H373 ** H317 |
GHS06 GHS05 GHS08 Dgr |
H314 H331 H301 H312 H373 ** H317 |
|
Skin Corr. 1B; H314: C≥50 % Skin Irrit. 2; H315: 25 %≤ C < 50 % Eye Irrit. 2; H319: 25 %≤ C<50 % |
D |
603-077-00-4 |
1-dimethylaminopropaan-2-ol; dimepranol (INN) |
203-556-4 |
108-16-7 |
Flam. Liq. 3 Acute Tox. 4 * Skin Corr. 1B |
H226 H302 H314 |
GHS02 GHS05 GHS07 Dgr |
H226 H302 H314 |
|
|
|
603-078-00-X |
prop-2-yn-1-ol; propargylalcohol |
203-471-2 |
107-19-7 |
Flam. Liq. 3 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Aquatic Chronic 2 |
H226 H331 H311 H301 H314 H411 |
GHS02 GHS06 GHS05 GHS09 Dgr |
H226 H331 H311 H301 H314 H411 |
|
|
|
603-079-00-5 |
2,2'-methyliminodiëthanol; N-methyldiëthanolamine |
203-312-7 |
105-59-9 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
603-080-00-0 |
2-methylaminoëthanol; N-methyl-2-aminoëthanol; N-methyl-2-ethanolamine; N-methyl-2-aminoëthanol; 2-(methylamino)ethanol |
203-710-0 |
109-83-1 |
Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H312 H302 H314 |
GHS05 GHS07 Dgr |
H312 H302 H314 |
|
STOT SE 3; H335: C≥5 % |
|
603-081-00-6 |
2,2'-thiodiëthanol; thiodiglycol |
203-874-3 |
111-48-8 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
603-082-00-1 |
1-aminopropaan-2-ol; isopropanolamine |
201-162-7 |
78-96-6 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
|
|
603-083-00-7 |
1,1'-iminodipropaan-2-ol diisopropanolamine |
203-820-9 |
110-97-4 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
603-084-00-2 |
styreenoxide; (epoxyethyl)benzeen; fenyloxiraan |
202-476-7 |
96-09-3 |
Carc. 1B Acute Tox. 4 * Eye Irrit. 2 |
H350 H312 H319 |
GHS08 GHS07 Dgr |
H350 H312 H319 |
|
|
|
603-085-00-8 |
bronopol (INN); 2-broom-2-nitropropaan-1,3-diol |
200-143-0 |
52-51-7 |
Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 |
H312 H302 H335 H315 H318 H400 |
GHS05 GHS07 GHS09 Dgr |
H312 H302 H335 H315 H318 H400 |
|
M=10 |
|
603-086-00-3 |
ethirimol (ISO); 5-butyl-2-ethylamino-6-methylpyrimidine-4-ol |
245-949-3 |
23947-60-6 |
Acute Tox. 4 * |
H312 |
GHS07 Wng |
H312 |
|
|
|
603-087-00-9 |
2-ethylhexaan-1,3-diol; octyleenglycol; ethohexadiol |
202-377-9 |
94-96-2 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
603-088-00-4 |
2-(octylthio)ethanol; 2-hydroxyethyloctylsulfide |
222-598-4 |
3547-33-9 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
603-089-00-X |
7,7-dimethyl-3-oxa-6-azaoctaan-1-ol |
400-390-6 |
— |
Skin Corr. 1A Acute Tox. 4 * |
H314 H302 |
GHS05 GHS07 Dgr |
H314 H302 |
|
|
|
603-090-00-5 |
2-(2-broomethoxy)anisool |
402-010-4 |
4463-59-6 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
603-091-00-0 |
exo-1-methyl-4-(1-methylethyl)-7-oxabicyclo[2.2.1]heptaan-2-ol |
402-470-6 |
87172-89-2 |
Acute Tox. 4 * Eye Dam. 1 |
H302 H318 |
GHS05 GHS07 Dgr |
H302 H318 |
|
|
|
603-092-00-6 |
4-fenyl-2-methylpentanol |
402-770-7 |
92585-24-5 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
603-093-00-1 |
cinmethylin (ISO); exo-(±)-1-methyl-2-(2-methylbenzyloxy)-4-isopropyl-7-oxabicyclo(2.2.1)heptaan |
402-410-9 |
87818-31-3 |
Acute Tox. 4 * Aquatic Chronic 2 |
H332 H411 |
GHS07 GHS09 Dgr |
H332 H411 |
|
|
|
603-094-00-7 |
1,3-bis(2,3-epoxypropoxy)-2,2-dimethylpropaan |
241-536-7 |
17557-23-2 |
Skin Irrit. 2 Skin Sens. 1 |
H315 H317 |
GHS07 Wng |
H315 H317 |
|
|
|
603-095-00-2 |
2-(propyloxy)ethanol; EGPE |
220-548-6 |
2807-30-9 |
Acute Tox. 4 * Eye Irrit. 2 |
H312 H319 |
GHS07 Wng |
H312 H319 |
|
|
|
603-096-00-8 |
2-(2-butoxyethoxy)ethanol; diëthyleenglycolmonobutylether |
203-961-6 |
112-34-5 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
603-097-00-3 |
1,1’,1’-nitrilotripropaan-2-ol; triisopropanolamine |
204-528-4 |
122-20-3 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
603-098-00-9 |
2-fenoxyethanol |
204-589-7 |
122-99-6 |
Acute Tox. 4 * Eye Irrit. 2 |
H302 H319 |
GHS07 Wng |
H302 H319 |
|
|
|
603-099-00-4 |
3-(N-methyl-N-(4-methylamino-3-nitrofenyl)amino)propaan-1,2-diolhydrochloride |
403-440-5 |
93633-79-5 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
603-100-00-8 |
1,2-dimethoxypropaan |
404-630-0 |
7778-85-0 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
EUH019 |
|
|
603-101-00-3 |
tetrahydro-2-isobutyl-4-methylpyran-4-ol, mengsel van isomeren (cis en trans) |
405-040-6 |
— |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
603-103-00-4 |
oxiraan, mono[(C12-14-alkyloxy)methyl]-derivaten |
271-846-8 |
68609-97-2 |
Skin Irrit. 2 Skin Sens. 1 |
H315 H317 |
GHS07 Wng |
H315 H317 |
|
|
|
603-104-00-X |
fenarimol (ISO); 2,4'-dichloor-α-(pyrimidine-5-yl)benzhydrylalcohol |
262-095-7 |
60168-88-9 |
Repr. 2 Lact. Aquatic Chronic 2 |
H361fd H362 H411 |
GHS08 GHS09 Wng |
H361fd H362 H411 |
|
|
|
603-105-00-5 |
furan |
203-727-3 |
110-00-9 |
Flam. Liq. 1 Carc. 1B Muta. 2 Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Aquatic Chronic 3 |
H224 H350 H341 H332 H302 H373 ** H315 H412 |
GHS02 GHS08 GHS07 Dgr |
H224 H350 H341 H332 H302 H373 ** H315 H412 |
EUH019 |
|
|
603-106-00-0 |
2-methoxypropanol |
216-455-5 |
1589-47-5 |
Flam. Liq. 3 Repr. 1B STOT SE 3 Skin Irrit. 2 Eye Dam. 1 |
H226 H360D *** H335 H315 H318 |
GHS02 GHS08 GHS05 GHS07 Dgr |
H226 H360D *** H335 H315 H318 |
|
|
|
603-107-00-6 |
2-(2-methoxyethoxy)ethanol; diëthyleenglycolmonomethylether |
203-906-6 |
111-77-3 |
Repr. 2 |
H361d *** |
GHS08 Wng |
H361d *** |
|
|
|
603-108-00-1 |
2-methylpropaan-1-ol; isobutanol |
201-148-0 |
78-83-1 |
Flam. Liq. 3 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 STOT SE 3 |
H226 H335 H315 H318 H336 |
GHS02 GHS05 GHS07 Dgr |
H226 H335 H315 H318 H336 |
|
|
|
603-109-00-7 |
reactiemassa van: 1-ethoxy-1,1,2,3,3,3-hexafluor-2-(trifluormethyl)propaan; 1-ethoxy-1,1,2,2,3,3,4,4,4-nonafluorbutaan |
425-340-0 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
603-110-00-2 |
reactiemassa van: cis-2-isobutyl-5-methyl-1,3-dioxaan; trans-2-isobutyl-5-methyl-1,3-dioxaan |
426-130-1 |
166301-21-9 |
Skin Irrit. 2 Aquatic Chronic 3 |
H315 H412 |
GHS07 Wng |
H315 H412 |
|
|
|
603-111-00-8 |
reactiemassa van: 1-(1,1-dimethylpropyl)-4-ethoxy-cis-cyclohexaan; 1-(1,1-dimethylpropyl)-4-ethoxy-trans-cyclohexaan |
426-530-6 |
— |
Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Wng |
H315 H410 |
|
|
|
603-112-00-3 |
cyclopentyl-2-fenylethylether |
428-340-9 |
— |
Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Wng |
H315 H410 |
|
|
|
603-113-00-9 |
6-glycidyloxynaft-1-yloxymethyloxiraan |
429-960-2 |
27610-48-6 |
Muta. 2 Acute Tox. 4 * Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H341 H312 H315 H317 H412 |
GHS08 GHS07 Wng |
H341 H312 H315 H317 H412 |
|
|
|
603-114-00-4 |
9-(2-propenyloxy)tricyclo[5.2.1.0(2,6)]dec-3(of - 4)-een |
430-830-2 |
26912-64-1 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
603-115-00-X |
reactiemassa van: O, O',O''-(methylsilaantriyl)tris(4-methyl-2-pentanonoxim) (3 stereoisomeren) |
423-580-0 |
— |
STOT RE 2 * Aquatic Chronic 4 |
H373** H413 |
GHS08 Wng |
H373** H413 |
|
|
|
603-116-00-5 |
(Z)-(2,4-difluorfenyl)piperidine-4-ylmethanonoxim-monohydrochloride |
424-740-2 |
138271-16-6 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 |
H302 H318 H412 |
GHS05 GHS07 Dgr |
H302 H318 H412 |
|
|
|
603-117-00-0 |
propaan-2-ol; isopropylalcohol; isopropanol |
200-661-7 |
67-63-0 |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 |
H225 H319 H336 |
GHS02 GHS07 Dgr |
H225 H319 H336 |
|
|
|
603-118-00-6 |
6-dimethylaminohexaan-1-ol |
404-680-3 |
1862-07-3 |
Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 3 |
H302 H314 H412 |
GHS05 GHS07 Dgr |
H302 H314 H412 |
|
|
|
603-119-00-1 |
1,1'-(1,3-fenyleendioxy)bis(3-(2-(prop-2-enyl)fenoxy)propaan-2-ol) |
405-840-5 |
— |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
603-120-00-7 |
2-methyl-5-fenylpentanol |
405-890-8 |
25634-93-9 |
Eye Irrit. 2 Skin Irrit. 2 |
H319 H315 |
GHS07 Wng |
H319 H315 |
|
|
|
603-121-00-2 |
4-[4-(1,3-dihydroxyprop-2-yl)fenylamino]-1,8-dihydroxy-5-nitroantrachinon |
406-057-1 |
114565-66-1 |
Carc. 2 Skin Sens. 1 Aquatic Chronic 4 |
H351 H317 H413 |
GHS08 GHS07 Wng |
H351 H317 H413 |
|
|
|
603-122-00-8 |
natrium-2-ethylhexanolaat |
406-150-7 |
38411-13-1 |
Flam. Sol. 1 Skin Corr. 1B Aquatic Chronic 3 |
H228 H314 H412 |
GHS02 GHS05 Dgr |
H228 H314 H412 |
|
|
T |
603-123-00-3 |
4-methyl-8-methyleentricyclo[3.3.1.1 3,7]decaan-2-ol |
406-330-5 |
122760-84-3 |
Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H315 H317 H411 |
GHS07 GHS09 Wng |
H315 H317 H411 |
|
|
|
603-124-00-9 |
1,4-bis[2-(vinyloxy)ethoxy]benzeen |
406-900-3 |
84563-49-5 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
603-125-00-4 |
2-(2,4-dichloorfenyl)-1-(1H—1,2,4-triazool-1-yl)pent-4-een-2-ol |
407-850-5 |
89544-40-1 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H411 |
|
|
|
603-126-00-X |
2-((4-methyl-2-nitrofenyl)amino)ethanol |
408-090-7 |
100418-33-5 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 3 |
H302 H317 H412 |
GHS07 Wng |
H302 H317 H412 |
|
|
|
603-127-00-5 |
butaan-2-ol; [1] (S)-butaan-2-ol; [2] (R)-butaan-2-ol; [3] (±)-butaan-2-ol [4] |
201-158-5 [1] 224-168-1 [2] 238-967-8 [3] 240-029-8 [4] |
78-92-2 [1] 4221-99-2 [2] 14898-79-4 [3] 15892-23-6 [4] |
Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 STOT SE 3 |
H226 H319 H335 H336 |
GHS02 GHS07 Wng |
H226 H319 H335 H336 |
|
|
C |
603-128-00-0 |
2-(fenylmethoxy)naftaleen |
405-490-3 |
613-62-7 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
603-129-00-6 |
1-tert-butoxypropaan-2-ol |
406-180-0 |
57018-52-7 |
Flam. Liq. 3 Eye Dam. 1 |
H226 H318 |
GHS02 GHS05 Dgr |
H226 H318 |
|
|
|
603-130-00-1 |
reactiemassa van isomeren van: α-((dimethyl)bifenyl)-ω-hydroxypoly(oxyethyleen) |
406-325-8 |
— |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
603-131-00-7 |
reactiemassa (3:1) van: 1-deoxy-1-[methyl-(1-oxododecyl)amino]-D-glucitol; 1-deoxy-1-[methyl-(1-oxotetradecyl)amino]-D-glucitol |
407-290-1 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
603-132-00-2 |
2-hydroxymethyl-9-methyl-6-(1-methylethyl)-1,4-dioxaspiro[4.5]decaan |
408-200-3 |
63187-91-7 |
Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H315 H318 H412 |
GHS05 Dgr |
H315 H318 H412 |
|
|
|
603-133-00-8 |
reactiemassa van: 3-[(4-amino-2-chloor-5-nitrofenyl)amino]propaan-1,2-diol; 3,3'-(2-chloor-5-nitro-1,4-fenyleendiimino)bis(propaan-1,2-diol) |
408-240-1 |
— |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
603-134-00-3 |
reactiemassa van gesubstitueerde dodecyl- en/of tetradecyl-difenylethers. De stof wordt geproduceerd door de Friedel-Crafts-reactie. De katalysator wordt weggenomen uit het reactieproduct. Difenylether wordt vervangen door C1-C10-alkylgroepen. De alkylgroepen worden willekeurig tussen C1 en C6 gebonden. Er wordt lineair C12 en C14 gebruikt in 50/50-verhouding. |
410-450-3 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
603-135-00-9 |
bis[[2,2',2''-nitrilotris-[ethanolato]]-1-N,O]-bis[2-(2-methoxyethoxy)ethoxy]-titaan |
410-500-4 |
— |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
603-136-00-4 |
3-((4-(bis(2-hydroxyethyl)amino)-2-nitrofenyl)amino)-1-propanol |
410-910-3 |
104226-19-9 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
603-137-00-X |
reactiemassa van:1-deoxy-1-[methyl-(1-oxohexadecyl)amino]-D-glucitol; 1-deoxy-1-[methyl-(1-oxoöctadecyl)amino]-D-glucitol |
411-130-6 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
603-138-00-5 |
3-(2,2-dimethyl-3-hydroxypropyl)tolueen; (alt.): 2,2-dimethyl-3-(3-methylfenyl)propanol |
403-140-4 |
103694-68-4 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
603-139-00-0 |
bis(2-methoxyethyl)ether |
203-924-4 |
111-96-6 |
Flam. Liq. 3 Repr. 1B |
H226 H360FD |
GHS02 GHS08 Dgr |
H226 H360FD |
EUH019 |
|
|
603-140-00-6 |
2,2'-oxybisethanol; diëthyleenglycol |
203-872-2 |
111-46-6 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
603-141-00-1 |
reactiemassa van: dodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethyl-ethanoxy)]pentadecaan; dodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethyl-ethanoxy)]heptadecaan |
413-780-6 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
603-142-00-7 |
2-(2-(2-hydroxyethoxy)-ethyl)-2-aza-bicyclo[2.2.1]heptaan |
407-360-1 |
116230-20-7 |
Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 |
H312 H302 H373 ** H315 H318 |
GHS06 GHS08 GHS05 Dgr |
H312 H302 H373 ** H315 H318 |
|
|
|
603-143-00-2 |
R—2,3-epoxy-1-propanol |
404-660-4 |
57044-25-4 |
Self-react. C **** Carc. 1B Muta. 2 Repr. 1B Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H242 H350 H341 H360F *** H331 H312 H302 H314 |
GHS02 GHS06 GHS08 GHS05 Dgr |
H242 H350 H341 H360F *** H331 H312 H302 H314 |
|
|
|
603-144-00-8 |
Reactiemassa van: 2,6,9-trimethyl-2,5,9-cyclododecatrieen-1-ol; 6,9-dimethyl-2-methyleen-5,9-cyclododecadieen-1-ol |
413-530-6 |
111850-00-1 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
603-145-00-3 |
2-isopropyl-2-(1-methylbutyl)-1,3-dimethoxypropaan |
406-970-5 |
129228-11-1 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
603-146-00-9 |
2-[(2-[2-(dimethylamino)ethoxy]ethyl)methylamino]ethanol |
406-080-7 |
83016-70-0 |
Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 3 |
H302 H314 H412 |
GHS05 GHS07 Dgr |
H302 H314 H412 |
|
|
|
603-147-00-4 |
(–)-trans-4-(4'-fluorfenyl)-3-hydroxymethyl-N-methylpiperidine |
406-030-4 |
105812-81-5 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H411 |
|
|
|
603-148-00-X |
1,4-bis[(vinyloxy)methyl]cyclohexaan |
413-370-7 |
17351-75-6 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
603-149-00-5 |
reactiemassa van: diastereoisomeren van 1-(1-hydroxyethyl)-4-(1-methylethyl)cyclohexaan |
407-640-3 |
63767-86-2 |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 |
H319 H315 H411 |
GHS07 GHS09 Wng |
H319 H315 H411 |
|
|
|
603-150-00-0 |
(±) trans—3,3-dimethyl-5-(2,2,3-trimethyl-cyclopent-3-een-1-yl)-pent-4-een-2-ol |
411-580-3 |
107898-54-4 |
Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Wng |
H315 H410 |
|
|
|
603-151-00-6 |
(±)-2-(2,4-dichloorfenyl)-3-(1H-1,2,4-triazool-1-yl)propaan-1-ol |
413-570-4 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
603-152-00-1 |
2-(4-tert-butylfenyl)ethanol |
410-020-5 |
5406-86-0 |
Repr. 2 STOT RE 2 * Eye Dam. 1 Aquatic Chronic 2 |
H361f *** H373 ** H318 H411 |
GHS08 GHS05 GHS09 Dgr |
H361f *** H373 ** H318 H411 |
|
|
|
603-153-00-7 |
3-((2-nitro-4-(trifluormethyl)fenyl)amino)propaan-1,2-diol |
410-010-0 |
104333-00-8 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
603-154-00-2 |
1-[(2-tert-butyl)cyclohexyloxy]-2-butanol |
412-300-2 |
139504-68-0 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
603-156-00-3 |
2-(2,4-dichloorfenyl)-2-(2-propenyl)oxiraan |
411-210-0 |
89544-48-9 |
Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H315 H317 H410 |
|
|
|
603-157-00-9 |
6,9-bis(hexadecyloxymethyl)-4,7-dioxanonaan-1,2,9-triol |
411-450-6 |
143747-72-2 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
603-158-00-4 |
reactiemassa van: 4 diastereoisomeren van 2,7-dimethyl-10-(1-methylethyl)-1-oxaspiro[4.5]deca-3,6-dieen |
412-460-3 |
— |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
603-159-00-X |
2-cyclododecylpropaan-1-ol |
411-410-8 |
118562-73-5 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
603-160-00-5 |
1,2-diëthoxypropaan |
412-180-1 |
10221-57-5 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
EUH019 |
|
|
603-161-00-0 |
1,3-diëthoxypropaan |
413-140-6 |
3459-83-4 |
Flam. Liq. 3 |
H226 |
GHS02 Wng |
H226 |
|
|
|
603-162-00-6 |
α[2-[[[(2-hydroxyethyl)methylamino]acetyl]amino]propyl]-ω nonylfenoxy)poly[oxo(methyl-1,2-ethaandiyl)] |
413-420-8 |
144736-29-8 |
Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 |
H314 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H314 H317 H411 |
|
|
|
603-163-00-1 |
2-fenyl-1,3-propaandiol |
411-810-2 |
1570-95-2 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
603-164-00-7 |
2-butyl-4-chloor-4,5-dihydro-5-hydroxymethyl-1-[2'-(2-trifenylmethyl-1,2,3,4-2H-tetrazool-5-yl)-1,1'-bifenyl-4-methyl]-1H-imidazool |
412-420-5 |
133909-99-6 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
603-165-00-2 |
reactiemassa van: 4-allyl-2,6-bis(2,3-epoxypropyl)fenol; 4-allyl-6-[3-[6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)fenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)fenoxy]-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)fenoxy]-2-hydroxypropyl]-2-(2,3-epoxypropyl)fenol; 4-allyl-6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)fenoxy)-2-hydroxypropyl]-2-(2,3-epoxypropyl)fenol; 4-allyl-6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)fenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)fenoxy]-2-hydroxypropyl]-2-(2,3-epoxypropyl)fenol |
417-470-1 |
— |
Muta. 2 Skin Sens. 1 |
H341 H317 |
GHS08 GHS07 Wng |
H341 H317 |
|
|
|
603-166-00-8 |
(R)-1-chloor-2,3-epoxypropaan |
424-280-2 |
51594-55-9 |
Flam. Liq. 3 Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Skin Sens. 1 |
H226 H350 H331 H311 H301 H314 H317 |
GHS02 GHS06 GHS08 GHS05 Dgr |
H226 H350 H331 H311 H301 H314 H317 |
|
|
|
603-167-00-3 |
3,3',5,5'-tetra-tert-butylbifenyl-2,2'-diol |
407-920-5 |
6390-69-8 |
Aquatic Chronic 4 |
H413 |
GHS05 Dgr |
H413 |
|
|
|
603-168-00-9 |
3-(2-ethylhexyloxy)propaan-1,2-diol |
408-080-2 |
70445-33-9 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
603-169-00-4 |
(±)-trans-4-(4-fluorfenyl)-3-hydroxymethyl-N-methylpiperidine |
415-550-0 |
109887-53-8 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H411 |
|
|
|
603-170-00-X |
reactiemassa van: 2-methyl-1-(6-methylbicyclo[2.2.1]hept-5-een-2-yl)pent-1-een-3-ol; 2-methyl-1-(1-methylbicyclo[2.2.1]hept-5-een-2-yl)-pent-1-een-3-ol; 2-methyl-1-(5-methylbicyclo[2.2.1]hept-5-een-2-yl)pent-1-een-3-ol |
415-990-3 |
67739-11-1 |
Eye Irrit. 2 Aquatic Chronic 2 |
H319 H411 |
GHS07 GHS09 Wng |
H319 H411 |
|
|
|
603-171-00-5 |
5-thiazolylmethanol |
414-780-9 |
38585-74-9 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
603-172-00-0 |
mono-2-[2-(4-dibenzo[b,f][1,4]thiazepine-11-yl)piperazinium-1-yl]ethoxy)ethanol-trans-buteendioaat |
415-180-1 |
773058-82-5 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H411 |
|
|
|
603-173-00-6 |
4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]octaan |
421-750-9 |
57280-22-5 |
Eye Irrit. 2 Skin Sens. 1 |
H319 H317 |
GHS07 Wng |
H319 H317 |
|
|
|
603-174-00-1 |
4-cyclohexyl-2-methyl-2-butanol |
420-630-3 |
83926-73-2 |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
603-175-00-7 |
2-(2-hexyloxyethoxy)ethanol; DEGHE; diëthyleenglycolmonohexylether; 3,6-dioxa-1-dodecanol; hexylcarbitol; 3,6-dioxadodecaan-1-ol |
203-988-3 |
112-59-4 |
Acute Tox. 4 * Eye Dam. 1 |
H312 H318 |
GHS05 GHS07 Dgr |
H312 H318 |
|
|
|
603-176-00-2 |
1,2-bis(2-methoxyethoxy)ethaan; TEGDME; triëthyleenglycoldimethylether; triglyme |
203-977-3 |
112-49-2 |
Repr. 1B |
H360Df |
GHS08 Dgr |
H360Df |
EUH019 |
|
|
603-177-00-8 |
1-ethoxypropaan-2-ol; 2PG1EE; 1-ethoxy-2-propanol; propyleenglycolmonoëthylether; [1] 2-ethoxy-1-methylethylacetaat; 2PG1EEA [2] |
216-374-5 [1] 259-370-9 [2] |
1569-02-4 [1] 54839-24-6 [2] |
Flam. Liq. 3 STOT SE 3 |
H226 H336 |
GHS02 GHS07 Wng |
H226 H336 |
|
|
|
603-178-00-3 |
2-hexyloxyethanol; ethyleenglycolmonohexylether; n-hexylglycol |
203-951-1 |
112-25-4 |
Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H312 H302 H314 |
GHS05 GHS07 Dgr |
H312 H302 H314 |
|
|
|
603-179-00-9 |
ergocalciferol (ISO); vitamine D2 |
200-014-9 |
50-14-6 |
Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 |
H330 H311 H301 H372 ** |
GHS06 GHS08 Dgr |
H330 H311 H301 H372 ** |
|
|
|
603-180-00-4 |
colecalciferol; vitamine D3 |
200-673-2 |
67-97-0 |
Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 |
H330 H311 H301 H372 ** |
GHS06 GHS08 Dgr |
H330 H311 H301 H372 ** |
|
|
|
603-181-00-X |
tert-butylmethylether; MTBE; 2-methoxy-2-methylpropaan |
216-653-1 |
1634-04-4 |
Flam. Liq. 2 Skin Irrit. 2 |
H225 H315 |
GHS02 GHS07 Dgr |
H225 H315 |
|
|
|
603-182-00-5 |
reactieproduct van: verzadigde, enkelvoudig onverzadigde en meervoudig onverzadigde gedeeltelijk veresterde alcoholen met een lange keten van plantaardige oorsprong (Brassica napus L., Brassica rapa L., Helianthus annuus L., Glycine hispida, Gossypium hirsutum L., Cocos nucifera L., Elaeis guineensis) met O, O-diisobutyldithiofosfaat en 2-ethylhexylamine en waterstofperoxide |
428-630-5 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
603-183-00-0 |
2-[2-(2-butoxyethoxy)ethoxy]ethanol; TEGBE; triëthyleenglycolmonobutylether; butoxytriëthyleenglycol |
205-592-6 |
143-22-6 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
Eye Dam.1; H318: C≥30 % Eye Irrit. 2; H319: 20 % ≤C< 30 % |
|
603-184-00-6 |
2-(hydroxymethyl)-2-[[2-hydroxy-3-(isoöctadecyloxy)propoxy]methyl]-1,3-propaandiol |
416-380-1 |
146925-83-9 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
603-185-00-1 |
2,4-dichloor-3-ethyl-6-nitrofenol |
420-740-1 |
99817-36-4 |
Acute Tox. 3 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H318 H317 H400 H410 |
GHS06 GHS05 GHS09 Dgr |
H301 H318 H317 H410 |
|
|
|
603-186-00-7 |
trans-(5RS,6SR)-6-amino-2,2-dimethyl-1,3-dioxepaan-5-ol |
419-050-3 |
79944-37-9 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
603-187-00-2 |
2-((4,6-bis(4-(2-(1-methylpyridinium-4-yl)vinyl)fenylamino)-1,3,5-triazine-2-yl)(2-hydroxyethyl)amino)ethanoldichloride |
419-360-9 |
163661-77-6 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
603-188-00-8 |
reactiemassa van: 6,7-epoxy-1,2,3,4,5,6,7,8-octahydro-1,1,2,4,4,7-hexamethylnaftaleen; 7,8-epoxy-1,2,3,4,6,7,8,8a-octahydro-1,1,2,4,4,7-hexamethylnaftaleen |
426-970-9 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
603-189-00-3 |
reactiemassa van complexen van: titaan, 2,2'-oxydiëthanol, ammoniumlactaat, nitrilotris(2-propanol) en ethyleenglycol |
405-250-8 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
603-190-00-9 |
8,8-dimethyl-7-isopropyl-6,10-dioxaspiro[4.5]decaan |
424-030-2 |
62406-73-9 |
Skin Irrit. 2 Aquatic Chronic 3 |
H315 H412 |
GHS07 Wng |
H315 H412 |
|
|
|
603-191-00-4 |
2-(4,6-bis(2,4-dimethylfenyl)-1,3,5-triazine-2-yl)-5-(3-((2-ethylhexyl)oxy)-2-hydroxypropoxy)fenol |
419-740-4 |
137658-79-8 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
603-192-00-X |
(E,E)-3,7,11-trimethyldodeca-1,4,6,10-tetraeen-3-ol |
423-240-1 |
125474-34-2 |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H315 H318 H317 H410 |
|
|
|
603-193-00-5 |
dinatrium-9,10-antraceendioxide |
426-030-8 |
46492-07-3 |
Skin Corr. 1A |
H314 |
GHS05 Dgr |
H314 |
|
|
|
603-194-00-0 |
2-(2-aminoethylamino)ethanol; (AEEA) |
203-867-5 |
111-41-1 |
Repr. 1B Skin Corr. 1B Skin Sens. 1 |
H360Df H314 H317 |
GHS05 GHS08 GHS07 Dgr |
H360Df H314 H317 |
|
STOT SE 3; H335: C≥5 % |
|
603-195-00-6 |
2-[4-(4-methoxyfenyl)-6-fenyl-1,3,5-triazine-2-yl]fenol |
430-810-3 |
154825-62-4 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
603-196-00-1 |
2-(7-ethyl-1H-indool-3-yl)ethanol |
431-020-1 |
41340-36-7 |
Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 2 |
H302 H373 ** H411 |
GHS08 GHS07 GHS09 Wng |
H302 H373 ** H411 |
|
|
|
603-199-00-8 |
etoxazol (ISO); (RS)-5-tert-butyl-2-[2-(2,6-difluorfenyl)-4,5-dihydro-1,3-oxazool-4-yl]fenetool |
— |
153233-91-1 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
M = 100 |
|
603-200-00-1 |
1-pentanol; [1] 3-pentanol [2] |
200-752-1 [1] 209-526-7 [2] |
71-41-0 [1] 584-02-1 [2] |
Flam. Liq. 3 Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 |
H226 H332 H335 H315 |
GHS02 GHS07 Wng |
H226 H332 H335 H315 |
|
|
|
603-201-00-7 |
(E)-(7R,11R)-3,7,11,15-tetramethylhexadec-2-een-1-ol |
416-120-5 |
— |
Skin Irrit. 2 Aquatic Chronic 4 |
H315 H413 |
GHS07 Wng |
H315 H413 |
|
|
|
603-202-00-2 |
4,4,5,5,5-pentafluorpentaan-1-ol |
421-360-9 |
148043-73-6 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
603-203-00-8 |
(1R,3S,7R,8R,10R,13R)-5,5,7,9,9,13-hexamethyl-4,6-dioxatetracyclo[6.5.1.01,10.03,7]tetradecaan |
427-580-1 |
— |
Skin Irrit. 2 |
H315 |
GHS07 Wng |
H315 |
|
|
|
603-204-00-3 |
reactiemassa van: 2,2'-(heptaan-1,7-diyl)bis-(1,3-dioxolaan); 2,2'-(heptaan-1,6-diyl)bis-(1,3-dioxolaan) |
428-110-8 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
603-205-00-9 |
(1S-cis)-4-(2-amino-6-chloor-9H-purine-9-yl)-2-cyclopenteen-1-methanolhydrochloride |
426-200-1 |
172015-79-1 |
STOT RE 1 Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H372** H302 H318 H317 H412 |
GHS05 GHS08 GHS07 Dgr |
H372** H302 H318 H317 H412 |
|
|
|
603-206-00-4 |
2,2-dichloor-1,3-benzodioxool |
426-850-6 |
2032-75-9 |
Flam. Liq. 3 Skin Corr. 1A Acute Tox. 4 * Skin Sens. 1 |
H226 H314 H302 H317 |
GHS02 GHS05 GHS07 Dgr |
H226 H314 H302 H317 |
EUH014 |
|
|
603-207-00-X |
2-isobutyl-2-isopropyl-1,3-dimethoxypropaan |
430-800-9 |
129228-21-3 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
603-208-00-5 |
1,2-diëthoxyethaan |
211-076-1 |
629-14-1 |
Flam. Liq. 2 Repr. 1A Eye Irrit. 2 |
H225 H360Df H319 |
GHS02 GHS08 GHS07 Dgr |
H225 H360Df H319 |
EUH019 |
|
|
603-209-00-0 |
spinosad (ISO) (reactiemassa van spinosyn A en spinosyn D in verhoudingen tussen 95:5 en 50:50); reactiemassa van 50-95 % van (2R,3aS,5aR,5bS,9S,13S,14R, 16aS,16bR)-2-(6-deoxy-2,3,4-tri-O-methyl-α-l-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-D-erytropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-14-methyl-1H-8-oxacyclododeca[b]as-indaceen-7,15-dion en 50-5 % (2S,3aR,5aS,5bS,9S,13S,14R,16aS,16bS)-2-(6-deoxy-2,3,4-tri-O-methyl-α-l-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-D-erytropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-4,14-dimethyl-1H-8-oxacyclododeca[b]as-indaceen-7,15-dion; [1] spinosyn A; [2] spinosyn D [3] |
-[1] -[2] -[3] |
-[1] 131929-60-7 [2] 131929-63-0 [3] |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
M=10 |
|
603-210-00-6 |
2,4-diëthyl-1,5-pentaandiol |
429-310-8 |
57987-55-0 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
603-211-00-1 |
2,3-epoxypropyltrimethylammoniumchloride … %; glycidyltrimethylammoniumchloride … % |
221-221-0 |
3033-77-0 |
Carc. 1B Muta. 2 Repr. 2 Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H350 H341 H361f*** H312 H302 H373** H318 H317 H412 |
GHS05 GHS08 GHS07 Dgr |
H350 H341 H361f*** H312 H302 H373** H318 H317 H412 |
|
|
B |
603-212-00-7 |
1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylindeno[5,6-c]pyran; galaxolide; (HHCB) |
214-946-9 |
1222-05-5 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
603-213-00-2 |
2-methoxy-2-methylbutaan; tert-amylmethylether |
213-611-4 |
994-05-8 |
Flam. Liq. 2 Acute Tox. 4 * STOT SE 3 |
H225 H302 H336 |
GHS02 GHS07 Dgr |
H225 H302 H336 |
|
|
|
603-214-00-8 |
1,1-diisopropoxycyclohexaan |
413-740-8 |
1132-95-2 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
|
|
603-215-00-3 |
1-hydroxy-4-fluor-1,4-diazoniabicyclo[2.2.2]octaanbis(tetrafluoroboraat) |
418-330-2 |
162241-33-0 |
Expl. 1.1**** Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H201 H302 H373** H318 H317 H400 H410 |
GHS01 GHS05 GHS08 GHS07 GHS09 Dgr |
H201 H302 H373** H318 H317 H410 |
|
|
|
603-216-00-9 |
cis-1-amino-2,3-dihydro-1H-indeen-2-ol |
422-660-2 |
7480-35-5 |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Dgr |
H318 H317 H412 |
|
|
|
603-217-00-4 |
2,4,6-tri-tert-butylfenyl-2-butyl-2-ethyl-1,3-propaandiolfosfiet |
423-560-1 |
161717-32-4 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
603-220-00-0 |
1-{]benzyl[}2-(2-methoxyfenoxy)ethyl]amino}-3-(9H-carbazool-4-yloxy)propaan-2-ol |
432-890-5 |
72955-94-3 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
603-221-00-6 |
1-(2-amino-5-chloorfenyl)-2,2,2-trifluor-1,1-ethaandiol, hydrochloride; [met < 0,1 % 4-chlooraniline (EG-nr. 203-401-0)] |
433-580-2 |
214353-17-0 |
Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 2 |
H302 H314 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H314 H411 |
|
|
|
603-221-01-3 |
1-(2-amino-5-chloorfenyl)-2,2,2-trifluor-1,1-ethaandiol, hydrochloride; [met ≥ 0,1 % 4-chlooraniline (EG-nr. 203-401-0)] |
433-580-2 |
214353-17-0 |
Carc. 1B Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 2 |
H350 H302 H314 H411 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H350 H302 H314 H411 |
|
|
|
603-222-00-1 |
(2R,3S,4R,5R,7R,9R,10R,11S,12S,13R)-10-[(4-dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-yl)oxy]-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-1-oxacyclotetradecaan |
433-820-6 |
118058-74-5 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
603-223-00-7 |
2-cyclopentylideencyclopentanol; 1,1'-bi(cyclopentylideen)-2-ol |
434-270-1 |
6261-30-9 |
Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H315 H318 H412 |
GHS05 Dgr |
H315 H318 H412 |
|
|
|
603-224-00-2 |
3-ethoxy-1,1,1,2,3,4,4,5,5,6,6,6-dodecafluor-2-(trifluormethyl)hexaan |
435-790-1 |
297730-93-9 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
603-225-00-8 |
erytromycine A9-oxim (E); (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-((2,6-didesoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopiranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-tridesoxy-3-dimethylamino-β-D-xylohexapiranosyl)oxy)oxacyclotetradecaan-2-on-10-oxim (E) |
437-070-0 |
13127-18-9 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
603-226-00-3 |
4,4'-(4-(4-methoxyfenyl)-1,3,5-triazine-2,4-diyl)bisbenzeen-1,3-diol |
444-500-0 |
1440-00-2 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
603-227-00-9 |
α-hydro-ω-[[[(1,1-dimethylethyl)dioxy]carbonyl]oxy]poly[oxy(methyl-1,2-ethaandiyl)], ether met 2,2-bis(hydroxymethyl)propaan-1,3-diol (4:1); reactieproduct van: α-hydro-ω-((chloorcarbonyl)oxy)poly(oxy(methyl-1,2-ethaandiyl)), ether met 2,2-bis(hydroxymethyl)propaan-1,3-diol, met kalium-1,1-dimethylethylperoxalaat |
445-060-2 |
203574-04-3 |
**** Aquatic Acute 1 Aquatic Chronic 1 |
**** H400 H410 |
**** GHS09 Wng |
**** H410 |
|
|
|
603-228-00-4 |
(±)-(R*,R*)-6-fluor-3,4-dihydro-2-oxiranyl-2H-1-benzopyran; 6-fluor-2-(2-oxiranyl)chromaan |
419-620-1 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
603-229-00-X |
natrium-(Z)-3-chloor-3-(4-chloorfenyl)-1-hydroxy-2-propeen-1-sulfonaat |
420-800-7 |
— |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H315 H318 H317 H410 |
|
|
|
603-230-00-5 |
2,6,6,7,8,8-hexamethyldecahydro-2H-indeno[4,5-b]furan |
440-030-5 |
— |
Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 4 |
H315 H318 H413 |
GHS05 Dgr |
H315 H318 H413 |
|
|
|
603-231-00-0 |
(S)-1,1-difenylpropaan-1,2-diol |
443-220-6 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
603-232-00-6 |
3,3,8,8,10,10-hexamethyl-9-[1-(4-oxiranylmethoxyfenyl)ethoxy]-1,5-dioxa-9-azaspiro[5.5]undecaan |
444-420-6 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
603-233-00-1 |
reactiemassa van: 4-(1,3a,4,6,7,7a-hexahydro-4,7-methanoïndeen-5-ylideen)-3-methylbutaan-2-ol; 4-(3,3a,4,6,7,7a-hexahydro-4,7-methanoïndeen-5-ylideen)-3-methylbutaan-2-ol; 1-(1,3a,4,6,7,7a-hexahydro-4,7-methanoïndeen-5-ylideen)pentaan-3-ol; 1-(3,3a,4,6,7,7a-hexahydro-4,7-methanoïndeen-5-ylideen)pentaan-3-ol; (E)-4-(3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoïndeen-5-yl)-3-methylbut-3-een-2-ol; (E)-4-(3a,4,5,6,7,7a-hexahydro-3H-4,7-methanoïndeen-5-yl)-3-methylbut-3-een-2-ol |
444-430-0 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
603-234-00-7 |
(1R,4R)-4-methoxy-2,2,7,7-tetramethyltricyclo[6.2.1.01,6]undec-5-een |
444-480-3 |
— |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
604-001-00-2 |
fenol; carbolzuur; monohydroxybenzeen; fenylalcohol |
203-632-7 |
108-95-2 |
Muta. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Skin Corr. 1B |
H341 H331 H311 H301 H373 ** H314 |
GHS06 GHS08 GHS05 Dgr |
H341 H331 H311 H301 H373 ** H314 |
|
* Skin Corr. 1B; H314: C ≥ 3 % Skin Irrit. 2; H315 1 % ≤ C<3 % Eye Irrit. 2; H319:1 % ≤C<3 % |
|
604-002-00-8 |
pentachloorfenol |
201-778-6 |
87-86-5 |
Carc. 2 Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H330 H311 H301 H319 H335 H315 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H330 H311 H301 H319 H335 H315 H410 |
|
|
|
604-003-00-3 |
natriumpentachloorfenolaat; [1] kaliumpentachloorfenolaat [2] |
205-025-2 [1] 231-911-3 [2] |
131-52-2 [1] 7778-73-6 [2] |
Carc. 2 Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H330 H311 H301 H319 H335 H315 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H330 H311 H301 H319 H335 H315 H410 |
|
|
|
604-004-00-9 |
m-cresol; [1] o-cresol; [2] p-cresol; [3] mix-cresol [4] |
203-577-9 [1] 202-423-8 [2] 203-398-6 [3] 215-293-2 [4] |
108-39-4 [1] 95-48-7 [2] 106-44-5 [3] 1319-77-3 [4] |
Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B |
H311 H301 H314 |
GHS06 GHS05 Dgr |
H311 H301 H314 |
|
* |
C |
604-005-00-4 |
1,4-dihydroxybenzeen; hydrochinon; chinol |
204-617-8 |
123-31-9 |
Carc. 2 Muta. 2 Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 |
H351 H341 H302 H318 H317 H400 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H351 H341 H302 H318 H317 H400 |
|
M=10 |
|
604-006-00-X |
3,4-xylenol; [1] 2,5-xylenol; [2] 2,4-xylenol; [3] 2,3-xylenol; [4] 2,6-xylenol; [5] xylenol; [6] 2,4(of 2,5)-xylenol [7] |
202-439-5 [1] 202-461-5 [2] 203-321-6 [3] 208-395-3 [4] 209-400-1 [5] 215-089-3 [6] 276-245-4 [7] |
95-65-8 [1] 95-87-4 [2] 105-67-9 [3] 526-75-0 [4] 576-26-1 [5] 1300-71-6 [6] 71975-58-1 [7] |
Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Aquatic Chronic 2 |
H311 H301 H314 H411 |
GHS06 GHS05 GHS09 Dgr |
H311 H301 H314 H411 |
|
|
C |
604-007-00-5 |
2-naftol |
205-182-7 |
135-19-3 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 |
H332 H302 H400 |
GHS07 GHS09 Wng |
H332 H302 H400 |
|
|
|
604-008-00-0 |
2-chloorfenol; [1] 4-chloorfenol; [2] 3-chloorfenol; [3] chloorfenol [4] |
202-433-2 [1] 203-402-6 [2] 203-582-6 [3] 246-691-4 [4] |
95-57-8 [1] 106-48-9 [2] 108-43-0 [3] 25167-80-0 [4] |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 2 |
H332 H312 H302 H411 |
GHS07 GHS09 Wng |
H332 H312 H302 H411 |
|
|
C |
604-009-00-6 |
pyrogallol; 1,2,3-trihydroxybenzeen |
201-762-9 |
87-66-1 |
Muta. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 3 |
H341 H332 H312 H302 H412 |
GHS08 GHS07 Wng |
H341 H332 H312 H302 H412 |
|
* |
|
604-010-00-1 |
resorcinol; 1,3-benzeendiol |
203-585-2 |
108-46-3 |
Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 |
H302 H319 H315 H400 |
GHS07 GHS09 Wng |
H302 H319 H315 H400 |
|
* |
|
604-011-00-7 |
2,4-dichloorfenol |
204-429-6 |
120-83-2 |
Acute Tox. 3 * Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 2 |
H311 H302 H314 H411 |
GHS06 GHS05 GHS09 Dgr |
H311 H302 H314 H411 |
|
|
|
604-012-00-2 |
4-chloor-o-cresol; 4-chloor-2-methylfenol |
216-381-3 |
1570-64-5 |
Acute Tox. 3 * Skin Corr. 1A Aquatic Acute 1 |
H331 H314 H400 |
GHS06 GHS05 GHS09 Dgr |
H331 H314 H400 |
|
STOT SE 3; H335: C≥1 % |
|
604-013-00-8 |
2,3,4,6-tetrachloorfenol |
200-402-8 |
58-90-2 |
Acute Tox. 3 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H319 H315 H400 H410 |
GHS06 GHS09 Dgr |
H301 H319 H315 H410 |
|
* Eye Irrit. 2; H319:C≥5 % Skin Irrit. 2; H315: C≥5 % |
|
604-014-00-3 |
chloorcresol; 4-chloor-m-cresol; 4-chloor-3-methylfenol |
200-431-6 |
59-50-7 |
Acute Tox. 4 * Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 |
H312 H302 H318 H317 H400 |
GHS05 GHS07 GHS09 Dgr |
H312 H302 H318 H317 H400 |
|
* |
|
604-015-00-9 |
2,2'-methyleen-bis-(3,4,6-trichloorfenol); hexachlorofeen |
200-733-8 |
70-30-4 |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H311 H301 H410 |
|
* |
|
604-016-00-4 |
1,2-dihydroxybenzeen; pyrocatechol |
204-427-5 |
120-80-9 |
Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 |
H312 H302 H319 H315 |
GHS07 Wng |
H312 H302 H319 H315 |
|
|
|
604-017-00-X |
2,4,5-trichloorfenol |
202-467-8 |
95-95-4 |
Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H315 H410 |
|
* Eye Irrit. 2; H319: C≥5 % Skin Irrit.2; H315: C ≥5 % |
|
604-018-00-5 |
2,4,6-trichloorfenol |
201-795-9 |
88-06-2 |
Carc. 2 Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H302 H319 H315 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H302 H319 H315 H410 |
|
|
|
604-019-00-0 |
dichlorofeen (ISO) |
202-567-1 |
97-23-4 |
Acute Tox. 4 * Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H410 |
|
|
|
604-020-00-6 |
2-fenylfenol (ISO); bifenyl-2-ol; 2-hydroxybifenyl; |
201-993-5 |
90-43-7 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 |
H319 H335 H315 H400 |
GHS07 GHS09 Wng |
H319 H335 H315 H400 |
|
|
|
604-021-00-1 |
natrium-2-bifenylaat; 2-fenylfenol, natriumzout |
205-055-6 |
132-27-4 |
Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 |
H302 H335 H315 H318 H400 |
GHS05 GHS07 GHS09 Wng |
H302 H335 H315 H318 H400 |
|
|
|
604-022-00-7 |
2,2-dimethyl-1,3-benzodioxool-4-ol |
400-900-7 |
22961-82-6 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
604-023-00-2 |
2,4-dichloor-3-ethylfenol |
401-060-4 |
— |
Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H314 H400 H410 |
GHS05 GHS09 Dgr |
H314 H410 |
|
|
|
604-024-00-8 |
4,4-isobutylethylideendifenol |
401-720-1 |
6807-17-6 |
Repr. 1B Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H360F *** H319 H400 H410 |
GHS08 GHS09 Dgr |
H360F *** H319 H410 |
|
|
|
604-025-00-3 |
2,5-bis(1,1-dimethylbutyl)hydrochinon |
400-220-0 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
604-026-00-9 |
2,2-spirobi(6-hydroxy-4,4,7-trimethylchromaan) |
400-270-3 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
604-027-00-4 |
2-methyl-5-(1,1,3,3-tetramethylbutyl)hydrochinon |
400-530-6 |
— |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H318 H317 H411 |
|
|
|
604-028-00-X |
4-amino-3-fluorfenol |
402-230-0 |
399-95-1 |
Carc. 1B Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H350 H302 H317 H411 |
GHS08 GHS07 GHS09 Dgr |
H350 H302 H317 H411 |
|
|
|
604-029-00-5 |
1-naftol |
201-969-4 |
90-15-3 |
Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 |
H312 H302 H335 H315 H318 |
GHS05 GHS07 Dgr |
H312 H302 H335 H315 H318 |
|
|
|
604-031-00-6 |
guajacol |
201-964-7 |
90-05-1 |
Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 |
H302 H319 H315 |
GHS07 Wng |
H302 H319 H315 |
|
|
|
604-032-00-1 |
thymol |
201-944-8 |
89-83-8 |
Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 2 |
H302 H314 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H314 H411 |
|
|
|
604-033-00-7 |
isobutylbut-3-enoaat |
401-170-2 |
24342-03-8 |
Flam. Liq. 3 |
H226 |
GHS02 Wng |
H226 |
|
|
|
604-034-00-2 |
4,4'-thiodi-o-cresol |
403-330-7 |
24197-34-0 |
Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Dgr |
H318 H410 |
|
|
|
604-035-00-8 |
4-nonylfenol, reactieproducten met formaldehyde en dodecaan-1-thiol |
404-160-6 |
— |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
604-036-00-3 |
4,4'-oxybis(ethyleenthio)difenol |
404-590-4 |
90884-29-0 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
604-037-00-9 |
3,5-xylenol; 3,5-dimethylfenol |
203-606-5 |
108-68-9 |
Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B |
H311 H301 H314 |
GHS06 GHS05 Dgr |
H311 H301 H314 |
|
|
|
604-038-00-4 |
4-chloor-3,5-dimethylfenol; [1] chloorxylenol [2] |
201-793-8 [1] 215-316-6 [2] |
88-04-0 [1] 1321-23-9 [2] |
Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H302 H319 H315 H317 |
GHS07 Wng |
H302 H319 H315 H317 |
|
|
|
604-039-00-X |
ethyl-2-[4-[(6-chloorbenzoxazool-2-yl)oxy]fenoxy]propionaat; fenoxaprop-ethyl |
266-362-9 |
66441-23-4 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
604-040-00-5 |
fomesafen (ISO); 5-[2-chloor-4-(trifluormethyl)fenoxy]-N-(methylsulfonyl)-2-nitrobenzamide |
276-439-9 |
72178-02-0 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
604-041-00-0 |
acifluorfen (ISO); 5-[2-chloor-4-(trifluormethyl)fenoxy]-2-nitrobenzoëzuur [1] natrium-5-[2-chloor-4-(trifluormethyl)fenoxy]-2-nitrobenzoaat; acifluorfen-natrium [2] |
256-634-5 [1] 263-560-7 [2] |
50594-66-6 [1] 62476-59-9 [2] |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H318 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H302 H315 H318 H410 |
|
|
|
604-042-00-6 |
4-nitrosofenol |
203-251-6 |
104-91-6 |
Muta. 2 Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H341 H302 H318 H411 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H341 H302 H318 H411 |
|
|
|
604-043-00-1 |
monobenzon; 4-hydroxyfenylbenzylether; hydrochinonmonobenzylether |
203-083-3 |
103-16-2 |
Eye Irrit. 2 Skin Sens. 1 |
H319 H317 |
GHS07 Wng |
H319 H317 |
|
|
|
604-044-00-7 |
mequinol; 4-methoxyfenol; hydrochinonmonomethylether |
205-769-8 |
150-76-5 |
Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 |
H302 H319 H317 |
GHS07 Wng |
H302 H319 H317 |
|
|
|
604-045-00-2 |
2,3,5-trimethylhydrochinon |
211-838-3 |
700-13-0 |
Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H332 H335 H315 H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H332 H335 H315 H318 H317 H410 |
|
|
|
604-046-00-8 |
4-(4-isopropoxyfenylsulfonyl)fenol |
405-520-5 |
95235-30-6 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
604-047-00-3 |
4-(4-tolyloxy)bifenyl |
405-730-7 |
51601-57-1 |
STOT RE 2 * Aquatic Chronic 4 |
H373 ** H413 |
GHS08 Wng |
H373 ** H413 |
|
|
|
604-048-00-9 |
4,4',4''-(ethaan-1,1,1-triyl)trifenol |
405-800-7 |
27955-94-8 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
604-049-00-4 |
4-4'-methyleenbis(oxyethyleenthio)difenol |
407-480-4 |
93589-69-6 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
604-051-00-5 |
3,5-bis((3,5-di-tert-butyl-4-hydroxy)benzyl)-2,4,6-trimethylfenol |
401-110-5 |
87113-78-8 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
604-052-00-0 |
2,2'-methyleenbis(6-(2H-benzotriazool-2-yl)-4-(1,1,3,3-tetramethylbutyl)fenol) |
403-800-1 |
103597-45-1 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
604-053-00-6 |
2-methyl-4-(1,1-dimethylethyl)-6-(1-methyl-pentadecyl)-fenol |
410-760-9 |
157661-93-3 |
Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H315 H317 H410 |
|
|
|
604-054-00-1 |
reactiemassa van: 2-methoxy-4-(tetrahydro-4-methyleen-2H-pyran-2-yl)-fenol; 4-(3,6-dihydro-4-methyl-2H-pyran-2-yl)-2-methoxyfenol |
412-020-0 |
— |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
604-055-00-7 |
2,2'-((3,3', 5,5'-tetramethyl-(1,1'-bifenyl)-4,4'-diyl)-bis(oxymethyleen))-bis-oxiraan |
413-900-7 |
85954-11-6 |
Carc. 2 Skin Sens. 1 |
H351 H317 |
GHS08 GHS07 Wng |
H351 H317 |
|
|
|
604-056-00-2 |
2-(2-hydroxy-3,5-dinitroanilino)ethanol |
412-520-9 |
99610-72-7 |
Flam. Sol. 2 Repr. 2 Acute Tox. 4 * |
H228 H361f *** H302 |
GHS02 GHS07 GHS08 Dgr |
H228 H361f *** H302 |
|
|
|
604-058-00-3 |
1,2-bis(3-methylfenoxy)ethaan |
402-730-9 |
54914-85-1 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
604-059-00-9 |
2-n-hexadecylhydrochinon |
406-400-5 |
— |
STOT RE 2 * Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 |
H373 ** H315 H317 H413 |
GHS08 GHS07 Wng |
H373 ** H315 H317 H413 |
|
|
|
604-060-00-4 |
9,9-bis(4-hydroxyfenyl)fluoreen |
406-950-6 |
3236-71-3 |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H315 H400 H410 |
GHS07 GHS09 Wng |
H319 H315 H410 |
|
|
|
604-061-00-X |
reactiemassa van: 2-chloor-5-sec-tetradecylhydrochinonen waarbij sec-tetradecyl = 1-methyltridecyl; 1-ethyldodecyl; 1-propylundecyl; 1-butyldecyl; 1-pentylnonyl; 1-hexyloctyl |
407-740-7 |
— |
Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H315 H317 H412 |
GHS07 Wng |
H315 H317 H412 |
|
|
|
604-062-00-5 |
2,4-dimethyl-6-(1-methyl-pentadecyl)-fenol |
411-220-5 |
— |
Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H315 H317 H410 |
|
|
|
604-063-00-0 |
5,6-dihydroxy-indool |
412-130-9 |
3131-52-0 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H411 |
|
|
|
604-064-00-6 |
2-(4,6-difenyl-1,3,5-triazine-2-yl)-5-((hexyl)oxy)-fenol |
411-380-6 |
147315-50-2 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
604-065-00-1 |
4,4',4''-(1-methylpropaan-1-yl-3-ylideen)tris(2-cyclohexyl-5-methylfenol) |
407-460-5 |
111850-25-0 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
604-066-00-7 |
reactiemassa van: fenol, 6-(1,1-dimethylethyl)-4-tetrapropyl-2-[(2-hydroxy-5-tetra-propylfenyl)methyl (C41-verbinding) en methaan, 2,2'-bis[6-(1,1-dimethyl-ethyl)-1-hydroxy-4-tetrapropyl-fenyl)]-(C45-verbinding); 2,6-bis(1,1-dimethylethyl)-4-tetrapropylfenol en 2-(1,1-dimethylethyl)-4-tetrapropylfenol; 2,6-bis[(6-(1,1-dimethylethyl)-1-hydroxy-4-tetrapropylfenyl)methyl]-4-(tetrapropyl)fenol en 2-[(6-(1,1-dimethylethyl)-1-hydroxy-4-tetrapropylfenylmethyl]-6-[1-hydroxy-4-tetrapropylfenyl)methyl]-4-(tetrapropyl)fenol |
414-550-8 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
604-067-00-2 |
reactiemassa van: 2,2'-[[(2-hydroxyethyl)imino]bis(methyleen)bis[4-dodecylfenol]; formaldehyde, oligomeer met 4-dodecylfenol en 2-aminoethanol(n = 2); formaldehyde, oligomeer met 4-dodecylfenol en 2-aminoethanol(n = 3, 4 en hoger) |
414-520-4 |
— |
Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H400 H410 |
GHS05 GHS09 Dgr |
H315 H318 H410 |
|
|
|
604-068-00-8 |
(±)-4-[2-[[3-(4-hydroxyfenyl)-1-methylpropyl]amino]-1-hydroxyethyl]fenolhydrochloride |
415-170-5 |
90274-24-1 |
Acute Tox. 4 * Acute Tox. 4 * Skin Sens. 1 |
H332 H302 H317 |
GHS07 Wng |
H332 H302 H317 |
|
|
|
604-069-00-3 |
2-(1-methylpropyl)-4-tert-butylfenol |
421-740-4 |
51390-14-8 |
Skin Corr. 1B Aquatic Chronic 2 |
H314 H411 |
GHS05 GHS09 Dgr |
H314 H411 |
|
|
|
604-070-00-9 |
triclosan; 2,4,4'-trichloor-2'-hydroxy-difenylether; 5-chloor-2-(2,4-dichloorfenoxy)fenol |
222-182-2 |
3380-34-5 |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H315 H400 H410 |
GHS07 GHS09 Wng |
H319 H315 H410 |
|
M = 100 |
|
604-071-00-4 |
4,4'-(1-{4-[1-(4-hydroxyfenyl)-1-methylethyl]fenyl}ethylideen)difenol |
425-600-3 |
110726-28-8 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
604-072-00-X |
1,2-bis(fenoxymethyl)benzeen |
428-620-0 |
10403-74-4 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
604-073-00-5 |
(E)-3-[1-[4-[2-(dimethylamino)ethoxy]fenyl]-2-fenylbut-1-enyl]fenol |
428-010-4 |
82413-20-5 |
Carc. 2 Repr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H360F*** H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H351 H360F*** H317 H410 |
|
|
|
604-074-00-0 |
tetrabroombisfenol-A; 2,2',6,6'-tetrabroom-4,4'-isopropylideendifenol |
201-236-9 |
79-94-7 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
604-075-00-6 |
4-(1,1,3,3-tetramethylbutyl)fenol; 4-tert-octylfenol |
205-426-2 |
140-66-9 |
Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H400 H410 |
GHS05 GHS09 Dgr |
H315 H318 H410 |
|
M=10 |
|
604-076-00-1 |
fenolftaleïne |
201-004-7 |
77-09-8 |
Carc. 1B Muta. 2 Repr. 2 |
H350 H341 H361f*** |
GHS08 Dgr |
H350 H341 H361f*** |
|
Carc. 1B; H350: C ≥1 % |
|
604-077-00-7 |
2-benzotriazool-2-yl-4-methyl-6-(2-methylallyl)fenol |
419-750-9 |
98809-58-6 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
604-079-00-8 |
4,4'-(1,3-fenyleenbis(1-methylethylideen))bisfenol |
428-970-4 |
13595-25-0 |
Repr. 2 Skin Sens. 1 Aquatic Chronic 2 |
H361f*** H317 H411 |
GHS08 GHS07 GHS09 Wng |
H361f*** H317 H411 |
|
|
|
604-080-00-3 |
4-fluor-3-trifluormethylfenol |
432-560-0 |
61721-07-1 |
Acute Tox. 4 * Skin Corr. 1A Skin Sens. 1 Aquatic Chronic 2 |
H332 H314 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H332 H314 H317 H411 |
|
|
|
604-081-00-9 |
1,1-bis(4-hydroxyfenyl)-1-fenylethaan |
433-130-5 |
1571-75-1 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
604-082-00-4 |
2-chloor-6-fluorfenol |
433-890-8 |
2040-90-6 |
Muta. 1B Repr. 2 Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 |
H340 H361f*** H302 H314 H317 H411 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H340 H361f*** H302 H314 H317 H411 |
|
|
|
604-083-00-X |
4,4'-sulfonylbisfenol, polymeer met ammoniumchloride (NH4Cl), pentachloorfosforaan en fenol |
439-270-3 |
260408-02-4 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
604-084-00-5 |
1-ethoxy-2,3-difluorbenzeen |
441-000-4 |
121219-07-6 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
604-087-00-1 |
reactiemassa van: 1,2-naftochinondiazide-5-sulfonylchloride (of -sulfonzuur), monoester met 4,4'-(1-(4-(1-(4-hydroxyfenyl)-1-methylethyl)fenyl)ethylideen)bisfenol; 1,2-naftochinondiazide-5-sulfonylchloride(of -sulfonzuur), diëster met 4,4'-(1-(4-(1-(4-hydroxyfenyl)-1-methylethyl)fenyl)ethylideen)bisfenol; 1,2-naftochinondiazide-5-sulfonylchloride (of -sulfonzuur), triëster met 4,4'-(1-(4-(1-(4-hydroxyfenyl)-1-methylethyl)fenyl)ethylideen)bisfenol |
433-640-8 |
— |
Pyr. Sol. 1 Aquatic Chronic 4 |
H250 H413 |
GHS02 Dgr |
H250 H413 |
EUH044 |
|
|
604-089-00-2 |
2-methyl-5-tert-butylthiofenol |
444-970-7 |
— |
Flam. Liq. 3 Repr. 2 STOT RE 2 * Asp. Tox. 1 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 |
H226 H361d*** H373** H304 H319 H315 H317 H336 H400 H410 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H226 H361d*** H373** H304 H319 H315 H317 H336 H410 |
|
|
|
604-090-00-8 |
4-tert-butylfenol |
202-679-0 |
98-54-4 |
Repr. 2 Skin Irrit. 2 Eye Dam. 1 |
H361f H315 H318 |
GHS08 GHS05 Dgr |
H361f H315 H318 |
|
|
|
604-091-00-3 |
etofenprox (ISO); 2-(4-ethoxyfenyl)-2-methylpropyl-3-fenoxybenzylether |
407-980-2 |
80844-07-1 |
Lact. Aquatic Acute 1 Aquatic Chronic 1 |
H362 H400 H410 |
GHS09 Wng |
H362 H410 |
|
M = 100 M = 1 000 |
|
605-001-00-5 |
formaldehyde … % |
200-001-8 |
50-00-0 |
Carc. 1B Muta. 2 Acute Tox. 3* Acute Tox. 3* Acute Tox. 3* Skin Corr. 1B Skin Sens. 1 |
H350 H341 H301 H311 H331 H314 H317 |
GHS08 GHS06 GHS05 Dgr |
H350 H341 H301 H311 H331 H314 H317 |
|
* Skin Corr. 1B; H314: C ≥25 % Skin Irrit. 2; H315: 5 % ≤C < 25 % Eye Irrit. 2; H319: 5 % ≤ C <25 % STOT SE 3; H335: C ≥ 5 % SkinSens.; H317: C ≥ 0,2 % |
B, D |
605-002-00-0 |
1,3,5-trioxaan; trioxymethyleen |
203-812-5 |
110-88-3 |
Flam. Sol. 1 Repr. 2 STOT SE 3 |
H228 H361d *** H335 |
GHS02 GHS08 GHS07 Dgr |
H228 H361d *** H335 |
|
|
T |
605-003-00-6 |
aceetaldehyde; ethanal |
200-836-8 |
75-07-0 |
Flam. Liq. 1 Carc. 2 Eye Irrit. 2 STOT SE 3 |
H224 H351 H319 H335 |
GHS02 GHS08 GHS07 Dgr |
H224 H351 H319 H335 |
|
|
|
605-004-00-1 |
2,4,6-trimethyl-1,3,5-trioxaan; paraldehyde |
204-639-8 |
123-63-7 |
Flam. Liq. 3 |
H226 |
GHS02 Wng |
H226 |
|
|
|
605-005-00-7 |
2,4,6,8-tetramethyl-1,3,5,7-tetraoxacycloöctaan; metaldehyde |
203-600-2 |
108-62-3 |
Flam. Sol. 2 Acute Tox. 4 * |
H228 H302 |
GHS02 GHS07 Wng |
H228 H302 |
|
|
|
605-006-00-2 |
butyraldehyde |
204-646-6 |
123-72-8 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
|
|
|
605-007-00-8 |
1,1-dimethoxyethaan; dimethylacetaal |
208-589-8 |
534-15-6 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
|
|
|
605-008-00-3 |
acroleïne; prop-2-enal; acrylaldehyde |
203-453-4 |
107-02-8 |
Flam. Liq. 2 Acute Tox. 1 Acute Tox. 2 Acute Tox. 3 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H225 H330 H300 H311 H314 H400 H410 |
GHS02 GHS06 GHS05 GHS09 Dgr |
H225 H330 H300 H311 H314 H410 |
EUH071 |
Skin Corr. 1B; H314:C≥ 0,1 % M = 100 M = 1 |
D |
605-009-00-9 |
crotonaldehyde; 2-butenal; [1] (E)-2-butenal; (E)-crotonaldehyde [2] |
224-030-0 [1] 204-647-1 [2] |
4170-30-3 [1] 123-73-9 [2] |
Flam. Liq. 2 Muta. 2 Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 |
H225 H341 H330 H311 H301 H373 ** H335 H315 H318 H400 |
GHS02 GHS06 GHS08 GHS05 GHS09 Dgr |
H225 H341 H330 H311 H301 H373 ** H335 H315 H318 H400 |
|
|
|
605-010-00-4 |
2-furaldehyde |
202-627-7 |
98-01-1 |
Carc. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H351 H331 H301 H312 H319 H335 H315 |
GHS06 GHS08 Dgr |
H351 H331 H301 H312 H319 H335 H315 |
|
|
|
605-011-00-X |
2-chloorbenzaldehyde; o-chloorbenzaldehyde |
201-956-3 |
89-98-5 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
|
|
605-012-00-5 |
benzaldehyde |
202-860-4 |
100-52-7 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
605-014-00-6 |
chloralhydraat; 2,2,2-trichloorethaan-1,1-diol |
206-117-5 |
302-17-0 |
Acute Tox. 3 * Eye Irrit. 2 Skin Irrit. 2 |
H301 H319 H315 |
GHS06 Dgr |
H301 H319 H315 |
|
|
|
605-015-00-1 |
1,1-diëthoxy-ethaan; acetaal |
203-310-6 |
105-57-7 |
Flam. Liq. 2 Eye Irrit. 2 Skin Irrit. 2 |
H225 H319 H315 |
GHS02 GHS07 Dgr |
H225 H319 H315 |
|
|
|
605-016-00-7 |
glyoxal … %; ethandial … % |
203-474-9 |
107-22-2 |
Muta. 2 Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H341 H332 H319 H315 H317 |
GHS07 GHS08 Wng |
H341 H332 H319 H315 H317 |
|
* |
B |
605-017-00-2 |
1,3-dioxolaan |
211-463-5 |
646-06-0 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
|
|
|
605-018-00-8 |
propanal; propionaldehyde |
204-623-0 |
123-38-6 |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H225 H319 H335 H315 |
GHS02 GHS07 Dgr |
H225 H319 H335 H315 |
|
|
|
605-019-00-3 |
citral |
226-394-6 |
5392-40-5 |
Skin Irrit. 2 Skin Sens. 1 |
H315 H317 |
GHS07 Wng |
H315 H317 |
|
|
|
605-020-00-9 |
safrool; 5-allyl-1,3-benzodioxool |
202-345-4 |
94-59-7 |
Carc. 1B Muta. 2 Acute Tox. 4 * |
H350 H341 H302 |
GHS08 GHS07 Dgr |
H350 H341 H302 |
|
|
|
605-021-00-4 |
formaldehyde, reactieproducten met butylfenol |
294-145-9 |
91673-30-2 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
605-024-00-0 |
2-broom-5-hydroxy-4-methoxybenzaldehyde |
426-540-0 |
2973-59-3 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
605-025-00-6 |
chlooraceetaldehyde |
203-472-8 |
107-20-0 |
Carc. 2 Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Aquatic Acute 1 |
H351 H330 H311 H301 H314 H400 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H351 H330 H311 H301 H314 H400 |
|
STOT SE 3; H335: C≥ 5 % |
|
605-026-00-1 |
2,5,7,7-tetramethyloctanal |
405-690-0 |
114119-97-0 |
Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H315 H317 H411 |
GHS07 GHS09 Wng |
H315 H317 H411 |
|
|
|
605-027-00-7 |
reactiemassa van: 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indeen-6-carboxaldehyde; 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indeen-5-carboxaldehyde |
410-480-7 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
605-028-00-2 |
β-methyl-3-(1-methylethyl)-benzeenpropanal |
412-050-4 |
125109-85-5 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
605-029-00-8 |
2-cyclohexyl propanal |
412-270-0 |
2109-22-0 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
605-030-00-3 |
1-(p-methoxyfenyl)-aceetaldehydeoxim |
411-510-1 |
3353-51-3 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
605-031-00-9 |
reactiemassa van: 2,2-dimethoxyethanal [hoewel deze component qua identiteit, structuur en samenstelling als watervrij wordt beschouwd, bestaat 2,2-dimethoxyethanal ook als hydraat. 60 % watervrij stemt overeen met 70.4 % hydraat; water (met inbegrip van vrij water en water in gehydrateerd 2,2-dimethoxyethanal) |
421-890-0 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
605-032-00-4 |
3-[3-(4-fluorfenyl)-1-(1-methylethyl)-1H-indool-2-yl]-(E)-2-propenal |
425-370-4 |
93957-50-7 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
605-033-00-X |
reactiemassa van: 3,7,11-trimethyl-cis-6,10-dodecadiënal; 3,7,11-trimethyl-trans-6,10-dodecadiënal |
425-910-9 |
32480-08-3 |
Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Wng |
H315 H410 |
|
|
|
605-034-00-5 |
reactiemassa van: (1RS,2RS,3SR,6RS,9SR)-9-methoxytricyclo[5.2.1.02,6]decaan-3-carbaldehyde; (1RS,2RS,3RS,6RS,8SR)-8-methoxytricyclo[5.2.1.02,6]decaan-3-carbaldehyde; (1RS,2RS,4SR,6RS,8SR)-8-methoxytricyclo[5.2.1.02,6]decaan-4-carbaldehyde |
429-860-9 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
605-035-00-0 |
(E)-3-(4-(4-fluorfenyl)-5-methoxymethyl-2,6-bis(1-methoxymethyl)pyridine-3-yl)prop-2-enal |
426-330-9 |
177964-68-0 |
Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 |
H319 H317 H413 |
GHS07 Wng |
H319 H317 H413 |
|
|
|
605-036-00-6 |
2-broommalonaldehyde |
430-470-6 |
2065-75-0 |
Acute Tox. 4 * Eye Dam. 1 |
H302 H318 |
GHS05 GHS07 Dgr |
H302 H318 |
|
|
|
605-037-00-1 |
trans-3-[2-(7-chloor-2-chinolinyl)vinyl]benzaldehyde; 3-[(E)-2-(7-chloor-2-chinolinyl)vinyl]benzaldehyde |
421-800-1 |
120578-03-2 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
605-038-00-7 |
5-fenyl-3-methylpentaan-1-al |
433-900-0 |
55066-49-4 |
Acute Tox. 4 * Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H302 H315 H317 H411 |
GHS07 GHS09 Wng |
H302 H315 H317 H411 |
|
|
|
605-039-00-2 |
3,4-dihydroxy-5-nitrobenzaldehyde |
441-810-8 |
116313-85-0 |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 |
H302 H318 H317 |
GHS05 GHS07 Dgr |
H302 H318 H317 |
|
|
|
606-001-00-8 |
aceton; propaan-2-on; propanon |
200-662-2 |
67-64-1 |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 |
H225 H319 H336 |
GHS02 GHS07 Dgr |
H225 H319 H336 |
EUH066 |
|
|
606-002-00-3 |
butanon; ethylmethylketon |
201-159-0 |
78-93-3 |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 |
H225 H319 H336 |
GHS02 GHS07 Dgr |
H225 H319 H336 |
EUH066 |
|
|
606-003-00-9 |
heptaan-3-on; butylethylketon |
203-388-1 |
106-35-4 |
Flam. Liq. 3 Acute Tox. 4 * Eye Irrit. 2 |
H226 H332 H319 |
GHS02 GHS07 Wng |
H226 H332 H319 |
|
|
|
606-004-00-4 |
4-methylpentaan-2-on; methylisobutylketon |
203-550-1 |
108-10-1 |
Flam. Liq. 2 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 |
H225 H332 H319 H335 |
GHS02 GHS07 Dgr |
H225 H332 H319 H335 |
EUH066 |
|
|
606-005-00-X |
2,6-dimethylheptaan-4-on; diisobutylketon |
203-620-1 |
108-83-8 |
Flam. Liq. 3 STOT SE 3 |
H226 H335 |
GHS02 GHS07 Wng |
H226 H335 |
|
STOT SE 3; H335: C ≥ 10 % |
|
606-006-00-5 |
pentaan-3-on; diëthylketon |
202-490-3 |
96-22-0 |
Flam. Liq. 2 STOT SE 3 STOT SE 3 |
H225 H335 H336 |
GHS02 GHS07 Dgr |
H225 H335 H336 |
EUH066 |
|
|
606-007-00-0 |
3-methylbutaan-2-on; methylisopropylketon |
209-264-3 |
563-80-4 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
|
|
|
606-009-00-1 |
4-methyl-3-penteen-2-on; mesityloxide |
205-502-5 |
141-79-7 |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H226 H332 H312 H302 |
GHS02 GHS07 Wng |
H226 H332 H312 H302 |
|
* |
|
606-010-00-7 |
cyclohexanon |
203-631-1 |
108-94-1 |
Flam. Liq. 3 Acute Tox. 4 * |
H226 H332 |
GHS02 GHS07 Wng |
H226 H332 |
|
|
|
606-011-00-2 |
2-methylcyclohexanon |
209-513-6 |
583-60-8 |
Flam. Liq. 3 Acute Tox. 4 * |
H226 H332 |
GHS02 GHS07 Wng |
H226 H332 |
|
|
|
606-012-00-8 |
3,5,5-trimethylcyclohex-2-enon; isoforon |
201-126-0 |
78-59-1 |
Carc. 2 Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 |
H351 H312 H302 H319 H335 |
GHS08 GHS07 Wng |
H351 H312 H302 H319 H335 |
|
STOT SE 3; H335: C ≥10 % |
|
606-013-00-3 |
p-benzochinon; chinon |
203-405-2 |
106-51-4 |
Acute Tox. 3 * Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 |
H331 H301 H319 H335 H315 H400 |
GHS06 GHS09 Dgr |
H331 H301 H319 H335 H315 H400 |
|
M=10 |
|
606-016-00-X |
pindone (ISO); 2-pivaloylindaan-1,3-dion |
201-462-8 |
83-26-1 |
Acute Tox. 3 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H372 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H301 H372 ** H410 |
|
|
|
606-017-00-5 |
diketeen; diketen |
211-617-1 |
674-82-8 |
Flam. Liq. 3 Acute Tox. 4 * |
H226 H332 |
GHS02 GHS07 Wng |
H226 H332 |
|
|
D |
606-018-00-0 |
dichlone (ISO); 2,3-dichloor-1,4-naftochinon |
204-210-5 |
117-80-6 |
Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H315 H410 |
|
|
|
606-019-00-6 |
chloordecone (ISO); perchloorpentacyclo[5,3,0,02,6,03,9,0 4,8]decaan-5-on; decachloorpentacyclo[5,2,1,02,6,03,9,05,8]decaan-4-on |
205-601-3 |
143-50-0 |
Carc. 2 Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H311 H301 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H311 H301 H410 |
|
|
|
606-020-00-1 |
5-methylheptaan-3-on |
208-793-7 |
541-85-5 |
Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 |
H226 H319 H335 |
GHS02 GHS07 Wng |
H226 H319 H335 |
|
STOT SE 3; H335: C≥10 % |
|
606-022-00-2 |
1-fenyl-3-pyrazolidon |
202-155-1 |
92-43-3 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
606-023-00-8 |
4-methoxy-4-methylpentaan-2-on |
203-512-4 |
107-70-0 |
Flam. Liq. 3 Acute Tox. 4 * |
H226 H332 |
GHS02 GHS07 Wng |
H226 H332 |
|
|
|
606-024-00-3 |
heptaan-2-on; amyl(methyl)keton |
203-767-1 |
110-43-0 |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * |
H226 H332 H302 |
GHS02 GHS07 Wng |
H226 H332 H302 |
|
|
|
606-025-00-9 |
cyclopentanon |
204-435-9 |
120-92-3 |
Flam. Liq. 3 Eye Irrit. 2 Skin Irrit. 2 |
H226 H319 H315 |
GHS02 GHS07 Wng |
H226 H319 H315 |
|
|
|
606-026-00-4 |
5-methylhexaan-2-on; isoamyl(methyl)ketone |
203-737-8 |
110-12-3 |
Flam. Liq. 3 Acute Tox. 4 * |
H226 H332 |
GHS02 GHS07 Wng |
H226 H332 |
|
|
|
606-027-00-X |
heptaan-4-on; di-n-propylketon |
204-608-9 |
123-19-3 |
Flam. Liq. 3 Acute Tox. 4 * |
H226 H332 |
GHS02 GHS07 Wng |
H226 H332 |
|
|
|
606-028-00-5 |
2,4-dimethylpentaan-3-on; diisopropylketon |
209-294-7 |
565-80-0 |
Flam. Liq. 2 Acute Tox. 4 * |
H225 H332 |
GHS02 GHS07 Dgr |
H225 H332 |
|
|
|
606-029-00-0 |
pentaan-2,4-dion; acetylaceton |
204-634-0 |
123-54-6 |
Flam. Liq. 3 Acute Tox. 4 * |
H226 H302 |
GHS02 GHS07 Wng |
H226 H302 |
|
|
|
606-030-00-6 |
hexaan-2-on; methylbutylketon; butylmethylketon; methyl-n-butylketon |
209-731-1 |
591-78-6 |
Flam. Liq. 3 Repr. 2 STOT RE 1 STOT SE 3 |
H226 H361f *** H372 ** H336 |
GHS02 GHS08 GHS07 Dgr |
H226 H361f *** H372 ** H336 |
|
|
|
606-031-00-1 |
3-propanolide; 1,3-propiolacton |
200-340-1 |
57-57-8 |
Carc. 1B Acute Tox. 2 * Eye Irrit. 2 Skin Irrit. 2 |
H350 H330 H319 H315 |
GHS06 GHS08 Dgr |
H350 H330 H319 H315 |
|
|
|
606-032-00-7 |
hexachlooraceton |
204-129-5 |
116-16-5 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
606-033-00-2 |
2-(3,4-dichloorfenyl)-4-methyl-1,2,4-oxadiazolidinedion; methazool |
243-761-6 |
20354-26-1 |
Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 |
H312 H302 H319 H315 H411 |
GHS07 GHS09 Wng |
H312 H302 H319 H315 H411 |
|
|
|
606-034-00-8 |
metribuzin (ISO); 4-amino-6-tert-butyl-3-methylthio-1,2,4-triazine-5(4H)-on; 4-amino-4,5-dihydro-6-(1,1-dimethylethyl)-3-methylthio-1,2,4-triazine-5-on |
244-209-7 |
21087-64-9 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
M=10 |
|
606-035-00-3 |
chlooridazon (ISO); 5-amino-4-chloor-2-fenylpyridazine-3-(2H)-on; pyrazon |
216-920-2 |
1698-60-8 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
606-036-00-9 |
quinomethionaat; chinomethionaat (ISO); 6-methyl-1,3-dithiolo(4,5-b)chinoxaline-2-on |
219-455-3 |
2439-01-2 |
Repr. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361f *** H332 H312 H302 H373 ** H319 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H361f *** H332 H312 H302 H373 ** H319 H317 H410 |
|
|
|
606-037-00-4 |
triadimefon (ISO); 1-(4-chloorfenoxy)-3,3-dimethyl-1-(1,2,4-triazool-1-yl)butanon |
256-103-8 |
43121-43-3 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H302 H317 H411 |
GHS07 GHS09 Wng |
H302 H317 H411 |
|
|
|
606-038-00-X |
difacinon (ISO); 2-difenylacetylindaan-1,3-dion |
201-434-5 |
82-66-6 |
Acute Tox. 2 * STOT RE 1 |
H300 H372 ** |
GHS06 GHS08 Dgr |
H300 H372 ** |
|
|
|
606-039-00-5 |
5(of 6)-tert-butyl-2'-chloor-6'-ethylamino-3',7'-dimethylspiro(isobenzofuran-1(1H),9'-xantheen)-3-on |
400-680-2 |
— |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H400 H410 |
GHS07 GHS09 Wng |
H332 H410 |
|
|
|
606-040-00-0 |
(N-benzyl-N-ethyl)amino-3-hydroxyacetofenonhydrochloride |
401-840-4 |
55845-90-4 |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
606-042-00-1 |
acetofenon |
202-708-7 |
98-86-2 |
Acute Tox. 4 * Eye Irrit. 2 |
H302 H319 |
GHS07 Wng |
H302 H319 |
|
|
|
606-043-00-7 |
2,4-di-tert-butylcyclohexanon |
405-340-7 |
13019-04-0 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
606-044-00-2 |
2,4,6-trimethylbenzofenon |
403-150-9 |
954-16-5 |
Acute Tox. 4 * Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H410 |
|
|
|
606-045-00-8 |
oxadiazon (ISO); 3-[2,4-dichloor-5-(1-methylethoxy)fenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazool-2(3H)-on |
243-215-7 |
19666-30-9 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
606-046-00-3 |
reactiemassa van cis- en trans-cyclohexadec-8-een-1-on |
401-700-2 |
3100-36-5 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
606-047-00-9 |
2-benzyl-2-dimethylamino-4-morfolinobutyrofenon |
404-360-3 |
119313-12-1 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
606-048-00-4 |
2'-anilino-3'-methyl-6'-dipentylaminospiro(isobenzofuran-1(1H),9'-xantheen)-3-on |
406-480-1 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
606-049-00-X |
4-(trans-4-propylcyclohexyl)acetofenon |
406-700-6 |
78531-61-0 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
606-050-00-5 |
6-anilino-1-benzoyl-4-(4-tert-pentylfenoxy)nafto[1,2,3-de]chinoline-2,7-(3H)-dion |
412-480-2 |
72453-58-8 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
606-051-00-0 |
4-pentylcyclohexanon |
406-670-4 |
61203-83-6 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
606-052-00-6 |
4-(N,N-dibutylamino)-2-hydroxy-2'-carboxybenzofenon |
410-410-5 |
54574-82-2 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
606-053-00-1 |
flurtamone (ISO); (RS)-5-methylamino-2-fenyl-4-(α, α,α-trifluor-m-tolyl)furan-3(2H)-on |
— |
96525-23-4 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
606-055-00-2 |
1-(2,3-dihydro-1,3,3,6-tetramethyl-1-(1-methylethyl)-1H-indeen-5-yl)-ethanon |
411-180-9 |
92836-10-7 |
Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 2 |
H302 H373 ** H411 |
GHS08 GHS07 GHS09 Wng |
H302 H373 ** H411 |
|
|
|
606-056-00-8 |
4-chloor-3',4'-dimethoxybenzofenon |
404-610-1 |
116412-83-0 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
606-057-00-3 |
4-propylcyclohexanon |
406-810-4 |
40649-36-3 |
Skin Irrit. 2 Aquatic Chronic 3 |
H315 H412 |
GHS07 Wng |
H315 H412 |
|
|
|
606-058-00-9 |
4'-fluor-2,2-dimethoxyacetofenon |
407-500-1 |
21983-80-2 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
606-059-00-4 |
2,4-difluor-α-(1H-1,2,4-triazool-1-yl)acetofenonhydrochloride |
412-390-3 |
86386-75-6 |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 |
H302 H318 H317 |
GHS05 GHS07 Dgr |
H302 H318 H317 |
|
|
|
606-060-00-X |
reactiemassa van: trans-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naftaleen-2-yl)-1,3-dioxolaan; cis-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naftaleen-2-yl)-1,3-dioxolaan |
412-950-7 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
606-061-00-5 |
(3-chloorfenyl)-(4-methoxy-3-nitrofenyl)methanon |
423-290-4 |
66938-41-8 |
Muta. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H341 H400 H410 |
GHS08 GHS09 Wng |
H341 H410 |
|
|
|
606-062-00-0 |
tetrahydrothiopyran-3-carboxaldehyde |
407-330-8 |
61571-06-0 |
Repr. 1B Eye Dam. 1 Aquatic Chronic 3 |
H360D *** H318 H412 |
GHS08 GHS05 Dgr |
H360D *** H318 H412 |
|
|
|
606-063-00-6 |
(E)-3-(2-chloorfenyl)-2-(4-fluorfenyl)propenal |
410-980-5 |
112704-51-5 |
Eye Irrit. 2 Skin Sens. 1 |
H319 H317 |
GHS07 Wng |
H319 H317 |
|
|
|
606-064-00-1 |
pregn-5-een-3,20-dionbis(ethyleenketal) |
407-450-0 |
7093-55-2 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
606-065-00-7 |
1-(4-morfolinofenyl)butaan-1-on |
413-790-0 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
606-066-00-2 |
(E)-5[(4-chloorfenyl)methyleen]-2,2-dimethylcyclopentanon |
410-440-9 |
164058-20-2 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
606-067-00-8 |
reactiemassa van: 1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz[g]indeen-4-yl)ethanon; 1-(2,3,5,6,7,8-hexahydro-1,1-dimethyl-1H-benz[f]indeen-4-yl)ethanon; 1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz[g]indeen-5-yl)ethanon; 1-(2,3,6,7,8,9-hexahydro-3,3-dimethyl-1H-benz[g]indeen-5-yl)ethanon |
414-870-8 |
96792-67-5 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
606-068-00-3 |
2,7,11-trimethyl-13-(2,6,6-trimethylcyclohex-1-een-1-yl)tridecahexaeen-2,4,6,8,10,12-al |
415-770-7 |
1638-05-7 |
STOT RE 2 * Skin Sens. 1 Aquatic Chronic 3 |
H373 ** H317 H412 |
GHS08 GHS07 Wng |
H373 ** H317 H412 |
|
|
|
606-069-00-9 |
spiro[1,3-dioxolaan-2,5'-(4',4',8',8'-tetramethyl-hexahydro-3',9'-methanonaftaleen)] |
415-460-1 |
154171-76-3 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
606-070-00-4 |
butroxydim (ISO); 5-(3-butyryl-2,4,6-trimethylfenyl)-2-[1-(ethoxyimino)propyl]-3-hydroxycyclohex-2-een-1-on; |
414-790-3 |
138164-12-2 |
Repr. 2 Acute Tox. 4 * Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H361fd H302 H315 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H361fd H302 H315 H410 |
|
|
|
606-071-00-X |
17-spiro(5,5-dimethyl-1,3-dioxaan-2-yl)androsta-1,4-dieen-3-on |
421-050-3 |
13258-43-0 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
606-072-00-5 |
3-acetyl-1-fenylpyrrolidine-2,4-dion |
421-600-2 |
719-86-8 |
STOT RE 2 * Aquatic Chronic 2 |
H373 ** H411 |
GHS08 GHS09 Wng |
H373 ** H411 |
|
|
|
606-073-00-0 |
4,4'-bis(dimethylamino)benzofenon; Michlers keton |
202-027-5 |
90-94-8 |
Carc. 1B Muta. 2 Eye Dam. 1 |
H350 H341 H318 |
GHS08 GHS05 Dgr |
H350 H341 H318 |
|
|
|
606-074-00-6 |
reactiemassa van: (1R*,2S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-1,2,8,8-tetramethylnaftaleen; (2R*,3S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethylnaftaleen |
425-570-1 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
606-075-00-1 |
1-benzyl-5-ethoxyimidazolidine-2,4-dion |
417-340-4 |
65855-02-9 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
606-076-00-7 |
1-((2-chinolinylcarbonyl)oxy)-2,5-pyrrolidinedion |
418-630-3 |
136465-99-1 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
606-077-00-2 |
(3S,4S)-3-hexyl-4-[(R)-2-hydroxytridecyl]-2-oxetanon |
418-650-2 |
104872-06-2 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
606-078-00-8 |
1-octylazepine-2-on |
420-040-6 |
59227-88-2 |
Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 |
H314 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H314 H317 H411 |
|
|
|
606-079-00-3 |
2-n-butylbenzo[d]isothiazool-3-on |
420-590-7 |
4299-07-4 |
Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H314 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H314 H317 H410 |
|
|
|
606-081-00-4 |
(3β, 5α, 6β)-3-(acetyloxy)-5-broom-6-hydroxy-androstaan-17-on |
419-790-7 |
4229-69-0 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
606-082-00-X |
reactiemassa van: butaan-2-on-oxim; syn-O,O'-di(butaan-2-on-oxim)diëthoxysilaan |
406-930-7 |
|
STOT RE 1 Skin Sens. 1 Aquatic Chronic 3 |
H372 ** H317 H412 |
GHS08 GHS07 Dgr |
H372 ** H317 H412 |
|
|
|
606-083-00-5 |
2-chloor-5-sec-hexadecylhydrochinon |
407-750-1 |
137193-60-3 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H319 H315 H317 H412 |
GHS07 Wng |
H319 H315 H317 H412 |
|
|
|
606-084-00-0 |
1-(4-methoxy-5-benzofuranyl)-3-fenyl-1,3-propaandion |
414-540-3 |
484-33-3 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
606-085-00-6 |
(1R,4S)-2-azabicyclo[2.2.1]hept-5-een-3-on |
418-530-1 |
79200-56-9 |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 |
H302 H318 H317 |
GHS05 GHS07 Dgr |
H302 H318 H317 |
|
|
|
606-086-00-1 |
1-(3,3-dimethylcyclohexyl)pent-4-een-1-on |
422-330-8 |
56973-87-6 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
606-087-00-7 |
6-ethyl-5-fluor-4(3H)-pyrimidon |
422-460-5 |
137234-87-8 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
606-088-00-2 |
2,4,4,7-tetramethyl-6-octeen-3-on |
422-520-0 |
74338-72-0 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
606-089-00-8 |
reactiemassa van: 1,4-diamino-2-chloor-3-fenoxyantrachinon; 1,4-diamino-2,3-bis-fenoxyantrachinon |
423-220-2 |
12223-77-7 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
606-090-00-3 |
1-[3-[(dimethylamino)methyl]-4-hydroxyfenyl]ethanon |
430-920-1 |
73096-98-7 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 |
H302 H318 H412 |
GHS05 GHS07 Dgr |
H302 H318 H412 |
|
|
|
606-091-00-9 |
6-chloor-5-(2-chloorethyl)-1,3-dihydroïndool-2-on |
421-320-0 |
118289-55-7 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
606-092-00-4 |
reactiemassa van: (E)-oxacyclohexadec-12-een-2-on; (E)-oxacyclohexadec-13-een-2-on; a) (Z)-oxacyclohexadec-(12)-een-2-on en b) (Z)-oxacyclohexadec-(13)-een-2-on |
422-320-3 |
|
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
606-093-00-X |
5-ethyl-2,4-dihydro-4-(2-fenoxyethyl)-3H-1,2,4-triazool-3-on |
414-470-3 |
95885-13-5 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
606-094-00-5 |
N-[ethyl(3-methylbutyl)amino]-3-methyl-1-fenyl-spiro[[1]benzo-pyrano[2,3-c]pyrazool-4(1H),1'(3'H)-isobenzofuran]-3'-on |
417-460-7 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
606-095-00-0 |
(R,S)-2-azabicyclo[2.2.1]hept-5-een-3-on |
421-830-3 |
49805-30-3 |
Acute Tox. 4 * Skin Sens. 1 |
H302 H317 |
GHS07 Wng |
H302 H317 |
|
|
|
606-096-00-6 |
3-(6-O-(6-desoxy-α-l-mannopyranosyl-O-(α-D-glucopyranosyl)-(β-D-glucopyranosyl)oxy)-2-(3,4-dihydroxydenyl)-5,7-dihydroxy-4H-1-benzopyran-4-on |
424-170-4 |
130603-71-3 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
606-097-00-1 |
2,2''-dihydroxy-4,4''-(2-hydroxypropaan-1,3-diyldioxy)dibenzofenon |
424-210-0 |
23911-85-5 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
606-098-00-7 |
1-benzyl-5-(hexadecyloxy)-2,4-imidazolidinedion |
431-220-9 |
158574-65-3 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
606-099-00-2 |
5-methoxy-4'-(trifluormethyl)valerofenon |
425-000-1 |
61718-80-7 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
606-100-00-6 |
2-butyryl-3-hydroxy-5-thiocyclohexaan-3-ylcyclohex-2-een-1-on |
425-150-8 |
94723-86-1 |
Repr. 1B Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 3 |
H360F*** H302 H317 H412 |
GHS08 GHS07 Dgr |
H360F*** H302 H317 H412 |
|
|
|
606-101-00-1 |
reactiemassa van: 1,5-bis[(2-ethylhexyl)amino]-9,10-antraceendion; 1-[(2-ethylhexyl)amino]-5-[3-[(2-ethylhexyl)oxy]propyl]amino-9,10-antraceendion; 1,5-bis[3-[(2-ethylhexyl)oxy]propyl]amino-9,10-antraceendion; 1-[(2-ethylhexyl)amino]-5-[(3-methoxypropyl)amino]-9,10-anthraceendion; 1-[3-[(2-ethylhexyl)oxy]propyl]amino-5-[(3-methoxypropyl)amino]-9,10-antraceendion; 1,5-bis[(3-methyloxypropyl)amino]-9,10-antraceendion |
426-050-7 |
165038-51-7 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
606-102-00-7 |
4-(3-triëthoxysilylpropoxy)-2-hydroxybenzofenon |
431-490-8 |
79876-59-8 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
606-103-00-2 |
1-(4-(trans-4-ethylcyclohexyl)fenyl)ethanon |
426-460-6 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
606-104-00-8 |
1-(4-(trans-4-pentylcyclohexyl)fenyl)ethanon |
426-830-7 |
78531-59-6 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
606-105-00-3 |
3,4,3', 4'-tetrafenyl-1,1'-ethaandiylbispyrol-2,5-dion |
431-500-0 |
226065-73-2 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
606-106-00-9 |
1-(4-(trans-4-butylcyclohexyl)fenyl)ethanon |
427-320-7 |
83626-30-6 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
606-107-00-4 |
8-azaspiro[4.5]decaan-7,9-dion |
427-770-4 |
1075-89-4 |
Acute Tox. 3 * Aquatic Chronic 2 |
H301 H411 |
GHS06 GHS09 Dgr |
H301 H411 |
|
|
|
606-108-00-X |
1,1,1,2,2,4,5,5,5-nonafluor-4-(trifluormethyl)-3-pentanon |
436-710-6 |
756-13-8 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
606-109-00-5 |
2-(4-methyl-3-pentenyl)antrachinon |
428-320-1 |
71308-16-2 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 4 |
H302 H317 H413 |
GHS07 Wng |
H302 H317 H413 |
|
|
|
606-110-00-0 |
5-ethoxy-5H-furan-2-on |
428-330-4 |
2833-30-9 |
Skin Corr. 1B Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 |
H314 H312 H302 H373** H317 |
GHS05 GHS08 GHS07 Dgr |
H314 H312 H302 H373** H317 |
|
|
|
606-111-00-6 |
5-amino-6-methyl-1,3-dihydrobenzoïmidazool-2-on |
428-410-9 |
67014-36-2 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H302 H317 H411 |
GHS07 GHS09 Wng |
H302 H317 H411 |
|
|
|
606-112-00-1 |
(4aR*,8aR*)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepine-6-on |
428-690-2 |
1668-86-6 |
Acute Tox. 4 * Eye Irrit. 2 Aquatic Chronic 3 |
H302 H319 H412 |
GHS07 Wng |
H302 H319 H412 |
|
|
|
606-113-00-7 |
1-[4-(4-benzoylfenylsulfanyl)fenyl]-2-methyl-2-(4-methylfenylsulfonyl)propaan-1-on |
429-040-0 |
272460-97-6 |
Eye Dam. 1 Aquatic Chronic 4 |
H318 H413 |
GHS05 Dgr |
H318 H413 |
|
|
|
606-114-00-2 |
4,4', 5,5',6,6',7,7'-octachloor-(2,2')biisoïndolyl-1,1',3,3'-tetraon |
429-150-9 |
67887-47-2 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
606-115-00-8 |
profoxydim (ISO); 2-{(EZ)-1-[(2RS)-2-(4-chloorfenoxy)propoxyimino]butyl}-3-hydroxy-5-(thiaan-3-yl)cyclohex-2-een-1-on |
— |
139001-49-3 |
Carc. 2 Repr. 2 Skin Sens. 1 |
H351 H361d H317 |
GHS08 GHS07 Wng |
H351 H361d H317 |
|
|
|
606-116-00-3 |
tepraloxydim (ISO); (RS)-(EZ)-2-{1-[(2E)-3-chloorallyloxyimino]propyl}-3-hydroxy-5-perhydropyran-4-ylcyclohex-2-een-1-on |
— |
149979-41-9 |
Carc. 2 Repr. 2 |
H351 H361fd |
GHS08 Wng |
H351 H361fd |
|
|
|
606-117-00-9 |
2,6-bis(1,1-dimethylethyl)-4-(fenyleenmethyleen)cyclohexa-2,5-dieen-1-on |
429-460-4 |
7078-98-0 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
606-118-00-4 |
N-(1,3-dimethylbutyl)-N'-fenyl-1,4-benzochinondiimine |
429-640-2 |
52870-46-9 |
Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H400 H410 |
GHS07 GHS09 Wng |
H319 H410 |
|
|
|
606-119-00-X |
(E)-3-methyl-5-cyclopentadeceen-1-on |
429-900-5 |
— |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
606-120-00-5 |
2,5-dihydroxy-5-methyl-3-(morfoline-4-yl)-2-cyclopenteen-1-on |
430-170-5 |
114625-74-0 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
606-121-00-0 |
(+)-(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]heptaan-3-spiro-1'-(cyclohex-2'-een-4'-on) |
430-460-1 |
133636-82-5 |
Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H314 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H314 H317 H410 |
|
|
|
606-122-00-6 |
3-(2-broompropionyl)-4,4-dimethyl-1,3-oxazolaan-2-on |
430-820-8 |
114341-88-7 |
Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373** H315 H318 H317 H400 H410 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H302 H373** H315 H318 H317 H410 |
|
|
|
606-123-00-1 |
4-hexadecyl-1-fenylpyrazolidine-3-on |
430-840-7 |
— |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
606-124-00-7 |
1-cyclopropyl-3-(2-methylthio-4-trifluormethylfenyl)-1,3-propaandion |
421-080-7 |
161462-35-7 |
STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H373** H400 H410 |
GHS08 GHS09 Wng |
H373** H410 |
|
|
|
606-125-00-2 |
1-benzylimidazolidine-2,4-dion |
421-340-1 |
6777-05-5 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
606-126-00-8 |
1,4-bis(2,3-dihydroxypropylamino)antrachinon |
421-470-7 |
99788-75-7 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
606-128-00-9 |
2,2'-(1,3-fenyleen)bis[5-chloor-1H-isoïndool]-1,3(2H)-dion |
422-650-8 |
148935-94-8 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
606-129-00-4 |
5-amino-[2S-di(methylfenyl)amino]-1,6-difenyl-4Z-hexeen-3-on; (2S, 4Z)-5-amino-2-(dibenzylamino)-1,6-difenylhex-4-een-3-on |
423-090-7 |
156732-13-7 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
606-130-00-X |
4-(1,4-dioxaspiro[4.5]dec-8-yl)cyclohexanon |
423-860-2 |
56309-94-5 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
606-131-00-5 |
cyclisch 3-(1,2-ethaandiylacetaal)oestra-5(10),9(11)-dieen-3,17-dion |
427-230-8 |
5571-36-8 |
Repr. 1B STOT RE 2 * Aquatic Chronic 2 |
H360F*** H373** H411 |
GHS08 GHS09 Dgr |
H360F*** H373** H411 |
|
|
|
606-132-00-0 |
(6β)-6,19-epoxyandrost-4-een-3,17-dion |
433-490-3 |
6563-83-3 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
606-134-00-1 |
androsta-1,4,9(11)-trieen-3,17-dion |
433-560-3 |
15375-21-0 |
Repr. 2 |
H361f*** |
GHS08 Wng |
H361f*** |
|
|
|
606-135-00-7 |
cyclohexadecanon |
438-930-8 |
2550-52-9 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
606-136-00-2 |
(3S,6R, S,12R,15S,18R,21S,24R)-6,18-dibenzyl-3,9,15,21-tetraïsobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraäzacyclo-tetracosaan-2,5,8,11,14,17,20,23-octaon |
444-350-6 |
133413-70-4 |
Eye Irrit. 2 Aquatic Chronic 4 |
H319 H413 |
GHS07 Wng |
H319 H413 |
|
|
|
606-137-00-8 |
trans-7,7'-dimethyl-(4H,4H')-(2,2')bi[benzo[1,4]thiazinylideen]-3,3'-dion |
444-750-0 |
211387-26-7 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
606-138-00-3 |
(2-butyl-5-nitrobenzofuran-3-yl)[4-(3-dibutylaminopropoxy)fenyl]methanon |
444-800-1 |
141645-23-0 |
Flam. Liq. 3 Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H226 H302 H373** H315 H318 H317 H400 H410 |
GHS02 GHS05 GHS08 GHS07 GHS09 Dgr |
H226 H302 H373** H315 H318 H317 H410 |
|
M=10 |
|
606-139-00-9 |
(S)-4-(3,4-dichloorfenyl)-3,4-dihydro-2H-naftaleen-1-on |
444-830-5 |
124379-29-9 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
606-140-00-4 |
2-hydroxy-1-(4-(4-(2-hydroxy-2-methylpropionyl)benzyl)fenyl)-2-methylpropaan-1-on |
444-860-9 |
474510-57-1 |
STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H373** H400 H410 |
GHS08 GHS09 Wn |
H373** H410 |
|
|
|
606-141-00-X |
natrium-3-(methoxycarbonyl)-4-oxo-3,4,5,6-tetrahydro-2-pyridinolaat |
418-410-7 |
— |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
606-142-00-5 |
reactiemassa van: (1RS,2SR,7SR,8SR, E) 9 en 10-ethylideen-3-oxatricyclo[6.2.1.0(2,7)]undecaan-4-on (1RS,2SR,7SR,8SR, Z)-10-ethylideen-3-oxatricyclo[6.2.1.0(2,7)]undecaan-4-on; (1RS,2SR,7SR,8SR, Z)-9-ethylideen-3-oxatricyclo[6.2.1.02,7]undecaan-4-on |
434-290-9 |
— |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
606-143-00-0 |
abamectine (combinatie van avermectine B1a en avermectine B1b) (ISO) [1] avermectine B1a (zuiverheid ≥ 80 %); [2] |
_ [1] 265-610-3 [2] |
71751-41-2 [1] 65195-55-3 [2] |
Repr. 2 Acute Tox. 2 Acute Tox. 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361d H300 H330 H372 (zenuwstelsel) H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H361d H300 H330 H372 (zenuwstelsel) H410 |
|
STOT RE 1; H372: C ≥ 5 % STOT RE 2; H373: 0,5 % ≤C< 5 % M = 10 000 |
|
606-144-00-6 |
acequinocyl (ISO); 3-dodecyl-1,4-dioxo-1,4-dihydronaftaleen-2-ylacetaat |
— |
57960-19-7 |
Skin Sens. 1 STOT SE 1 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H370 (long) (inademing) H373 (bloed) H400 H410 |
GHS07 GHS08 GHS09 Dgr |
H317 H370 (long) (inademing) H373 (bloed) H410 |
|
M = 1 000 |
|
606-145-00-1 |
sulcotrione (ISO); 2-[2-chloor-4-(methylsulfonyl)benzoyl]cyclohexaan-1,3-dion |
|
99105-77-8 |
Repr. 2 STOT RE 2 Skin Sens. 1A Aquatic Acute 1 Aquatic Chronic 1 |
H361d H373 (nieren) H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H361d H373 (nieren) H317 H410 |
|
M = 1 M = 10 |
|
606-146-00-7 |
tralkoxydim (ISO); 2-(N-ethoxypropanimidoyl)-3-hydroxy-5-mesitylcyclohex-2-een-1-on |
— |
87820-88-0 |
Carc. 2 Acute Tox. 4 Aquatic Chronic 2 |
H351 H302 H411 |
GHS08 GHS07 GHS09 Wng |
H351 H302 H411 |
|
|
|
606-147-00-2 |
cycloxydim (ISO); 2-(N-ethoxybutanimidoyl)-3-hydroxy-5-(tetrahydro-2H-thiopyran-3-yl)cyclohex-2-een-1-on |
405-230-9 |
101205-02-1 |
Repr. 2 |
H361d |
GHS08 Wng |
H361d |
|
|
|
607-001-00-0 |
formiaatzuur … % |
200-579-1 |
64-18-6 |
Skin Corr. 1A |
H314 |
GHS05 Dgr |
H314 |
|
Skin Corr. 1A; H314: C ≥ 90 % Skin Corr. 1B; H314: 10 % ≤ C < 90 % Skin Irrit. 2; H315: 2 % ≤C < 10 % Eye Irrit. 2; H319: 2 %≤ <10 % |
B |
607-002-00-6 |
azijnzuur … % |
200-580-7 |
64-19-7 |
Flam. Liq. 3 Skin Corr. 1A |
H226 H314 |
GHS02 GHS05 Dgr |
H226 H314 |
|
Skin Corr. 1A; H314: C ≥90 % Skin Corr. 1B; H314: 25 %≤ C <90 % Skin Irrit. 2; H315: 10 % ≤C <25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 % |
B |
607-003-00-1 |
chloorazijnzuur |
201-178-4 |
79-11-8 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Aquatic Acute 1 |
H331 H311 H301 H314 H400 |
GHS06 GHS05 GHS09 Dgr |
H331 H311 H301 H314 H400 |
|
STOT SE 3; H335: C≥ 5 % |
|
607-004-00-7 |
TCA (ISO); trichloorazijnzuur |
200-927-2 |
76-03-9 |
Skin Corr. 1A Aquatic Acute 1 Aquatic Chronic 1 |
H314 H400 H410 |
GHS05 GHS09 Dgr |
H314 H410 |
|
STOT SE 3; H335: C ≥ 1 % |
|
607-005-00-2 |
TCA-natrium (ISO); natriumtrichlooracetaat |
211-479-2 |
650-51-1 |
STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 |
H335 H400 H410 |
GHS07 GHS09 Wng |
H335 H410 |
|
|
|
607-006-00-8 |
oxaalzuur |
205-634-3 |
144-62-7 |
Acute Tox. 4 * Acute Tox. 4 * |
H312 H302 |
GHS07 Wng |
H312 H302 |
|
* |
|
607-007-00-3 |
zouten van oxaalzuur (tenzij elders in deze bijlage vermeld) |
— |
— |
Acute Tox. 4 * Acute Tox. 4 * |
H312 H302 |
GHS07 Wng |
H312 H302 |
|
* |
A |
607-008-00-9 |
azijnzuuranhydride |
203-564-8 |
108-24-7 |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H226 H332 H302 H314 |
GHS02 GHS05 GHS07 Dgr |
H226 H332 H302 H314 |
|
Skin Corr. 1B; H314: C ≥ 2 % Skin Irrit. 2; H315: 5 % ≤C < 25 % Eye Dam. 1; H318: 5 % ≤ C < 25 % Eye Irrit. 2; H319: 1 % ≤C < 5 % STOT SE 3; H335: C ≥ 5 % |
|
607-009-00-4 |
ftaalzuuranhydride |
201-607-5 |
85-44-9 |
Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H302 H335 H315 H318 H334 H317 |
GHS08 GHS05 GHS07 Dgr |
H302 H335 H315 H318 H334 H317 |
|
|
|
607-010-00-X |
propionzuuranhydride |
204-638-2 |
123-62-6 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 % |
|
607-011-00-5 |
acetylchloride |
200-865-6 |
75-36-5 |
Flam. Liq. 2 Skin Corr. 1B |
H225 H314 |
GHS02 GHS05 Dgr |
H225 H314 |
EUH014 |
|
|
607-012-00-0 |
benzoylchloride |
202-710-8 |
98-88-4 |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 |
H332 H312 H302 H314 H317 |
GHS05 GHS07 Dgr |
H332 H312 H302 H314 H317 |
|
|
|
607-013-00-6 |
dimethylcarbonaat |
210-478-4 |
616-38-6 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
|
|
|
607-014-00-1 |
methylformiaat |
203-481-7 |
107-31-3 |
Flam. Liq. 1 Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 |
H224 H332 H302 H319 H335 |
GHS02 GHS07 Dgr |
H224 H332 H302 H319 H335 |
|
|
|
607-015-00-7 |
ethylformiaat |
203-721-0 |
109-94-4 |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 |
H225 H332 H302 H319 H335 |
GHS02 GHS07 Dgr |
H225 H332 H302 H319 H335 |
|
|
|
607-016-00-2 |
propylformiaat; [1] isopropylformiaat [2] |
203-798-0 [1] 210-901-2 [2] |
110-74-7 [1] 625-55-8 [2] |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 STOT SE 3 |
H225 H319 H335 H336 |
GHS02 GHS07 Dgr |
H225 H319 H335 H336 |
|
|
C |
607-017-00-8 |
butylformiaat; [1] tert-butylformiaat; [2] isobutylformiaat [3] |
209-772-5 [1] 212-105-0 [2] 208-818-1 [3] |
592-84-7 [1] 762-75-4 [2] 542-55-2 [3] |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 |
H225 H319 H335 |
GHS02 GHS07 Dgr |
H225 H319 H335 |
|
|
C |
607-018-00-3 |
isopentylformiaat; [1] 2-methylbutylformiaat [2] |
203-769-2 [1] 252-343-2 [2] |
110-45-2 [1] 35073-27-9 [2] |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 |
H225 H319 H335 |
GHS02 GHS07 Dgr |
H225 H319 H335 |
|
|
C |
607-019-00-9 |
methylchloorformiaat |
201-187-3 |
79-22-1 |
Flam. Liq. 2 Acute Tox. 2 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H225 H330 H312 H302 H314 |
GHS02 GHS06 GHS05 Dgr |
H225 H330 H312 H302 H314 |
|
|
|
607-020-00-4 |
ethylchloorformiaat |
208-778-5 |
541-41-3 |
Flam. Liq. 2 Acute Tox. 2 * Acute Tox. 4 * Skin Corr. 1B |
H225 H330 H302 H314 |
GHS02 GHS06 GHS05 Dgr |
H225 H330 H302 H314 |
|
|
|
607-021-00-X |
methylacetaat |
201-185-2 |
79-20-9 |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 |
H225 H319 H336 |
GHS02 GHS07 Dgr |
H225 H319 H336 |
EUH066 |
|
|
607-022-00-5 |
ethylacetaat |
205-500-4 |
141-78-6 |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 |
H225 H319 H336 |
GHS02 GHS07 Dgr |
H225 H319 H336 |
EUH066 |
|
|
607-023-00-0 |
vinylacetaat |
203-545-4 |
108-05-4 |
Flam. Liq. 2 Carc. 2 Acute Tox. 4 STOT SE 3 |
H225 H351 H332 H335 |
GHS02 GHS08 GHS07 Dgr |
H225 H351 H332 H335 |
|
|
D |
607-024-00-6 |
propylacetaat; [1] isopropylacetaat [2] |
203-686-1 [1] 203-561-1 [2] |
109-60-4 [1] 108-21-4 [2] |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 |
H225 H319 H336 |
GHS02 GHS07 Dgr |
H225 H319 H336 |
EUH066 |
|
C |
607-025-00-1 |
n-butylacetaat |
204-658-1 |
123-86-4 |
Flam. Liq. 3 STOT SE 3 |
H226 H336 |
GHS02 GHS07 Wng |
H226 H336 |
EUH066 |
|
|
607-026-00-7 |
sec-butylacetaat; [1] isobutylacetaat; [2] tert-butylacetaat [3] |
203-300-1 [1] 203-745-1 [2] 208-760-7 [3] |
105-46-4 [1] 110-19-0 [2] 540-88-5 [3] |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
EUH066 |
|
C |
607-027-00-2 |
methylpropionaat |
209-060-4 |
554-12-1 |
Flam. Liq. 2 Acute Tox. 4 * |
H225 H332 |
GHS02 GHS07 Dgr |
H225 H332 |
|
|
|
607-028-00-8 |
ethylpropionaat |
203-291-4 |
105-37-3 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
|
|
|
607-029-00-3 |
n-butylpropionaat; [1] sec-butylpropionaat; [2] isobutylpropionaat [3] |
209-669-5 [1] -[2] 208-746-0 [3] |
590-01-2 [1] 591-34-4 [2] 540-42-1 [3] |
Flam. Liq. 3 |
H226 |
GHS02 Wng |
H226 |
|
|
C |
607-030-00-9 |
propylpropionaat |
203-389-7 |
106-36-5 |
Flam. Liq. 3 Acute Tox. 4 * |
H226 H332 |
GHS02 GHS07 Wng |
H226 H332 |
|
|
|
607-031-00-4 |
butylbutyraat |
203-656-8 |
109-21-7 |
Flam. Liq. 3 |
H226 |
GHS02 Wng |
H226 |
|
|
C |
607-032-00-X |
ethylacrylaat |
205-438-8 |
140-88-5 |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H225 H332 H312 H302 H319 H335 H315 H317 |
GHS02 GHS07 Dgr |
H225 H332 H312 H302 H319 H335 H315 H317 |
|
Skin Irrit. 2; H315: C ≥ 5 % Eye Irrit. 2; H319: C ≥ 5 % STOT SE 3; H335: C ≥ 5 % |
D |
607-033-00-5 |
n-butylmethacrylaat |
202-615-1 |
97-88-1 |
Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H226 H319 H335 H315 H317 |
GHS02 GHS07 Wng |
H226 H319 H335 H315 H317 |
|
|
D |
607-034-00-0 |
methylacrylaat; methylpropenoaat |
202-500-6 |
96-33-3 |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H225 H332 H312 H302 H319 H335 H315 H317 |
GHS02 GHS07 Dgr |
H225 H332 H312 H302 H319 H335 H315 H317 |
|
|
D |
607-035-00-6 |
methylmethacrylaat; methyl-2-methylprop-2-enoaat; methyl-2-methylpropenoaat |
201-297-1 |
80-62-6 |
Flam. Liq. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H225 H335 H315 H317 |
GHS02 GHS07 Dgr |
H225 H335 H315 H317 |
|
|
D |
607-036-00-1 |
2-methoxyethylacetaat; methylglycolacetaat |
203-772-9 |
110-49-6 |
Repr. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H360FD H332 H312 H302 |
GHS08 GHS07 Dgr |
H360FD H332 H312 H302 |
|
|
|
607-037-00-7 |
2-ethoxyethylacetaat; ethylglycolacetaat |
203-839-2 |
111-15-9 |
Flam. Liq. 3 Repr. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H226 H360FD H332 H312 H302 |
GHS02 GHS08 GHS07 Dgr |
H226 H360FD H332 H312 H302 |
|
|
|
607-038-00-2 |
2-butoxyethylacetaat; butylglycolacetaat |
203-933-3 |
112-07-2 |
Acute Tox. 4 * Acute Tox. 4 * |
H332 H312 |
GHS07 Wng |
H332 H312 |
|
|
|
607-039-00-8 |
2,4-D (ISO); 2,4-dichloorfenoxyazijnzuur |
202-361-1 |
94-75-7 |
Acute Tox. 4 * STOT SE 3 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H302 H335 H318 H317 H412 |
GHS05 GHS07 Dgr |
H302 H335 H318 H317 H412 |
|
|
|
607-040-00-3 |
zouten van 2,4-D |
— |
— |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H302 H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H317 H411 |
|
|
A |
607-041-00-9 |
2,4,5-T (ISO); 2,4,5-trichloorfenoxyazijnzuur |
202-273-3 |
93-76-5 |
Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H335 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H335 H315 H410 |
|
|
|
607-042-00-4 |
zouten en esters van 2,4,5-T; zouten en esters van 2,4,5-trichloorfenoxyazijnzuur |
— |
— |
Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H335 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H335 H315 H410 |
|
|
A |
607-043-00-X |
dicamba (ISO); 2,5-dichloor-6-methoxybenzoëzuur; 3,6-dichloor-2-methoxybenzoëzuur |
217-635-6 |
1918-00-9 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 |
H302 H318 H412 |
GHS05 GHS07 Dgr |
H302 H318 H412 |
|
|
|
607-044-00-5 |
3,6-dichloor-o-anijszuur, verbinding met dimethylamine (1:1); [1] kalium-3,6-dichloor-o-anisaat[2] |
218-951-7 [1] 233-002-7 [2] |
2300-66-5 [1] 10007-85-9 [2] |
Eye Irrit. 2 Aquatic Chronic 3 |
H319 H412 |
GHS07 Wng |
H319 H412 |
|
|
|
607-045-00-0 |
dichloorprop (ISO); 2-(2,4-dichloorfenoxy)propionzuur |
204-390-5 |
120-36-5 |
Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 |
H312 H302 H315 H318 |
GHS05 GHS07 Dgr |
H312 H302 H315 H318 |
|
|
|
607-046-00-6 |
zouten van dichloorprop |
— |
— |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H332 H312 H302 |
GHS07 Wng |
H332 H312 H302 |
|
|
A |
607-047-00-1 |
fenoprop (ISO); 2-(2,4,5-trichloorfenoxy)propionzuur |
202-271-2 |
93-72-1 |
Acute Tox. 4 * Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H315 H410 |
|
|
|
607-048-00-7 |
zouten van fenoprop; zouten van 2-(2,4,5-trichloorfenoxy)propionzuur |
— |
— |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H312 H302 H410 |
|
|
A |
607-049-00-2 |
mecoprop (ISO); 2-(4-chloor-o-tolyloxy)propionzuur; (RS)-2-(4-chloor-o-tolyloxy)propionzuur; [1] 2-(4-chloor-2-methylfenoxy)propionzuur [2] |
230-386-8 [1] 202-264-4 [2] |
7085-19-0 [1] 708519-0 [2] |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H318 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H302 H315 H318 H410 |
|
M=100 |
|
607-050-00-8 |
zouten van mecoprop |
— |
— |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H318 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H302 H315 H318 H410 |
|
|
A |
607-051-00-3 |
MCPA (ISO); 4-chloor-o-tolyloxyazijnzuur |
202-360-6 |
94-74-6 |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H318 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H302 H315 H318 H410 |
|
|
|
607-052-00-9 |
zouten en esters van MCPA |
— |
— |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H312 H302 H410 |
|
|
A |
607-053-00-4 |
MCPB (ISO); 4-(4-chloor-o-tolyloxy)boterzuur |
202-365-3 |
94-81-5 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
607-054-00-X |
zouten en esters van MCPB |
— |
— |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
A |
607-055-00-5 |
endothal-natrium (ISO); dinatrium-7-oxabicyclo(2,2,1)heptaan-2,3-dicarboxylaat |
204-959-8 |
129-67-9 |
Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H301 H312 H319 H335 H315 |
GHS06 Dgr |
H301 H312 H319 H335 H315 |
|
|
|
607-057-00-6 |
cumachloor (ISO); 3-[1-(4-chloorfenyl)-3-oxobutyl]-4-hydroxycumarine |
201-378-1 |
81-82-3 |
STOT RE 2 * Aquatic Chronic 3 |
H373 ** H412 |
GHS08 Wng |
H373 ** H412 |
|
|
|
607-058-00-1 |
cumafuryl (ISO); fumarin; (RS)-3-(1-(2-furyl)-3-oxobutyl)4-hydroxycumarine; 4-hydroxy-3-[3-oxo-1-(2-furyl)butyl]cumarine |
204-195-5 |
117-52-2 |
Acute Tox. 3 * STOT RE 1 Aquatic Chronic 3 |
H301 H372 ** H412 |
GHS06 GHS08 Dgr |
H301 H372 ** H412 |
|
|
|
607-060-00-2 |
dicumarol; 4,4'-dihydroxy-3,3'-methyleenbis(2H-chromeen-2-on) |
200-632-9 |
66-76-2 |
STOT RE 1 Acute Tox. 4 * Aquatic Chronic 2 |
H372 ** H302 H411 |
GHS08 GHS07 GHS09 Dgr |
H372 ** H302 H411 |
|
|
|
607-061-00-8 |
acrylzuur; prop-2-eenzuur |
201-177-9 |
79-10-7 |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A Aquatic Acute 1 |
H226 H332 H312 H302 H314 H400 |
GHS02 GHS05 GHS07 GHS09 Dgr |
H226 H332 H312 H302 H314 H400 |
|
STOT SE 3; H335: C ≥ 1 % |
D |
607-062-00-3 |
n-butylacrylaat |
205-480-7 |
141-32-2 |
Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H226 H319 H335 H315 H317 |
GHS02 GHS07 Wng |
H226 H319 H335 H315 H317 |
|
|
D |
607-063-00-9 |
isoboterzuur |
201-195-7 |
79-31-2 |
Acute Tox. 4 * Acute Tox. 4 * |
H312 H302 |
GHS07 Wng |
H312 H302 |
|
|
|
607-064-00-4 |
benzylchloorformiaat |
207-925-0 |
501-53-1 |
Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H314 H400 H410 |
GHS05 GHS09 Dgr |
H314 H410 |
|
STOT SE 3; H335: C ≥ 5 % |
|
607-065-00-X |
broomazijnzuur |
201-175-8 |
79-08-3 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1A Skin Sens. 1 Aquatic Acute 1 |
H331 H311 H301 H314 H317 H400 |
GHS06 GHS05 GHS09 Dgr |
H331 H311 H301 H314 H317 H400 |
|
|
|
607-066-00-5 |
dichloorazijnzuur |
201-207-0 |
79-43-6 |
Skin Corr. 1A Aquatic Acute 1 |
H314 H400 |
GHS05 GHS09 Dgr |
H314 H400 |
|
|
|
607-067-00-0 |
dichlooracetylchloride |
201-199-9 |
79-36-7 |
Skin Corr. 1A Aquatic Acute 1 |
H314 H400 |
GHS05 GHS09 Dgr |
H314 H400 |
|
|
|
607-068-00-6 |
joodazijnzuur |
200-590-1 |
64-69-7 |
Acute Tox. 3 * Skin Corr. 1A |
H301 H314 |
GHS06 GHS05 Dgr |
H301 H314 |
|
|
|
607-069-00-1 |
ethylbroomacetaat |
203-290-9 |
105-36-2 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * |
H330 H310 H300 |
GHS06 Dgr |
H330 H310 H300 |
|
|
|
607-070-00-7 |
ethylchlooracetaat |
203-294-0 |
105-39-5 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 |
H331 H311 H301 H400 |
GHS06 GHS09 Dgr |
H331 H311 H301 H400 |
|
|
|
607-071-00-2 |
ethylmethacrylaat |
202-597-5 |
97-63-2 |
Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H225 H319 H335 H315 H317 |
GHS02 GHS07 Dgr |
H225 H319 H335 H315 H317 |
|
|
D |
607-072-00-8 |
2-hydroxyethylacrylaat |
212-454-9 |
818-61-1 |
Acute Tox. 3 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 |
H311 H314 H317 H400 |
GHS06 GHS05 GHS09 Dgr |
H311 H314 H317 H400 |
|
* Skin Sens. 1; H317: C ≥ 0,2 % |
D |
607-073-00-3 |
4-CPA (ISO); 4-chloorfenoxyazijnzuur |
204-581-3 |
122-88-3 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
607-074-00-9 |
chloorfenac (ISO); 2,3,6-trichloorfenylazijnzuur |
201-599-3 |
85-34-7 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
607-075-00-4 |
chloorfenprop-methyl; methyl-2-chloor-3-(4-chloorfenyl)propionaat |
238-413-5 |
14437-17-3 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H312 H302 H410 |
|
|
|
607-076-00-X |
dodine (ISO); dodecylguanidiniumacetate |
219-459-5 |
2439-10-3 |
Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H315 H410 |
|
|
|
607-077-00-5 |
erbon (ISO); 2-(2,4,5-trichloorfenoxy)ethyl2,2-dichloorpropionaat |
— |
136-25-4 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
607-078-00-0 |
fluenetil (ISO); 2-fluorethylbifenyl-4-ylacetaat |
— |
4301-50-2 |
Acute Tox. 1 Acute Tox. 2 * |
H310 H300 |
GHS06 Dgr |
H310 H300 |
|
|
|
607-079-00-6 |
kelevan (ISO); ethyl-5-(perchloor-5-hydroxypentacyclo[5,3,0,02,6,03,9,04,8]decaan-5-yl)-4-oxopentanoaat; ethyl-5-(1,2,3,5,6,7,8,9,10,10-decachloor-4-hydroxypentacyclo(5,2,1,02,6,03,9,05,8)dec-4-yl)-4-oxovaleraat |
— |
4234-79-1 |
Acute Tox. 3 * Acute Tox. 4 * Aquatic Chronic 2 |
H311 H302 H411 |
GHS06 GHS09 Dgr |
H311 H302 H411 |
|
|
|
607-080-00-1 |
chlooracetylchloride |
201-171-6 |
79-04-9 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 Skin Corr. 1A Aquatic Acute 1 |
H331 H311 H301 H372 ** H314 H400 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H331 H311 H301 H372 ** H314 H400 |
EUH014 EUH029 |
|
|
607-081-00-7 |
fluorazijnzuur |
205-631-7 |
144-49-0 |
Acute Tox. 2 * Aquatic Acute 1 |
H300 H400 |
GHS06 GHS09 Dgr |
H300 H400 |
|
|
|
607-082-00-2 |
fluoracetaten, oplosbare |
— |
— |
Acute Tox. 2 * Aquatic Acute 1 |
H300 H400 |
GHS06 GHS09 Dgr |
H300 H400 |
|
|
A |
607-083-00-8 |
2,4-DB (ISO); 4-(2,4-dichloorfenoxy)boterzuur |
202-366-9 |
94-82-6 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
607-084-00-3 |
zouten van 2,4-DB |
— |
— |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H411 |
|
|
A |
607-085-00-9 |
benzylbenzoaat |
204-402-9 |
120-51-4 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
607-086-00-4 |
diallylftalaat |
205-016-3 |
131-17-9 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
607-088-00-5 |
methacrylzuur; 2-methylpropenzuur |
201-204-4 |
79-41-4 |
Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A |
H312 H302 H314 |
GHS05 GHS07 Dgr |
H312 H302 H314 |
|
STOT SE 3; H335: C ≥ 1 % |
D |
607-089-00-0 |
propionzuur … % |
201-176-3 |
79-09-4 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H319 10 % ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 % STOT SE 3; H335: C ≥ 10 % |
B |
607-090-00-6 |
thioglycolzuur |
200-677-4 |
68-11-1 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B |
H331 H311 H301 H314 |
GHS06 GHS05 Dgr |
H331 H311 H301 H314 |
|
* |
|
607-091-00-1 |
trifluorazijnzuur . . . % |
200-929-3 |
76-05-1 |
Acute Tox. 4 * Skin Corr. 1A Aquatic Chronic 3 |
H332 H314 H412 |
GHS05 GHS07 Dgr |
H332 H314 H412 |
|
* |
B |
607-092-00-7 |
methyllactaat; [1] methyl-(±)-lactaat; [2] methyl-(R)-lactaat; [3] methyl (S)-(–)-lactaat [4] |
208-930-0 [1] 218-449-8 [2] 241-420-6 [3] 248-704-9 [4] |
547-64-8 [1] 2155-30-8 [2] 17392-83-5 [3] 27871-49-4 [4] |
Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 |
H226 H319 H335 |
GHS02 GHS07 Wng |
H226 H319 H335 |
|
|
C |
607-093-00-2 |
propionylchloride |
201-170-0 |
79-03-8 |
Flam. Liq. 2 Skin Corr. 1B |
H225 H314 |
GHS02 GHS05 Dgr |
H225 H314 |
EUH014 |
|
B D |
607-094-00-8 |
perazijnzuur . . . % |
201-186-8 |
79-21-0 |
Flam. Liq. 3 Org. Perox. D **** Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A Aquatic Acute 1 |
H226 H242 H332 H312 H302 H314 H400 |
GHS02 GHS05 GHS07 GHS09 Dgr |
H226 H242 H332 H312 H302 H314 H400 |
|
* STOT SE 3; H335: C ≥ 1 % |
B D |
607-095-00-3 |
maleïnezuur |
203-742-5 |
110-16-7 |
Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H302 H319 H335 H315 H317 |
GHS07 Wng |
H302 H319 H335 H315 H317 |
|
Skin Sens. 1; H317: C ≥0,1 % |
|
607-096-00-9 |
maleïnezuuranhydride |
203-571-6 |
108-31-6 |
Acute Tox. 4 * Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 |
H302 H314 H334 H317 |
GHS08 GHS05 GHS07 Dgr |
H302 H314 H334 H317 |
|
|
|
607-097-00-4 |
benzeen-1,2,4-tricarbonzuur-1,2-anhydride; trimellietzuuranhydride |
209-008-0 |
552-30-7 |
STOT SE 3 Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H335 H318 H334 H317 |
GHS08 GHS05 GHS07 Dgr |
H335 H318 H334 H317 |
|
|
|
607-098-00-X |
benzeen-1,2:4,5-tetracarbonzuurdianhydride; 1,2,4,5-benzeentetracarbonzuurdianhydride; pyromellietzuurdianhydride; |
201-898-9 |
89-32-7 |
Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H318 H334 H317 |
GHS08 GHS05 Dgr |
H318 H334 H317 |
|
|
|
607-099-00-5 |
1,2,3,6-tetrahydroftaalzuuranhydride; [1] cis-1,2,3,6-tetrahydroftaalzuuranhydride; [2] 3,4,5,6-tetrahydroftaalzuuranhydride; [3] tetrahydroftaalzuuranhydride [4] |
201-605-4 [1] 213-308-7 [2] 219-374-3 [3] 247-570-9 [4] |
85-43-8 [1] 935-79-5 [2] 2426-02-0 [3] 26266-63-7 [4] |
Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H334 H317 H412 |
GHS08 GHS05 Dgr |
H318 H334 H317 H412 |
|
|
C |
607-100-00-9 |
benzofenon-3,3',4,4'-tetracarbonzuurdianhydride; 4,4'-carbonyldi(ftaalzuuranhydride) |
219-348-1 |
2421-28-5 |
Eye Irrit. 2 STOT SE 3 |
H319 H335 |
GHS07 Wng |
H319 H335 |
|
Eye Irrit 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % |
|
607-101-00-4 |
1,4,5,6,7,7-hexachloorbicyclo[2,2,1]hept-5-een-2,3-dicarbonzuuranhydride; chlorendinezuuranhydride |
204-077-3 |
115-27-5 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H319 H335 H315 |
GHS07 Wng |
H319 H335 H315 |
|
Skin Irrit.2; H315: C ≥ 1 % Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % |
|
607-102-00-X |
cyclohexaan-1,2-dicarbonzuuranhydride; [1] cis-cyclohexaan-1,2-dicarbonzuuranhydride; [2] trans-cyclohexaan-1,2-dicarbonzuuranhydride [3] |
201-604-9 [1] 236-086-3 [2] 238-009-9 [3] |
85-42-7 [1] 13149-00-3 [2] 14166-21-3 [3] |
Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H318 H334 H317 |
GHS08 GHS05 Dgr |
H318 H334 H317 |
|
|
C |
607-103-00-5 |
barnsteenzuuranhydride |
203-570-0 |
108-30-5 |
Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 |
H302 H319 H335 |
GHS07 Wng |
H302 H319 H335 |
|
* Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % |
|
607-104-00-0 |
cyclopentaan-1,2,3,4-tetracarbonzuurdianhydride |
227-964-7 |
6053-68-5 |
Eye Irrit. 2 STOT SE 3 |
H319 H335 |
GHS07 Wng |
H319 H335 |
|
Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % |
|
607-105-00-6 |
8,9,10-trinorborn-5-een-2,3-dicarbonzuuranhydride; [1] 1,2,3,6-tetrahydro-3,6-methanoftaalzuuranhydride; [2] (1α,2α,3β,6β)-1,2,3,6-tetrahydro-3,6-methanoftaalzuuranhydride [3] |
204-957-7 [1] 212-557-9 [2] 220-384-5 [3] |
129-64-6 [1] 826-62-0 [2] 2746-19-2 [3] |
Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H318 H334 H317 |
GHS08 GHS05 Dgr |
H318 H334 H317 |
|
|
C |
607-106-00-1 |
8,9-dinorborn-5-een-2,3-dicarbonzuuranhydride |
— |
123748-85-6 |
Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 |
H302 H319 H335 H315 H334 |
GHS08 GHS07 Dgr |
H302 H319 H335 H315 H334 |
|
STOT SE 3; H335: C ≥ 10 % |
C |
607-107-00-7 |
2-ethylhexylacrylaat |
203-080-7 |
103-11-7 |
STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H335 H315 H317 |
GHS07 Wng |
H335 H315 H317 |
|
|
D |
607-108-00-2 |
2-hydroxy-1-methylethylacrylaat; [1] 2-hydroxypropylacrylaat; [2] acrylzuur, monoester met propaan-1,2-diol [3] |
220-852-9 [1] 213-663-8 [2] 247-118-0 [3] |
2918-23-2 [1] 999-61-1 [2] 25584-83-2 [3] |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Skin Sens. 1 |
H331 H311 H301 H314 H317 |
GHS06 GHS05 Dgr |
H331 H311 H301 H314 H317 |
|
* Skin Sens. 1; H317:C ≥0,2 % |
C D |
607-109-00-8 |
hexamethyleendiacrylaat; hexaan-1,6-dioldiacrylaat |
235-921-9 |
13048-33-4 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Wng |
H319 H315 H317 |
|
|
D |
607-110-00-3 |
pentaërytritoltriacrylaat |
222-540-8 |
3524-68-3 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Wng |
H319 H315 H317 |
|
|
D |
607-111-00-9 |
2,2-bis(acryloyloxymethyl)butylacrylaat; trimethylolpropaantriacrylaat |
239-701-3 |
15625-89-5 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Wng |
H319 H315 H317 |
|
|
D |
607-112-00-4 |
2,2-dimethyltrimethyleendiacrylaat; neopentylglycoldiacrylaat |
218-741-5 |
2223-82-7 |
Acute Tox. 3 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H311 H319 H315 H317 |
GHS06 Dgr |
H311 H319 H315 H317 |
|
* |
D |
607-113-00-X |
isobutylmethacrylaat |
202-613-0 |
97-86-9 |
Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 |
H226 H319 H335 H315 H317 H400 |
GHS02 GHS07 GHS09 Wng |
H226 H319 H335 H315 H317 H400 |
|
|
D |
607-114-00-5 |
ethyleendimethacrylaat |
202-617-2 |
97-90-5 |
STOT SE 3 Skin Sens. 1 |
H335 H317 |
GHS07 Wng |
H335 H317 |
|
STOT SE 3; H335: C ≥ 10 % |
D |
607-115-00-0 |
isobutylacrylaat |
203-417-8 |
106-63-8 |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Skin Sens. 1 |
H226 H332 H312 H315 H317 |
GHS02 GHS07 Wng |
H226 H332 H312 H315 H317 |
|
|
D |
607-116-00-6 |
cyclohexylacrylaat |
221-319-3 |
3066-71-5 |
STOT SE 3 Skin Irrit. 2 Aquatic Chronic 2 |
H335 H315 H411 |
GHS07 GHS09 Wng |
H335 H315 H411 |
|
STOT SE 3; H335: C ≥ 10 % |
D |
607-117-00-1 |
2,3-epoxypropylacrylaat; glycidylacrylaat |
203-440-3 |
106-90-1 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Skin Sens. 1 |
H331 H311 H301 H314 H317 |
GHS06 GHS05 Dgr |
H331 H311 H301 H314 H317 |
|
* Skin Sens. 1; H317:C ≥0,2 % |
D |
607-118-00-7 |
1-methyltrimethyleendiacrylaat; 1,3-butyleenglycoldiacrylaat |
243-105-9 |
19485-03-1 |
Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 |
H312 H314 H317 |
GHS05 GHS07 Dgr |
H312 H314 H317 |
|
|
D |
607-119-00-2 |
tetramethyleendiacrylaat; 1,4-butyleenglycoldiacrylaat |
213-979-6 |
1070-70-8 |
Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 |
H312 H314 H317 |
GHS05 GHS07 Dgr |
H312 H314 H317 |
|
|
D |
607-120-00-8 |
2,2'-oxydiëthyldiacrylaat; diëthyleenglycoldiacrylaat |
223-791-6 |
4074-88-8 |
Acute Tox. 3 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H311 H319 H315 H317 |
GHS06 Dgr |
H311 H319 H315 H317 |
|
* Skin Sens. 1; H317:C≥0,2 % |
D |
607-121-00-3 |
8,9,10-trinorborn-2-ylacrylaat |
— |
10027-06-2 |
Acute Tox. 4 * Skin Irrit. 2 Skin Sens. 1 |
H312 H315 H317 |
GHS07 Wng |
H312 H315 H317 |
|
|
D |
607-122-00-9 |
pentaërytritoltetraäcrylaat |
225-644-1 |
4986-89-4 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Wng |
H319 H315 H317 |
|
|
D |
607-124-00-X |
2-hydroxyethylmethacrylaat |
212-782-2 |
868-77-9 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Wng |
H319 H315 H317 |
|
|
D |
607-125-00-5 |
2-hydroxypropylmethacrylaat; [1] 3-hydroxypropylmethacrylaat [2] |
213-090-3 [1] 220-426-2 [2] |
923-26-2 [1] 2761-09-3 [2] |
Eye Irrit. 2 Skin Sens. 1 |
H319 H317 |
GHS07 Wng |
H319 H317 |
|
|
C D |
607-126-00-0 |
2,2'-(ethyleendioxy)diëthyldiacrylaat; triëthyleenglycoldiacrylaat |
216-853-9 |
1680-21-3 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Wng |
H319 H315 H317 |
|
|
D |
607-127-00-6 |
2-diëthylaminoëthylmethacrylaat |
203-275-7 |
105-16-8 |
Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H332 H319 H315 H317 |
GHS07 Wng |
H332 H319 H315 H317 |
|
|
D |
607-128-00-1 |
2-tert-butylaminoëthylmethacrylaat |
223-228-4 |
3775-90-4 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Wng |
H319 H315 H317 |
|
|
D |
607-129-00-7 |
ethyllactaat; ethyl-DL-lactaat; [1] ethyl-(S)-2-hydroxypropionaat; ethyl-L-lactaat; ethyl-(S)-lactaat [2] |
202-598-0 [1] 211-694-1 [2] |
97-64-3 [1] 687-47-8 [2] |
Flam. Liq. 3 STOT SE 3 Eye Dam. 1 |
H226 H335 H318 |
GHS02 GHS05 GHS07 Dgr |
H226 H335 H318 |
|
|
C |
607-130-00-2 |
pentylacetaat; [1] isopentylacetaat; [2] 1-methylbutylacetaat; [3] 2-methylbutylacetaat; [4] 2(of 3)-methylbutylacetaat [5] |
211-047-3 [1] 204-662-3 [2] 210-946-8 [3] 210-843-8 [4] 282-263-3 [5] |
628-63-7 [1] 123-92-2 [2] 626-38-0 [3] 624-41-9 [4] 84145-37-9 [5] |
Flam. Liq. 3 |
H226 |
GHS02 Wng |
H226 |
EUH066 |
|
C |
607-131-00-8 |
isopentylpropionaat; [1] pentylpropionaat; [2] 2-methylbutylpropionaat [3] |
203-322-1 [1] 210-852-7 [2] 219-449-0 [3] |
105-68-0 [1] 624-54-4 [2] 2438-20-2 [3] |
Flam. Liq. 3 |
H226 |
GHS02 Wng |
H226 |
|
|
C |
607-132-00-3 |
2-dimethylaminoëthylmethacrylaat |
220-688-8 |
2867-47-2 |
Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H312 H302 H319 H315 H317 |
GHS07 Wng |
H312 H302 H319 H315 H317 |
|
|
D |
607-133-00-9 |
monoalkyl- of monoaryl- of monoalkylarylesters van acrylzuur, tenzij elders in deze bijlage vermeld |
— |
— |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 2 |
H319 H335 H315 H411 |
GHS07 GHS09 Wng |
H319 H335 H315 H411 |
|
STOT SE 3; H335: C ≥ 10 % |
A |
607-134-00-4 |
monoalkyl- of monoaryl- of monoalkylarylesters van methacrylzuur, tenzij elders in deze bijlage vermeld |
— |
— |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H319 H335 H315 |
GHS07 Wng |
H319 H335 H315 |
|
STOTSE 3; H335: C ≥ 10 % |
A |
607-135-00-X |
boterzuur |
203-532-3 |
107-92-6 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
|
|
607-136-00-5 |
butyrylchloride |
205-498-5 |
141-75-3 |
Flam. Liq. 2 Skin Corr. 1B |
H225 H314 |
GHS02 GHS05 Dgr |
H225 H314 |
|
|
|
607-137-00-0 |
methylacetoacetaat |
203-299-8 |
105-45-3 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
607-138-00-6 |
butylchloorformiaat; chloormierenzuur, butylester |
209-750-5 |
592-34-7 |
Flam. Liq. 3 Acute Tox. 3 * Skin Corr. 1B |
H226 H331 H314 |
GHS02 GHS06 GHS05 Dgr |
H226 H331 H314 |
|
|
|
607-139-00-1 |
2-chloorpropionzuur |
209-952-3 |
598-78-7 |
Acute Tox. 4 * Skin Corr. 1A |
H302 H314 |
GHS05 GHS07 Dgr |
H302 H314 |
|
|
|
607-140-00-7 |
isobutyrylchloride |
201-194-1 |
79-30-1 |
Flam. Liq. 2 Skin Corr. 1A |
H225 H314 |
GHS02 GHS05 Dgr |
H225 H314 |
|
|
|
607-141-00-2 |
oxydiëthyleenbis(chloorformiaat) |
203-430-9 |
106-75-2 |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 2 |
H302 H315 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H315 H318 H411 |
|
|
|
607-142-00-8 |
propylchloorformiaat; chloormierenzuur, propylester; n-propylchloorformiaat |
203-687-7 |
109-61-5 |
Flam. Liq. 2 Acute Tox. 3 * Skin Corr. 1B |
H225 H331 H314 |
GHS02 GHS06 GHS05 Dgr |
H225 H331 H314 |
|
|
|
607-143-00-3 |
valeriaanzuur |
203-677-2 |
109-52-4 |
Skin Corr. 1B Aquatic Chronic 3 |
H314 H412 |
GHS05 Dgr |
H314 H412 |
|
|
|
607-144-00-9 |
adipinezuur |
204-673-3 |
124-04-9 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
607-145-00-4 |
methaansulfonzuur |
200-898-6 |
75-75-2 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
|
|
607-146-00-X |
fumaarzuur |
203-743-0 |
110-17-8 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
607-147-00-5 |
oxaalzuur, diëthylester diëthyloxalaat |
202-464-1 |
95-92-1 |
Acute Tox. 4 * Eye Irrit. 2 |
H302 H319 |
GHS07 Wng |
H302 H319 |
|
|
|
607-148-00-0 |
guanidiniumchloride; guanadinehydrochloride |
200-002-3 |
50-01-1 |
Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 |
H302 H319 H315 |
GHS07 Wng |
H302 H319 H315 |
|
|
|
607-149-00-6 |
urethaan (INN); ethylcarbamaat |
200-123-1 |
51-79-6 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
607-150-00-1 |
endothal (ISO); 7-oxabicyclo(2,2,1)heptaan-2,3-dicarbonzuur |
205-660-5 |
145-73-3 |
Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H301 H312 H319 H335 H315 |
GHS06 Dgr |
H301 H312 H319 H335 H315 |
|
|
|
607-151-00-7 |
propargiet (ISO); 2-(4-tert-butylfenoxy)cyclohexyl-prop-2-ynyl-sulfiet |
219-006-1 |
2312-35-8 |
Carc. 2 Acute Tox. 3 * Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H331 H315 H318 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H351 H331 H315 H318 H410 |
|
M = 10 |
|
607-152-00-2 |
2,3,6-TBA (ISO); 2,3,6-trichloorbenzoëzuur |
200-026-4 |
50-31-7 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
607-153-00-8 |
benazoline (ISO); 4-chloor-2,3-dihydro-2-oxo-1,3-benzothiazool-3-ylazijnzuur |
223-297-0 |
3813-05-6 |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 3 |
H319 H315 H412 |
GHS07 Wng |
H319 H315 H412 |
|
|
|
607-154-00-3 |
ethyl-N-benzoyl-N-(3,4-dichloorfenyl)-DL-alaninaat; benzoylprop-ethyl (ISO) |
244-845-5 |
22212-55-1 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
607-155-00-9 |
3-(3-amino-5-(1-methylguanidino)-1-oxopentylamino-6-(4-amino-2-oxo-2,3-dihydro-pyrimidine-1-yl)-2,3-dihydro-(6H)-pyran-2-carbonzuur; blasticidin-s |
— |
2079-00-7 |
Acute Tox. 2 * |
H300 |
GHS06 Dgr |
H300 |
|
|
|
607-156-00-4 |
chloorfenson (ISO); 4-chloorfenyl-4-chloorbenzeensulfonaat |
201-270-4 |
80-33-1 |
Acute Tox. 4 * Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H315 H410 |
|
|
|
607-158-00-5 |
natriumzout van chloorazijnzuur; natriumchlooracetaat |
223-498-3 |
3926-62-3 |
Acute Tox. 3 * Skin Irrit. 2 Aquatic Acute 1 |
H301 H315 H400 |
GHS06 GHS09 Dgr |
H301 H315 H400 |
|
|
|
607-159-00-0 |
chloorbenzilaat (ISO); ethyl-2,2-di(4-chloorfenyl)-2-hydroxyacetaat; ethyl-4,4'-dichloorbenzilaat; |
208-110-2 |
510-15-6 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
607-160-00-6 |
isobutyl-2-(4-(4-chloorfenoxy)fenoxy)propionaat; clofop-isobutyl (ISO) |
— |
51337-71-4 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
607-161-00-1 |
diëthanolaminezout van 4-CPA |
— |
— |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
607-162-00-7 |
dalapon; 2,2-dichloorpropionzuur; [1] dalapon-natrium; natrium-2,2-dichloorpropionaat [2] |
200-923-0 [1] 204-828-5 [2] |
75-99-0 [1] 127-20-8 [2] |
Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H315 H318 H412 |
GHS05 Dgr |
H315 H318 H412 |
|
|
|
607-163-00-2 |
3-acetyl-6-methyl-2H-pyran-2,4(3H)-dion; dehydroazijnzuur |
208-293-9 |
520-45-6 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
607-164-00-8 |
natrium-1-(3,4-dihydro-6-methyl-2,4-dioxo-2H-pyran-3-ylideen)ethanolaat; natrium-dehydracetaat |
224-580-1 |
4418-26-2 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
607-165-00-3 |
diclofop-methyl (ISO); methyl-2-(4-(2,4-dichloorfenoxy)fenoxy)propionaat; methyl-(RS)-2-[4-(2,4-dichloorfenoxy)fenoxy]propionaat; |
257-141-8 |
51338-27-3 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
|
607-166-00-9 |
medinoterb-acetaat (ISO); 6-tert-butyl-3-methyl-2,4-dinitrofenylacetaat |
219-634-6 |
2487-01-6 |
Acute Tox. 3 * Acute Tox. 4 * |
H301 H312 |
GHS06 Dgr |
H301 H312 |
|
|
|
607-167-00-4 |
natrium-3-chlooracrylaat |
— |
4312-97-4 |
Acute Tox. 4 * Acute Tox. 4 * |
H312 H302 |
GHS07 Wng |
H312 H302 |
|
|
|
607-168-00-X |
dipropyl-6,7-methyleendioxy-1,2,3,4-tetrahydro-3-methylnaftaleen-1,2-dicarboxylaat; propylisome |
— |
83-59-0 |
Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H311 H302 H400 H410 |
GHS06 GHS09 Dgr |
H311 H302 H410 |
|
|
|
607-169-00-5 |
natriumfluoracetaat |
200-548-2 |
62-74-8 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 |
H330 H310 H300 H400 |
GHS06 GHS09 Dgr |
H330 H310 H300 H400 |
|
|
|
607-170-00-0 |
bis(1,2,3-trithiacyclohexyldimethylammonium)oxalaat; thiocyclam-oxalaat |
250-859-2 |
31895-22-4 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H312 H302 H410 |
|
|
|
607-173-00-7 |
dimethyl-(3-methyl-4-(5-nitro-3-ethoxycarbonyl-2-thiënyl)azo)fenylnitrilodipropionaat |
400-460-6 |
— |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
607-174-00-2 |
reactiemassa van dodecyl-3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosaan-20-yl)propionaat en tetradecyl-3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosaan-20-yl)propionaat |
400-580-9 |
— |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
607-175-00-8 |
methyl-2-(2-nitrobenzylideen)acetoacetaat |
400-650-9 |
39562-27-1 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
607-176-00-3 |
reactiemassa van α-3-(3-(2H-benzotriazool-2-yl)-5-tert-butyl-4-hydroxyfenyl)propionyl-ω-hydroxypoly(oxyethyleen) en α-3-(3-(2H-benzotriazool-2-yl)-5-tert-butyl-4-hydroxyfenyl)propionyl-ω-3-(3-(2H-benzotriazool-2-yl)-5-tert-butyl-4-hydroxyfenyl)propionyloxypoly(oxyethyleen) |
400-830-7 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
607-177-00-9 |
tribenuron-methyl (ISO); 2-[4-methoxy-6-methyl-1,3,5-triazine-2-yl(methyl)carbamoylsulfamoyl]benzoëzuur, methylester; methyl-2-(3-(4-methoxy-6-methyl-1,3,5-triazine-2-yl)-3-methylureïdosulfonyl)benzoaat |
401-190-1 |
101200-48-0 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
M = 100 |
|
607-178-00-4 |
methyl-α-((4,6-dimethoxypyrimidine-2-yl)ureïdosulfonyl)-o-toluaat |
401-340-6 |
83055-99-6 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
607-179-00-X |
(benzothiazool-2-ylthio)barnsteenzuur |
401-450-4 |
95154-01-1 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
607-180-00-5 |
kalium-2-hydroxycarbazool-1-carboxylaat |
401-630-2 |
96566-70-0 |
Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Aquatic Chronic 3 |
H302 H319 H335 H412 |
GHS07 Wng |
H302 H319 H335 H412 |
|
|
|
607-181-00-0 |
3,5-dichloor-2,4-difluorbenzoylfluoride |
401-800-6 |
101513-70-6 |
Acute Tox. 3 * Skin Corr. 1B Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 3 |
H331 H314 H302 H317 H412 |
GHS06 GHS05 Dgr |
H331 H314 H302 H317 H412 |
EUH029 |
|
|
607-182-00-6 |
methyl-3-sulfamoyl-2-thenoaat |
402-050-2 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
607-183-00-1 |
zink-2-hydroxy-5-C13-18 alkylbenzoaat |
402-280-3 |
— |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 |
H319 H315 H411 |
GHS07 GHS09 Wng |
H319 H315 H411 |
|
|
|
607-184-00-7 |
S-(3-trimethoxysilyl)propyl-19-isocyanato-11-(6-isocyanatohexyl)-10,12-dioxo-2,9,11,13-tetraäzanonadecaanthioaat |
402-290-8 |
85702-90-5 |
Flam. Liq. 3 Resp. Sens. 1 Skin Sens. 1 |
H226 H334 H317 |
GHS02 GHS08 Dgr |
H226 H334 H317 |
|
|
|
607-185-00-2 |
ethyl-trans-3-dimethylaminoacrylaat |
402-650-4 |
1117-37-9 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
607-186-00-8 |
quinclorac (ISO); 3,7-dichloorchinoline-8-carbonzuur; |
402-780-1 |
84087-01-4 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
607-187-00-3 |
bis(2,2,6,6-tetramethyl-4-piperidyl)succinaat |
402-940-0 |
62782-03-0 |
Eye Irrit. 2 Aquatic Chronic 3 |
H319 H412 |
GHS07 Wng |
H319 H412 |
|
|
|
607-188-00-9 |
hydrogeen-natrium-N-carboxylatoëthyl-N-octadec-9-enylmaleamaat |
402-970-4 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
607-189-00-4 |
trimethyleendiaminetetraäzijnzuur |
400-400-9 |
1939-36-2 |
Acute Tox. 4 * Eye Dam. 1 |
H302 H318 |
GHS05 GHS07 Dgr |
H302 H318 |
|
|
|
607-190-00-X |
methylacrylamidomethoxyacetaat (met ≥ 0,1 % acrylamide) |
401-890-7 |
77402-03-0 |
Carc. 1B Muta. 1B Acute Tox. 4 * Eye Irrit. 2 |
H350 H340 H302 H319 |
GHS08 GHS07 Dgr |
H350 H340 H302 H319 |
|
|
|
607-191-00-5 |
isobutyl-3,4-epoxybutyraat |
401-920-9 |
100181-71-3 |
Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H315 H317 H410 |
|
|
|
607-192-00-0 |
dinatrium-N-carboxymethyl-N-(2-(2-hydroxyethoxy)ethyl)glycinaat |
402-360-8 |
92511-22-3 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
607-194-00-1 |
propyleencarbonaat |
203-572-1 |
108-32-7 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
607-195-00-7 |
2-methoxy-1-methylethylacetaat |
203-603-9 |
108-65-6 |
Flam. Liq. 3 |
H226 |
GHS02 Wng |
H226 |
|
|
|
607-196-00-2 |
heptaanzuur |
203-838-7 |
111-14-8 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
|
|
607-198-00-3 |
propyl-3,4,5-trihydroxybenzoaat |
204-498-2 |
121-79-9 |
Acute Tox. 4 * Skin Sens. 1 |
H302 H317 |
GHS07 Wng |
H302 H317 |
|
|
|
607-199-00-9 |
octyl-3,4,5-trihydroxybenzoaat |
213-853-0 |
1034-01-1 |
Acute Tox. 4 * Skin Sens. 1 |
H302 H317 |
GHS07 Wng |
H302 H317 |
|
|
|
607-200-00-2 |
dodecyl-3,4,5-trihydroxybenzoaat |
214-620-6 |
1166-52-5 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
607-201-00-8 |
thiocarbonylchloride |
207-341-6 |
463-71-8 |
Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H331 H302 H319 H335 H315 |
GHS06 Dgr |
H331 H302 H319 H335 H315 |
|
|
|
607-203-00-9 |
2-ethylhexyl-[[[3,5-bis(1,1-dimethylethyl)-4-hydroxyfenyl]methyl]thio]acetaat |
279-452-8 |
80387-97-9 |
Repr. 1B Skin Sens. 1 Aquatic Chronic 3 |
H360D *** H317 H412 |
GHS08 GHS07 Dgr |
H360D *** H317 H412 |
|
|
|
607-204-00-4 |
(chloorfenyl)(chloortolyl)methaan, mengsel van isomeren |
400-140-6 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
607-205-00-X |
methylchlooracetaat |
202-501-1 |
96-34-4 |
Flam. Liq. 3 Acute Tox. 3 * Acute Tox. 3 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 |
H226 H331 H301 H335 H315 H318 |
GHS02 GHS06 GHS05 Dgr |
H226 H331 H301 H335 H315 H318 |
|
|
|
607-206-00-5 |
isopropylchlooracetaat |
203-301-7 |
105-48-6 |
Flam. Liq. 3 Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H226 H301 H319 H335 H315 |
GHS02 GHS06 Dgr |
H226 H301 H319 H335 H315 |
|
|
|
607-207-00-0 |
haloxyfop-etotyl (ISO); 2-ethoxyethyl-2-(4-(3-chloor-5-trifluormethyl-2-pyridyloxy)fenoxy)propionaat; haloxyfop-(2-ethoxyethyl) |
402-560-5 |
87237-48-7 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
607-208-00-6 |
4,8,12-trimethyltrideca-3,7,11-trieenzuur, mengsel van isomeren |
403-000-2 |
91853-67-7 |
Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Wng |
H315 H410 |
|
|
|
607-209-00-1 |
reactiemassa van O,O'-diisopropyl-(pentathio)dithioformiaat en O,O'-diisopropyl-(trithio)dithioformiaat en O,O'-diisopropyl-(tetrathio)dithioformiaat |
403-030-6 |
— |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
|
607-210-00-7 |
methylacrylamidoglycolaat (met ≥ 0,1 % acrylamide) |
403-230-3 |
77402-05-2 |
Carc. 1B Muta. 1B Skin Corr. 1B Skin Sens. 1 |
H350 H340 H314 H317 |
GHS08 GHS05 GHS07 Dgr |
H350 H340 H314 H317 |
|
|
|
607-211-00-2 |
methyl-3-(3-tert-butyl-4-hydroxy-5-methylfenyl)propionaat |
403-270-1 |
6386-39-6 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
607-212-00-8 |
poly(oxypropyleencarbonyl-co-oxy(ethylethyleen)carbonyl), met 27 % hydroxyvaleraat |
403-300-3 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
607-213-00-3 |
ethyl-3,3-bis(tert-pentylperoxy)butyraat |
403-320-2 |
67567-23-1 |
Org. Perox. D**** Flam. Liq. 3 Aquatic Chronic 2 |
H242 H226 H411 |
GHS02 GHS09 Dgr |
H242 H226 H411 |
|
|
|
607-214-00-9 |
N,N-hydrazinodiazijnzuur |
403-510-5 |
19247-05-3 |
Acute Tox. 3 * STOT RE 2 * Skin Sens. 1 Aquatic Chronic 3 |
H301 H373 ** H317 H412 |
GHS06 GHS08 Dgr |
H301 H373 ** H317 H412 |
|
|
|
607-215-00-4 |
3-(3-tert-butyl-4-hydroxyfenyl)propionzuur |
403-920-4 |
107551-67-7 |
Acute Tox. 4 * Eye Irrit. 2 |
H302 H319 |
GHS07 Wng |
H302 H319 |
|
|
|
607-216-00-X |
glutaminezuur, reactieproducten met N-(C12-14-alkyl)propyleendiamine |
403-950-8 |
— |
Acute Tox. 2 * Acute Tox. 4 * Skin Corr. 1B Aquatic Acute 1 |
H330 H302 H314 H400 |
GHS06 GHS05 GHS09 Dgr |
H330 H302 H314 H400 |
|
|
|
607-217-00-5 |
2-ethoxyethyl-2-(4-(7-fenyl-2,6-dihydro-2,6-dioxo-1,5-dioxaïndaceen-3-yl)fenoxy)acetaat |
403-960-2 |
— |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
607-218-00-0 |
dichloorprop-P (ISO); (+)-R-2-(2,4-dichloorfenoxy)propionzuur |
403-980-1 |
15165-67-0 |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H302 H315 H318 H317 |
GHS05 GHS07 Dgr |
H302 H315 H318 H317 |
|
|
|
607-219-00-6 |
bis(2-ethylhexyl)dithioacetaat |
404-510-8 |
62268-47-7 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H302 H317 H411 |
GHS07 GHS09 Wng |
H302 H317 H411 |
|
|
|
607-221-00-7 |
2-docosyloxy-1-hydroxy-4-(1-(4-hydroxy-3-methylfenantreen-1-yl)-3-oxo-2-oxafenaleen-1-yl)naftaleen-2-carbonzuur |
404-550-6 |
— |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
607-222-00-2 |
6-(2,3-dimethylmaleïmido)hexylmethacrylaat |
404-870-6 |
63740-41-0 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
607-223-00-8 |
transfluthrin (ISO); 2,3,5,6-tetrafluorbenzyl-trans-2-(2,2-dichloorvinyl)-3,3-dimethylcyclopropaancarboxylaat; |
405-060-5 |
118712-89-3 |
Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Wng |
H315 H410 |
|
|
|
607-224-00-3 |
methyl-2-(3-nitrobenzylideen)acetoacetaat |
405-270-7 |
39562-17-9 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
607-225-00-9 |
3-azidosulfonylbenzoëzuur |
405-310-3 |
15980-11-7 |
Self-React. C **** STOT RE 2 * Eye Dam. 1 Skin Sens. 1 |
H241 H373 ** H318 H317 |
GHS02 GHS08 GHS05 GHS07 Dgr |
H241 H373 ** H318 H317 |
|
|
|
607-226-00-4 |
reactiemassa van 2-acryloyloxyethyl-hydrogeen-cyclohexaan-1,2-dicarboxylaat en 2-methacryloyloxyethyl-hydrogeen-cyclohexaan-1,2-dicarboxylaat |
405-360-6 |
— |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H315 H318 H317 H412 |
GHS05 GHS07 Dgr |
H315 H318 H317 H412 |
|
|
|
607-227-00-X |
kalium-2-amino-2-methylpropionaat-octahydraat |
405-560-3 |
120447-91-8 |
Acute Tox. 4 * Skin Corr. 1A |
H302 H314 |
GHS05 GHS07 Dgr |
H302 H314 |
|
|
|
607-228-00-5 |
bis(2-methoxyethyl)ftalaat |
204-212-6 |
117-82-8 |
Repr. 1B |
H360Df |
GHS08 Dgr |
H360Df |
|
|
|
607-229-00-0 |
diëthylcarbamoylchloride |
201-798-5 |
88-10-8 |
Carc. 2 Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H351 H332 H302 H319 H335 H315 |
GHS08 GHS07 Wng |
H351 H332 H302 H319 H335 H315 |
|
|
|
607-230-00-6 |
2-ethylhexaanzuur |
205-743-6 |
149-57-5 |
Repr. 2 |
H361d *** |
GHS08 Wng |
H361d *** |
|
|
|
607-231-00-1 |
clopyralid (ISO); 3,6-dichloorpyridine-2-carbonzuur |
216-935-4 |
1702-17-6 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
607-232-00-7 |
pyridaat (ISO); O-(6-chloor-3-fenylpyridazine-4-yl)-S-octylthiocarbonaat |
259-686-7 |
55512-33-9 |
Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H315 H317 H410 |
|
|
|
607-233-00-2 |
hexylacrylaat |
219-698-5 |
2499-95-8 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H319 H335 H315 H317 H411 |
GHS07 GHS09 Wng |
H319 H335 H315 H317 H411 |
|
|
|
607-234-00-8 |
flurenol (ISO); 9-hydroxy-9H-fluoreen-9-carbonzuur |
207-397-1 |
467-69-6 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
607-235-00-3 |
mecrilaat; methyl-2-cyaanacrylaat |
205-275-2 |
137-05-3 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H319 H335 H315 |
GHS07 Wng |
H319 H335 H315 |
|
STOT SE 3; H335: C ≥ 10 % |
|
607-236-00-9 |
ethyl-2-cyaanacrylaat |
230-391-5 |
7085-85-0 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H319 H335 H315 |
GHS07 Wng |
H319 H335 H315 |
|
STOT SE 3; H335: C ≥ 10 % |
|
607-237-00-4 |
benzyl-2-chloor-4-(trifluormethyl)thiazool-5-carboxylaat; flurazool |
276-942-3 |
72850-64-7 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
607-238-00-X |
tau-fluvalinaat (ISO); cyaan-(3-fenoxyfenyl)methyl N-[2-chloor-4-(trifluormethyl)fenyl]-D-valinaat |
— |
102851-06-9 |
Acute Tox. 4 * Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H315 H400 H410 |
GHS07 GHS09 Wng |
H302 H315 H410 |
|
|
|
607-239-00-5 |
fenpropathrin (ISO); α-cyaan-3-fenoxybenzyl-2,2,3,3-tetramethylcyclopropaancarboxylaat; |
254-485-0 |
39515-41-8 |
Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H301 H312 H400 H410 |
GHS06 GHS09 Dgr |
H330 H301 H312 H410 |
|
|
|
607-240-00-0 |
cis-1,2,3,6-tetrahydro-4-methylftaalzuuranhydride; [1] 1,2,3,6-tetrahydro-4-methylftaalzuuranhydride; [2] 1,2,3,6-tetrahydro-3-methylftaalzuuranhydride; [3] tetrahydromethylftaalzuuranhydride; [4] 1,2,3,6-tetrahydromethylftaalzuuranhydride; [5] tetrahydro-4-methylftaalzuuranhydride; [6] 2,3,5,6-tetrahydro-2-methylftaalzuuranhydride [7] |
216-906-6 [1] 222-323-8 [2] 226-247-6 [3] 234-290-7 [4] 247-830-1 [5] 251-823-9 [6] 255-853-3 [7] |
1694-82-2 [1] 3425-89-6 [2] 5333-84-6 [3] 11070-44-3 [4] 26590-20-5 [5] 34090-76-1 [6] 42498-58-8 [7] |
Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H318 H334 H317 |
GHS08 GHS05 Dgr |
H318 H334 H317 |
|
|
C |
607-241-00-6 |
hexahydro-4-methylftaalzuuranhydride; [1] hexahydromethylftaalzuuranhydride; [2] hexahydro-1-methylftaalzuuranhydride; [3] hexahydro-3-methylftaalzuuranhydride [4] |
243-072-0 [1] 247-094-1 [2] 256-356-4 [3] 260-566-1 [4] |
19438-60-9 [1] 25550-51-0 [2] 48122-14-1 [3] 57110-29-9 [4] |
Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H318 H334 H317 |
GHS08 GHS05 Dgr |
H318 H334 H317 |
|
|
C |
607-242-00-1 |
tetrachloorftaalzuuranhydride |
204-171-4 |
117-08-8 |
Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H334 H317 H400 H410 |
GHS08 GHS05 GHS09 Dgr |
H318 H334 H317 H410 |
|
|
|
607-243-00-7 |
natrium-3,6-dichloor-o-anisaat; [1] 3,6-dichloor-o-anijszuur, verbinding met 2,2'-iminodiëthanol (1:1); [2] 3,6-dichloor-o-anijszuur, verbinding met 2-aminoëthanol (1:1) [3] |
217-846-3 [1] 246-590-5 [2] 258-527-9 [3] |
1982-69-0 [1] 25059-78-3 [2] 53404-28-7 [3] |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
607-244-00-2 |
isoöctylacrylaat |
249-707-8 |
29590-42-9 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H335 H315 H400 H410 |
GHS07 GHS09 Wng |
H319 H335 H315 H410 |
|
STOT SE 3; H335: C ≥ 10 % |
|
607-245-00-8 |
tert-butylacrylaat |
216-768-7 |
1663-39-4 |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H225 H332 H312 H302 H335 H315 H317 H411 |
GHS02 GHS07 GHS09 Dgr |
H225 H332 H312 H302 H335 H315 H317 H411 |
|
|
D |
607-246-00-3 |
allylmethacrylaat; 2-methyl-2-propeenzuur, 2-propenylester |
202-473-0 |
96-05-9 |
Flam. Liq. 3 Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 |
H226 H331 H312 H302 H400 |
GHS02 GHS06 GHS09 Dgr |
H226 H331 H312 H302 H400 |
|
|
|
607-247-00-9 |
dodecylmethacrylaat |
205-570-6 |
142-90-5 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H335 H315 H400 H410 |
GHS07 GHS09 Wng |
H319 H335 H315 H410 |
|
STOT SE 3; H335: C ≥ 10 % |
|
607-248-00-4 |
naptalam-natrium (ISO); natrium-N-naft-1-ylftalamaat |
205-073-4 |
132-67-2 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
607-249-00-X |
(1-methyl-1,2-ethaandiyl)bis[oxy(methyl-2,1-ethaandiyl)diacrylaat |
256-032-2 |
42978-66-5 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H319 H335 H315 H317 H411 |
GHS07 GHS09 Wng |
H319 H335 H315 H317 H411 |
|
STOT SE 3; H335: C ≥ 10 % |
|
607-250-00-5 |
4H-3,1-benzoxazine-2,4(1H)-dion |
204-255-0 |
118-48-9 |
Eye Irrit. 2 Skin Sens. 1 |
H319 H317 |
GHS07 Wng |
H319 H317 |
|
|
|
607-251-00-0 |
2-methoxypropylacetaat |
274-724-2 |
70657-70-4 |
Flam. Liq. 3 Repr. 1B STOT SE 3 |
H226 H360D *** H335 |
GHS02 GHS08 GHS07 Dgr |
H226 H360D *** H335 |
|
|
|
607-252-00-6 |
lambda-cyhalothrin (ISO); reactiemassa van: (S)-α-cyaan-3-fenoxybenzyl(Z)-(1R)-cis-3-(2-chloor-3,3,3-trifluorpropenyl)-2,2-dimethylcyclopropaancarboxylaat en (R)-α-cyaan-3-fenoxybenzyl(Z)-(1S)-cis-3-(2-chloor-3,3,3-trifluorpropenyl)-2,2-dimethylcyclopropaancarboxylaat (1:1) |
415-130-7 |
91465-08-6 |
Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H301 H312 H400 H410 |
GHS06 GHS09 Dgr |
H330 H301 H312 H410 |
|
M=10000 |
|
607-253-00-1 |
cyfluthrin (ISO); α-cyaan-4-fluor-3-fenoxybenzyl-3-(2,2-dichloorvinyl)-2,2-dimethylcyclopropaancarboxylaat |
269-855-7 |
68359-37-5 |
Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H300 H331 H400 H410 |
GHS06 GHS09 Dgr |
H300 H331 H410 |
|
M=1000 |
|
607-254-00-7 |
α-cyaan-4-fluor-3-fenoxybenzyl-3-(2,2-dichloorvinyl)-2,2-dimethylcyclopropaancarboxylaat; beta-cyfluthrin |
269-855-7 |
68359-37-5 |
Acute Tox. 2 * Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H300 H400 H410 |
GHS06 GHS09 Dgr |
H330 H300 H410 |
|
|
|
607-255-00-2 |
fluroxypyr (ISO); 4-amino-3,5-dichloor-6-fluor-2-pyridyloxyazijnzuur |
— |
69377-81-7 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
607-256-00-8 |
azoxystrobin (ISO); methyl-(E)-2-{2-[6-(2-cyaanfenoxy)pyrimidine-4-yloxy]fenyl}-3-methoxyacrylaat |
— |
131860-33-8 |
Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H400 H410 |
GHS06 GHS09 Dgr |
H331 H410 |
|
|
|
607-257-00-3 |
isopropylpropionaat |
211-300-8 |
637-78-5 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
|
|
|
607-258-00-9 |
dodecyl-3-(2-(3-benzyl-4-ethoxy-2,5-dioxoïmidazolidine-1-yl)-3-(4-methoxybenzoyl)aceetamido)-4-chloorbenzoaat |
403-990-6 |
70950-45-7 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
607-259-00-4 |
methyl-2R,3S-(–)-3-(4-methoxyfenyl)oxiraancarboxylaat |
404-130-2 |
105560-93-8 |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Dgr |
H318 H317 H412 |
|
|
|
607-260-00-X |
ethyl-2-(3-nitrobenzylideen)acetoacetaat |
404-490-0 |
39562-16-8 |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Dgr |
H318 H317 H412 |
|
|
|
607-261-00-5 |
iso(C10-C14)alkyl-(3,5-di-tert-butyl-4-hydroxyfenyl)methylthioacetaat |
404-800-4 |
118832-72-7 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
607-262-00-0 |
7-chloor-1-cyclopropyl-6-fluor-1,4-dihydro-4-oxochinoline-3-carbonzuur |
405-050-0 |
86393-33-1 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
607-263-00-6 |
kalium/ijzer(III)-1,3-propaandiamine-N,N,N',N'-tetraäcetaat-hemihydraat |
405-680-6 |
— |
Self-heat. 2 **** Aquatic Chronic 2 |
H252 H411 |
GHS02 GHS09 Wng |
H252 H411 |
|
|
|
607-264-00-1 |
2-chloor-4-(methylsulfonyl)benzoëzuur |
406-520-8 |
53250-83-2 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
607-265-00-7 |
ethyl-2-chloor-2,2-difenylacetaat |
406-580-5 |
52460-86-3 |
Skin Irrit. 2 Aquatic Chronic 3 |
H315 H412 |
GHS07 Wng |
H315 H412 |
|
|
|
607-266-00-2 |
reactiemassa van: hydroxyaluminium-bis[2-hydroxy-3,5-di-tert-butylbenzoaat]; 3,5-di-tert-butyl-salicylzuur |
406-890-0 |
130296-87-6 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
607-267-00-8 |
tert-butyl-(5S,6R,7R)-3-broommethyl-5,8-dioxo-7-(2-fenylaceetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-een-2-carboxylaat |
407-620-4 |
33610-13-8 |
Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 3 |
H334 H317 H412 |
GHS08 Dgr |
H334 H317 H412 |
|
|
|
607-268-00-3 |
2-methylpropyl-(R)-2-hydroxypropanoaat |
407-770-0 |
61597-96-4 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
607-269-00-9 |
(R)-2-(4-hydroxyfenoxy)propaanzuur |
407-960-3 |
94050-90-5 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
607-270-00-4 |
3,9-bis(2-(3-(3-tert-butyl-4-hydroxy-5-methylfenyl)propionyloxy-1,1-dimethylethyl)-2,4,8,10-tetraoxaspiro[5.5]undecaan |
410-730-5 |
90498-90-1 |
Acute Tox. 4 * |
H312 |
GHS07 Wng |
H312 |
|
|
|
607-271-00-X |
2-isopropyl-5-methylcyclohexyloxycarbonyloxy-2-hydroxypropaan |
417-420-9 |
156324-82-2 |
Eye Irrit. 2 Aquatic Chronic 2 |
H319 H411 |
GHS07 GHS09 Wng |
H319 H411 |
|
|
|
607-272-00-5 |
fluroxypyr-meptyl (ISO); methylheptyl, O-(4-amino-3,5-dichloor-6-fluor-2-pyridyloxy)acetaat; [1] fluroxypyr-butometyl (ISO); 2-butoxy-1-methylethyl, O-(4-amino-3,5-dichloor-6-fluor-2-pyridyloxy)acetaat [2] |
279-752-9 [1] -[2] |
81406-37-3 [1] 154486-27-8 [2] |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
607-273-00-0 |
ammonium-7-(2,6-dimethyl-8-(2,2-dimethylbutyryloxy)-1,2,6,7,8,8a-hexahydro-1-naftyl)-3,5-dihydroxyheptanoaat |
404-520-2 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
607-274-00-6 |
2-(N-benzyl-N-methylamino)ethyl-3-amino-2-butenoaat |
405-350-1 |
54527-73-0 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
607-275-00-1 |
natrium-benzoyloxybenzeen-4-sulfonaat |
405-450-5 |
66531-87-1 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
607-276-00-7 |
bis[(1-methylimidazool)-(2-ethyl-hexanoaat)], zinkcomplex |
405-635-0 |
— |
Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H400 H410 |
GHS05 GHS09 Dgr |
H315 H318 H410 |
|
|
|
607-277-00-2 |
reactiemassa van: 2-(hexylthio)ethylaminehydrochloride; natrium-propionaat |
405-720-2 |
— |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H302 H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H317 H411 |
|
|
|
607-278-00-8 |
reactiemassa van isomeren van: natriumfenethylnaftaleensulfonaat; natriumnaftylethylbenzeensulfonaat |
405-760-0 |
— |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Dgr |
H318 H317 H412 |
|
|
|
607-279-00-3 |
reactiemassa van: n-octadecylaminodiëthylbis(hydrogeen-maleaat); n-octadecylaminodiëthyl-waterstofmaleaat-waterstofftalaat |
405-960-8 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
607-280-00-9 |
natrium-4-chloor-1-hydroxybutaan-1-sulfonaat |
406-190-5 |
54322-20-2 |
Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 |
H302 H319 H317 |
GHS07 Wng |
H302 H319 H317 |
|
|
|
607-281-00-4 |
reactiemassa van vertakte en lineaire C7-C9 alkyl-3-[3-(2H-benzotriazool-2-yl)-5-(1,1-dimethylethyl)-4-hydroxyfenyl]propionaten |
407-000-3 |
127519-17-9 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
607-282-00-X |
2-acetoxymethyl-4-benzyloxybutylacetaat |
407-140-5 |
131266-10-9 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
607-283-00-5 |
E-ethyl-4-oxo-4-fenylcrotonaat |
408-040-4 |
15121-89-8 |
Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H315 H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H312 H302 H315 H318 H317 H410 |
|
|
|
607-284-00-0 |
reactiemassa (9:1) van: natrium-3,3'-(1,4-fenyleenbis(carbonylimino-3,1-propaandiylimino))bis(10-amino-6,13-dichloor)-4,11-trifenodioxazinedisulfonaat); lithium-3,3'-(1,4-fenyleenbis(carbonylimino-3,1-propaandiylimino))bis(10-amino-6,13-dichloor)-4,11-trifenodioxazinedisulfonaat) |
410-040-4 |
136213-76-8 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
607-285-00-6 |
reactiemassa van: 7-(((3-aminofenyl)sulfonyl)amino)-naftaleen-1,3-disulfonzuur; natrium-7-(((3-aminofenyl)sulfonyl)amino)-naftaleen-1,3-disulfonaat; kalium-7-(((3-aminofenyl)sulfonyl)amino)-naftaleen-1,3-disulfonaat |
410-065-0 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
|
|
|
|
607-286-00-1 |
reactiemassa van: natrium/kalium-7-[[[3-[[4-((2-hydroxy-naftyl)azo)-fenyl]azo]fenyl]sulfonyl]amino]naftaleen-1,3-disulfonaat |
410-070-8 |
141880-36-6 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
607-287-00-7 |
O'-methyl-O-(1-methyl-2-methacryloyloxy-ethyl)-1,2,3,6-tetrahydroftalaat |
410-140-8 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
607-288-00-2 |
tetranatrium-(c-(3-(1-(3-(e-6-dichloor-5-cyaanpyrimidine-f-yl(methyl)amino)propyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)-4-sulfonatofenylsulfamoyl)ftalocyanine-a, b,d-trisulfonato(6–))nikkelaat(II), waarbij a is 1 of 2 of 3 of 4,b is 8 of 9 of 10 of 11,c is 15 of 16 of 17 of 18, d is 22 of 23 of 24 of 25 en waarbij e en f samen respectievelijk 2 en 4 of 4 en 2 zijn |
410-160-7 |
148732-74-5 |
Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H319 H317 H412 |
GHS07 Wng |
H319 H317 H412 |
|
|
|
607-289-00-8 |
3-(3-(4-(2,4-bis(1,1-dimethylpropyl)fenoxy)butylaminocarbonyl-4-hydroxy-1-naftalenyl)thio)propaanzuur |
410-370-9 |
105488-33-3 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
607-290-00-3 |
reactiemassa (verhouding onbekend) van: ammonium-1-C14-C18-alkyloxycarbonyl-2-(3-allyloxy-2-hydroxypropoxycarbonyl)ethaan-1-sulfonaat; ammonium-2-C14-C18-alkyloxycarbonyl-1-(3-allyloxy-2-hydroxypropoxycarbonyl)ethaan-1-sulfonaat |
410-540-2 |
— |
Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H315 H317 H410 |
|
|
|
607-291-00-9 |
dodecyl-ω-(C5/C6-cycloalkyl)alkylcarboxylaat |
410-630-1 |
104051-92-5 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
607-292-00-4 |
reactiemassa van: [1-(methoxymethyl)-2-(C12-alkoxy)-ethoxy]azijnzuur; [1-(methoxymethyl)-2-(C14-alkoxy)-ethoxy]azijnzuur |
410-640-6 |
— |
Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H400 H410 |
GHS05 GHS09 Dgr |
H315 H318 H410 |
|
|
|
607-293-00-X |
reactiemassa van: N-aminoëthylpiperazonium-mono-2,4,6-trimethylnonyldifenyletherdisulfonaat; N-aminoëthylpiperazonium-di-2,4,6-trimethylnonyldifenyletherdisulfonaat |
410-650-0 |
— |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H318 H317 H411 |
|
|
|
607-294-00-5 |
natrium-2-benzoyloxy-1-hydroxyethaan-sulfonaat |
410-680-4 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
607-295-00-0 |
reactiemassa van: tetranatrium-fosfonethaan-1,2-dicarboxylaat; hexanatrium-fosfonobutaan-1,2,3,4-tetracarboxylaat |
410-800-5 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
607-296-00-6 |
reactiemassa van: tetraësters van pentaërytriol met heptaanzuur en 2-ethylhexaanzuur |
410-830-9 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
607-297-00-1 |
(E-E)-3,3'-(1,4-fenyleendimethylideen)bis(2-oxobornaan-10-sulfonzuur) |
410-960-6 |
92761-26-7 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
607-298-00-7 |
2-(trimethylammonium)ethoxycarboxybenzeen-4-sulfonaat |
411-010-3 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
607-299-00-2 |
methyl-3-(acetylthio)-2-methyl-propanoaat |
411-040-7 |
97101-46-7 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
|
607-300-00-6 |
trinatrium-[2-(5-chloor-2,6-difluorpyrimidine-4-ylamino)-5-(b-sulfamoyl-c, d-sulfonatoftalocyanine-a-yl-K 4,N 29,N 30,N 31,N 32-sulfonylamino)benzoato(5–)]cupraat(II) waarbij a = 1,2,3,4 b = 8,9,10,11 c = 15,16,17,18 d = 22,23,24,25 |
411-430-7 |
— |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
607-301-00-1 |
reactiemassa van: dodecaanzuur; poly(1-7)lactaatesters van dodecaanzuur |
411-860-5 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
607-302-00-7 |
reactiemassa van: tetradecaanzuur; poly(1-7)lactaatesters van tetradecaanzuur |
411-910-6 |
— |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H315 H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H315 H318 H317 H411 |
|
|
|
607-303-00-2 |
1-cyclopropyl-6,7-difluor-1,4-dihydro-4-oxochinoline-3-carbonzuur |
413-760-7 |
93107-30-3 |
Repr. 2 Aquatic Chronic 3 |
H361f *** H412 |
GHS08 Wng |
H361f *** H412 |
|
|
|
607-304-00-8 |
fluazifop-butyl (ISO); butyl-(RS)-2-[4-(5-trifluormethyl-2-pyridyloxy)fenoxy]propionaat |
274-125-6 |
69806-50-4 |
Repr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H360D *** H400 H410 |
GHS08 GHS09 Dgr |
H360D *** H410 |
|
|
|
607-305-00-3 |
fluazifop-P-butyl (ISO); butyl-(R)-2-[4-(5-trifluormethyl-2-pyridyloxy)fenoxy]propionaat |
— |
79241-46-6 |
Repr. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H361d *** H400 H410 |
GHS08 GHS09 Wng |
H361d *** H410 |
|
|
|
607-306-00-9 |
chlozolinaat (ISO); ethyl-(RS)-3-(3,5-dichloorfenyl)-5-methyl-2,4-dioxo-oxazolidine-5-carboxylaat |
282-714-4 |
84332-86-5 |
Carc. 2 Aquatic Chronic 2 |
H351 H411 |
GHS08 GHS09 Wng |
H351 H411 |
|
|
|
607-307-00-4 |
vinclozolin (ISO); N-3,5-dichloorfenyl-5-methyl-5-vinyl-1,3-oxazolidine-2,4-dion |
256-599-6 |
50471-44-8 |
Carc. 2 Repr. 1B Skin Sens. 1 Aquatic Chronic 2 |
H351 H360FD H317 H411 |
GHS08 GHS07 GHS09 Dgr |
H351 H360FD H317 H411 |
|
|
|
607-308-00-X |
esters van 2,4-D |
— |
— |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
A |
607-309-00-5 |
carfentrazone-ethyl (ISO); ethyl-(RS)-2-chloor-3-[2-chloor-4-fluor-5-[4-difluormethyl-4,5-dihydro-3-methyl-5-oxo-1H-1,2,4-triazool-1-yl]fenyl]propionaat |
— |
128639-02-1 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
607-310-00-0 |
kresoxim-methyl (ISO); methyl-(E)-2-methoxyimino-[2-(o-tolyloxymethyl)fenyl]acetaat |
— |
143390-89-0 |
Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H400 H410 |
GHS08 GHS09 Wng |
H351 H410 |
|
|
|
607-311-00-6 |
benazolin-ethyl; ethyl-4-chloor-2-oxo-2H-benzothiazool-3-acetaat; |
246-591-0 |
25059-80-7 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
607-312-00-1 |
methoxyazijnzuur |
210-894-6 |
625-45-6 |
Repr. 1B Acute Tox. 4 * Skin Corr. 1B |
H360FD H302 H314 |
GHS08 GHS05 GHS07 Dgr |
H360FD H302 H314 |
|
STOT SE 3; H335: C ≥ 5 % |
|
607-313-00-7 |
neodecanoylchloride |
254-875-0 |
40292-82-8 |
Acute Tox. 2 * Acute Tox. 4 * Skin Corr. 1B |
H330 H302 H314 |
GHS06 GHS06 Dgr |
H330 H302 H314 |
|
STOT SE 3; H335: C ≥ 5 % |
|
607-314-00-2 |
ethofumesaat (ISO); (±)-2-ethoxy-2,3-dihydro-3,3-dimethylbenzofuran-5-ylmethaansulfonaat |
247-525-3 |
26225-79-6 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
607-315-00-8 |
glyfosaat (ISO); N-(fosfonomethyl)glycine |
213-997-4 |
1071-83-6 |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
607-316-00-3 |
glyfosaat-trimesium; glyfosaat-trimethylsulfonium |
— |
81591-81-3 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
607-317-00-9 |
bis(2-ethylhexyl)ftalaat; di-(2-ethylhexyl)ftalaat; DEHP |
204-211-0 |
117-81-7 |
Repr. 1B |
H360FD |
GHS08 Dgr |
H360FD |
|
|
|
607-318-00-4 |
dibutylftalaat; DBP |
201-557-4 |
84-74-2 |
Repr. 1B Aquatic Acute 1 |
H360Df H400 |
GHS08 GHS09 Dgr |
H360Df H400 |
|
|
|
607-319-00-X |
deltamethrin (ISO); (S)-α-cyaan-3-fenoxybenzyl(1R,3R)-3-(2,2-dibroomvinyl)-2,2-dimethylcyclopropaancarboxylaat |
258-256-6 |
52918-63-5 |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H400 H410 |
GHS06 GHS09 Dgr |
H331 H301 H410 |
|
M=1000000 |
|
607-320-00-5 |
bis[4-(ethenyloxy)butyl]-1,3-benzeendicarboxylaat |
413-930-0 |
130066-57-8 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
607-321-00-0 |
(S)-methyl-2-chloorpropionaat |
412-470-8 |
73246-45-4 |
Flam. Liq. 3 STOT RE 2 * Eye Irrit. 2 |
H226 H373 ** H319 |
GHS02 GHS08 Wng |
H226 H373 ** H319 |
|
|
|
607-322-00-6 |
4-(4,4-dimethyl-3-oxo-pyrazolidine-1-yl)-benzoëzuur |
413-120-7 |
107144-30-9 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
607-323-00-1 |
2-(1-(2-hydroxy-3,5-di-tert-pentyl-fenyl)ethyl)-4,6-di-tert-pentylfenyl-acrylaat |
413-850-6 |
123968-25-2 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
607-324-00-7 |
reactiemassa van: N, N-di(gehydrogeneerde alkyl C14-C18)ftaalaminezuur; digehydrogeneerde alkyl (C14-C18)amine |
413-800-3 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
607-325-00-2 |
(S)-2-chloorpropionzuur |
411-150-5 |
29617-66-1 |
Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A |
H312 H302 H314 |
GHS05 GHS07 Dgr |
H312 H302 H314 |
|
|
|
607-326-00-8 |
reactiemassa van: isobutylwaterstof-2-(α-2,4,6-trimethylnon-2-enyl)succinaat; isobutylwaterstof-2-(ß-2,4,6-trimeyhylnon-2-enyl)succinaat |
410-720-0 |
141847-13-4 |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
607-327-00-3 |
2-(2-joodethyl)-1,3-propaandiol-diacetaat |
411-780-0 |
127047-77-2 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
607-328-00-9 |
methyl-4-broommethyl-3-methoxybenzoaat |
410-310-1 |
70264-94-7 |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H315 H318 H317 H410 |
|
|
|
607-329-00-4 |
reactiemassa van: natrium-2-(C12-18-n-alkyl)amino-1,4-butandioaat; natrium-2-octadeceenyl-amino-1,4-butaandioaat |
411-250-9 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
607-330-00-X |
(S)-2,3-dihydro-1H-indool-2-carbonzuur |
410-860-2 |
79815-20-6 |
Repr. 2 STOT RE 2 * Skin Sens. 1 |
H361f *** H373 ** H317 |
GHS08 GHS07 Wng |
H361f *** H373 ** H317 |
|
|
|
607-331-00-5 |
reactiemassa van: bis(2,2,6,6-tetramethyl-1-octyloxypiperidine-4-yl)-1,10-decaandioaat; 1,8-bis[(2,2,6,6-tetramethyl-4-((2,2,6,6-tetramethyl-1-octyloxypiperidine-4-yl)-decaan-1,10-dioyl)piperidine-1-yl)oxy]octaan |
406-750-9 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
607-332-00-0 |
cyclopentylchloorformiaat |
411-460-0 |
50715-28-1 |
Flam. Liq. 3 Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 |
H226 H331 H302 H373 ** H318 H317 |
GHS02 GHS06 GHS08 GHS05 Dgr |
H226 H331 H302 H373 ** H318 H317 |
|
|
|
607-333-00-6 |
reactiemassa van: dodecyl-N-(2,2,6,6-tetramethylpiperidine-4-yl)-β-alaninaat; tetradecyl-N-(2,2,6,6-tetramethylpiperidine-4-yl)-β-alaninaat |
405-670-1 |
— |
Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373 ** H314 H400 H410 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H302 H373 ** H314 H410 |
|
|
|
607-334-00-1 |
ethyl-1-ethyl-6,7,8-trifluor-1,4-dihydro-4-oxochinoline-3-carboxylaat |
405-880-3 |
100501-62-0 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
607-335-00-7 |
methyl-(R)-2-(4-(3-chloor-5-trifluormethyl-2-pyridyloxy)fenoxy)propionaat |
406-250-0 |
72619-32-0 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
607-336-00-2 |
4-methyl-8-methyleentricyclo[3.3.1.13,7]dec-2-ylacetaat |
406-560-6 |
122760-85-4 |
Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H315 H317 H411 |
GHS07 GHS09 Wng |
H315 H317 H411 |
|
|
|
607-337-00-8 |
di-tert-(C12-14)-alkylammonium-2-benzothiazoolylthiosuccinaat |
406-052-4 |
125078-60-6 |
Flam. Liq. 3 Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 2 |
H226 H302 H315 H318 H411 |
GHS02 GHS05 GHS07 GHS09 Dgr |
H226 H302 H315 H318 H411 |
|
|
|
607-338-00-3 |
2-methylpropyl-2-hydroxy-2-methylbut-3-enoaat |
406-235-9 |
72531-53-4 |
Eye Irrit. 2 Skin Irrit. 2 |
H319 H315 |
GHS07 Wng |
H319 H315 |
|
|
|
607-339-00-9 |
2,3,4,5-tetrachloorbenzoylchloride |
406-760-3 |
42221-52-3 |
Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 |
H302 H314 H317 |
GHS05 GHS07 Dgr |
H302 H314 H317 |
|
|
|
607-340-00-4 |
1,3-bis(4-benzoyl-3-hydroxyfenoxy)prop-2-ylacetaat |
406-990-4 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
607-341-00-X |
(9S)-9-amino-9-deoxyerytromycine |
406-790-7 |
26116-56-3 |
Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Dgr |
H318 H410 |
|
|
|
607-342-00-5 |
4-chloorbutylveratraat |
410-950-1 |
69788-75-6 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
607-343-00-0 |
4,7-methanoöctahydro-1H-indeen-diyldimethylbis(2-carboxybenzoaat) |
407-410-2 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
607-344-00-6 |
reactiemassa van: 3-(N-(3-dimethylaminopropyl)-(C4-8)perfluoralkylsulfonamido)propionzuur; N-[dimethyl-3-(C4-8-perfluoralkylsulfonamido)propylammonium-propionaat; 3-(N-(3-dimethyl-propylammonium)-(C4-8)perfluoralkylsulfonamido)propionzuur-propionaat |
407-810-7 |
— |
STOT RE 2 * |
H373 ** |
GHS08 Wng |
H373 ** |
|
|
|
607-345-00-1 |
kalium-2-(2,4-dichloorfenoxy)-(R)-propionaat |
413-580-9 |
113963-87-4 |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H302 H315 H318 H317 |
GHS05 GHS07 Dgr |
H302 H315 H318 H317 |
|
|
|
607-346-00-7 |
3-icosyl-4-henicosylideen-2-oxetanon |
401-210-9 |
83708-14-9 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
607-347-00-2 |
natrium-(R)-2-(2,4-dichloorfenoxy)propionaat |
413-340-3 |
119299-10-4 |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H302 H315 H318 H317 |
GHS05 GHS07 Dgr |
H302 H315 H318 H317 |
|
|
|
607-348-00-8 |
magnesium-bis((R)-2-(2,4-dichloorfenoxy)propionaat) |
413-360-2 |
— |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H302 H315 H318 H317 |
GHS05 GHS07 Dgr |
H302 H315 H318 H317 |
|
|
|
607-349-00-3 |
mono-(tetrapropylammonium)waterstof-2,2'-dithiobisbenzoaat |
411-270-8 |
— |
Aquatic Chronic 3 |
H412 |
|
H412 |
|
|
|
607-350-00-9 |
bis(4-(1,2-bis(ethoxycarbonyl)-ethylamino)-3-methyl-cyclohexyl)methaan |
412-060-9 |
136210-32-7 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
607-351-00-4 |
methyl-O-(4-amino-3,5-dichloor-6-fluorpyridine-2-yloxy)acetaat |
407-550-4 |
69184-17-4 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
607-352-00-X |
4,4'-oxydiftaalzuuranhydride |
412-830-4 |
1823-59-2 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
607-353-00-5 |
reactiemassa van: ethyl-exo-tricyclo[5.2.1.02,6]decaan-endo-2-carboxylaat; ethyl-endo-tricyclo[5.2.1.02,6]decaan-exo-2-carboxylaat |
407-520-0 |
80657-64-3 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
607-354-00-0 |
ethyl-2-cyclohexylpropionaat |
412-280-5 |
2511-00-4 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
607-355-00-6 |
p-tolyl-4-chloorbenzoaat |
411-530-0 |
15024-10-9 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
607-356-00-1 |
ethyl-trans-2,2,6-trimethylcyclohexaancarboxylaat |
412-540-8 |
— |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
607-357-00-7 |
reactiemassa van: trans-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran; cis-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran |
412-450-9 |
131766-73-9 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
607-358-00-2 |
(1S,3S,5R,6R)-(4-nitrofenylmethyl)-1-dioxo-6-fenylaceetamido-penam-3-carboxylaat |
412-670-5 |
54275-93-3 |
Resp. Sens. 1 |
H334 |
GHS08 Dgr |
H334 |
|
|
|
607-359-00-8 |
(1S,4R,6R,7R)-(4-nitrofenylmethyl)-3-methyleen-1-oxo-7-fenylaceetamido-cefam-4-carboxylaat |
412-800-0 |
76109-32-5 |
Resp. Sens. 1 |
H334 |
GHS08 Dgr |
H334 |
|
|
|
607-360-00-3 |
natrium-3-acetoacetylamino-4-methoxytolyl-6-sulfonaat |
411-680-7 |
133167-77-8 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
607-361-00-9 |
methyl-(R)-2-(4-hydroxyfenoxy)-propionaat |
411-950-4 |
96562-58-2 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
607-362-00-4 |
reactiemassa van: (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]-ammonium-2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)hexadec-4-enoaat; (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium-2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)tetradec-4-enoaat; (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]-ammonium-2-(3-methoxypropylcarbamoylmethyl)hexadec-4-enoaat; (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium-2-(3-methoxypropylcarbamoylmethyl)tetradec-4-enoaat |
413-500-2 |
— |
Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 2 |
H315 H318 H411 |
GHS05 GHS09 Dgr |
H315 H318 H411 |
|
|
|
607-363-00-X |
methyl-3-methoxyacrylaat |
412-900-4 |
5788-17-0 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
607-364-00-5 |
3-fenyl-7-[4-(tetrahydrofurfuryloxy)fenyl]-1,5-dioxa-s-indaceen-2,6-dion |
413-330-9 |
134724-55-3 |
Aquatic Chronic 4 |
H413 |
|
H413 |
|
|
|
607-365-00-0 |
2-(2-amino-1,3-thiazool-4-yl)-(Z)-2-methoxyiminoacetylchloride-hydrochloride |
410-620-7 |
119154-86-8 |
Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 |
H302 H314 H317 |
GHS05 GHS07 Dgr |
H302 H314 H317 |
|
|
|
607-366-00-6 |
3,5-dimethylbenzoylchloride |
413-010-9 |
6613-44-1 |
Skin Corr. 1B Skin Sens. 1 |
H314 H317 |
GHS05 GHS07 Dgr |
H314 H317 |
|
|
|
607-367-00-1 |
kalium-bis(N-carboxymethyl)-N-methyl-glycinato-(2–)N,O,O,N)-ferraat-(1–)monohydraat |
411-640-9 |
153352-59-1 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
607-368-00-7 |
1-(N,N-dimethylcarbamoyl)-3-tert-butyl-5-carbethoxymethylthio-1H-1,2,4-triazool |
411-650-3 |
110895-43-7 |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H400 H410 |
GHS06 GHS09 Dgr |
H331 H301 H410 |
|
|
|
607-369-00-2 |
reactiemassa van: trans-(2R)-5-acetoxy-1,3-oxathiolaan-2-carbonzuur; cis-(2R)-5-acetoxy-1,3-oxathiolaan-2-carbonzuur |
411-660-8 |
147027-04-1 |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H302 H315 H318 H317 |
GHS05 GHS07 Dgr |
H302 H315 H318 H317 |
|
|
|
607-370-00-8 |
2-[[2-(acetyloxy)-3-(1,1-dimethyl-ethyl)-5-methylfenyl]methyl]-6-(1,1-dimethylethyl)-4-methylfenol |
412-210-3 |
41620-33-1 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
607-371-00-3 |
3-ethyl-5-methyl-4-(2-chloorfenyl)-1,4-dihydro-2-[2-(1,3-dihydro-1,3-dioxo-(2)isoïndool-2-yl)-ethoxymethyl]-6-methyl-3,5-pyridinedicarboxylaat |
413-410-3 |
88150-62-3 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
607-372-00-9 |
geëthoxyleerde bisfenol A-di-(norborneencarboxylaat) |
412-410-0 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
607-373-00-4 |
(±)-tetrahydrofurfuryl-(R)-2-[4-(6-chloorchinoxaline-2-yloxy)-fenyloxy]propionaat |
414-200-4 |
119738-06-6 |
Muta. 2 Repr. 1B Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H341 H360Df H302 H373 ** H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H341 H360Df H302 H373 ** H410 |
|
|
|
607-374-00-X |
5-amino-2,4,6-trijood-1,3-benzeendicarbonyldichloride |
417-220-1 |
37441-29-5 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
607-376-00-0 |
benzyl-2,4-dibroombutanoaat |
420-710-8 |
23085-60-1 |
Repr. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361f *** H315 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H361f *** H315 H317 H410 |
|
|
|
607-377-00-6 |
trans-4-cyclohexyl-L-proline-monohydrochloride |
419-160-1 |
90657-55-9 |
Repr. 2 Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H361f *** H302 H315 H318 H317 |
GHS08 GHS05 GHS07 Dgr |
H361f *** H302 H315 H318 H317 |
|
|
|
607-378-00-1 |
ammonium-(Z)-α-methoxyimino-2-furylacetaat |
405-990-1 |
97148-39-5 |
Flam. Sol. 2 |
H228 |
GHS02 Dgr |
H228 |
|
|
T |
607-379-00-7 |
reactiemassa van: 2-[N-(2-hydroxyethyl)stearamido]ethylstearaat; natrium-[bis[2-(stearoyloxy)ethyl]amino]methylsulfonaat; natrium-[bis(2-hydroxyethyl)amino]methylsulfonaat; N,N-bis(2-hydroxyethyl)stearamide |
401-230-8 |
|
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
607-380-00-2 |
reactiemassa van: ammonium-1,2-bis(hexyloxycarbonyl)ethaansulfonaat; ammonium-1-hexyloxycarbonyl-2-octyloxycarbonylethaansulfonaat; ammonium-2-hexyloxycarbonyl-1-octyloxycarbonylethaansulfonaat |
407-320-3 |
— |
Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H315 H318 H412 |
GHS05 Dgr |
H315 H318 H412 |
|
|
|
607-381-00-8 |
reactiemassa van triësters van 2,2-bis(hydroxymethyl)butanol met C7-alkaanzuren en 2-ethylhexaanzuur |
413-710-4 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
607-382-00-3 |
2-((4-amino-2-nitrofenyl)amino)benzoëzuur |
411-260-3 |
117907-43-4 |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Dgr |
H318 H317 H412 |
|
|
|
607-383-00-9 |
reactiemassa van: 2,2,6,6-tetramethylpiperidine-4-yl-hexadecanoaat; 2,2,6,6-tetramethylpiperidine-4-yl-octadecanoaat |
415-430-8 |
86403-32-9 |
Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H318 H317 H410 |
|
|
|
607-384-00-4 |
reactiemassa van: esters van C14-C15-vertakte alcoholen met 3,5-di-t-butyl-4-hydroxyfenylpropionzuur; C15-vertakt en lineair alkyl, 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzeenpropanoaat; C13-vertakt en lineair alkyl, 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzeenpropanoaat |
413-750-2 |
171090-93-0 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
607-385-00-X |
copolymeer van vinylalcohol en vinylacetaat, gedeeltelijk geacetyleerd met 4-(2-(4-formylfenyl)ethenyl)-1-methylpyridinium-methylsulfaat |
414-590-6 |
125229-74-5 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
607-386-00-5 |
reactiemassa van: tetradecaanzuur (42,5-47,5 %); poly(1-7)lactaatesters van tetradecaanzuur (52.5-57.5 %) |
412-580-6 |
174591-51-6 |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H315 H318 H317 H410 |
|
|
|
607-387-00-0 |
reactiemassa van: dodecaanzuur (35-40 %); poly(1-7)lactaatesters van dodecaanzuur (60-65 %) |
412-590-0 |
58856-63-6 |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H315 H318 H317 H410 |
|
|
|
607-388-00-6 |
4-ethylamino-3-nitrobenzoëzuur |
412-090-2 |
2788-74-1 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 3 |
H302 H317 H412 |
GHS07 Wng |
H302 H317 H412 |
|
|
|
607-389-00-1 |
trinatrium-N,N-bis(carboxymethyl)-3-amino-2-hydroxypropionaat |
414-130-4 |
119710-96-2 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
607-390-00-7 |
1,2,3,4-tetrahydro-6-nitro-chinoxaline |
414-270-6 |
41959-35-7 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
607-391-00-2 |
dimethylcyclopropaan-1,1-dicarboxylaat |
414-240-2 |
6914-71-2 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
607-392-00-8 |
2-fenoxyethyl-4-((5-cyaan-1,6-dihydro-2-hydroxy-1,4-dimethyl-6-oxo-3-pyridinyl)azo)benzoaat |
414-260-1 |
88938-37-8 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
607-393-00-3 |
3-(cis-1-propenyl)-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-een-2-carbonzuur |
415-750-8 |
106447-44-3 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
607-394-00-9 |
5-methylpyrazine-2-carbonzuur |
413-260-9 |
5521-55-1 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
607-395-00-4 |
reactiemassa van: natrium-1-tridecyl-4-allyl-(2 of 3)-sulfobutaandioaat; natrium-1-dodecyl-4allyl-(2 of 3)-sulfobutaandioaat |
410-230-7 |
— |
Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 |
H314 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H314 H317 H411 |
|
|
|
607-396-00-X |
bis(1,2,2,6,6-pentamethyl-4-piperidinyl)-2-(4-methoxybenzylideen)malonaat |
414-840-4 |
147783-69-5 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
607-397-00-5 |
reactiemassa van: Ca-salicylaten (vertakt C10-14 en C18-30 gealkyleerd); Ca-fenolaten (vertakt C10-14 en C18-30 gealkyleerd); Ca-gesulfureerde fenolaten (vertakt C10-14 en C18-30 gealkyleerd) |
415-930-6 |
— |
Repr. 2 Skin Sens. 1 |
H361f*** H317 |
GHS08 GHS07 Wng |
H361f*** H317 |
|
|
|
607-398-00-0 |
ethyl-N-(5-chloor-3-(4-(diëthylamino)-2-methylfenylimino)-4-methyl-6-oxo-1,4-cyclohexadiënyl)carbamaat |
414-820-5 |
125630-94-6 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
607-399-00-6 |
2,2-dimethyl-3-methyl-3-butenylpropanoaat |
415-610-6 |
104468-21-5 |
Skin Irrit. 2 Aquatic Chronic 3 |
H315 H412 |
GHS07 Wng |
H315 H412 |
|
|
|
607-400-00-X |
methyl-3-[[(dibutylamino)thioxomethyl]thio]propanoaat |
414-400-1 |
32750-89-3 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
607-401-00-5 |
ethyl-3-hydroxy-5-oxo-3-cyclohexeen-1-carboxylaat |
414-450-4 |
88805-65-6 |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H315 H318 H317 |
GHS05 GHS07 Dgr |
H315 H318 H317 |
|
|
|
607-402-00-0 |
methyl-N-(fenoxycarbonyl)-L-valinaat |
414-500-5 |
153441-77-1 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
607-403-00-6 |
reactiemassa van: bis(1S,2S,4S)-(1-benzyl-4-tert-butoxycarboxamido-2-hydroxy-5-fenyl)pentylammoniumsuccinaat; isopropylalcohol |
414-810-0 |
— |
STOT RE 2 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H373 ** H318 H400 H410 |
GHS08 GHS05 GHS09 Dgr |
H373 ** H318 H410 |
|
|
|
607-404-00-1 |
reactiemassa van: ((Z)-3,7-dimethyl-2,6-octadiënyl)oxycarbonylpropaanzuur; di-((E)-3,7-dimethyl-2,6-octadiënyl)butaandioaat; di-((Z)-3,7-dimethyl-2,6-octadiënyl)butaandioaat; (Z)-3,7-dimethyl-2,6-octadiënyl-butaandioaat; ((E)-3,7-dimethyl-2,6-octadiënyl)oxycarbonylpropaanzuur |
415-190-4 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
607-405-00-7 |
2-hexyldecyl-p-hydroxybenzoaat |
415-380-7 |
148348-12-3 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
607-406-00-2 |
kalium-2,5-dichloorbenzoaat |
415-700-5 |
184637-62-5 |
Acute Tox. 4 * Eye Dam. 1 |
H302 H318 |
GHS05 GHS07 Dgr |
H302 H318 |
|
|
|
607-407-00-8 |
ethyl-2-carboxy-3-(2-thiënyl)propionaat |
415-680-8 |
143468-96-6 |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H315 H318 H317 |
GHS05 GHS07 Dgr |
H315 H318 H317 |
|
|
|
607-408-00-3 |
kalium-N-(4-fluorfenyl)glycinaat |
415-710-1 |
184637-63-6 |
STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H373 ** H318 H317 H412 |
GHS08 GHS05 GHS07 Dgr |
H373 ** H318 H317 H412 |
|
|
|
607-409-00-9 |
reactiemassa van: (3R)-[1S-(1α,2α, 6β-((2S)-2-methyl-1-oxo-butoxy)-8aγ)hexahydro-2,6-dimethyl-1-naftaleen]-3,5-dihydroxyheptaanzuur; inerte biomassa van Aspergillus terreus |
415-840-7 |
— |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
607-410-00-4 |
mono[2-(dimethylamino)ethyl]monowaterstof-2-(hexadec-2-enyl)butaandioaat en/of mono[2-(dimethylamino)ethyl]monowaterstof-3-(hexadec-2-enyl)butaandioaat |
415-880-5 |
779343-34-9 |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H315 H318 H317 H410 |
|
|
|
607-411-00-X |
oxiraanmethanol, 4-methylbenzeensulfonaat, (S)- |
417-210-7 |
70987-78-9 |
Carc. 1B Muta. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H350 H341 H318 H317 H411 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H350 H341 H318 H317 H411 |
|
|
|
607-412-00-5 |
ethyl-2-(1-cyaancyclohexyl)acetaat |
415-970-4 |
133481-10-4 |
Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 3 |
H302 H373 ** H412 |
GHS08 GHS07 Wng |
H302 H373 ** H412 |
|
|
|
607-413-00-0 |
trans-4-fenyl-L-proline |
416-020-1 |
96314-26-0 |
Repr. 2 Skin Sens. 1 |
H361f *** H317 |
GHS08 GHS07 Wng |
H361f *** H317 |
|
|
|
607-414-00-6 |
tris(2-ethylhexyl)-4,4',4''-(1,3,5-triazine-2,4,6-triyltriimino)tribenzoaat |
402-070-1 |
88122-99-0 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
607-415-00-1 |
poly-(methylmethacrylaat)-co-(butylmethacrylaat)-co-(4-acryloxybutyl-isopropenyl-α, α-dimethylbenzylcarbamaat)-co-(maleïnezuuranhydride) |
419-590-1 |
— |
Flam. Sol. 1 Skin Sens. 1 |
H228 H317 |
GHS02 GHS07 Dgr |
H228 H317 |
|
|
T |
607-416-00-7 |
4-(2-carboxymethylthio)ethoxy-1-hydroxy-5-isobutyloxycarbonylamino-N-(3-dodecyloxypropyl)-2-naftamide |
420-730-7 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
607-417-00-2 |
3-chloorpropylchloorformiaat |
425-770-9 |
628-11-5 |
Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H331 H302 H373** H315 H318 H317 |
GHS06 GHS05 GHS08 Dgr |
H331 H302 H373** H315 H318 H317 |
|
|
|
607-418-00-8 |
2-ethylhexyl-4-aminobenzoaat |
420-170-3 |
26218-04-2 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
607-419-00-3 |
(3'-carboxymethyl-5-(2-(3-ethyl-3H-benzothiazool-2-ylideen)-1-methylethylideen)-4,4'-dioxo-2'-thioxo-(2,5')bithiazolidinylideen-3-yl)-azijnzuur |
422-240-9 |
166596-68-5 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
607-420-00-9 |
2,2-bis(hydroxymethyl)butaanzuur |
424-090-1 |
10097-02-6 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
607-421-00-4 |
cypermethrin cis/trans +/-40/60; (RS)-α-cyaan-3-fenoxybenzyl(1RS,3RS;1RS,3SR)-3-(2,2-dichloorvinyl)-2,2-dimethylcyclopropaancarboxylaat |
257-842-9 |
52315-07-8 |
Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 |
H332 H302 H335 H400 H410 |
GHS07 GHS09 Wng |
H332 H302 H335 H410 |
|
|
|
607-422-00-X |
α-cypermethrin (ISO); een racemaat bestaande uit (R)-α-cyaan-3-fenoxybenzyl-(1S,3S)-3-(2,2-dichloorvinyl)-2,2-dimethylcyclopropaancarboxylaat; (S)-α-cyaan-3-fenoxybenzyl(1R,3R)-3-(2,2-dichloorvinyl)-2,2-dimethylcyclopropaancarboxylaat |
257-842-9 |
67375-30-8 |
Acute Tox. 3 * STOT RE 2 * STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H373** H335 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H301 H373** H335 H410 |
|
M=1000 |
|
607-423-00-5 |
esters van mecoprop en van mecoprop-P |
— |
— |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
A |
607-424-00-0 |
trifloxystrobin (ISO); (E, E)-α-methoxyimino-{2-[[[[1-[3-(trifluormethyl)fenyl]ethylideen]amino]oxy]methyl]benzeenazijnzuur, methylester |
— |
141517-21-7 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
607-425-00-6 |
metalaxyl (ISO); methyl-N-(2,6-dimethylfenyl)-N-(methoxyacetyl)-DL-alaninaat |
260-979-7 |
57837-19-1 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 3 |
H302 H317 H412 |
GHS07 Wng |
H302 H317 H412 |
|
|
|
607-426-00-1 |
1,2-benzeendicarbonzuur, dipentylester, vertakt en lineair; [1] n-pentyl-isopentylftalaat; [2] di-n-pentylftalaat; [3] diisopentylftalaat [4] |
284-032-2 [1] -[2] 205-017-9 [3] 210-088-4 [4] |
84777-06-0 [1] -[2] 131-18-0 [3] 605-50-5 [4] |
Repr. 1B Aquatic Acute 1 |
H360FD H400 |
GHS08 GHS09 Dgr |
H360FD H400 |
|
|
|
607-427-00-7 |
bromoxynilheptanoaat (ISO); 2,6-dibroom-4-cyaanfenylheptanoaat |
260-300-4 |
56634-95-8 |
Repr. 2 Acute Tox. 4 * Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361d *** H332 H302 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H361d *** H332 H302 H317 H410 |
|
|
|
607-428-00-2 |
tetranatriumethyleendiaminetetraäcetaat |
200-573-9 |
64-02-8 |
Acute Tox. 4 * Eye Dam. 1 |
H302 H318 |
GHS05 GHS07 Dgr |
H302 H318 |
|
|
|
607-429-00-8 |
edetinezuur; (EDTA) |
200-449-4 |
60-00-4 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
607-430-00-3 |
BBP; benzylbutylftalaat e |
201-622-7 |
85-68-7 |
Repr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H360Df H400 H410 |
GHS08 GHS09 Dgr |
H360Df H410 |
|
|
|
607-431-00-9 |
prallethrin (ISO); ETOC; 2-methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-een-1-yl-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropaancarboxylaat |
245-387-9 |
23031-36-9 |
Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H302 H400 H410 |
GHS06 GHS09 Dgr |
H331 H302 H410 |
|
|
|
607-432-00-4 |
S-metolachloor; reactiemassa van (S)-2-chloor-N-(2-ethyl-6-methyl-fenyl)-N-(2-methoxy-1-methyl-ethyl)-aceetamide (80-100 %); [1] (R)-2-chloor-N-(2-ethyl-6-methyl-fenyl)-N-(2-methoxy-1-methyl-ethyl)-aceetamide (0-20 %) [2] |
-[1] -[2] |
87392-12-9 [1] 178961-20-1 [2] |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
607-433-00-X |
cypermethrin cis/trans +/-80/20; (RS)-α-cyaan-3-fenoxybenzyl-(1RS;3RS; 1RS,3SR)-3-(2,2-dichloorvinyl)-2,2-dimethylcyclopropaancarboxylaat |
257-842-9 |
52315-07-8 |
Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H335 H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H335 H315 H317 H410 |
|
|
|
607-434-00-5 |
mecoprop-P [1] en zijn zouten; (R)-2-(4-chloor-2-methylfenoxy)propionzuur |
240-539-0 |
16484-77-8 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H411 |
|
|
|
607-435-00-0 |
2S-isopropyl-5R-methyl-1R-cyclohexyl-2,2-dihydroxyacetaat |
416-810-6 |
111969-64-3 |
STOT RE 2 * Eye Dam. 1 Aquatic Chronic 2 |
H373 ** H318 H411 |
GHS08 GHS05 GHS09 Dgr |
H373 ** H318 H411 |
|
|
|
607-436-00-6 |
2-hydroxy-3-(2-ethyl-4-methylimidazoyl)propylneodecanoaat |
417-350-9 |
— |
Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H400 H410 |
GHS05 GHS09 Dgr |
H315 H318 H410 |
|
|
|
607-437-00-1 |
3-(4-aminofenyl)-2-cyaan-2-propeenzuur |
417-480-6 |
252977-62-1 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
607-438-00-7 |
methyl-2-[(aminosulfonyl)methyl]benzoaat |
419-010-5 |
112941-26-1 |
Acute Tox. 4 * Eye Irrit. 2 |
H302 H319 |
GHS07 Wng |
H302 H319 |
|
|
|
607-439-00-2 |
methyltetrahydro-2-furancarboxylaat |
420-670-1 |
37443-42-8 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
607-440-00-8 |
methyl-2-aminosulfonyl-6-(trifluormethyl)pyridine-3-carboxylaat |
421-220-7 |
144740-59-0 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
607-441-00-3 |
3-[3-(2-dodecyloxy-5-methylfenylcarbamoyl)-4-hydroxy-1-naftylthio]propionzuur |
421-490-6 |
167684-63-1 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
607-442-00-9 |
benzyl-[hydroxy-(4-fenylbutyl)fosfinyl]acetaat |
416-050-5 |
87460-09-1 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
607-444-00-X |
reactiemassa van: cis-1,4-dimethylcyclohexyldibenzoaat; trans-1,4-dimethylcyclohexyldibenzoaat |
416-230-3 |
35541-81-2 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
607-445-00-5 |
ijzer(III) tris(4-methylbenzeensulfonaat) |
420-960-8 |
77214-82-5 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
607-446-00-0 |
methyl-2-[4-(2-chloor-4-nitrofenylazo)-3-(1-oxopropyl)amino]fenylaminopropionaat |
416-240-8 |
155522-12-6 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
607-447-00-6 |
natrium-4-[4-(4-hydroxyfenylazo)fenylamino]-3-nitrobenzeensulfonaat |
416-370-5 |
156738-27-1 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
607-448-00-1 |
2,3,5,6-tetrafluorbenzoëzuur |
416-800-1 |
652-18-6 |
Skin Irrit. 2 Eye Dam. 1 |
H315 H318 |
GHS05 Dgr |
H315 H318 |
|
|
|
607-449-00-7 |
reactiemassa van: 4,4',4''-[(2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,3,5-triyl)tris[methyleen(3,5,5-trimethyl-3,1-cyclohexaandiyl)iminocarbonyloxy-2,1-ethaandiyl(ethyl)amino]]trisbenzeendiazoniumtri[bis(2-methylpropyl)naftaleensulfonaat];4,4',4'',4'''-[[5,5'-[carbonylbis[imino(1,5,5-trimethyl-3,1-cyclohexaandiyl)methyleen]]-2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,1',3,3'-tetrayl]tetrakis[methyleen(3,5,5-trimethyl-3,1-cyclohexaandiyl)iminocarbonyloxy-2,1-ethaandiyl(ethyl)amino]]tetrakisbenzeendiazoniumtetra[bis(2-methylpropyl)naftaleensulfonaat] |
417-080-1 |
— |
Self-react. D **** Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H242 H317 H400 H410 |
GHS02 GHS07 GHS09 Dgr |
H242 H317 H410 |
|
|
|
607-450-00-2 |
2-mercaptobenzothiazolyl-(Z)-(2-aminothiazool-4-yl)-2-(tert-butoxycarbonyl)-isopropoxyiminoacetaat |
419-040-9 |
89604-92-2 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
607-451-00-8 |
4-[4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)-fenylazo)-2,7-disulfonaft-6-ylazo]-6-[3-(4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)-fenylazo)-2,7-disulfonaft-6-ylazo]-fenyl-carbonyl-amino]-benzeensulfonzuur, natriumzout |
417-640-5 |
161935-19-9 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
607-453-00-9 |
4-benzyl-2,6-dihydroxy-4-aza-heptyleen-bis(2,2-dimethyloctanoaat) |
418-100-1 |
172964-15-7 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
607-454-00-4 |
reactiemassa van: trans-2-(1-methylethyl)-1,3-dioxaan-5-carbonzuur; cis-2-(1-methylethyl)-1,3-dioxaan-5-carbonzuur |
418-170-3 |
116193-72-7 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
607-455-00-X |
1-amino-4-(3-[4-chloor-6-(2,5-di-sulfofenylamino)-1,3,5-triazine-2-ylamino]-2,2-dimethyl-propylamino)-antrachinon-2-sulfonzuur, natrium-/lithiumzout |
419-520-8 |
172890-93-6 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
607-456-00-5 |
3-amino-4-chloorbenzoëzuur, hexadecylester |
419-700-6 |
143269-74-3 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
607-457-00-0 |
tetranatriumdiwaterstof-1,1''-dihydroxy-8,8''-[p-fenylbis(imino-{6-[4-(2-aminoëthyl)piperazine-1-yl]}-1,3,5-triazine-4,2-diyl-imino)]bis(2,2'-azonaftaleen-1',3,6-trisulfonaat) |
420-350-1 |
172277-97-3 |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
607-458-00-6 |
reactiemassa van: 2-ethyl-[2,6-dibroom-4-[1-[3,5-dibroom-4-(2-hydroxyethoxy)fenyl]-1-methylethyl]fenoxy]propenoaat; 2,2'-diëthyl-[4,4'-bis(2,6-dibroomfenoxy)-1-methylethylideen]-dipropenoaat; 2,2'-[(1-methylethylideen)bis[[2,6-dibroom-4,1-fenyleen)oxy]ethanol]] |
420-850-1 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
607-459-00-1 |
isopentyl-4-{2-[5-cyaan-1,2,3,6-tetrahydro-1-(2-isopropoxyethoxy-carbonylmethyl)-4-methyl-2,6-dioxo-3-pyridylideen]hydrazino}benzoaat |
418-930-4 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
607-460-00-7 |
3-tridecyloxypropylammonium-9-octadecenoaat |
418-990-1 |
778577-53-0 |
STOT RE 2 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H373 ** H319 H315 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H373 ** H319 H315 H410 |
|
|
|
607-461-00-2 |
reactiemassa van: pentanatrium-2-{4-{3-methyl-4-[6-sulfonato-4-(2-sulfonato-fenylazo)-naftaleen-1-ylazo]-fenylamino}-6-[3-(2-sulfato-ethaansulfonyl)-fenylamino]-1,3,5-triazine-2-ylamino}-benzeen-1,4-disulfonaat; pentanatrium-2-{4-{3-methyl-4-[7-sulfonato-4-(2-sulfonato-fenylazo)-naftaleen-1-ylazo]-fenylamino}-6-[3-(2-sulfato-ethaansulfonyl)-fenylamino]-1,3,5-triazine-2-ylamino}-benzeen-1,4-disulfonaat |
421-160-1 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
607-462-00-8 |
reactiemassa van: 1-hexylacetaat; 2-methyl-1-pentylacetaat; 3-methyl-1-pentylacetaat; 4-methyl-1-pentylacetaat; andere gemengde lineaire en vertakte C6-alkylacetaten |
421-230-1 |
88230-35-7 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
607-463-00-3 |
3-(fenothiazine-10-yl)propionzuur |
421-260-5 |
362-03-8 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
607-464-00-9 |
reactiemassa van: 7-chloor-1-ethyl-6-fluor-1,4-dihydro-4-oxo-chinoline-3-carbonzuur; 5-chloor-1-ethyl-6-fluor-1,4-dihydro-4-oxo-chinoline-3-carbonzuur |
421-280-4 |
|
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
607-465-00-4 |
tris(2-hydroxyethyl)ammonium-7-{4-[4-(2-cyaanamino-4-hydroxy-6-oxidopyrimidine-5-ylazo)benzamido]-2-ethoxy-fenylazo}naftaleen-1,3-disulfonaat |
421-440-3 |
778583-04-3 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
607-466-00-X |
reactiemassa van: fenyl-1-(1-[2-chloor-5-(hexadecyloxycarbonyl)fenylcarbamoyl]-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazool-5-carboxylaat; fenyl-2-(1-(2-chloor-5-(hexadecyloxycarbonyl)fenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazool-5-carboxylaat; fenyl-3-(1-(2-chloor-5-(hexadecyloxycarbonyl)fenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazool-5-carboxylaat |
421-480-1 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
607-467-00-5 |
1,1,3,3-tetrabutyl-1,3-ditinoxydicaprylaat |
419-430-9 |
56533-00-7 |
Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H373 ** H314 H400 H410 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H312 H302 H373 ** H314 H410 |
|
|
|
607-468-00-0 |
reactiemassa van: mononatrium-4-((4-(5-sulfonaat-2-methoxyfenylamino)-6-chloor-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonaatmethyl-1,2-dihydropyridine-3-yl)azo)benzeensulfonaat; dinatrium-4-((4-(5-sulfonaat-2-methoxyfenylamino)-6-chloor-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonaatmethyl-1,2-dihydropyridine-3-yl)azo)benzeensulfonaat; trinatrium-4-((4-(5-sulfonaat-2-methoxyfenylamino)-6-chloor-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonaatmethyl-1,2-dihydropyridine-3-yl)azo)benzeensulfonaat; tetranatrium-4-((4-(5-sulfonaat-2-methoxyfenylamino)-6-chloor-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonaatmethyl-1,2-dihydropyridine-3-yl)azo)benzeensulfonaat |
419-450-8 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
607-469-00-6 |
dinatrium-7-((4,6-bis(3-diëthylaminopropylamino)-1,3,5-triazine-2-yl)amino)-4-hydroxy-3-(4-(4-sulfonaatfenylazo)fenylazo)-2-naftaleensulfonaat |
419-460-2 |
120029-06-3 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
607-470-00-1 |
kaliumnatrium-6,13-dichloor-3,10-bis{2-[4-[3-(2-hydroxysulfonyloxyethaansulfonyl)fenylamino]-6-(2,5-disulfonatofenylamino)-1,3,5-triazine-2-ylamino]ethylamino}benzo[5,6][1,4]oxazino[2,3-b]fenoxazine-4,11-disulfonaat |
414-100-0 |
154336-20-6 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
607-471-00-7 |
1,6-bis((dibenzylthiocarbamoyl)disulfanyl)hexaan |
429-280-6 |
151900-44-6 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
607-473-00-8 |
pentaërytritol, dipentaërytritol, vetzuren, C6-10, gemengde esters met adipinezuur, heptaanzuur en isostearinezuur |
426-590-3 |
187412-41-5 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
607-474-00-3 |
4(-4-(4-dimethylaminobenzylideen-1-yl)-3-methyl-5-oxo-2-pyrazoline-1-yl)benzoëzuur |
410-430-4 |
117573-89-4 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
607-475-00-9 |
reactiemassa (50/50) van: tetranatrium-7-(4-[4-chloor-6-[methyl-(3-sulfonatofenyl)amino]-1,3,5-triazine-2-ylamino]-2-ureïdofenylazo)naftaleen-1,3,6-trisulfonaat; tetranatrium-7-(4-[4-chloor-6-[methyl-(4-sulfonatofenyl)amino]-1,3,5-triazine-2-ylamino]-2-ureïdofenylazo)naftaleen-1,3,6-trisulfonaat |
412-940-2 |
148878-18-6 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
607-476-00-4 |
trinatrium-N,N-bis(carboxymethyl)-β-alanine |
414-070-9 |
129050-62-0 |
Skin Corr. 1B Aquatic Chronic 3 |
H314 H412 |
GHS05 Dgr |
H314 H412 |
|
|
|
607-477-00-X |
(1α5α6α)-6-nitro-3-benzyl-3-azabicyclo[3.1.0]hexaanmethaansulfonaatzout |
426-740-8 |
— |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H411 |
|
|
|
607-478-00-5 |
tetramethylammoniumwaterstofftalaat |
416-900-5 |
79723-02-7 |
Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 |
H301 H373 ** H400 |
GHS06 GHS08 GHS09 Dgr |
H301 H373 ** H400 |
|
|
|
607-479-00-0 |
hexadecyl-4-chloor-3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-yl)-4,4-dimethyl-3-oxopentamido]benzoaat |
418-550-9 |
168689-49-4 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
607-480-00-6 |
1,2-benzeendicarbonzuur; di-C7-11-vertakte en lineaire alkylesters |
271-084-6 |
68515-42-4 |
Repr. 1B |
H360Df |
GHS08 Dgr |
H360Df |
|
|
|
607-481-00-1 |
reactiemassa van: trihexylcitraat; dihexyloctylcitraat; dioctylhexylcitraat; dihexyldecylcitraat |
430-290-8 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
607-482-00-7 |
N-[1-(S)-ethoxycarbonyl-3-fenylpropyl]-L-alanyl-N-carboxyanhydride |
430-360-8 |
84793-24-8 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
607-483-00-2 |
1,2-benzeendicarbonzuur; di-C6-8-vertakte alkylesters, C7-rijk |
276-158-1 |
71888-89-6 |
Repr. 1B |
H360D*** |
GHS08 Dgr |
H360D*** |
|
|
|
607-484-00-8 |
ethyl-2-{[3-acetylamino-4-(6-broom-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoïndool-5-ylazo)fenyl{]ethylamino[}propionaat |
430-480-0 |
221452-67-1 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
607-485-00-3 |
(3S-trans)-fenyl-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorfenyl)-1-piperidinecarboxylaat |
430-510-2 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
607-486-00-9 |
kaliumnatrium-5'-(6-chloor-4-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazine-2-ylamino)-4'-hydroxy-2,3'-azodinaftaleen-1,2',5,7'-disulfonaat |
402-110-8 |
110081-40-8 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
607-487-00-4 |
reactiemassa van: dinatrium-4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-hydroxy-1-(4-sulfonatofenyl)pyrazool-4-yl)penta-2,4-diënylideen)-4,5-dihydro-5-oxopyrazool-1-yl)benzeensulfonaat; trinatrium-4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-oxido-1-(4-sulfonatofenyl)pyrazool-4-yl)penta-2,4-diënylideen)-4,5-dihydro-5-oxopyrazool-1-yl)benzeensulfonaat |
402-660-9 |
— |
Repr. 1B Aquatic Chronic 3 |
H360D *** H412 |
GHS08 Dgr |
H360D *** H412 |
|
|
|
607-488-00-X |
ethyl-(2-acetylamino-5-fluor-4-isothiocyanaatfenoxy)acetaat |
414-210-9 |
147379-38-2 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
607-489-00-5 |
reactiemassa van: 2-ethylhexyl-linolenaat, linoleaat en oleaat; 2-ethylhexyl-epoxyoleaat; 2-ethylhexyl diëpoxylinoleaat; 2-ethylhexyl-triëpoxylinolenaat |
414-890-7 |
71302-79-9 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
607-490-00-0 |
N-[2-hydroxy-3-(C12-16-alkyloxy)propyl]-N-methylglycinaat |
415-060-7 |
— |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
607-491-00-6 |
reactiemassa van: diëster van 4,4'-methyleenbis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylfenol] en 6-diazo-5,6-dihydro-5-oxonaftaleen-1-sulfonzuur (1:2); triëster van 4,4'-methyleenbis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylfenol] en 6-diazo-5,6-dihydro-5-oxonaftaleen-1-sulfonzuur (1:3) |
427-140-9 |
— |
Carc. 2 |
H351 |
GHS08 Wng |
H351 |
|
|
|
607-492-00-1 |
2-(1-(3',3'-dimethyl-1'-cyclohexyl)ethoxy)-2-methylpropylpropanoaat |
415-490-5 |
141773-73-1 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
607-493-00-7 |
methyl-(3aR,4R,7aR)-2-methyl-4-(1S,2R,3-triacetoxypropyl)-3a,7a-dihydro-4H-pyrano[3,4-d]oxazool-6-carboxylaat |
415-670-3 |
78850-37-0 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
607-494-00-2 |
bis(2-ethylhexyl)octylfosfonaat |
417-170-0 |
52894-02-7 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
607-495-00-8 |
natrium-4-sulfofenyl-6-((1-oxononyl)amino)hexanoaat |
417-550-6 |
168151-92-6 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
607-496-00-3 |
2,2'-methyleenbis(4,6-di-tert-butylfenyl)-2-ethylhexylfosfiet |
418-310-3 |
126050-54-2 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
607-497-00-9 |
ceriumoxideïsostearaat |
419-760-3 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
607-498-00-4 |
(E)-3,7-dimethyl-2,6-octadiënylhexadecanoaat |
421-370-3 |
3681-73-0 |
Skin Irrit. 2 Aquatic Chronic 4 |
H315 H413 |
GHS07 Wng |
H315 H413 |
|
|
|
607-499-00-X |
bis(dimethyl-(2-hydroxyethyl)ammonium)-1,2-ethaandiyl-bis(2-hexadecenylsuccinaat) |
421-660-1 |
— |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H318 H317 H411 |
|
|
|
607-500-00-3 |
calcium-2,2,bis[(5-tetrapropyleen-2-hydroxy)fenyl]ethanoaat |
421-670-4 |
— |
Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H400 H410 |
GHS07 GHS09 Wng |
H315 H410 |
|
|
|
607-501-00-9 |
reactiemassa van: trifenylthiofosfaat en tertiaire gebutyleerde fenylderivaten |
421-820-9 |
192268-65-8 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
607-502-00-4 |
(N-benzyl-N,N,N-tributyl)ammonium 4-dodecylbenzeensulfonaat |
422-200-0 |
178277-55-9 |
Skin Corr. 1B Acute Tox. 4 * Aquatic Chronic 2 |
H314 H302 H411 |
GHS05 GHS07 GHS09 Dgr |
H314 H302 H411 |
|
|
|
607-503-00-X |
2,4,6-tri-n-propyl-2,4,6-trioxo-1,3,5,2,4,6-trioxatrifosforinaan |
422-210-5 |
68957-94-8 |
Skin Corr. 1B |
H314 |
GHS05 Dgr |
H314 |
|
|
|
607-504-00-5 |
diammonium-1-hydroxy-2-(4-(4-carboxyfenylazo)-2,5-dimethoxyfenylazo)-7-amino-3-naftaleensulfonaat |
422-670-7 |
— |
Repr. 2 Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H361f H301 H373** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H361f H301 H373** H410 |
|
|
|
607-505-00-0 |
pentanatrium-7-(4-(4-(5-amino-4-sulfonato-2-(4-((2-(sulfonatoëthoxy)sulfonyl)fenylazo)fenylamino)-6-chloor-1,3,5-triazine-2-yl)amino-2-ureïdofenylazo)naftaleen-1,3,6-trisulfonaat |
422-930-1 |
|
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
607-506-00-6 |
reactiemassa van: strontium-(4-chloor-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatofenyl)-1H-pyrazool-4-yl)azo)-5-methyl)benzeensulfonaat; dinatrium-(4-chloor-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatofenyl)-1H-pyrazool-4-yl)azo)-5-methyl)benzeensulfonaat |
422-970-8 |
|
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
607-507-00-1 |
kalium, natrium-2,4-diamino-3-[4-(2-sulfonatoëthoxysulfonyl)fenylazo]-5-[4-(2-sulfonatoëthoxysulfonyl)-2-sulfonatofenylazo]-benzeensulfonaat |
422-980-2 |
187026-95-5 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
607-508-00-7 |
dinatrium-3,3'-[iminobis[sulfonyl-4,1-fenyleen-(5-hydroxy-3-methylpyrazool-1,4-diyl)azo-4,1-fenyleensulfonylimino-(4-amino-6-hydroxypyrimidine-2,5-diyl)azo-4,1-fenyleensulfonylimino(4-amino-6-hydroxypyrimidine-2,5-diyl)azo]bis(benzeensulfonaat)] |
423-110-4 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
607-509-00-2 |
2-fenoxyethyl 4-aminobenzoaat |
430-880-5 |
88938-23-2 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
607-510-00-8 |
(2S,5R)-6,6-dibroom3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptaan-2-carbonzuur-4,4-dioxide |
427-200-4 |
76646-91-8 |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H302 H315 H318 H317 |
GHS05 GHS07 Dgr |
H302 H315 H318 H317 |
|
|
|
607-511-00-3 |
reactiemassa van: 4-[(3-decyloxypropyl)(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)amino]-4-oxoboterzuur; 4-[(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)(3-octyloxypropyl)amino]-4-oxoboterzuur |
423-750-4 |
— |
Eye Irrit. 2 Aquatic Chronic 2 |
H319 H411 |
GHS07 GHS09 Wng |
H319 H411 |
|
|
|
607-512-00-9 |
trinatrium-2,4-diamino-3,5-bis-[4-(2-sulfonatoëthoxy)sulfonyl)fenylazo]benzeensulfonaat |
423-970-0 |
182926-43-8 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
607-513-00-4 |
reactiemassa van: trinatrium-4-benzoylamino-6-(6-etheensulfonyl-1-sulfato-naftaleen-2-ylazo)-5-hydroxynaftaleen-2,7-disulfonaat; natriumzout van 5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfoxy)ethyl)sulfonyl)-2-naftyl)azo)naftaleen-2,7-disulfonzuur; 5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfoxy)ethyl)sulfonyl)-2-naftyl)azo)naftaleen-2,7-disulfonzuur |
423-200-3 |
— |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Dgr |
H318 H317 H412 |
|
|
|
607-514-00-X |
kalium-N-(1-methoxy-1-oxobut-2-een-3-yl)valinaat |
427-240-2 |
134841-35-3 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
607-515-00-5 |
reactiemassa van: dinatriumhexyldifenyletherdisulfonaat; dinatriumdihexyldifenyletherdisulfonaat |
429-650-7 |
147732-60-3 |
Eye Irrit. 2 Aquatic Chronic 2 |
H319 H411 |
GHS07 GHS09 Wng |
H319 H411 |
|
|
|
607-516-00-0 |
N, N'-bis(trifluoracetyl)-S, S'-bis-L-homocysteïne |
429-670-6 |
105996-54-1 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
607-517-00-6 |
(S)-α-(acetylthio)benzeenpropaanzuur |
430-300-0 |
76932-17-7 |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 |
H302 H318 H317 |
GHS05 GHS07 Dgr |
H302 H318 H317 |
|
|
|
607-518-00-1 |
3-oxoandrost-4-een-17-β-carbonzuur |
414-990-0 |
302-97-6 |
Repr. 2 Aquatic Chronic 4 |
H361f H413 |
GHS08 Wng |
H361f H413 |
|
|
|
607-519-00-7 |
poly-[((4-((4-ethylethyleen)amino)fenyl)-(4-(ethyl-(2-oxyethyleen)amino)fenyl)methinyl)cyclohexa-2,5-diënylideen)-N-ethyl-N-(2-hydroxyethyl)ammoniumacetaat] |
427-280-0 |
176429-27-9 |
STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H335 H315 H318 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H335 H315 H318 H410 |
|
|
|
607-520-00-2 |
reactiemassa van: natrium-4,5-dihydro-2-[(propionato)(C6-18)alkyl]-3H-imidazolium-N-ethylfosfaat; dinatrium-4,5-dihydro-2-[(dipropionato)(C6-18)alkyl]-3H-imidazolium-N-ethylfosfaat |
427-740-0 |
— |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
607-521-00-8 |
tetraëthyl N, N'-(methyleendicyclohexaan-4,1-diyl)bis-DL-aspartaat |
429-270-1 |
136210-30-5 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
607-522-00-3 |
natriumzout van de polymeer van: natrium-2-methyl-buta-1,3-dieen-1-sulfonaat met acrylzuur en 2-hydroxyethyl-2-methylacrylaat |
429-720-7 |
184246-86-4 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
607-523-00-9 |
reactiemassa van mono- tot tetra-(lithium en/of natrium)3-amino-10-[4-(4-amino-3-sulfonatoanilino)-6-[methyl-(2-sulfonatoëthyl)amino]-1,3,5-triazine-2-ylamino]-6-13-dichloorbenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonaat; mono- tot tetra-(lithium en/of natrium)3-amino-10-[4,6-bis(4-amino-3-sulfonatoanilino)-1,3,5-triazine-2-ylamino]-6-13-dichloorbenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonaat; mono- tot penta-(lithium en/of natrium)10,10'-diamino-6,6',13,13'-tetrachloor-3,3'-[6-[methyl-(2-sulfonatoëthyl)amino]-1,3,5-triazine-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonaat; mono- tot hepta-(lithium en/of natrium)10-amino-6,6', 13,13'-tetrachloor-10'[4-(4-amino-3-sulfonatoanilino)-[6-methyl-(2-sulfonatoëthyl)amino]-1,3,5-triazine-2,4-diimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonaat; mono- tot hepta-(lithium en/of natriium)10,10'-diamino-6,6',3,3'[(2-sulfonato)-1,4-fenyleendiiminobis[6-methyl-(2-sulfonatoëthyl)amino]-1,3,5-triazine-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonaat |
430-200-7 |
— |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
607-524-00-4 |
tallolie 2-[(tetrahydro-2H-pyran-2-yl)thio]ethylesters |
430-310-5 |
— |
Aquatic Chronic 4 |
H413 |
|
H413 |
|
|
|
607-525-00-X |
(Z)-2-methoxyimino-2-[2-(tritylamino)thiazool-4-yl]azijnzuur |
431-520-1 |
64485-90-1 |
Flam. Sol. 1**** Carc. 2 Aquatic Chronic 3 |
H228 H351 H412 |
GHS02 GHS08 Dgr |
H228 H351 H412 |
|
|
|
607-526-00-5 |
cartap (ISO); 1,3-bis(carbamoylthio)-2-(dimethylamino)propaan |
— |
15263-53-3 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
607-527-00-0 |
reactiemassa van: 1-(1'H,1'H,2'H,2'H-tridecafluoroctyl)-12-(1''H,1''H,2''H,2''H-tridecafluoroctyl)dodecaandioaat; 1-(1'H,1'H,2'H,2'H-tridecafluoroctyl)-12-(1''H,1''H,2''H,2''H-heptdecafluordecyl)dodecaandioaat; 1-(1'H,1'H,2'H,2'H-tridecafluoroctyl)-12-(1''H,1''H,2''H,2''H-heneïcosafluordodecyl)dodecaandioaat; 1-(1'H,1'H,2'H,2'H-tridecafluoroctyl)-12-(1''H,1''H,2''H,2''H-pentacosafluortetradecyl)dodecaandioaat; 1-(1'H,1'H,2'H,2'H-heptadecafluordecyl)-12-(1''H,1''H,2''H,2''H-heptadecafluordecyl)dodecaandioaat; 1-(1'H,1'H,2'H,2'H-heptadecafluordecyl)-12-(1''H,1''H,2''H,2''H-heneïcosafluordodecyl)dodecaandioaat |
423-180-6 |
— |
STOT RE 2 * |
H373 ** |
GHS08 Wng |
H373 ** |
|
|
|
607-528-00-6 |
(S)-3-methyl-2-(2-oxotetrahydropyrimidine-1-yl)boterzuur |
430-900-2 |
192725-50-1 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
607-529-00-1 |
benzyl-cis-4-ammonium-4'-tolueensulfonato-1-cyclohexaancarboxylaat |
426-070-6 |
67299-45-0 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
607-530-00-7 |
reactiemassa van isomeren van: C7-9-alkyl-3-(3,5-di-tert-butyl-4-hydroxyfenyl)propionaat |
406-040-9 |
125643-61-0 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
607-531-00-2 |
methyl-3-amino-4,6-dibroom-2-methylbenzoaat |
425-190-6 |
119916-05-1 |
STOT RE 2 * Aquatic Chronic 2 |
H373** H411 |
GHS08 GHS09 Wng |
H373** H411 |
|
|
|
607-532-00-8 |
(S)-1-[2-trans-butoxycarbonyl-3-(2-methoxyethoxy)propyl]-1-cyclopentaancarbonzuur, cyclohexylaminezout |
425-510-4 |
167944-94-7 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
607-533-00-3 |
pentanatriummonowaterstof-6-chloor-3,10-bis[2-[4-chloor-6-(2,4-disulfofenylamino)-1,3,5-triazine-2-yl-amino]ethylamino]-13-ethylbenzo[5.6][1.4]oxazino[2,3-b]fenoxazine-4,11-disulfonaat |
414-910-4 |
— |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
607-534-00-9 |
ethyl-2-(3-benzoylfenyl)propanoaat |
414-920-9 |
60658-04-0 |
Acute Tox. 3 * STOT RE 1 Skin Sens. 1 Aquatic Chronic 2 |
H301 H372** H317 H411 |
GHS06 GHS08 GHS09 Dgr |
H301 H372** H317 H411 |
|
|
|
607-535-00-4 |
kalium-4-jood-2-sulfonato-benzoëzuur |
426-620-5 |
— |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
607-536-00-X |
(2,6-xylyloxy)azijnzuur |
430-910-7 |
13335-71-2 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 |
H302 H318 H412 |
GHS05 GHS07 Dgr |
H302 H318 H412 |
|
|
|
607-537-00-5 |
isopropylammonium-2-(3-benzoylfenyl)propionaat |
417-970-1 |
— |
Acute Tox. 3 * Acute Tox. 4 * STOT RE 1 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H312 H372** H318 H400 H410 |
GHS06 GHS05 GHS08 GHS09 Dgr |
H301 H312 H372** H318 H410 |
|
|
|
607-539-00-6 |
propyl((4-(5-oxo-3-propylisoxazolidine-4-ylideenmethinyl)fenyl)propoxycarbonylmethyleenamino)acetaat |
431-000-2 |
198705-81-6 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
607-540-00-1 |
1-(mercaptomethyl)cyclopropylazijnzuur |
420-240-3 |
162515-68-6 |
Skin Corr. 1B Acute Tox. 4 * Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H314 H312 H302 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H314 H312 H302 H317 H411 |
|
|
|
607-541-00-7 |
[(1-methyl-1,2-ethaandiyl)bis[nitrilo-bis(methyleen)]]tetrakis(fosfonzuur) |
421-940-1 |
28698-31-9 |
Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Dgr |
H318 H410 |
|
|
|
607-542-00-2 |
methyl-2-(4-butaansulfonamidofenoxy)tetradecanoaat |
422-110-1 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
607-543-00-8 |
poly-[((4-((4-(ethylethyleen)amino)fenyl)-(4-(ethyl-(2-oxyethyleen)amino)fenyl)methinyl)-3-methylcyclohexa-2,5-diënylideen)-N-ethyl-N-(2-hydroxyethyl)ammoniumacetaat] |
427-480-8 |
176429-22-4 |
STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H335 H315 H318 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H335 H315 H318 H410 |
|
|
|
607-544-00-3 |
ethyl-6,8-difluor-1-(formylmethylamino)-1,4-dihydro-7-(4-methyl)piperazine-1-yl)-4-oxochinoline-3-carboxylaat |
427-490-2 |
158585-86-5 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
607-545-00-9 |
1,2-dimethyl-3-(1-methylethenyl)cyclopentylacetaat |
424-070-0 |
94346-09-5 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
607-546-00-4 |
reactiemassa van: methyl-{[5-acetylamino-4-(2-chloor-4-nitrofenylazo)fenyl]methoxycarbonylmethylamino}acetaat; methyl-{[5-acetylamino-4-(2-chloor-4-nitrofenylazo)fenyl]ethoxycarbonylmethylamino}acetaat |
424-290-7 |
188070-47-5 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
607-547-00-X |
18-methylnonadecyl-2,2-dimethylpropanoaat |
424-370-1 |
125496-22-2 |
Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 |
H315 H317 H413 |
GHS07 Wng |
H315 H317 H413 |
|
|
|
607-548-00-5 |
1-(2,4-dichloorfenyl)-2-(1H-imidazool-1-yl)ethanonmethaansulfonaat |
431-010-7 |
154486-26-7 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H411 |
|
|
|
607-549-00-0 |
methyl-(E)-2((3-(1,3-benzodioxol-5-yl)-2-methyl-1-propenyl)amino)benzoaat |
424-430-7 |
125778-19-0 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
607-550-00-6 |
2-amino-4-broom-5-chloorbenzoëzuur |
424-700-4 |
— |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
607-551-00-1 |
tetrabutylammonium-2-amino-6-joodpurinaat |
424-710-9 |
156126-48-6 |
Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H312 H302 H373** H315 H318 H317 H411 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H312 H302 H373** H315 H318 H317 H411 |
|
|
|
607-552-00-7 |
hexadecyl-amino-4-isopropoxybenzoaat |
424-830-1 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
607-553-00-2 |
7-amino-4-hydroxy-2-naftaleensulfonzuur, gekoppeld met 5(of 8)-amino-8(of 5)-[[4-[[4-[[4-amino-6(of 7)-sulfo-1-naftyl]azo]fenyl]amino]-3-sulfofenyl]azo]-2-naftaleensulfonzuur en 4-hydroxy-7-(fenylamino)-2-naftaleensulfonzuur, natriumzout |
424-850-0 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
607-554-00-8 |
2,4-diamino-5-[4-[(2-sulfoxylethyl)sulfonyl]fenylazo]benzeensulfonzuur |
424-870-1 |
27624-67-5 |
Expl. 1.1 Eye Dam. 1 Aquatic Chronic 3 |
H201 H318 H412 |
GHS01 GHS05 Dgr |
H201 H318 H412 |
|
|
|
607-555-00-3 |
1,1,3,3-tetramethylbutylperoxypivalaat |
424-980-8 |
22288-41-1 |
Flam. Liq. 2 Org. Perox. D Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H225 H242 H315 H317 H411 |
GHS02 GHS07 GHS09 Dgr |
H225 H242 H315 H317 H411 |
|
|
|
607-556-00-9 |
2-acetoxymethyleen-4-acetylfenylacetaat |
425-160-2 |
24085-06-1 |
Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373** H318 H317 H400 H410 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H302 H373** H318 H317 H410 |
|
|
|
607-557-00-4 |
zout van: (1S-cis)-1-amino-2,3-dihydro-1H-indeen-2-ol en [R-[R*R*]]-2,3-dihydroxybutaandizuur |
425-210-3 |
169939-84-8 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
607-558-00-X |
2S-isopropyl-5R-methyl-1R-cyclohexyl-(2R,5S)-5-(4-amino-2-oxo-2H-pyrimidine-1-yl)-[1.3]-oxathiolaan-2-carboxylaat |
425-250-1 |
147027-10-9 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
607-559-00-5 |
kokosolie, reactieproducten met glycerolesters van 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzeenpropaanzuur |
425-400-6 |
179986-09-5 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
607-560-00-0 |
(R,S)-2-butyloctaandizuur |
431-210-4 |
50905-10-7 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
607-561-00-6 |
natrium-4-hydroxy-3-(N'-(2-(2-hydroxyethyleensulfonyl)ethyleen)ureïdo)-5-nitrobenzeensulfonaat |
425-460-3 |
— |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
607-562-00-1 |
reactiemassa van: (2R,3R)-3-(2-ethoxyfenoxy)-2-hydroxy-3-fenylpropylammonium-methaansulfonaat; (2S,3S)-3-(2-ethoxyfenoxy)-2-hydroxy-3-fenylpropylammonium-methaansulfonaat |
425-530-3 |
98769-75-6 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H411 |
|
|
|
607-563-00-7 |
5,7-dichloor-4-hydroxychinoline-3-carbonzuur |
431-250-2 |
171850-30-9 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
607-564-00-2 |
1,6-hexaandiammonium, natrium-5-sulfato-1,3-benzeendicarboxylaat |
425-730-0 |
51178-75-7 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
607-565-00-8 |
3-ethyl-5-methyl-2-(2-aminoëthoxymethyl)-4-(2-chloorfenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylaat |
425-820-1 |
88150-42-9 |
Acute Tox. 3 * STOT RE 2 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H373** H318 H400 H410 |
GHS06 GHS05 GHS08 GHS09 Dgr |
H301 H373** H318 H410 |
|
|
|
607-566-00-3 |
reactiemassa van: (dodecylfenyl)dodecylhydroxybenzeencarboxylaat; bis(dodecylfenyl)dodecylhydroxybenzeendicarboxylaat |
426-140-6 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
607-567-00-9 |
kalium-3-jood-6-methylbenzeensulfonaat |
426-300-5 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
607-568-00-4 |
kalium-2-chloor-3-(benzyloxy)propionaat |
426-350-8 |
138666-92-9 |
Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 |
H302 H373** H318 H317 |
GHS05 GHS08 GHS07 Dgr |
H302 H373** H318 H317 |
|
|
|
607-569-00-X |
reactiemassa van: natrium-2-amino-4-(2,6-difluorpyrimidine-4-ylamino)benzeensulfonaat; natrium-2-amino-4-(4,6-difluorpyrimidine-4-ylamino)benzeensulfonaat |
426-470-0 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
607-570-00-5 |
natrium-(6R-trans)-7-amino-8-oxo-3-[[[1-(sulfomethyl)-1H-tetrazool-5-yl]thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-een-2-carboxylaat-monohydraat |
426-520-1 |
71420-85-4 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
607-571-00-0 |
3-hydroxy-2-pentyl-2-cyclopenteen-1-azijnzuur, methylester |
431-400-7 |
57374-49-9 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
607-572-00-6 |
diëthylthiofosforyl-(Z)-(2-aminothiazool-4-yl)methoxyiminoacetaat |
426-790-0 |
162208-27-7 |
Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H373** H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H312 H302 H373** H317 H410 |
|
|
|
607-573-00-1 |
reactiemassa van: dinatrium-7-(2,4-difluorpyrimidine-6-ylamino)-4-hydroxy-3-(4-methoxy-2-sulfonatofenylazo)naftaleen-2-sulfonaat; dinatrium; 7-(4,6-difluorpyrimidine-2-ylamino)-4-hydroxy-3-(4-methoxy-2-sulfonatofenylazo)naftaleen-2-sulfonaat |
426-840-1 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
607-574-00-7 |
[1R-(1-α, 2β,5α)]-mono[5-methyl-2-(1-methylethyl)cyclohexyl]butaandioaat |
426-890-4 |
77341-67-4 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
607-575-00-2 |
4-(5-(5-[1-(4-carboxyfenyl)hexahydro-2,4,6-trioxopyrimidine-5-ylideen]penta-1,3-diënyl)-1,2,3,4-tetrahydro-6-hydroxy-2,4-dioxopyrimidine-1-yl)benzoëzuur, triëthylaminezout |
426-900-7 |
— |
STOT SE 3 Aquatic Chronic 3 |
H335 H412 |
GHS07 Wng |
H335 H412 |
|
|
|
607-576-00-8 |
vertakt octyl-3-[3,5-di(tert-butyl)-4-hydroxyfenyl]propanoaat |
427-030-0 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
607-577-00-3 |
(2R*,3S*)-2-(2,4-difluorfenyl)-3-(5-fluor-4-pyrimidinyl)-1-(1H-1,2,4-triazool-1-yl)butaan-2-ol-(1R)-10-kamfersulfonaat |
427-100-0 |
— |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H302 H318 H317 H412 |
GHS05 GHS07 Dgr |
H302 H318 H317 H412 |
|
|
|
607-578-00-9 |
ethyl-4-((4-diëthylamino-2-methylfenyl)imino)-4,5-dihydro-1-isopropyl-5-oxo-1H-pyrazool-3-carboxylaat |
427-110-5 |
— |
Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 4 |
H302 H373** H413 |
GHS08 GHS07 Wng |
H302 H373** H413 |
|
|
|
607-579-00-4 |
diëthyl-[(p-ethoxyanilino)methyleen]malonaat |
431-430-0 |
103976-28-9 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
607-580-00-X |
ethyl-7-chloor-1-(2,4-difluorfenyl)-6-fluor-1,4-dihydro-4-oxo-1,8-naftyridine-3-carboxylaat |
422-360-1 |
100491-29-0 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
607-581-00-5 |
ethyl-2-ethoxy-4-carboxymethylbenzoaat |
427-630-2 |
99469-99-5 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
607-582-00-0 |
reactiemassa van: tetranatrium-7-(4-(4-fluor-6-(4-(2-sulfonatoëthylsulfonyl)fenylamino)-1,3,5-triazine-2-ylamino)-2-ureïdofenylazo)naftaleen-1,3,6-trisulfonaat; tetranatrium-7-(4-(4-hydroxy-6-(4-(2-sulfonatoëthylsulfonyl)fenylamino)-1,3,5-triazine-2-ylamino)-2-ureïdofenylazo)naftaleen-1,3,6-trisulfonaat |
427-650-1 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
607-583-00-6 |
4-amino-3-[[4-[[2-(sulfoxy)ethyl]sulfonyl]fenyl]azo]-1-naftaleensulfonzuur |
427-680-5 |
188907-52-0 |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Dgr |
H318 H317 H412 |
|
|
|
607-584-00-1 |
trinatrium-3-[2-acetylamino-4-[4-chloor-6-[4-(2-sulfonatooxyethylsulfonyl)fenylamino]-1,3,5-triazine-2-ylamino]fenylazo]naftaleen-1,5-disulfonaat |
427-710-7 |
215612-56-9 |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Dgr |
H318 H317 H412 |
|
|
|
607-585-00-7 |
strontium-2-[(2-hydroxy-6-sulfonato-1-naftyl)azo]naftaleen-1-sulfonaat |
427-930-3 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
607-586-00-2 |
dodecyl-3-amino-4-chloorbenzoaat |
428-020-9 |
6195-20-6 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
607-587-00-8 |
ethyl-cis-4-[4-[[2-(2,4-dichloorfenyl)-2-(1H-imidazool-1-ylmethyl)-1,3-dioxolaan-4-yl]-methoxy]fenyl]piperazine-1-carboxylaat |
428-030-3 |
67914-69-6 |
Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373** H400 H410 |
GHS08 GHS07 GHS09 Wng |
H302 H373** H410 |
|
|
|
607-588-00-3 |
reactiemassa van: 2-ethylhexyl-2,3,4,5-tetrabroombenzoaat; bis(2-ethylhexyl)-3,4,5,6-tetrabroomftalaat |
428-050-2 |
— |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
607-589-00-9 |
tetrakis(1,2,2,6,6-pentamethyl-4-piperidyl)-1,2,3,4-butaantetracarboxylaat |
428-070-1 |
91788-83-9 |
STOT RE 1 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H372** H302 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H372** H302 H410 |
|
|
|
607-590-00-4 |
hexadecyl-3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-yl)-4,4-dimethyl-3-oxovaleeramido]-4-isopropoxybenzoaat |
428-140-1 |
210706-50-6 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
607-591-00-X |
reactiemassa van: trinatrium-5-(4-fluor-6-morfoline-4-yl-1,3,5-triazine-2-ylamino)-4-hydroxy-3-(4-(2-sulfoöoxyethaansulfonyl)fenylazo)naftaleen-2,7-disulfonaat; dinatrium-3-(4-etheensulfonylfenylazo)-5-(4-fluor-6-morfoline-4-yl-1,3,5-triazine-2-ylamino)-4-hydroxynaftaleen-2,7-disulfonaat |
428-400-4 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
607-592-00-5 |
di(C9-11-alkyl)cyclohexaan-1,4-dicarboxylaat |
428-870-0 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
607-593-00-0 |
4-(2-methylacryloyloxy)fenyl4-allyloxybenzoaat |
429-000-2 |
159235-16-2 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
607-594-00-6 |
ethyl-(1S,5R,6S)-5-(1-ethylpropoxy)-7-oxabicyclo[4.1.0]hept-3-een-3-carboxylaat |
429-020-1 |
204254-96-6 |
STOT RE 2 * Skin Sens. 1 |
H373** H317 |
GHS08 GHS07 Wng |
H373** H317 |
|
|
|
607-595-00-1 |
N-amidino-N-methylglycine-2-oxopropionaat |
429-120-5 |
208535-04-0 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
607-596-00-7 |
ethyl-2-(4-fenoxyfenyl)lactaat |
429-220-9 |
132584-17-9 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
607-597-00-2 |
tetranatrium-4,4'-bis{4-[4-(2-hydroxyethylamino)-6-(4-sulfonatoanilino)-1,3,5-triazine-2-ylamino]fenylazo}stilbeen-2,2'-disulfonaat |
429-230-3 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
607-598-00-8 |
trinatrium-3-amino-4-[4-[4-(2-(2-ethenylsulfonylethoxy)ethylamino)-6-fluor-1,3,5-triazine-2-ylamino]-2-sulfofenylazo]-5-hydroxynaftaleen-2,7-disulfonaat |
429-240-8 |
212652-59-0 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
607-599-00-3 |
1,1-dimethylpropyl-3,5,5-trimethylperoxyhexanoaat |
431-610-9 |
68860-54-8 |
Org. Perox. D Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H242 H317 H400 H410 |
GHS02 GHS07 GHS09 Dgr |
H242 H317 H410 |
|
|
|
607-600-00-7 |
(1S, 1'R)-[1-(3',3'-dimethyl-1'-cyclohexyl)ethoxycarbonyl]methylpropanoaat |
431-700-8 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
607-601-00-2 |
1,4-dihydroxy-2,2,6,6-tetramethylpiperidinium-2-hydroxy-1,2,3-propaantricarboxylaat |
429-370-5 |
220410-74-2 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
607-602-00-8 |
ethyl-(3-cyaanmethyl-3,4-dihydro-4-oxoftalazine-1-yl)acetaat |
429-680-0 |
122665-86-5 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
607-603-00-3 |
lithiumnatrium-4,4', 4''-(nitrilotris(ethaan-2,1-diylimino(6-chloor-1,3,5-triazine-4,2-diyl)imino))tris(5-hydroxy-6-(1-sulfonaftaleen-2-ylazo)-2,7-aftaleen)disulfonaat |
429-730-1 |
193562-37-7 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
607-604-00-9 |
guanidiniumbenzoaat |
429-820-0 |
26739-54-8 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
607-605-00-4 |
methyl-4-jood-2-(3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)ureïdosulfonyl)benzoaat |
429-890-2 |
144550-06-1 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
607-606-00-X |
(Z)-2-(2-t-butoxycarbonylamino-4-thiazolyl)pent-2-eenzuur |
430-100-3 |
86978-24-7 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
607-607-00-5 |
reactiemassa van: calcium-bis(C10-14-vertakt alkylsalicylaat); calcium-bis(C18-30-alkylsalicylaat); calcium-C10-14 -vertakt alkylsalicylato-C18-30-alkylsalicylaat; calcium-bis(C10-14 -vertakt alkylfenolaat); calcium-bis(C18-30-alkylfenolaat); calcium-C10-14 -vertakt alkylfenolato-C18-30-alkylfenolaat; C10-14 -vertakt alkylfenol; C18-30-alkylfenol |
430-180-1 |
— |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
607-608-00-0 |
pentakalium-2-(4-{5-[1-(2,5-disulfofenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazool-4-ylideen]-3-(2-pyrrolidinon-1-yl)-1,3-pentadiënyl}-3-methylcarbamoyl-5-oxopyrazool-1-yl)benzeen-1,4-disulfonaat |
430-210-1 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
607-609-00-6 |
ethyl-(3R)-4-cyaan-3-hydroxybutanoaat |
430-220-6 |
141942-85-0 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
607-610-00-1 |
trinatrium-4-hydroxy-6-(sulfonatomethylamino)-5-(2-(2-sulfatoethylsulfonyl)fenylazo)naftaleen-2-sulfonaat |
430-280-3 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
607-611-00-7 |
methyl-3-amino-2,2,3-trimethylbutyraat |
431-720-7 |
90886-53-6 |
Skin Corr. 1B Acute Tox. 4 * Aquatic Chronic 3 |
H314 H302 H412 |
GHS05 GHS07 Dgr |
H314 H302 H412 |
|
|
|
607-612-00-2 |
reactiemassa van: 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluor-1-octaansulfonzuur; ammonium 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluor-1-octaansulfonaat |
432-190-1 |
182176-52-9 |
Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 |
H302 H373** H318 |
GHS05 GHS08 GHS07 Dgr |
H302 H373** H318 |
|
|
|
607-613-00-8 |
reactiemassa van:; barnsteenzuur; diperbarnsteenzuur; monomethylester van barnsteenzuur; monomethylester van perbarnsteenzuur; dimethylsuccinaat, glutaarzuur; monoperglutaarzuur; diperglutaarzuur; monomethylester van glutaarzuur; monomethylester van perglutaarzuur; dimethylglutaraat; adipinezuur; monoperadipinezuur; diperadipinezuur; monomethylester van adipinezuur; monomethylester van peradipinezuur; dimethyladipaat; waterstofperoxide; methanol; water |
432-790-1 |
|
Acute Tox. 4* Acute Tox. 4* Acute Tox. 4* Skin Corr. 1B STOT SE 2 |
H332 H312 H302 H314 H371 (ogen) |
GHS07 GHS05 GHS08 Dgr |
H332 H312 H302 H314 H371 (ogen) |
|
|
|
607-614-00-3 |
2-(10-oxo-10H-9-oxa-10-fosfafenantreen-10-ylmethyl)barnsteenzuur |
426-480-5 |
63562-33-4 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
607-615-00-9 |
reactiemassa van thioglycerol en mercaptoazijnzuur, voornamelijk bestaande uit 3-mercapto-1,2-bismercaptoacetoxypropaan en oligomeren van deze stof |
431-120-5 |
— |
Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 |
H331 H302 H319 H317 |
GHS06 Dgr |
H331 H302 H319 H317 |
|
|
|
607-616-00-4 |
2,4-dichloor-5-fluorbenzoylchloride |
428-390-1 |
86393-34-2 |
STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H335 H315 H318 H317 H412 |
GHS05 GHS07 Dgr |
H335 H315 H318 H317 H412 |
|
|
|
607-617-00-X |
bis(2-ethylhexyl)-4,5-epoxycyclohexaan-1,2-dicarboxylaat |
430-700-5 |
10138-36-0 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
607-618-00-5 |
menadionnatriumbisulfiet; 1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaftaleen-2-sulfonzuur, natriumzout |
204-987-0 |
130-37-0 |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H315 H400 H410 |
GHS07 GHS09 Wng |
H319 H315 H410 |
|
|
|
607-619-00-0 |
menadionnicotinamidebisulfiet; 1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaftaleen-2-sulfonzuur, verbinding met nicotine-3-amide (1:1) |
277-543-7 |
73581-79-0 |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H315 H400 H410 |
GHS07 GHS09 Wng |
H319 H315 H410 |
|
|
|
607-620-00-6 |
trinatriumnitrilotriacetaat |
225-768-6 |
5064-31-3 |
Carc. 2 Acute Tox. 4 * Eye Irrit. 2 |
H351 H302 H319 |
GHS08 GHS07 Wng |
H351 H302 H319 |
|
Carc. 2; H351: C ≥ 5 % |
|
607-621-00-1 |
milbemectin (ISO); [mengsel van milbemycine A3 (CAS-nr. 51596-10-2) en milbemycine A4 (CAS-nr. 51596-11-3) (30:70)] |
— |
— |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H302 H410 |
|
M=100 |
|
607-622-00-7 |
2-ethylhexyl-2-ethylhexanoaat |
231-057-1 |
7425-14-1 |
Repr. 2 |
H361d*** |
GHS08 Wng |
H361d*** |
|
|
|
607-624-00-8 |
perfluoroctaansulfonzuur; heptadecafluoroctaan-1-sulfonzuur; [1] kaliumperfluoroctaansulfonaat; kaliumheptadecafluoroctaan-1-sulfonaat; [2] diëthanolamineperfluoroctaansulfonaat; [3] ammoniumperfluoroctaansulfonaat; ammoniumheptadecafluoroctaansulfonaat; [4] lithiumperfluoroctaansulfonaat; lithiumheptadecafluoroctaansulfonaat [5] |
217-179-8 [1] 220-527-1 [2] 274-460-8 [3] 249-415-0 [4] 249-644-6 [5] |
1763-23-1 [1] 2795-39-3 [2] 70225-14-8 [3] 29081-56-9 [4] 29457-72-5 [5] |
Carc. 2 Repr. 1B STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Lact. Aquatic Chronic 2 |
H351 H360D*** H372** H332 H302 H362 H411 |
GHS08 GHS07 GHS09 Dgr |
H351 H360D*** H372** H332 H302 H362 H411 |
|
|
|
607-625-00-3 |
clodinafop-propargyl (ISO) |
— |
105512-06-9 |
Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373** H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H302 H373** H317 H410 |
|
Skin Sens. 1; H317: C ≥ 0,001 % M=1 |
|
607-626-00-9 |
ethyl-1-(2,4-dichloorfenyl)-5-(trichloormethyl)-1H-1,2,4-triazool-3-carboxylaat |
401-290-5 |
103112-35-2 |
Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H400 H410 |
GHS08 GHS09 Dgr |
H350 H410 |
|
|
|
607-627-00-4 |
[(4S,5S)-4-benzyl-2-oxo-5-oxazolidinyl]methyl 4-nitrobenzeensulfonaat |
416-360-0 |
162221-28-5 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
607-628-00-X |
4-oxo-4-(p-tolyl)boterzuur, adduct met 4-ethylmorfoline |
419-240-6 |
171054-89-0 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
607-629-00-5 |
[[2-methyl-1-(1-oxopropoxy)propoxy](4-fenylbutyl)fosfinyl]azijnzuur |
419-270-1 |
123599-82-6 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
607-630-00-0 |
acrylzuur, 3-(trimethoxysilyl)propylester |
419-560-6 |
4369-14-6 |
Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 3 |
H332 H314 H317 H412 |
GHS05 GHS07 Dgr |
H332 H314 H317 H412 |
|
|
|
607-631-00-6 |
mengsel van: 2-(2-((oxo(fenyl)acetyl)oxy)ethoxy)ethyloxo(fenyl)acetaat; (2-(2-hydroxyethoxy)ethyl)oxo(fenyl)acetaat |
442-300-8 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
607-632-00-1 |
N-[3-(2,4-di(1,1-dimethylpropyl)fenoxy)propyl]-1-hydroxy-5-(2-methylpropyloxycarbonylamino)naftamide |
420-210-1 |
111244-14-5 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
607-633-00-7 |
trinatrium-5-{[4-chloor-6-(1-naftylamino)-1,3,5-triazine-2-yl]amino}-4-hydroxy-3-[(E)-(4-methoxy-2-sulfonatofenyl)diazenyl]-2,7-naftaleendisulfonaat |
440-480-2 |
341026-59-3 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
607-634-00-2 |
(S)-(–)-2-acetoxypropionylchloride; (1S)-2-chloor-1-methyl-2-oxoëthylacetaat |
420-610-4 |
36394-75-9 |
Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 |
H302 H314 H317 |
GHS05 GHS07 Dgr |
H302 H314 H317 |
|
|
|
607-635-00-8 |
trinatrium-N-(3-propionato)-l-aspartaat |
422-090-4 |
172737-80-3 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
607-636-00-3 |
1-broom-2-methylpropylpropionaat |
422-900-6 |
158894-67-8 |
Flam. Liq. 3 Carc. 2 Skin Corr. 1B Skin Sens. 1 |
H226 H351 H314 H317 |
GHS02 GHS05 GHS08 GHS07 Dgr |
H226 H351 H314 H317 |
|
|
|
607-637-00-9 |
dinatrium-8-amino-5-{4-[2-(sulfonatoëthoxy)sulfonyl]fenylazo}naftaleen-2-sulfonaat |
423-730-5 |
250688-43-8 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
607-638-00-4 |
2-hydroxybenzoëzuur, 2-butyloctylester |
431-090-3 |
190085-41-7 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
607-639-00-X |
2-(2-oxo-5-(1,1,3,3-tetramethylbutyl)-2,3-dihydro-1-benzofuran-3-yl)-4-(1,1,3,3-tetramethylbutyl)fenylacetaat |
431-770-1 |
216698-07-6 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
607-641-00-0 |
2-(formylamino)-3-thiofeencarbonzuur; 2-formamido-3-thiofeencarbonzuur |
431-930-9 |
43028-69-9 |
Acute Tox. 4 * Skin Sens. 1 |
H302 H317 |
GHS07 Wng |
H302 H317 |
|
|
|
607-642-00-6 |
3,6,9-trithiaündecamethyleen-1,11-dimethacrylaat |
432-210-7 |
141631-22-3 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
607-643-00-1 |
dimethyl-(2S)-2-hydroxysuccinaat |
432-310-0 |
617-55-0 |
Flam. Liq. 3 Eye Dam. 1 Skin Sens. 1 |
H226 H318 H317 |
GHS02 GHS05 GHS07 Dgr |
H226 H318 H317 |
|
|
|
607-644-00-7 |
methyl-2,2-dimethyl-6-methyleencyclohexaancarboxylaat |
432-350-9 |
81752-87-6 |
Skin Irrit. 2 |
H315 |
GHS07 Wng |
H315 |
|
|
|
607-645-00-2 |
tetranatrium-2-(4-fluor-6-(methyl(2-(sulfatoethylsulfonyl)ethyl)amino)-1,3,5-triazine-2-ylamino)-5-hydroxy-6-(4-methyl-2-sulfonatofenylazo)naftaleen-1,7-disulfonaat |
432-550-6 |
243858-01-7 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
607-646-00-8 |
D-erytro-hexaanzuur-2,4-dideoxy-3,5-O-(1-methylethylideen)-1,1-dimethylethylester; tert-butyl 2-[(4R,6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxaan-4-yl]acetaat |
432-960-5 |
124655-09-0 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
607-647-00-3 |
5-acetoxy-2-(R, S)butyryloxymethyl-1,3-oxathiolaan |
433-530-1 |
143446-73-5 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 |
H302 H317 H400 |
GHS07 GHS09 Wng |
H302 H317 H400 |
|
|
|
607-649-00-4 |
[3-(chloorcarbonyl)-2-methylfenyl]acetaat |
433-690-0 |
167678-46-8 |
Skin Corr. 1A Skin Sens. 1 |
H314 H317 |
GHS05 GHS07 Dgr |
H314 H317 |
|
|
|
607-650-00-X |
2-methyl-1,5-pentaandiamine-1,3-benzeendicarboxylaat |
433-910-5 |
145153-52-2 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
607-651-00-5 |
natrium-2-(nonanoyloxy)benzeensulfonaat |
434-360-9 |
91125-43-8 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
607-652-00-0 |
ethyl-N 2-dodecanoyl-l-argininaat-hydrochloride |
434-630-6 |
60372-77-2 |
Eye Dam. 1 Aquatic Acute 1 |
H318 H400 |
GHS05 GHS09 Dgr |
H318 H400 |
|
|
|
607-653-00-6 |
tetrakis(bis(2-hydroxyethyl)methylammonium)-3-(4-(7-acetylamino-1-hydroxy-3-sulfonatonaftaleen-2-ylazo)-5-methoxy-2-sulfonatofenylazo)-7-(4-amino-3-sulfonatofenylamino)-4-hydroxynaftaleen-2-sulfonaat |
434-840-8 |
225786-91-4 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
607-654-00-1 |
(S)-3-hydroxy-γ-butyrolacton |
434-990-4 |
7331-52-4 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
607-655-00-7 |
ethyl-6,8-dichlooroctanoaat |
435-080-1 |
1070-64-0 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
607-656-00-2 |
natriumzout van 4-amino-3,6-bis[[5-[[4-chloor-6-[(2-methyl-4-sulfofenyl)amino]-1,3,5-triazine-2-yl]amino]-2-sulfofenyl]azo]-5-hydroxy-2,7-naftaleendisulfonzuur |
435-350-7 |
141250-43-3 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
607-657-00-8 |
pentanatrium-7-(4-(4-(3-(2-sulfatoëthaansulfonyl)fenylamino)-6-(4-(2-sulfatoëthaansulfonyl)fenylamino)-1,3,5-triazine-2-ylamino)-2-ureïdofenylazo)naftaleen-1,3,6-trisulfonaat |
436-920-8 |
172399-10-9 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
607-658-00-3 |
3,10-diamino-6,13-dichloor-2-((6-(((4-(1,1-dimethylethyl)fenyl)sulfonyl)amino)-2-naftalenyl)sulfonyl)-4,11-trifenodioxazinedisulfonzuur, lithiumkaliumnatriumzout |
440-770-9 |
371921-63-0 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
607-659-00-9 |
pentanatrium-N-[5-[[4-[[3-[(aminocarbonyl)amino]-4-[(3,6,8-trisulfonatonaftaleen-2-yl)azo]fenyl]amino]-6-chloor-1,3,5-triazine-2-yl]amino]-2-sulfonato-4-[[4-[[-2-(oxysulfonato)ethyl]sulfonyl]fenyl]azo]fenyl]-3-aminopropaanzuur |
442-030-0 |
321912-47-4 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
607-660-00-4 |
2-{4-[4-[4-fluor-6-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazine-2-ylamino]fenylazofenylazo}naftaleen-4,6,8-trisulfonaat, trinatriumzout |
442-230-8 |
321679-52-1 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
607-661-00-X |
1,1-dimethylethyl-4'-(broommethyl)bifenyl-2-carboxylaat |
442-850-9 |
114772-40-6 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
607-662-00-5 |
methyl-2-(acetylamino)-3-chloorpropionaat |
442-860-3 |
87333-22-0 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
607-663-00-0 |
bis(2-ethylhexyl)naftaleen-2,6-dicarboxylaat |
442-980-6 |
127474-91-3 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
607-664-00-6 |
methyl-2-chloorsulfonyl-4-(methaansulfonylaminomethyl)benzoaat |
443-120-2 |
393509-79-0 |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
607-665-00-1 |
trans-methyl-2-ethyl-but-2-enoaat |
443-150-6 |
101226-85-1 |
Flam. Liq. 3 |
H226 |
GHS02 Wng |
H226 |
|
|
|
607-666-00-7 |
(2S)-5-(benzyloxy)-2-(1,3-dioxo-1,3-dihydro-2H-isoïndool-2-yl)-5-oxopentaanzuur |
443-560-5 |
88784-33-2 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
607-667-00-2 |
chloor-1-ethylcyclohexylcarbonaat |
444-950-8 |
99464-83-2 |
Muta. 2 Skin Sens. 1 |
H341 H317 |
GHS08 GHS07 Wng |
H341 H317 |
|
|
|
607-668-00-8 |
trans-2-isopropyl-5-carboxy-1,3-dioxaan |
445-770-2 |
42031-28-7 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
607-669-00-3 |
methyl(9-acetoxy-3,8,10-triëthyl-7,8,10-trimethyl-1,5-dioxa-9-azaspiro[5.5]undec-3-yl)octadecanoaat |
445-990-9 |
376588-17-9 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
607-670-00-9 |
dibutyl-3-(4-(5-ammonio-2-butyl)benzofuran-3-yl)carbonyl)fenoxy)propylammoniumoxalaat; (5-amino-2-butylbenzofuran-3-yl)[4-(3-dibutylaminopropoxy)fenyl]methanon, dioxalaat |
448-700-9 |
500791-70-8 |
STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H373** H318 H317 H400 H410 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H373** H318 H317 H410 |
|
M=10 |
|
607-671-00-4 |
diëthyl-1,4-cyclohexaandicarboxylaat |
417-310-0 |
72903-27-6 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
607-672-00-X |
reactiemassa van: 2-hydroxy-3-(methacryloyloxy)propyl (2-benzoyl)benzoaat; 1-hydroxymethyl-2-(methacryloyloxy)ethyl-(2-benzoyl)benzoaat; x-hydroxy-y-(methacryloyloxy)propyl(of -ethyl)(2-benzoyl)benzoaat |
419-000-0 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
607-673-00-5 |
1-ethyl-5,6,7,8-tetrahydrochinoliniumtosylaat |
419-570-0 |
— |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
607-675-00-6 |
reactiemassa van: cis-9-octadeceendizuur; cis-9-cis-12-octadecadieendizuur; hexadecaandizuur; octadecaandizuur |
422-260-8 |
— |
Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Dgr |
H318 H410 |
|
|
|
607-676-00-1 |
mengsel van: 2-methylnonaandizuur; 2,4-dimethyl-4-methoxycarbonylundecaandizuur; 2,4,6-trimethyl-4,6-dimethoxycarbonyltridecaandizuur; 8,9-dimethyl-8,9-dimethoxycarbonylhexadecaandizuur |
423-670-1 |
— |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
607-677-00-7 |
2,5-dioxopyrrolidine-1-yl N-{[methyl[[2-(1-methylethyl)-4-thiazoly]methyl]amino]carbonyl}-L-valinaat |
424-660-8 |
— |
STOT RE 2 * Eye Dam. 1 Skin Sens. 1 |
H373** H318 H317 |
GHS05 GHS08 GHS07 Dgr |
H373** H318 H317 |
|
|
|
607-678-00-2 |
reactiemassa van: ethyl-(2R,3R)-3-isopropylbicyclo[2.2.1]hept-5-een-2-carboxylaat; ethyl-(2S,3S)-3-isopropylbicyclo[2.2.1]hept-5-een-2-carboxylaat |
427-090-8 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
607-679-00-8 |
reactiemassa van: 3-{5-[3-(4-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo[}benzamido)fenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(methyl)ammoniumdi(acetaat); 3-{5-[4-(3-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido]fenylazo-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammoniumdi(acetaat); 3-{5-[3-(4-{1-[3-(dimethylammonio)propyl]-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo}benzamido)fenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammoniumdi(acetaat) |
431-440-5 |
— |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
607-680-00-3 |
tert-butyl(6-{2-[4-(4-fluorofenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidine-5-ylvinyl}(4S,6S)-2,2-dimethyl[1,3]dioxaan-4-yl)acetaat |
432-810-9 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
607-681-00-9 |
reactiemassa van: 9-nonyl-10-octyl-19-carbonyloxyhexadecylnonadecaanzuur; 9-nonyl-10-octyl-19-carbonyloxyoctadecylnonadecaanzuur; dihexadecyl-9-nonyl-10-octylnonadecaandioaat; 1-octadecyl, 19-hexadecyl-9-nonyl-10-octylnonadecaandioaat; dioctadecyl-9-nonyl-10-octylnonadecaandioaat |
432-910-2 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
607-682-00-4 |
complex mengsel van Chinese gomhars, post-reacted met acrylzuur |
434-230-1 |
144413-22-9 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
607-683-00-X |
reactiemassa van: methyl-3-((1E)-2-methylprop-1-enyl)-2,2-dimethylcyclopropaancarboxylaat; methyl-3-((1Z)-2-methylprop-1-enyl)-2,2-dimethylcyclopropaancarboxylaat (20:80) |
435-450-0 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
607-684-00-5 |
alkenen, C12-14, hydroformyleringsproducten, destillatieresiduen, C-(waterstofsulfobutaandioaten), dinatriumzouten |
435-660-2 |
243662-67-1 |
Skin Irrit. 2 Skin Sens. 1 |
H315 H317 |
GHS07 Wng |
H315 H317 |
|
|
|
607-685-00-0 |
ammonium-2-cocoyloxyethaansulfonaat |
441-050-7 |
— |
Skin Irrit. 2 Eye Dam. 1 |
H315 H318 |
GHS05 Dgr |
H315 H318 |
|
|
|
607-686-00-6 |
6,6'-bis(diazo-5,5',6,6'-tetrahydro-5,5'-dioxo)[methyleen-bis(5-(6-diazo-5,6-dihydro-5-oxo-1-naftylsulfonyloxy)-6-methyl-2-fenyleen]di(naftaleen-1-sulfonaat) |
441-550-5 |
— |
Self-react. C **** Carc. 2 |
H242 H351 |
GHS02 GHS08 Dgr |
H242 H351 |
|
|
|
607-687-00-1 |
reactiemassa van: 2-{3,6-bis-[(2-ethylfenyl)-methylamino]-xanthylium-9-yl[}-benzeensulfonate (2-10 %); 2-{3,6-bis[(2,3-dimethylfenyl)methylamino]xanthylium-9-yl}benzeensulfonaat (2-10 %); 2-{3,6-bis[(2,4-dimethylfenyl)methylamino]xanthylium-9-yl}benzeensulfonaat (2-10 %); 2-{3,6-bis[(2,5-dimethylfenyl)methylamino]xanthylium-9-yl}benzeensulfonaat (2-10 %); 2-{3-[(2,3-dimethylfenyl)methylamino]-6-[(2-ethylfenyl)methylamino]xanthylium-9-yl}benzeensulfonaat (7-20 %); 2-{3-[(2,4-dimethylfenyl)methylamino]-6-[(2-ethylfenyl)methylamino]xanthylium-9-yl}benzeensulfonaat (7-20 %); 2-{3-[(2,5-dimethylfenyl)methylamino]-6-[(2-ethylfenyl)methylamino]xanthylium-9-yl}benzeensulfonaat (7-20 %); 2-{3-[(2,3-dimethylfenyl)methylamino]-6-[(2,4-dimethylfenyl)methylamino]xanthylium-9-yl}benzeensulfonaat (7-20 %); 2-{3-[(2,3-dimethylfenyl)methylamino]-6-[(2,5-dimethylfenyl)methylamino]xanthylium-9-yl}benzeensulfonaat (7-20 %); 2-{3-[(2,4-dimethylfenyl)methylamino]-6-[(2,5-dimethylfenyl)methylamino]xanthylium-9-yl}benzeensulfonaat (7-20 %) |
442-800-6 |
— |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
607-688-00-7 |
(R)-1-cyclohexa-1,4-diënyl-1-methoxycarbonylmethylammoniumchloride |
444-320-2 |
— |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
607-689-00-2 |
reactiemassa van: methyl-1,4-dimethylcyclohexaancarboxylaat (‘para-isomeer’ inclusief cis- en trans-isomeren); methyl-1,3-dimethylcyclohexaancarboxylaat (‘meta-isomeer’ inclusief cis- en trans-isomers) |
444-920-4 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
607-690-00-8 |
dimethyl[2S,2S']-6,6,6'6'-tetramethoxy-2,2'-[N, N'-bis(trifluoracetyl)-S, S'-bi(L-homocysteïnyl)-diimino]dihexanoaat |
432-860-1 |
255387-46-3 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
607-691-00-3 |
magnesiumzouten, vetzuren, C16-18 en C18 onverzadigd, vertakt en lineair |
448-690-6 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
607-692-00-9 |
zinkzouten, vetzuren, C16-18 en C18 onverzadigd, vertakt en lineair |
446-470-4 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
607-693-00-4 |
hexyl-2-(1-(diëthylaminohydroxyfenyl)methanoyl)benzoaat |
443-860-6 |
302776-68-7 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
607-694-00-X |
ethyl-5,5-difenyl-2-isoxazoline-3-carboxylaat |
443-870-0 |
163520-33-0 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
|
607-696-00-0 |
pentylformiaat |
211-340-6 |
638-49-3 |
Flam. Liq. 3 Eye Irrit. 2 STOT SE 3 |
H226 H319 H335 |
GHS02 GHS07 Dgr |
H226 H319 H335 |
|
|
C |
607-697-00-6 |
tert-butylpropionaat |
— |
20487-40-5 |
Flam. Liq. 2 |
H225 |
GHS02 Dgr |
H225 |
|
|
C |
607-698-00-1 |
4-tert-butylbenzoëzuur |
202-696-3 |
98-73-7 |
Repr. 1B STOT RE 1 Acute Tox. 4 |
H360F H372 H302 |
GHS07 GHS08 Dgr |
H360F H372 H302 |
|
|
|
607-699-00-7 |
bifenthrin (ISO); (2-methylbifenyl-3-yl)methylrel-(1R,3R)-3-[(1Z)-2-chloor-3,3,3-trifluorprop-1-een-1-yl]-2,2-dimethylcyclopropaancarboxylaat |
|
82657-04-3 |
Carc. 2 Acute Tox. 3 Acute Tox. 2 STOT RE 1 Skin Sens. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H351 H331 H300 H372 (zenuw stelsel) H317 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H331 H300 H372 (zenuw stelsel) H317 H410 |
|
M = 10 000 M = 100 000 |
|
607-700-00-0 |
indoxacarb (ISO); methyl-(4aS)-7-chloor-2-{(methoxycarbonyl)[4-(trifluormethoxy)fenyl]carbamoyl}-2,5-dihydroïndeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylaat [1] reactiemassa van (S)-indoxacarb en (R)-indoxacarb 75:25; methyl-7-chloor-2-{(methoxycarbonyl)[4-(trifluormethoxy)fenyl]carbamoyl}-2,5-dihydroïndeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylaat [2] |
|
173584-44-6 [1] 144171-61-9 [2] |
Acute Tox. 3 Acute Tox. 4 STOT RE 1 Skin Sens. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H301 H332 H372 (bloed, zenuwstelsel, hart) H317 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H301 H332 H372 (bloed, zenuwstelsel, hart) H317 H410 |
|
M = 1 M = 1 |
|
607-702-00-1 |
dihexylftalaat |
201-559-5 |
84-75-3 |
Repr. 1B |
H360FD |
GHS08 Dgr |
H360FD |
|
|
|
607-703-00-7 |
ammoniumpentadecafluoroctanoaat |
223-320-4 |
3825-26-1 |
Carc. 2 Repr. 1B Lact. Acute Tox. 4 Acute Tox. 4 STOT RE 1 Eye Dam.1 |
H351 H360D H362 H332 H302 H372 (lever) H318 |
GHS08 GHS07 GHS05 Dgr |
H351 H360D H362 H332 H302 H372 (lever) H318 |
|
|
|
607-704-00-2 |
perfluoroctaanzuur |
206-397-9 |
335-67-1 |
Carc. 2 Repr. 1B Lact. Acute Tox. 4 Acute Tox. 4 STOT RE 1 Eye Dam. 1 |
H351 H360D H362 H332 H302 H372 (lever) H318 |
GHS08 GHS07 GHS05 Dgr |
H351 H360D H362 H332 H302 H372 (lever) H318 |
|
|
|
607-705-00-8 |
benzoëzuur |
200-618-2 |
65-85-0 |
STOT RE 1 Skin Irrit. 2 Eye Dam. 1 |
H372 (longen) (inademing) H315 H318 |
GHS08 GHS05 Dgr |
H372 (longen) (inademing) H315 H318 |
|
|
|
607-706-00-3 |
methyl-2,5-dichloorbenzoaat |
220-815-7 |
2905-69-3 |
Acute Tox. 4 STOT SE 3 Aquatic Chronic 2 |
H302 H336 H411 |
GHS07 GHS09 Wng |
H302 H336 H411 |
|
|
|
608-001-00-3 |
acetonitril; cyaanmethaan |
200-835-2 |
75-05-8 |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 |
H225 H332 H312 H302 H319 |
GHS02 GHS07 Dgr |
H225 H332 H312 H302 H319 |
|
|
|
608-002-00-9 |
trichlooracetonitril |
208-885-7 |
545-06-2 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Chronic 2 |
H331 H311 H301 H411 |
GHS06 GHS09 Dgr |
H331 H311 H301 H411 |
|
|
|
608-003-00-4 |
acrylnitril |
203-466-5 |
107-13-1 |
Flam. Liq. 2 Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H225 H350 H331 H311 H301 H335 H315 H318 H317 H411 |
GHS02 GHS06 GHS08 GHS05 GHS09 Dgr |
H225 H350 H331 H311 H301 H335 H315 H318 H317 H411 |
|
* |
D |
608-004-00-X |
2-hydroxy-2-methylpropionitril; acetoncyaanhydrine; acetoncyaanhydrine |
200-909-4 |
75-86-5 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H330 H310 H300 H410 |
|
|
|
608-005-00-5 |
n-butyronitril |
203-700-6 |
109-74-0 |
Flam. Liq. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * |
H225 H331 H311 H301 |
GHS02 GHS06 Dgr |
H225 H331 H311 H301 |
|
|
|
608-006-00-0 |
bromoxynil (ISO); 3,5-dibroom-4-hydroxybenzonitril; bromoxynil-fenol |
216-882-7 |
1689-84-5 |
Repr. 2 Acute Tox. 2 * Acute Tox. 3 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361d *** H330 H301 H317 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H361d *** H330 H301 H317 H410 |
|
M = 10 |
|
608-007-00-6 |
ioxynil (ISO); 4-hydroxy-3,5-diiodobenzonitril |
216-881-1 |
1689-83-4 |
Repr. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H361d *** H331 H301 H312 H373 ** H319 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H361d *** H331 H301 H312 H373 ** H319 H410 |
|
M = 10 |
|
608-008-00-1 |
chlooracetonitril |
203-467-0 |
107-14-2 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Chronic 2 |
H331 H311 H301 H411 |
GHS06 GHS09 Dgr |
H331 H311 H301 H411 |
|
|
|
608-009-00-7 |
malononitril |
203-703-2 |
109-77-3 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H331 H311 H301 H410 |
|
|
|
608-010-00-2 |
methacrylonitril; 2-methyl-2-propeennitril |
204-817-5 |
126-98-7 |
Flam. Liq. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Sens. 1 |
H225 H331 H311 H301 H317 |
GHS02 GHS06 Dgr |
H225 H331 H311 H301 H317 |
|
* Skin Sens. 1; H317: C ≥0,2 % |
D |
608-011-00-8 |
oxalonitril; cyanogeen |
207-306-5 |
460-19-5 |
Press. Gas Flam. Gas 1 Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H220 H331 H400 H410 |
GHS02 GHS04 GHS06 GHS09 Dgr |
H220 H331 H410 |
|
|
U |
608-012-00-3 |
benzonitril |
202-855-7 |
100-47-0 |
Acute Tox. 4 * Acute Tox. 4 * |
H312 H302 |
GHS07 Wng |
H312 H302 |
|
|
|
608-013-00-9 |
2-chloorbenzonitril |
212-836-5 |
873-32-5 |
Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 |
H312 H302 H319 |
GHS07 Wng |
H312 H302 H319 |
|
|
|
608-014-00-4 |
chloorthalonil (ISO); tetrachloorisoftalonitril |
217-588-1 |
1897-45-6 |
Carc. 2 Acute Tox. 2 * STOT SE 3 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H330 H335 H318 H317 H400 H410 |
GHS06 GHS05 GHS08 GHS09 Dgr |
H351 H330 H335 H318 H317 H410 |
|
M=10 |
|
608-015-00-X |
dichlobenil (ISO); 2,6-dichloorbenzonitril |
214-787-5 |
1194-65-6 |
Acute Tox. 4 * Aquatic Chronic 2 |
H312 H411 |
GHS07 GHS09 Wng |
H312 H411 |
|
|
|
608-016-00-5 |
1,4-dicyano-2,3,5,6-tetra-chloor-benzeen |
401-550-8 |
1897-41-2 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
608-017-00-0 |
bromoxyniloctanoaat (ISO); 2,6-dibroom-4-cyaanfenyloctanoaat; |
216-885-3 |
1689-99-2 |
Repr. 2 Acute Tox. 3 * Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361d *** H331 H302 H317 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H361d *** H331 H302 H317 H410 |
|
M = 10 |
|
608-018-00-6 |
ioxyniloctanoaat (ISO); 4-cyaan-2,6-dijoodfenyloctanoaat |
223-375-4 |
3861-47-0 |
Repr. 2 Acute Tox. 3 * Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361d *** H301 H319 H317 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H361d *** H301 H319 H317 H410 |
|
M = 10 |
|
608-019-00-1 |
2,2'-dimethyl-2,2'-azodipropiononitril; ADZN |
201-132-3 |
78-67-1 |
Self-react. C Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 3 |
H242 H332 H302 H412 |
GHS02 GHS07 Dgr |
H242 H332 H302 H412 |
|
|
T |
608-020-00-7 |
difenoxymethyleencyaanamide |
427-300-8 |
79463-77-7 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
608-021-00-2 |
3-(2-(diaminomethyleenamino)thiazool-4-ylmethylthio)propiononitril |
403-710-2 |
76823-93-3 |
Acute Tox. 4 * Skin Sens. 1 |
H302 H317 |
GHS07 Wng |
H302 H317 |
|
|
|
608-022-00-8 |
3,7-dimethyloctaannitril |
403-620-3 |
40188-41-8 |
Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H315 H317 H411 |
GHS07 GHS09 Wng |
H315 H317 H411 |
|
|
|
608-023-00-3 |
fenbuconazool (ISO); 4-(4-chloorfenyl)-2-fenyl-2-[(1H-1,2,4-triazool-1-yl)methyl]butaannitril |
406-140-2 |
114369-43-6 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
608-024-00-9 |
2-(4-(N-butyl-N-fenethylamino)fenyl)ethyleen-1,1,2-tricarbonitril |
407-650-8 |
97460-76-9 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
608-025-00-4 |
2-nitro-4,5-bis(benzyloxy)fenylacetonitril |
410-970-0 |
117568-27-1 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
608-026-00-X |
3-cyaan-3,5,5-trimethylcyclohexanon |
411-490-4 |
7027-11-4 |
Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Chronic 3 |
H302 H373 ** H317 H412 |
GHS08 GHS07 Wng |
H302 H373 ** H317 H412 |
|
|
|
608-027-00-5 |
reactiemassa van: 3-(4-ethylfenyl)-2,2-dimethylpropaannitril; 3-(2-ethylfenyl)-2,2-dimethylpropaannitril; 3-(3-ethylfenyl)-2,2-dimethylpropaannitril |
412-660-0 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
608-028-00-0 |
4-(2-cyaan-3-fenylamino-acryloyloxymethyl)-cyclohexyl-methyl 2-cyaan-3-fenylamino)-acrylaat |
413-510-7 |
147374-67-2 |
STOT RE 2 * Skin Sens. 1 Aquatic Chronic 2 |
H373 ** H317 H411 |
GHS08 GHS09 Wng |
H373 ** H317 H411 |
|
|
|
608-029-00-6 |
1,2-dihydro-6-hydroxy-4-methyl-1-[3-(1-methylethoxy)propyl]-2-oxo-3-pyridinecarbonitril |
411-990-2 |
68612-94-2 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
608-030-00-1 |
N-acetyl-N-[5-cyaan-3-(2-dibutylamino-4-fenylthiazool-5-yl-methyleen)-4-methyl-2,6-dioxo-1,2,3,6-tetrahydropyridine-1-yl]benzamide |
412-340-0 |
147741-93-3 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
608-031-00-7 |
2-benzyl-2-methyl-3-buteennitril |
407-870-4 |
97384-48-0 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
608-032-00-2 |
acetamiprid (ISO); (E)-N 1-[(6-chloor-3-pyridyl)methyl]-N 2-cyaan-N 1-methylacetamidine |
— |
135410-20-7 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
608-033-00-8 |
N-butyl-3-(2-chloor-4-nitrofenylhydrazono)-1-cyaan-2-methylprop-1-een-1,3-dicarboximide |
407-970-8 |
75511-91-0 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
608-034-00-3 |
chloorfenapyr (ISO); 4-broom-2-(4-chloorfenyl)-1-ethoxymethyl-5-trifluormethylpyrrool-3-carbonitril |
— |
122453-73-0 |
Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H302 H400 H410 |
GHS06 GHS09 Dgr |
H331 H302 H410 |
|
M=100 |
|
608-035-00-9 |
(±)-α-[(2-acetyl-5-methylfenyl)-amino]-2,6-dichloorbenzeen-acetonitril |
419-290-9 |
— |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
608-036-00-4 |
3-(2-{4-[2-(4-cyaanfenyl)vinyl]fenyl}vinyl)benzonitril |
419-060-8 |
79026-02-1 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
608-037-00-X |
reactiemassa van: (E)-2,12-tridecadieennitril; (E)-3,12-tridecadieennitril; (Z)-3,12-tridecadieennitril |
422-190-8 |
|
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
608-038-00-5 |
2,2,4-trimethyl-4-fenylbutaannitril |
422-580-8 |
75490-39-0 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
608-039-00-0 |
2-fenylhexaannitril |
423-460-8 |
3508-98-3 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
608-040-00-6 |
4,4'-dithiobis(5-amino-1-(2,6-dichloor-4-(trifluormethyl)fenyl)-1H-pyrazool-3-carbonitril) |
423-490-1 |
130755-46-3 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
608-041-00-1 |
4'-((2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-een-3-yl)methyl)(1,1'-bifenyl)-2-carbonitril |
423-500-4 |
138401-24-8 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
608-042-00-7 |
(S)-2,2-difenyl-2-(3-pyrrolidinyl)acetonitrilhydrobromide |
421-810-4 |
194602-27-2 |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H302 H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H317 H411 |
|
|
|
608-043-00-2 |
3-(cis-3-hexenyloxy)propaannitril |
415-220-6 |
142653-61-0 |
Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H302 H400 H410 |
GHS06 GHS09 Dgr |
H331 H302 H410 |
|
|
|
608-044-00-8 |
2-cyclohexylideen-2-fenyl-acetonitril |
423-740-1 |
10461-98-0 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
608-046-00-9 |
5-(4-chloor-2-nitrofenylazo)-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxopyridine-3-carbonitril |
425-310-7 |
77889-90-8 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
608-047-00-4 |
2-piperidine-1-yl-benzonitril |
427-330-1 |
72752-52-4 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
608-048-00-X |
1-(3-cyclopentyloxy-4-methoxyfenyl)-4-oxocyclohexaancarbonitril |
427-450-4 |
152630-47-2 |
Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Chronic 2 |
H302 H373** H317 H411 |
GHS08 GHS07 GHS09 Wng |
H302 H373** H317 H411 |
|
|
|
608-049-00-5 |
2-(4-(4-(butyl-(1-methylhexyl)amino)fenyl)-3-cyaan-5-oxo-1,5-dihydropyrrool-2-ylideen)-propaandinitril |
429-180-2 |
157362-53-3 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
608-050-00-0 |
reactiemassa van: 5-(2-cyaan-4-nitrofenylazo)-2-(2-(2-hydroxyethoxy)ethylamino)-4-methyl-6-fenylamino-nicotinonitril; 5-(2-cyaan-4-nitrofenylazo)-6-(2-(2-hydroxyethoxy)-ethylamino)-4-methyl-2-fenylaminonicotinonitril |
429-760-5 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
608-051-00-6 |
(R)-4-(4-dimethylamino-1-(4-fluorfenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitril |
430-760-2 |
219861-18-4 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H302 H317 H411 |
GHS07 GHS09 Wng |
H302 H317 H411 |
|
|
|
608-052-00-1 |
(S)-4-(4-dimethylamino-1-(4-fluorfenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitril |
430-770-7 |
128173-52-4 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H302 H317 H411 |
GHS07 GHS09 Wng |
H302 H317 H411 |
|
|
|
608-053-00-7 |
(R,S)-4-(4-dimethylamino-1-(4-fluorfenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitril |
430-780-1 |
103146-25-4 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H302 H317 H411 |
GHS07 GHS09 Wng |
H302 H317 H411 |
|
|
|
608-054-00-2 |
(R,S)-4-(4-dimethylamino-1-(4-fluorfenyl)-1-hydroxybutyl)3-(hydroxymethyl)benzonitril-hemisulfaat |
430-790-6 |
— |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H302 H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H317 H411 |
|
|
|
608-056-00-3 |
N-methyl-N-cyaanmethylmorfoliniummethylsulfaat |
429-340-1 |
— |
Acute Tox. 4 * Eye Dam. 1 |
H302 H318 |
GHS05 GHS07 Dgr |
H302 H318 |
|
|
|
608-057-00-9 |
4-(cyaanmethyl)-4-methylmorfoline-4-ium-hydrogeen-sulfaat |
431-200-1 |
208538-34-5 |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 |
H302 H318 H317 |
GHS05 GHS07 Dgr |
H302 H318 H317 |
|
|
|
608-058-00-4 |
esfenvaleraat (ISO); (S)-α-cyaan-3-fenoxybenzyl-(S)-2-(4-chloorfenyl)-3-methylbutyraat |
— |
66230-04-4 |
Acute Tox. 3 * Acute Tox. 3 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H317 H400 H410 |
GHS06 GHS09 Dgr |
H331 H301 H317 H410 |
|
M = 10000 |
|
608-059-00-X |
5-amino-1-(2,6-dichloor-4-(trifluormethyl)fenyl)-1H-pyrazool-3-carbonitril |
421-240-6 |
120068-79-3 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
608-060-00-5 |
5-methyl-2-[(2-nitrofenyl)amino]-3-thiofeencarbonitril |
421-300-1 |
138564-59-7 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
608-062-00-6 |
2-fluor-4-hydroxybenzonitril |
422-810-7 |
82380-18-5 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H411 |
|
|
|
608-063-00-1 |
(S)-α-hydroxy-3-fenoxybenzeenacetonitril |
441-070-6 |
61826-76-4 |
Acute Tox. 3 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H318 H317 H400 H410 |
GHS06 GHS05 GHS09 Dgr |
H301 H318 H317 H410 |
|
|
|
608-064-00-7 |
cyaanmethyltrimethylammoniummethylsulfaat |
433-720-2 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
608-065-00-2 |
zouten van bromoxynil, tenzij elders in deze bijlage vermeld |
— |
— |
Repr. 2 Acute Tox. 2 * Acute Tox. 3 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361d *** H330 H301 H317 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H361d *** H330 H301 H317 H410 |
|
M = 10 |
A |
608-066-00-8 |
zouten van ioxynil, tenzij elders in deze bijlage vermeld |
— |
— |
Repr. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H361d *** H331 H301 H312 H373 ** H319 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H361d *** H331 H301 H312 H373 ** H319 H410 |
|
M = 10 |
A |
609-001-00-6 |
1-nitropropaan |
203-544-9 |
108-03-2 |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H226 H332 H312 H302 |
GHS02 GHS07 Wng |
H 226 H332 H312 H302 |
|
* |
|
609-002-00-1 |
2-nitropropaan |
201-209-1 |
79-46-9 |
Flam. Liq. 3 Carc. 1B Acute Tox. 4 * Acute Tox. 4 * |
H226 H350 H332 H302 |
GHS02 GHS08 GHS07 Dgr |
H226 H350 H332 H302 |
|
|
|
609-003-00-7 |
nitrobenzeen |
202-716-0 |
98-95-3 |
Carc. 2. Repr. 1B Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 STOT RE 1 Aquatic Chronic 3 |
H351 H360F H301 H331 H311 H372 (bloed) H412 |
GHS06 GHS08 Dgr |
H351 H360F H301 H331 H311 H372 (bloed) H412 |
|
|
|
609-004-00-2 |
dinitrobenzeen; [1] 1,4-dinitrobenzeen; [2] 1,3-dinitrobenzeen; [3] 1,2-dinitrobenzeen [4] |
246-673-6 [1] 202-833-7 [2] 202-776-8 [3] 208-431-8 [4] |
25154-54-5 [1] 100-25-4 [2] 99-65-0 [3] 528-29-0 [4] |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H330 H310 H300 H373 ** H410 |
|
|
|
609-005-00-8 |
1,3,5-trinitrobenzeen |
202-752-7 |
99-35-4 |
Expl. 1.1 Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 |
H201 H330 H310 H300 H373** H400 H410 |
GHS01 GHS06 GHS08 GHS09 Dgr |
H201 H330 H310 H300 H373** H410 |
|
|
|
609-006-00-3 |
4-nitrotolueen |
202-808-0 |
99-99-0 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Chronic 2 |
H331 H311 H301 H373 ** H411 |
GHS06 GHS08 GHS09 Dgr |
H331 H311 H301 H373 ** H411 |
|
|
|
609-007-00-9 |
2,4-dinitrotolueen; [1] dinitrotolueen [2] |
204-450-0 [1] 246-836-1 [2] |
121-14-2 [1] 25321-14-6 [2] |
Carc. 1B Muta. 2 Repr. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H350 H341 H361f*** H331 H311 H301 H373** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350 H341 H361f*** H331 H311 H301 H373** H410 |
|
|
|
609-008-00-4 |
2,4,6-trinitrotolueen; TNT |
204-289-6 |
118-96-7 |
Expl. 1.1 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Chronic 2 |
H201 H331 H311 H301 H373 ** H411 |
GHS01 GHS06 GHS08 GHS09 Dgr |
H201 H331 H311 H301 H373 ** H411 |
|
|
|
609-009-00-X |
2,4,6-trinitrofenol; picrinezuur |
201-865-9 |
88-89-1 |
Expl. 1.1 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * |
H201 H331 H311 H301 |
GHS01 GHS06 Dgr |
H201 H331 H311 H301 |
|
|
|
609-010-00-5 |
zouten van picrinezuur |
— |
— |
Unst. Expl Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * |
H201 H331 H311 H301 |
GHS01 GHS06 Dgr |
H201 H331 H311 H301 |
|
|
T |
609-011-00-0 |
2,4,6-trinitroanisool |
— |
606-35-9 |
Expl. 1.1 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 2 |
H201 H332 H312 H302 H411 |
GHS01 GHS07 GHS09 Wng |
H201 H332 H312 H302 H411 |
|
|
|
609-012-00-6 |
2,4,6-trinitro-m-kresol |
210-027-1 |
602-99-3 |
Expl. 1.1 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H201 H332 H312 H302 |
GHS01 GHS07 Wng |
H201 H332 H312 H302 |
|
|
|
609-013-00-1 |
2,4,6-trinitro-m-xyleen |
211-187-5 |
632-92-8 |
Expl. 1.1 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * |
H201 H332 H312 H302 H373 ** |
GHS01 GHS08 GHS07 Wng |
H201 H332 H312 H302 H373 ** |
|
|
|
609-015-00-2 |
4-nitrofenol; p-nitrofenol |
202-811-7 |
100-02-7 |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * |
H332 H312 H302 H373 ** |
GHS08 GHS07 Wng |
H332 H312 H302 H373 ** |
|
|
|
609-016-00-8 |
dinitrofenol (reactiemassa van isomeren); [1] 2,4(of 2,6)-dinitrofenol [2] |
247-096-2 [1] 275-732-9 [2] |
25550-58-7 [1] 71629-74-8 [2] |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H331 H311 H301 H373 ** H410 |
|
|
|
609-018-00-9 |
2,4,6-trinitroresorcinol; styfninezuur |
201-436-6 |
82-71-3 |
Expl. 1.1 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H201 H332 H312 H302 |
GHS01 GHS07 Dgr |
H201 H332 H312 H302 |
|
|
|
609-019-00-4 |
lood-2,4,6-trinitro-m-fenyleendioxide; lood-2,4,6-trinitroresorcinoxide; loodstyfnaat |
239-290-0 |
15245-44-0 |
Unst. Expl Repr. 1A Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H200 H360Df H332 H302 H373 ** H400 H410 |
GHS01 GHS08 GHS07 GHS09 Dgr |
H200 H360Df H332 H302 H373 ** H410 |
|
|
1 |
609-019-01-1 |
lood-2,4,6-trinitro-m-fenyleendioxide; lood-2,4,6-trinitroresorcinoxide; loodstyfnaat (≥ 20 % flegmatisator) |
239-290-0 |
15245-44-0 |
Expl. 1.1 Repr. 1A Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H201 H360Df H332 H302 H373 ** H400 H410 |
GHS01 GHS08 GHS07 GHS09 Dgr |
H201 H360Df H332 H302 H373 ** H410 |
|
|
1 |
609-020-00-X |
DNOC (ISO); 4,6-dinitro-o-cresol |
208-601-1 |
534-52-1 |
Muta. 2 Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H341 H330 H310 H300 H315 H318 H317 H400 H410 |
GHS06 GHS08 GHS05 GHS07 GHS09 Dgr |
H341 H330 H310 H300 H315 H318 H317 H410 |
EUH044 |
|
|
609-021-00-5 |
natriumzout van DNOC; natrium-4,6-dinitro-o-cresolaat; [1] kaliumzout van DNOC; kalium 4,6-dinitro-o-cresolaat [2] |
219-007-7 [1] -[2] |
2312-76-7 [1] 5787-96-2 [2] |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H331 H311 H301 H373 ** H410 |
|
|
|
609-022-00-0 |
ammoniumzout van DNOC; ammonium-4,6-dinitro-o-tolyloxide |
221-037-0 |
2980-64-5 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H330 H310 H300 H373 ** H410 |
|
|
|
609-023-00-6 |
dinocap (ISO); (RS)-2,6-dinitro-4-octylfenylcrotonaten en (RS)-2,4-dinitro-6-octylfenylcrotonaten, waarbij „octyl” een reactiemassa van 1-methylheptyl-, 1-ethylhexyl- en 1-propylpentylgroepen is |
254-408-0 |
39300-45-3 |
Repr. 1B Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H360D*** H332 H302 H373** H315 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H360D*** H332 H302 H373** H315 H317 H410 |
|
M=100 |
|
609-024-00-1 |
binapacryl (ISO); 2-sec-butyl-4,6-dinitrofenyl-3-methylcrotonaat |
207-612-9 |
485-31-4 |
Repr. 1B Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H360D *** H312 H302 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H360D *** H312 H302 H410 |
|
|
|
609-025-00-7 |
dinoseb (ISO); 6-sec-butyl-2,4-dinitrofenol |
201-861-7 |
88-85-7 |
Repr. 1B Acute Tox. 3 * Acute Tox. 3 * Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H360Df H311 H301 H319 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H360Df H311 H301 H319 H410 |
EUH044 |
|
|
609-026-00-2 |
zouten en esters van dinoseb, tenzij elders in deze bijlage vermeld |
— |
— |
Repr. 1B Acute Tox. 3 * Acute Tox. 3 * Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H360Df H311 H301 H319 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H360Df H311 H301 H319 H410 |
EUH044 |
|
A |
609-027-00-8 |
dinocton; reactiemassa van isomeren: methyl-2-octyl-4,6-dinitrofenylcarbonaat, methyl-4-octyl-2,6-dinitrofenylcarbonaat |
— |
63919-26-6 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
609-028-00-3 |
dinex (ISO); 2-cyclohexyl-4,6-dinitrofenol |
205-042-5 |
131-89-5 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H331 H311 H301 H410 |
|
|
|
609-029-00-9 |
zouten en esters van dinex |
— |
— |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H331 H311 H301 H410 |
|
|
A |
609-030-00-4 |
dinoterb (ISO); 2-tert-butyl-4,6-dinitrofenol |
215-813-8 |
1420-07-1 |
Repr. 1B Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H360D *** H300 H311 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H360D *** H300 H311 H410 |
EUH044 |
|
|
609-031-00-X |
zouten en esters van dinoterb |
— |
— |
Repr. 1B Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H360D *** H300 H311 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H360D *** H300 H311 H410 |
|
|
A |
609-032-00-5 |
bromofenoxim (ISO); 3,5-dibroom-4-hydroxybenzaldehyde-O-(2,4-dinitrofenyl)oxim |
236-129-6 |
13181-17-4 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
609-033-00-0 |
dinosam (ISO); 2-(1-methylbutyl)-4,6-dinitrofenol |
— |
4097-36-3 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H331 H311 H301 H410 |
|
|
|
609-034-00-6 |
zouten en esters van dinosam |
— |
— |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H331 H311 H301 H410 |
|
|
A |
609-035-00-1 |
nitroëthaan |
201-188-9 |
79-24-3 |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * |
H226 H332 H302 |
GHS02 GHS07 Wng |
H226 H332 H302 |
|
* |
|
609-036-00-7 |
nitromethaan |
200-876-6 |
75-52-5 |
Flam. Liq. 3 Acute Tox. 4 * |
H226 H302 |
GHS02 GHS07 Wng |
H226 H302 |
|
* |
|
609-037-00-2 |
5-nitroacenafteen |
210-025-0 |
602-87-9 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
609-038-00-8 |
2-nitronaftaleen |
209-474-5 |
581-89-5 |
Carc. 1B Aquatic Chronic 2 |
H350 H411 |
GHS08 GHS09 Dgr |
H350 H411 |
|
|
|
609-039-00-3 |
4-nitrobifenyl |
202-204-7 |
92-93-3 |
Carc. 1B Aquatic Chronic 2 |
H350 H411 |
GHS08 GHS09 Dgr |
H350 H411 |
|
|
|
609-040-00-9 |
nitrofen (ISO); 2,4-dichloorfenyl-4-nitrofenylether |
217-406-0 |
1836-75-5 |
Carc. 1B Repr. 1B Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H350 H360D *** H302 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350 H360D *** H302 H410 |
|
|
|
609-041-00-4 |
2,4-dinitrofenol |
200-087-7 |
51-28-5 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 |
H331 H311 H301 H373 ** H400 |
GHS06 GHS08 GHS09 Dgr |
H331 H311 H301 H373 ** H400 |
|
|
|
609-042-00-X |
pendimethalin (ISO); N-(1-ethylpropyl)-2,6-dinitro-3,4-xylidine |
254-938-2 |
40487-42-1 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
609-043-00-5 |
quintozeen (ISO); pentachloornitrobenzeen |
201-435-0 |
82-68-8 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
609-044-00-0 |
tecnazeen (ISO); 1,2,4,5-tetrachloor-3-nitrobenzeen |
204-178-2 |
117-18-0 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
|
609-045-00-6 |
reactiemassa van: 4,6-dinitro-2-(3-octyl)fenylmethylcarbonaat en 4,6-dinitro-2-(4-octyl)fenylmethylcarbonaat; dinocton-6 |
— |
8069-76-9 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
609-046-00-1 |
trifluralin (ISO) (met < 0,5 ppm NPDA); α, α,α-trifluor-2,6-dinitro-N,N-dipropyl-p-toluïdine (met < 0,5 ppm NPDA); 2,6-dinitro-N,N-dipropyl-4-trifluormethylaniline (met < 0,5 ppm NPDA); N,N-dipropyl-2,6-dinitro-4-trifluormethylaniline (met < 0,5 ppm NPDA) |
216-428-8 |
1582-09-8 |
Carc. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H317 H410 |
|
M=10 |
|
609-047-00-7 |
2-nitroanisool |
202-052-1 |
91-23-6 |
Carc. 1B Acute Tox. 4 * |
H350 H302 |
GHS08 GHS07 Dgr |
H350 H302 |
|
|
|
609-048-00-2 |
natrium-3-nitrobenzeensulfonaat |
204-857-3 |
127-68-4 |
Eye Irrit. 2 Skin Sens. 1 |
H319 H317 |
GHS07 Wng |
H319 H317 |
|
|
|
609-049-00-8 |
2,6-dinitrotolueen |
210-106-0 |
606-20-2 |
Carc. 1B Muta. 2 Repr. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Chronic 3 |
H350 H341 H361f *** H331 H311 H301 H373 ** H412 |
GHS06 GHS08 Dgr |
H350 H341 H361f *** H331 H311 H301 H373 ** H412 |
|
|
|
609-050-00-3 |
2,3-dinitrotolueen |
210-013-5 |
602-01-7 |
Carc. 1B Muta. 2 Repr. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H350 H341 H361f *** H331 H311 H301 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350 H341 H361f *** H331 H311 H301 H373 ** H410 |
|
|
|
609-051-00-9 |
3,4-dinitrotolueen |
210-222-1 |
610-39-9 |
Carc. 1B Muta. 2 Repr. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Chronic 2 |
H350 H341 H361f *** H331 H311 H301 H373 ** H411 |
GHS06 GHS08 GHS09 Dgr |
H350 H341 H361f *** H331 H311 H301 H373 ** H411 |
|
|
|
609-052-00-4 |
3,5-dinitrotolueen |
210-566-2 |
618-85-9 |
Carc. 1B Muta. 2 Repr. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Chronic 3 |
H350 H341 H361f *** H331 H311 H301 H373 ** H412 |
GHS06 GHS08 Dgr |
H350 H341 H361f *** H331 H311 H301 H373 ** H412 |
|
|
|
609-053-00-X |
hydrazine-trinitromethaan |
414-850-9 |
— |
Expl. 1.1 **** Self-react. A Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Skin Sens. 1 |
H201 H240 H350 H331 H301 H317 |
GHS01 GHS06 GHS08 Dgr |
H201 H240 H350 H331 H301 H317 |
|
|
|
609-054-00-5 |
2,3-dinitrofenol; [1] 2,5-dinitrofenol; [2] 2,6-dinitrofenol; [3] 3,4-dinitrofenol; [4] zouten van dinitrofenol [5] |
200-628-7 [1] 206-348-1 [2] 209-357-9 [3] 209-415-3 [4]-[5] |
66-56-8 [1] 329-71-5 [2] 573-56-8 [3] 577-71-9 [4]-[5] |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Chronic 2 |
H331 H311 H301 H373 ** H411 |
GHS06 GHS08 GHS09 Dgr |
H331 H311 H301 H373 ** H411 |
|
|
|
609-055-00-0 |
2,5-dinitrotolueen |
210-581-4 |
619-15-8 |
Carc. 1B Muta. 2 Repr. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Chronic 2 |
H350 H341 H361f *** H331 H311 H301 H373 ** H411 |
GHS06 GHS08 GHS09 Dgr |
H350 H341 H361f *** H331 H311 H301 H373 ** H411 |
|
|
|
609-056-00-6 |
2,2-dibroom-2-nitroëthanol |
412-380-9 |
69094-18-4 |
Expl. 1.1 Carc. 2 Acute Tox. 4 * STOT RE 2 * Skin Corr. 1A Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H201 H351 H302 H373 ** H314 H317 H400 H410 |
GHS01 GHS08 GHS05 GHS07 GHS09 Dgr |
H201 H351 H302 H373 ** H314 H317 H410 |
|
* STOT SE 3; H335: C ≥ 1 % |
T |
609-057-00-1 |
3-chloor-2,4-difluornitrobenzeen |
411-980-8 |
3847-58-3 |
Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H314 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H302 H314 H317 H410 |
|
|
|
609-058-00-7 |
2-nitro-2-fenyl-1,3-propaandiol |
410-360-4 |
5428-02-4 |
STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H372 ** H312 H302 H317 H411 |
GHS08 GHS07 GHS09 Dgr |
H372 ** H312 H302 H317 H411 |
EUH070 |
|
|
609-059-00-2 |
2-chloor-6-(ethylamino)-4-nitrofenol |
411-440-1 |
131657-78-8 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H302 H317 H411 |
GHS07 GHS09 Wng |
H302 H317 H411 |
|
|
|
609-060-00-8 |
4-[(3-hydroxypropyl)amino]-3-nitrofenol |
406-305-9 |
92952-81-3 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
609-061-00-3 |
(E,Z)-4-chloorfenyl(cyclopropyl)keton-O-(4-nitrofenylmethyl)oxim |
406-100-4 |
94097-88-8 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
609-062-00-9 |
2-broom-2-nitropropanol |
407-030-7 |
24403-04-1 |
Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H311 H302 H373 ** H314 H317 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H311 H302 H373 ** H314 H317 H410 |
|
|
|
609-063-00-4 |
2-[(4-chloor-2-nitrofenyl)amino]ethanol |
413-280-8 |
59320-13-7 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
609-064-00-X |
mesotrione (ISO); 2-[4-(methylsulfonyl)-2-nitrobenzoyl]-1,3-cyclohexaandion |
— |
104206-82-8 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
609-065-00-5 |
2-nitrotolueen |
201-853-3 |
88-72-2 |
Carc. 1B Muta. 1B Repr. 2 Acute Tox. 4 * Aquatic Chronic 2 |
H350 H340 H361f *** H302 H411 |
GHS08 GHS07 GHS09 Dgr |
H350 H340 H361f *** H302 H411 |
|
|
|
609-066-00-0 |
llithiumnatrium-3-amino-10-{4-(10-amino-6,13-dichloor-4,11-disulfonatobenzo[5,6][1,4]oxazino[2,3-b]fenoxazine-3-ylamino)-6-[methyl(2-sulfonatoëthyl)amino]-1,3,5-triazine-2-ylamino}-6,13-dichloorbenzo[5,6][1,4]oxazino[2,3-b]fenoxazine-4,11-disulfonaat |
418-870-9 |
154212-58-5 |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT SE 2 ** |
H332 H312 H302 H371 ** |
GHS08 GHS07 Dgr |
H332 H312 H302 H371 ** |
|
|
|
609-067-00-6 |
natrium- en kalium-4-(3-aminopropylamino)-2,6-bis[3-(4-methoxy-2-sulfofenylazo)-4-hydroxy-2-sulfo-7-naftylamino]-1,3,5-triazine |
416-280-6 |
156769-97-0 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
609-068-00-1 |
muskusxyleen; 5-tert-butyl-2,4,6-trinitro-m-xyleen |
201-329-4 |
81-15-2 |
Expl. 1.1 Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H201 H351 H400 H410 |
GHS01 GHS08 GHS09 Wng |
H201 H351 H410 |
|
|
T |
609-069-00-7 |
muskusketon; 3,5-dinitro-2,6-dimethyl-4-tert-butylacetofenon; 4'-tert-butyl-2', 6'-dimethyl-3',5'-dinitroacetofenon |
201-328-9 |
81-14-1 |
Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H400 H410 |
GHS08 GHS09 Wng |
H351 H410 |
|
|
|
609-070-00-2 |
1,4-dichloor-2-(1,1,2,3,3,3-hexafluorpropoxy)-5-nitrobenzeen |
415-580-4 |
130841-23-5 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
|
609-071-00-8 |
reactiemassa van: 2-methylsulfanyl-4,6-bis-(2-hydroxy-4-methoxyfenyl)-1,3,5-triazine; 2-(4,6-bis-methylsulfanyl-1,3,5-triazine-2-yl)-5-methoxyfenol |
423-520-3 |
156137-33-6 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
609-072-00-3 |
4-mesyl-2-nitrotolueen |
430-550-0 |
1671-49-4 |
Repr. 2 Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 3 |
H361f*** H302 H317 H412 |
GHS08 GHS07 Wng |
H361f*** H302 H317 H412 |
|
|
|
609-073-00-9 |
kaliumlithiumnatrium-N,N''-bis{6-[7-[4-(4-chloor-1,3,5-triazine-2-yl)amino-4-(2-ureïdofenylazo)]naftaleen-1,3,6-trisulfonato]}-N'-(2-aminoëthyl)piperazine |
427-850-9 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
610-001-00-3 |
trichloornitromethaan; chloorpicrine |
200-930-9 |
76-06-2 |
Acute Tox. 2 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H330 H302 H319 H335 H315 |
GHS06 Dgr |
H330 H302 H319 H335 H315 |
|
|
|
610-002-00-9 |
1,1-dichloor-1-nitroëthaan |
209-854-0 |
594-72-9 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * |
H331 H311 H301 |
GHS06 Dgr |
H331 H311 H301 |
|
|
|
610-003-00-4 |
dinitrochloorbenzeen |
— |
— |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H331 H311 H301 H373 ** H410 |
|
|
C |
610-004-00-X |
2-chloor-1,3,5-trinitrobenzeen |
201-864-3 |
88-88-0 |
Expl. 1.1 Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H201 H330 H310 H300 H400 H410 |
GHS01 GHS06 GHS09 Dgr |
H201 H330 H310 H300 H410 |
|
|
|
610-005-00-5 |
1-chloor-4-nitrobenzeen |
202-809-6 |
100-00-5 |
Carc. 2 Muta. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Chronic 2 |
H351 H341 H331 H311 H301 H373 ** H411 |
GHS06 GHS08 GHS09 Dgr |
H351 H341 H331 H311 H301 H373 ** H411 |
|
|
|
610-006-00-0 |
chloornitroanilinen, tenzij elders in deze bijlage vermeld |
— |
— |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Chronic 2 |
H330 H310 H300 H373 ** H411 |
GHS06 GHS08 GHS09 Dgr |
H330 H310 H300 H373 ** H411 |
|
|
A C |
610-007-00-6 |
1-chloor-1-nitropropaan |
209-990-0 |
600-25-9 |
Acute Tox. 4 * Acute Tox. 4 * |
H332 H302 |
GHS07 Wng |
H332 H302 |
|
* |
|
610-008-00-1 |
2,6-dichloor-4-nitroanisool |
403-350-6 |
17742-69-7 |
Acute Tox. 3 * Aquatic Chronic 2 |
H301 H411 |
GHS06 GHS09 Dgr |
H301 H411 |
|
|
|
610-009-00-7 |
2-chloor-4-nitroaniline |
204-502-2 |
121-87-9 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
610-010-00-2 |
2-broom-1-(2-furyl)-2-nitroëthyleen |
406-110-9 |
35950-52-8 |
Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373 ** H314 H317 H400 H410 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H302 H373 ** H314 H317 H410 |
|
|
|
611-001-00-6 |
azobenzeen |
203-102-5 |
103-33-3 |
Carc. 1B Muta. 2 Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H350 H341 H332 H302 H373 ** H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350 H341 H332 H302 H373 ** H410 |
|
|
|
611-002-00-1 |
azoxybenzeen |
207-802-1 |
495-48-7 |
Acute Tox. 4 * Acute Tox. 4 * |
H332 H302 |
GHS07 Wng |
H332 H302 |
|
|
|
611-003-00-7 |
fenaminosulf (ISO); natrium-4-dimethylaminobenzeendiazosulfonaat |
205-419-4 |
140-56-7 |
Acute Tox. 3 * Acute Tox. 4 * Aquatic Chronic 3 |
H301 H312 H412 |
GHS06 Dgr |
H301 H312 H412 |
|
|
|
611-004-00-2 |
methyl-O,N,N-azoxymethylacetaat; methylazoxymethylacetaat |
209-765-7 |
592-62-1 |
Carc. 1B Repr. 1B |
H350 H360D *** |
GHS08 Dgr |
H350 H360D *** |
|
|
|
611-005-00-8 |
dinatrium-{5-[(4'-((2,6-hydroxy-3-((2-hydroxy-5-sulfofenyl)azo)fenyl)azo)(1,1'-bifenyl)-4-yl)azo]salicylato-(4–)}cupraat(2–); CI Direct Brown 95 |
240-221-1 |
16071-86-6 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
611-006-00-3 |
4-o-tolylazo-o-toluïdine; 4-amino-2',3-dimethylazobenzeen; fast garnet GBC base; AAT; o-aminoazotolueen |
202-591-2 |
97-56-3 |
Carc. 1B Skin Sens. 1 |
H350 H317 |
GHS08 Dgr |
H350 H317 |
|
|
|
611-007-00-9 |
tricyclazool (ISO); 5-methyl-1,2,4-triazolo(3,4-b)benzo-1,3-thiazool; |
255-559-5 |
41814-78-2 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
611-008-00-4 |
4-aminoazobenzeen; 4-fenylazoaniline |
200-453-6 |
60-09-3 |
Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H400 H410 |
GHS08 GHS09 Dgr |
H350 H410 |
|
|
|
611-009-00-X |
natrium-(1-(5-(4-(4-anilino-3-sulfofenylazo)-2-methyl-5-methylsulfonamidofenylazo)4-hydroxy-2-oxido-3-(fenylazo)fenylazo)-5-nitro-4-sulfonato-2-naftolato)ijzer(II) |
401-220-3 |
— |
Acute Tox. 4 * Aquatic Chronic 3 |
H332 H412 |
GHS07 Wng |
H332 H412 |
|
|
|
611-010-00-5 |
2'-(2-cyaan-4,6-dinitrofenylazo)-5'-(N,N-dipropylamino)propionanilide |
403-010-7 |
106359-94-8 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
611-011-00-0 |
N,N,N',N'-tetramethyl-3,3'-(propyleenbis(iminocarbonyl-4,1-fenyleenazo(1,6-dihydro-2-hydroxy-4-methyl-6-oxopyridine-3,1-diyl)))di(propylammonium)dilactaat |
403-340-1 |
— |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dg |
H318 H411 |
|
|
|
611-012-00-6 |
reactiemassa van 2,2-iminodiëthanol-6-methyl-2-(4-(2,4,6-triaminopyrimidine-5-ylazo)fenyl)benzothiazool-7-sulfonaat en 2-methylaminoëthanol-6-methyl-2-(4-(2,4,6-triaminopyrimidine-5-ylazo)fenyl)benzothiazool-7-sulfonaat en N,N-diëthylpropaan-1,3-diamine-6-methyl-2-(4-(2,4,6-triaminopyrimidine-5-ylazo)fenyl)benzothiazool-7-sulfonaat |
403-410-1 |
114565-65-0 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
611-013-00-1 |
trilithium-1-hydroxy-7-(3-sulfonatoanilino)-2-(3-methyl-4-(2-methoxy-4-(3-sulfonatofenylazo)fenylazo)fenylazo)naftaleen-3-sulfonaat |
403-650-7 |
117409-78-6 |
Expl. 1.3 **** Aquatic Chronic 2 |
H203 H411 |
GHS01 GHS09 Dgr |
H203 H411 |
|
|
|
611-014-00-7 |
(tetranatrium-1-(4-(3-aceetamido-4-(4'-nitro-2,2'-disulfonatostilbeen-4-ylazo)anilino)-6-(2,5-disulfonatoanilino)-1,3,5-triazine-2-yl)-3-carboxypyridinium)hydroxide |
404-250-5 |
115099-55-3 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
611-015-00-2 |
tetranatrium-4-amino-5-hydroxy-6-(4-(2-(2-(sulfonatoöxy)ethylsulfonyl)ethylcarbamoyl)fenylazo)-3-(4-(2-(sulfonatoöxy)ethylsulfonyl)fenylazo)naftaleen-2,7-disulfonaat |
404-320-5 |
116889-78-2 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
611-016-00-8 |
reactiemassa van 1,1'-((dihydroxyfenyleen)bis(azo-3,1-fenileenazo(1-(3-(dimethylamino)propyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))dipyridiniumdichloridedihydrochloride, mengsel van isomeren en 1-(1-(3-dimethylaminopropyl)-5-(3-((4-(1-(3-dimethylaminopropyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-5-pyridinio-3-pyridylazo)fenylazo)-2,4(of 2,6 of 3,5)-dihydroxyfenylazo)fenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-3-pyridyl)pyridiniumdichloride |
404-540-1 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
611-017-00-3 |
2-(4-(diëthylaminopropylcarbamoyl)fenylazo)-3-oxo-N-(2,3-dihydro-2-oxobenzimidazool-5-yl)butyramide |
404-910-2 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
611-018-00-9 |
tetraämmonium-5-(4-(7-amino-1-hydroxy-3-sulfonato-2-naftylazo)-6-sulfonato-1-naftylazo)isoftalaat |
405-130-5 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
611-019-00-4 |
tetralithium-6-amino-4-hydroxy-3-(7-sulfonato-4-(4-sulfonatofenylazo)-1-naftylazo)naftaleen-2,7-disulfonaat |
405-150-4 |
106028-58-4 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
611-020-00-X |
tetrakis(tetramethylammonium)- 6-amino-4-hydroxy-3-(7-sulfonato-4-(4-sulfonatofenylazo)-1-naftylazo)naftaleen-2,7-disulfonaat |
405-170-3 |
116340-05-7 |
Acute Tox. 3 * Skin Sens. 1 Aquatic Chronic 3 |
H301 H317 H412 |
GHS06 Dgr |
H301 H317 H412 |
|
|
|
611-021-00-5 |
2-(4-(4-cyaan-3-methylisothiazool-5-ylazo)-N-ethyl-3-methylanilino)ethylacetaat |
405-480-9 |
— |
Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Aquatic Chronic 4 |
H302 H373 ** H315 H413 |
GHS08 GHS07 Wng |
H302 H373 ** H315 H413 |
|
|
|
611-022-00-0 |
4-dimethylaminobenzeendiazonium-3-carboxy-4-hydroxybenzeendisulfonaat |
404-980-4 |
— |
Self-react. C Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H242 H331 H301 H312 H373 ** H318 H317 H400 H410 |
GHS02 GHS06 GHS08 GHS05 GHS09 Dgr |
H242 H331 H301 H312 H373 ** H318 H317 H410 |
|
|
T |
611-023-00-6 |
dinatrium-7-(4,6-dichloor-1,3,5-triazine-2-ylamino)-4-hydroxy-3-(4-(2-(sulfonatoöxy)ethylsulfonyl)fenylazo)naftaleen-2-sulfonaat |
404-600-7 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
611-024-00-1 |
azokleurstoffen op basis van benzidine; 4,4'-diarylazobifenylkleurstoffen, tenzij elders in deze bijlage vermeld |
— |
— |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
A |
611-025-00-7 |
dinatrium-4-amino-3-[[4'-[(2,4-diaminofenyl)azo][1,1'-bifenyl]-4-yl]azo]-6-(fenylazo)-5-hydroxynaftaleen-2,7-disulfonaat; C.I. Direct Black 38 |
217-710-3 |
1937-37-7 |
Carc. 1B Repr. 2 |
H350 H361d *** |
GHS08 Dgr |
H350 H361d *** |
|
|
|
611-026-00-2 |
tetranatrium-3,3'-[[1,1'-bifenyl]-4,4'diylbis(azo)]bis[5-amino-4-hydroxynaftaleen-2,7-disulfonaat]; C.I. Direct Blue 6 |
220-012-1 |
2602-46-2 |
Carc. 1B Repr. 2 |
H350 H361d *** |
GHS08 Dgr |
H350 H361d *** |
|
|
|
611-027-00-8 |
dinatrium-3,3'-[[1,1'-bifenyl]-4,4'-diylbis(azo)]bis(4-aminonaftaleen-1-sulfonaat); C.I. Direct Red 28 |
209-358-4 |
573-58-0 |
Carc. 1B Repr. 2 |
H350 H361d *** |
GHS08 Dgr |
H350 H361d *** |
|
|
|
611-028-00-3 |
C,C'-azodi(formamide) |
204-650-8 |
123-77-3 |
Resp. Sens. 1 |
H334 |
GHS08 Dgr |
H334 |
|
|
G |
611-029-00-9 |
azokleurstoffen op basis van o-dianisidine, tenzij elders in deze bijlage vermeld; 4,4'-diarylazo-3,3'-dimethoxybifenylkleurstoffen, tenzij elders in deze bijlage vermeld |
— |
— |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
A |
611-030-00-4 |
kleurstoffen op basis van o-tolidine; 4,4'-diarylazo-3,3'-dimethylbifenylkleurstoffen, tenzij elders in deze bijlage vermeld |
— |
— |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
A |
611-031-00-X |
4,4'-(4-iminocyclohexa-2,5-diënylideenmethyleen)dianilinehydrochloride; C.I. Basic Red 9 |
209-321-2 |
569-61-9 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
611-032-00-5 |
1,4,5,8-tetraäminoantrachinon; C.I. Disperse Blue 1 |
219-603-7 |
2475-45-8 |
Carc. 1B Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 |
H350 H315 H318 H317 |
GHS08 GHS05 GHS07 Dgr |
H350 H315 H318 H317 |
|
|
|
611-033-00-0 |
hexanatrium-[4,4''-azoxybis(2,2'-disulfonatostilbeen-4,4'diylazo)]-bis[5'-sulfonatobenzeen-2,2'-diolato-O(2), O(2),N(1)]-koper(II) |
400-020-3 |
82027-60-9 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
611-034-00-6 |
N-(5-(bis(2-methoxyethyl)amino)-2-((5-nitro-2,1-benzisothiazool-3-yl)azo)fenylacetamide |
402-430-8 |
105076-77-5 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
611-035-00-1 |
tetralithium-6-amino-4-hydroxy-3-[7-sulfonato-4-(5-sulfonato-2-naftylazo)-1-naftylazo]naftaleen-2,7-disulfonaat |
403-660-1 |
107246-80-0 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
611-036-00-7 |
2-(4-(5,6(of 6,7)-dichloor-1,3-benzothiazool-2-ylazo)-N-methyl-m-toluïdino)ethylacetaat |
405-440-0 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
611-037-00-2 |
3(of 5)-(4-(N-benzyl-N-ethylamino)-2-methylfenylazo)-1,4-dimethyl-1,2,4-triazoliummethylsulfaat |
406-055-0 |
124584-00-5 |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H302 H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H317 H411 |
|
|
|
611-038-00-8 |
trinatrium-1-hydroxynaftaleen-2-azo-4'(5',5''-dimethylbifenyl)-4''-azo(4''-fenylsulfonyloxybenzeen)-2',2'',4-trisulfonaat |
406-820-9 |
— |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
611-039-00-3 |
7-[((4,6-dichloor-1,3,5-triazine-2-yl)amino)-4-hydroxy-3-(4-((2-sulfoxy)ethyl)sulfonyl)fenylazo]naftaleen-2-sulfonzuur |
407-050-6 |
117715-57-8 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
611-040-00-9 |
3-(5-aceetamido-4-(4-[4,6-bis(3-diëthylaminopropylamino)-1,3,5-triazine-2-ylamino]fenylazo)-2-(2-methoxyethoxy)fenylazo)-6-amino-4-hydroxy-2-naftaleensulfonzuur |
407-670-7 |
115099-58-6 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
611-041-00-4 |
2-[[4[[4,6-bis[[3-(diëthylamino)propyl]amino]-1,3,5-triazine-2-yl]amino]fenyl]azo]-N-(2,3-dihydro-2-oxo-1H-benzimidazool-5-yl)-3-oxobutaanamide |
407-680-1 |
98809-11-1 |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H318 H317 H411 |
|
|
|
611-042-00-X |
trinatrium-5-amino-3-[5-(2-bromacryloylamino)-2-sulfonatofenylazo]-4-hydroxy-6-(4-vinylsulfonylfenylazo)naftaleen-2,7-disulfonaat |
411-770-6 |
136213-71-3 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
611-043-00-5 |
reactiemassa (2:1:1) van: trinatriumN(1')-N(2):N(1''')-N(2'')-η-6-[2-amino-4-(of 6)-hydroxy-(of 4-amino-2-hydroxy)fenylazo]-6''-(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''-disulfamoyl-3,3''-disulfonatobis(naftaleen-2,1'-azobenzeen-1,2'-diolato-O(1), O(2'))-chromaat; trinatrium-N(1')-N(2):N(1''')N(2'')-η-6,6''-bis(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''disulfamoyl-3,3''-disulfonato-bis(naftaleen-2,1'azobenzeen-1,2'-diolato-O(1),O(2'))-chromaat; trinatrium-N(1')-N(2):N(1''')N(2'')-η-6,6''-bis[2-amino-4-(of 6)-hydroxy-(of 4-amino-2-hydroxy)fenylazo]5',5'''disulfamoyl-3,3''-disulfonatobis(naftaleen-2,1'azobenzeen-1,2'-diolato-O(1),O(2'))-chromaat |
402-850-1 |
— |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
611-044-00-0 |
reactiemassa van: tert-alkyl(C12-C14)ammonium-bis[1-[(2-hydroxy-5-nitrofenyl)azo]-2-naftalenolato(2–)]-chromaat(1–); tert-alkyl(C12-C14)ammonium-bis[1-[(2-hydroxy-4-nitrofenyl)azo]-2-naftalenolato(2–)]-chromaat(1–); tert-alkyl(C12-C14)ammonium-bis[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrofenyl]azo]-2-naftalenolato(2–)]-chromaat(1–); tert-alkyl(C12-C14)ammonium-[[1-[(2-hydroxy-5-nitrofenyl)azo]-2-naftalenolato(2–)]-[1-[(2-hydroxy-5-nitrofenyl)azo]-2-naftalenolato(2–)]]-chromaat(1–); tert-alkyl(C12-C14)ammonium-[[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrofenyl]azo]-2-naftalenolato(2–)]-[1-[(2-hydroxy-5-nitrofenyl)azo]-2-naftalenolato(2–)]]-chromaat(1–); tert-alkyl(C12-C14)ammonium- ((1-(4(of 5)-nitro-2-oxidofenylazo)-2-naftolato)(1-(3-nitro-2-oxido-5-pentylfenylazo)-2-naftolato))chromaat(1–) |
403-720-7 |
117527-94-3 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
611-045-00-6 |
2-[4-[N-(4-acetoxybutyl)-N-ethyl]amino-2-methylfenylazo]-3-acetyl-5-nitrothiofeen |
404-830-8 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
611-046-00-1 |
4,4'-diamino-2-methylazobenzeen |
407-590-2 |
43151-99-1 |
Acute Tox. 3 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H373 ** H317 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H301 H373 ** H317 H410 |
|
|
|
611-047-00-7 |
reactiemassa (1:1) van: 2-[[4-[N-ethyl-N-(2-acetoxyethyl)amino]fenyl]azo]-5,6-dichloorbenzothiazool; 2-[[4-[N-ethyl-N-(2-acetoxyethyl)amino]fenyl]azo]-6,7-dichloorbenzothiazool |
407-890-3 |
111381-11-4 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
611-048-00-2 |
reactiemassa (1:1) van: 2-[[4-[bis(2-acetoxyethyl)amino]fenyl]azo]-5,6-dichloorbenzothiazool; 2-[[4-[bis(2-acetoxyethyl)amino]fenyl]azo]-6,7-dichloorbenzothiazool |
407-900-6 |
111381-12-5 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
611-049-00-8 |
reactiemassa (2:1:1) van 7-[4-(3-diëthylaminopropylamino)-6-(3-diëthylammoniopropylamino)-1,3,5-triazine-2-ylamino]-4-hydroxy-3-(4-fenylazofenylazo)-naftaleen-2-sulfonaat, azijnzuur, melkzuur |
408-000-6 |
118658-98-3 |
STOT RE 2 * Skin Sens. 1 Aquatic Chronic 3 |
H373 ** H317 H412 |
GHS08 Wng |
H373 ** H317 H412 |
|
|
|
611-050-00-3 |
reactiemassa van: pentanatrium-7-amino-3-[[4-[[4-[[4-[[4-[(6-amino-1-hydroxy-3-sulfonato-2-naftyl]azo]-7-sulfonato-1-naftyl]azo]fenyl]amino]-3-sulfonatofenyl]azo]-6-sulfonato-1-naftyl]azo]-4-hydroxynaftaleen-2-sulfonaat; pentanatrium-7-amino-8-[4-[4-[4-[4-(2-amino-5-hydroxy-7-sulfonatonaftaleen-1-ylazo)-7-sulfonatonaftaleen-1-ylazo]-fenylamino]-3-sulfonato-fenylazo]-6-sulfonatonaftaleen-1-ylazo]-4-hydroxynaftaleen-2-sulfonaat; pentanatrium-3-amino-8-[4-[4-[4-[4-(6-amino-1-hydroxy-3-sulfonatonaftaleen-1-ylazo)-7-sulfonatonaftaleen-1-ylazo]-fenylamino]-3-sulfonato-fenylazo]-6-sulfonatonaftaleen-1-ylazo]-4-hydroxynaftaleen-2-sulfonaat; tetranatrium-7-amino-4-hydroxy-3-[4-[4-[4-(4-hydroxy-7-sulfonatonaftaleen-1-ylazo)-2-sulfonatofenylamino]fenylazo]-6-sulfonatonaftaleen-1-ylazo]naftaleen-2-sulfonaat; tetranatrium-7-amino-4-hydroxy-3-[4-[4-[4-(4-amino-7-sulfonatonaftaleen-1-ylazo)-2-sulfonatofenylamino]fenylazo]-6-sulfonatonaftaleen-1-ylazo]naftaleen-2-sulfonaat |
415-350-3 |
— |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
611-051-00-9 |
2-(4-(N-ethyl-N-(2-hydroxy)ethyl)amino-2-methylfenyl)azo-6-methoxy-3-methyl-benzothiazoliumchloride |
411-110-7 |
136213-74-6 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
611-052-00-4 |
mononatrium-aqua-[5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrofenyl)azo]fenyl]azo]-2-naftaleensulfonaat], ijzercomplex |
400-720-9 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
611-053-00-X |
2,2'-azobis[2-methylpropionamidine]dihydrochloride |
221-070-0 |
2997-92-4 |
Acute Tox. 4 * Skin Sens. 1 |
H302 H317 |
GHS07 Wng |
H302 H317 |
|
|
|
611-055-00-0 |
C.I. Disperse Yellow 3; N-[4-[(2-hydroxy-5-methylfenyl)azo]fenyl]acetamide |
220-600-8 |
2832-40-8 |
Carc. 2 Skin Sens. 1 |
H351 H317 |
GHS08 GHS07 Wng |
H351 H317 |
|
|
|
611-056-00-6 |
C.I. Solvent Yellow 14; 1-fenylazo-2-naftol |
212-668-2 |
842-07-9 |
Carc. 2 Muta. 2 Skin Sens. 1 Aquatic Chronic 4 |
H351 H341 H317 H413 |
GHS08 GHS07 Wng |
H351 H341 H317 H413 |
|
|
|
611-057-00-1 |
6-hydroxy-1-(3-isopropoxypropyl)-4-methyl-2-oxo-5-[4-(fenylazo)fenylazo]-1,2-dihydro-3-pyridinecarbonitril |
400-340-3 |
85136-74-9 |
Carc. 1B Aquatic Chronic 4 |
H350 H413 |
GHS08 Wng |
H350 H413 |
|
|
|
611-058-00-7 |
(6-(4-hydroxy-3-(2-methoxyfenylazo)-2-sulfonato-7-naftylamino)-1,3,5-triazine-2,4-diyl)bis[(amino-1-methylethyl)ammonium]-formiaat |
402-060-7 |
108225-03-2 |
Carc. 1B Eye Dam. 1 Aquatic Chronic 2 |
H350 H318 H411 |
GHS08 GHS05 GHS09 Dgr |
H350 H318 H411 |
|
|
|
611-059-00-2 |
octanatrium 2-(6-(4-chloor-6-(3-(N-methyl-N-(4-chloor-6-(3,5-disulfonato-2-naftylazo)-1-hydroxy-6-naftylamino)-1,3,5-triazine-2-yl)aminomethyl)fenylamino)-1,3,5-triazine-2-ylamino)-3,5-disulfonato-1-hydroxy-2-naftylazo)naftaleen-1,5-disulfonaat |
412-960-1 |
148878-21-1 |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Dgr |
H318 H317 H412 |
|
|
|
611-060-00-8 |
reactiemassa van: natrium-5-[8-[4-[4-[4-[7-(3,5-dicarboxylaat-fenylazo)-8-hydroxy-3,6-disulfonatonaftaleen-1-ylamino]-6-hydroxy-1,3,5-triazine-2-yl]-2,5-dimethylpiperazine-1-yl]-6-hydroxy-1,3,5-triazine-2-ylamino]-1-hydroxy-3,6-disulfonaatnaftaleen-2-ylazo]-isoftalaat; ammonium-5-[8-[4-[4-[4-[7-(3,5-dicarboxylatofenylazo)-8-hydroxy-3,6-disulfonatonaftaleen-1-ylamino]-6-hydroxy-1,3,5-triazine-2-yl]-2,5-dimethylpiperazine-1-yl]-6-hydroxy-1,3,5-triazine-2-ylamino]-1-hydroxy-3,6-disulfonatonaftaleen-2-ylazo]-isoftalaat; 5-[8-[4-[4-[4-[7-(3,5-dicarboxylaat-fenylazo)-8-hydroxy-3,6-disulfonatonaftaleen-1-ylamino]-6-hydroxy-1,3,5-triazine-2-yl]-2,5-dimethylpiperazine-1-yl]-6-hydroxy-1,3,5-triazine-2-ylamino]-1-hydroxy-3,6-disulfonaatnaftaleen-2-ylazo]-isoftaalzuur |
413-180-4 |
187285-15-0 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
611-061-00-3 |
dinatrium-5-[5-[4-(5-chloor-2,6-difluorpyrimidine-4-ylamino)benzamido]-2-sulfonatofenylazo]-1-ethyl-6-hydroxy-4-methyl-2-oxo-3-pyridylmethylsulfonaat |
412-530-3 |
— |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
611-062-00-9 |
octanatrium-2-(8-(4-chloor-6-(3-((4-chloor-6-(3,6-disulfonato-2-(1,5-disulfonatonaftaleen-2-ylazo)-1-hydroxynaftaleen-8-ylamino)-1,3,5-triazine-2-yl)aminomethyl)fenylamino)-1,3,5-triazine-2-ylamino)-3,6-disulfonato-1-hydroxynaftaleen-2-ylazo)naftaleen-1,5-disulfonaat |
413-550-5 |
— |
Skin Irrit. 2 Eye Dam. 1 |
H315 H318 |
GHS05 Dgr |
H315 H318 |
|
|
|
611-063-00-4 |
trinatrium-[4'-(8-acetylamino-3,6-disulfonato-2-naftylazo)-4''-(6-benzoylamino-3-sulfonato2-naftylazo)-bifenyl-1,3',3'',1'''-tetraolato-O,O',O'',O''']koper(II) |
413-590-3 |
164058-22-4 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
611-064-00-X |
4-(3,4-dichloorfenylazo)-2,6-di-sec-butyl-fenol |
410-600-8 |
124719-26-2 |
STOT RE 2 * Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H373 ** H315 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H373 ** H315 H410 |
|
|
|
611-065-00-5 |
4-(4-nitrofenylazo)-2,6-di-sec-butyl-fenol |
410-610-2 |
111850-24-9 |
STOT RE 2 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H373 ** H319 H315 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H373 ** H319 H315 H317 H410 |
|
|
|
611-066-00-0 |
tetranatrium-5-[4-chloor-6-(N-ethyl-anilino)-1,3,5-triazine-2-ylamino]-4-hydroxy-3-(1,5-disulfonatonaftaleen-2-ylazo)-naftaleen-2,7-disulfonaat |
411-540-5 |
130201-57-9 |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H318 H317 H411 |
|
|
|
611-067-00-6 |
reactiemassa van: bis(tris(2-(2-hydroxy(1-methyl)ethoxy)ethyl)ammonium)-7-anilino-4-hydroxy-3-(2-methoxy-5-methyl-4-(4-sulfonatofenylazo)fenylazo)naftaleen-2-sulfonaat; bis(tris(2-(2-hydroxy(2-methyl)ethoxy)ethyl)ammonium)-7-anilino-4-hydroxy-3-(2-methoxy-5-methyl-4-(4-sulfonatofenylazo)fenylazo)naftaleen-2-sulfonaat |
406-910-8 |
— |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
611-068-00-1 |
tetranatrium-4-amino-3,6-bis(5-[4-chloor-6-(2-hydroxyethylamino)-1,3,5-triazine-2-ylamino]-2-sulfonatofenylazo)-5-hydroxynaftaleen-2,7-disulfonaat |
400-690-7 |
85665-98-1 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
611-069-00-7 |
N,N-di-[poly(oxyethyleen)-co-poly(oxypropyleen)]-4-[(3,5-dicyaan-4-methyl-2-thiënyl)azo)]-3-methylaniline |
413-380-1 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
611-070-00-2 |
reactiemassa van: dinatrium-(6-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidofenylazo)-1-naftolato)(1-(5-chloor-2-oxidofenylazo)-2-naftolato)chromaat(1–); trinatriumbis(5-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidofenylazo)-1-naftolato)chromaat(1–) |
405-665-4 |
— |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
611-071-00-8 |
tris(tetramethylammonium)-5-hydroxy-1-(4-sulfonatofenyl)-4-(4-sulfonatofenylazo)pyrazool-3-carboxylaat |
406-073-9 |
131013-81-5 |
Acute Tox. 3 * Aquatic Chronic 3 |
H301 H412 |
GHS06 Dgr |
H301 H412 |
|
|
|
611-072-00-3 |
2,4-bis[2,2'-[2-(N,N-dimethylamino)ethyloxycarbonyl]fenylazo]-1,3-dihydroxybenzeen, dihydrochloride |
407-010-8 |
118208-02-9 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H411 |
|
|
|
611-073-00-9 |
dimethyl-3,3'-(N-(4-(4-broom-2,6-dicyaanfenylazo)-3-hydroxyfenyl)imino)dipropionaat |
407-310-9 |
122630-55-1 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
611-074-00-4 |
reactiemassa van: natrium/kalium-(3-(4-(5-(5-chloor-2,6-difluorpyrimidine-4-ylamino)-2-methoxy-3-sulfonatofenylazo)-2-oxidofenylazo)-2,5,7-trisulfonato-4-naftolato)koper(II); natrium/kalium-(3-(4-(5-(5-chloor-4,6-difluorpyrimidine-2-ylamino)-2-methoxy-3-sulfonatofenylazo)-2-oxidofenylazo)-2,5,7-trisulfonato-4-naftolato)koper(II) |
407-100-7 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
611-075-00-X |
reactiemassa (2:1) van: tris(3,5,5-trimethylhexylammonium)-4-amino-3-(4-(4-(2-amino-4-hydroxyfenylazo)anilino)-3-sulfonatofenylazo)-5,6-dihydro-5-oxo-6-fenylhydrazononaftaleen-2,7-disulfonaat; tris(3,5,5-trimethylhexylammonium)-4-amino-3-(4-(4-(4-amino-2-hydroxyfenylazo)anilino)-3-sulfonatofenylazo)-5,6-dihydro-5-oxo-6-fenylhydrazononaftaleen-2,7-disulfonaat |
406-000-0 |
— |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
611-076-00-5 |
3-(2,6-dichloor-4-nitrofenylazo)-1-methyl-2-fenylindool |
406-280-4 |
117584-16-4 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
611-077-00-0 |
dilithiumdinatrium-(5,5'-diamino-(μ-4,4'-dihydroxy-1:2κ-2,O4,O4',-3,3'-[3,3'-dihydroxy-1:2-κ-2-O3,O3'-bifenyl-4,4'-yleenbisazo-1:2-(N3, N4-η:N3', N4'-η)]-dinaftaleen-2,7-disulfonato(8)))dicupraat(2–) |
407-230-4 |
126637-70-5 |
Acute Tox. 4 * Skin Sens. 1 |
H302 H317 |
GHS07 Wng |
H302 H317 |
|
|
|
611-078-00-6 |
(2,2'-(3,3'-dioxidobifenyl-4,4'-diyldiazo)bis(6-(4-(3-(diëthylamino)propylamino)-6-(-3-(diëthylammonio)propylamino)1,3,5-triazine-2-ylamino)-3-sulfonato-1-naftolato))dikoper(II)acetaatlactaat |
407-240-9 |
159604-94-1 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
611-079-00-1 |
dinatrium-7-[4-chloor-6-(N-ethyl-o-toluïdino)-1,3,5-triazine=2-ylamino]-4-hydroxy-3-(4-methoxy-2-sulfonatofenylazo)2-naftaleensulfonaat |
410-390-8 |
147703-64-8 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
611-080-00-7 |
natrium-3-(2-acetamido-4-(4-(2-hydroxybutoxy)fenylazo)fenylazo)benzeensulfonaat |
410-150-2 |
147703-65-9 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
611-081-00-2 |
tetranatrium-[7-(2,5-dihydroxy-KO2-7-sulfonato-6-[4-(2,5,6-trichloor-pyrimidine-4-ylamino)fenylazo]-(N1,N7-N)1-naftylazo)-8-hydroxy-KO8-naftaleen-1,3,5-trisulfonato(6)]cupraat(II) |
411-470-5 |
141048-13-7 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
611-082-00-8 |
reactiemassa van: pentanatriumbis(1-(3(of 5)-(4-anilino-3-sulfonatofenylazo)-4-hydroxy-2-oxidofenylazo)-6-nitro-4-sulfonato-2-naftolato)ferraat(1–); pentanatrium-[(1-(3-(4-anilino-3-sulfonatofenylazo)-4-hydroxy-2-oxidofenylazo)-6-nitro-4-sulfonato-2-naftolato)-(5-(4-anilino-3-sulfonatofenylazo)-4-hydroxy-2-oxidofenylazo)-6-nitro-4-sulfonato-2-naftolato]ferraat(1–) |
407-570-3 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
611-083-00-3 |
reactiemassa (1:1) van: 2-[N-ethyl-4-[(5,6-dichloorbenzothiazool-2-yl)azo]-m-toludino]ethylacetaat; 2-[N-ethyl-4-[(6,7-dichloorbenzothiazool-2-yl)azo]-m-toludino]ethyl-acetaat |
411-560-4 |
— |
STOT RE 1 Skin Sens. 1 Aquatic Chronic 2 |
H372 ** H317 H411 |
GHS08 GHS07 GHS09 Dgr |
H372 ** H317 H411 |
|
|
|
611-085-00-4 |
reactiemassa van: 3-cyaan-5-(2-cyaan-4-nitro-fenylazo)-2-(2-hydroxy-ethylamino)-4-methyl-6-[3-(2-fenoxyethoxy)-propylamino]-pyridine; 3-cyaan-5-(2-cyaan-4-nitro-fenylazo)-6-(2-hydroxy-ethylamino)-4-methyl-2-[3-(2-fenoxyethoxy)-propylamino]-pyridine; 3-cyaan-5-(2-cyaan-4-nitro-fenylazo)-2-amino-4-methyl-6-[3-(3-hydroxypropoxy)propylamino]-pyridine; 3-cyaan-5-(2-cyaan-4-nitro-fenylazo)-6-amino-4-methyl-2-[3-(3-methoxypropoxy)propylamino]-pyridine |
411-880-4 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
611-086-00-X |
monolithium-5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrofenyl)azo]fenyl]azo]-2-naftaleensulfonaat], ijzercomplex, monohydraat |
411-360-7 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
611-087-00-5 |
reactiemassa van: 3-((5-cyaan-1,6-dihydro-1,4-dimethyl-2-hydroxy-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-fenoxyethaan; 3-((5-cyaan-1,6-dihydro-1,4-dimethyl-2-hydroxy-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-ethyloxy-2-(ethylfenol) |
411-710-9 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
611-088-00-0 |
reactiemassa van: trilithium-4-amino-3-((4-((4-((2-amino-4-hydroxyfenyl)azo)fenyl)amino)-3-sulfofenyl)azo)-5-hydroxy-6-(fenylazo)naftaleen-2,7-disulfonaat; trilithium-4-amino-3-((4-((4-((4-amino-2-hydroxyfenyl)azo)fenyl)amino)-3-sulfofenyl)azo)-5-hydroxy-6-(fenylazo)-naftaleen-2,7-disulfonaat |
411-890-9 |
— |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 |
H302 H318 H412 |
GHS05 GHS07 Dgr |
H302 H318 H412 |
|
|
|
611-089-00-6 |
2-((4-(ethyl-(2-hydroxyethyl)amino)-2-methylfenyl)azo)-6-methoxy-3-methyl-benzothiazolium-methylsulfaat |
411-100-2 |
136213-73-5 |
STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H373 ** H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H373 ** H317 H410 |
|
|
|
611-090-00-1 |
2,5-dibutoxy-4-(morfoline-4-yl)-benzeendiazonium-4-methylbenzeensulfonaat |
413-290-2 |
93672-52-7 |
Self-react. C Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H242 H302 H318 H317 H412 |
GHS02 GHS05 GHS07 Dgr |
H242 H302 H318 H317 H412 |
|
|
T |
611-091-00-7 |
natrium (1,0-1,95)/lithium (0,051)-5-((5-((5-chloor-6-fluor-pyrimidine-4-yl)amino)-2-sulfonatofenyl)azo)-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxo-3-pyridinemethylsulfonaat |
413-470-0 |
134595-59-8 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
611-092-00-2 |
tert-(dodecyl/tetradecyl)-ammonium-bis(3-(4-((5-(1,1-dimethyl-propyl)-2-hydroxy-3-nitrofenyl)azo)-3-methyl-5-hydroxy-(1H)-pyrazool-1-yl)benzeensulfonamidato)chromaat |
413-210-6 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
611-093-00-8 |
natrium-2-(4-(4-fluor-6-(2-sulfo-ethylamino)-[1,3,5]triazine-2-ylamino)-2-ureïdo-fenylazo)-5-(4-sulfofenylazo)benzeen-1-sulfonaat |
410-770-3 |
146177-84-6 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
611-094-00-3 |
reactiemassa (1:1) van: 2-[2-acetylamino-4-[N,N-bis[2-ethoxy-carbonyloxy)ethyl]amino]fenylazo]-5,6-dichloor-1,3-benzothiazool 2-[2-acetylamino-4-[N,N-bis[2-ethoxy-carbonyloxy)ethyl]amino]fenylazo]-6,7-dichloor-1,3-benzotriazool |
411-600-0 |
143145-93-1 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
611-095-00-9 |
hexanatrium-1,1'-[(1-amino-8-hydroxy-3,6-disulfonaat-2,7-naftaleendiyl)bis(azo(4-sulfonaat-1,3-fenyl)imino[6[(4-chloor-3-sulfonatofenyl)amino]-1,3,5-triazine-2,4-diyl]]]bis[3-carboxypyridinium]-dihydroxide |
412-240-7 |
89797-03-5 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
611-096-00-4 |
methyl-N-[(3-acetylamino)-4-(2-cyaan-4-nitrofenylazo)fenyl]-N-[(1-methoxy)acetyl]glycinaat |
413-040-2 |
149850-30-6 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
611-097-00-X |
reactiemassa van ijzercomplexen van: 1,3-dihydroxy-4-[(5-fenylaminosulfonyl)-2-hydroxyfenylazo]-n-(5-amino-sulfonyl-2-hydroxyfenylazo)benzeen en: 1,3-dihydroxy-4-[(5-fenylaminosulfonyl)-2-hydroxyfenylazo]-n-[4-(4-nitro-2-sulfofenylamino)fenylazo]benzeen (n=2,5,6) |
414-150-3 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
611-098-00-5 |
tetrakis(tetramethylammonium)-3,3'-(6-(2-hydroxyethylamino)-1,3,5-triazine-2,4-diyldiiminobis(2-methyl-4,1-fenyleenazo))dinaftaleen-1,5-disulfonaat |
405-950-3 |
131013-83-7 |
Acute Tox. 3 * Aquatic Chronic 3 |
H301 H412 |
GHS06 Dgr |
H301 H412 |
|
|
|
611-099-00-0 |
(methyleenbis(4,1-fenyleenazo(1-(3-(dimethylamino)propyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))-1,1'dipyridiniumdichloridedihydrochloride |
401-500-5 |
118658-99-4 |
Carc. 1B Aquatic Chronic 2 |
H350 H411 |
GHS08 GHS09 Dgr |
H350 H411 |
|
|
|
611-100-00-4 |
kaliumnatrium-3,3'-(3(of 4)-methyl-1,2-fenyleenbis(imino(6-chloor)-1,3,5-triazine-4,2-diylimino(2-aceetamido-5-methoxy)-4,1-fenyleenazo)dinaftaleen-1,5-disulfonaat |
403-810-6 |
140876-13-7 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
611-101-00-X |
2'-(4-chloor-3-cyaan-5-formyl-2-thiënyl)azo-5'-diëthylaminoaceetanilide |
405-200-5 |
104366-25-8 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
611-102-00-5 |
reactieproduct van: C.I. Leuco Sulfur Black 1 en reactiemassa van: dinatrium-4-{4-[8-amino-1-hydroxy-7-(4-sulfamoylfenylazo)-3,6-disulfonato-2-naftylazo]fenylsulfonylamino}benzeendiazoniumchloride; dinatrium-4-{4-[2,6-dihydroxy-3-(8-hydroxy-3,6-disulfonato-1-naftylazo)fenylazo]fenylsulfonylamino}benzeen-diazoniumchloride |
424-500-7 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
611-103-00-0 |
trinatrium-(1-(3-carboxylato-2-oxido-5-sulfonatofenylazo)-5-hydroxy-7-sulfonatonaftaleen-2-amido)nikkel(II) |
407-110-1 |
— |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H318 H317 H411 |
|
|
|
611-104-00-6 |
reactiemassa van: trinatrium-(2,4(of 2,6 of 4,6)-bis(3,5-dinitro-2-oxidofenylazo)-5-hydroxyfenolato)(2(of 4 of 6)-(3,5-dinitro-2-oxidofenylazo)-5-hydroxy-4(of 2 of 6)-(4-(4-nitro-2-sulfonatoanilino)fenylazo)fenolato)ferraat(1–); trinatrium-bis(2,4(of 2,6 of 4,6)-bis(3,5-dinitro-2-oxidofenylazo)-5-hydroxyfenolato)ferraat(1–); trinatrium-(2,4(of 2,6 of 4,6)-bis(3,5-dinitro-2-oxidofenylazo)-5-hydroxyfenolato)(2(of 4 of 6)-(3,5-dinitro-2-oxidofenylazo)-5-hydroxy-4(of 2 of 6)-(4-nitro-2-sulfonatofenylazo)fenolato)ferraat(1–); trinatrium-(2,4(of 2,6 of 4,6)-bis(3,5-dinitro-2-oxidofenylazo)-5-hydroxyfenolato)(2(of 4 of 6)-(3,5-dinitro-2-oxidofenylazo)-5-hydroxy-4(of 2 of 6)-(3-sulfonatofenylazo)fenolato)ferraat(1–); dinatrium-3,3'-(2,4-dihydroxy1,3(of 1,5 of 3,5)-fenyleendiazo)dibenzeensulfonaat |
406-870-1 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
611-105-00-1 |
natrium-4-(4-chloor-6-(N-ethylanilino)-1,3,5-triazine-2-ylamino)-2-(1-(2-chloorfenyl)-5-hydroxy-3-methyl-1H-pyrazool-4-ylazo)benzeensulfonaat |
407-800-2 |
136213-75-7 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
611-106-00-7 |
hexanatrium-4,4'-dihydroxy-3,3'-bis[2-sulfonato-4-(4-sulfonatofenylazo)fenylazo]-7,7'[p-fenyleenbis[imino(6-chloor-1,3,5-triazine-4,2-diyl)imino]]dinaftaleen-2-sulfonaat |
410-180-6 |
157627-99-1 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
611-107-00-2 |
kaliumnatrium-4-(4-chloor-6-(3,6-disulfonato-7-(5,8-disulfonato-naftaleen-2-ylazo)-8-hydroxy-naftaleen-1-ylamino)-1,3,5-triazine-2-ylamino)-5-hydroxy-6-(4-(2-sulfatoëthaansulfonyl)-fenylazo)-naftaleen-1,7-disulfonaat |
412-490-7 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
611-108-00-8 |
dinatrium-5-((4-((4-chloor-3-sulfonatofenyl)azo)-1-naftyl)azo)-8-(fenylamino)-1-naftaleensulfonaat |
413-600-6 |
6527-62-4 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
611-109-00-3 |
reactieproducten (2:1) van: koper(II)sulfaat en tetranatrium-2,4-bis[6-(2-methoxy-5-sulfonatofenylazo)-5-hydroxy-7-sulfonato-2-naftylamino]-6-(2-hydroxyethylamino)-1,3,5-triazine |
407-710-3 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
611-110-00-9 |
tetra-natrium/lithium-4,4'-bis-(8-amino-3,6-disulfonato-1-naftol-2-ylazo)-3-methylazobenzeen |
408-210-8 |
124605-82-9 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
611-111-00-4 |
dinatrium-2-[[4-(2-chloorethylsulfonyl)fenyl]-[(2-hydroxy-5-sulfo-3-[3-[2-(2-(sulfoöxy)ethylsulfonyl)ethylazo]-4-sulfobenzoato(3–)cupraat(1–) |
414-230-8 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
611-112-00-X |
tetranatrium-4-hydroxy-5-[4-[3-(2-sulfatoëthaansulfonyl)fenylamino]-6-morfoline-4-yl-1,3,5-triazine-2-ylamino]-3-(1-sulfonatonaftaleen-2-ylazo)naftaleen-2,7-disulfonaat |
413-070-6 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
611-113-00-5 |
lithiumnatrium-(2-(((5-((2,5-dichloorfenyl)azo)-2-hydroxyfenyl)methyleen)amino)benzoato(2–))(2-((4,5-dihydro-3-methyl-5-oxo-1-fenyl-1H-pyrazool-4-yl)azo)-5-sulfobenzoato(3–))-chromaat(2–) |
414-280-0 |
149626-00-6 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
611-114-00-0 |
lithiumnatrium-(4-((5-chloor-2-hydroxyfenyl)azo)-2,4-dihydro-5-methyl-3H-pyrazool-3-onato(2–))(3-((4,5-dihydro-3-methyl-1-(4-methylfenyl)-5-oxo-1H-pyrazool-4-yl)azo)-4-hydroxy-5-nitrobenzeensulfonato(3–))chromaat(2–) |
414-250-7 |
149564-66-9 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 |
H302 H318 H412 |
GHS05 GHS07 Dgr |
H302 H318 H412 |
|
|
|
611-115-00-6 |
trilithiumbis(4-((4-(diëthylamino)-2-hydroxyfenyl)azo)-3-hydroxy-1-naftaleensulfonato(3–))chromaat(3–) |
414-290-5 |
149564-65-8 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
611-116-00-1 |
reactiemassa van: trinatrium-5{4-chloor-6-[2-(2,6-dichloor-5-cyanopyrimidine-4-ylamino)-propylamino]-1,3,5-triazine-2-ylamino}-4-hydroxy-3-(1-sulfonatonaftaleen-2-ylazo)-naftaleen-2,7-disulfonaat; trinatrium-5-{4-chloor-6-[2-(2,6-dichloor-5-cyaanpyrimidine-4-ylamino)-1-methyl-ethylamino]-1,3,5-triazine-2-ylamino}-4-hydroxy-3-(1-sulfonatonaftaleen-2-ylazo)-naftaleen-2,7-disulfonaat; trinatrium-5-{4-chloor-6-[2-(4,6-dichloor-5-cyaanpyrimidine-2-ylamino)-propylamino]-1,3,5-triazine-2-ylamino}-4-hydroxy-3-(1-sulfonatonaftaleen-2-ylazo)-naftaleen-2,7-disulfonaat; trinatrium-5-{4-chloor-6-[2-(4,6-dichloor-5-cyaanpyrimidine-2-ylamino)-1-methyl-ethylamino]-1,3,5-triazine-2-ylamino}-4-hydroxy-3-(1-sulfonatonaftaleen-2-ylazo)-naftaleen-2,7-disulfonaat |
414-620-8 |
— |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
611-117-00-7 |
1,3-bis{6-fluor-4-[1,5-disulfo-4-(3-aminocarbonyl-1-ethyl-6-hydroxy-4-methyl-pyrid-2-on-5-ylazo)-fenyl-2-ylamino]-1,3,5-triazine-2-ylamino}propaan, lithium-/natriumzout |
415-100-3 |
149850-29-3 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
611-118-00-2 |
natrium-1,2-bis[4-[4-{4-(4-sulfofenylazo)-2-sulfofenylazo}-2-ureïdo-fenyl-amino]-6-fluor-1,3,5-triazine-2-ylamino]-propaan, natriumzout |
413-990-8 |
|
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
611-119-00-8 |
tetranatrium-4-[4-chloor-6-(4-methyl-2-sulfofenylamino)-1,3,5-triazine-2-ylamino]-6-(4,5-dimethyl-2-sulfofenylazo)-5-hydroxynaftaleen-2,7-disulfonaat |
415-400-4 |
148878-22-2 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
611-120-00-3 |
5-{4-[5-amino-2-[4-(2-sulfoxyethylsulfonyl)fenylazo]-4-sulfo-fenylamino]-6-chloor-1,3,5-triazine-2-ylamino}-4-hydroxy-3-(1-sulfo-naftaleen-2-ylazo)-naftaleen-2,7-disulfonzuur, natriumzout |
418-340-7 |
157707-94-3 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
611-121-00-9 |
hoofdbestanddeel 6 (isomeer): asym. 1:2 Cr(III)-complex van: A: 3-hydroxy-4-(2-hydroxy-naftaleen-1-ylazo)naftaleen-1-sulfonzuur, Na-zout en B: 1-[2-hydroxy-5-(4-methoxy-fenylazo)fenylazo]naftaleen-2-ol; hoofdbestanddeel 8 (isomeer): asym. 1:2 Cr-complex van: A: 3-hydroxy-4-(2-hydroxy-naftaleen-1-ylazo)-naftaleen-1-sulfonzuur, Na-zout en B: 1-[2-hydroxy-5-(4-methoxy-fenylazo)-fenylazo]-naftaleen-2-ol |
417-280-9 |
30785-74-1 |
Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Dgr |
H318 H410 |
|
|
|
611-122-00-4 |
hexanatrium-(di[N-(3-(4-[5-(5-amino-3-methyl-1-fenylpyrazool-4-ylazo)-2,4-disulfoanilino]-6-chloor-1,3,5-triazine-2-ylamino}fenyl)-sulfamoyl](disulfo)-ftalocyaninato)nikkel |
417-250-5 |
151436-99-6 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
611-123-00-X |
3-(2,4-bis(4-((5-(4,6-bis(2-aminopropylamino)-1,3,5-triazine-2-ylamino)-4-hydroxy-2,7-disulfonaftaleen-3-yl)azo)fenylamino)-1,3,5-triazine-6-ylamino)propyldiëthylammoniumlactaat |
424-310-4 |
178452-66-9 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
611-124-00-5 |
reactiemassa van: pentanatrium-5-amino-3-(5-{4-chloor-6-[4-(2-sulfoxyethoxysulfonato)fenylamino]-1,3,5-triazine-2-ylamino}-2-sulfonatofenylazo)-6-[5-(2,3-dibroompropionylamino)-2-sulfonatofenylazo]-4-hydroxynaftaleen-2,7-disulfonaat; pentanatrium-5-amino-6-[5-(2-broomacryloylamino)-2-sulfonatofenylazo]-3-(5-{4-chloor-6-[4-(2-sulfoxyethoxysulfonato)fenylamino]-1,3,5-triazine-2-ylamino}-2-sulfonatofenylazo)-4-hydroxynaftaleen-2,7-disulfonaat; tetranatrium-5-amino-3-[5-{4-chloor-6-[4-(vinylsulfonyl)fenylamino]-1,3,5-triazine-2-ylamino}-2-sulfonatofenylazo]-6-[5-(2,3-dibroompropionylamino)-2-sulfonatofenylazo]-4-hydroxynaftaleen-2,7-disulfonaat |
424-320-9 |
|
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
611-125-00-0 |
reactiemassa van: dinatrium-6-[3-carboxy-4,5-dihydro-5-oxo-4-sulfonatofenyl)pyrazoline-4-yl-azo]-3-[2-oxido-4-(ethenylsulfonyl)-5-methoxyfenylazo]-4-oxidonaftaleen-2-sulfonaatkoper(II)complex dinatrium-6-[3-carboxy-4,5-dihydro-5-oxo-4-sulfonatofenyl)pyrazoline-4-yl-azo]-3-[2-oxido-4-(2-hydroxyethylsulfonyl)-5-methoxyfenylazo]-4-oxidonaftaleen-2-sulfonaatkoper(II)complex |
423-940-7 |
— |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
611-126-00-6 |
2,6-bis-(2-(4-(4-aminofenylamino)-fenylazo)-1,3-dimethyl-3H-imidazolium)-4-dimethylamino-1,3,5-triazine, dichloride |
424-120-1 |
174514-06-8 |
Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Dgr |
H318 H410 |
|
|
|
611-127-00-1 |
pentanatrium 4-amino-6-(5-(4-(2-ethylfenylamino)-6-(2-sulfatoëthaansulfonyl)-1,3,5-triazine-2-ylamino)-2-sulfonatofenylazo)-5-hydroxy-3-(4-(2-sulfatoëthaansulfonyl)fenylazo)naftaleen-2,7-disulfonaat |
423-790-2 |
— |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Dgr |
H318 H317 H412 |
|
|
G |
611-128-00-7 |
N,N'-bis{6-chloor-4-[6-(4-vinylsulfonylfenylazo)-2,7-disulfonzuur-5-hydroxynaft-4-ylamino]-1,3,5-triazine-2-yl}-N-(2-hydroxyethyl)ethaan-1,2-diamine, natriumzout |
419-500-9 |
171599-85-2 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
611-129-00-2 |
reactiemassa van: 5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naftyl)azo]-2,5-diëthoxyfenyl)azo]-2-[(3-fosfonofenyl)azo]benzoëzuur; 5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naftyl)azo]-2,5-diëthoxyfenyl)azo]-3-[(3-fosfonofenyl)azo]benzoëzuur |
418-230-9 |
163879-69-4 |
Expl. 1.3 **** Repr. 2 STOT RE 2 * Skin Sens. 1 Aquatic Chronic 2 |
H203 H361f *** H373 ** H317 H411 |
GHS01 GHS08 GHS07 GHS09 Dgr |
H203 H361f *** H373 ** H317 H411 |
|
|
|
611-130-00-8 |
tetraämmonium-2-[6-[7-(2-carboxylatofenylazo)-8-hydroxy-3,6-disulfonato-1-naftylamino]-4-hydroxy-1,3,5-triazine-2-ylamino]benzoaat |
418-520-5 |
183130-96-3 |
Eye Irrit. 2 Aquatic Chronic 3 |
H319 H412 |
GHS07 Wng |
H319 H412 |
|
|
|
611-131-00-3 |
2-[2-hydroxy-3-(2-chloorfenyl)carbamoyl-1-naftylazo]-7-[2-hydroxy-3-(3-methylfenyl)carbamoyl-1-naftylazo]fluoreen-9-on |
420-580-2 |
151798-26-4 |
Repr. 1B Aquatic Chronic 4 |
H360D *** H413 |
GHS08 Dgr |
H360D *** H413 |
|
|
|
611-132-00-9 |
pentanatrium-bis{7-[4-(1-butyl-5-cyaan-1,2-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)fenylsulfonylamino]-5'-nitro-3,3'-disulfonatonaftaleen-2-azobenzeen-1,2'-diolato}chromaat(III) |
419-210-2 |
178452-71-6 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
611-133-00-4 |
ijzercomplex van azokleurstoffen met een „product-by-process”-definitie, verkregen door de koppelingsreactie van een mengsel van gediazoteerd 2-amino-1-hydroxybenzeen-4-sulfanilide en 2-amino-1-hydroxybenzeen-4-sulfonamide met resorcine, en vervolgens een tweede koppelingsreactie van het verkregen mengsel met een mengsel van gediazoteerd 3-aminobenzeen-1-sulfonzuur (metanilzuur) en 4'-amino-4-nitro-1,1'-difenylamine-2-sulfonzuur en metallisatie met ferrichloride, natriumzout |
419-260-5 |
— |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
611-134-00-X |
trinatrium-2-{α[2-hydroxy-3-[4-chloor-6-[4-(2,3-dibroompropionylamino)-2-sulfonatofenylamino]-1,3,5-triazine-2-ylamino]-5-sulfonatofenylazo]-benzylideenhydrazino}-4-sulfonatobenzoaat, kopercomplex |
423-770-3 |
— |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
611-135-00-5 |
reactieproduct van: 2-[[4-amino-2-ureïdofenylazo]-5-[(2-(sulfoöxy)ethyl)sulfonyl]]benzeensulfonzuur met 2,4,6-trifluorpyrimidine en partiële hydrolyse tot het overeenkomstige vinylsulfonylderivaat, gemengd kalium-/natriumzout |
424-250-9 |
— |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
611-136-00-0 |
2-{4-(2-ammoniopropylamino)-6-[4-hydroxy-3-(5-methyl-2-methoxy-4-sulfamoylfenylazo)-2-sulfonatonaft-7-ylamino]-1,3,5-triazine-2-ylamino}-2-aminopropylformiaat |
424-260-3 |
— |
Repr. 2 Eye Dam. 1 Aquatic Chronic 2 |
H361f *** H318 H411 |
GHS05 GHS08 GHS09 Dgr |
H361f *** H318 H411 |
|
|
|
611-137-00-6 |
6-tert-butyl-7-chloor-3-tridecyl-7,7a-dihydro-1H-pyrazolo[5,1-c]-1,2,4-triazool |
419-870-1 |
159038-16-1 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
611-138-00-1 |
2-(4-aminofenyl)-6-tert-butyl-1H-pyrazolo[1,5-b][1,2,4]triazool |
415-910-7 |
152828-25-6 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
611-139-00-7 |
reactieproduct van: C.I. Leuco Sulphur Black 1 met (3-chloor-2-hydroxypropyl)trimethylammoniumchloride |
424-510-1 |
— |
Eye Dam. 1 Aquatic Chronic 2 |
H318 H411 |
GHS05 GHS09 Dgr |
H318 H411 |
|
|
|
611-140-00-2 |
azafenidin (ISO); 2-(2,4-dichloor-5-prop-2-ynyloxyfenyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyridine-3(2H)-on |
— |
68049-83-2 |
Repr. 1B STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H360Df H373 ** H400 H410 |
GHS08 GHS09 Dgr |
H360Df H373 ** H410 |
|
M = 1 000 |
|
611-141-00-8 |
5-(4-[4-[4-(3,5-dicarboxyfenylazo)fenylamino]-6-morfoline-4-yl-1,3,5-triazine-2-ylamino]fenylazo)isoftaalzuur, gemengd mononatrium- en diammoniumzout |
414-410-6 |
— |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
611-142-00-3 |
polyazokleurstof met een „product-by-process”-definitie, verkregen door de koppelingsreactie van 4-[4-(1-amino-8-hydroxy-3,6-disulfo-2-naftylazo)fenylsulfonylamino]benzeendiazonium met een reactiemassa van 4-carboxybenzeendiazonium en difenylamine-3-sulfo-4,4'-bisdiazonium, en vervolgens een koppelingsreactie van de verkregen verbindingen met een reactiemassa van naft-2-ol en 3-aminofenol, natriumzouten; natriumchloride |
425-740-5 |
— |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
611-143-00-9 |
reactiemassa van: trinatrium-2-(2-[α-(2-carboxylato-κ-O-4-sulfonatofenylazo)benzylideen]hydrazino-κ-N')-6-(2,6-difluoropyrimidine-4-ylamino)-4-sulfonatofenolatocupraat(II); trinatrium-2-(2-[α-(2-carboxylato-κ-O-4-sulfonatofenylazo)benzylideen]hydrazino-κ-N')-6-(4,6-difluorpyrimidine-2-ylamino)-4-sulfonatofenolatocupraat(II) |
428-260-4 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
611-144-00-4 |
reactiemassa van: 7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)fenylazo]-4-hydroxynaftaleen-2-sulfonzuur, Na/K-zout; 7-amino-3-[4-(2-sulfoxyethylsulfonyl)fenylazo]-4-hydroxy-8-[4-(2-sulfoxyethylsulfonyl)-2-sulfofenylazo]naftaleen-2-sulfonzuur, Na/K-zout; 7-amino-8-[4-(2-sulfoxyethylsulfonyl)fenylazo]-4-hydroxy-3-[4-(2-sulfoxyethylsulfonyl)-2-sulfofenylazo]naftaleen-2-sulfonzuur, Na/K-zout; 7-amino-3,8-bis[4-(2-sulfoxyethylsulfonyl)-2-sulfofenylazo]-4-hydroxynaftaleen-2-sulfonzuur, Na/K-zout |
429-070-4 |
214362-06-8 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
611-145-00-X |
reactiemassa van: tetranatrium-3-(1,5-disulfonatonaftaleen-2-ylazo)-4-hydroxy-7-{4-chloor-6-[4-(2-sulfoxyethylsulfonyl)fenylamino]-1,3,5-triazine-2-ylamino}naftaleen-2-sulfonaat; 3-(2,5-disulfofenylazo)-4-hydroxy-7-{4-chloor-6-[4-(2-sulfoxyethylsulfonyl)fenylamino{1,3,5-triazine-2-ylamino}naftaleen-2-sulfonzuur, natriumzout |
429-440-5 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
611-146-00-5 |
reactiemassa van: pentanatrium-3-(4-(4-(7-(2,4-diamino-5-sulfonato-3-(4-sulfonatofenylazo)fenylazo)-1-hydroxy-3-sulfonatonaftaleen-2-ylazo)-2-sulfonatofenylamino)fenylazo)-4-hydroxy-6-(2-oxo-1-fenylcarbamoylpropylazo)naftaleen-2-sulfonaat; pentanatrium-6-((2,4-diamino-5-sulfonatofenyl)azo)-3-((4-((4-((7-((2,4-diamino-5-sulfonatofenyl)azo)-1-hydroxy-3-sulfonatonaftaleen-2-yl)azo)fenyl)amino)-2-sulfonatofenyl)azo)-4-hydroxynaftaleen-2-sulfonaat; pentanatrium-6-((2,4-diamino-5-sulfonato-3-((4-sulfonatofenyl)azo)fenyl)azo)-3-((4-((4-((1,7-dihydroxy-3-sulfonatonaftaleen-2-yl)azo)-2-sulfonatofenyl)amino)fenyl)azo)-4-hydroxynaftaleen-2-sulfonaat; hexanatrium-6-((2,4-diamino-5-sulfonatofenyl)azo)-3-((4-((4-((7-((2,4-diamino-5-sulfonato-3-((4-sulfonatofenyl)azo)fenyl)azo)-1-hydroxy-3-sulfonatonaftaleen-2-yl)azo)-2-sulfonatofenyl)amino)fenyl)azo)-4-hydroxynaftaleen-2-sulfonaat |
430-070-1 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
611-147-00-0 |
natrium-, kalium-, lithium-5-amino-3,6-bis(5-(4-chloor-6-(methyl-(2-methylaminoacetyl)amino)-1,3,5-triazine-2-ylamino)-2-sulfonatofenylazo)-4-hydroxynaftaleen-2,7-disulfonaat |
430-090-0 |
205764-96-1 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
611-148-00-6 |
reactiemassa van: 2-(3-(2,6-dichloor-4-nitrofenylazo)carbazool-9-yl)ethanol; 2-(2-(3-(2,6-dichloor-4-nitro-fenylazo)-carbazool-9-yl)ethoxy)ethanol; 3-(2,6-dichloor-4-nitrofenylazo)carbazool |
429-590-1 |
— |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
611-149-00-1 |
2-(2-chlooracetoxy)ethyl-3-((4-(2,5-dichloor-4-fluorsulfonylfenylazo)-3-methylfenyl)ethylamino)propionaat |
427-570-7 |
193486-83-8 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
611-150-00-7 |
tetralithium-2-[6-[7-[2-(carboxylato)fenylazo]-8-hydroxy-3,6-disulfonato-1-naftylamino]-4-hydroxy-1,3,5-triazine-2-ylamino]benzoaat |
440-460-3 |
— |
Eye Irrit. 2 Aquatic Chronic 3 |
H319 H412 |
GHS07 Wng |
H319 H412 |
|
|
|
611-151-00-2 |
chrysoïdine; 4-(fenylazo)benzeen-1,3-diamine |
207-803-7 |
495-54-5 |
Muta. 2 Acute Tox. 4 * Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H341 H302 H315 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H341 H302 H315 H410 |
|
|
|
611-152-00-8 |
chrysoïdinemonohydrochloride; 4-fenylazofenyleen-1,3-diaminemonohydrochloride; [1] chrysoïdinemonoacetaat; 4-(fenylazo)benzeen-1,3-diaminemonoacetaat; [2] chrysoïdineacetaat; 4-(fenylazo)benzeen-1,3-diamineacetaat; [3] chrysoïdine-p-dodecylbenzeensulfonaat; dodecylbenzeensulfonzuur, verbinding met 4-(fenylazo)benzeen-1,3-diamine (1:1); [4] chrysoïdinedihydrochloride; 4-(fenylazo)benzeen-1,3-diaminedihydrochloride; [5] chrysoïdinesulfaat; bis[4-(fenylazo)benzeen-1,3-diamine]sulfaat [6] |
208-545-8 [1] 278-290-5 [2] 279-116-0 [3] 264-409-8 [4] 281-549-5 [5] 282-432-1 [6] |
532-82-1 [1] 75660-25-2 [2] 79234-33-6 [3] 63681-54-9 [4] 83968-67-6 [5] 84196-22-5 [6] |
Muta. 2 Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H341 H302 H315 H318 H400 H410 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H341 H302 H315 H318 H410 |
|
|
|
611-153-00-3 |
chrysoïdine C10-14-alkylderivaten; benzeensulfonzuur, mono-C10-14-alkylderivaten, verbindingen met 4-(fenylazo)-1,3-benzeendiamine; [1] chrysoïdineverbinding met dibutylnaftaleensulfonzuur; dibutylnaftaleensulfonzuur, verbinding met 4-(fenylazo)benzeen-1,3-diamine (1:1) [2] |
286-946-7 [1] 304-236-8 [2] |
85407-90-5 [1] 94247-67-3 [2] |
Muta. 2 Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 |
H341 H302 H315 H318 |
GHS05 GHS08 GHS07 Dgr |
H341 H302 H315 H318 |
|
|
|
611-154-00-9 |
trinatrium-5-benzamido-4-hydroxy-3-(4-methyl-2-sulfonatofenylazo)naftaleen-2,7-disulfonaat |
403-670-6 |
92408-46-3 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
611-155-00-4 |
4,4'-oxybis(benzeensulfonylazide) |
431-850-4 |
7456-68-0 |
Expl. 1.1**** STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H201 H373** H400 H410 |
GHS01 GHS08 GHS09 Dgr |
H201 H373** H410 |
|
|
|
611-156-00-X |
triammonium-4-[4-[7-(4-carboxylatoanilino)-1-hydroxy-3-sulfonato-2-naftylazo]-2,5-dimethoxyfenylazo]benzoaat |
432-270-4 |
221354-37-6 |
Repr. 2 STOT RE 2 * Aquatic Chronic 2 |
H361f*** H373** H411 |
GHS08 GHS09 Wng |
H361f*** H373** H411 |
|
|
|
611-157-00-5 |
benzeensulfonzuur, 3,3'-(methyleenbis((dihydroxyfenyleen)azo))bis-, kaliumnatriumzout; kaliumnatrium-3-[(E)-(6{3,4-dihydroxy-2-}(Z)-(3-sulfonatofenyl)diazenyl]benzyl}-2,3-dihydroxyfenyl)diazenyl]benzeensulfonaat |
432-590-4 |
243869-48-9 |
Eye Irrit. 2 Aquatic Chronic 3 |
H319 H412 |
GHS07 Wng |
H319 H412 |
|
|
|
611-158-00-0 |
reactieproduct van: 2,3,4,2',3', 4'-hexahydroxy-5,5'-diacethyl-difenylmethaan en 6-diazo-5,6-dihydro-5-oxo-1-naftaleensulfonylchloride en 3-diazo-3,4-dihydro-6-methoxy-4-oxo-1-naftaleensulfonylchloride |
421-520-8 |
— |
**** Aquatic Chronic 4 |
**** H413 |
**** |
**** H413 |
|
|
|
611-159-00-6 |
dinatrium-4-amino-6-((4-((4-(2,4-diaminofenyl)azo)fenylsulfamoyl)fenyl)azo)-5-hydroxy-3-((4-nitrofenyl)azo)naftaleen-2,7-disulfonaat |
421-880-6 |
— |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
611-160-00-1 |
reactiemassa van: 1,1,1-tris(fenyl-4'-(3''-diazo-3'', 4''-dihydro-4''-oxo-naftaleen-1''-sulfonato)ethaan; 1,1,1-tris(fenyl-4'-(6''-diazo-5'', 6''-dihydro-5''-oxo-naftaleen-1''-sulfonato)ethaan; reactieproduct van 1,1,1-tris(p-hydroxyfenyl)ethaan met 6-diazo-5,6-dihydro-5-oxo-1-naftylsulfonylchloride en 3-diazo-3,4-dihydro-4-oxo-1-naftylsulfonylchloride (2:1); reactieproduct van 1,1,1-tris(p-hydroxyfenyl)ethaan met 6-diazo-5,6-dihydro-5-oxo-1-naftylsulfonylchloride en 3-diazo-3,4-dihydro-4-oxo-1-naftylsulfonylchloride (1:2) |
422-760-6 |
— |
**** Aquatic Chronic 4 |
**** H413 |
**** |
**** H413 |
|
|
|
611-161-00-7 |
trinatrium[1,2'-(2-(8-amino-3,5-disulfonatonaftaleen)azo)-(4'-nitrobenzeen)diolato-O,O,N][(Z)-2,2-((fenylcarbamoylprop-1'-enyl)azo)-5-sulfamoylbenzeen)diolato-O,O,N]chromaat(III) |
423-100-1 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
611-162-00-2 |
2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)fen-2-ylazo)benzeen-1,3-diolbis(methaansulfonaat) |
429-600-4 |
— |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H411 |
|
|
|
611-163-00-8 |
2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)fen-2-ylazo)benzeen-1,3-diolsulfaat |
429-610-9 |
— |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 2 |
H302 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H411 |
|
|
|
611-164-00-3 |
reactiemassa van: 2,2’-dimethyl-2,2’-azobutaannitril; 2-methylpentaannitril-2-azo-2’-(2’-methylpropaannitril); 2,2’-dimethyl-2,2’-azoheptaannitril; 2-methylheptaannitril-2-azo-2’-(2’-methylpropaannitril); 2-methylheptaannitril-2-azo-2’-(2’-methylbutaannitril) |
429-710-2 |
— |
Self-react. D Acute Tox. 4 * Aquatic Chronic 2 |
H242 H302 H411 |
GHS02 GHS07 GHS09 Dgr |
H242 H302 H411 |
|
|
|
611-165-00-9 |
reactiemassa van: tetranatrium-4-amino-6-(5-(2,6-difluorpyrimidine-4-ylamino)-2-sulfonatofenylazo)-5-hydroxy-3-(4-(sulfatoëthylsulfonyl)fenylazo)naftaleen-2,7-disulfonaat; tetranatrium-4-amino-6-(5-(4,6-difluorpyrimidine-2-ylamino)-2-sulfonatofenylazo)-5-hydroxy-3-(4-(2-sulfatoëthylsulfonyl)fenylazo)naftaleen-2,7-disulfonaat |
431-830-5 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
611-166-00-4 |
reactiemassa van: pentanatrium-4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatoöxy)ethylsulfonyl]fenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatoöxy)ethylsulfonyl]fenylazo}naftaleen-2,7-disulfonaat; tetranatrium-4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatoöxy)ethylsulfonyl]fenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)fenylazo]naftaleen-2,7-disulfonaat; tetranatrium-4-amino-5-hydroxy-6-(E)-2-sulfonato-4-}2-(sulfonatoöxy)ethylsulfonyl{fenylazo}-3-[(E)-4-(vinylsulfonyl)fenylazo]naftaleen-2,7-disulfonaat |
432-100-9 |
— |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
611-167-00-X |
natriumbis[tris(2-hydroxyethyl)ammonium][6-anilino-4'-(4,8-disulfonato-2-naftylazo)-5'-methyl-3-sulfonatonaftaleen-2-azobenzeen-1,2'-diolato]cupraat(II) |
435-240-9 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
611-168-00-5 |
reactiemassa van: 3-[[4-chloor-6-[[7-[(1,5-disulfo-2-naftalenyl)azo]-8-hydroxy-3,6-disulfo-1-naftalenyl]amino]-1,3,5-triazine-2-yl]amino]-5-[[4-chloor-6-[[8-hydroxy-3,6-disulfo-7-[(2-sulfofenyl)azo]-1-naftalenyl]amino]-1,3,5-triazine-2-yl]amino]benzoëzuur; 3,5-bis[[4-chloor-6-[[7-[(1,5-disulfo-2-naftalenyl)azo]-8-hydroxy-3,6-disulfo-1-naftalenyl]amino]-1,3,5-triazine-2-yl]amino]benzoëzuur |
435-440-6 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
611-169-00-0 |
natrium-5-(2-carboxyfenylazo)-6-hydroxynaftaleen-2-sulfonaat |
435-800-2 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
611-170-00-6 |
reactiemassa van: trinatrium-2-((1-(2-hydroxy-κ-O-5-(2-sulfonatoëthansulfonyl)fenylazo-κ-N 2)-1-fenylmethyl)azo-κ-N 1)4-sulfonatobenzoaat(5–)-κ-O)cupraat(II); dinatrium-2-((1-(5-etheensulfonyl-2-hydroxy-κ-O-fenylazo-κ-N 2)-1-fenylmethyl)azo-κ-N 1)-4-sulfonatobenzoaat-κ-O-(5))cupraat(II) |
435-880-9 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
611-171-00-1 |
reactiemassa van trinatrium-3-(5-(2,6-difluorpyrimidine-4-ylamino)-2-sulfonatofenylazo)-5-(4-fluor-6-morfoline-4-yl-1,3,5-triazine-2-ylamino)-4-hydroxy-2,7-naftaleendisulfonaat; trinatrium-3-(5-(4,6-difluorpyrimidine-2-ylamino)-2-sulfonatofenylazo)-5-(4-fluor-6-morfoline-4-yl-1,3,5-triazine-2-ylamino)-4-hydroxy-2,7-naftaleendisulfonaat |
436-890-6 |
— |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
611-172-00-7 |
reactiemassa van: triammonium-6-amino-3-((2,5-diëthoxy-4-(3-fosfonofenyl)azo)fenyl)azo-4-hydroxy-2-naftaleensulfonaat; diammonium-3-((4-((7-amino-1-hydroxy-3-sulfonaftaleen-2-yl)azo)-2,5-diëthoxyfenyl)azo)benzoaat |
438-310-7 |
— |
Self-react. C**** Repr. 2 Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 3 |
H242 H361f*** H302 H373** H412 |
GHS02 GHS08 GHS07 Dgr |
H242 H361f*** H302 H373** H412 |
|
|
|
611-173-00-2 |
reactiemassa van: 3-[3-carbamoyl-5-(5-{4-chloor-6[4-(2-sulfonatoöxyethylsulfonyl)anilino]-1,3,5-triazine-2-ylamino}-2-sulfonatofenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propaanzuur, trinatriumzout; 3-[3-carbamoyl-5-(5-{4-chloor-6-[4-(vinylsulfonyl)anilino]-1,3,5-triazine-2-ylamino}-2-sulfonatofenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propaanzuur, dinatriumzout |
440-510-4 |
— |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
611-174-00-8 |
reactiemassa van: 3-[5-(4-etheensulfonylbutyrylamino)-2-sulfofenylazo]-5-4-chloor-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaftaleen-4-ylazo)-3-sulfofenylamino]-1,3,5-triazine-2-ylamino-4-hydroxynaftaleen-2,7-disulfonzuur, natriumzout; 3-[5-(4-(2-chloorethaansulfonyl)butyrylamino)-2-sulfofenylazo]-5-4-chloor-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaftaleen-4-ylazo)-3-sulfofenylamino]-1,3,5-triazine-2-ylamino}-4-hydroxynaftaleen-2,7-disulfonzuur, natriumzout |
442-290-5 |
457624-86-1 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
611-175-00-3 |
reactiemassa van: trinatrium-5-{4-chloor-6-[N-ethyl-(3-(2-sulfonatoöxy)ethylsulfonyl)aniline]-1,3,5-triazine-2-ylamino}-4-hydroxy-3-[4-(vinylsulfonyl)fenylazo{naftaleen-2,7-disulfonaat; trinatrium-5-4-chloor-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazine-2-ylamino}-4-hydroxy-3-[4-(2-(sulfonatoöxy)ethylsulfonyl)fenylazo]naftaleen-2,7-disulfonaat; dinatrium-5-4-chloor-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazine-2-ylamino}-4-hydroxy-3-[(4-vinylsulfonyl)fenylazo]naftaleen-2,7-disulfonaat; tetranatrium-5-4-chloor-6-[N-ethyl-3-(2-(sulfonatoöxy)ethylsulfonyl)anilino]-1,3,5-triazine-2-ylamino}-3-[4(2-(sulfonatoöxy)ethylsulfonyl)fenylazo]-4-hydroxynaftaleen-2,7-disulfonaat |
444-050-5 |
— |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
611-176-00-9 |
2,6-bis(2,3,4-trihydroxybenzyl)-p-cresol, ester met 6-diazo-5,6-dihydro-5-oxo-1-naftaleensulfonaat |
444-250-2 |
— |
Self-react. C**** Aquatic Chronic 2 |
H242 H411 |
GHS02 GHS09 Dgr |
H242 H411 |
|
|
|
611-177-00-4 |
reactiemassa van: pentanatriumbis[6-anilino-3,5'-disulfonatonaftaleen-2-azobenzeen-1,2'-diolato]kobaltaat(III); tetranatrium-[6-anilino-3,5'-disulfonatonaftaleen-2-azobenzeen-1,2'-diolato][6-anilino-5'-sulfamoyl-3-sulfonatonaftaleen-2-azobenzeen-1,2'-diolato]kobaltaat(III); trinatriumbis[6-anilino-5'-sulfamoyl-3-sulfonatonaftaleen-2-azobenzeen-1,2'-diolato]kobaltaat(III) |
444-290-0 |
508202-43-5 |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Dgr |
H318 H317 H412 |
|
|
|
611-178-00-X |
reactiemassa van: pentanatrium-4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatoöxy)ethylsulfonyl]fenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatoöxy)ethylsulfonyl]fenylazo}naftaleen-2,7-disulfonaat; tetranatrium-4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatoöxy)ethylsulfonyl]fenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)fenylazo]naftaleen-2,7-disulfonaat; tetranatrium-4-amino-5-hydroxy-6-{(E)-2-sulfonato-4-[2-(sulfonatoöxy)ethylsulfonyl]fenylazo}-3-[(E)-4-(vinylsulfonyl)fenylazo]naftaleen-2,7-disulfonaat; trinatrium-4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)fenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)fenylazo]naftaleen-2,7-disulfonaat; trinatrium-4-amino-5-hydroxy-3-[(2-hydroxyethylsulfonyl)fenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)fenylazo]naftaleen-2,7-disulfonaat; trinatrium-4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)fenylazo]-6-[2-sulfonato-4-(2-hydroxyethylsulfonyl)fenylazo]naftaleen-2,7-disulfonaat |
445-280-9 |
— |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Dgr |
H318 H317 H412 |
|
|
|
611-179-00-5 |
reactiemassa van: pentanatrium-2-[[8-[[4-chloor-6-[[4-(2-sulfonatethylsulfonyl)]fenyl]amino]-1,3,5-triazine-2-yl]amino-1-hydroxy-3,6-disulfonato-2-naftaleenyl]azo]naftaleen-1,5-disulfonaat; 2-[[8-[[4-chloor-6-[[4-[[2-ethenyl]sulfonyl]fenyl]amino]1,3,5-triazine-2-yl]amino]-1-hydroxy-3,6-disulfonato-2-naftalenyl]azo]naftaleen-1,5-disulfonaat |
450-010-8 |
— |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
611-180-00-0 |
ijzer, complexen met gediazoteerd 4-aminobenzeensulfonamide, gediazoteerd 3-aminobenzeensulfonzuur, gediazoteerd 3-amino-4-hydroxybenzeensulfonamide, gediazoteerd 3-amino-4-hydroxy-N-fenylbenzeensulfonamide, gediazoteerd 5-amino-2-(fenylamino)benzeensulfonzuur en resorcinol, natriumzouten |
417-850-7 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
612-001-00-9 |
mono-methylamine; [1] di-methylamine; [2] tri-methylamine [3] |
200-820-0 [1] 204-697-4 [2] 200-875-0 [3] |
74-89-5 [1] 124-40-3 [2] 75-50-3 [3] |
Flam. Gas 1 Press. Gas Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 |
H220 H332 H335 H315 H318 |
GHS02 GHS04 GHS05 GHS07 Dgr |
H220 H332 H335 H315 H318 |
|
* Skin Irrit. 2; H315: C ≥ 5 % Eye Dam. 1; H318: C ≥ 5 % Eye Irrit. 2; H319: 0,5 % ≤ C < 5 % STOT SE 3; H335: C ≥ 5 % |
U5 |
612-001-01-6 |
mono-methylamine … %; [1] di-methylamine … %; [2] tri-methylamine … [3] |
200-820-0 [1] 204-697-4 [2] 200-875-0 [3] |
74-89-5 [1] 124-40-3 [2] 75-50-3 [3] |
Flam. Liq. 1 Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H224 H332 H302 H314 |
GHS02 GHS05 GHS07 Dgr |
H224 H332 H302 H314 |
|
* STOT SE 3; H335: C ≥ 5 % |
B |
612-002-00-4 |
ethylamine |
200-834-7 |
75-04-7 |
Flam. Gas 1 Press. Gas Eye Irrit. 2 STOT SE 3 |
H220 H319 H335 |
GHS02 GHS04 GHS07 Dgr |
H220 H319 H335 |
|
|
U |
612-003-00-X |
diëthylamine |
203-716-3 |
109-89-7 |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A |
H225 H332 H312 H302 H314 |
GHS02 GHS05 GHS07 Dgr |
H225 H332 H312 H302 H314 |
|
STOT SE 3; H335: C ≥ 1 % |
|
612-004-00-5 |
triëthylamine |
204-469-4 |
121-44-8 |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A |
H225 H332 H312 H302 H314 |
GHS02 GHS05 GHS07 Dgr |
H225 H332 H312 H302 H314 |
|
STOT SE 3; H335: C ≥ 1 % |
|
612-005-00-0 |
butylamine |
203-699-2 |
109-73-9 |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A |
H225 H332 H312 H302 H314 |
GHS02 GHS05 GHS07 Dgr |
H225 H332 H312 H302 H314 |
|
STOT SE 3; H335: C ≥ 1 % |
|
612-006-00-6 |
ethyleendiamine; 1,2-diaminoëthaan |
203-468-6 |
107-15-3 |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 |
H226 H312 H302 H314 H334 H317 |
GHS02 GHS08 GHS05 GHS07 Dgr |
H226 H312 H302 H314 H334 H317 |
|
|
|
612-007-00-1 |
2-aminopropaan; isopropylamine |
200-860-9 |
75-31-0 |
Flam. Liq. 1 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H224 H319 H335 H315 |
GHS02 GHS07 Dgr |
H224 H319 H335 H315 |
|
|
|
612-008-00-7 |
aniline |
200-539-3 |
62-53-3 |
Carc. 2 Muta. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 |
H351 H341 H331 H311 H301 H372 ** H318 H317 H400 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H351 H341 H331 H311 H301 H372 ** H318 H317 H400 |
|
* STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,2 % ≤ C < 1 % |
|
612-009-00-2 |
zouten van aniline |
— |
— |
Carc. 2 Muta. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 |
H351 H341 H331 H311 H301 H372 ** H318 H317 H400 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H351 H341 H331 H311 H301 H372 ** H318 H317 H400 |
|
* STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,2 % ≤ C < 1 % |
A |
612-010-00-8 |
chlooranilinen, tenzij elders in deze bijlage vermeld |
— |
— |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H331 H311 H301 H373 ** H410 |
|
|
C |
612-011-00-3 |
4-nitrosoaniline |
211-535-6 |
659-49-4 |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H332 H312 H302 |
GHS07 Wng |
H332 H312 H302 |
|
|
|
612-012-00-9 |
o-nitroaniline; [1] m-nitroaniline; [2] p-nitroaniline [3] |
201-855-4 [1] 202-729-1 [2] 202-810-1 [3] |
88-74-4 [1] 99-09-2 [2] 100-01-6 [3] |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Chronic 3 |
H331 H311 H301 H373 ** H412 |
GHS06 GHS08 Dgr |
H331 H311 H301 H373 ** H412 |
|
|
C |
612-013-00-4 |
3-aminobenzeensulfonzuur; metanilzuur |
204-473-6 |
121-47-1 |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H332 H312 H302 |
GHS07 Wng |
H332 H312 H302 |
|
|
|
612-014-00-X |
sulfanilzuur; 4-aminobenzeensulfonzuur |
204-482-5 |
121-57-3 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H319 H315 H317 |
GHS07 Wng |
H319 H315 H317 |
|
|
|
612-015-00-5 |
N-methylaniline |
202-870-9 |
100-61-8 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H331 H311 H301 H373 ** H410 |
|
|
|
612-016-00-0 |
N,N-dimethylaniline |
204-493-5 |
121-69-7 |
Carc. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Chronic 2 |
H351 H331 H311 H301 H411 |
GHS06 GHS08 GHS09 Dgr |
H351 H331 H311 H301 H411 |
|
|
|
612-017-00-6 |
N-methyl-N-2,4,6-tetranitroaniline; tetryl |
207-531-9 |
479-45-8 |
Expl. 1.1 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 |
H201 H331 H311 H301 H373** |
GHS01 GHS06 GHS08 Dgr |
H201 H331 H311 H301 H373** |
|
|
|
612-018-00-1 |
bis(2,4,6-trinitrofenyl)amine; hexyl |
205-037-8 |
131-73-7 |
Expl. 1.1 Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 Aquatic Chronic 2 |
H201 H330 H310 H300 H373** H411 |
GHS01 GHS06 GHS08 GHS09 Dgr |
H201 H330 H310 H300 H373** H411 |
|
|
|
612-019-00-7 |
dipicrylamine, ammoniumzout |
220-639-0 |
2844-92-0 |
Expl. 1.1 Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 Aquatic Chronic 2 |
H201 H330 H310 H300 H373** H411 |
GHS01 GHS06 GHS08 GHS09 Dgr |
H201 H330 H310 H300 H373** H411 |
|
|
|
612-020-00-2 |
1-naftylamine |
205-138-7 |
134-32-7 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
612-022-00-3 |
2-naftylamine |
202-080-4 |
91-59-8 |
Carc. 1A Acute Tox. 4 * Aquatic Chronic 2 |
H350 H302 H411 |
GHS08 GHS07 GHS09 Dgr |
H350 H302 H411 |
|
Carc. 1A; H350: C ≥ 0,01 % |
|
612-023-00-9 |
fenylhydrazine; [1] fenylhydraziniumchloride; [2] fenylhydrazinehydrochloride; [3] fenylhydraziniumsulfaat (2:1) [4] |
202-873-5 [1] 200-444-7 [2] 248-259-0 [3] 257-622-2 [4] |
100-63-0 [1] 59-88-1 [2] 27140-08-5 [3] 52033-74-6 [4] |
Carc. 1B Muta. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 |
H350 H341 H331 H311 H301 H372 ** H319 H315 H317 H400 |
GHS06 GHS08 GHS09 Dgr |
H350 H341 H331 H311 H301 H372 ** H319 H315 H317 H400 |
|
|
|
612-024-00-4 |
m-toluïdine; 3-aminotolueen |
203-583-1 |
108-44-1 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 |
H331 H311 H301 H373 ** H400 |
GHS06 GHS08 GHS09 Dgr |
H331 H311 H301 H373 ** H400 |
|
|
|
612-025-00-X |
nitrotoluïdine |
— |
— |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Chronic 2 |
H331 H311 H301 H373 ** H411 |
GHS06 GHS08 GHS09 Dgr |
H331 H311 H301 H373 ** H411 |
|
|
C |
612-026-00-5 |
difenylamine |
204-539-4 |
122-39-4 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H373 ** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H331 H311 H301 H373 ** H410 |
|
|
|
612-027-00-0 |
xylidinen, tenzij elders in deze bijlage vermeld; dimethylanilinen, tenzij elders in deze bijlage vermeld |
— |
— |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Chronic 2 |
H331 H311 H301 H373 ** H411 |
GHS06 GHS08 GHS09 Dgr |
H331 H311 H301 H373 ** H411 |
|
|
C |
612-028-00-6 |
p-fenyleendiamine |
203-404-7 |
106-50-3 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H319 H317 H400 H410 |
GHS06 GHS09 Dgr |
H331 H311 H301 H319 H317 H410 |
|
|
|
612-029-00-1 |
benzeen-1,4-diaminedihydrochloride; p-fenyleendiaminedihydrochloride |
210-834-9 |
624-18-0 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H319 H317 H400 H410 |
GHS06 GHS09 Dgr |
H331 H311 H301 H319 H317 H410 |
|
|
|
612-030-00-7 |
2-methyl-p-fenyleendiaminesulfaat [1] |
210-431-8 [1] 228-871-4 [2] |
615-50-9 [1] 6369-59-1 [2] |
Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H301 H332 H312 H317 H411 |
GHS06 GHS09 Dgr |
H301 H332 H312 H317 H411 |
|
|
|
612-031-00-2 |
N,N-dimethylbenzeen-1,3-diamine; [1] 4-amino-N,N-dimethylaniline; 3-amino-N,N-dimethylaniline [2] |
220-623-3 [1] 202-807-5 [2] |
2836-04-6 [1] 99-98-9 [2] |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * |
H331 H311 H301 |
GHS06 Dgr |
H331 H311 H301 |
|
|
C |
612-032-00-8 |
N, N,N',N'-tetramethyl-p-fenyleendiamine |
202-831-6 |
100-22-1 |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H332 H312 H302 |
GHS07 Wng |
H332 H312 H302 |
|
|
|
612-033-00-3 |
2-aminofenol |
202-431-1 |
95-55-6 |
Muta. 2 Acute Tox. 4 * Acute Tox. 4 * |
H341 H332 H302 |
GHS08 GHS07 Wng |
H341 H332 H302 |
|
|
|
612-034-00-9 |
2-amino-4,6-dinitrofenol; picraminezuur |
202-544-6 |
96-91-3 |
Expl. 1.1 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 3 |
H201 H332 H312 H302 H412 |
GHS01 GHS07 Dgr |
H201 H332 H312 H302 H412 |
|
|
|
612-034-01-6 |
2-amino-4,6-dinitrofenol; picraminezuur; [≥ 20 % water] |
202-544-6 |
96-91-3 |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 3 |
H332 H312 H302 H412 |
GHS07 Wng |
H332 H312 H302 H412 |
|
|
G |
612-035-00-4 |
2-methoxyaniline; o-anisidine |
201-963-1 |
90-04-0 |
Carc. 1B Muta. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * |
H350 H341 H331 H311 H301 |
GHS06 GHS08 Dgr |
H350 H341 H331 H311 H301 |
|
|
|
612-036-00-X |
3,3'-dimethoxybenzidine; o-dianisidine |
204-355-4 |
119-90-4 |
Carc. 1B Acute Tox. 4 * |
H350 H302 |
GHS08 GHS07 Dgr |
H350 H302 |
|
|
|
612-037-00-5 |
zouten van 3,3'-dimethoxybenzidine; zouten van o-dianisidine |
— |
— |
Carc. 1B Acute Tox. 4 * |
H350 H302 |
GHS08 GHS07 Dgr |
H350 H302 |
|
|
A |
612-038-00-0 |
2-nitro-p-anisidine; 4-methoxy-2-nitroaniline |
202-547-2 |
96-96-8 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Chronic 3 |
H330 H310 H300 H373 ** H412 |
GHS06 GHS08 Dgr |
H330 H310 H300 H373 ** H412 |
|
|
|
612-039-00-6 |
2-ethoxyaniline; o-fenetidine |
202-356-4 |
94-70-2 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * |
H331 H311 H301 H373 ** |
GHS06 GHS08 Dgr |
H331 H311 H301 H373 ** |
|
|
|
612-040-00-1 |
2,4-dinitroaniline |
202-553-5 |
97-02-9 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Chronic 2 |
H330 H310 H300 H373 ** H411 |
GHS06 GHS08 GHS09 Dgr |
H330 H310 H300 H373 ** H411 |
|
|
|
612-041-00-7 |
4,4'-bi-o-toluïdine |
204-358-0 |
119-93-7 |
Carc. 1B Acute Tox. 4 * Aquatic Chronic 2 |
H350 H302 H411 |
GHS08 GHS07 GHS09 Dgr |
H350 H302 H411 |
|
|
|
612-042-00-2 |
benzidine; 1,1'-bifenyl-4,4'-diamine; 4,4'-diaminobifenyl; bifenyl-4,4'-yleendiamine |
202-199-1 |
92-87-5 |
Carc. 1A Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H350 H302 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350 H302 H410 |
|
Carc. 1A; H350: C ≥ 0,01 % |
|
612-043-00-8 |
N,N'-dimethylbenzidine |
— |
2810-74-4 |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H332 H312 H302 |
GHS07 Wng |
H332 H312 H302 |
|
|
|
612-044-00-3 |
N,N'-diacetylbenzidine |
210-338-2 |
613-35-4 |
Carc. 1B Muta. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H350 H341 H332 H312 H302 |
GHS08 GHS07 Dgr |
H350 H341 H332 H312 H302 |
|
|
|
612-046-00-4 |
allylamine |
203-463-9 |
107-11-9 |
Flam. Liq. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Chronic 2 |
H225 H331 H311 H301 H411 |
GHS02 GHS06 GHS09 Dgr |
H225 H331 H311 H301 H411 |
|
|
|
612-047-00-X |
benzylamine |
202-854-1 |
100-46-9 |
Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H312 H302 H314 |
GHS05 GHS07 Dgr |
H312 H302 H314 |
|
|
|
612-048-00-5 |
dipropylamine |
205-565-9 |
142-84-7 |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A |
H225 H332 H312 H302 H314 |
GHS02 GHS05 GHS07 Dgr |
H225 H332 H312 H302 H314 |
|
STOT SE 3; H335: C ≥ 1 % |
|
612-049-00-0 |
di-n-butylamine; [1] di-sec-butylamine [2] |
203-921-8 [1] 210-937-9 [2] |
111-92-2 [1] 626-23-3 [2] |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H226 H332 H312 H302 |
GHS02 GHS07 Wng |
H226 H332 H312 H302 |
|
|
|
612-050-00-6 |
cyclohexylamine |
203-629-0 |
108-91-8 |
Flam. Liq. 3 Repr. 2 Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H226 H361f*** H312 H302 H314 |
GHS02 GHS05 GHS08 GHS07 Dgr |
H226 H361f*** H312 H302 H314 |
|
|
|
612-051-00-1 |
4,4'-diaminodifenylmethaan; 4,4'-methyleendianiline |
202-974-4 |
101-77-9 |
Carc. 1B Muta. 2 STOT SE 1 STOT RE 2 * Skin Sens. 1 Aquatic Chronic 2 |
H350 H341 H370 ** H373 ** H317 H411 |
GHS08 GHS07 GHS09 Dgr |
H350 H341 H370 ** H373 ** H317 H411 |
|
|
|
612-052-00-7 |
(S)-sec-butylamine; (S)-2-aminobutaan; [1] (R)-sec-butylamine; (R)-2-aminobutaan; [2] sec-butylamine; 2-aminobutaan [3] |
208-164-7 [1] 236-232-6 [2] 237-732-7 [3] |
513-49-5 [1] 13250-12-9 [2] 13952-84-6 [3] |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A Aquatic Acute 1 |
H225 H332 H302 H314 H400 |
GHS02 GHS05 GHS07 GHS09 Dgr |
H225 H332 H302 H314 H400 |
|
|
C |
612-053-00-2 |
N-ethylaniline |
203-135-5 |
103-69-5 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * |
H331 H311 H301 H373 ** |
GHS06 GHS08 Dgr |
H331 H311 H301 H373 ** |
|
|
|
612-054-00-8 |
N,N-diëthylaniline |
202-088-8 |
91-66-7 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Chronic 2 |
H331 H311 H301 H373 ** H411 |
GHS06 GHS08 GHS09 Dgr |
H331 H311 H301 H373 ** H411 |
|
* |
|
612-055-00-3 |
N-methyl-o-toluïdine; [1] N-methyl-m-toluïdine; [2] N-methyl-p-toluïdine [3] |
210-260-9 [1] 211-795-0 [2] 210-769-6 [3] |
611-21-2 [1] 696-44-6 [2] 623-08-5 [3] |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Chronic 3 |
H331 H311 H301 H373 ** H412 |
GHS06 GHS08 Dgr |
H331 H311 H301 H373 ** H412 |
|
|
C |
612-056-00-9 |
N,N-dimethyl-p-toluïdine; [1] N,N-dimethyl-m-toluïdine; [2] N,N-dimethyl-o-toluïdine [3] |
202-805-4 [1] 204-495-6 [2] 210-199-8 [3] |
99-97-8 [1] 121-72-2 [2] 609-72-3 [3] |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Chronic 3 |
H331 H311 H301 H373 ** H412 |
GHS06 GHS08 Dgr |
H331 H311 H301 H373 ** H412 |
|
* |
C |
612-057-00-4 |
piperazine; [vast] |
203-808-3 |
110-85-0 |
Repr. 2 Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 |
H361fd H314 H334 H317 |
GHS05 GHS08 Dgr |
H361fd H314 H334 H317 |
|
|
|
612-057-01-1 |
piperazine; [vloeibaar] |
203-808-3 |
110-85-0 |
Repr. 2 Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 |
H361fd H314 H334 H317 |
GHS05 GHS08 Dgr |
H361fd H314 H334 H317 |
|
|
|
612-058-00-X |
2,2'-iminodiëthylamine; diëthyleentriamine |
203-865-4 |
111-40-0 |
Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 |
H312 H302 H314 H317 |
GHS05 GHS07 Dgr |
H312 H302 H314 H317 |
|
|
|
612-059-00-5 |
3,6-diazaoctaanethyleendiamine; triëthyleentetramine |
203-950-6 |
112-24-3 |
Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 3 |
H312 H314 H317 H412 |
GHS05 GHS07 Dgr |
H312 H314 H317 H412 |
|
|
|
612-060-00-0 |
1,11-diamino-3,6,9-triazaündecaan; tetraëthyleenpentamine |
203-986-2 |
112-57-2 |
Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 |
H312 H302 H314 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H312 H302 H314 H317 H411 |
|
|
|
612-061-00-6 |
3-(dimethylamino)propylamine; N,N-dimethyl-1,3-diaminopropaan |
203-680-9 |
109-55-7 |
Flam. Liq. 3 Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 |
H226 H302 H314 H317 |
GHS02 GHS05 GHS07 Dgr |
H226 H302 H314 H317 |
|
|
|
612-062-00-1 |
3-(diëthylamino)propylamine; N,N-diëthyl-1,3-diaminopropaan; |
203-236-4 |
104-78-9 |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 |
H226 H312 H302 H314 H317 |
GHS02 GHS05 GHS07 Dgr |
H226 H312 H302 H314 H317 |
|
|
|
612-063-00-7 |
3,3'-iminodi(propylamine); dipropyleentriamine |
200-261-2 |
56-18-8 |
Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 4 * Skin Corr. 1A Skin Sens. 1 |
H330 H311 H302 H314 H317 |
GHS06 GHS05 Dgr |
H330 H311 H302 H314 H317 |
|
|
|
612-064-00-2 |
1,14-diamine-3,6,9,12-tetraäzatetradecaan; pentaëthyleenhexamine |
223-775-9 |
4067-16-7 |
Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H314 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H314 H317 H410 |
|
|
|
612-065-00-8 |
polyethyleenpolyamine, tenzij elders in deze bijlage vermeld |
— |
— |
Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H314 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H312 H302 H314 H317 H410 |
|
|
|
612-066-00-3 |
dicyclohexylamine |
202-980-7 |
101-83-7 |
Acute Tox. 4 * Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H302 H314 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H302 H314 H410 |
|
|
|
612-067-00-9 |
3-aminomethyl-3,5,5-trimethylcyclohexylamine |
220-666-8 |
2855-13-2 |
Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 3 |
H312 H302 H314 H317 H412 |
GHS05 GHS07 Dgr |
H312 H302 H314 H317 H412 |
|
|
|
612-068-00-4 |
3,3'-dichloorbenzidine; 3,3'-dichloorbifenyl-4,4'-yleendiamine |
202-109-0 |
91-94-1 |
Carc. 1B Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H312 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350 H312 H317 H410 |
|
|
|
612-069-00-X |
zouten van 3,3'-dichloorbenzidine; zouten van 3,3'-dichloorbifenyl-4,4'-yleendiamine |
— |
— |
Carc. 1B Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H312 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350 H312 H317 H410 |
|
|
A |
612-070-00-5 |
zouten van benzidine |
208-519-6 208-520-1 244-236-4 252-984-8 |
531-85-1 531-86-2 21136-70-9 36341-27-2 |
Carc. 1A Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H350 H302 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350 H302 H410 |
|
|
A |
612-071-00-0 |
zouten van 2-naftylamine |
209-030-0 210-313-6 |
553-00-4 612-52-2 |
Carc. 1A Acute Tox. 4 * Aquatic Chronic 2 |
H350 H302 H411 |
GHS08 GHS07 GHS09 Dgr |
H350 H302 H411 |
|
|
A |
612-072-00-6 |
bifenyl-4-ylamine; xenylamine; 4-aminobifenyl |
202-177-1 |
92-67-1 |
Carc. 1A Acute Tox. 4 * |
H350 H302 |
GHS08 GHS07 Dgr |
H350 H302 |
|
|
|
612-073-00-1 |
zouten van bifenyl-4-ylamine; zouten van xenylamine; zouten van 4-aminobifenyl |
— |
— |
Carc. 1A Acute Tox. 4 * |
H350 H302 |
GHS08 GHS07 Dgr |
H350 H302 |
|
|
A |
612-074-00-7 |
benzyldimethylamine |
203-149-1 |
103-83-3 |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 3 |
H226 H332 H312 H302 H314 H412 |
GHS02 GHS05 GHS07 Dgr |
H226 H332 H312 H302 H314 H412 |
|
|
|
612-075-00-2 |
2-aminoëthyldimethylamine; 2-dimethylaminoëthylamine |
203-541-2 |
108-00-9 |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A |
H225 H312 H302 H314 |
GHS02 GHS05 GHS07 Dgr |
H225 H312 H302 H314 |
|
|
|
612-076-00-8 |
ethyldimethylamine |
209-940-8 |
598-56-1 |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H225 H332 H302 H314 |
GHS02 GHS05 GHS07 Dgr |
H225 H332 H302 H314 |
|
|
|
612-077-00-3 |
dimethylnitrosoamine; N-nitrosodimethylamine |
200-549-8 |
62-75-9 |
Carc. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Aquatic Chronic 2 |
H350 H330 H301 H372 ** H411 |
GHS06 GHS08 GHS09 Dgr |
H350 H330 H301 H372 ** H411 |
|
Carc. 1B; H350: C ≥ 0,001 % |
|
612-078-00-9 |
2,2'-dichloor-4,4'-methyleendianiline; 4,4'-methyleenbis(2-chlooraniline) |
202-918-9 |
101-14-4 |
Carc. 1B Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H350 H302 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350 H302 H410 |
|
|
|
612-079-00-4 |
zouten van 2,2'-dichloor-4,4'-methyleendianiline; zouten van 4,4'-methyleenbis(2-chlooraniline) |
— |
— |
Carc. 1B Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H350 H302 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350 H302 H410 |
|
|
A |
612-080-00-X |
4-amino-N,N-dëthylaniline; N,N-diëthyl-p-fenyleendiamine |
202-214-1 |
93-05-0 |
Acute Tox. 3 * Skin Corr. 1B |
H301 H314 |
GHS06 GHS05 Dgr |
H301 H314 |
|
|
|
612-081-00-5 |
zouten van 4,4'-bi-o-toluïdine; zouten van 3,3'-dimethylbenzidine; zouten van o-tolidine |
210-322-5 265-294-7 277-985-0 |
612-82-8 64969-36-4 74753-18-7 |
Carc. 1B Acute Tox. 4 * Aquatic Chronic 2 |
H350 H302 H411 |
GHS08 GHS07 GHS09 Dgr |
H350 H302 H411 |
|
|
A |
612-082-00-0 |
thioureum; thiocarbamide |
200-543-5 |
62-56-6 |
Carc. 2 Repr. 2 Acute Tox. 4 * Aquatic Chronic 2 |
H351 H361d *** H302 H411 |
GHS08 GHS07 GHS09 Wng |
H351 H361d *** H302 H411 |
|
|
|
612-083-00-6 |
1-methyl-3-nitro-1-nitrosoguanidine |
200-730-1 |
70-25-7 |
Carc. 1B Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 |
H350 H332 H319 H315 H411 |
GHS08 GHS07 GHS09 Dgr |
H350 H332 H319 H315 H411 |
|
Carc. 1B; H350: C ≥ 0,01 % |
|
612-084-00-1 |
dapsone; 4,4'-diaminodifenylsulfon |
201-248-4 |
80-08-0 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
612-085-00-7 |
4,4'-methyleendi-o-toluïdine |
212-658-8 |
838-88-0 |
Carc. 1B Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H302 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H350 H302 H317 H410 |
|
|
|
612-086-00-2 |
amitraz (ISO); N,N-bis(2,4-xylyliminomethyl)-methylamine |
251-375-4 |
33089-61-1 |
Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373 ** H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H302 H373 ** H317 H410 |
|
M = 10 |
|
612-087-00-8 |
guazatine (ISO) |
|
108173-90-6 |
Acute Tox. 2 * Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H312 H302 H335 H315 H318 H400 H410 |
GHS06 GHS05 GHS09 Dgr |
H330 H312 H302 H335 H315 H318 H410 |
|
|
|
612-088-00-3 |
simazine (ISO); 6-chloor-N,N'-diëthyl-1,3,5-triazine-2,4-diamine |
204-535-2 |
122-34-9 |
Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H400 H410 |
GHS08 GHS09 Wng |
H351 H410 |
|
|
|
612-089-00-9 |
1,5-naftyleendiamine |
218-817-8 |
2243-62-1 |
Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H400 H410 |
GHS08 GHS09 Wng |
H351 H410 |
|
|
|
612-090-00-4 |
2,2'-(nitrosoïmino)bisethanol |
214-237-4 |
1116-54-7 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
612-091-00-X |
o-toluïdine; 2-aminotolueen |
202-429-0 |
95-53-4 |
Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Eye Irrit. 2 Aquatic Acute 1 |
H350 H331 H301 H319 H400 |
GHS06 GHS08 GHS09 Dgr |
H350 H331 H301 H319 H400 |
|
|
|
612-092-00-5 |
N, N'-(2,2-dimethylpropylideen)hexamethyleendiamine |
401-660-6 |
1000-78-8 |
Skin Irrit. 2 Skin Sens. 1 |
H315 H317 |
GHS07 Wng |
H315 H317 |
|
|
|
612-093-00-0 |
3,5-dichloor-4-(1,1,2,2-tetrafluorethoxy)aniline |
401-790-3 |
104147-32-2 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
612-094-00-6 |
4-(2-chloor-4-trifluormethyl)fenoxy-2-fluoranilinehydrochloride |
402-190-4 |
113674-95-6 |
STOT RE 1 Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H372** H302 H373** H318 H317 H400 H410 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H372** H302 H373** H318 H317 H410 |
|
|
|
612-095-00-1 |
benzyl-2-hydroxydodecyldimethylammoniumbenzoaat |
402-610-6 |
113694-52-3 |
Skin Corr. 1B Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H314 H302 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H314 H302 H410 |
|
|
|
612-096-00-7 |
4,4'-carbonimidoylbis[N,N-dimethylaniline] |
207-762-5 |
492-80-8 |
Carc. 2 Acute Tox. 4 * Eye Irrit. 2 Aquatic Chronic 2 |
H351 H302 H319 H411 |
GHS08 GHS07 GHS09 Wng |
H351 H302 H319 H411 |
|
|
|
612-097-00-2 |
zouten van 4,4'-carbonimidoylbis[N,N-dimethylaniline] |
— |
— |
Carc. 2 Acute Tox. 4 * Eye Irrit. 2 Aquatic Chronic 2 |
H351 H302 H319 H411 |
GHS08 GHS07 GHS09 Wng |
H351 H302 H319 H411 |
|
|
A |
612-098-00-8 |
nitrosodipropylamine |
210-698-0 |
621-64-7 |
Carc. 1B Acute Tox. 4 * Aquatic Chronic 2 |
H350 H302 H411 |
GHS08 GHS07 GHS09 Dgr |
H350 H302 H411 |
|
Carc. 1B; H350: C ≥ 0,001 % |
|
612-099-00-3 |
4-methyl-m-fenyleendiamine; 2,4-tolueendiamine |
202-453-1 |
95-80-7 |
Carc. 1B Muta. 2 Repr. 2 Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Chronic 2 |
H350 H341 H361f*** H301 H312 H373** H317 H411 |
GHS06 GHS08 GHS09 Dgr |
H350 H341 H361f*** H301 H312 H373** H317 H411 |
|
|
|
612-100-00-7 |
propyleendiamine |
201-155-9 |
78-90-0 |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A |
H226 H312 H302 H314 |
GHS02 GHS05 GHS07 Dgr |
H226 H312 H302 H314 |
|
|
|
612-101-00-2 |
methenamine; hexamethyleentetramine |
202-905-8 |
100-97-0 |
Flam. Sol. 2 Skin Sens. 1 |
H228 H317 |
GHS02 GHS07 Wng |
H228 H317 |
|
|
|
612-102-00-8 |
N, N-bis(3-aminopropyl)methylamine |
203-336-8 |
105-83-9 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * Skin Corr. 1B |
H331 H311 H302 H314 |
GHS06 GHS05 Dgr |
H331 H311 H302 H314 |
|
|
|
612-103-00-3 |
N,N,N',N'-tetramethylethyleendiamine |
203-744-6 |
110-18-9 |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H225 H332 H302 H314 |
GHS02 GHS05 GHS07 Dgr |
H225 H332 H302 H314 |
|
|
|
612-104-00-9 |
hexymethyleendiamine |
204-679-6 |
124-09-4 |
Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Corr. 1B |
H312 H302 H335 H314 |
GHS05 GHS07 Dgr |
H312 H302 H335 H314 |
|
|
|
612-105-00-4 |
2-piperazine-1-ylethylamine |
205-411-0 |
140-31-8 |
Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 3 |
H312 H302 H314 H317 H412 |
GHS05 GHS07 Dgr |
H312 H302 H314 H317 H412 |
|
|
|
612-106-00-X |
2,6-diëthylaniline |
209-445-7 |
579-66-8 |
Acute Tox. 4 * |
H302 |
— |
H302 |
|
|
|
612-107-00-5 |
1-fenylethylamine; [1] DL-α-methylbenzylamine [2] |
202-706-6 [1] 210-545-8 [2] |
98-84-0 [1] 618-36-0 [2] |
Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H312 H302 H314 |
GHS05 GHS07 Dgr |
H312 H302 H314 |
|
|
|
612-108-00-0 |
3-aminopropyltriëthoxysilaan |
213-048-4 |
919-30-2 |
Acute Tox. 4 * Skin Corr. 1B |
H302 H314 |
GHS05 GHS07 Dgr |
H302 H314 |
|
|
|
612-109-00-6 |
bis(2-dimethylaminoëthyl)(methyl)amine |
221-201-1 |
3030-47-5 |
Acute Tox. 3 * Acute Tox. 4 * Skin Corr. 1B |
H311 H302 H314 |
GHS06 GHS05 Dgr |
H311 H302 H314 |
|
|
|
612-110-00-1 |
2,2'-dimethyl-4,4'-methyleenbis(cyclohexylamine) |
229-962-1 |
6864-37-5 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * Skin Corr. 1A Aquatic Chronic 2 |
H331 H311 H302 H314 H411 |
GHS06 GHS05 GHS09 Dgr |
H331 H311 H302 H314 H411 |
|
|
|
612-111-00-7 |
2-methyl-m-fenyleendiamine; 2,6-tolueendiamine |
212-513-9 |
823-40-5 |
Muta. 2 Acute Tox. 4 * Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H341 H312 H302 H317 H411 |
GHS08 GHS07 GHS09 Wng |
H341 H312 H302 H317 H411 |
|
|
|
612-112-00-2 |
p-anisidine; 4-methoxyaniline |
203-254-2 |
104-94-9 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * STOT RE 2 * Aquatic Acute 1 |
H330 H310 H300 H373 ** H400 |
GHS06 GHS08 GHS09 Dgr |
H330 H310 H300 H373 ** H400 |
|
|
|
612-113-00-8 |
6-methyl-2,4-bis(methylthio)fenyleen-1,3-diamine |
403-240-8 |
106264-79-3 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
|
612-114-00-3 |
R,R-2-hydroxy-5-(1-hydroxy-2-(4-fenylbut-2-ylamino)ethyl)benzamidehydrogeen-2,3-bis(benzoyloxy)succinaat |
404-390-7 |
— |
Flam. Sol. 1 Skin Sens. 1 Aquatic Chronic 3 |
H228 H317 H412 |
GHS02 GHS07 Wng |
H228 H317 H412 |
|
|
|
612-115-00-9 |
dimethyldioctadecylammoniumhydrogeensulfaat |
404-050-8 |
123312-54-9 |
Eye Irrit. 2 Aquatic Chronic 4 |
H319 H413 |
GHS07 Wng |
H319 H413 |
|
|
|
612-116-00-4 |
C8-18-alkylbis(2-hydroxyethyl)ammoniumbis(2-ethylhexyl)fosfaat |
404-690-8 |
68132-19-4 |
Acute Tox. 3 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H331 H314 H317 H400 H410 |
GHS06 GHS05 GHS09 Dgr |
H331 H314 H317 H410 |
|
|
|
612-117-00-X |
C12-14-tert-alkylamine, methylfosfonzuurzout |
404-750-3 |
119415-07-5 |
Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 2 |
H302 H314 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H314 H411 |
|
|
|
612-118-00-5 |
een reactiemassa van: (1,3-dioxo-2H-benzo[de]isochinoline-2-ylpropyl)hexadecyldimethylammonium-4-tolueensulfonaat; (1,3-dioxo-2H-benzo[de]isochinoline-2-ylpropyl)hexadecyldimethylammoniumbromide |
405-080-4 |
— |
Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Dgr |
H318 H410 |
|
|
|
612-119-00-0 |
benzyldimethyloctadecylammonium-3-nitrobenzeensulfonaat |
405-330-2 |
— |
Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H400 H410 |
GHS05 GHS09 Dgr |
H315 H318 H410 |
|
|
|
612-120-00-6 |
aclonifen (ISO); 2-chloor-6-nitro-3-fenoxyaniline |
277-704-1 |
74070-46-5 |
Carc. 2 Skin Sens. 1A Aquatic Acute 1 Aquatic Chronic 1 |
H351 H317 H400 H410 |
GHS08 GHS07 GH09 Wng |
H351 H317 H410 |
|
M = 100 M = 10 |
|
612-121-00-1 |
aminen, polyethyleenpoly-; HEPA |
268-626-9 |
68131-73-7 |
Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H314 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H312 H302 H314 H317 H410 |
|
|
|
612-122-00-7 |
hydroxylamine … % [> 55 % in waterige oplossing] |
232-259-2 |
7803-49-8 |
Unst. Expl. Met. Corr. 1 Carc. 2 Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 |
H200 H290 H351 H312 H302 H373** H335 H315 H318 H317 H400 |
GHS01 GHS05 GHS08 GHS07 GHS09 Dgr |
H200 H290 H351 H312 H302 H373** H335 H315 H318 H317 H400 |
|
|
B |
612-122-01-4 |
hydroxylamine … % [≤ 55 % in waterige oplossing] |
232-259-2 |
7803-49-8 |
Met. Corr. 1 Carc. 2 Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 |
H290 H351 H312 H302 H373** H335 H315 H318 H317 H400 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H290 H351 H312 H302 H373** H335 H315 H318 H317 H400 |
|
|
B |
612-123-00-2 |
hydroxylammoniumchloride; hydroxylaminehydrochloride; [1] bis(hydroxylammonium)sulfaat; hydroxylaminesulfaat (2:1) [2] |
226-798-2 [1] 233-118-8 [2] |
5470-11-1 [1] 10039-54-0 [2] |
Met. Corr. 1 Carc. 2 Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 |
H290 H351 H312 H302 H373** H319 H315 H317 H400 |
GHS05 GHS08 GHS07 GHS09 Wng |
H290 H351 H312 H302 H373** H319 H315 H317 H400 |
|
|
|
612-124-00-8 |
N,N,N-trimethylaniliniumchloride |
205-319-0 |
138-24-9 |
Acute Tox. 3 * Acute Tox. 3 * |
H311 H301 |
GHS06 Dgr |
H311 H301 |
|
|
|
612-125-00-3 |
2-methyl-p-fenyleendiamine; 2,5-tolueendiamine |
202-442-1 |
95-70-5 |
Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H301 H332 H312 H317 H411 |
GHS06 GHS09 Dgr |
H301 H332 H312 H317 H411 |
|
|
|
612-126-00-9 |
tolueen-2,4-diammoniumsulfaat; 4-methyl-m-fenyleendiaminesulfaat |
265-697-8 |
65321-67-7 |
Carc. 1B Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H350 H301 H312 H319 H317 H411 |
GHS06 GHS08 GHS09 Dgr |
H350 H301 H312 H319 H317 H411 |
|
|
|
612-127-00-4 |
3-aminofenol |
209-711-2 |
591-27-5 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 2 |
H332 H302 H411 |
GHS07 GHS09 Wng |
H332 H302 H411 |
|
|
|
612-128-00-X |
4-aminofenol |
204-616-2 |
123-30-8 |
Muta. 2 Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H341 H332 H302 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H341 H332 H302 H410 |
|
|
|
612-129-00-5 |
diisopropylamine |
203-558-5 |
108-18-9 |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H225 H332 H302 H314 |
GHS02 GHS05 GHS07 Dgr |
H225 H332 H302 H314 |
|
STOT SE 3; H335: C ≥ 5 % |
|
612-130-00-0 |
2,6-diamino-3,5-diëthyltolueen; 4,6-diëthyl-2-methyl-1,3-benzeendiamine; [1] 2,4-diamino-3,5-diëthyltolueen; 2,4-diëthyl-6-methyl-1,3-benzeendiamine; [2] diëthylmethylbenzeendiamine [3] |
218-255-3 [1] 218-256-9 [2] 270-877-4 [3] |
2095-01-4 [1] 2095-02-5 [2] 68479-98-1 [3] |
Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H373 ** H319 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H312 H302 H373 ** H319 H410 |
|
|
C |
612-131-00-6 |
didecyldimethylammoniumchloride |
230-525-2 |
7173-51-5 |
Acute Tox. 4 * Skin Corr. 1B |
H302 H314 |
GHS05 GHS07 Dgr |
H302 H314 |
|
|
|
612-132-00-1 |
N,N'-difenyl-p-fenyleendiamine; N, N'-difenyl-1,4-benzeendiamine |
200-806-4 |
74-31-7 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
612-133-00-7 |
(4-ammonio-m-tolyl)ethyl(2-hydroxyethyl)ammoniumsulfaat; 4-(N-ethyl-N-2-hydroxyethyl)-2-methylfenyleendiaminesulfaat |
247-162-0 |
25646-77-9 |
Acute Tox. 3 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H373 ** H317 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H301 H373 ** H317 H410 |
|
|
|
612-134-00-2 |
N-(2-(4-amino-N-ethyl-m-toluïdino)ethyl)methaansulfonamidesesquisulfaat; 4-(N-ethyl-N-2-methaansulfonylaminoëthyl)-2-methylfenyleendiamine-sesquisulfaat-monohydraat |
247-161-5 |
25646-71-3 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
|
612-135-00-8 |
N-2-naftylaniline; N-fenyl-2-naftylamine |
205-223-9 |
135-88-6 |
Carc. 2 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H351 H319 H315 H317 H411 |
GHS08 GHS07 GHS09 Wng |
H351 H319 H315 H317 H411 |
|
|
|
612-136-00-3 |
N'-fenyl-N-isopropyl-p-fenyleendiamine |
202-969-7 |
101-72-4 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
Skin Sens. 1; H317:C ≥0,1 % |
|
612-137-00-9 |
4-chlooraniline |
203-401-0 |
106-47-8 |
Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H331 H311 H301 H317 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350 H331 H311 H301 H317 H410 |
|
|
|
612-138-00-4 |
furalaxyl (ISO); methyl-N-(2,6-dimethylfenyl)-N-(2-furylcarbonyl)-DL-alaninaat |
260-875-1 |
57646-30-7 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
612-139-00-X |
mefenacet (ISO); 2-(benzothiazool-2-yloxy)-N-methyl-N-fenylacetamide |
277-328-8 |
73250-68-7 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
612-140-00-5 |
quaternaire ammoniumverbindingen, benzyl-C8-18-alkyldimethyl, chloriden |
264-151-6 |
63449-41-2 |
Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B Aquatic Acute 1 |
H312 H302 H314 H400 |
GHS05 GHS07 GHS09 Dgr |
H312 H302 H314 H400 |
|
|
|
612-141-00-0 |
4,4'-methyleenbis(2-ethylaniline); 4,4'-methyleenbis(2-ethylbenzeenamine) |
243-420-1 |
19900-65-3 |
Carc. 2 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H302 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H302 H410 |
|
|
|
612-142-00-6 |
bifenyl-2-ylamine |
201-990-9 |
90-41-5 |
Carc. 2 Acute Tox. 4 * Aquatic Chronic 3 |
H351 H302 H412 |
GHS08 GHS07 Wng |
H351 H302 H412 |
|
|
|
612-143-00-1 |
N 5,N 5-diëthyltolueen-2,5-diaminemonohydrochloride; 4-diëthylamino-2-methylanilinemonohydrochloride |
218-130-3 |
2051-79-8 |
Acute Tox. 3 * Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H319 H317 H400 H410 |
GHS06 GHS09 Dgr |
H301 H319 H317 H410 |
|
|
|
612-144-00-7 |
flumetralin (ISO); N-(2-chloor-6-fluorbenzyl)-N-ethyl-α, α,α-trifluor-2,6-dinitro-p-toluïdine |
— |
62924-70-3 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H319 H315 H317 H410 |
|
|
|
612-145-00-2 |
o-fenyleendiamine |
202-430-6 |
95-54-5 |
Carc. 2 Muta. 2 Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H341 H301 H332 H312 H319 H317 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H341 H301 H332 H312 H319 H317 H410 |
|
|
|
612-146-00-8 |
o-fenyleendiaminedihydrochloride |
210-418-7 |
615-28-1 |
Carc. 2 Muta. 2 Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H341 H301 H332 H312 H319 H317 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H351 H341 H301 H332 H312 H319 H317 H410 |
|
|
|
612-147-00-3 |
m-fenyleendiamine |
203-584-7 |
108-45-2 |
Muta. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H341 H331 H311 H301 H319 H317 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H341 H331 H311 H301 H319 H317 H410 |
|
|
|
612-148-00-9 |
m-fenyleendiaminedihydrochloride |
208-790-0 |
541-69-5 |
Muta. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H341 H331 H311 H301 H319 H317 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H341 H331 H311 H301 H319 H317 H410 |
|
|
|
612-149-00-4 |
1,3-difenylguanidine |
203-002-1 |
102-06-7 |
Repr. 2 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 2 |
H361f *** H302 H319 H335 H315 H411 |
GHS08 GHS07 GHS09 Wng |
H361f *** H302 H319 H335 H315 H411 |
|
|
|
612-151-00-5 |
methylfenyleendiamine; diaminotolueen; [technisch product — reactiemassa van 4-methyl-m-fenyleendiamine (EG-nr. 202-453-1) en 2-methyl-m-fenyleendiamine (EG-nr. 212-513-9)] |
— |
— |
Carc. 1B Muta. 2 Repr. 2 Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H350 H341 H361f*** H301 H312 H373** H319 H317 H411 |
GHS06 GHS08 GHS09 Dgr |
H350 H341 H361f*** H301 H312 H373** H319 H317 H411 |
|
|
|
612-152-00-0 |
N,N-diëthyl-N',N'-dimethylpropaan-1,3-diyl-diamine |
406-610-7 |
62478-82-4 |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Corr. 1A Aquatic Chronic 3 |
H226 H332 H302 H373 ** H314 H412 |
GHS02 GHS08 GHS05 GHS07 Dgr |
H226 H332 H302 H373 ** H314 H412 |
|
|
|
612-153-00-6 |
4-[N-ethyl-N-(2-hydroxyethyl)amino]-1-(2-hydroxyethyl)amino-2-nitrobenzeenmonohydrochloride |
407-020-2 |
132885-85-9 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 3 |
H302 H317 H412 |
GHS07 Wng |
H302 H317 H412 |
|
|
|
612-154-00-1 |
6'-(isobutylethylamino)-3'-methyl-2'-fenylamino-spiro[isobenzo-2-oxofuran-7,9'-[9H]-xantheen] |
410-890-6 |
95235-29-3 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
612-155-00-7 |
2'-anilino-6'-((3-ethoxypropyl)ethylamino)-3'-methylspiro(isobenzo-3-oxofuran)-1-(1H)-9'-xantheen |
411-730-8 |
93071-94-4 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
612-156-00-2 |
reactiemassa van: trihexadecylmethylammoniumchloride; dihexadecyldimethylammoniumchloride |
405-620-9 |
— |
Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Dgr |
H318 H410 |
|
|
|
612-157-00-8 |
(Z)-1-benzo[b]thieen-2-ylethanonoxim-hydrochloride |
410-780-8 |
— |
Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H302 H373 ** H318 H317 H411 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H302 H373 ** H318 H317 H411 |
|
|
|
612-158-00-3 |
reactiemassa van: bis(5-dodecyl-2-hydroxybenzald-oximaat)-koper(II); de C12-alkylgroep is vertakt; 4-dodecylsalicylaldoxim |
410-820-4 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
612-159-00-9 |
reactieproducten van: trimethylhexamethyleendiamine (een mengsel van 2,2,4-trimethyl-1,6-hexaandiamine en 2,4,4-trimethyl-1,6-hexaandiamine, in Einecs-lijst), Epoxide 8 (mono[(C10-C16-alkyloxy)methyl]oxiraanderivaten) en p-tolueensulfonzuur |
410-880-1 |
— |
Acute Tox. 4 * Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H302 H314 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H302 H314 H410 |
|
|
|
612-160-00-4 |
p-toluïdine; 4-aminotolueen; [1] toluidiniumchloride; [2] toluïdinesulfaat (1:1) [3] |
203-403-1 [1] 208-740-8 [2] 208-741-3 [3] |
106-49-0 [1] 540-23-8 [2] 540-25-0 [3] |
Carc. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 |
H351 H331 H311 H301 H319 H317 H400 |
GHS06 GHS08 GHS09 Dgr |
H351 H331 H311 H301 H319 H317 H400 |
|
|
|
612-161-00-X |
2,6-xylidine; 2,6-dimethylaniline |
201-758-7 |
87-62-7 |
Carc. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Aquatic Chronic 2 |
H351 H332 H312 H302 H335 H315 H411 |
GHS08 GHS07 GHS09 Wng |
H351 H332 H312 H302 H335 H315 H411 |
|
|
|
612-162-00-5 |
dimethyldioctadecylammoniumchloride; DODMAC |
203-508-2 |
107-64-2 |
Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Dgr |
H318 H410 |
|
|
|
612-163-00-0 |
metalaxyl-M (ISO); mefenoxam; (R)-2-[(2,6-dimethylfenyl)-methoxyacetylamino]propionzuur-methylester |
— |
70630-17-0 |
Acute Tox. 4 * Eye Dam. 1 |
H302 H318 |
GHS05 GHS07 Dgr |
H302 H318 |
|
|
|
612-164-00-6 |
2-butyl-2-ethyl-1,5-diaminopentaan |
412-700-7 |
137605-95-9 |
Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 3 |
H312 H302 H373 ** H314 H317 H412 |
GHS08 GHS05 GHS07 Dgr |
H312 H302 H373 ** H314 H317 H412 |
|
|
|
612-165-00-1 |
N,N'-difenyl-N,N'-bis(3-methylfenyl)-(1,1'-difenyl)-4,4'-diamine |
413-810-8 |
65181-78-4 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
612-166-00-7 |
reactiemassa van: cis-(5-ammonium-1,3,3-trimethyl)-cyclohexaanmethylammonium-fosfaat (1:1); trans-(5-ammonium-1,3,3-trimethyl)-cyclohexaanmethylammonium-fosfaat (1:1) |
411-830-1 |
114765-88-7 |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Dgr |
H318 H317 H412 |
|
|
|
612-167-00-2 |
5-acetyl-3-amino-10,11-dihydro-5H-dibenzo[b,f]azepine-hydrochloride |
410-490-1 |
— |
Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H302 H373 ** H318 H317 H411 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H302 H373 ** H318 H317 H411 |
|
|
|
612-168-00-8 |
3,5-dichloor-2,6-difluorpyridine-4-amine |
220-630-1 |
2840-00-8 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 2 |
H312 H302 H411 |
GHS07 GHS09 Wng |
H312 H302 H411 |
|
|
|
612-169-00-3 |
bis(N-methyl-N-fenylhydrazine)sulfaat |
423-170-1 |
618-26-8 |
Flam. Liq. 2 STOT RE 1 Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H225 H372** H302 H318 H317 H400 H410 |
GHS02 GHS05 GHS08 GHS07 GHS09 Dgr |
H225 H372** H302 H318 H317 H410 |
|
|
|
612-170-00-9 |
4-chloorfenylcyclopropylketon-O-(4-aminobenzyl)oxim |
405-260-2 |
— |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
|
612-171-00-4 |
N,N,N',N'-tetraglycidyl-4,4'-diamino-3,3'-diëthyldifenylmethaan |
410-060-3 |
130728-76-6 |
Muta. 2 Skin Sens. 1 Aquatic Chronic 2 |
H341 H317 H411 |
GHS08 GHS09 Wng |
H341 H317 H411 |
|
|
|
612-172-00-X |
4,4'-methyleenbis(N,N'-dimethyl-cyclohexaanamine) |
412-840-9 |
13474-64-1 |
Acute Tox. 4 * STOT RE 2 * Skin Corr. 1A Aquatic Chronic 3 |
H302 H373 ** H314 H412 |
GHS08 GHS05 GHS07 Dgr |
H302 H373 ** H314 H412 |
|
|
|
612-173-00-5 |
lithium-1-amino-4-(4-tert-butylanilino)-antrachinon-2-sulfonaat |
411-140-0 |
125328-86-1 |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H318 H317 H411 |
|
|
|
612-174-00-0 |
4,4-dimethoxybutylamine |
407-690-6 |
19060-15-2 |
Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 3 |
H302 H314 H317 H412 |
GHS05 GHS07 Dgr |
H302 H314 H317 H412 |
|
|
|
612-175-00-6 |
2-(O-aminoöxy)ethylaminedihydrochloride |
412-310-7 |
37866-45-8 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
612-176-00-1 |
polymeer van 1,3-dibroompropaan en N,N-diëthyl-N',N'-dimethyl-1,3-propaandiamine |
410-570-6 |
143747-73-3 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
612-177-00-7 |
2-naftylamino-6-sulfomethylamide |
412-120-4 |
104295-55-8 |
STOT RE 2 * Skin Sens. 1 Aquatic Chronic 2 |
H373 ** H317 H411 |
GHS08 GHS09 Wng |
H373 ** H317 H411 |
|
|
|
612-178-00-2 |
1,4,7,10-tetraäzacyclododecaandisulfaat |
412-080-8 |
112193-77-8 |
Acute Tox. 4 * STOT SE 3 Eye Dam. 1 Aquatic Chronic 3 |
H302 H335 H318 H412 |
GHS05 GHS07 Dgr |
H302 H335 H318 H412 |
|
|
|
612-179-00-8 |
1-(2-propenyl)pyridiniumchloride |
412-740-5 |
25965-81-5 |
Acute Tox. 4 * Skin Sens. 1 |
H302 H317 |
GHS07 Wng |
H302 H317 |
|
|
|
612-180-00-3 |
3-aminobenzylamine |
412-230-2 |
4403-70-7 |
Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 2 |
H302 H314 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H314 H411 |
|
|
|
612-181-00-9 |
2-fenylthioaniline |
413-030-8 |
1134-94-7 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
612-182-00-4 |
1-ethyl-1-methylmorfoliniumbromide |
418-210-1 |
65756-41-4 |
Muta. 2 |
H341 |
GHS08 Wng |
H341 |
|
|
|
612-183-00-X |
1-ethyl-1-methylpyrrolidiniumbromide |
418-200-5 |
69227-51-6 |
Muta. 2 |
H341 |
GHS08 Wng |
H341 |
|
|
|
612-184-00-5 |
6'-(dibutylamino)-3'-methyl-2'-(fenylamino)spiro[isobenzofuraan-1(3H),9-(9H)-xantheen]-3-on |
403-830-5 |
89331-94-2 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
612-185-00-0 |
1-[3-[4-((heptadecafluornonyl)oxy)-benzamido]propyl]-N,N,N-trimethylammoniumjodide |
407-400-8 |
59493-72-0 |
Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Dgr |
H318 H410 |
|
|
|
612-186-00-6 |
bis(N-(7-hydroxy-8-methyl-5-fenylfenazine-3-ylideen)dimethylammonium)sulfaat |
406-770-8 |
149057-64-7 |
STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H373 ** H318 H317 H400 H410 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H373 ** H318 H317 H410 |
|
|
|
612-187-00-1 |
2,3,4-trifluoraniline |
407-170-9 |
3862-73-5 |
Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 2 |
H312 H302 H373 ** H315 H318 H411 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H312 H302 H373 ** H315 H318 H411 |
|
|
|
612-188-00-7 |
4,4'-(9H-fluoreen-9-ylideen)bis(2-chlooraniline) |
407-560-9 |
107934-68-9 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
612-189-00-2 |
4-amino-2-(aminomethyl)fenoldihydrochloride |
412-510-4 |
135043-64-0 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
|
612-190-00-8 |
4,4'-methyleenbis(2-isopropyl-6-methylaniline) |
415-150-6 |
16298-38-7 |
STOT RE 2 * Aquatic Chronic 2 |
H373 ** H411 |
GHS08 GHS09 Wng |
H373 ** H411 |
|
|
|
612-191-00-3 |
polymeer van allylaminehydrochloride |
415-050-2 |
71550-12-4 |
Acute Tox. 4 * Skin Sens. 1 |
H302 H317 |
GHS07 Wng |
H302 H317 |
|
|
|
612-192-00-9 |
2-isopropyl-4-(N-methyl)aminomethylthiazool |
414-800-6 |
154212-60-9 |
Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 2 |
H312 H302 H315 H318 H411 |
GHS05 GHS07 GHS09 Dgr |
H312 H302 H315 H318 H411 |
|
|
|
612-193-00-4 |
3-methylaminomethylfenylamine |
414-570-7 |
18759-96-1 |
Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H314 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H312 H302 H314 H317 H410 |
|
|
|
612-194-00-X |
2-hydroxy-3-[(2-hydroxyethyl)-[2-(1-oxotetradecyl)amino]ethyl]amino]-N,N,N-trimethyl-1-propaanammoniumchloride |
414-670-0 |
141890-30-4 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H318 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H410 |
|
|
|
612-195-00-5 |
bis[tributyl(4-methylbenzyl)ammonium]-1,5-naftaleendisulfonaat |
415-210-1 |
160236-81-7 |
Acute Tox. 4 * Acute Tox. 4 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H332 H302 H318 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H332 H302 H318 H410 |
|
|
|
612-196-00-0 |
4-chloor-o-toluïdine; [1] 4-chloor-o-toluïdinehydrochloride [2] |
202-441-6[1] 221-627-8[2] |
95-69-2[1] 3165-93-3[2] |
Carc. 1B Muta. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H350 H341 H331 H311 H301 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H350 H341 H331 H311 H301 H410 |
|
|
|
612-197-00-6 |
2,4,5-trimethylaniline; [1] 2,4,5-trimethylanilinehydrochloride [2] |
205-282-0[1]-[2] |
137-17-7 [1] 21436-97-5[2] |
Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Chronic 2 |
H350 H331 H311 H301 H411 |
GHS06 GHS08 GHS09 Dgr |
H350 H331 H311 H301 H411 |
|
|
|
612-198-00-1 |
4,4'-thiodianiline [1] en zijn zouten |
205-370-9 |
139-65-1 |
Carc. 1B Acute Tox. 4 * Aquatic Chronic 2 |
H350 H302 H411 |
GHS08 GHS07 GHS09 Dgr |
H350 H302 H411 |
|
|
|
612-199-00-7 |
4,4'-oxydianiline [1] en zijn zouten; p-aminofenylether |
202-977-0 |
101-80-4 |
Carc. 1B Muta. 1B Repr. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Chronic 2 |
H350 H340 H361f *** H331 H311 H301 H411 |
GHS06 GHS08 GHS09 Dgr |
H350 H340 H361f *** H331 H311 H301 H411 |
|
|
|
612-200-00-0 |
2,4-diaminoanisool; 4-methoxy-m-fenyleendiamine; [1] 2,4-diaminoanisoolsulfaat [2] |
210-406-1 [1] 254-323-9 [2] |
615-05-4 [1] 39156-41-7 [2] |
Carc. 1B Muta. 2 Acute Tox. 4 * Aquatic Chronic 2 |
H350 H341 H302 H411 |
GHS08 GHS07 GHS09 Dgr |
H350 H341 H302 H411 |
|
|
|
612-201-00-6 |
N,N,N',N'-tetramethyl-4,4'-methyleendianiline |
202-959-2 |
101-61-1 |
Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H350 H400 H410 |
GHS08 GHS09 Dgr |
H350 H410 |
|
|
|
612-202-00-1 |
3,4-dichlooraniline |
202-448-4 |
95-76-1 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H318 H317 H400 H410 |
GHS06 GHS05 GHS09 Dgr |
H331 H311 H301 H318 H317 H410 |
|
|
|
612-203-00-7 |
C8-10-alkyldimethylhydroxyethylammoniumchloride (keten < C8: < 3 %, keten = C8: 15 % - 70 %, keten = C10: 30 % - 85 %, keten > C10: < 3 %) |
417-360-3 |
— |
Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 |
H312 H302 H315 |
GHS07 Wng |
H312 H302 H315 |
|
|
|
612-204-00-2 |
C.I. Basic Violet 3; 4-[4,4'-bis(dimethylamino)benzhydrylideen]cyclohexa-2,5-dieen-1-ylideen]dimethylammoniumchloride |
208-953-6 |
548-62-9 |
Carc. 2 Acute Tox. 4 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H302 H318 H400 H410 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H351 H302 H318 H410 |
|
|
|
612-205-00-8 |
C.I. Basic Violet 3 met ≥ 0,1 % Michler's keton (EG-nr. 202-027-5) |
208-953-6 |
548-62-9 |
Carc. 1B Acute Tox. 4 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H302 H318 H400 H410 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H350 H302 H318 H410 |
|
|
|
612-206-00-3 |
famoxadone (ISO); 3-aniline-5-methyl-5-(4-fenoxyfenyl)-1,3-oxazolidine-2,4-dion |
— |
131807-57-3 |
STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H373 ** H400 H410 |
GHS08 GHS09 Wng |
H373 ** H410 |
|
|
|
612-207-00-9 |
4-ethoxyaniline; p-fenetidine |
205-855-5 |
156-43-4 |
Muta. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 |
H341 H332 H312 H302 H319 H317 |
GHS08 GHS07 Wng |
H341 H332 H312 H302 H319 H317 |
|
|
|
612-208-00-4 |
N-methylbenzeen-1,2-diammonium-hydrogeen-fosfaat |
424-460-0 |
— |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H302 H317 H411 |
GHS07 GHS09 Wng |
H302 H317 H411 |
|
|
|
612-209-00-X |
6-methoxy-m-toluïdine; p-cresidine |
204-419-1 |
120-71-8 |
Carc. 1B Acute Tox. 4 * |
H350 H302 |
GHS08 GHS07 Dgr |
H350 H302 |
|
|
|
612-210-00-5 |
5-nitro-o-toluïdine; [1] 5-nitro-o-toluïdinehydrochloride [2] |
202-765-8 [1] 256-960-8 [2] |
99-55-8 [1] 51085-52-0 [2] |
Carc. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Chronic 3 |
H351 H331 H311 H301 H412 |
GHS06 GHS08 Dgr |
H351 H331 H311 H301 H412 |
|
|
|
612-211-00-0 |
N-[(benzotriazool-1-yl)methyl)]4-carboxy-benzeensulfonamide |
416-470-9 |
170292-97-4 |
Eye Irrit. 2 Aquatic Chronic 2 |
H319 H411 |
GHS07 GHS09 Wng |
H319 H411 |
|
|
|
612-212-00-6 |
2,6-dichloor-4-trifluormethylaniline |
416-430-0 |
24279-39-8 |
Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H332 H302 H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H332 H302 H315 H317 H410 |
|
|
|
612-213-00-1 |
isobutylideen-(2-(2-isopropyl-4,4-dimethyloxazolidine-3-yl)-1,1-dimethylethyl)amine |
419-850-2 |
148348-13-4 |
Skin Corr. 1B Aquatic Chronic 3 |
H314 H412 |
GHS05 Dgr |
H314 H412 |
|
|
|
612-214-00-7 |
4-(2,2-difenylethenyl)-N,N-difenylbenzeenamine |
421-390-2 |
89114-90-9 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
612-215-00-2 |
3-chloor-2-(isopropylthio)aniline |
421-700-6 |
179104-32-6 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
612-216-00-8 |
1-amino-1-cyaanamino-2,2-dicyaanethyleen, natriumzout |
425-870-2 |
19450-38-5 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
612-217-00-3 |
1-methoxy-2-propylamine |
422-550-4 |
37143-54-7 |
Flam. Liq. 2 Skin Corr. 1B Acute Tox. 4 * Aquatic Chronic 3 |
H225 H314 H302 H412 |
GHS02 GHS05 GHS07 Dgr |
H225 H314 H302 H412 |
|
|
|
612-219-00-4 |
(2-hydroxy-3-(3,4-dimethyl-9-oxo-10-thiaantraceen-2-yloxy)propyl)trimethylammoniumchloride |
402-200-7 |
— |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
612-220-00-X |
N-nitro-N-(3-methyl-3,6-dihydro-2H-1,3,5-oxadiazine-4-yl)amine |
431-060-1 |
153719-38-1 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 3 |
H302 H317 H412 |
GHS07 Wng |
H302 H317 H412 |
|
|
|
612-221-00-5 |
2-amino-4-(trifluormethyl)benzeenthiolhydrochloride |
429-560-8 |
4274-38-8 |
Skin Corr. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 |
H314 H332 H312 H302 H373** H317 H400 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H314 H332 H312 H302 H373** H317 H400 |
|
|
|
612-222-00-0 |
cis-1-(3-(4-fluorfenoxy)propyl)-3-methoxy-4-piperidinamine |
425-080-8 |
104860-26-6 |
Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H373** H318 H400 H410 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H312 H302 H373** H318 H410 |
|
|
|
612-223-00-6 |
N-benzyl-N-ethyl-(4-(5-nitrobenzo[c]isothiazool-3-ylazo)fenyl)amine |
425-300-2 |
186450-73-7 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
612-224-00-1 |
N 2,N 4,N 6-tris{4-[(1,4-dimethylpentyl)amino]fenyl}-1,3,5-triazine-2,4,6-triamine |
426-150-0 |
121246-28-4 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
612-225-00-7 |
1,4,7,10-tetraäzacyclododecaan |
425-450-9 |
294-90-6 |
Skin Corr. 1B Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H314 H312 H302 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H314 H312 H302 H410 |
|
|
|
612-226-00-2 |
3-(2'-fenoxyethoxy)propylamine |
427-870-8 |
6903-18-0 |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H302 H315 H318 H412 |
GHS05 GHS07 Dgr |
H302 H315 H318 H412 |
|
|
|
612-227-00-8 |
benzyl-N-(2-(2-methoxyfenoxy)ethyl)aminehydrochloride |
428-290-8 |
120606-08-8 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H318 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H410 |
|
|
|
612-228-00-3 |
reactiemassa van: N-benzyl-N-(3-trimethoxysilyl)propyl)ethyleendiamine; N-benzyl-N-(3-trimethoxysilyl)propyl)ethyleendiamine; N-benzyl-N'-[3-(trimethoxysilyl)propyl]ethyleendiamine; N,N'-bis-benzyl-N'-[3-(trimethoxysilyl)propyl]ethyleendiamine; N,N,N'-tris-benzyl-N'-[3-(trimethoxysilyl)propyl]ethyleendiamine; N,N-bis-benzyl-N'-[3-(trimethoxysilyl)propyl]ethyleendiamine |
414-340-6 |
— |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT SE 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H226 H332 H312 H302 H371 H318 H317 H412 |
GHS02 GHS05 GHS08 GHS07 Dgr |
H226 H332 H312 H302 H371 H318 H317 H412 |
|
|
|
612-229-00-9 |
mepanipyrim; 4-methyl-N-fenyl-6-(1-propynyl)-2-pyrimidinamine |
— |
110235-47-7 |
Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H400 H410 |
GHS08 GHS09 Wng |
H351 H410 |
|
|
|
612-230-00-4 |
N,N-bis(cocoyl-2-oxypropyl)-N,N-dibutylammoniumbromide |
431-530-4 |
— |
Skin Corr. 1A Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H314 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H314 H317 H410 |
|
|
|
612-231-00-X |
3-((C12-18)-acylamino)-N-(2-((2-hydroxyethyl)amino)-2-oxoëthyl)-N,N-dimethyl-1-propaanaminiumchloride |
427-370-1 |
164288-56-6 |
Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Dgr |
H318 H410 |
|
|
|
612-232-00-5 |
reactiemassa van: triisopropanolaminezout van 1-amino-4-(3-propionamidoanilino)antrachinon-2-sulfonzuur; triisopropanolaminezout van 1-amino-4-[3,4-dimethyl-5-(2-hydroxyethylaminosulfonyl)anilino]antrachinon-2-sulfonzuur |
430-410-9 |
186148-38-9 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
612-237-00-2 |
hydroxylammoniumwaterstofsulfaat; hydroxylaminesulfaat (1:1); [1] hydroxylaminefosfaat; [2] hydroxylaminediwaterstoffos- faat; [3] hydroxylamine-4-methylbenzeensulfonaat [4] |
233-154-4 [1] 244-077-0 [2] 242-818-2 [3] 258-872-5 [4] |
10046-00-1 [1] 20845-01-6 [2] 19098-16-9 [3] 53933-48-5 [4] |
Expl. 1.1 Carc. 2 Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 |
H201 H351 H312 H302 H373** H319 H315 H317 H400 |
GHS01 GHS08 GHS07 GHS09 Dgr |
H201 H351 H312 H302 H373** H319 H315 H317 H400 |
|
|
T |
612-238-00-8 |
(3-chloor-2-hydroxypropyl)trimethylammoniumchloride … % |
222-048-3 |
3327-22-8 |
Carc. 2 Aquatic Chronic 3 |
H351 H412 |
GHS08 Wng |
H351 H412 |
|
|
B |
612-239-00-3 |
bifenyl-3,3',4,4'-tetrayltetraämine; diaminobenzidine |
202-110-6 |
91-95-2 |
Carc. 1B Muta. 2 |
H350 H341 |
GHS08 Dgr |
H350 H341 |
|
|
|
612-240-00-9 |
pyrimethanil (ISO); N-(4,6-dimethylpyrimidine-2-yl)aniline |
— |
53112-28-0 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
612-241-00-4 |
piperazinehydrochloride; [1] piperazinedihydrochloride; [2] piperazinefosfaat [3] |
228-042-7 [1] 205-551-2 [2] 217-775-8 [3] |
6094-40-2 [1] 142-64-3 [2] 1951-97-9 [3] |
Repr. 2 Eye Irrit. 2 Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 3 |
H361fd H319 H315 H334 H317 H412 |
GHS08 Dgr |
H361fd H319 H315 H334 H317 H412 |
|
|
|
612-242-00-X |
cyprodinil (ISO); 4-cyclopropyl-6-methyl-N-fenylpyrimidine-2-amine |
— |
121552-61-2 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
M=10 |
|
612-243-00-5 |
(1S-cis)-4-(3,4-dichloorfenyl)-1,2,3,4-tetrahydro-N-methyl-1-naftaleenamine-2-hydroxy-2-fenylacetaat |
420-560-3 |
79617-97-3 |
Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Dgr |
H318 H410 |
|
M=10 |
|
612-244-00-0 |
3-(piperazine-1-yl)-benzo[d]isothiazoolhydrochloride |
421-310-6 |
87691-88-1 |
Repr. 2 Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361f*** H302 H319 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H361f*** H302 H319 H317 H410 |
|
|
|
612-245-00-6 |
2-ethylfenylhydrazinehydrochloride |
421-460-2 |
19398-06-2 |
Carc. 2 STOT RE 1 Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H372** H302 H318 H317 H400 H410 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H351 H372** H302 H318 H317 H410 |
|
M=10 |
|
612-246-00-1 |
(2-chloorethyl)(3-hydroxypropyl)ammoniumchloride |
429-740-6 |
40722-80-3 |
Carc. 1B Muta. 1B STOT RE 2 * Skin Sens. 1 Aquatic Chronic 3 |
H350 H340 H373** H317 H412 |
GHS08 GHS07 Dgr |
H350 H340 H373** H317 H412 |
|
|
|
612-247-00-7 |
N-[3-(1,1-dimethylethyl)-1H-pyrazool-5-yl]-N'-hydroxy-4-nitrobenzeencarboximidamide |
423-530-8 |
152828-23-4 |
STOT RE 1 Acute Tox. 4 * Aquatic Chronic 3 |
H372** H302 H412 |
GHS08 GHS07 Dgr |
H372** H302 H412 |
|
|
|
612-248-00-2 |
reactieproduct van difenylamine, fenothiazine en alkenen, vertakt (C8-10, C9-rijk) |
439-540-0 |
— |
Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 4 |
H315 H317 H413 |
GHS07 Wng |
H315 H317 H413 |
|
|
|
612-249-00-8 |
4-[(3-chloorfenyl)(1H-imidazool-1-yl)methyl]-1,2-benzeendiaminedihydrochloride |
425-030-5 |
159939-85-2 |
Repr. 2 Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 |
H361f*** H302 H314 H317 H411 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H361f*** H302 H314 H317 H411 |
|
|
|
612-250-00-3 |
chloor-N,N-dimethylformiminiumchloride |
425-970-6 |
3724-43-4 |
Repr. 1B Acute Tox. 4 * Skin Corr. 1A |
H360D*** H302 H314 |
GHS05 GHS08 GHS07 Dgr |
H360D*** H302 H314 |
EUH014 |
|
|
612-251-00-9 |
cis-1-(3-chloorallyl)-3,5,7-triaza-1-azoniaädamantaanchloride |
426-020-3 |
51229-78-8 |
Flam. Sol. 2 Repr. 2 Acute Tox. 4 * Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H228 H361d*** H302 H315 H317 H411 |
GHS02 GHS08 GHS07 GHS09 Wng |
H228 H361d*** H302 H315 H317 H411 |
|
|
|
612-252-00-4 |
imidacloprid (ISO); 1-(6-chloorpyridine-3-ylmethyl)-N-nitroïmidazolidine-2-ylideenamine |
428-040-8 |
138261-41-3 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
612-253-00-X |
7-methoxy-6-(3-morfoline-4-ylpropoxy)-3H-chinazoline-4-on; [met < 0,5 % formamide (EG-nr. 200-842-0)] |
429-400-7 |
199327-61-2 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
612-253-01-7 |
7-methoxy-6-(3-morfoline-4-ylpropoxy)-3H-chinazoline-4-on; [met ≥ 0,5 % formamide (EG-nr. 200-842-0)] |
429-400-7 |
199327-61-2 |
Repr. 1B Aquatic Chronic 3 |
H360D*** H412 |
GHS08 Dgr |
H360D*** H412 |
|
|
|
612-254-00-5 |
reactieproducten van diisopropanolamine met formaldehyde (1:4) |
432-440-8 |
220444-73-5 |
Carc. 2 Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 |
H351 H302 H314 H317 H411 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H351 H302 H314 H317 H411 |
|
|
|
612-255-00-0 |
1-(3-methoxypropyl)-4-piperidinamine |
431-950-8 |
179474-79-4 |
Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 3 |
H312 H302 H314 H412 |
GHS05 GHS07 Dgr |
H312 H302 H314 H412 |
|
|
|
612-256-00-6 |
benzyl-(S)-2-[(2'-cyanobifenyl-4-ylmethyl)pentanoylamino]-3-methylbutyraat |
427-470-3 |
137864-22-3 |
Acute Tox. 4 * Skin Sens. 1 |
H302 H317 |
GHS07 Wng |
H302 H317 |
|
|
|
612-257-00-1 |
tripropylammoniumdiwaterstoffosfaat |
433-700-3 |
35687-90-2 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
612-259-00-2 |
N-ethyl-3-trimethoxysilyl-2-methylpropaanamine |
437-720-3 |
227085-51-0 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
612-261-00-3 |
3,5-dichloor-2-fluor-4-(1,1,2,3,3,3-hexafluorpropoxy)aniline |
441-190-9 |
121451-05-6 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
M=10 |
|
612-265-00-5 |
bis(2-hydroxyethyl)(2-hydroxypropyl)ammoniumacetaat |
444-360-0 |
191617-13-7 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
612-266-00-0 |
3-chloor-4-(3-fluorbenzyloxy)aniline |
445-590-4 |
202197-26-0 |
Muta. 2 Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H341 H302 H373** H400 H410 |
GHS08 GHS07 GHS09 Wng |
H341 H302 H373** H410 |
|
|
|
612-267-00-6 |
bis(gehydrogeneerde talk C16-18-alkyl)hydroxylamine |
418-370-0 |
— |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
612-269-00-7 |
reactiemassa van: 1-[di(4-octylfenyl)aminomethyl]-5-methyl-1H-benzotriazool; 1-[di(4-octylfenyl)aminomethyl]-4-methyl-1H-benzotriazool; reactiemassa van: N-[(5-methyl-1H-benzotriazool-1-yl)methyl]-4-octyl-N-(4-octylfenyl)aniline; N-[(4-methyl-1H-benzotriazool-1yl)methyl]-4-octyl-N-(4-octylfenyl)aniline |
420-720-2 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
612-270-00-2 |
(S)-azetidine-2-carbonzuur 4-cyaanbenzylamidehydrochloride |
433-010-2 |
— |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 3 |
H302 H317 H412 |
GHS07 Wng |
H302 H317 H412 |
|
|
|
612-271-00-8 |
reactiemassa van: ethyl-2-((4-(5,6-dichloorbenzothiazool-2-ylazo)fenyl)ethylamino)benzoaat; ethyl-2-((4-(6,7-dichloorbenzothiazool-2-ylazo)fenyl)ethylamino)benzoaat |
434-970-5 |
160987-57-5 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
612-272-00-3 |
ammonium-(η-6-2-(2-(1,2-dicarboxylatoëthylamino)ethylamino)butaan-1,4-dioato(4))ijzer(3+)-monohydraat |
435-210-5 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
612-273-00-9 |
alkyl(koolzaadolie), bis(2-hydroxyethyl)ammoniumfluoride |
435-650-8 |
— |
Acute Tox. 4 * Skin Corr. 1A Aquatic Acute 1 Aquatic Chronic 1 |
H302 H314 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H302 H314 H410 |
|
|
|
612-274-00-4 |
(R,S)-1-[2-amino-1(4-methoxyfenyl)ethyl]cyclohexanolacetaat |
445-750-3 |
— |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H302 H318 H317 H412 |
GHS05 GHS07 Dgr |
H302 H318 H317 H412 |
|
|
|
612-275-00-X |
vetzuren, C18-onverzadigd, dimeren, reactieproducten met 1-piperazineëthanamine en tallolie |
447-880-6 |
206565-89-1 |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H315 H318 H317 H410 |
|
M=10 |
|
612-276-00-5 |
1-amino-4-[(4-amino-2-sulfofenyl)amino]-9,10-dihydro-9,10-dioxo-2-antraceensulfonzuur, dinatriumzout, reactieproducten met 2-[[3-[(4,6-dichloor-1,3,5-triazine-2-yl)ethylamino]fenyl]sulfonyl]ethyl-hydrogeen-sulfaat, natriumzouten |
451-430-4 |
500717-36-2 |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Dgr |
H318 H317 H412 |
|
|
|
612-277-00-0 |
reactiemassa van: 4-amino-3-(4-etheensulfonyl-2-sulfonatofenylazo)-5-hydroxy-6-(5-{4-chloor-6-[4-(2-sulfonatoöxyethaansulfonyl)fenylamino]-1,3,5-triazine-2-ylamino}-2-sulfonatofenylazo)naftaleen-2,7-disulfonaat kalium/natrium; 4-amino-5-hydroxy-6-(5-{4-chloor-6-[4-(2-sulfonatoöxyethaansulfonyl)fenylamino]1,3,5-triazine-2-ylamino}-2-sulfonatofenylazo)-3-(2-sulfonato-4-(2-sulfonatoöxyethaansulfonyl)fenylazo)naftaleen-2,7-disulfonaat kalium/natrium |
451-440-9 |
586372-44-3 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
612-278-00-6 |
ethidiumbromide; 3,8-diamino-1-ethyl-6-fenylfenantridiniumbromide |
214-984-6 |
1239-45-8 |
Muta. 2 Acute Tox. 2 * Acute Tox. 4 * |
H341 H330 H302 |
GHS06 GHS08 Dgr |
H341 H330 H302 |
|
|
|
612-279-00-1 |
(R, S)-2-amino-3,3-dimethylbutaanamide |
447-860-7 |
144177-62-8 |
Repr. 2 STOT RE 2 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H361f*** H373** H319 H315 H317 |
GHS08 GHS07 Wng |
H361f*** H373** H319 H315 H317 |
|
|
|
612-280-00-7 |
3-amino-9-ethylcarbazool; 9-ethylcarbazool-3-ylamine |
205-057-7 |
132-32-1 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
612-281-00-2 |
leucomalachietgroen; N,N,N',N'-tetramethyl-4,4'-benzylideendianiline |
204-961-9 |
129-73-7 |
Carc. 2 Muta. 2 |
H351 H341 |
GHS08 Wng |
H351 H341 |
|
|
|
612-282-00-8 |
octadecylamine |
204-695-3 |
124-30-1 |
Asp. Tox. 1 STOT RE 2 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H304 H373 (spijsverteringskanaal, lever, immuun- systeem) H315 H318 H400 H410 |
GHS05 GHS08 GHS09 Dgr |
H304 H373 (spijsverteringskanaal, lever, immuun- systeem) H315 H318 H410 |
|
M = 10 M = 10 |
|
612-283-00-3 |
(Z)-octadec-9-enylamine |
204-015-5 |
112-90-3 |
Acute Tox. 4 Asp Tox. 1 STOT SE 3 STOT RE 2 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H302 H304 H335 H373 (spijsverteringskanaal, lever, immuunsysteem) H314 H400 H410 |
GHS05 GHS07 GHS08 GHS09 Dgr |
H302 H304 H335 H373 (spijsverteringskanaal, lever, immuunsysteem) H314 H410 |
|
M = 10 M = 10 |
|
612-284-00-9 |
aminen, gehydrogeneerd talkalkyl |
262-976-6 |
61788-45-2 |
Asp Tox. 1 STOT RE 2 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H304 H373 (spijsverteringskanaal, lever, immuunsysteem) H315 H318 H400 H410 |
GHS08 GHS05 GHS09 Dgr |
H304 H373 (spijsverteringskanaal, lever, immuunsysteem) H315 H318 H410 |
|
M = 10 M = 10 |
|
612-285-00-4 |
aminen, cocoalkyl |
262-977-1 |
61788-46-3 |
Acute Tox. 4 Asp. Tox. 1 STOT SE 3 STOT RE 2 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H302 H304 H335 H373 (spijsverteringskanaal, lever, immuunsysteem) H314 H400 H410 |
GHS05 GHS07 GHS08 GHS09 Dgr |
H302 H304 H335 H373 (spijsverteringskanaal, lever, immuunsysteem) H314 H410 |
|
M = 10 M = 10 |
|
612-286-00-X |
aminen, talkalkyl |
263-125-1 |
61790-33-8 |
Acute Tox. 4 Asp. Tox. 1 STOT RE 2 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H302 H304 H373 (spijsverteringskanaal, lever, immuunsysteem) H314 H400 H410 |
GHS05 GHS07 GHS08 GHS09 Dgr |
H302 H304 H373 (spijsverteringskanaal, lever, immuunsysteem) H314 H410 |
|
M = 10 M = 10 |
|
612-287-00-5 |
fluazinam (ISO); 3-chloor-N-[3-chloor-2,6-dinitro-4-(trifluormethyl)fenyl]-5-(trifluormethyl)pyridine-2-amine |
— |
79622-59-6 |
Repr. 2 Acute Tox. 4 Eye Dam. 1 Skin Sens. 1A Aquatic Acute 1 Aquatic Chronic 1 |
H361d H332 H318 H317 H400 H410 |
GHS08 GHS07 GHS05 GHS09 Dgr |
H361d H332 H318 H317 H410 |
|
M = 10 M = 10 |
|
613-001-00-1 |
ethyleenimine; aziridine |
205-793-9 |
151-56-4 |
Flam. Liq. 2 Carc. 1B Muta. 1B Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Skin Corr. 1B Aquatic Chronic 2 |
H225 H350 H340 H330 H310 H300 H314 H411 |
GHS02 GHS06 GHS08 GHS05 GHS09 Dgr |
H225 H350 H340 H330 H310 H300 H314 H411 |
|
|
D |
613-002-00-7 |
pyridine |
203-809-9 |
110-86-1 |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H225 H332 H312 H302 |
GHS02 GHS07 Dgr |
H225 H332 H312 H302 |
|
* |
|
613-003-00-2 |
1,2,3,4-tetranitrocarbazool |
— |
6202-15-9 |
Expl. 1.1 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * |
H201 H332 H312 H302 |
GHS01 GHS07 Dgr |
H201 H332 H312 H302 |
|
|
|
613-004-00-8 |
crimidine (ISO); 2-chloor-6-methylpyrimidine-4- yldimethylamine |
208-622-6 |
535-89-7 |
Acute Tox. 2 * |
H300 |
GHS06 Dgr |
H300 |
|
|
|
613-007-00-4 |
desmetryne (ISO); 6-isopropylamino-2-methylamino-4-methylthio-1,3,5- triazine |
213-800-1 |
1014-69-3 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H312 H302 H410 |
|
|
|
613-008-00-X |
dazomet (ISO); tetrahydro-3,5-dimethyl-1,3,5- thiadiazine-2-thion |
208-576-7 |
533-74-4 |
Acute Tox. 4 * Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H410 |
|
|
|
613-009-00-5 |
2,4,6-trichloor-1,3,5-triazine; cyanuurchloride |
203-614-9 |
108-77-0 |
Acute Tox. 2 * Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 |
H330 H302 H314 H317 |
GHS06 GHS05 Dgr |
H330 H302 H314 H317 |
EUH014 |
STOT SE 3; H335: C ≥ 5 % |
|
613-010-00-0 |
ametryn (ISO); N-ethyl-N'-isopropyl-6-(methyl-thio)-1,3,5-triazine-2,4-diamine |
212-634-7 |
834-12-8 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
M = 100 |
|
613-011-00-6 |
amitrool (ISO);1,2,4-triazool-3-ylamine |
200-521-5 |
61-82-5 |
Repr. 2 STOT RE 2 * Aquatic Chronic 2 |
H361d *** H373 ** H411 |
GHS08 GHS09 Wng |
H361d *** H373 ** H411 |
|
|
|
613-012-00-1 |
bentazon (ISO); 3-isopropyl-2,1,3-benzothiadiazine-4-on-2,2-dioxide |
246-585-8 |
25057-89-0 |
Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H302 H319 H317 H412 |
GHS07 Wng |
H302 H319 H317 H412 |
|
|
|
613-013-00-7 |
cyanazine (ISO); 2-(4-chloor-6-ethylamino-1,3,5- triazine-2-ylamino)-2-methylpropionitril |
244-544-9 |
21725-46-2 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
613-014-00-2 |
ethoxyquine (ISO); 6-ethoxy-2,2,4-trimethyl-1,2-dihydrochinoline |
202-075-7 |
91-53-2 |
Acute Tox. 4* |
H302 |
GHS07 Wng |
H302 |
|
|
|
613-015-00-8 |
fenazafloor (ISO); fenyl-5,6-dichloor-2-trifluormethylbenzimidazool-1-carboxylaat |
238-134-9 |
14255-88-0 |
Acute Tox. 4* Acute Tox. 4* Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H312 H302 H410 |
|
|
|
613-016-00-3 |
fuberidazool (ISO); 2-(2-furyl-)-1H-benzimidazool |
223-404-0 |
3878-19-1 |
Carc. 2 Acute Tox. 4 STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H302 H373 (hart) H317 H400 H410 |
GHS07 GHS08 GHS09 Wng |
H351 H302 H373 (hart) H317 H410 |
|
M = 1 |
|
613-017-00-9 |
bis(8-hydroxychinolinium)sulfaat |
205-137-1 |
134-31-6 |
Acute Tox. 4* |
H302 |
GHS07 Wng |
H302 |
|
|
|
613-018-00-4 |
morfamquat (ISO); 1,1'-bis(3,5-dimethylmorfolinocarbonylmethyl)-4,4'-dipyridilium-ion |
|
7411-47-4 |
Acute Tox. 4* Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 3 |
H302 H319 H335 H315 H412 |
GHS07 Wng |
H302 H319 H335 H315 H412 |
|
|
|
613-019-00-X |
thioquinox (ISO); 2-thio-1,3-dithiolo(4,5,b)chinoxaline |
202-272-8 |
93-75-4 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
613-020-00-5 |
tridemorf (ISO); 2,6-dimethyl-4-tridecylmorfoline |
246-347-3 |
24602-86-6 |
Repr. 1B Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H360D *** H332 H302 H315 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H360D *** H332 H302 H315 H410 |
|
|
|
613-021-00-0 |
dithianon (ISO); 5,10-dihydro-5,10-dioxonafto(2,3-b)(1,4)dithiazine-2,3- dicarbonitril |
222-098-6 |
3347-22-6 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
613-022-00-6 |
pyrethrinen met inbegrip van cinerinen, tenzij elders in deze bijlage vermeld |
— |
— |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H312 H302 H410 |
|
|
A |
613-023-00-1 |
2-methyl-4-oxo-3-(penta-2,4-diënyl)cyclopent-2-enyl[1R-[1α[S*(Z)],3β]]-chrysanthemaat; pyrethrine I |
204-455-8 |
121-21-1 |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H312 H302 H410 |
|
|
|
613-024-00-7 |
2-methyl-4-oxo-3-(penta-2,4-diënyl)cyclopent-2-enyl[1R-[1α[S*(Z)](3β)]]-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)-2,2-dimethylcyclopropaancarboxylaat; pyrethrine II |
204-462-6 |
121-29-9 |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H312 H302 H410 |
|
|
|
613-025-00-2 |
cinerine I; 3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropaancarboxylaat |
246-948-0 |
25402-06-6 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
613-026-00-8 |
cinerine II; 3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl-2,2-dimethyl-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)cyclopropaancarboxylaat |
204-454-2 |
121-20-0 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
613-027-00-3 |
piperidine |
203-813-0 |
110-89-4 |
Flam. Liq. 2 Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B |
H225 H331 H311 H314 |
GHS02 GHS06 GHS05 Dgr |
H225 H331 H311 H314 |
|
* |
|
613-028-00-9 |
morfoline |
203-815-1 |
110-91-8 |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H226 H332 H312 H302 H314 |
GHS02 GHS05 GHS07 Dg |
H226 H332 H312 H302 H314 |
|
|
|
613-029-00-4 |
dichloor-1,3,5-triazinetrion; dichloorisocyanuurzuur |
220-487-5 |
2782-57-2 |
Ox. Sol. 2 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 |
H272 H302 H319 H335 H400 H410 |
GHS03 GHS07 GHS09 Dgr |
H272 H302 H319 H335 H410 |
EUH031 |
|
T |
613-030-00-X |
trocloseenkalium; [1] trocloseennatrium [2] |
218-828-8 [1] 220-767-7 [2] |
2244-21-5 [1] 2893-78-9 [2] |
Ox. Sol. 2 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 |
H272 H302 H319 H335 H400 H410 |
GHS03 GHS07 GHS09 Dgr |
H272 H302 H319 H335 H410 |
EUH031 |
* STOT SE 3; H335: C ≥ 10 % EUH031: C ≥10 % |
G |
613-030-01-7 |
trocloseennatrium, dihydraat |
220-767-7 |
51580-86-0 |
Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H335 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H335 H410 |
EUH031 |
|
|
613-031-00-5 |
symcloseen; trichloorisocyanuurzuur; trichloor-1,3,5-triazinetrion |
201-782-8 |
87-90-1 |
Ox. Sol. 2 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1 |
H272 H302 H319 H335 H400 H410 |
GHS03 GHS07 GHS09 Dgr |
H272 H302 H319 H335 H410 |
EUH031 |
|
|
613-032-00-0 |
methyl-2,3,5,6-tetrachloor-4-pyridylsulfon; 2,3,5,6-tetrachloor-4-(methylsulfonyl)pyridine |
236-035-5 |
13108-52-6 |
Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 |
H312 H302 H319 H317 |
GHS07 Wng |
H312 H302 H319 H317 |
|
|
|
613-033-00-6 |
2-methylaziridine; propyleenimine |
200-878-7 |
75-55-8 |
Flam. Liq. 2 Carc. 1B Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Eye Dam. 1 Aquatic Chronic 2 |
H225 H350 H330 H310 H300 H318 H411 |
GHS02 GHS06 GHS08 GHS05 GHS09 Dgr |
H225 H350 H330 H310 H300 H318 H411 |
|
Carc. 1B; H350: C ≥ 0,01 % |
|
613-034-00-1 |
1,2-dimethylimidazool |
217-101-2 |
1739-84-0 |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 |
H302 H315 H318 |
GHS05 GHS07 Dgr |
H302 H315 H318 |
|
|
|
613-035-00-7 |
1-methylimidazool |
210-484-7 |
616-47-7 |
Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B |
H312 H302 H314 |
GHS05 GHS07 Dgr |
H312 H302 H314 |
|
|
|
613-036-00-2 |
2-methylpyridine; 2-picoline |
203-643-7 |
109-06-8 |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 |
H226 H332 H312 H302 H319 H335 |
GHS02 GHS07 Wng |
H226 H332 H312 H302 H319 H335 |
|
|
|
613-037-00-8 |
4-methylpyridine; 4-picoline |
203-626-4 |
108-89-4 |
Flam. Liq. 3 Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H226 H311 H332 H302 H319 H335 H315 |
GHS02 GHS06 Dgr |
H226 H311 H332 H302 H319 H335 H315 |
|
|
|
613-038-00-3 |
6-fenyl-1,3,5-triazine-2,4-diyldiamine; 6-fenyl-1,3,5-triazine-2,4-diamine; benzoguanamine |
202-095-6 |
91-76-9 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
613-039-00-9 |
ethyleenthioureum; imidazolidine-2-thion; 2-imidazoline-2-thiol |
202-506-9 |
96-45-7 |
Repr. 1B Acute Tox. 4 * |
H360D *** H302 |
GHS08 GHS07 Dgr |
H360D *** H302 |
|
|
|
613-040-00-4 |
azaconazool (ISO); 1-{[2-(2,4-dichloorfenyl)-1,3-dioxolaan-2-yl]methyl}-1H-1,2.4-triazool |
262-102-3 |
60207-31-0 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
613-041-00-X |
morfoline-4-carbonylchloride |
239-213-0 |
15159-40-7 |
Carc. 2 Eye Irrit. 2 Skin Irrit. 2 |
H351 H319 H315 |
GHS08 Wng |
H351 H319 H315 |
EUH014 |
|
|
613-043-00-0 |
imazalil-sulfaat (ISO), poeder; 1-[2-(allyloxy)ethyl-2-(2,4- dichloorfenyl)]-1H-imidazolium-hydrogeen-sulfaat; [1](±)-1-[2-(allyloxy)ethyl-2-(2,4-dichloorfenyl)]-1H-imidazolium-hydrogeen-sulfaat [2] |
261-351-5 [1] 281-291-3 [2] |
58594-72-2 [1] 83918-57-4 [2] |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
|
613-043-01-8 |
imazalil-sulfaat (ISO), waterige oplossing; 1-[2-(allyloxy)ethyl-2-(2,4- dichloorfenyl)]-1H-imidazolium-hydrogeen-sulfaat; [1](±)-1-[2-(allyloxy)ethyl-2-(2,4-dichloorfenyl)]-1H-imidazolium-hydrogeen-sulfaat [2] |
261-351-5 [1] 281-291-3 [2] |
58594-72-2 [1] 83918-57-4 [2] |
Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H314 H317 H400 H410 |
GHS05 GHS07 GHS09 Wng |
H302 H314 H317 H410 |
|
Skin Corr. 1B; H314: C ≥ 50 % Skin Irrit. 2; H315: 30 % ≤ C < 50 % Eye Dam. 1; H318: 15 % ≤ C < 50 % Eye Irrit. 2; H319: 5 % ≤ C < 15 % |
|
613-044-00-6 |
captan (ISO); 1,2,3,6-tetrahydro-N-(trichloormethylthio)ftaalimide |
205-087-0 |
133-06-2 |
Carc. 2 Acute Tox. 3 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 |
H351 H331 H318 H317 H400 |
GHS06 GHS05 GHS08 GHS09 Dgr |
H351 H331 H318 H317 H400 |
|
M=10 |
|
613-045-00-1 |
folpet (ISO); N-(trichloormethylthio)ftaalimide |
205-088-6 |
133-07-3 |
Carc. 2 Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 |
H351 H332 H319 H317 H400 |
GHS08 GHS07 GHS09 Wng |
H351 H332 H319 H317 H400 |
|
M=10 |
|
613-046-00-7 |
captafol (ISO); 1,2,3,6-tetrahydro-N-(1,1,2,2-tetrachloorethylthio)ftaalimide |
219-363-3 |
2425-06-1 |
Carc. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H350 H317 H400 H410 |
GHS08 GHS09 Dgr |
H350 H317 H410 |
|
|
|
613-047-00-2 |
1-dimethylcarbamoyl-5-methylpyrazool-3-yldimethylcarbamaat; dimetilan (ISO) |
211-420-0 |
644-64-4 |
Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H312 H400 H410 |
GHS06 GHS09 Dgr |
H301 H312 H410 |
|
|
|
613-048-00-8 |
carbendazim (ISO); methylbenzimidazool-2-ylcarbamaat |
234-232-0 |
10605-21-7 |
Muta. 1B Repr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H340 H360FD H400 H410 |
GHS08 GHS09 Dgr |
H340 H360FD H410 |
|
|
|
613-049-00-3 |
benomyl (ISO); methyl-1-(butylcarbamoyl)benzimidazool-2-ylcarbamaat |
241-775-7 |
17804-35-2 |
Muta. 1B Repr. 1B STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H340 H360FD H335 H315 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H340 H360FD H335 H315 H317 H410 |
|
M = 10 |
|
613-050-00-9 |
carbadox (INN); methyl-3-(chinoxaline-2-ylmethyleen)carbazaat-1,4-dioxide; 2-(methoxycarbonylhydrazonomethyl)chinoxaline-1,4-dioxide |
229-879-0 |
6804-07-5 |
Flam. Sol. 1 Carc. 1B Acute Tox. 4 * |
H228 H350 H302 |
GHS02 GHS08 GHS07 Dgr |
H228 H350 H302 |
|
|
T |
613-051-00-4 |
molinaat (ISO); S-ethyl-1-perhydroazepinecarbothioaat; S-ethyl-perhydroazepine-1-carbothioaat |
218-661-0 |
2212-67-1 |
Carc. 2 Repr. 2 Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H361f *** H332 H302 H373 ** H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H361f *** H332 H302 H373 ** H317 H410 |
|
M = 100 |
|
613-052-00-X |
trifenmorf (ISO);4-tritylmorfoline |
215-812-2 |
1420-06-0 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
613-053-00-5 |
anilazine (ISO); 2-chloor-N-(4,6-dichloor-1,3,5- triazine-2-yl)aniline |
202-910-5 |
101-05-3 |
Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H315 H400 H410 |
GHS07 GHS09 Wng |
H319 H315 H410 |
|
|
|
613-054-00-0 |
thiabendazool (ISO); 2-(thiazool-4-yl)benzimidazool |
205-725-8 |
148-79-8 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
613-056-00-1 |
1,2-dimethyl-3,5-difenylpyrazoliummethylsulfaat; difenzoquat-methylsulfaat |
256-152-5 |
43222-48-6 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS09 Wng |
H302 H410 |
|
|
|
613-058-00-2 |
permethrin (ISO);m-fenoxybenzyl-3-(2,2-dichloorvinyl)-2,2-dimethylcyclopropaancarboxylaat |
258-067-9 |
52645-53-1 |
Acute Tox. 4 * Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H332 H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H332 H302 H317 H410 |
|
M = 1 000 |
|
613-059-00-8 |
profluralin (ISO); N-(cyclopropylmethyl)-α, α,α- trifluor-2,6-dinitro-N-propyl-p-toluïdine |
247-656-6 |
26399-36-0 |
Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H400 H410 |
GHS07 GHS09 Wng |
H319 H410 |
|
|
|
613-060-00-3 |
resmethrin (ISO); 5-benzyl-3-furylmethyl-(±)-cis-trans-chrysanthemaat |
233-940-7 |
10453-86-8 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
M=1000 |
|
613-061-00-9 |
6-(1α,5aβ,8aβ,9-pentahydroxy-7β-isopropyl-2β,5β,8β-trimethylperhydro-8bα,9-epoxy-5,8-ethanocyclopenta[1,2-b]indenyl)-pyrrool-2-carboxylaat; ryania |
239-732-2 |
15662-33-6 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H312 H302 H410 |
|
|
|
613-062-00-4 |
sabadilla (ISO); veratrine |
— |
8051-02-3 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H319 H335 H315 |
GHS07 Wng |
H319 H335 H315 |
|
|
|
613-063-00-X |
secbumeton (ISO); 2-sec-butylamino-4-ethylamino-6-methoxy-1,3,5-triazine |
247-554-1 |
26259-45-0 |
Acute Tox. 4 * Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H410 |
|
|
|
613-064-00-5 |
5-(3,6,9-trioxa-2-undecyloxy)benzo[d]-1,3-dioxolaan; sesamex |
— |
51-14-9 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
613-065-00-0 |
simetryn (ISO); 2,4-bis(ethylamino)-6- methylthio-1,3,5-triazine |
213-801-7 |
1014-70-6 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
613-066-00-6 |
terbumeton (ISO); 2-tert-butylamino-4-ethylamino-6-methoxy-1,3,5-triazine |
251-637-8 |
33693-04-8 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
613-067-00-1 |
propazine (ISO); 2-chloor-4,6-bis(isopropylamino)-1,3,5-triazine |
205-359-9 |
139-40-2 |
Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H400 H410 |
GHS08 GHS09 Wng |
H351 H410 |
|
|
|
613-068-00-7 |
atrazine (ISO); 2-chloor-4-ethylamine-6-isopropylamine-1,3,5-triazine |
217-617-8 |
1912-24-9 |
STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H373 ** H317 H400 H410 |
GHS08 GHS09 Wng |
H373 ** H317 H410 |
|
|
|
613-069-00-2 |
ε-caprolactam |
203-313-2 |
105-60-2 |
Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 |
H332 H302 H319 H335 H315 |
GHS07 Wng |
H332 H302 H319 H335 H315 |
|
|
|
613-070-00-8 |
propyleenthioureum |
— |
2122-19-2 |
Repr. 2 Acute Tox. 4 * Aquatic Chronic 3 |
H361d *** H302 H412 |
GHS08 GHS07 Wng |
H361d *** H302 H412 |
|
|
|
613-071-00-3 |
2-fluor-5-trifluormethyl-pyridine |
400-290-2 |
69045-82-5 |
Flam. Liq. 3 Skin Sens. 1 Aquatic Chronic 3 |
H226 H317 H412 |
GHS02 GHS07 Wng |
H226 H317 H412 |
|
|
|
613-072-00-9 |
N, N-bis(2-ethylhexyl)-((1,2,4-triazool-1-yl)methyl)amine |
401-280-0 |
91273-04-0 |
Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 |
H314 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H314 H317 H411 |
|
|
|
613-073-00-4 |
N, N-dimethyl-2-(3-(4-chloorfenyl)-4,5-dihydropyrazool-1-ylfenylsulfonyl)ethylamine |
401-410-6 |
10357-99-0 |
STOT RE 2 * Skin Sens. 1 Aquatic Chronic 2 |
H373 ** H317 H411 |
GHS08 GHS09 Wng |
H373 ** H317 H411 |
|
|
|
613-074-00-X |
3-(3-methylpent-3-yl)isoxazool-5-ylamine |
401-460-9 |
82560-06-3 |
Acute Tox. 3 * Acute Tox. 3 * Eye Dam. 1 Aquatic Chronic 3 |
H331 H301 H318 H412 |
GHS06 GHS05 Dgr |
H331 H301 H318 H412 |
|
|
|
613-075-00-5 |
1,3-dichloor-5-ethyl-5-methylimidazolidine-2,4-dion |
401-570-7 |
89415-87-2 |
Ox. Sol. 1 **** Acute Tox. 3 * Skin Corr. 1B Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 |
H271 H331 H314 H302 H317 H400 |
GHS03 GHS06 GHS05 GHS09 Dgr |
H271 H331 H314 H302 H317 H400 |
|
|
|
613-076-00-0 |
3-chloor-5-trifluormethyl-2-pyridylamine |
401-670-0 |
79456-26-1 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
613-077-00-6 |
reactiemassa van 5-heptyl-1,2,4-triazool-3-ylamine en 5-nonyl-1,2,4-triazool-3-ylamine |
401-940-8 |
— |
Acute Tox. 4 * Eye Irrit. 2 Aquatic Chronic 2 |
H302 H319 H411 |
GHS07 GHS09 Wng |
H302 H319 H411 |
|
|
|
613-078-00-1 |
N,N,N,N-tetrakis(4,6-bis(butyl-(N-methyl-2,2,6,6-tetramethylpiperidine-4-yl)amino)triazine-2-yl)-4,7-diazadecaan-1,10-diamine |
401-990-0 |
106990-43-6 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
613-079-00-7 |
4-(1(of 4 of 5 of 6)-methyl-8,9,10-trinorborn-5-een-2-yl)pyridine, reactiemass van isomeren |
402-520-7 |
— |
Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H312 H302 H315 H317 H410 |
|
|
|
613-080-00-2 |
3-(bis(2-ethylhexyl)aminomethyl)benzothiazool-2(3H)-thion |
402-540-6 |
105254-85-1 |
Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H314 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H314 H317 H410 |
|
|
|
613-081-00-8 |
1-butyl-2-methylpyridiniumbromide |
402-680-8 |
26576-84-1 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
613-082-00-3 |
2-methyl-1-pentylpyridiniumbromide |
402-690-2 |
— |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 3 |
H312 H302 H412 |
GHS07 Wng |
H312 H302 H412 |
|
|
|
613-083-00-9 |
2-(4-(3-(4-chloorfenyl)-2-pyrazoline-1-yl)fenylsulfonyl)ethyldimethylammoniumformiaat |
402-120-2 |
— |
Skin Corr. 1B STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H314 H373 ** H317 H400 H410 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H314 H373 ** H317 H410 |
|
|
|
613-084-00-4 |
2-(4-(3-(4-chloorfenyl)-4,5-dihydropyrazolyl)fenylsulfonyl)ethyldimethylammonium-hydrogeen-fosfonaat |
402-490-5 |
106359-93-7 |
Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H400 H410 |
GHS07 GHS09 Wng |
H319 H410 |
|
|
|
613-085-00-X |
reactiemassa van 1,1'-(methyleenbis(4,1-fenyleen))dipyrrool-2,5-dion en N-(4-(4-(2,5-dioxopyrrool-1-yl)benzyl)fenyl)acetamide en 1-(4-(4-(5-oxo-2H-2-furylideenamino)benzyl)fenyl)pyrrool-2,5-dion |
401-970-1 |
— |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
613-086-00-5 |
cafeïne |
200-362-1 |
58-08-2 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
613-087-00-0 |
tetrahydrothiofeen |
203-728-9 |
110-01-0 |
Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 3 |
H225 H332 H312 H302 H319 H315 H412 |
GHS02 GHS07 Dgr |
H225 H332 H312 H302 H319 H315 H412 |
|
|
|
613-088-00-6 |
1,2-benzisothiazool-3(2H)-on; 1,2-benzisothiazoline-3-on |
220-120-9 |
2634-33-5 |
Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 |
H302 H315 H318 H317 H400 |
GHS05 GHS07 GHS09 Dgr |
H302 H315 H318 H317 H400 |
|
Skin Sens. 1; H317: C≥0,05 % |
|
613-089-00-1 |
diquatdibromide; [1] diquatdichloride; [2]6,7-dihydrodipyrido[1,2-α:2',1'-c]pyrazinediyliumdihydroxide [3] |
201-579-4 [1] 223-714-6 [2] 301-467-6 [3] |
85-00-7 [1] 4032-26-2 [2] 94021-76-8 [3] |
Acute Tox. 2 * STOT RE 1 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H372 ** H302 H319 H335 H315 H317 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H330 H372 ** H302 H319 H335 H315 H317 H410 |
|
|
|
613-090-00-7 |
paraquatdichloride; 1,1-dimethyl-4,4'-bipyridiniumdichloride; [1] paraquat-dimethylsulfaat; 1,1-dimethyl-4,4'-bipyridiniumdimethylsulfaat [2] |
217-615-7 [1] 218-196-3 [2] |
1910-42-5 [1] 2074-50-2 [2] |
Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H311 H301 H372 ** H319 H335 H315 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H330 H311 H301 H372 ** H319 H335 H315 H410 |
|
|
|
613-091-00-2 |
morfamquat-dichloride; [1] morfamquat-sulfaat [2] |
225-062-8 [1] [2] |
4636-83-3 [1] 29873-36-7 [2] |
Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Chronic 3 |
H302 H319 H335 H315 H412 |
GHS07 Wng |
H302 H319 H335 H315 H412 |
|
|
|
613-092-00-8 |
1,10-fenantroline |
200-629-2 |
66-71-7 |
Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H400 H410 |
GHS06 GHS09 Dgr |
H301 H410 |
|
|
|
613-093-00-3 |
hexanatrium-6,13-dichloor-3,10-bis((4-(2,5-disulfonatoanilino)-6-fluor-1,3,5-triazine-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentaceen-4,11-disulfonaat |
400-050-7 |
85153-92-0 |
Resp. Sens. 1 Skin Sens. 1 |
H334 H317 |
GHS08 Dgr |
H334 H317 |
|
|
|
613-094-00-9 |
4-methoxy-N,6-dimethyl-1,3,5- triazine-2-ylamine |
401-360-5 |
5248-39-5 |
Acute Tox. 4 * STOT RE 2 * |
H302 H373 ** |
GHS08 GHS07 Wng |
H302 H373 ** |
|
|
|
613-095-00-4 |
natrium-3-(2H-benzotriazool-2-yl)-5-sec-butyl-4-hydroxybenzeensulfonaat |
403-080-9 |
92484-48-5 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
613-096-00-X |
2-amino-6-ethoxy-4-methylamino-1,3,5-triazine |
403-580-7 |
62096-63-3 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
613-097-00-5 |
7-amino-3-((5-carboxymethyl-4-methyl-1,3-thiazool-2-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-een-2-carbonzuur |
403-690-5 |
111298-82-9 |
Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 3 |
H334 H317 H412 |
GHS08 Dgr |
H334 H317 H412 |
|
|
|
613-098-00-0 |
N-(n-octyl)-2-pyrrolidon |
403-700-8 |
2687-94-7 |
Skin Corr. 1B Aquatic Chronic 2 |
H314 H411 |
GHS05 GHS09 Dgr |
H314 H411 |
|
|
|
613-099-00-6 |
1-dodecyl-2-pyrrolidon |
403-730-1 |
2687-96-9 |
Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H314 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H314 H317 H410 |
|
|
|
613-100-00-X |
2,9-bis(3-(diëthylamino)propylsulfamoyl)chino(2,3-b)acridine-7,14-dion |
404-230-6 |
— |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
613-101-00-5 |
N—tert-pentyl-2-benzothiazoolsulfeenamide |
404-380-2 |
110799-28-5 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
613-102-00-0 |
dimethomorf (ISO); 4-(3-(4-chloorfenyl)-3-(3,4-dimethoxyfenyl)acryloyl)morfoline |
404-200-2 |
110488-70-5 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
613-103-00-6 |
natrium-5-n-benzotriazool |
404-450-2 |
118685-34-0 |
Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 |
H302 H314 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H314 H317 H411 |
|
|
|
613-104-00-1 |
5-tert-butyl-3-isoxazolylaminehydrochloride |
404-840-2 |
— |
Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Aquatic Chronic 3 |
H302 H373 ** H318 H412 |
GHS08 GHS05 GHS07 Dgr |
H302 H373 ** H318 H412 |
|
|
|
613-105-00-7 |
hexakis(tetramethylammonium)-4,4'-vinyleenbis((3-sulfonato-4,1-fenyleen)imino(6-morfolino-1,3,5-triazine-4,2-diyl)imino)bis(5-hydroxy-6-fenylazonaftaleen-2,7-disulfonaat) |
405-160-9 |
124537-30-0 |
Acute Tox. 3 * Skin Sens. 1 Aquatic Chronic 3 |
H301 H317 H412 |
GHS06 Dgr |
H301 H317 H412 |
|
|
|
613-106-00-2 |
tetrakalium-2-(4-(5-(1-(2,5-disulfonatofenyl)-3-ethoxycarbonyl-5-hydroxypyrazool-4-yl)penta-2,4-diënylideen)-3-ethoxycarbonyl-5-oxo-2-pyrazoline-1-yl)benzeen-1,4-disulfonaat |
405-240-3 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
613-107-00-8 |
hexanatrium-2,2'-vinyleenbis((3-sulfonato-4,1-fenyleen)imino(6-(N-cyaanethyl-N-(2-hydroxypropyl)amino)-1,3,5-triazine-4,2-diyl)imino)dibenzeen-1,4-disulfonaat |
405-280-1 |
76508-02-6 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
613-108-00-3 |
benzothiazool-2-thiol |
205-736-8 |
149-30-4 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
613-109-00-9 |
bis(piperidinothiocarbonyl)disulfide |
202-328-1 |
94-37-1 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 |
H319 H335 H315 H317 |
GHS07 Wng |
H319 H335 H315 H317 |
|
|
|
613-110-00-4 |
dimepiperaat (ISO); S-(1-methyl-1-fenylethyl) piperidine-1-carbothioaat |
262-784-2 |
61432-55-1 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
613-111-00-X |
1,2,4-triazool |
206-022-9 |
288-88-0 |
Repr. 2 Acute Tox. 4 * Eye Irrit. 2 |
H361d *** H302 H319 |
GHS08 GHS07 Wng |
H361d *** H302 H319 |
|
|
|
613-112-00-5 |
octhilinone (ISO); 2-octyl-2H-isothiazool-3-on |
247-761-7 |
26530-20-1 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H302 H314 H317 H400 H410 |
GHS06 GHS05 GHS09 Dgr |
H331 H311 H302 H314 H317 H410 |
|
Skin Sens. 1; H317: C≥0,05 % |
|
613-113-00-0 |
2-(morfolinothio)benzothiazool |
203-052-4 |
102-77-2 |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H319 H315 H317 H411 |
GHS07 GHS09 Wng |
H319 H315 H317 H411 |
|
|
|
613-114-00-6 |
2,2',2''-(hexahydro-1,3,5-triazine-1,3,5-triyl)triëthanol; 1,3,5-tris(2-hydroxyethyl)hexahydro-1,3,5-triazine |
225-208-0 |
4719-04-4 |
Acute Tox. 4 * Skin Sens. 1 |
H302 H317 |
GHS07 Wng |
H302 H317 |
|
Skin Sens. 1; H317: C ≥ 0,1 % |
|
613-115-00-1 |
hymexazol (ISO); 3-hydroxy-5-methylisoxazool |
233-000-6 |
10004-44-1 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 |
H302 H318 H412 |
GHS05 GHS07 Dgr |
H302 H318 H412 |
|
|
|
613-116-00-7 |
tolylfluanide (ISO); dichloor-N-[(dimethylamino)sulfonyl]fluor-N-(p-tolyl)methaansulfenamide; [met ≥ 0,1 % (m/m) deeltjes met een aerodynamische diameter van minder dan 50 μm] |
211-986-9 |
731-27-1 |
Acute Tox. 2 * STOT RE 1 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 |
H330 H372** H319 H335 H315 H317 H400 |
GHS06 GHS08 GHS09 Dgr |
H330 H372** H319 H335 H315 H317 H400 |
|
M=10 |
|
613-116-01-4 |
tolylfluanide (ISO); dichloor-N-[(dimethylamino)sulfonyl]fluor-N-(p-tolyl)methaansulfenamide; [met < 0,1 % (m/m) deeltjes met een aerodynamische diameter van minder dan 50 μm] |
211-986-9 |
731-27-1 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 |
H319 H335 H315 H317 H400 |
GHS07 GHS09 Wng |
H319 H335 H315 H317 H400 |
|
M=10 |
|
613-117-00-2 |
diniconazool (ISO); (E)-β-[(2,4-dichloorfenyl)methyleen]-α-(1,1-dimethylethyl)-1H—1,2,4-triazool-1-ethanol; (E)-(RS)-1-(2,4-dichloorfenyl)-4,4-dimethyl-2-(1H—1,2,4- triazool-1-yl)pent-1-een-3-ol |
— |
76714-88-0 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
613-118-00-8 |
flubenzimine (ISO); N-[3-fenyl-4,5-bis[(trifluormethyl)imino]thiazolidine-2-ylideen]aniline |
253-703-1 |
37893-02-0 |
Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H319 H400 H410 |
GHS07 GHS09 Wng |
H319 H410 |
|
|
|
613-119-00-3 |
(benzothiazool-2-ylthio)methylthiocyanaat; TCMTB |
244-445-0 |
21564-17-0 |
Acute Tox. 2 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H302 H319 H315 H317 H400 H410 |
GHS06 GHS09 Dgr |
H330 H302 H319 H315 H317 H410 |
|
|
|
613-120-00-9 |
bioresmethrin (ISO); (5-benzyl-3-furyl)methyl/(1R)-2,2-dimethyl-3-(2-methylprop-1- een-1-yl)cyclopropaancarboxylaat |
249-014-0 |
28434-01-7 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
M = 1000 |
|
613-122-00-X |
diclobutrazool (ISO); (R*, R*)-(±)-β-[(2,4-dichloorfenyl)methyl]-α-(1,1-dimethylethyl)-1H-1,2,4-triazool-1-ethanol; (2RS, 3RS)-1-(2,4-dichloorfenyl)-4,4-dimethyl-2-(1H—1,2,4-triazool-1yl)pentaan-3-ol |
— |
75736-33-3 |
Eye Irrit. 2 Aquatic Chronic 2 |
H319 H411 |
GHS07 GHS09 Wng |
H319 H411 |
|
|
|
613-123-00-5 |
5,6-dihydro-3H-imidazo[2,1-c]-1,2,4-dithiazool-3-thion; etem |
251-684-4 |
33813-20-6 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
613-124-00-0 |
fenpropimorf (ISO); cis-4-[3-(p-tert-butylfenyl)-2-methylpropyl]-2,6-dimethylmorfoline |
266-719-9 |
67564-91-4 |
Repr. 2 Acute Tox. 4 * Skin Irrit. 2 Aquatic Chronic 2 |
H361d *** H302 H315 H411 |
GHS08 GHS07 GHS09 Wng |
H361d *** H302 H315 H411 |
|
|
|
613-125-00-6 |
hexythiazox(ISO); trans-5-(4-chloorfenyl)-N-cyclohexyl-4-methyl-2-oxo-3-thiazolidine-carboxamide |
— |
78587-05-0 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
613-126-00-1 |
imazapyr (ISO); 2-[4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1H-imidazool-2-yl]-3-pyridinecarboxylaat |
— |
81334-34-1 |
Eye Irrit. 2 Aquatic Chronic 3 |
H319 H412 |
GHS07 Wng |
H319 H412 |
|
|
|
613-127-00-7 |
1,1-dimethylpiperidiniumchloride; mepiquat-chloride |
246-147-6 |
24307-26-4 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
613-128-00-2 |
prochloraz (ISO); N-propyl-N-[2-(2,4,6-trichloorfenoxy)ethyl]-1H-imidazoole-1-carboxamide |
266-994-5 |
67747-09-5 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
613-129-00-8 |
metamitron (ISO); 4-amino-3-methyl-6-fenyl-1,2,4-triazine-5-on |
255-349-3 |
41394-05-2 |
Acute Tox. 4 * Aquatic Acute 1 |
H302 H400 |
GHS07 GHS09 Wng |
H302 H400 |
|
|
|
613-131-00-9 |
pyroquilon (ISO); 1,2,5,6-tetrahydropyrrolo[3,2,1-ij]chinoline-4-on |
— |
57369-32-1 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
613-132-00-4 |
hexazinone (ISO); 3-cyclohexyl-6-dimethylamino-1-methyl-1,2,3,4-tetrahydro-1,3,5-triazine-2,4-dion |
257-074-4 |
51235-04-2 |
Acute Tox. 4 * Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H410 |
|
|
|
613-134-00-5 |
myclobutanil (ISO); 2-(4-chloorfenyl)-2-(1H-1,2,4-triazool-1-ylmethyl)hexaannitril |
— |
88671-89-0 |
Repr. 2 Acute Tox. 4 * Eye Irrit. 2 Aquatic Chronic 2 |
H361d *** H302 H319 H411 |
GHS08 GHS07 GHS09 Wng |
H361d *** H302 H319 H411 |
|
|
|
613-135-00-0 |
di(benzothiazool-2-yl)disulfide |
204-424-9 |
120-78-5 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
EUH031 |
|
|
613-136-00-6 |
N-cyclohexylbenzothiazool-2-sulfeenamide |
202-411-2 |
95-33-0 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
613-137-00-1 |
methabenzthiazuron (ISO); 1-(1,3-benzothiazool-2-yl)1,3-dimethylureum |
242-505-0 |
18691-97-9 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
613-138-00-7 |
quinoxyfen (ISO); 5,7-dichloor-4-(4-fluorfenoxy)chinoline |
— |
124495-18-7 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
613-139-00-2 |
metsulfuron-methyl (ISO); methyl-2-{[(4-methoxy-6-methyl-1,3,5-triazine-2-yl)carbamoyl]sulfamoyl}benzoaat |
— |
74223-64-6 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
M = 1000 |
|
613-140-00-8 |
cycloheximide (ISO); 4-{(2R)-2-[(1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl}piperidine-2,6-dion |
200-636-0 |
66-81-9 |
Muta. 2 Repr. 1B Acute Tox. 2 * Aquatic Chronic 2 |
H341 H360D *** H300 H411 |
GHS06 GHS08 GHS09 Dgr |
H341 H360D *** H300 H411 |
|
|
|
613-141-00-3 |
1,4-diamino-2-(2-butyltetrazool-5-yl)-3-cyaanantrachinon |
401-470-3 |
93686-63-6 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
613-142-00-9 |
trans—N-methyl-2-styryl-[4'-aminomethine-(1-acetyl-1-(2-methoxyfenyl)acetamido)]pyridiniumacetaat |
405-860-4 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
613-143-00-4 |
1-(3-fenylpropyl)-2-methylpyridiniumbromide |
405-930-4 |
10551-42-5 |
Acute Tox. 4 * Eye Irrit. 2 Aquatic Chronic 3 |
H302 H319 H412 |
GHS07 Wng |
H302 H319 H412 |
|
|
|
613-144-00-X |
reactieproducten van: poly(vinylacetaat), gedeeltelijk gehydrolyseerd, met (E)-2-(4-formylstyryl)-3,4-dimethylthiazoliummethylsulfaat |
406-460-2 |
125139-08-4 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
613-145-00-5 |
(S)-3-benzyloxycarbonyl-1,2,3,4-tetrahydro-isochinolinium-4-methylbenzeensulfonaat |
406-960-0 |
77497-97-3 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
613-146-00-0 |
N-ethyl-N-methylpiperidiniumjodide |
407-780-5 |
4186-71-4 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
613-147-00-6 |
4-[2-(1-methyl-2-(4-morfolinyl)ethoxy)ethyl]morfoline |
407-940-4 |
111681-72-2 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
613-148-00-1 |
tetranatrium-1,2-bis(4-fluor-6-[5-(1-amino-2-sulfonatoantrachinon-4-ylamino)-2,4,6-trimethyl-3-sulfonatofenylamino]-1,3,5-triazine-2-ylamino)ethaan |
411-240-4 |
143683-23-2 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
613-150-00-2 |
2,2'-[3,3'-(piperazine-1,4-diyl)dipropyl]bis(1H-benzimidazo[2,1—b]benzo[l, m,n][3,8]fenantroline-1,3,6-trion |
406-295-6 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
613-151-00-8 |
1-(3-mesyloxy-5-trityloxymethyl-2-D-treofuryl)thymine |
406-360-9 |
104218-44-2 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
613-152-00-3 |
fenyl-N-(4,6-dimethoxypyrimidine-2-yl)carbamaat |
406-600-2 |
89392-03-0 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
613-153-00-9 |
2,3,5-trichloorpyridine |
407-270-2 |
16063-70-0 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
613-154-00-4 |
2-amino-4-chloor-6-methoxypyrimidine |
410-050-9 |
5734-64-5 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
613-155-00-X |
5-chloor-2,3-difluorpyridine |
410-090-7 |
89402-43-7 |
Flam. Liq. 3 Acute Tox. 4 * Aquatic Chronic 3 |
H226 H302 H412 |
GHS02 GHS07 Wng |
H226 H302 H412 |
|
|
|
613-156-00-5 |
2-butyl-4-chloor-5-formylimidazool |
410-260-0 |
83857-96-9 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
613-157-00-0 |
2,4-diamino-5-methoxymethylpyrimidine |
410-330-0 |
54236-98-5 |
Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 |
H302 H373 ** H319 |
GHS08 GHS07 Wng |
H302 H373 ** H319 |
|
|
|
613-158-00-6 |
2,3-dichloor-5-trifluormethyl-pyridine |
410-340-5 |
69045-84-7 |
Acute Tox. 4 * Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H332 H302 H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H332 H302 H318 H317 H411 |
|
|
|
613-159-00-1 |
fenazaquin (ISO); 4-[2-[4-(1,1-dimethylethyl)fenyl]-ethoxy]chinazoline |
410-580-0 |
120928-09-8 |
Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H332 H400 H410 |
GHS06 GHS09 Dgr |
H301 H332 H410 |
|
|
|
613-160-00-7 |
(1S)-2-methyl-2,5-diazobicyclo[2.2.1]heptaandihydrobromide |
411-000-9 |
125224-62-6 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
613-161-00-2 |
(2,4-diaminopteridine-6-yl)methanolhydrobromide |
430-620-0 |
76145-91-0 |
STOT RE 2 * Skin Sens. 1 Aquatic Chronic 3 |
H373** H317 H412 |
GHS08 GHS07 Wng |
H373** H317 H412 |
|
|
|
613-162-00-8 |
(6R-trans)-1-((7-ammonio-2-carboxylato-8-oxo-5-thia-1-azabicyclo-[4.2.0]oct-2-een-3-yl)methyl)pyridiniumjodide |
423-260-0 |
100988-63-4 |
Muta. 2 Skin Sens. 1 Aquatic Chronic 2 |
H341 H317 H411 |
GHS08 GHS07 GHS09 Wng |
H341 H317 H411 |
|
|
|
613-163-00-3 |
azimsulfuron (ISO); 1-(4,6-dimethoxypyrimidine-2-yl)-3-[1-methyl-4-(2-methyl-2H-tetrazool-5-yl)pyrazool-5-ylsulfonyl]ureum |
— |
120162-55-2 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
M=1000 |
|
613-164-00-9 |
flufenacet (ISO); N-(4-fluorfenyl)-N-isopropyl-2-(5-trifluormethyl-[1,3,4]thiadiazool-2-yloxy)acetamide |
— |
142459-58-3 |
Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373** H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H302 H373** H317 H410 |
|
M=100 |
|
613-165-00-4 |
flupyrsulfuron-methyl-natrium (ISO); methyl-2-[[(4,6-dimethoxypyrimidine-2-ylcarbamoyl)sulfamoyl]-6-trifluormethyl]nicotinaat, mononatriumzout |
— |
144740-54-5 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
M=100 |
|
613-167-00-5 |
reactiemassa (3:1) van: 5-chloor-2-methyl-4-isothiazoline-3-on [EG-nr. 247-500-7] en 2-methyl-2H-isothiazool-3-on [EG-nr. 220-239-6]; reactiemassa (3:1) van: 5-chloor-2-methyl-4-isothiazoline-3-on [EG-nr. 247-500-7] en 2-methyl-4-isothiazoline-3-on [EG-nr. 220-239-6] |
— |
55965-84-9 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H331 H311 H301 H314 H317 H400 H410 |
GHS06 GHS05 GHS09 Dgr |
H331 H311 H301 H314 H317 H410 |
|
Skin Corr. 1B; H314: C ≥0,6 % Skin Irrit. 2; H315: 0,06 % ≤ C < 0,6 % Eye Irrit. 2; H319: 0,06 % ≤ C < 0,6 % Skin Sens. 1; H317: C ≥ 0,0015 % |
|
613-168-00-0 |
1-vinyl-2-pyrrolidon |
201-800-4 |
88-12-0 |
Carc. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * STOT SE 3 Eye Dam. 1 |
H351 H332 H312 H302 H373 ** H335 H318 |
GHS06 GHS05 GHS09 Dgr |
H351 H332 H312 H302 H373 ** H335 H318 |
|
|
D |
613-169-00-6 |
9-vinylcarbazool |
216-055-0 |
1484-13-5 |
Muta. 2 Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H341 H312 H302 H315 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H341 H312 H302 H315 H317 H410 |
|
M=100 |
|
613-170-00-1 |
2,2-ethylmethylthiazolidine |
404-500-3 |
694-64-4 |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H302 H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H317 H411 |
|
|
|
613-171-00-7 |
hexaconazool (ISO);(RS)-2-(2,4-dichloorfenyl)-1-(1H-1,2,4-triazool-1-yl)hexaan-2-ol |
413-050-7 |
79983-71-4 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H302 H317 H411 |
GHS07 GHS09 Wng |
H302 H317 H411 |
|
|
|
613-172-00-2 |
5-chloor-1,3-dihydro-2H-indool-2-on |
412-200-9 |
17630-75-0 |
Repr. 2 Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 3 |
H361f *** H302 H317 H412 |
GHS08 GHS07 Wng |
H361f *** H302 H317 H412 |
|
|
|
613-173-00-8 |
fluquinconazool (ISO); 3-(2,4-dichloorfenyl)-6-fluor-2-(1H-1,2,4-triazool-1-yl)chinazoline-4-(3H)-on |
411-960-9 |
136426-54-5 |
Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 Acute Tox. 4 * Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H372 ** H312 H315 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H331 H301 H372 ** H312 H315 H410 |
|
|
|
613-174-00-3 |
tetraconazool (ISO); (±)-2-(2,4-dichloorfenyl)-3-(1H-1,2,4-triazool-1-yl)propyl-1,1,2,2-tetrafluorethylether |
407-760-6 |
112281-77-3 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 2 |
H332 H302 H411 |
GHS07 GHS09 Wng |
H332 H302 H411 |
|
|
|
613-175-00-9 |
epoxiconazool (ISO); (2RS,3SR)-3-(2-chloorfenyl)-2-(4-fluorfenyl)-[(1H-1,2,4-triazool-1-yl)methyl]oxiraan |
406-850-2 |
133855-98-8 |
Carc. 2 Repr. 1B Aquatic Chronic 2 |
H351 H360Df H411 |
GHS08 GHS09 Dgr |
H351 H360Df H411 |
|
|
|
613-176-00-4 |
2-methyl-2-azabicyclo[2.2.1]heptaan |
404-810-9 |
4524-95-2 |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B |
H226 H312 H302 H373 ** H314 |
GHS02 GHS08 GHS05 GHS07 Dgr |
H226 H312 H302 H373 ** H314 |
|
|
|
613-177-00-X |
8-amino-7-methylchinoline |
412-760-4 |
5470-82-6 |
Acute Tox. 4 * Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H312 H302 H317 H411 |
GHS07 GHS09 Wng |
H312 H302 H317 H411 |
|
|
|
613-178-00-5 |
4-ethyl-2-methyl-2-isopentyl-1,3-oxazolidine |
410-470-2 |
137796-06-6 |
Skin Corr. 1B Skin Sens. 1 |
H314 H317 |
GHS05 GHS07 Dgr |
H314 H317 |
|
STOT SE 3; H335: C ≥ 5 % |
|
613-179-00-0 |
lithium-3-oxo-1,2(2H)-benzisothiazool-2-ide |
411-690-1 |
111337-53-2 |
Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 |
H302 H314 H317 H411 |
GHS05 GHS07 Dgr |
H302 H314 H317 H411 |
|
|
|
613-180-00-6 |
N-(1,1-dimethylethyl)bis(2-benzothiazoolsulfeen)amide |
407-430-1 |
3741-80-8 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
613-181-00-1 |
5,5-dimethyl-perhydro-pyrimidine-2-on-α-(4-trifluormethylstyryl)-α-(4-trifluormethyl)cinnamylideenhydrazon |
405-090-9 |
67485-29-4 |
STOT RE 1 Acute Tox. 4 * Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H372 ** H302 H319 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H372 ** H302 H319 H410 |
|
|
|
613-182-00-7 |
1-(1-naftylmethyl)chinoliniumchloride |
406-220-7 |
65322-65-8 |
Carc. 2 Muta. 2 Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H351 H341 H302 H315 H318 H412 |
GHS08 GHS05 GHS07 Dgr |
H351 H341 H302 H315 H318 H412 |
|
|
|
613-183-00-2 |
reactiemassa van: 5-(N-methylperfluoroctylsulfonamido)methyl-3-octadecyl-1,3-oxazolidine-2-on; 5-(N-methylperfluorheptylsulfonamido)methyl-3-octadecyl-1,3-oxazolidine-2-on |
413-640-4 |
— |
STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H373 ** H400 H410 |
GHS08 GHS09 Wng |
H373 ** H410 |
|
|
|
613-184-00-8 |
nitrilotriëthyleenammoniopropaan-2-ol-2-ethylhexanoaat |
413-670-8 |
— |
Eye Irrit. 2 Skin Sens. 1 |
H319 H317 |
GHS07 Wng |
H319 H317 |
|
|
|
613-185-00-3 |
2,3,5,6-tetrahydro-2-methyl-2H-cyclopenta[d]-1,2-thiazool-3-on |
407-630-9 |
82633-79-2 |
Acute Tox. 3 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H318 H317 H400 H410 |
GHS06 GHS05 GHS09 Dgr |
H301 H318 H317 H410 |
|
|
|
613-186-00-9 |
(2R,3R)-3-((R)-1-(tert-butyldimethylsiloxy)ethyl)-4-oxoazetidine-2-ylacetaat |
408-050-9 |
76855-69-1 |
Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H319 H317 H411 |
GHS07 GHS09 Wng |
H319 H317 H411 |
|
|
|
613-187-00-4 |
5-(2-amino-5-cyaan-6-[2-(2-hydroxyethoxy)ethylamino]-4-methylpyridine-3-ylazo)-3-methyl-2,4-dicarbonitrilthiofeen |
410-530-8 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
613-188-00-X |
1-(3-(4-fluorfenoxy)propyl)3-methoxy-4-piperidinon |
411-500-7 |
116256-11-2 |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H302 H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H317 H411 |
|
|
|
613-189-00-5 |
1,4,7,10-tetrakis(p-tolueensulfonyl)-1,4,7,10-tetraäzacyclododecaan |
414-030-0 |
52667-88-6 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
613-190-00-0 |
dinatrium-1-amino-4-(2-(5-chloor-6-fluor-pyrimidine-4-ylamino-methyl)-4-methyl-6-sulfofenylamino)-9,10-dioxo-9,10-dihydro-antraceen-2-sulfonaat |
414-040-5 |
149530-93-8 |
Acute Tox. 4 * Skin Sens. 1 |
H302 H317 |
GHS07 Wng |
H302 H317 |
|
|
|
613-191-00-6 |
3-ethyl-2-methyl-2-(3-methylbutyl)-1,3-oxazolidine |
421-150-7 |
143860-04-2 |
Repr. 1B Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H360F *** H314 H400 H410 |
GHS08 GHS05 GHS09 Dgr |
H360F *** H314 H410 |
|
|
|
613-192-00-1 |
3-benzyl-exo-6-nitro-2,4-dioxo-3-aza-cis-bicyclo[3.1.0]hexaan |
426-750-2 |
151860-15-0 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
613-193-00-7 |
pentakis[3-(dimethylammonio)propylsulfamoyl]-[(6-hydroxy-4,4,8,8-tetramethyl-4,8-diazoniaündecaan-1,11-diyldisulfamoyl)di[ftalocyaninekoper(II)]]-heptalactaat |
414-930-3 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
613-194-00-2 |
6,13-dichloor-3,10-bis{2-[4-fluor-6-(2-sulfofenylamino)-1,3,5-triazine-2-ylamino]propylamino}benzo[5,6][1,4]oxazino[2,3-b]fenoxazine-4,11-disulfonzuur, lithium-, natriumzout |
418-000-8 |
163062-28-0 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
613-195-00-8 |
2,2-(1,4-fenyleen)bis((4H—3,1-benzoxazine-4-on) |
418-280-1 |
18600-59-4 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
613-196-00-3 |
5-[[4-chloor-6-[[2-[[4-fluor-6-[[5-hydroxy-6-[(4-methoxy-2-sulfofenyl)azo]-7-sulfo-2-naftalenyl]amino]-1,3,5-triazine-2-yl]amino]-1-methylethyl]amino]-1,3,5-triazine-2-yl]amino]-3-[[4-(ethenylsulfonyl)fenyl]azo]-4-hydroxynaftaleen-2,7-disulfonzuur, natriumzout |
418-380-5 |
168113-78-8 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
613-197-00-9 |
reactiemassa van: 2,4,6-tri(butylcarbamoyl)-1,3,5-triazine; 2,4,6-tri(methylcarbamoyl)-1,3,5-triazine; [(2-butyl-4,6-dimethyl)tricarbamoyl]-1,3,5-triazine; [(2,4-dibutyl-6-methyl)tricarbamoyl]-1,3,5-triazine |
420-390-1 |
187547-46-2 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
613-198-00-4 |
2-amino-4-dimethylamino-6-trifluorethoxy-1,3,5-triazine |
415-500-8 |
145963-84-4 |
Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 3 |
H302 H373** H412 |
GHS08 GHS07 Wng |
H302 H373** H412 |
|
|
|
613-199-00-X |
reactiemassa van: 1,3,5-tris(3-aminomethylfenyl)-1,3,5-(1H,3H,5H)-triazine-2,4,6-trion; reactiemassa van oligomeren van: 3,5-bis(3-aminomethylfenyl)1-poly[3,5-bis(3-aminomethylfenyl)-2,4,6-trioxo-1,3,5-(1H,3H,5H)-triazine-1-yl]-1,3,5(1H,3H,5H)-triazine-2,4,6-trion |
421-550-1 |
— |
Carc. 1B Repr. 1B Skin Sens. 1 Aquatic Chronic 3 |
H350 H360D *** H317 H412 |
GHS08 Dgr |
H350 H360D *** H317 H412 |
|
|
|
613-200-00-3 |
reactieproduct van: koper, (29H,31H-ftalocyaninato(2–)-N 29,N 30,N 31,N 32)-, chloorzwavelzuur en 3-(2-sulfoöxyethylsulfonyl)aniline, natriumzouten |
420-980-7 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
613-201-00-9 |
(R)-5-broom-3-(1-methyl-2-pyrrolidinyl-methyl)-1H-indool |
422-390-5 |
143322-57-0 |
Repr. 2 STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361f *** H372 ** H332 H302 H317 H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H361f *** H372 ** H332 H302 H317 H410 |
EUH070 |
|
|
613-202-00-4 |
pymetrozine (ISO); (E)-4,5-dihydro-6-methyl-4-(3-pyridylmethyleenamino)-1,2,4-triazine-3(2H)-on |
— |
123312-89-0 |
Carc. 2 Aquatic Chronic 3 |
H351 H412 |
GHS08 Wng |
H351 H412 |
|
|
|
613-203-00-X |
pyraflufen-ethyl (ISO); 2-chloor-5-(4-chloor-5-difluormethoxy-1-methylpyrazool-3-yl)-4-fluorfenoxyazijnzuur-ethylester; [1] pyraflufen (ISO); 2-chloor-5-(4-chloor-5-difluormethoxy-1-methylpyrazool-3-yl)-4-fluorfenoxyazijnzuur [2] |
-[1] -[2] |
129630-19-9 [1] 129630-17-7 [2] |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
M=1000 |
|
613-204-00-5 |
oxadiargyl (ISO); 3-[2,4-dichloor-5-(2-propynyloxy)fenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazool-2(3H)-on |
254-637-6 |
39807-15-3 |
Repr. 2 STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H361d*** H373** H400 H410 |
GHS08 GHS09 Wng |
H361d*** H373** H410 |
|
M = 1000 |
|
613-205-00-0 |
propiconazool (ISO); (±) 1-[2-(2,4-dichloorfenyl)-4-propyl-1,3-dioxolaan-2-ylmethyl]-1H—1,2,4-triazool |
262-104-4 |
60207-90-1 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
|
613-206-00-6 |
fenamidone (ISO); (S)-5-methyl-2-methylthio-5-fenyl-3-fenylamino-3,5-dihydroïmidazool-4-on |
— |
161326-34-7 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
613-208-00-7 |
imazamox (ISO); (RS)-2-(4-isopropyl-4-methyl-5-oxo-2-imidazoline-2-yl)-5-methoxymethylnicotinezuur |
— |
114311-32-9 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
613-209-00-2 |
cis-1-(3-chloorpropyl)-2,6-dimethylpiperidinehydrochloride |
417-430-3 |
63645-17-0 |
Acute Tox. 3 * STOT RE 2 * Skin Sens. 1 Aquatic Chronic 2 |
H301 H373 ** H317 H411 |
GHS06 GHS08 GHS09 Dgr |
H301 H373 ** H317 H411 |
|
|
|
613-210-00-8 |
2-(3-chloorpropyl)-2,5,5-trimethyl-1,3-dioxaan |
417-650-1 |
88128-57-8 |
STOT RE 2 * Aquatic Chronic 3 |
H373 ** H412 |
GHS08 Wng |
H373 ** H412 |
|
|
|
613-211-00-3 |
N-methyl-4-(p-formylstyryl)pyridiniummethylsulfaat |
418-240-3 |
74401-04-0 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
613-212-00-9 |
4-[4-(2-ethylhexyloxy)fenyl](1,4-thiazinaan-1,1-dioxide) |
418-320-8 |
133467-41-1 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
613-213-00-4 |
cis-1-benzoyl-4-[(4-methylsulfonyl)oxy]-L-proline |
416-040-0 |
120807-02-5 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
613-214-00-X |
N,N-di-n-butyl-2-(1,2-dihydro-3-hydroxy-6-isopropyl-2-chinolylideen)-1,3-dioxoïndaan-5-carboxamide |
416-260-7 |
147613-95-4 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
613-215-00-5 |
2-chloormethyl-3,4-dimethoxypyridiniumchloride |
416-440-5 |
72830-09-2 |
Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H312 H302 H373 ** H315 H318 H317 H411 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H312 H302 H373 ** H315 H318 H317 H411 |
|
|
|
613-216-00-0 |
6-tert-butyl-7-(6-diëthylamino-2-methyl-3-pyridylimino)-3-(3-methylfenyl)pyrazolo[3,2-c][1,2,4]triazool |
416-490-8 |
162208-01-7 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
613-217-00-6 |
4-[3-(3,5-di-tert-butyl-4-hydroxyfenyl)propionyloxy]-1-[2-[3-(3,5-di-tert-butyl-4-hydrofenyl)propionyloxy]ethyl]-2,2,6,6-tetramethylpiperidine |
416-770-1 |
73754-27-5 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
613-218-00-1 |
6-hydroxyindool |
417-020-4 |
2380-86-1 |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H302 H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H317 H411 |
|
|
|
613-219-00-7 |
7a-ethyl-3,5-bis(1-methylethyl)-2,3,4,5-tetrahydroöxazolo[3,4-c]-2,3,4,5-tetrahydroöxazool |
417-140-7 |
79185-77-6 |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
613-220-00-2 |
trans-(4S,6S)-5,6-dihydro-6-methyl-4H-thiëno[2,3-b]thiopyran-4-ol, 7,7-dioxide |
417-290-3 |
147086-81-5 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
613-221-00-8 |
2-chloor-5-methylpyridine |
418-050-0 |
18368-64-4 |
Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Aquatic Chronic 3 |
H312 H302 H315 H412 |
GHS07 Wng |
H312 H302 H315 H412 |
|
|
|
613-222-00-3 |
4-(1-oxo-2-propenyl)-morfoline |
418-140-1 |
5117-12-4 |
Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 |
H302 H373 ** H318 H317 |
GHS08 GHS05 GHS07 Dgr |
H302 H373 ** H318 H317 |
|
|
|
613-223-00-9 |
N-isopropyl-3-(4-fluorfenyl)-1H-indool |
418-790-4 |
93957-49-4 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
613-224-00-4 |
2,5-dimercaptomethyl-1,4-dithiaan |
419-770-8 |
136122-15-1 |
Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H314 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H302 H314 H317 H410 |
|
|
|
613-225-00-X |
reactiemassa van: [2-(antrachinon-1-ylamino)-6-[(5-benzoylamino)-antrachinon-1-ylamino]-4-fenyl]-1,3,5-triazine; 2,6-bis-[(5-benzoylamino)-antrachinon-1-ylamino]-4-fenyl-1,3,5-triazine. |
421-290-9 |
— |
STOT RE 2 * Aquatic Chronic 4 |
H373 ** H413 |
GHS08 Wng |
H373 ** H413 |
|
|
|
613-226-00-5 |
1-(2-(ethyl(4-(4-(4-(4-(ethyl(2-pyridinoëthyl)amino)-2-methylfenylazo)benzoylamino)-fenylazo)-3-methylfenyl)amino)ethyl)pyridiniumdichloride |
420-950-3 |
163831-67-2 |
Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Dgr |
H318 H410 |
|
|
|
613-227-00-0 |
(±)-[(R*,R*) en (R*,S*)]-6-fluor-3,4-dihydro-2-oxiranyl-2H-1-benzopyran |
419-600-2 |
99199-90-3 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
613-228-00-6 |
(±)-(R*,S*)-6-fluor-3,4-dihydro-2-oxiranyl-2H-1-benzopyran |
419-630-6 |
793669-26-8 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
613-229-00-1 |
1-acetyl-4-(3-dodecyl-2,5-dioxo-1-pyrrolidinyl)-2,2,6,6-tetramethylpiperidine |
411-930-5 |
106917-31-1 |
Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H315 H317 H410 |
|
|
|
613-230-00-7 |
florasulam (ISO); 2',6',8-trifluor-5-methoxy-5-triazool[1,5-c]; pyrimidine-2-sulfonanilide |
— |
145701-23-1 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
613-231-00-2 |
2,6-diamino-3-((pyridin-3-yl)azo)pyridine |
421-430-9 |
28365-08-4 |
Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 2 |
H302 H373** H411 |
GHS08 GHS07 GHS09 Wng |
H302 H373** H411 |
|
|
|
613-232-00-8 |
3-(benzo[b]thieen-2-yl)-5,6-dihydro-1,4,2-oxathiazine-4-oxide |
431-030-6 |
163269-30-5 |
Acute Tox. 3 * STOT RE 2 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H331 H373** H318 H400 H410 |
GHS06 GHS05 GHS08 GHS09 Dgr |
H331 H373** H318 H410 |
|
|
|
613-233-00-3 |
4,4'-(oxy-(bismethyleen))-bis-1,3-dioxolaan |
423-230-7 |
56552-15-9 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
613-234-00-9 |
imidazo[1,2-b]pyridazinehydrochloride |
431-510-5 |
18087-70-2 |
Acute Tox. 4 * Eye Irrit. 2 |
H302 H319 |
GHS07 Wng |
H302 H319 |
|
|
|
613-235-00-4 |
2,3-dihydro-2,2-dimethyl-1H-perimidine |
424-060-6 |
6364-17-6 |
Acute Tox. 4* STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373** H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H302 H373** H317 H410 |
|
|
|
613-236-00-X |
2-chloor-3-trifluormethylpyridine |
424-520-6 |
65753-47-1 |
Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 Skin Corr. 1B Aquatic Chronic 3 |
H311 H301 H372** H314 H412 |
GHS06 GHS05 GHS08 Dgr |
H311 H301 H372** H314 H412 |
|
|
|
613-237-00-5 |
6-tert-butyl-3-(3-dodecylsulfonyl)propyl-7H-1,2,4-triazolo[3.4-b][1,3,4]thiadiazine |
424-950-4 |
133949-92-5 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
613-238-00-0 |
natrium-2-[[4-[(4,6-dichloor-1,3,5-triazine-2-yl)amino]fenyl]sulfonyl]ethylsulfaat |
430-890-1 |
81992-66-7 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
613-239-00-6 |
2-[3-(methylamino)propyl]-1H-benzimidazool |
425-760-4 |
64137-52-6 |
Eye Dam. 1 Aquatic Chronic 3 |
H318 H412 |
GHS05 Dgr |
H318 H412 |
|
|
|
613-241-00-7 |
3-(2H-tetrazool-5-yl)pyridine |
426-810-8 |
3250-74-6 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
613-242-00-2 |
reactieproducten van 3,10-bis((2-aminopropyl)amino)-6,13-dichloor-4,11-trifenodioxazinedisulfonzuur met 2-amino-1,4-benzeendisulfonzuur, 2-((4-aminofenyl)sulfonyl)ethyl-hydrogeen-sulfaat en 2,4,6-trifluor-1,3,5-triazine, natriumzouten |
426-860-0 |
191877-09-5 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
613-243-00-8 |
4,4'-(1,6-hexamethyleenbis(formylimino))bis(2,2,6,6-tetramethyl-1-oxylpiperidine) |
427-350-0 |
182235-14-9 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
613-244-00-3 |
5,7-dichloor-4-hydroxychinoline |
427-420-0 |
21873-52-9 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
613-245-00-9 |
2-fluor-6-trifluormethylpyridine |
428-100-3 |
94239-04-0 |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 3 |
H226 H332 H302 H412 |
GHS02 GHS07 Wng |
H226 H332 H302 H412 |
|
|
|
613-246-00-4 |
2-hydroxymethyl-3-methyl-4-(2,2,2-trifluorethoxy)pyridine |
428-200-7 |
103577-66-8 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
613-247-00-X |
3-(2-methoxy-4-methoxycarboxybenzyl)-5-nitroïndool |
428-910-7 |
107786-36-7 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
613-248-00-5 |
3,4-dimethyl-1H-pyrazool |
429-130-1 |
2820-37-3 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 |
H302 H318 H412 |
GHS05 GHS07 Dgr |
H302 H318 H412 |
|
|
|
613-249-00-0 |
1-(2-hydroxyethyl)-1H-pyrazool-4,5-diyldiammoniumsulfaat |
429-300-3 |
155601-30-2 |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H318 H317 H411 |
|
|
|
613-250-00-6 |
reactiemassa van: carbonato-bis-N-ethyl-2-isopropyl-1,3-oxazolidine; methylcarbonato-N-ethyl-2-isopropyl-1,3-oxazolidine; 2-isopropyl-N-hydroxyethyl-1,3-oxazolidine |
429-990-6 |
— |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H318 H317 H412 |
GHS05 GHS07 Dgr |
H318 H317 H412 |
|
|
|
613-251-00-1 |
(R)-3-[(1-methylpyrrolidine-2-yl)methyl]-5-[2-(fenylsulfonyl)ethenyl]-1H-indool |
430-560-5 |
180637-89-2 |
Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 |
H302 H373** H318 H317 |
GHS05 GHS08 GHS07 Dgr |
H302 H373** H318 H317 |
|
|
|
613-253-00-2 |
2,2-dialkyl-4-hydroxymethyl-1,3-dioxolaan; reactieproducten met ethyleenoxide (alkyl is C1-12 en de som niet groter dan C13, gemiddelde ethoxylatiegraad is 3,5) |
430-580-4 |
— |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
EUH019 |
|
|
613-254-00-8 |
forchloorfenuron (ISO); 1-(2-chloor-4-pyridyl)-3-fenylureum |
— |
68157-60-8 |
Carc. 2 Aquatic Chronic 2 |
H351 H411 |
GHS08 GHS09 Wng |
H351 H411 |
|
|
|
613-255-00-3 |
reactiemassa van isomeren van: natrium-[(2-hydroxyethylsulfamoyl){][}2-(2-piperazine-1-ylethylamino)ethylsulfamoyl][2-(4-aminoëthylpiperazine-1-yl)ethylsulfamoyl{](sulfamoyl)[}(sulfonatoftalocyaninato)]koper(II) |
424-270-8 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
613-256-00-9 |
3'5'-anhydrothymidine |
425-810-5 |
38313-48-3 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
613-257-00-4 |
2-ftalimidoëthyl-N-[4-(2-cyaan-4-nitrofenylazo)fenyl]-N-methyl-β-alaninaat |
426-400-9 |
170222-39-6 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
613-258-00-X |
reactiemassa van: 4-chloor-7-methylbenzotriazool, natriumzout; 4-chloor-5-methylbenzotriazool, natriumzout; 5-chloor-4-methylbenzotriazool, natriumzout |
427-730-6 |
202420-04-0 |
Skin Corr. 1B Aquatic Chronic 3 |
H314 H412 |
GHS05 Dgr |
H314 H412 |
|
|
|
613-259-00-5 |
reactiemassa van: [2,4-dioxo-(2-propyn-1-yl)imidazolidine-3-yl]methyl(1R)-cis-chrysanthemaat; [2,4-dioxo-(2-propyn-1-yl)imidazolidine-3-yl]methyl(1R)-trans-chrysantemaat |
428-790-6 |
72963-72-5 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
613-260-00-0 |
(±)-4-(3-chloorfenyl)-6-[(4-chloorfenyl)hydroxy(1-methyl-1H-imidazool-5-yl)methyl]-1-methyl-2(1H)-chinoline |
430-730-9 |
— |
Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H400 H410 |
GHS05 GHS09 Dgr |
H318 H410 |
|
|
|
613-261-00-6 |
pyrazool-1-carboxamidine-monohydrochloride |
429-520-1 |
4023-02-3 |
Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H302 H373** H318 H317 H412 |
GHS05 GHS08 GHS07 Dgr |
H302 H373** H318 H317 H412 |
|
|
|
613-262-00-1 |
dinatrium-(E)-1,2-bis(4-(4-methylamino-6-(4-methylcarbamoylfenylamino)-1,3,5-triazine-2-ylamino)fenyl-2-sulfonato)etheen |
427-310-2 |
180850-95-7 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
613-263-00-7 |
mononatrium-3-cyaan-5-fluor-6-hydroxypyridine-2-olaat |
429-570-2 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
613-266-00-3 |
2-chloor-5-chloormethylthiazool |
429-830-5 |
105827-91-6 |
Acute Tox. 3 * Skin Corr. 1B Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H311 H314 H302 H317 H411 |
GHS06 GHS05 GHS09 Dgr |
H311 H314 H302 H317 H411 |
|
|
|
613-267-00-9 |
thiamethoxam (ISO); 3-(2-chloorthiazool-5-ylmethyl)-5-methyl[1,3,5]oxadiazinaan-4-ylideen-N-nitroamine |
428-650-4 |
153719-23-4 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
M=10 |
|
613-268-00-4 |
(4aS-cis)-6-benzyloctahydropyrrolo[3.4-b]pyridine |
425-930-8 |
151213-39-7 |
Skin Corr. 1B Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 2 |
H314 H332 H302 H373** H411 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H314 H332 H302 H373** H411 |
|
|
|
613-269-00-X |
2-thiazolidinylideencyaanamide |
427-720-1 |
26364-65-8 |
Acute Tox. 4* STOT RE 2 * Aquatic Chronic 3 |
H302 H373** H412 |
GHS08 GHS07 Wng |
H302 H373** H412 |
|
|
|
613-270-00-5 |
5-amino-N-(2,6-dichloor-3-methylfenyl)-1H-1,2,4-triazool-3-sulfonamide |
428-150-6 |
113171-13-4 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
613-271-00-0 |
tritosulfuron (ISO) (met ≤ 0,02 % AMTT); 1-[4-methoxy-6-(trifluormethyl)-1,3,5-triazine-2-yl]-3-[2-(trifluormethyl)benzeensulfonyl]ureum (met ≤ 0,02 % AMTT) |
— |
142469-14-5 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
M=10 |
|
613-272-00-6 |
pyraclostrobine (ISO); methyl-N-{2-[1-(4-chloorfenyl)-1H-pyrazool-3-yloxymethyl]fenyl}(N-methoxy)carbamaat |
— |
— |
Acute Tox. 3 * Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H331 H315 H400 H410 |
GHS06 GHS09 Dgr |
H331 H315 H410 |
|
M=100 |
|
613-273-00-1 |
tetrahydro-3-methyl-5-((2-fenylthio)thiazool-5-ylmethyl)-[4H]-1,3,5-oxadiazinaan-4-ylideen-N-nitroamine |
427-600-9 |
192439-46-6 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
613-274-00-7 |
2,6-dichloor-1-fluorpyridiniumtetrafluorboraat |
427-400-1 |
140623-89-8 |
Skin Corr. 1B Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H314 H302 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H314 H302 H317 H410 |
|
|
|
613-275-00-2 |
3-(2-chloorethyl)-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]-pyrimidine-4-on-monohydrochloride |
424-530-0 |
93076-03-0 |
Acute Tox. 3 * STOT SE 2 STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H301 H371** H373** H318 H317 H411 |
GHS06 GHS05 GHS08 GHS09 Dgr |
H301 H371** H373** H318 H317 H411 |
|
|
|
613-276-00-8 |
1-(2-chloorfenyl)-1,2-dihydro-5H-tetrazool-5-on |
426-110-2 |
98377-35-6 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
613-277-00-3 |
(4-(6-diëthylamino-2-methylpyridine-3-yl)imino-4,5-dihydro-3-methyl-1(4-methylfenyl)-1H-pyrazool-5-on |
427-070-9 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
613-278-00-9 |
(3-aminofenyl)pyridine-3-ylmethanon |
428-230-0 |
79568-06-2 |
STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H373** H400 H410 |
GHS08 GHS09 Wng |
H373** H410 |
|
|
|
613-279-00-4 |
2-ethyl-2,3-dihydro-2-methyl-1H-perimidine |
424-380-6 |
43057-68-7 |
Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373** H400 H410 |
GHS08 GHS07 GHS09 Wng |
H302 H373** H410 |
|
|
|
613-280-00-X |
tetrahydro-1,3-dimethyl-1H-pyrimidine-2-on; dimethylpropyleenureum |
230-625-6 |
7226-23-5 |
Repr. 2 Acute Tox. 4 * Eye Dam. 1 |
H361f*** H302 H318 |
GHS05 GHS08 GHS07 Dgr |
H361f*** H302 H318 |
|
|
|
613-281-00-5 |
chinoline |
202-051-6 |
91-22-5 |
Carc. 1B Muta. 2 Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 |
H350 H341 H312 H302 H319 H315 H411 |
GHS08 GHS07 GHS09 Dgr |
H350 H341 H312 H302 H319 H315 H411 |
|
|
|
613-282-00-0 |
triticonazool (ISO); (RS)-(E)-5-(4-chloorbenzylideen)-2,2-dimethyl-1-(1H-1,2,4-triazool-1-methyl)cyclopentanol |
— |
131983-72-7 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
613-283-00-6 |
ketoconazool; 1-[4-[4-[[(2SR, 4RS)-2-(2,4-dichloorfenyl)-2-(imidazool-1-ylmethyl)-1,3-dioxolaan-4-yl]methoxy]fenyl]piperazine-1-yl]ethanon |
265-667-4 |
65277-42-1 |
Repr. 1B Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H360F*** H301 H373** H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H360F*** H301 H373** H410 |
|
|
|
613-284-00-1 |
metconazool (ISO); (1RS, 5RS;1RS, 5SR)-5-(4-chloorbenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazool-1-ylmethyl)cyclopentanol |
— |
125116-23-6 |
Repr. 2 Acute Tox. 4 * Aquatic Chronic 2 |
H361d*** H302 H411 |
GHS08 GHS07 GHS09 Wng |
H361d*** H302 H411 |
|
|
|
613-285-00-7 |
1-hydroxybenzotriazool, watervrij; [1] 1-hydroxybenzotriazool, monohydraat [2] |
219-989-7 [1] 219-989-7 [2] |
2592-95-2 [1] 123333-53-9 [2] |
Expl. 1.3 |
H203 |
GHS01 Dgr |
H203 |
|
|
|
613-286-00-2 |
kalium-1-methyl-3-morfolinocarbonyl-4-[3-(1-methyl-3-morfolinocarbonyl-5-oxo-2-pyrazoline-4-ylideen)-1-propenyl]pyrazool-5-olaat; [met < 0,5 % N, N-dimethylformamide (EG-nr. 200-679-5)] |
418-260-2 |
183196-57-8 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
613-286-01-X |
kalium-1-methyl-3-morfolinocarbonyl-4-[3-(1-methyl-3-morfolinocarbonyl-5-oxo-2-pyrazoline-4-ylideen)-1-propenyl]pyrazool-5-olaat; [met ≥ 0,5 % N, N-dimethylformamide (EG-nr. 200-679-5)] |
418-260-2 |
183196-57-8 |
Repr. 1B Skin Sens. 1 |
H360D*** H317 |
GHS08 GHS07 Dgr |
H360D*** H317 |
|
|
|
613-287-00-8 |
1-(3-jood-4-aminobenzyl)-1H-1,2,4-triazool |
419-540-7 |
160194-26-3 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H302 H317 H411 |
GHS07 GHS09 Wng |
H302 H317 H411 |
|
|
|
613-288-00-3 |
1,3-bis(dimethylcarbamoyl)imidazoliumchloride |
420-930-4 |
135756-61-5 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 |
H302 H318 H412 |
GHS05 GHS07 Dgr |
H302 H318 H412 |
|
|
|
613-289-00-9 |
3-(4-chloor-2-fluor-5-methylfenyl)-1-methyl-5-(trifluormethyl)-1H-pyrazool |
432-020-4 |
142623-48-1 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
613-290-00-4 |
4-hydroxy-7-(2-aminoëthyl)-1,3-benzothiazool-2(3H)-on-hydrochloride |
432-470-1 |
189012-93-9 |
Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H318 H317 H410 |
|
|
|
613-291-00-X |
2,4-dihydro-4-(4-(4-(4-hydroxyfenyl)-1-piperazinyl)fenyl)-2-(1-methylpropyl)-3H-1,2,4-triazool-3-on |
434-820-9 |
106461-41-0 |
STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H373** H400 H410 |
GHS08 GHS09 Wng |
H373** H410 |
|
|
|
613-292-00-5 |
N,N',N''-tris(2-methyl-2,3-epoxypropyl)perhydro-2,4,6-oxo-1,3,5-triazine |
435-010-8 |
26157-73-3 |
Muta. 2 Aquatic Chronic 3 |
H341 H412 |
GHS08 Wng |
H341 H412 |
|
|
|
613-293-00-0 |
2-(4-tert-butylfenyl)-6-cyaan-5-[bis(ethoxycarbonylmethyl)carbamoyloxy]-1H-pyrrolo[1,2-b][1,2,4]-triazool-7-carbonzuur, 2,6-di-tert-butyl-4-methylcyclohexylester |
448-050-6 |
444065-11-6 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
613-294-00-6 |
2-hexyldecaanzuur, [4-(6-tert-butyl-7-chloor-1H-pyrazolo[1,5-b][1,2,4]triazool-2-yl)fenylcarbamoyl]methylester |
448-260-8 |
379268-96-9 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
613-295-00-1 |
11-amino-3-chloor-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c, f][1,2]thiazepinehydrochloride |
448-720-8 |
363138-44-7 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 |
H302 H318 H412 |
GHS05 GHS07 Dgr |
H302 H318 H412 |
|
|
|
613-296-00-7 |
pentakalium-2-(4-(5-[1-(2,5-disulfonatofenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazool-4-ylideen]-3-methyl-1,3-pentadiënyl)-3-methylcarbamoyl-5-oxidopyrazool-1-yl)benzeen-1,4-disulfonaat |
418-270-7 |
— |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
613-297-00-2 |
5-(2-broomfenyl)-2-tert-butyl-2H-tetrazool |
420-820-6 |
— |
Flam. Liq. 3 Acute Tox. 4 * Aquatic Chronic 2 |
H226 H302 H411 |
GHS02 GHS07 GHS09 Wng |
H226 H302 H411 |
|
|
|
613-298-00-8 |
bis(6-hydroxy-4-methyl-5-(3-methylimidazolium-1-yl)-3-(4-fenylazo)-1H-pyridine-2-on)ethyleendilactaat |
421-560-6 |
— |
STOT RE 2 * Eye Dam. 1 Aquatic Chronic 2 |
H373** H318 H411 |
GHS05 GHS08 GHS09 Dgr |
H373** H318 H411 |
|
|
|
613-299-00-3 |
hoofdbestanddeel 1 (isomeer 1): 2-{6-fluor-4-[3-(2,5-disulfo-fenylazo)-4-hydroxy-2-sulfonaft-7-ylamino]-1,3,5-triazine-2-ylamino}-3-{6-fluor-4-[3-(1,5-disulfonaft-2-ylazo)-4-hydroxy-2-sulfonaft-7-ylamino]-1,3,5-triazine-2-ylamino}-propaan, natriumzout; hoofdbestanddeel 1 (isomeer 2): 2-{6-fluor-4-[3-(2,5-disulfofenylazo)-4-hydroxy-2-sulfonaft-7-ylamino]-1,3,5-triazine-2-ylamino}-3-{6-fluor-4-[3(2,5-disulfo-fenylazo)-4-hydroxy-2-sulfonaft-7-ylamino]-1,3,5-triazine-2-ylamino}-propaan, natriumzout; hoofdbestanddeel 2: 2,3-bis-{6-fluor-4-[3-(2,5-disulfo-fenylazo)-4-hydroxy-2-sulfonaft-7-ylamino]-1,3,5-triazine-2-ylamino}-propaan, natriumzout; hoofdbestanddeel 3: 2,3-bis-{6-fluor-4-[3-(1,5-disulfonaft-2-ylazo)-4-hydroxy-2-sulfonaft-7-ylamino]-1,3,5-triazine-2-ylamino}-propaan, natriumzout |
422-610-1 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
613-300-00-7 |
1-imidazool-1-yloctadecaan-2-ol |
434-120-3 |
— |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
613-301-00-2 |
dimethyl-1-{[2-methoxy-5-(2-methylbutoxycarbonyl)fenylcarbamoyl][2-octadecyl-1,1-dioxo-1,2,4-benzothiadiazine-3-yl]methyl}imidazool-4,5-dicarboxylaat |
443-910-7 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
613-302-00-8 |
dinatrium-2-(5-carbamoyl-1-ethyl-2-hydroxy-4-methyl-6-oxo-1,6-dihydropyridine-3-ylazo)-4-(4-fluor-6-(4-(2-sulfonyloxyethylsulfonyl)fenylamino)-1,3,5-triazine-2-ylamino)benzeensulfonaat |
432-980-4 |
243858-60-8 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
613-303-00-3 |
2-(1-methyl-2-(4-fenoxyfenoxy)ethoxy)pyridine |
429-800-1 |
95737-68-1 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
613-304-00-9 |
5,6-dihydroxy-2,3-dihydro-1H-indoliumbromide |
421-170-6 |
138937-28-7 |
Acute Tox. 4 * Eye Dam. 1 |
H302 H318 |
GHS05 GHS07 Dgr |
H302 H318 |
|
|
|
613-305-00-4 |
2-(2-hydroxy-4-octyloxyfenyl)-2H-benzotriazool |
448-630-9 |
3147-77-1 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
613-306-00-X |
(2,5-dioxopyrrolidine-1-yl)-9H-fluoreen-9-ylmethylcarbonaat |
433-520-5 |
82911-69-1 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2 |
H302 H317 H411 |
GHS07 GHS09 Wng |
H302 H317 H411 |
|
|
|
613-307-00-5 |
clothianidin (ISO); 3-[(2-chloor-1,3-thiazool-5-yl)methyl]-2-methyl-1-nitroguanidine |
— |
210880-92-5 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
M=10 |
|
613-308-00-0 |
2-amino-5-methylthiazool |
423-800-5 |
7305-71-7 |
Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373** H400 H410 |
GHS08 GHS07 GHS09 Wng |
H302 H373** H410 |
|
|
|
613-309-00-6 |
3-fenyl-1-methyl-1-piperazine |
431-180-2 |
5271-27-2 |
Acute Tox. 4 * Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3 |
H312 H302 H315 H318 H412 |
GHS05 GHS07 Dgr |
H312 H302 H315 H318 H412 |
|
|
|
613-310-00-1 |
(–)(3S, 4R)-4-(4-fluorfenyl)-3-(3,4-methyleendioxy-fenoxymethyl)-N-benzylpiperidinehydrochloride |
432-360-3 |
105813-13-6 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
|
613-311-00-7 |
methyl-5-nitrofenylguanidine |
435-500-1 |
152460-07-6 |
Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H302 H319 H317 H412 |
GHS07 Wng |
H302 H319 H317 H412 |
|
|
|
613-312-00-2 |
2-(2-fenyl-4-methyl-1-piperazinyl)benzeenmethanol-monohydrochloride |
420-200-5 |
— |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H302 H318 H317 H412 |
GHS05 GHS07 Dgr |
H302 H318 H317 H412 |
|
|
|
613-313-00-8 |
2-(4-(4-(3-pyridinyl)-1H-imidazool-1-yl)butyl)-1H-isoïndool-1,3(2H)-dion |
442-780-9 |
173838-67-0 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
613-314-00-3 |
4-decyloxazolidine-2-on; 4-decyl-1,3-oxazolidine-2-on |
443-770-7 |
7693-82-5 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
613-315-00-9 |
tetrakalium-4-[5-[3-carboxylato-4,5-dihydro-5-oxo-1-(4-sulfonatofenyl)pyrazool-4-ylideen]-3-(piperidinocarbonyl)penta-1,3-diënylideen]-5-hydroxy-1-(4-sulfonatofenyl)pyrazool-3-carboxylaat |
430-390-1 |
— |
Acute Tox. 4 * Aquatic Chronic 3 |
H332 H412 |
GHS07 Wng |
H332 H412 |
|
|
|
613-316-00-4 |
trimethylolpropaantris(3-aziridinylpropanoaat); (TAZ) |
257-765-0 |
52234-82-9 |
Muta. 2 Eye Dam. 1 Skin Sens. 1 |
H341 H318 H317 |
GHS05 GHS08 GHS07 Dgr |
H341 H318 H317 |
|
|
|
613-317-00-X |
penconazool (ISO); 1-[2-(2,4-dichloorfenyl)pentyl]-1H-1,2,4-triazool |
266-275-6 |
66246-88-6 |
Repr. 2 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 |
H361d H302 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H361d H302 H410 |
|
M = 1 M = 1 |
|
614-002-00-X |
nicotinezouten |
— |
— |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Chronic 2 |
H330 H310 H300 H411 |
GHS06 GHS09 Dgr |
H330 H310 H300 H411 |
|
|
A |
614-003-00-5 |
strychnine |
200-319-7 |
57-24-9 |
Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H310 H300 H410 |
|
|
|
614-004-00-0 |
strychninezouten |
— |
— |
Acute Tox. 2 * Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H300 H400 H410 |
GHS06 GHS09 Dgr |
H330 H300 H410 |
|
|
A |
614-005-00-6 |
colchicine |
200-598-5 |
64-86-8 |
Muta. 1B Acute Tox. 2 * |
H340 H300 |
GHS06 GHS08 Dgr |
H340 H300 |
|
|
|
614-006-00-1 |
brucine; 2,3-dimethoxystrychnine |
206-614-7 |
357-57-3 |
Acute Tox. 2 * Acute Tox. 2 * Aquatic Chronic 3 |
H330 H300 H412 |
GHS06 Dgr |
H330 H300 H412 |
|
|
|
614-007-00-7 |
brucinesulfaat; [1] brucinenitraat; [2] strychnidine-10-on, 2,3-dimethoxy-, mono[(R)-1-methylheptyl-1,2-benzeendicarboxylaat]; [3] strychnidine-10-on, 2,3-dimethoxy-, verbinding met (S)-mono(1-methylheptyl)-1,2-benzeendicarboxylaat (1:1) [4] |
225-432-9 [1] 227-317-9 [2] 269-439-5 [3] 269-710-8 [4] |
4845-99-2 [1] 5786-97-0 [2] 68239-26-9 [3] 68310-42-9 [4] |
Acute Tox. 2 * Acute Tox. 2 * Aquatic Chronic 3 |
H330 H300 H412 |
GHS06 Dgr |
H330 H300 H412 |
|
|
A |
614-008-00-2 |
aconitine |
206-121-7 |
302-27-2 |
Acute Tox. 2 * Acute Tox. 2 * |
H330 H300 |
GHS06 Dgr |
H330 H300 |
|
|
|
614-009-00-8 |
aconitinezouten |
— |
— |
Acute Tox. 2 * Acute Tox. 2 * |
H330 H300 |
GHS06 Dgr |
H330 H300 |
|
|
A |
614-010-00-3 |
atropine |
200-104-8 |
51-55-8 |
Acute Tox. 2 * Acute Tox. 2 * |
H330 H300 |
GHS06 Dgr |
H330 H300 |
|
|
|
614-011-00-9 |
atropinezouten |
— |
— |
Acute Tox. 2 * Acute Tox. 2 * |
H330 H300 |
GHS06 Dgr |
H330 H300 |
|
|
A |
614-012-00-4 |
hyoscyamine |
202-933-0 |
101-31-5 |
Acute Tox. 2 * Acute Tox. 2 * |
H330 H300 |
GHS06 Dgr |
H330 H300 |
|
|
|
614-013-00-X |
hyoscyaminezouten |
— |
— |
Acute Tox. 2 * Acute Tox. 2 * |
H330 H300 |
GHS06 Dgr |
H330 H300 |
|
|
A |
614-014-00-5 |
scopolamine |
200-090-3 |
51-34-3 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * |
H330 H310 H300 |
GHS06 Dgr |
H330 H310 H300 |
|
|
|
614-015-00-0 |
scopolaminezouten |
— |
— |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * |
H330 H310 H300 |
GHS06 Dgr |
H330 H310 H300 |
|
|
A |
614-016-00-6 |
pilocarpine |
202-128-4 |
92-13-7 |
Acute Tox. 2 * Acute Tox. 2 * |
H330 H300 |
GHS06 Dgr |
H330 H300 |
|
|
|
614-017-00-1 |
pilocarpinezouten |
— |
— |
Acute Tox. 2 * Acute Tox. 2 * |
H330 H300 |
GHS06 Dgr |
H330 H300 |
|
|
A |
614-018-00-7 |
papaverine |
200-397-2 |
58-74-2 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
614-019-00-2 |
zouten van papaverine |
— |
— |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
A |
614-020-00-8 |
physostigmine |
200-332-8 |
57-47-6 |
Acute Tox. 2 * Acute Tox. 2 * |
H330 H300 |
GHS06 Dgr |
H330 H300 |
|
|
|
614-021-00-3 |
physostigminezouten |
— |
— |
Acute Tox. 2 * Acute Tox. 2 * |
H330 H300 |
GHS06 Dgr |
H330 H300 |
|
|
A |
614-022-00-9 |
digitaline |
200-760-5 |
71-63-6 |
Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * |
H331 H301 H373 ** |
GHS06 GHS08 Dgr |
H331 H301 H373 ** |
|
|
|
614-023-00-4 |
efedrine |
206-080-5 |
299-42-3 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
614-024-00-X |
zouten van efedrine |
— |
— |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
A |
614-025-00-5 |
ouabaïne |
211-139-3 |
630-60-4 |
Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * |
H331 H301 H373 ** |
GHS06 GHS08 Dgr |
H331 H301 H373 ** |
|
|
|
614-026-00-0 |
k-strofantine |
234-239-9 |
11005-63-3 |
Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * |
H331 H301 H373 ** |
GHS06 GHS08 Dgr |
H331 H301 H373 ** |
|
|
|
614-027-00-6 |
6β-acetoxy-3β-(β-D-glucopyranosyloxy)-8,14-dihydroxybufa-4,20,22-triënolide; rode squille (zeeajuin); scilliroside |
208-077-4 |
507-60-8 |
Acute Tox. 2 * |
H300 |
GHS06 Dgr |
H300 |
|
|
|
614-028-00-1 |
reactiemassa van: 2-ethylhexyl-mono-D-glucopyranoside; 2-ethylhexyl-di-D-glucopyranoside |
414-420-0 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
614-029-00-7 |
constitutionele isomeren van penta-O-allyl-β-D-fructofuranosyl-α-D-glucopyranoside; constitutionele isomeren van hexa-O-allyl-β-D-fructofuranosyl-α-D-glucopyranoside; constitutionele isomeren van hepta-O-allyl-β-D-fructofuranosyl-α-D-glucopyranoside |
419-640-0 |
68784-14-5 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
615-001-00-7 |
methylisocyanaat |
210-866-3 |
624-83-9 |
Flam. Liq. 2 Repr. 2 Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * Resp. Sens. 1 Skin Sens. 1 STOT SE 3 Skin Irrit. 2 Eye Dam. 1 |
H225 H361d*** H330 H311 H301 H334 H317 H335 H315 H318 |
GHS02 GHS06 GHS05 GHS08 Dgr |
H225 H361d*** H330 H311 H301 H334 H317 H335 H315 H318 |
|
|
|
615-002-00-2 |
methylisothiocyanaat |
209-132-5 |
556-61-6 |
Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H331 H301 H314 H317 H400 H410 |
GHS06 GHS05 GHS09 Dgr |
H331 H301 H314 H317 H410 |
|
|
|
615-003-00-8 |
thiocyaanzuur |
207-337-4 |
463-56-9 |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 3 |
H332 H312 H302 H412 |
GHS07 Wng |
H332 H312 H302 H412 |
EUH032 |
|
|
615-004-00-3 |
zouten van thiocyaanzuur, tenzij elders in deze bijlage vermeld |
— |
— |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 3 |
H332 H312 H302 H412 |
GHS07 Wng |
H332 H312 H302 H412 |
EUH032 |
|
A |
615-005-00-9 |
4,4'-methyleendifenyldiisocyanaat; difenylmethaan-4,4'-diisocyanaat; [1] 2,2'-methyleendifenyldiisocyanaat; difenylmethaan-2,2'-diisocyanaat; [2] o-(p-isocyanatobenzyl)fenylisocyanaat; difenylmethaan-2,4'-diisocyanaat; [3] methyleendifenyldiisocyanaat [4] |
202-966-0 [1] 219-799-4 [2] 227-534-9 [3] 247-714-0 [4] |
101-68-8 [1] 2536-05-2 [2] 5873-54-1 [3] 26447-40-5 [4] |
Carc. 2 Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 |
H351 H332 H373** H319 H335 H315 H334 H317 |
GHS08 GHS07 Dgr |
H351 H332 H373** H319 H335 H315 H334 H317 |
|
Eye Irrit. 2; H319: C ≥ 5 % Skin Irrit. 2; H315: C ≥ 5 % Resp. Sens. 1; H334: C ≥ 0,1 % STOT SE 3; H335: C ≥ 5 % |
C2 |
615-006-00-4 |
2-methyl-m-fenyleendiisocyanaat; tolueen-2,4-diisocyanaat; [1] 4-methyl-m-fenyleendiisocyanaat; tolueen-2,6-diisocyanaat; [2] m-tolylideendiisocyanaat; tolueenediisocyanaat [3] |
202-039-0 [1] 209-544-5 [2] 247-722-4 [3] |
91-08-7 [1] 584-84-9 [2] 26471-62-5 [3] |
Carc. 2 Acute Tox. 2 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 3 |
H351 H330 H319 H335 H315 H334 H317 H412 |
GHS06 GHS08 Dgr |
H351 H330 H319 H335 H315 H334 H317 H412 |
|
Resp. Sens. 1; H334: C ≥ 0,1 % |
C |
615-007-00-X |
1,5-naftyleendiisocyanaat |
221-641-4 |
3173-72-6 |
Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 Aquatic Chronic 3 |
H332 H319 H335 H315 H334 H412 |
GHS08 GHS07 Dgr |
H332 H319 H335 H315 H334 H412 |
|
|
|
615-008-00-5 |
3-isocyanatomethyl-3,5,5-trimethylcyclohexylisocyanaat; isoforondiisocyanaat |
223-861-6 |
4098-71-9 |
Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 2 |
H331 H319 H335 H315 H334 H317 H411 |
GHS06 GHS08 GHS09 Dgr |
H331 H319 H335 H315 H334 H317 H411 |
|
* Resp. Sens. 1; H334: C ≥0,5 % Skin Sens.1; H317: C ≥0,5 % |
2 |
615-009-00-0 |
4,4'-methyleendi(cyclohexylisocyanaat); dicyclohexylmethane-4,4'-diisocyanaat |
225-863-2 |
5124-30-1 |
Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 |
H331 H319 H335 H315 H334 H317 |
GHS06 GHS08 Dgr |
H331 H319 H335 H315 H334 H317 |
|
* Resp. Sens. 1; H334: C ≥0,5 % Skin Sens. 1; H317: C ≥0,5 % |
2 |
615-010-00-6 |
2,2,4-trimethylhexamethyleen-1,6-diisocyanaat; [1] 2,4,4-trimethylhexamethyleen-1,6-diisocyanaat [2]; |
241-001-8 [1] 239-714-4 [2] |
16938-22-0 [1] 15646-96-5 [2] |
Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 |
H331 H319 H335 H315 H334 |
GHS06 GHS08 Dgr |
H331 H319 H335 H315 H334 |
|
* Resp. Sens. 1; H334: C ≥0,5 % Skin Sens. 1; H317: C ≥0,5 % |
C2 |
615-011-00-1 |
hexamethyleen-diisocyanaat |
212-485-8 |
822-06-0 |
Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 Skin Sens. 1 |
H331 H319 H335 H315 H334 H317 |
GHS06 GHS08 Dgr |
H331 H319 H335 H315 H334 H317 |
|
* Resp. Sens. 1; H334: C ≥ 0,5 % Skin Sens. 1; H317: C ≥0,5 % |
2 |
615-012-00-7 |
4-isocyanatosulfonyl-tolueen; tosylisocyanaat |
223-810-8 |
4083-64-1 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 |
H319 H335 H315 H334 |
GHS08 GHS07 Dgr |
H319 H335 H315 H334 |
EUH014 |
Eye Irrit.; H319: C ≥ 5 % STOT SE 3; H335: C ≥ 5 % Skin Irrit. 2; H315: C ≥ 5 % |
|
615-014-00-8 |
tris(1-dodecyl-2-fenyl-3-methylbenzimidazolium)hexacyaanferraat |
— |
7276-58-6 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
615-015-00-3 |
1,7,7-trimethylbicyclo(2.2.1)hept-2-ylthiocyanatoacetaat; isobornylthiocyaanacetaat |
204-081-5 |
115-31-1 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
615-016-00-9 |
kaliumcyanaat |
209-676-3 |
590-28-3 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
615-017-00-4 |
calciumcyaanamide |
205-861-8 |
156-62-7 |
Acute Tox. 4 * STOT SE 3 Eye Dam. 1 |
H302 H335 H318 |
GHS05 GHS07 Dgr |
H302 H335 H318 |
|
|
|
615-018-00-X |
2-(2-butoxyethoxy)ethylthiocyanaat |
203-985-7 |
112-56-1 |
Flam. Liq. 3 Acute Tox. 3 * Acute Tox. 3 * |
H226 H311 H301 |
GHS02 GHS06 Dgr |
H226 H311 H301 |
|
|
|
615-019-00-5 |
dicyclohexylcarbodiimide |
208-704-1 |
538-75-0 |
Acute Tox. 3 * Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 |
H311 H302 H318 H317 |
GHS06 GHS05 Dgr |
H311 H302 H38 H317 |
|
|
|
615-020-00-0 |
methyleendithiocyanaat |
228-652-3 |
6317-18-6 |
Acute Tox. 2 * Acute Tox. 3 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 |
H330 H301 H314 H317 H400 |
GHS06 GHS05 GHS09 Dgr |
H330 H301 H314 H317 H400 |
|
|
|
615-021-00-6 |
1,3,5-tris(oxiranylmethyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-trion; TGIC |
219-514-3 |
2451-62-9 |
Muta. 1B Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H340 H331 H301 H373 ** H318 H317 H412 |
GHS06 GHS08 GHS05 Dgr |
H340 H331 H301 H373 ** H318 H317 H412 |
|
|
|
615-022-00-1 |
methyl-3-isocyanatosulfonyl-2-thiofeencarboxylaat |
410-550-7 |
79277-18-2 |
STOT RE 2 * Resp. Sens. 1 Skin Sens. 1 |
H373** H334 H317 |
GHS08 Dgr |
H373** H334 H317 |
EUH014 |
|
|
615-023-00-7 |
2-(isocyanatosulfonylmethyl)benzoëzuur-methylester; (alt.): methyl-2-(isocyanatosulfonylmethyl)benzoaat |
410-900-9 |
83056-32-0 |
Flam. Liq. 3 Muta. 2 Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Resp. Sens. 1 |
H226 H341 H332 H373 ** H318 H334 |
GHS02 GHS08 GHS05 GHS07 Dgr |
H226 H341 H332 H373 ** H318 H334 |
EUH014 |
|
|
615-024-00-2 |
2-fenylethylisocyanaat |
413-080-0 |
1943-82-4 |
Acute Tox. 3 * Acute Tox. 4 * Skin Corr. 1A Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 2 |
H331 H302 H314 H334 H317 H411 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H331 H302 H314 H334 H317 H411 |
|
|
|
615-025-00-8 |
4,4'-ethylideendifenyldicyanaat |
405-740-1 |
47073-92-7 |
Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H332 H302 H373 ** H318 H400 H410 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H332 H302 H373 ** H318 H410 |
|
|
|
615-026-00-3 |
4,4'-methyleenbis(2,6-dimethylfenylcyanaat) |
405-790-4 |
101657-77-6 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
615-028-00-4 |
ethyl-2-(isocyanatosulfonyl)benzoaat |
410-220-2 |
77375-79-2 |
Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Resp. Sens. 1 Skin Sens. 1 |
H302 H373** H318 H334 H317 |
GHS05 GHS08 GHS07 Dgr |
H302 H373** H318 H334 H317 |
EUH014 |
|
|
615-029-00-X |
2,5-bis-isocyanatomethyl-bicyclo[2.2.1]heptaan |
411-280-2 |
— |
Acute Tox. 2 * Acute Tox. 4 * Skin Corr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 3 |
H330 H302 H314 H334 H317 H412 |
GHS06 GHS08 GHS05 Dgr |
H330 H302 H314 H334 H317 H412 |
|
|
|
615-030-00-5 |
alkalizouten en aardalkalizouten van thiocyaanzuur, tenzij elders in deze bijlage vermeld |
— |
— |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 3 |
H332 H312 H302 H412 |
GHS07 Wng |
H332 H312 H302 H412 |
|
|
A |
615-031-00-0 |
thalliumthiocyanaat |
222-571-7 |
3535-84-0 |
Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 4 * STOT RE 2 Aquatic Chronic 2 |
H330 H300 H312 H373** H411 |
GHS06 GHS08 GHS09 Dgr |
H330 H300 H312 H373** H411 |
|
|
|
615-032-00-6 |
metaalzouten van thiocyaanzuur, tenzij elders in deze bijlage vermeld |
— |
— |
Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H332 H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H332 H312 H302 H410 |
|
|
A |
615-033-00-1 |
reactieproduct van difenylmethaandiisocyanaat, octylamine, oleylamine en cyclohexylamine (1:1,58:0,32:0,097) |
430-980-9 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
615-034-00-7 |
reactieproduct van difenylmethaandiisocyanaat, octylamine, 4-ethoxyaniline en ethyleendiamine (1:0,37:1,53:0,05) |
430-750-8 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
615-035-00-2 |
reactieproduct van difenylmethaandiisocyanaat, octylamine en oleylamine (molverhouding 1:1,86:0,14) |
430-930-6 |
122886-55-9 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
615-036-00-8 |
reactieproduct van difenylmethaandiisocyanaat, tolueendiisocyanaat (reactie van isomeren: 65 % 2,4- en 35 % 2,6-diisocyanaat), octylamine, oleylamine en 4-ethoxyaniline (molverhouding 4:1:7:1:2) |
430-940-0 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
615-037-00-3 |
reactieproduct van difenylmethaandiisocyanaat, tolueendiisocyanaat (reactiemassa van isomeren: 65 % 2,4- en 35 % 2,6-diisocyanaat), octylamine en oleylamine (molverhouding 4:1:9:1) |
430-950-5 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
615-038-00-9 |
reactieproduct van tolueendiisocyanaat (reactiemassa van isomeren: 65 % 2,4- en 35 % 2,6-diisocyanaat) en aniline (molverhouding 1:2) |
430-960-1 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
615-039-00-4 |
reactieproduct van difenylmethaandiisocyanaat, tolueendiisocyanaat (reactiemassa van isomeren: 65 % 2,4- en 35 % 2,6-diisocyanaat), octylamine, oleylamine en 4-ethoxyaniline (molverhouding 3,88:1:6,38:0,47:2,91) |
430-970-4 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
615-044-00-1 |
4-chloorfenylisocyanaat |
203-176-9 |
104-12-1 |
Acute Tox. 2 * Acute Tox. 4 * STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Resp. Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H302 H335 H315 H318 H334 H400 H410 |
GHS06 GHS05 GHS08 GHS09 Dgr |
H330 H302 H335 H315 H318 H334 H410 |
|
|
|
615-045-00-7 |
4,4'-methyleenbis(3-chloor-2,6-diëthylfenylisocyanaat) |
420-530-1 |
— |
Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 4 |
H334 H317 H413 |
GHS08 Dgr |
H334 H317 H413 |
|
|
|
616-001-00-X |
N,N-dimethylformamide; dimethylformamide |
200-679-5 |
68-12-2 |
Repr. 1B Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 |
H360D *** H332 H312 H319 |
GHS08 GHS07 Dgr |
H360D *** H332 H312 H319 |
|
|
|
616-002-00-5 |
2-fluoraceetamide |
211-363-1 |
640-19-7 |
Acute Tox. 2 * Acute Tox. 3 * |
H300 H311 |
GHS06 Dgr |
H300 H311 |
|
|
|
616-003-00-0 |
acrylamide; prop-2-eenamide |
201-173-7 |
79-06-1 |
Carc. 1B Muta. 1B Repr. 2 Acute Tox. 3 * STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 |
H350 H340 H361f *** H301 H372 ** H332 H312 H319 H315 H317 |
GHS06 GHS08 Dgr |
H350 H340 H361f *** H301 H372 ** H332 H312 H319 H315 H317 |
|
|
D |
616-004-00-6 |
allidochloor (ISO); N,N-diallylchlooraceetamide |
202-270-7 |
93-71-0 |
Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 |
H312 H302 H319 H315 H411 |
GHS07 GHS09 Wng |
H312 H302 H319 H315 H411 |
|
|
|
616-005-00-1 |
chloorthiamide (ISO); 2,6-dichloor (thiobenzamide) |
217-637-7 |
1918-13-4 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
616-007-00-2 |
difenamide (ISO); 2,2-difenyl-N,N-dimethylaceetamide |
213-482-4 |
957-51-7 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
616-008-00-8 |
propachloor (ISO); 2-chloor-N-fenyl-N-isopropylaceetamide; α-chloor-N-isopropylaceetanilide |
217-638-2 |
1918-16-7 |
Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H319 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H319 H317 H410 |
|
|
|
616-009-00-3 |
propanil (ISO); 3',4'-dichloorpropionanilide |
211-914-6 |
709-98-8 |
Acute Tox. 4 * Aquatic Acute 1 |
H302 H400 |
GHS07 GHS09 Wng |
H302 H400 |
|
M=10 |
|
616-010-00-9 |
tosylchloramidenatrium |
204-854-7 |
127-65-1 |
Acute Tox. 4 * Skin Corr. 1B Resp. Sens. 1 |
H302 H314 H334 |
GHS08 GHS05 GHS07 Dg |
H302 H314 H334 |
EUH031 |
|
|
616-012-00-X |
N-(dichloorfluormethylthio)-ftaalimide; N-(fluordichloormethylthio)ftaalimide |
211-952-3 |
719-96-0 |
Skin Irrit. 2 |
H315 |
GHS07 Wng |
H315 |
|
|
|
616-013-00-5 |
butyraldehydoxim |
203-792-8 |
110-69-0 |
Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 |
H311 H302 H319 |
GHS06 Dgr |
H311 H302 H319 |
|
|
|
616-014-00-0 |
2-butanonoxim; ethylmethylketoxim; ethylmethylketonoxim |
202-496-6 |
96-29-7 |
Carc. 2 Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 |
H351 H312 H318 H317 |
GHS08 GHS05 GHS07 Dgr |
H351 H312 H318 H317 |
|
|
|
616-015-00-6 |
alachloor (ISO); 2-chloor-2',6'-diëthyl-N-(methoxymethyl)aceetanilide |
240-110-8 |
15972-60-8 |
Carc. 2 Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H302 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H302 H317 H410 |
|
M=10 |
|
616-016-00-1 |
1-(3,4-dichloorfenylimino) thiosemicarbazide |
— |
5836-73-7 |
Acute Tox. 2 * |
H300 |
GHS06 Dgr |
H300 |
|
|
|
616-017-00-7 |
cartaphydrochloride |
239-309-2 |
15263-52-2 |
Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H312 H302 H400 H410 |
GHS07 GHS09 Wng |
H312 H302 H410 |
|
|
|
616-018-00-2 |
N,N-diëthyl-m-toluamide; deet |
205-149-7 |
134-62-3 |
Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 3 |
H302 H319 H315 H412 |
GHS07 Wng |
H302 H319 H315 H412 |
|
|
|
616-019-00-8 |
perfluïdone (ISO); 1,1,1-trifluor-N-(4-fenylsulfonyl-o-tolyl)methaansulfonamide; |
253-718-3 |
37924-13-3 |
Acute Tox. 4 * Eye Irrit. 2 |
H302 H319 |
GHS07 Wng |
H302 H319 |
|
|
|
616-020-00-3 |
tebuthiuron (ISO); 1-(5-tert-butyl-1,3,4-thiadiazool-2-yl)-1,3-dimethylureum |
251-793-7 |
34014-18-1 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
616-021-00-9 |
thiazfluron (ISO); 1,3-dimethyl-1-(5-trifluormethyl-1,3,4-thiadiazool-2-yl)ureum |
246-901-4 |
25366-23-8 |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
616-022-00-4 |
aceetamide |
200-473-5 |
60-35-5 |
Carc. 2 |
H351 |
GHS08 Wng |
H351 |
|
|
|
616-023-00-X |
N-hexadecyl(of octadecyl)-N-hexadecyl(of octadecyl)benzamide |
401-980-6 |
— |
Skin Irrit. 2 Skin Sens. 1 |
H315 H317 |
GHS07 Wng |
H315 H317 |
|
|
|
616-024-00-5 |
2-(4,4-dimethyl-2,5-dioxoöxazolidine-1-yl)-2-chloor-5-(2-(2,4-di-tert-pentylfenoxy)butyramido)-4,4-dimethyl-3-oxovaleranilide |
402-260-4 |
54942-74-4 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
616-025-00-0 |
valinamide |
402-840-7 |
20108-78-5 |
Repr. 2 Eye Irrit. 2 Skin Sens. 1 |
H361f *** H319 H317 |
GHS08 Wng |
H361f *** H319 H317 |
|
|
|
616-026-00-6 |
thioaceetamide |
200-541-4 |
62-55-5 |
Carc. 1B Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 3 |
H350 H302 H319 H315 H412 |
GHS08 GHS07 Dgr |
H350 H302 H319 H315 H412 |
|
|
|
616-027-00-1 |
tris(2-(2-hydroxyethoxy)ethyl)ammonium-3-acetoaceetamido-4-methoxybenzeensulfonaat |
403-760-5 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
616-028-00-7 |
N-(4-(3-(4-cyaanfenyl)ureïdo)-3-hydroxyfenyl)-2-(2,4-di-tert-pentylfenoxy)octanamide |
403-790-9 |
108673-51-4 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
616-029-00-2 |
N,N'-ethyleenbis(vinylsulfonylaceetamide) |
404-790-1 |
66710-66-5 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
616-030-00-8 |
ethidimuron (ISO); 1-(5-ethylsulfonyl-1,3,4-thiadiazool-2-yl)-1,3-dimethylureum |
250-010-6 |
30043-49-3 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
616-031-00-3 |
dimethachloor (ISO); 2-chloor-N-(2,6-dimethylfenyl)-N-(2-methoxyethyl)aceetamide; |
256-625-6 |
50563-36-5 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
|
616-032-00-9 |
diflufenican (ISO); N-(2,4-difluorfenyl)-2-[3-(trifluormethyl)fenoxy]-3-pyridinecarboxamide |
— |
83164-33-4 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
616-033-00-4 |
cyprofuram (ISO); N-(3-chloorfenyl)-N-(tetrahydro-2-oxo-3-furyl)cyclopropaancarboxamide |
274-050-9 |
69581-33-5 |
Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H312 H400 H410 |
GHS06 GHS09 Dgr |
H301 H312 H410 |
|
|
|
616-034-00-X |
pyracarbolid; (ISO); 3,4-dihydro-6-methyl-2H-pyran-5-carboxanilide |
246-419-4 |
24691-76-7 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
616-035-00-5 |
cymoxanil (ISO); 2-cyaan-N-[(ethylamino)carbonyl]-2-(methoxyimino)aceetamide |
261-043-0 |
57966-95-7 |
Repr. 2 Acute Tox. 4 STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361fd H302 H373 (bloed, thymus) H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H361fd H302 H373 (bloed, thymus) H317 H410 |
|
M = 1 M = 1 |
|
616-036-00-0 |
2-chlooraceetamide |
201-174-2 |
79-07-2 |
Repr. 2 Acute Tox. 3 * Skin Sens. 1 |
H361f *** H301 H317 |
GHS06 GHS08 Dgr |
H361f *** H301 H317 |
|
Skin Sens. 1; H317: C ≥ 0,1 % |
|
616-038-00-1 |
(4-aminofenyl)-N-methylmethyleensulfonamidehydrochloride |
406-010-5 |
88918-84-7 |
Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H318 H317 H411 |
GHS05 GHS07 GHS09 Dgr |
H318 H317 H411 |
|
|
|
616-039-00-7 |
3',5'-dichloor-4'-ethyl-2'-hydroxypalmitanilide |
406-200-8 |
117827-06-2 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
616-040-00-2 |
kalium-N-(4-tolueensulfonyl)-4-tolueensulfonamide |
406-650-5 |
97888-41-0 |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
616-041-00-8 |
3',5'-dichloor-2-(2,4-di-tert-pentylfenoxy)-4'-ethyl-2'-hydroxy-hexaananilide |
406-840-8 |
101664-25-9 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
616-042-00-3 |
N-(2-(6-ethyl-7-(4-methylfenoxy)-1H-pyrazool[1,5-b][1,2,4]triazool-2-yl)propyl)-2-octadecyloxybenzamide |
407-070-5 |
142859-67-4 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
616-043-00-9 |
isoxaben (ISO); N-[3-(1-ethyl-1-methylpropyl)-1,2-oxazool-5-yl]-2,6-dimethoxybenzamide |
407-190-8 |
82558-50-7 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
616-044-00-4 |
N-(3,5-dichloor-4-ethyl-2-hydroxyfenyl)-2-(3-pentadecylfenoxy)-butaanamide |
402-510-2 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
616-045-00-X |
2'-(4-chloor-3-cyaan-5-formyl-2-thiënylazo)-5'-diëthylamino-2-methoxyaceetanilide |
405-190-2 |
122371-93-1 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
616-046-00-5 |
N-(2-(6-chloor-7-methylpyrazolo(1,5-b)-1,2,4-triazool-4-yl)propyl)-2-(2,4-di-tert-pentylfenoxy)octaanamide |
406-390-2 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
616-047-00-0 |
reactiemassa van: 2,2',2'',2'''-(ethyleendinitrilotetrakis-N, N-di(C16)alkylaceetamide; 2,2',2'',2'''-(ethyleendinitrilotetrakis-N, N-di(C18)alkylaceetamide |
406-640-0 |
— |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
616-048-00-6 |
3'-trifluormethylisobutyranilide |
406-740-4 |
1939-27-1 |
STOT RE 2 * Aquatic Chronic 2 |
H373 ** H411 |
GHS08 GHS09 Wng |
H373 ** H411 |
|
|
|
616-049-00-1 |
2-(2,4-bis(1,1-dimethylethyl)fenoxy)-N-(3,5-dichloor-4-ethyl-2-hydroxyfenyl)-hexaanamide |
408-150-2 |
99141-89-6 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
616-050-00-7 |
lufenuron (ISO); N-[2,5-dichloor-4-(1,1,2,3,3,3-hexafluorpropoxy)-fenyl-aminocarbonyl]-2,6-difluorbenzamide |
410-690-9 |
103055-07-8 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
616-051-00-2 |
reactiemassa van: 2,4 -bis(N'-(4-methylfenyl)-ureïdo)-tolueen; 2,6-bis(N'-(4-methylfenyl)-ureïdo)-tolueen |
411-070-0 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
616-052-00-8 |
formamide |
200-842-0 |
75-12-7 |
Repr. 1B |
H360D *** |
GHS08 Dgr |
H360D *** |
|
|
|
616-053-00-3 |
N-methylaceetamide |
201-182-6 |
79-16-3 |
Repr. 1B |
H360D *** |
GHS08 Dgr |
H360D *** |
|
|
|
616-054-00-9 |
iprodion (ISO); 3-(3,5-dichloorfenyl)-2,4-dioxo-N-isopropylimidazolidine-1-carboxamide |
253-178-9 |
36734-19-7 |
Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H400 H410 |
GHS08 GHS09 Wng |
H351 H410 |
|
|
|
616-055-00-4 |
propyzamide (ISO); 3,5-dichloor-N-(1,1-dimethylprop-2-ynyl)benzamide |
245-951-4 |
23950-58-5 |
Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H400 H410 |
GHS08 GHS09 Wng |
H351 H410 |
|
|
|
616-056-00-X |
N-methylformamide |
204-624-6 |
123-39-7 |
Repr. 1B Acute Tox. 4 * |
H360D *** H312 |
GHS08 GHS07 Dg |
H360D *** H312 |
|
|
|
616-057-00-5 |
reactiemassa van: N-[3-hydroxy-2-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide; N-[2,3-bis-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide; methacrylamide; 2-methyl-N-(2-methylacryloylaminomethoxymethyl)-acrylamide; N-(2,3-dihydroxypropoxymethyl)-2-methylacrylamide |
412-790-8 |
— |
Carc. 1B Muta. 2 STOT RE 2 * |
H350 H341 H373 ** |
GHS08 Dgr |
H350 H341 H373 ** |
|
|
|
616-058-00-0 |
1,3-bis(3-methyl-2,5-dioxo-1H-pyrrolinylmethyl)benzeen |
412-570-1 |
119462-56-5 |
STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H373 ** H318 H317 H400 H410 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H373 ** H318 H317 H410 |
|
|
|
616-059-00-6 |
4-((4-(diëthylamino)-2-ethoxyfenyl)imino)-1,4-dihydro-1-oxo-N-propyl-2-naftaleencarboxamide |
412-650-6 |
121487-83-0 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
616-060-00-1 |
condensatieproduct van: 3-(7-carboxyhept-1-yl)-6-hexyl-4-cyclohexeen-1,2-dicarbonzuur met polyaminen (voornamelijk amino-ethyl-piperazine en triëthyleentetramine) |
413-770-1 |
— |
Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H314 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H302 H314 H317 H410 |
|
|
|
616-061-00-7 |
N,N'—1,6-hexaandiylbis(N-(2,2,6,6-tetramethyl-piperidine-4-yl)-formamide |
413-610-0 |
124172-53-8 |
Eye Irrit. 2 Aquatic Chronic 3 |
H319 H412 |
GHS07 Wng |
H319 H412 |
|
|
|
616-062-00-2 |
N-[3-[(2-acetyloxy)ethyl](fenyl-methyl)amino]-4-methoxyfenyl-aceetamide |
411-590-8 |
70693-57-1 |
Skin Corr. 1B Aquatic Chronic 3 |
H314 H412 |
GHS05 Dgr |
H314 H412 |
|
|
|
616-063-00-8 |
3-dodecyl-(1-(1,2,2,6,6-pentamethyl-4-piperidin)yl)-2,5-pyrrolidindion |
411-920-0 |
106917-30-0 |
Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * Skin Corr. 1A Aquatic Acute 1 Aquatic Chronic 1 |
H331 H302 H373 ** H314 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H331 H302 H373 ** H314 H410 |
|
|
|
616-064-00-3 |
N—tert-butyl-3-methylpicolinamide |
406-720-5 |
32998-95-1 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
616-065-00-9 |
3'-(3-acetyl-4-hydroxyfenyl)-1,1-diëthylureum |
411-970-3 |
79881-89-3 |
Acute Tox. 4 * STOT RE 2 * |
H302 H373 ** |
GHS08 GHS07 Wng |
H302 H373 ** |
|
|
|
616-066-00-4 |
5,6,12,13-tetrachloorantra(2,1,9-def:6,5,10-d'e'f')diisochinoline-1,3,8,10(2H,9H)-tetron |
405-100-1 |
115662-06-1 |
Repr. 2 |
H361f *** |
GHS08 Wng |
H361f *** |
|
|
|
616-067-00-X |
dodecyl-3-(2-(3-benzyl-4-ethoxy-2,5-dioxoïmidazolidine-1-yl)-4,4-dimethyl-3-oxovaleramido)-4-chloorbenzoaat |
407-300-4 |
92683-20-0 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
616-068-00-5 |
kalium-4-(11-methacrylamidoündecanamido)benzeensulfonaat |
406-500-9 |
174393-75-0 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
616-069-00-0 |
1-hydroxy-5-(2-methylpropyloxycarbonylamino)-N-(3-dodecyloxypropyl)-2-naftoamide |
406-210-2 |
110560-22-0 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
616-070-00-6 |
reactiemassa van: 3,3'-dicyclohexyl-1,1'-methyleenbis(4,1-fenyleen)diureum; 3-cyclohexyl-1-(4-(4-(3-octadecylureïdo)benzyl)fenyl)ureum; 3,3'-dioctadecyl-1,1'-methyleenbis(4,1-fenyleen)diureum |
406-530-2 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
616-071-00-1 |
reactiemassa van: bis(N-cyclohexyl-N'-fenyleenureïdo)methyleen; bis(N-octadecyl-N'-fenyleenureïdo)methyleen; bis(N-dicyclohexyl-N'-fenyleenureïdo)methyleen |
406-550-1 |
— |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
616-072-00-7 |
1-(2-deoxy-5-O-trityl-β-D-treopentofuranosyl)thymine |
407-120-6 |
55612-11-8 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
616-073-00-2 |
4'-ethoxy-2-benzimidazool-anilide |
407-600-5 |
120187-29-3 |
Muta. 2 Aquatic Chronic 4 |
H341 H413 |
GHS08 Wng |
H341 H413 |
|
|
|
616-074-00-8 |
N-butyl-2-(4-morfolinylcarbonyl)benzamide |
407-730-2 |
104958-67-0 |
Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H319 H317 H412 |
GHS07 Wng |
H319 H317 H412 |
|
|
|
616-075-00-3 |
D, L-(N,N-diëthyl-2-hydroxy-2-fenylaceetamide) |
408-120-9 |
65197-96-8 |
Acute Tox. 4 * Eye Dam. 1 |
H302 H318 |
GHS05 GHS07 Dgr |
H302 H318 |
|
|
|
616-076-00-9 |
tebufenozide (ISO); N-tert-butyl-N'-(4-ethylbenzoyl)-3,5-dimethylbenzohydrazide |
412-850-3 |
112410-23-8 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
616-077-00-4 |
reactiemassa van: 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-antra[2,1,9-def: 6,5,10-d'e'f']diisochinoline-2-ylethaansulfonzuur; kalium-2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-antra[2,1,9-def: 6,5,10-d'e'f']diisochinoline-2-ylethaansulfaat |
411-310-4 |
— |
Eye Dam. 1 |
H318 |
GHS05 Dgr |
H318 |
|
|
|
616-078-00-X |
2-[2,4-bis(1,1-dimethyl-ethyl)fenoxy]-N-(2-hydroxy-5-methyl-fenyl)-hexaanamide |
411-330-3 |
104541-33-5 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
616-079-00-5 |
1,6-hexaandiyl-bis(2-(2-(1-ethylpentyl)-3-oxazolidinyl)ethyl)carbamaat |
411-700-4 |
140921-24-0 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
616-080-00-0 |
4-(2-((3-ethyl-4-methyl-2-oxo-pyrroline-1-yl)carboxamido)ethyl)benzeensulfonamide) |
411-850-0 |
119018-29-0 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
616-081-00-6 |
5-broom-8-naftolactam |
413-480-5 |
24856-00-6 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
|
616-082-00-1 |
N-(5-chloor-3-((4-(diëthylamino)-2-methylfenyl)imino-4-methyl-6-oxo-1,4-cyclohexadieen-1-yl)-benzamide |
413-200-1 |
129604-78-0 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
616-083-00-7 |
[2-[(4-nitrofenyl)amino]ethyl]ureum |
410-700-1 |
27080-42-8 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
616-084-00-2 |
2,4-bis[N'-(4-methylfenyl)ureïdo]-tolueen |
411-790-5 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
616-085-00-8 |
3-(2,4-dichloorfenyl)-6-fluorchinazoline-2,4(1H,3H)-dion |
412-190-6 |
168900-02-5 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
616-086-00-3 |
2-acetylamino-6-chloor-4-[(4-diëthylamino)2-methylfenyl-imino]-5-methyl-1-oxo-2,5-cyclohexadieen |
412-250-1 |
102387-48-4 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
616-087-00-9 |
reactiemassa van: 7,9,9-trimethyl-3,14-dioxa-4,13-dioxo-5,12-diazahexadecaan-1,16-diyl-prop-2-enoaat; 7,7,9-trimethyl-3,14-dioxa-4,13-dioxo-5,12-diazahexadecaan-1,16-diyl-prop-2-enoaat |
412-260-6 |
52658-19-2 |
Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H319 H317 H411 |
GHS07 GHS09 Wng |
H319 H317 H411 |
|
|
|
616-088-00-4 |
2-aminosulfonyl-N,N-dimethylnicotinamide |
413-440-7 |
112006-75-4 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
616-089-00-X |
5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidine)-3-fluor-2-hydroxymethyltetrahydrofuran |
415-360-8 |
41107-56-6 |
Muta. 2 |
H341 |
GHS08 Wng |
H341 |
|
|
|
616-090-00-5 |
1-(1,4-benzodioxaan-2-ylcarbonyl)piperazinehydrochloride |
415-660-9 |
70918-74-0 |
Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Chronic 2 |
H331 H311 H301 H373 ** H411 |
GHS06 GHS08 GHS09 Dgr |
H331 H311 H301 H373 ** H411 |
|
|
|
616-091-00-0 |
1,3,5-tris-[(2S en 2R)-2,3-epoxypropyl]-1,3,5-triazine-2,4,6-(1H,3H,5H)-trion |
423-400-0 |
59653-74-6 |
Muta. 1B Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1 |
H340 H331 H302 H373 ** H318 H317 |
GHS06 GHS08 GHS05 Dgr |
H340 H331 H302 H373 ** H318 H317 |
|
|
|
616-092-00-6 |
polymeer reactieproduct van bicyclo[2.2.1]hepta-2,5-dieen, etheen, 1,4-hexadieen, 1-propeen met N, N-di-2-propenylformamide |
404-035-6 |
— |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
616-093-00-1 |
reactieproducten van: aniline-tereftaalaldehyde-o-toluïdinecondensaat met maleïnezuuranhydride |
406-620-1 |
129217-90-9 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
616-095-00-2 |
3,3'-dioctadecyl-1,1'-methyleen bis(4,1-fenyleen)diureum |
406-690-3 |
43136-14-7 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
616-096-00-8 |
N-(3-hexadecyloxy-2-hydroxyprop-1-yl)-N-(2-hydroxyethyl)palmitamide |
408-110-4 |
110483-07-3 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
616-097-00-3 |
N,N'-1,4-fenyleenbis(2-((2-methoxy-4-nitrofenyl)azo)-3-oxobutaanamide |
411-840-6 |
83372-55-8 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
616-098-00-9 |
1-[4-chloor-3-((2,2,3,3,3-pentafluorpropoxy)methyl)fenyl]-5-fenyl-1H-1,2,4-triazool-3-carboxamide |
411-750-7 |
119126-15-7 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
616-099-00-4 |
2-[4-[(4-hydroxyfenyl)sulfonyl]fenoxy]-4,4-dimethyl-N-[5-[(methylsulfonyl)amino]-2-[4-(1,1,3,3-tetramethylbutyl)fenoxy]fenyl]-3-oxopentaanamide |
414-170-2 |
135937-20-1 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
616-100-00-8 |
1,3-dimethyl-1,3-bis(trimethylsilyl)ureum |
414-180-7 |
10218-17-4 |
Acute Tox. 4 * Skin Irrit. 2 |
H302 H315 |
GHS07 Wng |
H302 H315 |
|
|
|
616-101-00-3 |
(S)-N-tert-butyl-1,2,3,4-tetrahydro-3-isochinolinecarboxamide |
414-600-9 |
149182-72-9 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
616-102-00-9 |
reactiemassa van: α-[3-(3-mercaptopropanoxycarbonylamino)methylfenylaminocarbonyl]-ω-[3-(3-mercaptopropanoxycarbonylamino)methylfenylaminocarbonyloxy]-poly-(oxyethyleen-co-oxypropyleen); 1,2-(of 1,3-)bis[α-(3-mercaptopropanoxycarbonylamino)methylfenylaminocarbonyl)-ω-oxy-poly(oxyethyleen-co-oxypropyleen)]-3-(of 2-)propanol; 1,2,3-tris[α-(3-mercaptopropanoxycarbonylamino)methylfenylaminocarbonyl)-ω-oxy-poly-(oxyethyleen-co-oxypropyleen)]propaan] |
415-870-0 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
616-103-00-4 |
(S,S)-trans-4-(acetylamino)-5,6-dihydro-6-methyl-7,7-dioxo-4H-thieen[2,3-b]thiopyran-2-sulfonamide |
415-030-3 |
120298-38-6 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
616-104-00-X |
benalaxyl (ISO); methyl-N-(2,6-dimethylfenyl)-N-(fenylacetyl)-DL-alaninaat |
275-728-7 |
71626-11-4 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
616-105-00-5 |
chloortoluron (ISO); 3-(3-chloor-p-tolyl)-1,1-dimethylureum |
239-592-2 |
15545-48-9 |
Carc. 2 Repr. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H361d *** H400 H410 |
GHS08 GHS09 Wng |
H351 H361d *** H410 |
|
|
|
616-106-00-0 |
fenmedifam (ISO); methyl-3-(3-methylcarbaniloyloxy)carbanilaat |
237-199-0 |
13684-63-4 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
616-107-00-6 |
cinidon-ethyl (ISO); ethyl-(Z)-2-chloor-3-[2-chloor-5-(cyclohex-1-een-1,2-dicarboximido)fenyl]acrylaat |
— |
142891-20-1 |
Carc. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H317 H410 |
|
|
|
616-108-00-1 |
joodsulfuronmethylnatrium; natrium({[5-jood-2-(methoxycarbonyl)fenyl]sulfonyl}carbamoyl)(4-methoxy-6-methyl-1,3,5-triazine-2-yl)azanide |
— |
144550-36-7 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
616-109-00-7 |
sulfosulfuron (ISO); 1-(4,6-dimethoxypyrimidine-2-yl)-3-(2-ethylsulfonylimidazo[1,2-a]pyridine-3-yl)sulfonylureum |
— |
141776-32-1 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
616-110-00-2 |
cyclanilide (ISO); 1-(2,4-dichlooranilinecarbonyl)cyclopropaancarbonzuur |
419-150-7 |
113136-77-9 |
Acute Tox. 4 * Aquatic Chronic 2 |
H302 H411 |
GHS07 GHS09 Wng |
H302 H411 |
|
|
|
616-111-00-8 |
fenhexamide (ISO); N-(2,3-dichloor-4-hydroxyfenyl)-1-methylcyclohexaancarboxamide |
422-530-5 |
126833-17-8 |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
616-112-00-3 |
oxasulfuron (ISO); oxetaan-3-yl-2-[(4,6-dimethylpyrimidine-2-yl]-carbamoylsulfamoyl]benzoaat |
— |
144651-06-9 |
STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H373 ** H400 H410 |
GHS08 GHS09 Wng |
H373 ** H410 |
|
|
|
616-113-00-9 |
desmedifam (ISO); ethyl-3-fenylcarbamoyloxyfenylcarbamaat |
237-198-5 |
13684-56-5 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
M=10 |
|
616-114-00-4 |
dodecanamide, N,N'-(9,9',10,10'-tetrahydro-9,9',10,10'-tetraoxo(1,1'-biantraceen)-4,4'-diyl)bis- |
418-010-2 |
136897-58-0 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
616-115-00-X |
N-(3-acetyl-2-hydroxyfenyl)-4-(4-fenylbutoxy)benzamide |
416-150-9 |
136450-06-1 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
616-116-00-5 |
N-(4-dimethylaminopyridinium)-3-methoxy-4-(1-methyl-5-nitroïndool-3-ylmethyl)-N-(o-tolylsulfonyl)benzamidaat |
416-790-9 |
143052-96-4 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
616-117-00-0 |
N-[2-(3-acetyl-5-nitrothiofeen-2-ylazo)-5-diëthylaminofenyl]aceetamide |
416-860-9 |
777891-21-1 |
Repr. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H361f *** H317 H400 H410 |
GHS08 GHS09 Wng |
H361f *** H317 H410 |
|
|
|
616-118-00-6 |
N-(2',6'-dimethylfenyl)-2-piperidinecarboxamide-hydrochloride |
417-950-0 |
65797-42-4 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
616-119-00-1 |
2-(1-butyl-3,5-dioxo-2-fenyl-(1,2,4)-triazolidine-4-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-(2-(dodecyl-1-sulfonyl))propionylamino)-fenyl)-pentaanamide |
418-060-5 |
118020-93-2 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
616-120-00-7 |
reactiemassa van: N-(3-dimethylamino-4-methylfenyl)-benzamide; N-(3-dimethylamino-2-methylfenyl)-benzamide; N-(3-dimethylamino-3-methylfenyl)-benzamide |
420-600-1 |
— |
STOT RE 2 * Aquatic Chronic 2 |
H373 ** H411 |
GHS08 GHS09 Wng |
H373 ** H411 |
|
|
|
616-121-00-2 |
2,4-dihydroxy-N-(2-methoxyfenyl)benzamide |
419-090-1 |
129205-19-2 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
616-122-00-8 |
methylneodecaanamide |
414-460-9 |
105726-67-8 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
616-123-00-3 |
N-[3-[[4-(diëthylamino)-2-methylfenyl]imino]-6-oxo-1,4-cyclohexadiënyl]aceetamide |
414-740-0 |
96141-86-5 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
616-124-00-9 |
lithiumbis(trifluormethylsulfonyl)imide |
415-300-0 |
90076-65-6 |
Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Skin Corr. 1B Aquatic Chronic 3 |
H311 H301 H373** H314 H412 |
GHS06 GHS05 GHS08 Dgr |
H311 H301 H373** H314 H412 |
|
|
|
616-125-00-4 |
3-cyano-N-(1,1-dimethylethyl)androsta-3,5-dieen-17-β-carboxamide |
415-730-9 |
151338-11-3 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
410 |
|
|
|
616-126-00-X |
1-methyl-4-nitro-3-propyl-1H-pyrazool-5-carboxamide |
423-960-6 |
139756-01-7 |
Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 3 |
H302 H373** H412 |
GHS08 GHS07 Wng |
H302 H373** H412 |
|
|
|
616-127-00-5 |
reactiemassa van: N, N'-ethaan-1,2-diylbis(decaanamide); 12-hydroxy-N-[2-[1-oxydecyl)amino]ethyl]octadecaanamide; N, N'-ethaan-1,2-diylbis(12-hydroxyoctadecaanamide) |
430-050-2 |
— |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
616-128-00-0 |
N-(2-(1-allyl-4,5-dicyaanimidazool-2-ylazo)-5-(dipropylamino)fenyl)-aceetamide |
417-530-7 |
123590-00-1 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
616-129-00-6 |
N,N'-bis(2,2,6,6-tetramethyl-4-piperidyl)isoftaalamide |
419-710-0 |
42774-15-2 |
Acute Tox. 4 * Eye Irrit. 2 |
H302 H319 |
GHS07 Wng |
H302 H319 |
|
|
|
616-130-00-1 |
N-(3-(2-(4,4-dimethyl-2,5-dioxoïmidazoline-1-yl)-4,4-dimethyl-3-oxopentanoylamino)-4-methoxyfenyl)-octadecaanamide |
421-780-2 |
150919-56-5 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
616-131-00-7 |
1-aminocyclopentaancarboxamide |
422-950-9 |
17193-28-1 |
STOT RE 1 Acute Tox. 4 * Eye Dam. 1 |
H372** H302 H318 |
GHS05 GHS08 GHS07 Dgr |
H372** H302 H318 |
|
|
|
616-132-00-2 |
N-[4-(4-cyaan-2-furfurylideen-2,5-dihydro-5-oxo-3-furyl)fenyl]butaan-1-sulfonamide |
423-250-6 |
130016-98-7 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
616-133-00-8 |
N-cyclohexyl-S, S-dioxo-benzo[b]tiofeen-2-carboxamide |
423-990-1 |
149118-66-1 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H318 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H410 |
|
|
|
616-134-00-3 |
3,3'-bis(dioctyloxythiofosfinoylthio)-N,N'-oxybis(methyleen)dipropionamide |
401-820-5 |
793710-14-2 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
616-135-00-9 |
(3S,4aS,8aS)-2-[(2R,3S)-3-amino-2-hydroxy-4-fenylbutyl]-N-tert-butyldecahydro-isochinoline-3-carboxamide |
430-230-0 |
136522-17-3 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
616-136-00-4 |
reactieproduct van cocoalkyldiëthanolamiden en cocoalkylmonoglyceriden en molybdeentrioxide (1,75-2,2: 0,75-1,0:0,1-1,1) |
430-380-7 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
616-137-00-X |
4-dichlooracetyl-1-oxa-4-azaspiro[4.5]decaan |
401-130-4 |
71526-07-3 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
616-138-00-5 |
benzoëzuur, N-tert-butyl-N'-(4-chloorbenzoyl)hydrazide |
431-600-4 |
112226-61-6 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
616-139-00-0 |
(3S, 4aS, 8aS)-N-tert-butyldecahydro-3-isochinolinecarboxamide |
420-380-5 |
136465-81-1 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3 |
H302 H318 H412 |
GHS05 GHS07 Dgr |
H302 H318 H412 |
|
|
|
616-140-00-6 |
N,N''-(methyleendi-4,1-fenyleen)bis[N'-(4-methylfenyl)ureum] |
429-380-1 |
133336-92-2 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
616-141-00-1 |
zoxamide (ISO); (RS)-3,5-dichloor-N-(3-chloor-1-ethyl-1-methyl-2-oxopropyl)-p-toluamide |
— |
156052-68-5 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
M=10 |
|
616-142-00-7 |
1,3-bis(vinylsulfonylaceetamido)propaan |
428-350-3 |
93629-90-4 |
Muta. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H341 H318 H317 H412 |
GHS08 GHS05 GHS07 Dgr |
H341 H318 H317 H412 |
|
|
|
616-143-00-2 |
N,N'-dihexadecyl-N,N'-bis(2-hydroxyethyl)propaandiamide |
422-560-9 |
149591-38-8 |
Repr. 2 Eye Irrit. 2 Aquatic Chronic 4 |
H361f *** H319 H413 |
GHS08 Wng |
H361f *** H319 H413 |
|
|
|
616-144-00-8 |
3,4-dichloor-N-[5-chloor-4-[2-[4-dodecyloxyfenylsulfonyl]butyramido]-2-hydroxyfenyl]benzamide |
431-130-1 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
616-145-00-3 |
pethoxamide (ISO); 2-chloor-N-(2-ethoxyethyl)-N-(2-methyl-1-fenylprop-1-enyl)aceetamide |
— |
106700-29-2 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
M=100 |
|
616-146-00-9 |
N-(2-methoxy-5-octadecanoylaminofenyl)-2-(3-benzyl-2,5-dioxoïmidazolidine-1-yl)-4,4-dimethyl-3-oxopentaanzuuramide |
431-330-7 |
142776-95-2 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
616-147-00-4 |
1-methyl-4-(2-methyl-2H-tetrazool-5-yl)-1H-pyrazool-5-sulfonamide |
424-160-1 |
139481-22-4 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
616-148-00-X |
N-[6,9-dihydro-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-6-oxo-1H-purine-2-yl]aceetamide |
424-550-1 |
84245-12-5 |
Carc. 1B Muta. 1B Repr. 1B |
H350 H340 H360FD |
GHS08 Dgr |
H350 H340 H360FD |
|
|
|
616-150-00-0 |
(2R,3S)-N-(3-amino-2-hydroxy-4-fenylbutyl)-N-isobutyl-4-nitrobenzeensulfonamidehydrochloride |
425-260-6 |
— |
STOT RE 2 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H373** H318 H317 H411 |
GHS05 GHS08 GHS07 GHS09 Dgr |
H373** H318 H317 H411 |
|
|
|
616-151-00-6 |
N-(2-amino-4,6-dichloorpyrimidine-5-yl)formamide |
425-650-6 |
171887-03-9 |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H302 H318 H317 H412 |
GHS05 GHS07 Dgr |
H302 H318 H317 H412 |
|
|
|
616-152-00-1 |
4-(4-fluorfenyl)-2-(2-methyl-1-oxopropyl)-4-oxo-3,N-difenylbutaanamide |
425-850-3 |
125971-96-2 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
616-153-00-7 |
4-methyl-3-oxo-N-fenyl-2-(fenylmethyleen)pentaanamide |
425-860-8 |
125971-57-5 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
616-154-00-2 |
3,4-dichloor-N-[5-chloor-4-[2-[4-(hexadecyloxy)fenylsulfonyl]butyramido]-2-hydroxyfenyl]benzamide |
431-110-0 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
616-155-00-8 |
N,N,N',N'-tetracyclohexyl-1,3-benzeendicarboxamide |
431-040-0 |
104560-40-9 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
616-156-00-3 |
6-(2-chloor-6-cyaan-4-nitrofenylazo)-4-methoxy-3-[N-(methoxycarbonylmethyl)-N-(1-methoxycarbonylethyl)amino]aceetanilide |
430-500-8 |
204277-61-2 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
616-157-00-9 |
3-amino-4-hydroxy-N-(3-isopropoxypropyl)benzeensulfonamide-hydrochloride |
427-780-9 |
114565-70-7 |
Acute Tox. 4 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H318 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H302 H318 H410 |
|
|
|
616-158-00-4 |
N-[4-cyaan-3-trifluormethylfenyl]methacrylamide |
427-880-2 |
90357-53-2 |
STOT RE 2 * Aquatic Chronic 2 |
H373** H411 |
GHS08 GHS09 Wng |
H373** H411 |
|
|
|
616-160-00-5 |
2,2'-azobis[N-(2-hydroxyethyl)2-methylpropionamide] |
429-090-3 |
61551-69-7 |
Skin Sens. 1 Aquatic Chronic 3 |
H317 H412 |
GHS07 Wng |
H317 H412 |
|
|
|
616-161-00-0 |
2,4-dichloor-5-hydroxyaceetanilide |
429-110-0 |
67669-19-6 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
616-162-00-6 |
isostearinezuur-monoisopropanolamide |
431-540-9 |
— |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
616-163-00-1 |
4,4'-methyleenbis[N-(4-chloorfenyl)-3-hydroxynaftaleen-2-carboxamide] |
430-350-3 |
192463-88-0 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
616-164-00-7 |
dimoxystrobin (ISO); (E)-2-(methoxyimino)-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]aceetamide |
— |
149961-52-4 |
Carc. 2 Repr. 2 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H361d*** H332 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H361d*** H332 H410 |
|
M=10 |
|
616-165-00-2 |
beflubutamide (ISO); (RS)-N-benzyl-2-(α, α, α, 4-tetrafluor-m-tolyoxy)butyramide |
— |
113614-08-7 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
M=100 |
|
616-166-00-8 |
cyazofamide (ISO); 4-chloor-2-cyano-N,N-dimethyl-5-p-tolylimidazool-1-sulfonamide |
— |
120116-88-3 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
M=10 |
|
616-167-00-3 |
N,N-dibutyl(2,5-dihydro-5-thioxo-1H-tetrazool-1-yl)aceetamide |
418-290-6 |
168612-06-4 |
Eye Irrit. 2 Skin Sens. 1 |
H319 H317 |
GHS07 Wng |
H319 H317 |
|
|
|
616-168-00-9 |
1-dimethylcarbamoyl-4-(2-sulfonatoëthyl)pyridinium |
418-440-0 |
136997-71-2 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
616-169-00-4 |
4-[4-(2,2-dimethylpropaanamido)]fenylazo-3-(2-chloor-5-(2-(3-pentadecylfenoxy)butylamido)anilino)-1-(2,4,6-trichloorfenyl)-2-pyrazoline-5-on |
420-220-4 |
92771-56-7 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
616-170-00-X |
(2R)-2-amino-2-fenylaceetamide |
420-370-0 |
6485-67-2 |
Eye Irrit. 2 Skin Sens. 1 |
H319 H317 |
GHS07 Wng |
H319 H317 |
|
|
|
616-171-00-5 |
2-(p-chloorfenyl)glycinamide |
420-830-0 |
102333-75-5 |
Eye Dam. 1 Skin Sens. 1 |
H318 H317 |
GHS05 GHS07 Dgr |
H318 H317 |
|
|
|
616-172-00-0 |
N-(2,2,6,6-tetramethyl-1-oxylpiperidine-4-yl)aceetamide; (4-aceetamido-2,2,6,6-tetramethyl-1-piperidinyl)oxidanyl |
423-840-3 |
14691-89-5 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
616-174-00-1 |
2-butyl-1,3-diazaspiro[4.4]non-1-een-4-on-hydrochloride |
424-560-4 |
151257-01-1 |
Acute Tox. 4 * Eye Irrit. 2 |
H302 H319 |
GHS07 Wng |
H302 H319 |
|
|
|
616-175-00-7 |
2-(2-hexyldecyloxy)benzamide |
431-230-3 |
202483-62-3 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
616-176-00-2 |
3-N,N-bis(methoxyethyl)aminoaceetanilide |
432-530-7 |
24294-01-7 |
Acute Tox. 4 * Aquatic Chronic 3 |
H302 H412 |
GHS07 Wng |
H302 H412 |
|
|
|
616-177-00-8 |
(3-(4-(2-(butyl-(4-methylfenylsulfonyl)amino)fenylthio)5-oxo-1-(2,4,6-trichloorfenyl)-4,5-dihydro-1H-pyrazool-3-ylamino)-4-chloorfenyl)tetradecaanamide; N-[3-({4-[(2-{]butyl[}(4-methylfenyl)sulfonyl{]amino[}fenyl)thio{]-5-oxo-1-(2,4,6-trichloorfenyl)-4,5-dihydro-1H-pyrazool-3yl[}amino)-4-chloorfenyl]tetradecaanamide |
432-970-1 |
217324-98-6 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
616-178-00-3 |
N-(5-(bis(2-methoxyethyl)amino)-2-((2-cyaan-4,6-dinitrofenyl)azo)fenyl)aceetamide |
434-500-9 |
52583-35-4 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
616-179-00-9 |
2-chloor-N-(4-methylfenyl)aceetamide |
435-170-9 |
16634-82-5 |
Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H318 H317 H410 |
|
|
|
616-180-00-4 |
N,N-(dimethylamino)thioaceetamide-hydrochloride |
435-470-1 |
27366-72-9 |
Repr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H360D*** H400 H410 |
GHS08 GHS09 Dgr |
H360D*** H410 |
|
|
|
616-181-00-X |
4'-methyldodecaan-1-sulfonanilide |
435-490-9 |
17417-32-2 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
616-182-00-5 |
N'-(1,3-dimethylbutylideen)-3-hydroxy-2-naftohydrazide |
435-860-1 |
214417-91-1 |
Skin Sens. 1 Aquatic Chronic 2 |
H317 H411 |
GHS07 GHS09 Wng |
H317 H411 |
|
|
|
616-183-00-0 |
N-dodecyl-4-methoxybenzamide |
442-340-6 |
1854-15-5 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
616-184-00-6 |
3-methyl-N-(5,8,13,14-tetrahydro-5,8,14-trioxonaft[2,3-c]acridine-6-yl)benzamide |
442-560-2 |
105043-55-8 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
616-186-00-7 |
N,N'-(2-chloor-1,4-fenyleen)bis(3-oxobutaanamide) |
443-010-4 |
53641-10-4 |
Aquatic Chronic 3 |
H412 |
— |
H412 |
|
|
|
616-188-00-8 |
2-(5,5-dimethyl-2,4-dioxoöxazolidine-3-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-octadecanoylaminofenyl)pentaanzuuramide |
443-980-9 |
221215-20-9 |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
616-189-00-3 |
N-[5-(bis(2-methoxyethyl)amino]-2-(6-broom-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoïndool-5-ylazo)fenyl]aceetamide |
444-780-4 |
452962-97-9 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
616-190-00-9 |
N-decyl-4-nitrobenzamide |
445-880-0 |
64026-19-3 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
616-191-00-4 |
2-ethyl-N-methyl-N-(3-methylfenyl)butaanamide |
446-190-2 |
406488-30-0 |
Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H302 H319 H315 H317 H411 |
GHS07 GHS09 Wng |
H302 H319 H315 H317 H411 |
|
|
|
616-192-00-X |
2-[2-(3-butoxypropyl)-1,1-dioxo-1,2,4-benzothiadiazine-3-yl]-5'-tert-butyl-2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-yl)-2'-[(2-ethylhexyl)thio]aceetanilide |
448-060-0 |
727678-39-9 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
616-193-00-5 |
N-[2-(2-butyl-4,6-dicyaan-1,3-dioxo-2,3-dihydro-1H-isoïndool-5-ylazo)-5-diëthylaminofenyl]aceetamide |
449-940-7 |
368450-39-9 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
616-194-00-0 |
2,2-diëthoxy-N,N-dimethylaceetamide |
449-950-1 |
34640-92-1 |
Eye Irrit. 2 |
H319 |
GHS07 Wng |
H319 |
|
|
|
616-196-00-1 |
dinatriumzout van 1-hydroxy-4-(β-(4-(1-hydroxy-3,6-disulfo-8-acetylamino-2-naftylazo)fenoxy)ethoxy)-N-dodecyl-2-naftamide |
419-990-4 |
— |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
616-197-00-7 |
reactiemassa van: kalium-N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoroctaansulfonamidaat; N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoroctaan-sulfonamide |
422-500-1 |
— |
STOT RE 2 * |
H373** |
GHS08 Wng |
H373** |
|
|
|
616-198-00-2 |
1,3-bis[12-hydroxyoctadecaanamide-N-methyleen]benzeen |
423-300-7 |
— |
Skin Sens. 1 Aquatic Chronic 4 |
H317 H413 |
GHS07 Wng |
H317 H413 |
|
|
|
616-200-00-1 |
reactiemassa van N, N’-ethaan-1,2-diylbis(hexaanamide) en 12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecaanamide en N, N’-ethaan-1,2-diylbis(12-hydroxyoctadecaanamide) |
432-430-3 |
|
Aquatic Chronic 4 |
H413 |
|
H413 |
|
|
|
616-201-00-7 |
12-hydroxyoctadecaanzuur, reactieproducten met 1,3-benzeendimethaanamine en hexamethyleendiamine |
432-840-2 |
220926-97-6 |
Acute Tox. 4 * Aquatic Chronic 4 |
H332 H413 |
GHS07 Wng |
H332 H413 |
|
|
|
616-202-00-2 |
reactiemassa van: 2,2'-[(3,3'-dichloor[1,1'-bifenyl]-4,4'-diyl)bis(azo)]bis[N-(2,4-dimethylfenyl)]-3-oxo-butaanamide; 2-[[3,3'-dichloor-4'-[[1[[(2,4-dimethylfenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'bifenyl]-4-yl]azo]-N-(2-methylfenyl)-3-oxo-butaanamide; 2-[[3,3'-dichloor-4'-[[1[[(2,4-dimethylfenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'-bifenyl]-4-yl]azo]-N-(2-carboxylfenyl)-3-oxobutaanamide |
434-330-5 |
— |
Carc. 2 Skin Sens. 1 Aquatic Chronic 4 |
H351 H317 H413 |
GHS08 GHS07 Wng |
H351 H317 H413 |
|
|
|
616-203-00-8 |
reactiemassa van: N-[5-[bis-(2-methoxyethyl)amino]-2-(2-butyl-4,6-dicyaan-1,3-dioxo-2,3-dihydro-1H-isoïndol-5-yl-azo)fenyl]aceetamide; N-[2-(2-butyl-4,6-dicyaan-1,3-dioxo-2,3-dihydro-1H-isoïndol-5-ylazo)5-diëthylaminofenyl]aceetamide |
442-280-0 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
616-204-00-3 |
N,N''-(methyleendi-4,1-fenyleen)bis[N'-octylureum] |
451-060-3 |
122886-55-9 |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
616-205-00-9 |
metazachloor (ISO); 2-chloor-N-(2,6-dimethylfenyl)-N-(1H-pyrazool-1-ylmethyl)-aceetamide |
266-583-0 |
67129-08-2 |
Skin Sens. 1B Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H351 H400 H410 |
GHS07 GHS08 GHS09 Wng |
H317 H351 H410 |
|
M = 100 M = 100 |
|
616-206-00-4 |
flufenoxuron (ISO); 1-(4-(2-chloor-α, α,α-p-trifluortolyloxy)-2-fluorfenyl)-3-(2,6-difluorbenzolyl)ureum |
417-680-3 |
101463-69-8 |
Lact. Aquatic Acute 1 Aquatic Chronic 1 |
H362 H400 H410 |
GHS09 Wng |
H362 H410 |
|
M = 10 000 M = 10 000 |
|
616-208-00-5 |
N-ethyl-2-pyrrolidon; 1-ethylpyrrolidine-2-on |
220-250-6 |
2687-91-4 |
Repr. 1B |
H360D |
GHS08 Dgr |
H360D |
|
|
|
616-209-00-0 |
amidosulfuron (ISO); 3-(4,6-dimethoxypyrimidine-2-yl)-1-((N-methyl-N-methylsulfonylamino)sulfonyl)ureum |
407-380-0 |
120923-37-7 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
M = 100 M = 100 |
|
616-210-00-6 |
tebufenpyrad (ISO); N-(4-tert-butylbenzyl)-4-chloor-3-ethyl-1-methyl-1H-pyrazool-5-carboxamide |
|
119168-77-3 |
Acute Tox. 3 Acute Tox. 4 STOT RE 2 Skin Sens. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H301 H332 H373 (spijsverteringskanaal) (oraal) H317 H400 H410 |
GHS06 GHS08 GHS09 Dgr |
H301 H332 H373 (spijsverteringskanaal) (oraal) H317 H410 |
|
M = 10 M = 10 |
|
616-211-00-1 |
proquinazid (ISO); 6-jood-2-propoxy-3-propylchinazoline-4(3H)-on |
|
189278-12-4 |
Carc. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H351 H400 H410 |
GHS08 GHS09 Wng |
H351 H410 |
|
M = 1 M = 10 |
|
616-212-00-7 |
3-jood-2-propynylbutylcarbamaat; 3-joodprop-2-yn-1-ylbutylcarbamaat |
259-627-5 |
55406-53-6 |
Acute Tox. 3 Acute Tox. 4 STOT RE 1 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H331 H302 H372 (larynx) H318 H317 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H331 H302 H372 (larynx) H318 H317 H410 |
|
M = 10 M = 1 |
|
617-001-00-2 |
di-tert-butylperoxide |
203-733-6 |
110-05-4 |
Org. Perox. E Flam. Liq. 2 Muta. 2 |
H242 H225 H341 |
GHS02 GHS08 Dgr |
H242 H225 H341 |
|
|
|
617-002-00-8 |
α, α-dimethylbenzylhydroperoxide; cumeenhydroperoxide |
201-254-7 |
80-15-9 |
Org. Perox. E Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B Aquatic Chronic 2 |
H242 H331 H312 H302 H373 ** H314 H411 |
GHS02 GHS06 GHS08 GHS05 GHS09 Dgr |
H242 H331 H312 H302 H373 ** H314 H411 |
|
Skin Corr. 1B; H314: C ≥ 10 % Skin Irrit. 2; H315: 3 % ≤ C < 10 % Eye Dam. 1; H318: 3 % ≤ C < 10 % Eye Irrit. 2; H319: 1 % ≤ C < 3 % STOT SE 3; H335: C < 10 % |
|
617-003-00-3 |
dilauroylperoxide |
203-326-3 |
105-74-8 |
Org. Perox. D |
H242 |
GHS02 Dgr |
H242 |
|
|
|
617-004-00-9 |
1,2,3,4-tetrahydro-1-naftylhydroperoxide |
212-230-0 |
771-29-9 |
Org. Perox. D Acute Tox. 4 * Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1 |
H242 H302 H314 H400 H410 |
GHS02 GHS05 GHS07 GHS09 Dgr |
H242 H302 H314 H410 |
|
STOT SE 3; H335: C ≥ 5 % |
|
617-006-00-X |
bis(α, α-dimethylbenzyl) peroxide |
201-279-3 |
80-43-3 |
Org. Perox. F Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 2 |
H242 H319 H315 H411 |
GHS02 GHS07 GHS09 Wng |
H242 H319 H315 H411 |
|
|
|
617-007-00-5 |
tert-butyl-α, α-dimethylbenzylperoxide |
222-389-8 |
3457-61-2 |
Org. Perox. E Skin Irrit. 2 Aquatic Chronic 2 |
H242 H315 H411 |
GHS02 GHS07 GHS09 Wng |
H242 H315 H411 |
|
|
|
617-008-00-0 |
dibenzoylperoxide; benzoylperoxide |
202-327-6 |
94-36-0 |
Org. Perox. B Eye Irrit. 2 Skin Sens. 1 |
H241 H319 H317 |
GHS01 GHS02 GHS07 Dgr |
H241 H319 H317 |
|
|
|
617-010-00-1 |
1-hydroperoxycyclohexyl-1-hydroxycyclohexylperoxide; [1] 1,1’-dioxybiscyclohexaan-1-ol; [2] cyclohexylideenhydroperoxide; [3] cyclohexanon, peroxide [4] |
201-091-1 [1] 219-306-2 [2] 220-279-4 [3] 235-527-7 [4] |
78-18-2 [1] 2407-94-5 [2] 2699-11-8 [3] 12262-58-7 [4] |
Org. Perox. A Skin Corr. 1B Acute Tox. 4 * |
H240 H314 H302 |
GHS01 GHS05 GHS07 Dgr |
H240 H314 H302 |
|
STOT SE 3; H335: C ≥ 5 % |
C |
617-010-01-9 |
1-hydroperoxycyclohexyl-1-hydroxycyclohexylperoxide; [1] 1,1'-dioxybiscyclohexaan-1-ol; [2] cyclohexylideenhydroperoxide; [3] cyclohexanon, peroxide [4] [≤ 91 % oplossing] |
201-091-1 [1] 219-306-2 [2] 220-279-4 [3] 235-527-7 [4] |
78-18-2 [1] 2407-94-5 [2] 2699-11-8 [3] 12262-58-7 [4] |
Org. Perox. C Acute Tox. 4 * Skin Corr. 1B |
H242 H302 H314 |
GHS02 GHS05 GHS07 Dgr |
H242 H302 H314 |
|
STOT SE 3; H335: C ≥ 5 % |
C T |
617-012-00-2 |
8-p-menthanylhydroperoxide; p-menthaanhydroperoxide |
201-281-4 |
80-47-7 |
Org. Perox. D Skin Corr. 1B Acute Tox. 4 * |
H242 H314 H332 |
GHS02 GHS05 GHS07 Dgr |
H242 H314 H332 |
|
STOT SE 3; H335: C ≥ 5 % |
|
617-013-00-8 |
O,O-tert-butyl-O-docosylmonoperoxyoxalaat |
404-300-6 |
116753-76-5 |
Org. Perox. C **** Aquatic Acute 1 Aquatic Chronic 1 |
H242 H400 H410 |
GHS02 GHS09 Dgr |
H242 H410 |
|
|
|
617-014-00-3 |
6-(nonylamino)-6-oxo-peroxyhexaanzuur |
406-680-9 |
104788-63-8 |
Org. Perox. C **** Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 |
H242 H318 H317 H400 |
GHS02 GHS05 GHS07 GHS09 Dgr |
H242 H318 H317 H400 |
|
|
|
617-015-00-9 |
bis(4-methylbenzoyl)peroxide |
407-950-9 |
895-85-2 |
Org. Perox. B **** Aquatic Acute 1 Aquatic Chronic 1 |
H241 H400 H410 |
GHS01 GHS02 GHS09 Dgr |
H241 H410 |
|
|
|
617-016-00-4 |
3-hydroxy-1,1-dimethylbutyl-2-ethyl-2-methylheptaanperoxoaat |
413-910-1 |
— |
Org. Perox. C **** Flam. Liq. 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H242 H226 H315 H400 H410 |
GHS02 GHS07 GHS09 Dgr |
H242 H226 H315 H410 |
|
|
|
617-017-00-X |
reactiemassa van: 2,2'-bis(tert-pentylperoxy)-p-diisopropylbenzeen; 2,2'-bis(tert-pentylperoxy)-m-diisopropylbenzeen |
412-140-3 |
32144-25-5 |
Org. Perox. D Aquatic Chronic 4 |
H242 H413 |
GHS02 Dgr |
H242 H413 |
|
|
T |
617-018-00-5 |
reactiemassa van: 1-methyl-1-(3-(1-methylethyl)fenyl)ethyl-1-methyl-1-fenylethylperoxide, 63 gewichtsprocent; 1-methyl-1-(4-(1-methylethyl)fenyl)ethyl-1-methyl-1-fenylethylperoxide, 31 % gewichtsprocent |
410-840-3 |
71566-50-2 |
Org. Perox. C **** Aquatic Chronic 2 |
H242 H411 |
GHS02 GHS09 Dgr |
H242 H411 |
|
|
T |
617-019-00-0 |
6-(ftalimido)peroxyhexaanzuur |
410-850-8 |
128275-31-0 |
Org. Perox. D Eye Dam. 1 Aquatic Acute 1 |
H242 H318 H400 |
GHS02 GHS05 GHS09 DgDgr |
H242 H318 H400 |
|
|
T |
617-020-00-6 |
1,3-di(prop-2,2-diyl)benzeenbis(neodecanoylperoxide) |
420-060-5 |
117663-11-3 |
Flam. Liq. 3 Org. Perox. D **** Aquatic Chronic 2 |
H226 H242 H411 |
GHS02 GHS09 Dgr |
H226 H242 H411 |
|
|
|
617-021-00-1 |
methylethylketonperoxide, trimeer |
429-320-2 |
— |
Org. Perox. B**** Asp. Tox. 1 Skin Irrit. 2 Skin Sens. 1 |
H241 H304 H315 H317 |
GHS01 GHS02 GHS08 GHS07 Dgr |
H241 H304 H315 H317 |
|
|
|
617-022-00-7 |
reactiemassa van: 1,2-dimethylpropylideendihydroperoxide; dimethyl-1,2-benzeendicarboxylaat |
442-480-8 |
— |
Org. Perox. C Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 2 |
H242 H302 H314 H317 H411 |
GHS02 GHS05 GHS07 GHS09 Dgr |
H242 H302 H314 H317 H411 |
|
|
|
647-001-00-8 |
glucosidase, β- |
232-589-7 |
9001-22-3 |
Resp. Sens. 1 |
H334 |
GHS08 Dgr |
H334 |
|
|
|
647-002-00-3 |
cellulase |
232-734-4 |
9012-54-8 |
Resp. Sens. 1 |
H334 |
GHS08 Dgr |
H334 |
|
|
|
647-003-00-9 |
cellobiohydrolase, exo- |
253-465-9 |
37329-65-0 |
Resp. Sens. 1 |
H334 |
GHS08 Dgr |
H334 |
|
|
|
647-004-00-4 |
cellulasen, tenzij elders in deze bijlage vermeld |
— |
— |
Resp. Sens. 1 |
H334 |
GHS08 Dgr |
H334 |
|
|
A |
647-005-00-X |
bromelia, sap |
232-572-4 |
9001-00-7 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 |
H319 H335 H315 H334 |
GHS08 GHS07 Dgr |
H319 H335 H315 H334 |
|
|
|
647-006-00-5 |
ficine |
232-599-1 |
9001-33-6 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 |
H319 H335 H315 H334 |
GHS08 GHS07 Dgr |
H319 H335 H315 H334 |
|
|
|
647-007-00-0 |
papaïne |
232-627-2 |
9001-73-4 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 |
H319 H335 H315 H334 |
GHS08 GHS07 Dgr |
H319 H335 H315 H334 |
|
|
|
647-008-00-6 |
pepsine A |
232-629-3 |
9001-75-6 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 |
H319 H335 H315 H334 |
GHS08 GHS07 Dgr |
H319 H335 H315 H334 |
|
|
|
647-009-00-1 |
rennine |
232-645-0 |
9001-98-3 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 |
H319 H335 H315 H334 |
GHS08 GHS07 Dgr |
H319 H335 H315 H334 |
|
|
|
647-010-00-7 |
trypsine |
232-650-8 |
9002-07-7 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 |
H319 H335 H315 H334 |
GHS08 GHS07 Dgr |
H319 H335 H315 H334 |
|
|
|
647-011-00-2 |
chymotrypsine |
232-671-2 |
9004-07-3 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 |
H319 H335 H315 H334 |
GHS08 GHS07 Dgr |
H319 H335 H315 H334 |
|
|
|
647-012-00-8 |
subtilisine |
232-752-2 |
9014-01-1 |
STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Resp. Sens. 1 |
H335 H315 H318 H334 |
GHS08 GHS05 GHS07 Dgr |
H335 H315 H318 H334 |
|
|
|
647-013-00-3 |
proteïnase, microbieel neutraal |
232-966-6 |
9068-59-1 |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 |
H319 H335 H315 H334 |
GHS08 GHS07 Dgr |
H319 H335 H315 H334 |
|
|
|
647-014-00-9 |
proteasen, tenzij elders in deze bijlage vermeld |
— |
— |
Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Resp. Sens. 1 |
H319 H335 H315 H334 |
GHS08 GHS07 Dgr |
H319 H335 H315 H334 |
|
|
|
647-015-00-4 |
amylase, α- |
232-565-6 |
9000-90-2 |
Resp. Sens. 1 |
H334 |
GHS08 Dgr |
H334 |
|
|
|
647-016-00-X |
amylasen, tenzij elders in deze bijlage vermeld |
— |
— |
Resp. Sens. 1 |
H334 |
GHS08 Dgr |
H334 |
|
|
|
647-017-00-5 |
laccase |
420-150-4 |
80498-15-3 |
Resp. Sens. 1 |
H334 |
GHS08 Dgr |
H334 |
|
|
|
648-001-00-0 |
destillaten (koolteer), benzolfractie; lichte olie; [een complexe verzameling koolwaterstoffen die wordt verkregen door de destillatie van koolteer. Bestaat uit koolwaterstoffen, overwegend C4 tot en met C10, met een destillatietraject van ongeveer 80 oC tot 160 oC (175 oF tot 320 oF).] |
283-482-7 |
84650-02-2 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
648-002-00-6 |
teeroliën, bruinkool; lichte olie; [het destillaat van bruinkoolteer, met een kooktraject van ongeveer 80 oC tot 250 oC (176 oF tot 482 oF). Bestaat voornamelijk uit alifatische en aromatische koolwaterstoffen en monobasische fenolen.] |
302-674-4 |
94114-40-6 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
J |
648-003-00-1 |
benzolvoorloop (kool); lichte olie, herdestillaat, laagkokende fractie; [het destillaat van lichte olie uit de cokesoven, met een destillatietraject beneden ongeveer 100 oC (212 oF). Bestaat voornamelijk uit C4 tot C6 alifatische koolwaterstoffen.] |
266-023-5 |
65996-88-5 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
J |
648-004-00-7 |
destillaten (koolteer), benzolfractie, rijk aan benzeen, tolueen en xyleen; lichte olie, herdestillaat, laagkokende fractie; [een residu dat afkomstig is uit de destillatie van ruwe benzol om benzolvoorfracties te verwijderen. Bestaat voornamelijk uit benzeen, tolueen en xylenen, met een kooktraject van ongeveer 75 oC tot 200 oC (167 oF tot 392 oF).] |
309-984-9 |
101896-26-8 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
J |
648-005-00-2 |
aromatische koolwaterstoffen, C6-10, rijk aan C8; lichte olie, herdestillaat, laagkokende fractie |
292-697-5 |
90989-41-6 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
J |
648-006-00-8 |
oplosmiddelnafta (kool), licht; lichte olie, herdestillaat, laagkokende fractie |
287-498-5 |
85536-17-0 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
J |
648-007-00-3 |
oplosmiddelnafta (kool), xyleen-styreenfractie; lichte olie, herdestillaat, bij middentemperaturen kokend |
287-502-5 |
85536-20-5 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
J |
648-008-00-9 |
oplosmiddelnafta (kool), cumaron-styreen bevattend; lichte olie, herdestillaat, bij middentemperaturen kokend |
287-500-4 |
85536-19-2 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
J |
648-009-00-4 |
nafta (kool), destillatieresiduen; lichte olie, herdestillaat, hoogkokende fractie; [het residu dat resteert uit de destillatie van herwonnen nafta. Bestaat voornamelijk uit naftaleen en condensatieproducten van indeen en styreen.] |
292-636-2 |
90641-12-6 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
J |
648-010-00-X |
aromatische koolwaterstoffen, C8; lichte olie, herdestillaat, hoogkokende fractie |
292-694-9 |
90989-38-1 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
J |
648-012-00-0 |
aromatische koolwaterstoffen, C8-9, bijproduct koolwaterstofhars-polymerisatie; lichte olie, herdestillaat, hoogkokende fractie; [een complexe verzameling koolwaterstoffen die wordt verkregen door de verdamping onder vacuüm van oplosmiddel uit gepolymeriseerde koolwaterstofhars. Bestaat voornamelijk uit aromatische koolwaterstoffen, overwegend C8 en C9, met een kooktraject van ongeveer 120 oC tot 215 oC (248 oF tot 419 oF).] |
295-281-1 |
91995-20-9 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
J |
648-013-00-6 |
aromatische koolwaterstoffen, C9-12, benzeendestillatie; lichte olie, herdestillaat, hoogkokende fractie |
295-551-9 |
92062-36-7 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
J |
648-014-00-1 |
extractieresiduen (kool), benzolfractie alkalisch, zuurextract; lichte olie, extractieresidu, laagkokende fractie; [het herdestillaat dat afkomstig is uit het destillaat, ontdaan van teerzuren en teerbasen, uit bitumineuze hogetemperatuurkoolteer en dat een kooktraject heeft van ongeveer 90 oC tot 160 oC (194 oF tot 320 oF). Bestaat voornamelijk uit benzeen, tolueen en xylenen.] |
295-323-9 |
91995-61-8 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
J |
648-015-00-7 |
extractieresiduen (koolteer), benzolfractie alkalisch, zuurextract; lichte olie, extractieresidu, laagkokende fractie; [een complexe verzameling koolwaterstoffen die wordt verkregen door de herdestillatie van het destillaat van hogetemperatuurkoolteer (teerzuur- en teerbasevrij). Bestaat voornamelijk uit ongesubstitueerde en gesubstitueerde monocyclische aromatische koolwaterstoffen met een kooktraject van 85 oC tot 195 oC (185 oF tot 383 oF).] |
309-868-8 |
101316-63-6 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
J |
648-016-00-2 |
extractieresiduen (kool), benzolfractie zuur; lichte olie, extractieresidu, laagkokende fractie; [een zuur bezinksel dat als bijproduct gevormd wordt bij de zuivering met zwavelzuur van ruwe hogetemperatuurkool. Bestaat voornamelijk uit zwavelzuur en organische verbindingen.] |
298-725-2 |
93821-38-6 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
J |
648-017-00-8 |
extractieresiduen (kool), lichte olie alkalisch, destillatietopproducten; lichte olie, extractieresidu, laagkokende fractie; [de eerste fractie uit de destillatie van voorfractioneringsbodemfracties, rijk aan aromatische koolwaterstoffen, cumaron, naftaleen en indeen, of gewassen fenololie. Kookt grotendeels beneden 145 oC (293 oF). Bestaat voornamelijk uit alifatische en aromatische C7- en C8-koolwaterstoffen.] |
292-625-2 |
90641-02-4 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
J |
648-018-00-3 |
extractieresiduen (kool), lichte olie alkalisch, zuurextract, indeenfractie; lichte olie, extractieresidu, bij middentemperaturen kokend |
309-867-2 |
101316-62-5 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
J |
648-019-00-9 |
extractieresiduen (kool), lichte olie alkalisch, indeen-naftafractie; lichte olie, extractieresidu, hoogkokende fractie; [het destillaat van voorfractioneringsbodemfracties, rijk aan aromatische koolwaterstoffen, cumaron, naftaleen en indeen, of gewassen fenololiën met een kooktraject van ongeveer 155 oC tot 180 oC (311 oF tot 356 oF). Bestaat voornamelijk uit indeen, indaan en trimethylbenzenen.] |
292-626-8 |
90641-03-5 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
J |
648-020-00-4 |
oplosmiddelnafta (kool); lichte olie, extractieresidu, hoogkokende fractie; [het destillaat dat wordt verkregen uit het alkalische extractieresidu van hogetemperatuurkoolteer, lichte olie uit de cokesoven of koolteerolie, met een destillatietraject van ongeveer 130 oC tot 210 oC (266 oF tot 410 oF). Bestaat voornamelijk uit indeen en andere polycyclische ringsystemen die één aromatische ring bevatten. Kan fenolverbindingen en aromatische stikstofbasen bevatten.] |
266-013-0 |
65996-79-4 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
J |
648-021-00-X |
destillaten (koolteer), lichte oliën, neutrale fractie; lichte olie, extractieresidu, hoogkokende fractie; [een destillaat dat afkomstig is uit de fractionele destillatie van hogetemperatuurkoolteer. Bestaat voornamelijk uit alkylgesubstitueerde monocyclische aromatische koolwaterstoffen met een kooktraject van ongeveer 135 oC tot 210 oC (275 oF tot 410 oF). Kan bovendien onverzadigde koolwaterstoffen zoals indeen en cumaron bevatten.] |
309-971-8 |
101794-90-5 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
J |
648-022-00-5 |
destillaten (koolteer), lichte oliën, zuurextracten; lichte olie, extractieresidu, hoogkokende fractie; [deze olie is een complex mengsel van aromatische koolwaterstoffen, voornamelijk indeen, naftaleen, cumaron, fenol en o-, m- en p-kresol, met een kooktraject van 140 oC tot 215 oC (284 oF tot 419 oF).] |
292-609-5 |
90640-87-2 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
J |
648-023-00-0 |
destillaten (koolteer), lichte oliën; fenololie; [een complexe verzameling koolwaterstoffen die wordt verkregen door destillatie van koolteer. Bestaat uit aromatische en andere koolwaterstoffen, fenolverbindingen en aromatische stikstofverbindingen en heeft een destillatietraject van ongeveer 150 oC tot 210 oC (302 oF tot 410 oF).] |
283-483-2 |
84650-03-3 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
J |
648-024-00-6 |
teeroliën, kool; fenololie; [het destillaat van hogetemperatuurkoolteer, met een destillatietraject van ongeveer 130 oC tot 250 oC (266 oF tot 410 oF). Bestaat voornamelijk uit naftaleen, alkylnaftalenen, fenolverbindingen en aromatische stikstofbasen.] |
266-016-7 |
65996-82-9 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
J |
648-026-00-7 |
extractieresiduen (kool), lichte olie alkalisch, zuurextract; fenololie, extractieresidu; [de olie die wordt verkregen door alkalisch gewassen fenololie met zuur te wassen om de geringe hoeveelheden basische verbindingen (teerbasen) te verwijderen. Bestaat voornamelijk uit indeen, indaan en alkylbenzenen.] |
292-624-7 |
90641-01-3 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
J |
648-027-00-2 |
extractieresiduen (kool), teerolie alkalisch; fenololie, extractieresidu; [het residu dat wordt verkregen uit koolteerolie door alkalisch te wassen, bijvoorbeeld met verdund natriumhydroxide, na de verwijdering van ruwe koolteerzuren. Bestaat voornamelijk uit naftalenen en aromatische stikstofbasen.] |
266-021-4 |
65996-87-4 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
J |
648-028-00-8 |
extractieoliën (kool), lichte olie; zuurextract; [het waterige extract dat wordt verkregen door alkalisch gewassen fenololie met zuur te wassen. Bestaat voornamelijk uit zure zouten van verschillende aromatische stikstofbasen zoals pyridine en chinoline en alkylderivaten daarvan.] |
292-622-6 |
90640-99-6 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
J |
648-029-00-3 |
pyridine, alkylderivaten; ruwe teerbasen; [de complexe verzameling polygealkyleerde pyridinen, verkregen uit de destillatie van koolteer of als hoogkokend destillaat (boven ongeveer 150 oC (302 oF)) uit de reactie van ammoniak met aceetaldehyde, formaldehyde of paraformaldehyde.] |
269-929-9 |
68391-11-7 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
J |
648-030-00-9 |
teerbasen, kool, picolinefractie; gedestilleerde teerbasen; [pyridinebasen met een kooktraject van ongeveer 125 oC tot 160 oC (257 oF tot 320 oF) die worden verkregen door destillatie van geneutraliseerd zuurextract van de basebevattende teerfractie die wordt verkregen door de destillatie van bitumineuze koolteer. Bestaat voornamelijk uit lutidinen en picolinen.] |
295-548-2 |
92062-33-4 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
J |
648-031-00-4 |
teerbasen, kool, lutidinefractie; gedestilleerde teerbasen |
293-766-2 |
91082-52-9 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
J |
648-032-00-X |
extractieoliën (kool), teerbase, collidinefractie; gedestilleerde teerbasen; [het extract dat wordt gevormd door de zure extractie van basen uit aromatische oliën die afkomstig zijn uit ruwe koolteer, neutralisatie alsmede destillatie van de basen. Bestaat voornamelijk uit collidinen, aniline, toluïdinen, lutidinen en xylidinen.] |
273-077-3 |
68937-63-3 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
J |
648-033-00-5 |
teerbasen, kool, collidinefractie; gedestilleerde teerbasen; [de destillatiefractie met een kooktraject van ongeveer 181 oC tot 186 oC (356 oF tot 367 oF) die afkomstig is uit de ruwe basen die worden verkregen uit de geneutraliseerde zuurgeëxtraheerde basebevattende teerfracties die worden gevormd door de destillatie van bitumineuze koolteer. Bevat voornamelijk aniline en collidinen.] |
295-543-5 |
92062-28-7 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
J |
648-034-00-0 |
teerbasen, kool, anilinefractie; gedestilleerde teerbasen; [de destillatiefractie met een kooktraject van ongeveer 180 oC tot 200 oC (356 oF tot 392 oF) die afkomstig is uit de ruwe basen die worden verkregen door de verwijdering van fenolen en basen uit de gefenoliseerde olie die afkomstig is uit de destillatie van koolteer. Bevat voornamelijk aniline, collidinen, lutidinen en toluïdinen.] |
295-541-4 |
92062-27-6 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
J |
648-035-00-6 |
teerbasen, kool, toluïdinefractie; gedestilleerde teerbasen |
293-767-8 |
91082-53-0 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
J |
648-036-00-1 |
destillaten (aardolie), pyrolyseolie uit de alkeen-alkynproductie, gemengd met hogetemperatuurkoolteer, indeenfractie; geherdestilleerde fracties; [een complexe verzameling koolwaterstoffen die wordt verkregen als een herdestillaat uit de fractionele destillatie van bitumineuze hogetemperatuurkoolteer en residuoliën die zijn verkregen bij de pyrolytische productie van alkenen en alkynen uit aardolieproducten of aardgas. Bestaat voornamelijk uit indeen en heeft een kooktraject van ongeveer 160 oC tot 190 oC (320 oF tot 374 oF).] |
295-292-1 |
91995-31-2 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
J |
648-037-00-7 |
destillaten (kool), residuele pyrolyseoliën uit koolteer, naftaleenoliën; geherdestilleerde fracties; [het herdestillaat dat wordt verkregen uit de fractionele destillatie van bitumineuze hogetemperatuurkoolteer en residuele pyrolyseoliën, met een kooktraject van ongeveer 190 oC tot 270 oC (374 oF tot 518 oF). Bestaat voornamelijk uit gesubstitueerde bicyclische aromaten.] |
295-295-8 |
91995-35-6 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
J |
648-038-00-2 |
extractieoliën (kool), residuele pyrolyseoliën uit koolteer, naftaleenolie, herdestillaat; geherdestilleerde fracties; [het herdestillaat dat afkomstig is uit de fractionele destillatie van, van basen en fenolen ontdane, methylnaftaleenolie die wordt verkregen uit bitumineuze hogetemperatuurkoolteer en residuele pyrolyseoliën, met een kooktraject van ongeveer 220 oC tot 230 oC (428 oF tot 446 oF). Bestaat voornamelijk uit ongesubstitueerde en gesubstitueerde bicyclische aromatische koolwaterstoffen.] |
295-329-1 |
91995-66-3 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
J |
648-039-00-8 |
extractie-oliën (kool), koolteer en pyrolyse-residuoliën, naftaleenoliën; geherdestilleerde fracties; [een neutrale olie, die wordt verkregen door het van basen en fenolen ontdoen van de olie afkomstig uit de destillatie van hogetemperatuurteer en residuele pyrolyseoliën, met een kooktraject van 225 oC tot 255 oC (437 oF tot 491 oF). Bestaat voornamelijk uit gesubstitueerde bicyclische aromatische koolwaterstoffen.] |
310-170-0 |
122070-79-5 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
J |
648-040-00-3 |
extractieoliën (kool), koolteer en pyrolyse-residuoliën, naftaleenolie, destillatieresiduen geherdestilleerde fracties; [residu van de destillatie van, van fenolen en basen ontdane, methylnaftaleenolie (afkomstig uit bitumineuze koolteer en residuele pyrolyseoliën) met een kooktraject van 240 oC tot 260 oC (464 oF tot 500 oF). Bestaat voornamelijk uit gesubstitueerde bicyclische aromatische en heterocyclische koolwaterstoffen.] |
310-171-6 |
122070-80-8 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
J |
648-041-00-9 |
absorptieoliën, bicycloaromatische en heterocyclische koolwaterstoffractie; wasolie, herdestillaat; [een complexe verzameling koolwaterstoffen die wordt verkregen als een herdestillaat uit de destillatie van wasolie. Bestaat voornamelijk uit aromatische en heterocyclische koolwaterstoffen met twee ringen en heeft een kooktraject van ongeveer 260 oC tot 290 oC (500 oF tot 554 oF).] |
309-851-5 |
101316-45-4 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
M |
648-042-00-4 |
destillaten (koolteer), bovenste, rijk aan fluoreen; wasolie, herdestillaat; [een complexe verzameling koolwaterstoffen die wordt verkregen door kristallisatie van teerolie. Bestaat uit aromatische en polycyclische koolwaterstoffen, voornamelijk fluoreen en enig acenafteen.] |
284-900-0 |
84989-11-7 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
M |
648-043-00-X |
creosootolie, acenafteenfractie, acenafteenvrij; wasolie, herdestillaat; [de olie die resteert na verwijdering door een kristallisatieproces van acenafteen uit acenafteenolie afkomstig uit koolteer. Bestaat voornamelijk uit naftaleen en alkylnaftalenen.] |
292-606-9 |
90640-85-0 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
M |
648-044-00-5 |
destillaten (koolteer), zware oliën; zware antraceenolie; [destillaten die worden verkregen uit de gefractioneerde destillatie van koolteer uit bitumineuze kool, met een kooktraject van 240 oC tot 400 oC (464 oF tot 752 oF). Bestaat voornamelijk uit tri- en polynucleaire koolwaterstoffen en heterocyclische verbindingen.] |
292-607-4 |
90640-86-1 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
648-045-00-0 |
destillaten (koolteer), bovenste; zware antraceenolie; [het destillaat van koolteer met een destillatietraject van ongeveer 220 oC tot 450 oC (428 oF tot 842 oF). Bestaat voornamelijk uit aromatische koolwaterstoffen met drie- tot viervoudig gecondenseerde ringen en andere koolwaterstoffen.] |
266-026-1 |
65996-91-0 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
M |
648-046-00-6 |
antraceenolie, zuurextract; antraceenolie, extractieresidu; [een complexe verzameling koolwaterstoffen uit de van base ontdane fractie verkregen door de destillatie van koolteer, met een kooktraject van ongeveer 325 oC tot 365 oC (617 oF tot 689 oF). Bevat voornamelijk antraceen, fenantreen en alkylderivaten daarvan.] |
295-274-3 |
91995-14-1 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
M |
648-047-00-1 |
destillaten (koolteer); zware antraceenolie; [het destillaat van koolteer met een destillatietraject van ongeveer 100 oC tot 450 oC (212 oF tot 842 oF). Bestaat voornamelijk uit aromatische koolwaterstoffen met twee- tot viervoudig gecondenseerde ringen, fenolhoudende verbindingen en aromatische stikstofbasen.] |
266-027-7 |
65996-92-1 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
M |
648-048-00-7 |
destillaten (koolteer), pek, zware oliën; zware antraceenolie; [het destillaat dat afkomstig is uit de destillatie van de pek die wordt verkregen uit bitumineuze hogetemperatuurteer. Bestaat voornamelijk uit tri- en polynucleaire aromatische koolwaterstoffen, met een kooktraject van ongeveer 300 oC tot 470 oC (572 oF tot 878 oF). Het product kan tevens heteroatomen bevatten.] |
295-312-9 |
91995-51-6 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
M |
648-049-00-2 |
destillaten (koolteer), pek; zware antraceenolie; [de olie die wordt verkregen uit de condensatie van de dampen uit de warmtebehandeling van pek. Bestaat voornamelijk uit aromatische verbindingen met twee tot vier ringen en heeft een kooktraject van ongeveer 200 oC tot meer dan 400 oC (392 oF tot meer dan 752 oF).] |
309-855-7 |
101316-49-8 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
M |
648-050-00-8 |
destillaten (koolteer), zware oliën, pyreenfractie; zware antraceenolie, herdestillaat; [het herdestillaat dat wordt verkregen uit de gefractioneerde destillatie van pekdestillaat met een kooktraject van ongeveer 350 oC tot 400 oC (662 oF tot 752 oF). Bestaat voornamelijk uit tri- en polynucleaire aromaten en heterocyclische koolwaterstoffen.] |
295-304-5 |
91995-42-5 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
M |
648-051-00-3 |
destillaten (koolteer), pek, pyreenfractie; zware antraceenolie, herdestillaat; [het herdestillaat dat wordt verkregen uit de gefractioneerde destillatie van pekdestillaat en een kooktraject heeft van ongeveer 380 oC tot 410 oC (716 oF tot 770 oF). Bestaat voornamelijk uit tri- en polynucleaire aromatische koolwaterstoffen en heterocyclische verbindingen.] |
295-313-4 |
91995-52-7 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
M |
648-052-00-9 |
paraffinewassen (kool), bruinkool-hogetemperatuurteer, behandeld met kool; steenkoolteerextract; [een complexe verzameling koolwaterstoffen die wordt verkregen door de behandeling van lignietcarbonisatieteer met geactiveerde kool om sporenbestanddelen en onzuiverheden te verwijderen. Bestaat voornamelijk uit verzadigde vertakte en niet-vertakte koolwaterstoffen, overwegend groter dan C12.] |
308-296-6 |
97926-76-6 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
M |
648-053-00-4 |
paraffinewassen (kool), bruinkool-hogetemperatuurteer, behandeld met klei; steenkoolteerextract; [een complexe verzameling koolwaterstoffen die wordt verkregen door de behandeling van lignietcarbonisatieteer met bentoniet om sporenbestanddelen en onzuiverheden te verwijderen. Bestaat voornamelijk uit verzadigde vertakte en niet-vertakte koolwaterstoffen, overwegend groter dan C12.] |
308-297-1 |
97926-77-7 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
M |
648-054-00-X |
pek; pek |
263-072-4 |
61789-60-4 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
M |
648-055-00-5 |
pek, koolteer, hoge temperatuur; pek; [het residu dat wordt verkregen bij de destillatie van hogetemperatuurkoolteer. Het is een zwarte vaste stof met een verwekingstraject van ongeveer 30 oC tot 180 oC (86 oF tot 356 oF). Bestaat voornamelijk uit een complexe verzameling van aromatische koolwaterstoffen met drie- of meervoudig gecondenseerde ringen.] |
266-028-2 |
65996-93-2 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
648-056-00-0 |
pek, koolteer, hoge temperatuur, met warmte behandeld; pek; [het met warmte behandelde residu van de destillatie van hogetemperatuurkoolteer. Het is een zwarte vaste stof met een verwekingstraject van ongeveer 80 oC tot 180 oC (176 oF tot 356 oF). Bestaat voornamelijk uit een complexe verzameling van aromatische koolwaterstoffen met drie- of meervoudig gecondenseerde ringen.] |
310-162-7 |
121575-60-8 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
M |
648-057-00-6 |
pek, koolteer, hoge temperatuur, secundair; pek, herdestillaat; [het residu, verkregen tijdens de destillatie van hoogkokende fracties uit hogetemperatuurteer uit bitumineuze kool en/of pek-cokes-olie, met een verwekingspunt van 140 oC tot 170 oC (284 oF tot 392 oF)volgens DIN 52025. Bestaat voornamelijk uit tri- en polynucleaire aromatische verbindingen die ook heteroatomen bevatten.] |
302-650-3 |
94114-13-3 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
M |
648-058-00-1 |
residuen (koolteer), pekdestillatie-; pek, herdestillaat; [residu van de gefractioneerde destillatie van pekdestillaat, met een kooktraject van ongeveer 400 oC tot 470 oC (752 oF tot 846 oF). Bestaat voornamelijk uit polynucleaire aromatische koolwaterstoffen en heterocyclische verbindingen.] |
295-507-9 |
92061-94-4 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
M |
648-059-00-7 |
teer, kool, hoge temperatuur, destillatie- en opslagresiduen; steenkoolteer, vaste bestanddelen; [cokes en as bevattende vaste residuen die worden afgescheiden bij destillatie en thermische behandeling van uit bitumineuze kool afkomstige hogetemperatuurteer in destillatie-installaties en opslagtanks. Bestaat voornamelijk uit koolstof en bevat een kleine hoeveelheid heteroverbindingen alsmede asbestanddelen.] |
295-535-1 |
92062-20-9 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
M |
648-060-00-2 |
teer, kool, opslagresiduen; steenkoolteer, vaste bestanddelen; [het bezinksel dat wordt verwijderd uit ruwe koolteeropslag. Bestaat voornamelijk uit koolteer en koolstofhoudend deeltjesmateriaal.] |
293-764-1 |
91082-50-7 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
M |
648-061-00-8 |
teer, kool, hoge temperatuur, residuen; steenkoolteer, vaste bestanddelen; [vaste stoffen die worden gevormd tijdens de verkooksing van bitumineuze kool om ruwe bitumineuze hogetemperatuurkoolteer te vormen. Bestaat voornamelijk uit cokes en kooldeeltjes, in hoge mate gearomatiseerde verbindingen en minerale stoffen.] |
309-726-5 |
100684-51-3 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
M |
648-062-00-3 |
teer, kool, hoge temperatuur, hoge gehaltes aan vaste stof; steenkoolteer, vaste bestanddelen; [het condensatieproduct dat wordt verkregen door afkoeling tot ongeveer omgevingstemperatuur van het gas dat vrijkomt bij de destructieve destillatie bij hoge temperatuur (boven 700 oC (1 292 oF)) van kool. Bestaat voornamelijk uit een complex mengsel van aromatische koolwaterstoffen met gecondenseerde ringen en heeft een hoog gehalte aan vaste kool- en cokesachtige materialen.] |
273-615-7 |
68990-61-4 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
M |
648-063-00-9 |
vaste afvalstoffen, verkooksing van koolteerpek; steenkoolteer, vaste bestanddelen; [de combinatie van afvalstoffen die wordt gevormd door de verkooksing van bitumineuze koolteerpek. Bestaat voornamelijk uit koolstof.] |
295-549-8 |
92062-34-5 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
M |
648-064-00-4 |
extractresiduen (kool), bruin; steenkoolteerextract; [het residu dat afkomstig is van de tolueenextractie van gedroogde bruinkool.] |
294-285-0 |
91697-23-3 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
M |
648-065-00-X |
paraffinewassen (kool), bruinkool-hogetemperatuurteer; steenkoolteerextract; [een complexe verzameling koolwaterstoffen die wordt verkregen uit lignietcarbonisatieteer door oplosmiddelkristallisatie (met oplosmiddel ontoliën), door uitzweting of een adductieproces. Bestaat voornamelijk uit vertakte en niet-vertakte verzadigde koolwaterstoffen, overwegend groter dan C12.] |
295-454-1 |
92045-71-1 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
M |
648-066-00-5 |
paraffinewassen (kool), bruinkool-hogetemperatuurteer, met waterstof behandeld; steenkoolteerextract; [een complexe verzameling koolwaterstoffen die wordt verkregen uit lignietcarbonisatieteer door oplosmiddelkristallisatie (met oplosmiddel ontoliën), door uitzweting of een adductieproces, behandeld met waterstof in de aanwezigheid van een katalysator. Bestaat voornamelijk uit vertakte en niet-vertakte verzadigde koolwaterstoffen, overwegend groter dan C12.] |
295-455-7 |
92045-72-2 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
M |
648-067-00-0 |
paraffinewassen (kool), bruinkool-hogetemperatuurteer, behandeld met kiezelzuur; steenkoolteerextract; [een complexe verzameling koolwaterstoffen die wordt verkregen door de behandeling van lignietcarbonisatie teer met kiezelzuur om sporenbestanddelen en onzuiverheden te verwijderen. Bestaat voornamelijk uit verzadigde vertakte en niet-vertakte koolwaterstoffen, overwegend groter dan C12.] |
308-298-7 |
97926-78-8 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
M |
648-068-00-6 |
teer, kool, lage temperatuur, destillatieresiduen; teerolie, bij middentemperaturen kokend; [residuen die worden verkregen uit de fractionele destillatie van bij lage temperatuur verkregen koolteer, waarbij oliën met een kookpunt tot ongeveer 300 oC (572 oF) worden verwijderd. Bestaat voornamelijk uit aromatische verbindingen.] |
309-887-1 |
101316-85-2 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
M |
648-069-00-1 |
pek, koolteer, lage temperatuur; pekresidu; [een complexe zwarte vaste of halfvaste stof die wordt verkregen uit de destillatie van een lagetemperatuurkoolteer. Verweekt in het traject van ongeveer 40 oC tot 180 oC (104 oF tot 356 oF). Bestaat voornamelijk uit een complex mengsel van koolwaterstoffen.] |
292-651-4 |
90669-57-1 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
M |
648-070-00-7 |
pek, koolteer, lage temperatuur, geoxideerd; pekresidu, geoxideerd; [het product dat wordt verkregen door het doorblazen met lucht, bij verhoogde temperatuur, van lagetemperatuur-koolteerpek Heeft een verwekingstraject van ongeveer 70 oC tot 180 oC (158 oF tot 356 oF). Bestaat voornamelijk uit een complex mengsel van koolwaterstoffen.] |
292-654-0 |
90669-59-3 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
M |
648-071-00-2 |
pek, koolteer, lage temperatuur, met warmte behandeld; pekresidu, geoxideerd; pekresidu, met warmte behandeld; [een complexe zwarte vaste stof die wordt verkregen door de warmtebehandeling van lagetemperatuur-koolteerpek. Heeft een verwekingstraject van ongeveer 50 oC tot 140 oC (122 oF tot 284 oF). Bestaat voornamelijk uit een complex mengsel van aromatische verbindingen.] |
292-653-5 |
90669-58-2 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
M |
648-072-00-8 |
destillaten (kool-aardolie), gecondenseerde ringen aromatisch; destillaten; [het destillaat van een mengsel van koolteer en aromatische aardoliestromen, met een destillatietraject van ongeveer 220 oC tot 450 oC (428 oF tot 842 oF). Bestaat voornamelijk samengesteld uit aromatische koolwaterstoffen met drie of vier gecondenseerde ringen.] |
269-159-3 |
68188-48-7 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
M |
648-073-00-3 |
aromatische koolwaterstoffen, C20-28-, polycyclisch, afkomstig uit de pyrolyse van gemengde koolteerpek, polyethyleen en polypropyleen; pyrolyseproducten; [een complexe verzameling koolwaterstoffen die wordt verkregen uit de pyrolyse van gemengde koolteerpek, polyethyleen en polypropyleen. Bestaat voornamelijk uit polycyclische aromatische koolwaterstoffen, overwegend C20 tot en met C28, met een verwekingstraject van 100 oC tot 220 oC (212 oF tot 428 oF) volgens DIN 52025.]; |
309-956-6 |
101794-74-5 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
M |
648-074-00-9 |
aromatische koolwaterstoffen, C20-28-, polycyclisch, afkomstig uit de pyrolyse van gemengde koolteerpek en polyethyleen; pyrolyseproducten; [een complexe verzameling koolwaterstoffen die wordt verkregen uit de pyrolyse van gemengde koolteerpek en polyethyleen. Bestaat voornamelijk uit polycyclische aromatische koolwaterstoffen, overwegend C20 tot en met C28, met een verwekingstraject van 100 oC tot 220 oC (212 oF tot 428 oF) volgens DIN 52025.] |
309-957-1 |
101794-75-6 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
M |
648-075-00-4 |
aromatische koolwaterstoffen, C20-28-, polycyclisch, afkomstig uit de pyrolyse van gemengde koolteerpek en polystyreen; pyrolyseproducten; [een complexe verzameling koolwaterstoffen die wordt verkregen uit de pyrolyse van gemengde koolteerpek, polyethyleen en polypropyleen. Bestaat voornamelijk uit polycyclische aromatische koolwaterstoffen, overwegend C20 tot en met C28, met een verwekingstraject van 100 oC tot 220 oC (212 oF tot 428 oF) volgens DIN 52025.] |
309-958-7 |
101794-76-7 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
M |
648-076-00-X |
pek, koolteer-aardolie; pekresiduen; [residu uit de destillatie van een mengsel van koolteer en aromatische aardoliestromen. Het is een vaste stof met een verwekingstraject van 40 oC tot 180 oC (140 oF tot 356 oF). Bestaat voornamelijk uit een complexe verzameling van aromatische koolwaterstoffen met drie- of meervoudig gecondenseerde ringen.] |
269-109-0 |
68187-57-5 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
M |
648-077-00-5 |
fenantreen, destillatieresiduen; zware antraceenolie, herdestillaat; [residu dat wordt verkregen bij de destillatie van ruwe fenantreen met een kooktraject van ongeveer 340 oC tot 420 oC (644 oF tot 788 oF). Bestaat voornamelijk uit fenantreen, antraceen en carbazool.] |
310-169-5 |
122070-78-4 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
M |
648-078-00-0 |
destillaten (koolteer), bovenste, fluoreenvrij; wasolie, herdestillaat; [een complexe verzameling van koolwaterstoffen die wordt verkregen door de kristallisatie van teerolie. Bestaat uit aromatische polycyclische koolwaterstoffen, voornamelijk difenyl, dibenzofuran en acenafteen.] |
284-899-7 |
84989-10-6 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
M |
648-079-00-6 |
antraceenolie; antraceenolie; [een complexe verzameling polycyclische aromatische koolwaterstoffen die wordt verkregen uit koolteer met een destillatietraject van ongeveer 300 oC tot 400 oC (572 oF tot 752 oF). Bestaat voornamelijk uit fenantreen, antraceen en carbazool.] |
292-602-7 |
90640-80-5 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
M |
648-080-00-1 |
residuen (koolteer), creosootolie-destillatie; wasolie, herdestillaat; [het residu van de fractionele destillatie van wasolie, met een kooktraject van ongeveer 270 oC tot 330 oC (518 oF tot 626 oF). Bestaat voornamelijk uit bicyclische aromatische en heterocyclische koolwaterstoffen.] |
295-506-3 |
92061-93-3 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
M |
648-081-00-7 |
teer, steenkool; koolteer; [het bijproduct van de destructieve destillatie van steenkool. Nagenoeg zwarte halfvaste stof. Een complexe verzameling van aromatische koolwaterstoffen, fenolische verbindingen, stikstofbasen en thiofeen.] |
232-361-7 |
8007-45-2 |
Carc. 1A |
H350 |
GHS08 Dgr |
H350 |
|
|
|
648-082-00-2 |
teer, kool, hoge temperatuur; koolteer; [het condensatieproduct dat wordt verkregen door afkoeling tot ongeveer omgevingstemperatuur van het gas dat vrijkomt bij de destructieve destillatie van kool bij hoge temperatuur (hoger dan 700 oC (1 292 oF)). Een zwarte viskeuze vloeistof met een dichtheid groter dan water. Bestaat voornamelijk uit een complexe verzameling van aromatische koolwaterstoffen met gecondenseerde ringen. Kan geringe hoeveelheden fenolverbindingen en aromatische stikstofbasen bevatten.] |
266-024-0 |
65996-89-6 |
Carc. 1A |
H350 |
GHS08 Dgr |
H350 |
|
|
|
648-083-00-8 |
teer, kool, lage temperatuur; petroleum (steenolie); [het condensatieproduct dat wordt verkregen door afkoeling tot ongeveer omgevingstemperatuur van het gas dat vrijkomt bij de destructieve destillatie van kool bij lage temperatuur (lager dan 700 oC (1 292 oF)). Een zwarte viskeuze vloeistof met een dichtheid groter dan water. Bestaat voornamelijk uit aromatische koolwaterstoffen met gecondenseerde ringen, fenolhoudende verbindingen en aromatische stikstofbasen en hun alkylderivaten.] |
266-025-6 |
65996-90-9 |
Carc. 1A |
H350 |
GHS08 Dgr |
H350 |
|
|
|
648-084-00-3 |
destillaten (kool), lichte olie uit de cokesoven, naftaleenfractie; naftaleenolie; [de complexe verzameling koolwaterstoffen verkregen uit voorfractionering (continue destillatie) van lichte olie uit de cokesoven. Bestaat voornamelijk uit naftaleen, cumaron en indeen en kookt boven 148 oC (298 oF).] |
285-076-5 |
85029-51-2 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-085-00-9 |
destillaten (koolteer), naftaleenoliën; naftaleenolie; [een complexe verzameling koolwaterstoffen die wordt verkregen door de destillatie van koolteer. Bestaat voornamelijk uit aromatische en andere koolwaterstoffen, fenolverbindingen en aromatische stikstofverbindingen en heeft een destillatietraject van ongeveer 200 oC tot 250 oC (392 oF tot 482 oF).] |
283-484-8 |
84650-04-4 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-086-00-4 |
Destillaten (koolteer), naftaleenoliën, naftaleenarm; naftaleenolie, herdestillaat; [een complexe verzameling koolwaterstoffen die wordt verkregen door kristallisatie van naftaleenolie. Bestaat voornamelijk uit naftaleen, alkylnaftalenen en fenolverbindingen.] |
284-898-1 |
84989-09-3 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-087-00-X |
destillaten (koolteer), moederloog uit naftaleenoliekristallisatie; naftaleenolie, herdestillaat; [een complexe verzameling organische verbindingen die wordt verkregen als een filtraat uit de kristallisatie van de naftaleenfractie uit koolteer, met een kooktraject van ongeveer 200 oC tot 230 oC (392 oF tot 446 oF). Bevat voornamelijk naftaleen, thionafteen en alkylnaftalenen.] |
295-310-8 |
91995-49-2 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-088-00-5 |
extractieresiduen (kool), naftaleenolie, alkalisch; naftaleenolie, extractieresidu; [een complexe verzameling koolwaterstoffen die wordt verkregen bij het alkalisch wassen van naftaleenolie om fenolverbindingen (teerzuren) te verwijderen. Bestaat uit naftaleen en alkylnaftalenen.] |
310-166-9 |
121620-47-1 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-089-00-0 |
extractieresiduen (kool), naftaleenolie, alkalisch, naftaleenarm; naftaleenolie, extractieresidu; [een complexe verzameling koolwaterstoffen die resteert na de verwijdering van naftaleen, door middel van een kristallisatieproces, uit met alkali gewassen naftaleenolie. Bestaat voornamelijk uit naftaleen en alkylnaftalenen.] |
310-167-4 |
121620-48-2 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-090-00-6 |
destillaten (koolteer), naftaleenoliën, naftaleenvrij, alkalische extracten; naftaleenolie, extractieresidu; [de olie die resteert na de verwijdering van fenolverbindingen (teerzuren) uit afgegoten naftaleenolie door met alkali te wassen. Bestaat voornamelijk uit naftaleen en alkylnaftalenen.] |
292-612-1 |
90640-90-7 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-091-00-1 |
extractieresiduen (kool), naftaleenolie, alkalisch, destillatietopproducten; naftaleenolie, extractieresidu; [het destillaat van hogetemperatuurkoolteer, met een destillatietraject van ongeveer 130 oC tot 250 oC (356 oF tot 428 oF). Bestaat voornamelijk uit naftaleen, alkylbenzenen, indeen en indaan.] |
292-627-3 |
90641-04-6 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-092-00-7 |
destillaten (koolteer), naftaleenoliën, methylnaftaleenfractie; methylnaftaleenolie; [een destillaat dat afkomstig is uit de fractionele destillatie van hogetemperatuurkoolteer. Bestaat voornamelijk uit gesubstitueerde bicyclische aromatische koolwaterstoffen en aromatische stikstofbasen en heeft een kooktraject van ongeveer 225 oC tot 255 oC (437 oF tot 491 oF).] |
309-985-4 |
101896-27-9 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-093-00-2 |
destillaten (koolteer), naftaleenoliën, indool-methylnaftaleenfractie; methylnaftaleenolie; [een destillaat dat afkomstig is uit de fractionele destillatie van hogetemperatuurkoolteer. Bestaat voornamelijk uit indool en methylnaftaleen en heeft een kooktraject van ongeveer 235 oC tot 255 oC (455 oF tot 491 oF).] |
309-972-3 |
101794-91-6 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-094-00-8 |
destillaten (koolteer), naftaleenoliën, zuurextracten; methylnaftaleenolie, extractieresidu; [een complexe verzameling koolwaterstoffen die wordt verkregen door het van basen ontdoen van de methylnaftaleenfractie die wordt verkregen uit de destillatie van koolteer en die een kooktraject heeft van ongeveer 230 oC tot 255 oC (446 oF tot 491 oF). Bevat voornamelijk 1(2)-methylnaftaleen, naftaleen, dimethylnaftaleen en bifenyl.] |
295-309-2 |
91995-48-1 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-095-00-3 |
extractieresiduen (kool), naftaleenolie, alkalisch, destillatieresiduen; methylnaftaleenolie, extractieresidu; [het residu dat afkomstig is uit de destillatie van met alkali gewassen naftaleenolie, met een destillatietraject van ongeveer 220 oC tot 300 oC (428 oF tot 572 oF). Bestaat voornamelijk uit naftaleen, alkylnaftalenen en aromatische stikstofbasen.] |
292-628-9 |
90641-05-7 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-096-00-9 |
extractieoliën (kool), zuur, vrij van teerbasen; methylnaftaleenolie, extractieresidu; [de extractieolie met een kooktraject van ongeveer 220 oC tot 265 oC (428 oF tot 509 oF) uit alkalisch koolteerextractieresidu, verkregen door na destillatie te wassen met zuur, zoals verdund zwavelzuur, om teerbasen te verwijderen. Bestaat voornamelijk uit alkylnaftalenen.] |
284-901-6 |
84989-12-8 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-097-00-4 |
destillaten (koolteer), benzolfractie, destillatieresiduen; wasolie; [een complexe verzameling koolwaterstoffen die wordt verkregen door de destillatie van ruwe benzol (hogetemperatuurkoolteer). Kan een vloeistof zijn, met een destillatietraject van ongeveer 150 oC tot 300 oC (302 oF tot 572o F), of een vaste of halfvaste stof met een smeltpunt tot 70 oC (158 oF). Bestaat voornamelijk uit naftaleen en alkylnaftalenen.] |
310-165-3 |
121620-46-0 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-098-00-X |
creosootolie, acenafteenfractie; wasolie; [een complexe verzameling koolwaterstoffen, verkregen door de destillatie van koolteer, met een kooktraject van ongeveer 240 oC tot 280 oC (464 oF tot 536 oF). Bestaat voornamelijk uit acenafteen, naftaleen en alkylnaftaleen.] |
292-605-3 |
90640-84-9 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
M |
648-099-00-5 |
creosootolie; [een complexe verzameling koolwaterstoffen verkregen door de destillatie van koolteer. Bestaat voornamelijk uit aromatische koolwaterstoffen en kan aanzienlijke hoeveelheden teerzuren en teerbasen bevatten. Het destillatietraject ligt ongeveer tussen 200 oC en 325 oC (392 oF tot 617 oF).] |
263-047-8 |
61789-28-4 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
M |
648-100-00-9 |
creosootolie, hoogkokend destillaat; wasolie; [de hoogkokende destillatiefractie die wordt verkregen door bitumineuze kool bij hoge temperatuur te fenoliseren, en die verder wordt gezuiverd om een overmaat kristallijne zouten te verwijderen. Bestaat voornamelijk uit creosootolie waaruit enkele normale polycyclische aromatische zouten, bestanddelen van koolteerdestillaten, zijn verwijderd. Kristalvrij bij ongeveer 5 oC (41 oF).] |
274-565-9 |
70321-79-8 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
M |
648-101-00-4 |
creosoot; [het destillaat van koolteer verkregen bij de carbonisatie bij hoge temperatuur van vette kolen. Het bestaat voornamelijk uit aromatische koolwaterstoffen, teerzuren en teerbasen.] |
232-287-5 |
8001-58-9 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
648-102-00-X |
extractieresiduen (kool), creosootolie, zure; wasolie, extractieresidu; [een complexe verzameling koolwaterstoffen, verkregen uit de van basen ontdane destillatiefractie van koolteer, met een kooktraject van ongeveer 250 oC tot 280 oC (482 oF tot 536 oF). Bestaat voornamelijk uit bifenyl en isomere difenylnaftalenen.] |
310-189-4 |
122384-77-4 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
M |
648-103-00-5 |
antraceenolie, antraceenpasta; antraceenolie, fractie; [de antraceenrijke vaste stof die wordt verkregen door de kristallisatie en centrifugatie van antraceenolie. Bestaat voornamelijk uit antraceen, carbazool en fenantreen.] |
292-603-2 |
90640-81-6 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-104-00-0 |
antraceenolie, antraceenarm; antraceenolie, fractie; [de olie die resteert na de verwijdering, door middel van een kristallisatieproces, van een antraceenrijke vaste stof (antraceenpasta) uit antraceenolie. Bestaat voornamelijk uit aromatische verbindingen met twee, drie of vier ringen.] |
292-604-8 |
90640-82-7 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-105-00-6 |
residuen (koolteer), antraceenolie, destillatie-; antraceenolie, fractie; [het residu van de fractionele destillatie van ongezuiverd antraceen, met een kooktraject van ongeveer 340 oC tot 400 oC (644 oF tot 752 oF). Bestaat voornamelijk uit tri- en polynucleaire aromaten en heterocyclische koolwaterstoffen.] |
295-505-8 |
92061-92-2 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-106-00-1 |
antraceenolie, antraceenpasta, antraceenfractie; antraceenolie, fractie; [een complexe verzameling koolwaterstoffen uit de destillatie van antraceen die wordt verkregen door de kristallisatie van antraceenolie uit bitumineuze hogetemperatuurteer, met een kooktraject van 330 oC tot 350 oC (626 oF tot 662 oF). Bevat hoofdzakelijk antraceen, carbazool en fenantreen.] |
295-275-9 |
91995-15-2 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-107-00-7 |
antraceenolie, antraceenpasta, carbazoolfractie; antraceenolie, fractie; [een complexe verzameling koolwaterstoffen uit de destillatie van antraceen die wordt verkregen door kristallisatie van antraceenolie uit uit bitumineuze kool afkomstige hogetemperatuurteer, met een kooktraject van ongeveer 350 oC tot 360 oC (662 oF tot 680 oF). Bevat hoofdzakelijk antraceen, carbazool en fenantreen.] |
295-276-4 |
91995-16-3 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-108-00-2 |
antraceenolie, antraceenpasta, lichte destillatiefracties; antraceenolie, fractie; [een complexe verzameling koolwaterstoffen uit de destillatie van antraceen die wordt verkregen door kristallisatie van antraceenolie uit bitumineuze hogetemperatuurteer, met een kooktraject van ongeveer 290 oC tot 340 oC (554 oF tot 644 oF). Bevat hoofdzakelijk tricyclische aromaten en dihydroderivaten daarvan.] |
295-278-5 |
91995-17-4 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-109-00-8 |
teeroliën, kool, lage temperatuur; teerolie, hoogkokend; [een destillaat uit lagetemperatuurkoolteer. Bestaat voornamelijk uit koolwaterstoffen, fenolverbindingen en aromatische stikstofbasen, met een kooktraject van ongeveer 160 oC tot 340 oC (320 oF tot 644 oF).] |
309-889-2 |
101316-87-4 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-110-00-3 |
extractieresiduen (kool), lagetemperatuurkoolteer-alkalische; [het residu van lagetemperatuurkoolteeroliën na wassen met alkali, bijvoorbeeld met verdund natriumhydroxide, om ruwe koolteerzuren te verwijderen. Bestaat voornamelijk uit koolwaterstoffen en aromatische stikstofbasen.] |
310-191-5 |
122384-78-5 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-111-00-9 |
fenolen, ammoniakprocesvochtextract; alkalisch extract; [de verzameling fenolen die met isobutylacetaat worden geëxtraheerd uit het ammoniakprocesvocht dat wordt gecondenseerd uit het gas dat ontstaat bij de destructieve destillatie van kool bij lage temperatuur(minder dan 700 oC (1 292 oF)). Bestaat voornamelijk uit een reactiemassa van een- en tweewaardige fenolen.] |
284-881-9 |
84988-93-2 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-112-00-4 |
destillaten (koolteer), lichte oliën, alkalische extracten; alkalisch extract; [het waterig extract uit fenololie dat wordt verkregen door te wassen met alkali, zoals verdund natriumhydroxide. Bestaat voornamelijk uit de alkalizouten van verschillende fenolverbindingen.] |
292-610-0 |
90640-88-3 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-113-00-X |
extracten, koolteerolie, alkalische; alkalisch extract; [het extract van koolteerolie dat wordt verkregen door te wassen met alkali, zoals verdund natriumhydroxide. Bestaat voornamelijk uit de alkalizouten van verschillende fenolverbindingen.] |
266-017-2 |
65996-83-0 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-114-00-5 |
destillaten (koolteer), naftaleenoliën, alkalische extracten; alkalisch extract; [het waterig extract uit naftaleenolie dat wordt verkregen door te wassen met alkali, zoals verdund natriumhydroxide. Bestaat voornamelijk uit de alkalizouten van verschillende fenolverbindingen.] |
292-611-6 |
90640-89-4 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-115-00-0 |
extractieresiduen (kool), teerolie alkalisch, gecarboneerd, met ongebluste kalk behandeld; ruwe fenolen; [het product dat wordt verkregen door de behandeling van een alkalisch extract van koolteerolie met CO2 en CaO. Bestaat voornamelijk uit CaCO3, Ca(OH)2, Na2CO3 en andere organische en anorganische verontreinigingen.] |
292-629-4 |
90641-06-8 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-116-00-6 |
teerzuren, kool, ruw; ruwe fenolen; [het reactieproduct verkregen door het neutraliseren van een alkalisch extract van koolteerolie met een zure oplossing, zoals verdund zwavelzuur of gasvormig kooldioxide, om vrije zuren te verkrijgen. Bestaat voornamelijk uit teerzuren, zoals fenol, kresol en xylenolen.] |
266-019-3 |
65996-85-2 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-117-00-1 |
teerzuren, bruinkool, ruw; ruwe fenolen; [een aangezuurd alkalisch extract van bruinkoolteerdestillaat. Bestaat voornamelijk uit fenol en fenolhomologen.] |
309-888-7 |
101316-86-3 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-118-00-7 |
teerzuren, bruinkoolvergassing; ruwe fenolen; [een complexe verzameling organische verbindingen die wordt verkregen uit de bruinkoolvergassing. Bestaat voornamelijk uit C6-10-hydroxyaromaatfenolen en homologen daarvan.] |
295-536-7 |
92062-22-1 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-119-00-2 |
teerzuren, destillatieresiduen; gedestilleerde fenolen; [het residu van de destillatie van ruwe fenol uit kool. Bestaat voornamelijk uit fenolen, overwegend C8 tot en met C10, met een verwekingstraject van 60 oC tot 80 oC (140 oF tot 176 oF).] |
306-251-5 |
96690-55-0 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-120-00-8 |
teerzuren, methylfenolfractie; gedestilleerde fenolen; [de teerzuurfractie, rijk aan 3- en 4-methylfenol, die wordt verkregen door destillatie van ongezuiverde teerzuren uit lagetemperatuurkoolteer.] |
284-892-9 |
84989-04-8 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-121-00-3 |
teerzuren, polyalkylfenolfractie; gedestilleerde fenolen; [de teerzuurfractie die wordt verkregen door destillatie van ongezuiverde teerzuren uit lagetemperatuurkoolteer, met een kooktraject van ongeveer 225 oC tot 320 oC (437 oF tot 608 oF). Bestaat voornamelijk uit polyalkylfenolen.] |
284-893-4 |
84989-05-9 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-122-00-9 |
teerzuren, xylenolfractie; gedestilleerde fenolen; [de teerzuurfractie, rijk aan 2,4- en 2,5-dimethylfenol, die wordt verkregen door destillatie van ongezuiverde teerzuren uit lagetemperatuurkoolteer.] |
284-895-5 |
84989-06-0 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-123-00-4 |
teerzuren, ethylfenolfractie; gedestilleerde fenolen; [de teerzuurfractie, rijk aan 3- en 4-ethylfenol, die wordt verkregen door destillatie van ongezuiverde teerzuren uit lagetemperatuurkoolteer.] |
284-891-3 |
84989-03-7 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-124-00-X |
teerzuren, 3,5-xylenolfractie; gedestilleerde fenolen; [de teerzuurfractie, rijk aan 3,5-dimethylfenol, die wordt verkregen door destillatie van teerzuren uit lagetemperatuurkoolteer.] |
284-896-0 |
84989-07-1 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-125-00-5 |
teerzuren, residuen, destillaten, voorloop; gedestilleerde fenolen; [het residu van de destillatie van lichte fenololie op het kooktraject van 235 oC tot 355 oC (481 oF tot 697 oF).] |
270-713-1 |
68477-23-6 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-126-00-0 |
teerzuren, kresylhoudend, residuen; gedestilleerde fenolen; [het residu van teerzuren, afkomstig uit ruwe kool, na verwijdering van fenol, kresolen en xylenolen en fenolen met een hoger kookpunt. Een zwarte vaste stof met een smeltpunt van ongeveer 80 oC (176 oF). Bestaat voornamelijk uit polyalkylfenolen, harsgommen en anorganische zouten.] |
271-418-0 |
68555-24-8 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-127-00-6 |
fenolen, C9-11-; gedestilleerde fenolen |
293-435-2 |
91079-47-9 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-128-00-1 |
teerzuren, kresylhoudend; gedestilleerde fenolen; [een complexe verzameling organische verbindingen die wordt verkregen uit bruinkool, met een kooktraject van ongeveer 200 oC tot 230 oC (392 oF tot 446 oF). Bestaat voornamelijk uit fenolen en pyridinebasen.] |
295-540-9 |
92062-26-5 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-129-00-7 |
teerzuren, bruinkool, C2-alkylfenolfractie; gedestilleerde fenolen; [het destillaat van de verzuring van alkalisch gewassen bruinkoolteerdestillaat, met een kooktraject van ongeveer 200 oC tot 230 oC (392 oF tot 446 oF). Bestaat voornamelijk uit m- en p-ethylfenol, alsmede kresolen en xylenolen.] |
302-662-9 |
94114-29-1 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-130-00-2 |
extractieoliën (kool), naftaleenoliën; zuurextract; [het waterige extract dat wordt verkregen door wassen met zuur van alkalisch gewassen naftaleenolie. Bestaat voornamelijk uit zure zouten van uiteenlopende aromatische stikstofbasen, met inbegrip van pyridine, chinoline en alkylderivaten daarvan.] |
292-623-1 |
90641-00-2 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-131-00-8 |
teerbasen, chinolinederivaten; gedestilleerde teerbasen |
271-020-7 |
68513-87-1 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-132-00-3 |
teerbasen, kool, fractie van chinolinederivaten; gedestilleerde teerbasen |
274-560-1 |
70321-67-4 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-133-00-9 |
teerbasen, kool, destillatieresiduen; gedestilleerde teerbasen; [het destillatieresidu dat achterblijft na de destillatie van de geneutraliseerde met zuur geëxtraheerde basehoudende teerfracties die worden verkregen door de destillatie van koolteer. Bevat voornamelijk aniline, collidinen, chinoline, chinolinederivaten en toluïdinen.] |
295-544-0 |
92062-29-8 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-134-00-4 |
koolwaterstofoliën, aromatisch, gemengd met polyethyleen en polypropyleen, gepyrolyseerd, lichte oliefractie; thermisch behandelde producten; [de olie die wordt verkregen uit de thermische behandeling van een reactiemassa van polyethyleen en polypropyleen met koolteerpek of aromatische oliën. Bestaat voornamelijk uit benzeen en homologen daarvan en heeft een kooktraject van ongeveer 70 oC tot 120 oC (158 oF tot 248 oF).] |
309-745-9 |
100801-63-6 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-135-00-X |
koolwaterstofoliën, aromatisch, gemengd met polyethyleen, gepyrolyseerd, lichte oliefractie; thermisch behandelde producten; [de olie die wordt verkregen uit de thermische behandeling van polyethyleen met koolteerpek of aromatische oliën. Bestaat voornamelijk uit benzeen en homologen daarvan en heeft een kooktraject van ongeveer 70 oC tot 120 oC (158 oF tot 248 oF).] |
309-748-5 |
100801-65-8 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-136-00-5 |
koolwaterstofoliën, aromatisch, gemengd met polystyreen, gepyrolyseerd, lichte oliefractie; thermisch behandelde producten; [de olie die wordt verkregen uit de thermische behandeling van polystyreen met koolteerpek of aromatische oliën. Bestaat voornamelijk uit benzeen en homologen daarvan en heeft een kooktraject van ongeveer 70 oC tot 210 oC (158 oF tot 410 oF).] |
309-749-0 |
100801-66-9 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-137-00-0 |
extractieresiduen (kool), teerolie, alkalische, naftaleendestillatieresiduen; naftaleenolie, extractieresidu; [het residu dat wordt verkregen uit chemische olie die is geëxtraheerd na verwijdering van naftaleen door destillatie. Bestaat voornamelijk uit aromatische koolwaterstoffen met twee tot vier gecondenseerde ringen en aromatische stikstofbasen.] |
277-567-8 |
73665-18-6 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-138-00-6 |
creosootolie, bij lage temperaturen kokend destillaat; wasolie; [de bij lage temperaturen kokende destillatiefractie die wordt verkregen door bitumineuze kool bij hoge temperatuur te verkooksen, en die verder wordt gezuiverd om een overmaat kristallijne zouten te verwijderen. Bestaat voornamelijk uit creosootolie waaruit enkele normale polycyclische aromatische zouten, bestanddelen van koolteerdestillaten, zijn verwijderd. Kristalvrij bij ongeveer 38 oC (100 oF).] |
274-566-4 |
70321-80-1 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
M |
648-139-00-1 |
teerzuren, kresyl-, natriumzouten, loogoplossingen; alkalisch extract |
272-361-4 |
68815-21-4 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-140-00-7 |
extractieoliën (kool), teerbasen; zuurextract; [het extract uit het alkalisch extractieresidu van koolteerolie dat wordt verkregen door te wassen met zuur, zoals verdund zwavelzuur, na destillatie om naftaleen te verwijderen. Bestaat voornamelijk uit de zure zouten van verschillende aromatische stikstofbasen zoals pyridine en chinoline en alkylderivaten daarvan.] |
266-020-9 |
65996-86-3 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-141-00-2 |
teerbasen, kool, ruw; ruwe teerbasen; [het reactieproduct dat wordt verkregen door extractieolie uit koolteerbase met een alkalische oplossing, zoals verdund natriumhydroxide, te neutraliseren om de vrije basen te verkrijgen. Bestaat voornamelijk uit organische basen zoals acridine, fenantridine, pyridine, chinoline en hun alkylderivaten.] |
266-018-8 |
65996-84-1 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
JM |
648-142-00-8 |
residuen (kool), vloeibaar-oplosmiddelextractie; [een coherent poeder, samengesteld uit minerale stoffen uit kool en onopgeloste kool overblijvend na extractie van kool met een vloeibaar oplosmiddel.] |
302-681-2 |
94114-46-2 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
M |
648-143-00-3 |
koolvloeistoffen, vloeibaar-oplosmiddelextractie-oplossing; [het product verkregen na filtratie van minerale stoffen uit kool en onopgeloste kool, van een koolextractieoplossing geproduceerd door kool op te lossen in een vloeibaar oplosmiddel. Een zwarte, viskeuze, zeer complexe vloeibare combinatie, die voornamelijk bestaat uit aromatische en gedeeltelijk gehydrogeneerde aromatische koolwaterstoffen, aromatische stikstofverbindingen, aromatische zwavelverbindingen, fenolische en andere aromatische zuurstofverbindingen en de alkylderivaten daarvan.] |
302-682-8 |
94114-47-3 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
M |
648-144-00-9 |
koolvloeistoffen, vloeibaar-oplosmiddelextractie; [het in wezen oplosmiddelvrije product, verkregen bij de destillatie van het oplosmiddel van een gefilterde koolextractieoplossing, geproduceerd door kool op te lossen in een vloeibaar oplosmiddel. Een zwarte halfvaste stof, die voornamelijk bestaat uit een complexe verzameling aromatische koolwaterstoffen met gecondenseerde ringsystemen, aromatische stikstofverbindingen, fenolachtige verbindingen en andere aromatische zuurstofverbindingen en de alkylderivaten daarvan.] |
302-683-3 |
94114-48-4 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
M |
648-145-00-4 |
teer, bruinkool; [een olie die is gedestilleerd uit bruinkoolteer. Voornamelijk samengesteld uit alifatische, naftenische en één- tot drierings aromatische koolwaterstoffen, de alkylderivaten daarvan, heteroaromaten en één- en tweeringsfenolen, met een kooktraject van ongeveer 150 oC tot 360 oC (302 oF tot 680 oF).] |
309-885-0 |
101316-83-0 |
Carc. 1A |
H350 |
GHS08 Dgr |
H350 |
|
|
|
648-146-00-X |
teer, bruinkool, lage temperatuur; [een teer die wordt verkregen uit de carbonisatie bij lage temperatuur en vergassing bij lage temperatuur van bruinkool. Bestaat voornamelijk uit alifatische, naftenische en cyclische aromatische koolwaterstoffen, heteroaromatische koolwaterstoffen en cyclische fenolen.] |
309-886-6 |
101316-84-1 |
Carc. 1A |
H350 |
GHS08 Dgr |
H350 |
|
|
|
648-147-00-5 |
lichte olie (kool), cokesoven; ruwe benzol; [de vluchtige organische vloeistof die wordt geëxtraheerd uit het gas dat vrijkomt bij de destructieve destillatie van kool bij hoge temperatuur (hoger dan 700 oC (1 292 oF)). Bestaat voornamelijk uit benzeen, tolueen en xylenen. Kan kleinere hoeveelheden andere koolwaterstoffen bevatten.] |
266-012-5 |
65996-78-3 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
J |
648-148-00-0 |
destillaten (kool), primaire, vloeibaar-oplosmiddelextractie; [het vloeibare product uit de condensatie van de damp die vrijkomt bij het ontsluiten van kool in een vloeibaar oplosmiddel, met een kooktraject van ongeveer 30 oC tot 300 oC (86 oF tot 572 oF). Bestaat voornamelijk uit gedeeltelijk gehydrogeneerde aromatische koolwaterstoffen met gecondenseerde ringsystemen, aromatische verbindingen met stikstof, zuurstof en zwavel en de alkylderivaten daarvan, overwegend C4 tot en met C14.] |
302-688-0 |
94114-52-0 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
J |
648-149-00-6 |
destillaten (kool), oplosmiddelextractie, waterstofgekraakt; [het destillaat dat wordt verkregen door het met waterstof kraken van koolextract of de oplossing die wordt verkregen door extractie met vloeibaar oplosmiddel of met superkritisch gas, met een kooktraject van ongeveer 30 oC tot 300 oC (86 oF tot 572 oF). Bestaat voornamelijk uit aromatische, gehydrogeneerde aromatische en nafteenverbindingen, alkylderivaten daarvan en alkanen, overwegend C4 tot en met C14. Bevat eveneens stikstof-, zwavel- en zuurstofhoudende aromatische en gehydrogeneerde aromatische verbindingen.] |
302-689-6 |
94114-53-1 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
J |
648-150-00-1 |
nafta (kool), oplosmiddelextractie, waterstofgekraakt; [fractie van het destillaat dat wordt verkregen door het met waterstof kraken van koolextract of de oplossing die wordt verkregen door extractie met vloeibaar oplosmiddel of met superkritisch gas, met een kooktraject van ongeveer 30 oC tot 180 oC (86 oF tot 356 oF). Bestaat voornamelijk uit aromatische, gehydrogeneerde aromatische en nafteenverbindingen, alkylderivaten daarvan en alkanen, overwegend C4 tot en met C9. Bevat eveneens stikstof-, zwavel- en zuurstofhoudende aromatische en gehydrogeneerde aromatische verbindingen.] |
302-690-1 |
94114-54-2 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
J |
648-151-00-7 |
benzine, kool-oplosmiddelextractie, waterstofgekraakte nafta; [motorbrandstof, verkregen door het omvormen van de gezuiverde naftafractie van de producten van het met waterstof kraken van koolextract of de oplossing die wordt verkregen door extractie met vloeibaar oplosmiddel of met superkritisch gas, met een kooktraject van ongeveer 30 oC tot 180 oC (86 oF tot 356 oF). Bestaat voornamelijk uit aromatische en nafteenverbindingen en alkylderivaten daarvan en alkylkoolwaterstoffen, overwegend C4 tot en met C9.) |
302-691-7 |
94114-55-3 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
648-152-00-2 |
destillaten (kool), oplosmiddelextractie, waterstofgekraakte middenfractie; [het destillaat dat wordt verkregen door het met waterstof kraken van koolextract of de oplossing die wordt verkregen door extractie met vloeibaar oplosmiddel of met superkritisch gas, met een kooktraject van ongeveer 180 oC tot 300 oC (356 oF tot 572 oF). Bestaat voornamelijk uit bicyclische aromatische, gehydrogeneerde aromatische en nafteenverbindingen, alkylderivaten daarvan en alkanen, overwegend C9 tot en met C14. Bevat eveneens stikstof-, zwavel- en zuurstofhoudende verbindingen.] |
302-692-2 |
94114-56-4 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
J |
648-153-00-8 |
destillaten (kool), oplosmiddelextractie, waterstofgekraakte gehydrogeneerde middenfractie; [het destillaat dat wordt verkregen door de hydrogenering van waterstofgekraakte middenfractie van koolextract of de oplossing die wordt verkregen door extractie met vloeibaar oplosmiddel of superkritisch gas, met een kooktraject van ongeveer 180 oC tot 280 oC (356 oF tot 536 oF). Bestaat voornamelijk uit gehydrogeneerde bicyclische koolstofverbindingen en alkylderivaten daarvan, overwegend C9 tot en met C14.] |
302-693-8 |
94114-57-5 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
J |
648-154-00-3 |
brandstoffen voor straalvliegtuigen, kool-oplosmiddelextractie, waterstofgekraakt, gehydrogeneerd; [motorbrandstof, verkregen door hydrogenering van de middendestillaatfractie van de producten van het met waterstof kraken van koolextract of de oplossing die wordt verkregen door extractie met vloeibaar oplosmiddel of met superkritisch gas, met een kooktraject van ongeveer 180 oC tot 225 oC (356 oF tot 473 oF). Bestaat voornamelijk uit gehydrogeneerde bicyclische koolwaterstoffen en alkylderivaten daarvan, overwegend C10 tot en met C12.] |
302-694-3 |
94114-58-6 |
Carc. 2 |
H351 |
GHS08 Wng |
H350 |
|
|
|
648-155-00-9 |
brandstoffen, diesel, kool-oplosmiddelextractie, waterstofgekraakt, gehydrogeneerd; [dieselbrandstof, verkregen door de hydrogenering van de middendestillaatfractie van de producten van het met waterstof kraken van koolextract of de oplossing die wordt verkregen door extractie met vloeibaar oplosmiddel of met superkritisch gas, met een kooktraject van ongeveer 200 oC tot 280 oC (392 oF tot 536 oF). Bestaat voornamelijk uit gehydrogeneerde bicyclische koolwaterstoffen en alkylderivaten daarvan, overwegend C11 tot en met C14.] |
302-695-9 |
94114-59-7 |
Carc. 2 |
H351 |
GHS08 Wng |
H350 |
|
|
|
648-156-00-4 |
lichte olie (kool), semi-verkooksingsproces; verse olie; [de vluchtige organische vloeistof die wordt gecondenseerd uit het gas dat vrijkomt bij de destructieve destillatie van kool bij lage temperatuur (minder dan 700 oC (1 292 oF)). Bestaat voornamelijk uit C6-10-koolwaterstoffen.] |
292-635-7 |
90641-11-5 |
Carc. 1B Muta. 1B |
H350 H340 |
GHS08 Dgr |
H350 H340 |
|
|
J |
649-001-00-3 |
extracten (aardolie), naftenisch licht destillaat-oplosmiddel- |
265-102-1 |
64742-03-6 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-002-00-9 |
extracten (aardolie), paraffinisch zwaar destillaat-oplosmiddel- |
265-103-7 |
64742-04-7 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-003-00-4 |
extracten (aardolie), paraffinisch licht destillaat-oplosmiddel- |
265-104-2 |
64742-05-8 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-004-00-X |
extracten (aardolie), naftenisch zwaar destillaat-oplosmiddel- |
265-111-0 |
64742-11-6 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-005-00-5 |
extracten (aardolie), licht vacuümgasolie-oplosmiddel- |
295-341-7 |
91995-78-7 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-006-00-0 |
koolwaterstoffen, C26-55-, rijk aan aromaten; |
307-753-7 |
97722-04-8 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-007-00-6 |
vetzuren, tallolie, reactieproducten met iminodiëthanol en boorzuur |
400-160-5 |
— |
Skin Irrit. 2 Aquatic Chronic 2 |
H315 H411 |
GHS07 GHS09 Wng |
H315 H411 |
|
|
|
649-008-00-1 |
residuen (aardolie), atmosferische destillatietoren; stookolie; [een complex residu, verkregen door atmosferische destillatie van ruwe olie. Bestaat uit koolwaterstoffen, overwegend groter dan C20, kokend boven ongeveer 350 oC (662 oF). Deze stroom bevat waarschijnlijk 5 of meer gewichtsprocenten aromatische koolwaterstoffen met vier- tot zesvoudig gecondenseerde ringen.] |
265-045-2 |
64741-45-3 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-009-00-7 |
gasoliën (aardolie), zware vacuümdestillatiefractie; stookolie; [een complexe verzameling koolwaterstoffen, verkregen door de vacuümdestillatie van het residu van de atmosferische destillatie van ruwe olie. Bestaat uit koolwaterstoffen, overwegend C20 tot en met C50, met een kooktraject van ongeveer 350 oC tot 600 oC (662 oF tot 1 112 oF). Deze stroom bevat waarschijnlijk 5 of meer gewichtsprocenten aromatische koolwaterstoffen met vier- tot zesvoudig gecondenseerde ringen.] |
265-058-3 |
64741-57-7 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-010-00-2 |
destillaten (aardolie), zwaar katalytisch gekraakt; stookolie; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van producten van een katalytisch kraakproces. Bestaat uit koolwaterstoffen, overwegend C15 tot en met C35, met een kooktraject van ongeveer 260 oC tot 500 oC (500 oF tot 932 oF).] Deze stroom bevat waarschijnlijk 5 of meer gewichtsprocenten aromatische koolwaterstoffen met vier- tot zesvoudig gecondenseerde ringen.] |
265-063-0 |
64741-61-3 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-011-00-8 |
geklaarde oliën (aardolie), katalytisch gekraakt; stookolie; [een complexe verzameling koolwaterstoffen, verkregen als de residufractie van de destillatie van producten uit een katalytisch kraakproces. Bestaat uit koolwaterstoffen, overwegend groter dan C20, kokend boven ongeveer 350 oC (662 oF). Deze stroom bevat waarschijnlijk 5 of meer gewichtsprocenten aromatische koolwaterstoffen met vier- tot zesvoudig gecondenseerde ringen.] |
265-064-6 |
64741-62-4 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-012-00-3 |
residuen (aardolie), waterstofgekraakt; stookolie; [een complexe verzameling koolwaterstoffen, verkregen als de residufractie uit de destillatie van de producten van een waterstofkraakproces. Bestaat uit koolwaterstoffen, overwegend groter dan C20, kokend boven ongeveer 350 oC (662 oF).] |
265-076-1 |
64741-75-9 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-013-00-9 |
residuen (aardolie), thermisch gekraakt; stookolie; [een complexe verzameling koolwaterstoffen, verkregen als de residufractie van de destillatie van het product van een thermisch kraakproces. Bestaat voornamelijk uit onverzadigde koolwaterstoffen, overwegend groter dan C20, kokend boven ongeveer 350 oC (662 oF). Deze stroom bevat waarschijnlijk 5 of meer gewichtsprocenten aromatische koolwaterstoffen met vier- tot zesvoudig gecondenseerde ringen.] |
265-081-9 |
64741-80-6 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-014-00-4 |
destillaten (aardolie), zwaar thermisch gekraakt; stookolie; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van de producten van een thermisch kraakproces. Bestaat voornamelijk uit onverzadigde koolwaterstoffen, overwegend C15 tot en met C36, met een kooktraject van ongeveer 260 oC tot 480 oC (500 oF tot 896 oF). Deze stroom bevat waarschijnlijk 5 of meer gewichtsprocenten aromatische koolwaterstoffen met vier- tot zesvoudig gecondenseerde ringen.] |
265-082-4 |
64741-81-7 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-015-00-X |
gasoliën (aardolie), met waterstof behandelde vacuümdestillatiefractie; stookolie; [een complexe verzameling koolwaterstoffen, verkregen door het behandelen van een aardoliefractie met waterstof in aanwezigheid van een katalysator. Bestaat uit koolwaterstoffen, overwegend C13 tot en met C50, met een kooktraject van ongeveer 230 oC tot 600 oC (446 oF tot 1 112 oF).] Deze stroom bevat waarschijnlijk 5 of meer gewichtsprocenten aromatische koolwaterstoffen met vier- tot zesvoudig gecondenseerde ringen.] |
265-162-9 |
64742-59-2 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-016-00-5 |
residuen (aardolie), met waterstof ontzwaveld, atmosferische destillatietoren; stookolie; [een complexe verzameling koolwaterstoffen, verkregen door behandeling van een residu uit een atmosferische destillatietoren met waterstof in de aanwezigheid van een katalysator onder omstandigheden primair bedoeld om organische zwavelverbindingen te verwijderen. Bestaat uit koolwaterstoffen, overwegend groter dan C20, kokend boven ongeveer 350 oC (662 oF). Deze stroom bevat waarschijnlijk 5 of meer gewichtsprocenten aromatische koolwaterstoffen met vier- tot zesvoudig gecondenseerde ringen.] |
265-181-2 |
64742-78-5 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-017-00-0 |
gasoliën (aardolie), met waterstof ontzwavelde zware vacuümdestillatiefractie; stookolie; [een complexe verzameling koolwaterstoffen, verkregen door katalytische waterstofontzwaveling. Bestaat uit koolwaterstoffen, overwegend C20 tot en met C50, met een kooktraject van ongeveer 350 oC tot 600 oC (662 oF tot 1 112 oF).] Deze stroom bevat waarschijnlijk 5 of meer gewichtsprocenten aromatische koolwaterstoffen met vier- tot zesvoudig gecondenseerde ringen.] |
265-189-6 |
64742-86-5 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-018-00-6 |
residuen (aardolie), stoomgekraakt; stookolie; [een complexe verzameling koolwaterstoffen, verkregen als de residufractie van de destillatie van de producten van een stoomkraakproces (inclusief stoomkraken voor de productie van ethyleen). Bestaat voornamelijk uit onverzadigde koolwaterstoffen, overwegend groter dan C14, kokend boven ongeveer 260 oC (500 oF). Deze stroom bevat waarschijnlijk 5 of meer gewichtsprocenten aromatische koolwaterstoffen met vier- tot zesvoudig gecondenseerde ringen.] |
265-193-8 |
64742-90-1 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-019-00-1 |
residuen (aardolie), atmosferische destillatie; stookolie; [een complex residu, verkregen uit de atmosferische destillatie van ruwe olie. Bestaat uit koolwaterstoffen, overwegend groter dan C11, kokend boven ongeveer 200 oC (392 oF).] Deze stroom bevat waarschijnlijk 5 of meer gewichtsprocenten aromatische koolwaterstoffen met vier- tot zesvoudig gecondenseerde ringen.] |
269-777-3 |
68333-22-2 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-020-00-7 |
geklaarde oliën (aardolie), met waterstof ontzwavelde katalytisch gekraakte; stookolie; [een complexe verzameling koolwaterstoffen, verkregen door de behandeling van katalytisch gekraakte geklaarde olie met waterstof, om organisch zwavel om te zetten in waterstofsulfide dat verwijderd wordt. Bestaat uit koolwaterstoffen, overwegend groter dan C20, kokend boven ongeveer 350 oC (662 oF). Deze stroom bevat waarschijnlijk 5 of meer gewichtsprocenten aromatische koolwaterstoffen met vier- tot zesvoudig gecondenseerde ringen.] |
269-782-0 |
68333-26-6 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-021-00-2 |
destillaten (aardolie), met waterstof ontzwavelde katalytisch gekraakte tussenfractie; stookolie; [een complexe verzameling koolwaterstoffen die wordt verkregen door de behandeling van de katalytisch gekraakte destillaattussenfracties met waterstof om organisch zwavel om te zetten in waterstofsulfide dat verwijderd wordt. Bestaat uit koolwaterstoffen, overwegend C11 tot en met C30, met een kooktraject van ongeveer 205 oC tot 450 oC (401 oF tot 842 oF). Bevat een relatief grote hoeveelheid tricyclische aromatische koolwaterstoffen.] |
269-783-6 |
68333-27-7 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-022-00-8 |
destillaten (aardolie), met waterstof ontzwavelde zware katalytisch gekraakte fractie; stookolie; [een complexe verzameling koolwaterstoffen, verkregen uit de behandeling van zware katalytisch gekraakte destillaten met waterstof, waarbij organisch zwavel wordt omgezet in waterstofsulfide dat verwijderd wordt. Bestaat uit koolwaterstoffen, overwegend C15 tot en met C35, met een kooktraject van ongeveer 260 oC tot 500 oC (500 oF tot 932 oF).] Deze stroom bevat waarschijnlijk 5 of meer gewichtsprocenten aromatische koolwaterstoffen met vier- tot zesvoudig gecondenseerde ringen.] |
269-784-1 |
68333-28-8 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-023-00-3 |
stookolie, gasoliën verkregen uit residuen van directe destillatie, hoog zwavelgehalte; stookolie |
270-674-0 |
68476-32-4 |
Carc. 1B |
H350 |
HS08 Dgr |
H350 |
|
|
|
649-024-00-9 |
brandstofolie, residuaal; stookolie; [het vloeibare product dat wordt verkregen uit verscheidene raffineringsstromen, gewoonlijk residuen. De samenstelling is ingewikkeld, en varieert met de herkomst van de ruwe olie.] |
270-675-6 |
68476-33-5 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-025-00-4 |
residuen (aardolie), katalytischereformator-fractioneerder-residudestillatie-; stookolie; [een complex residu, afkomstig uit de destillatie van katalytischereformator-fractioneerder-residu. Kookt boven ongeveer 399 oC (750 oF).] |
270-792-2 |
68478-13-7 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-026-00-X |
residuen (aardolie), zware uit verkookser afkomstige gasolie- en vacuümgasolie-; stookolie; [een complexe verzameling koolwaterstoffen, gevormd als de residufractie uit de destillatie van zware gasolie uit een verkookser en vacuümgasolie. Bestaat voornamelijk uit koolwaterstoffen, overwegend groter dan C13, kokend boven ongeveer 230 oC (446 oF).] |
270-796-4 |
68478-17-1 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-027-00-5 |
residuen (aardolie), zware verkookser- en lichte vacuüm-; stookolie; [een complexe verzameling koolwaterstoffen, gevormd als de residufractie uit de destillatie van zware verkookser-gasolie en lichte vacuümgasolie. Bestaat voornamelijk uit koolwaterstoffen, overwegend groter dan C13, kokend boven ongeveer 230 oC (446 oF). |
270-983-0 |
68512-61-8 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-028-00-0 |
residuen (aardolie), lichte vacuüm-; stookolie; [een complex residu, afkomstig uit de vacuümdestillatie van het residu van de atmosferische destillatie van ruwe olie. Bestaat uit koolwaterstoffen, overwegend groter dan C13, kokend boven ongeveer 230 oC (446 oF).] |
270-984-6 |
68512-62-9 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-029-00-6 |
residuen (aardolie), stoomgekraakte lichte; stookolie; [een complex residu, afkomstig uit de destillatie van de producten uit een stoomkraakproces. Bestaat voornamelijk uit aromatische en onverzadigde koolwaterstoffen, overwegend groter dan C7, met een kooktraject van ongeveer 101 oC tot 555 oC (214 oF tot 1 030 oF).] |
271-013-9 |
68513-69-9 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-030-00-1 |
brandstofolie, nr. 6; stookolie; [een stookolie met een minimale viscositeit van 900 SUS bij 37,7 oC (100 oF) en een maximale viscositeit van 9 000 SUS bij 37,7 oC (100 oF).] |
271-384-7 |
68553-00-4 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-031-00-7 |
residuen (aardolie), aftopinrichting, laag zwavelgehalte; stookolie; [een complexe verzameling koolwaterstoffen met laag zwavelgehalte, gevormd als de residufractie uit de destillatie in de aftopinrichting van ruwe olie. Dit residu wordt gevormd na verwijdering van de aftap van direct door fractionering verkregen benzine, kerosine en gasolie.] |
271-763-7 |
68607-30-7 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-032-00-2 |
gasoliën (aardolie), zware atmosferische destillatiefractie; stookolie; [een complexe verzameling koolwaterstoffen, verkregen uit de destillatie van ruwe olie. Bestaat uit koolwaterstoffen, overwegend C7 tot en met C35, met een kooktraject van ongeveer 121 oC tot 510 oC (250 oF tot 950 oF).] |
272-184-2 |
68783-08-4 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-033-00-8 |
residuen (aardolie), verkookser-gasreiniger, bevat aromaten met gecondenseerde ringen; stookolie; [een zeer complexe verzameling koolwaterstoffen die wordt gevormd als de residufractie uit de destillatie van vacuümresidu en de producten uit een thermisch kraakproces. Bestaat voornamelijk uit koolwaterstoffen, overwegend groter dan C20, kokend boven ongeveer 350 oC (662 oF). Deze stroom bevat waarschijnlijk 5 of meer gewichtsprocenten aromatische koolwaterstoffen met vier- tot zesvoudig gecondenseerde ringen.] |
272-187-9 |
68783-13-1 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-034-00-3 |
destillaten (aardolie), aardolieresiduen vacuüm-; stookolie; [een complexe verzameling koolwaterstoffen die wordt gevormd door de vacuümdestillatie van het residu dat afkomstig is van de atmosferische destillatie van ruwe olie.] |
273-263-4 |
68955-27-1 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-035-00-9 |
residuen (aardolie), stoomgekraakt, harsachtig; stookolie; [een complex residu dat wordt verkregen door de destillatie van stoomgekraakte aardolieresiduen.] |
273-272-3 |
68955-36-2 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-036-00-4 |
destillaten (aardolie), middelste vacuüm-; stookolie; [een complexe verzameling koolwaterstoffen, verkregen door de vacuümdestillatie van het residu van de atmosferische destillatie van ruwe olie. Bestaat uit koolwaterstoffen, overwegend C14 tot en met C42, met een kooktraject van ongeveer 250 oC tot 545 oC (482 oF tot 1 013 oF). Deze stroom bevat waarschijnlijk 5 of meer gewichtsprocenten aromatische koolwaterstoffen met vier- tot zesvoudig gecondenseerde ringen.] |
274-683-0 |
70592-76-6 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-037-00-X |
destillaten (aardolie), lichte vacuüm-; stookolie; [een complexe verzameling koolwaterstoffen, verkregen door de vacuümdestillatie van het residu van de atmosferische destillatie van ruwe olie. Bestaat uit koolwaterstoffen, overwegend C11 tot en met C35, met een kooktraject van ongeveer 250 oC tot 545 oC (482 oF tot 1 013 oF).] |
274-684-6 |
70592-77-7 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-038-00-5 |
destillaten (aardolie), vacuüm-; stookolie; [een complexe verzameling koolwaterstoffen, verkregen door de vacuümdestillatie van het residu van de atmosferische destillatie van ruwe olie. Bestaat uit koolwaterstoffen, overwegend C15 tot en met C50, met een kooktraject van ongeveer 270 oC tot 600 oC (518 oF tot 1 112 oF). Deze stroom bevat waarschijnlijk 5 of meer gewichtsprocenten aromatische koolwaterstoffen met vier- tot zesvoudig gecondenseerde ringen.] |
274-685-1 |
70592-78-8 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-039-00-0 |
gasoliën (aardolie), met waterstof ontzwavelde verkookser zware vacuümdestillatiefractie; stookolie; [een complexe verzameling koolwaterstoffen verkregen door ontzwaveling met waterstof van zware destillaatgrondstoffen uit de verkookser. Bestaat uit koolwaterstoffen, overwegend C18 tot en met C44, met een kooktraject van ongeveer 304 oC tot 548 oC (579 oF tot 1 018 oF). Bevat waarschijnlijk 5 % of meer aromatische koolwaterstoffen met vier- tot zesvoudige gecondenseerde ringen.] |
285-555-9 |
85117-03-9 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-040-00-6 |
residuen (aardolie), stoomgekraakt, destillaten; stookolie; [een complexe verzameling koolwaterstoffen die wordt verkregen tijdens de productie van gezuiverde aardolieteer door de destillatie van stoomgekraakte teer. Bestaat voornamelijk uit aromatische en andere koolwaterstoffen en organische zwavelverbindingen.] |
292-657-7 |
90669-75-3 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-041-00-1 |
residuen (aardolie), vacuüm-, lichte; stookolie; [een complex residu dat afkomstig is uit de vacuümdestillatie van het residu uit de atmosferische destillatie van ruwe olie. Bestaat voornamelijk uit koolwaterstoffen, overwegend groter dan C24, kokend boven ongeveer 390 oC (734 oF). |
292-658-2 |
90669-76-4 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-042-00-7 |
stookolie, zware, hoog zwavelgehalte; stookolie; [een complexe verzameling koolwaterstoffen die wordt verkregen door de destillatie van ruwe aardolie. Bestaat voornamelijk uit alifatische, aromatische en cycloalifatische koolwaterstoffen, overwegend groter dan C25, kokend boven ongeveer 400 oC (752 oF). |
295-396-7 |
92045-14-2 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-043-00-2 |
residuen (aardolie), katalytische kraak-; stookolie; [een complexe verzameling koolwaterstoffen die wordt verkregen als de residufractie uit de destillatie van de producten van een katalytisch kraakproces. Bestaat voornamelijk uit koolwaterstoffen, overwegend groter dan C11, kokend boven ongeveer 200 oC (392 oF). |
295-511-0 |
92061-97-7 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-044-00-8 |
destillaten (aardolie), katalytisch gekraakte middenfracties, thermisch gedesintegreerd; stookolie; [een complexe verzameling koolwaterstoffen die wordt gevormd door de destillatie van producten uit een katalytisch kraakproces en die is gebruikt als een warmteoverdrachtsvloeistof. Bestaat voornamelijk uit koolwaterstoffen met een kooktraject van ongeveer 220 oC tot 450 oC (428 oF tot 842 oF). Deze stroom bevat waarschijnlijk organische zwavelverbindingen.] |
295-990-6 |
92201-59-7 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-045-00-3 |
residuoliën (aardolie); stookolie; [een complexe verzameling koolwaterstoffen, zwavelverbindingen en metaalhoudende organische verbindingen, verkregen als het residu van een fractioneringskraakproces in een raffinaderij. Vormt een voltooide olie met een viscositeit boven 2 cSt bij 100 oC.] |
298-754-0 |
93821-66-0 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-046-00-9 |
residuen, stoomgekraakt, thermisch behandeld; stookolie; [een complexe verzameling koolwaterstoffen verkregen uit de behandeling en destillatie van ruwe stoomgekraakte nafta. Bestaat voornamelijk uit onverzadigde koolwaterstoffen, kokend boven ongeveer 180 oC (356 oF).] |
308-733-0 |
98219-64-8 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-047-00-4 |
destillaten (aardolie), met waterstof ontzwaveld, totale middenfractie; stookolie; [een complexe verzameling koolwaterstoffen die wordt verkregen door de behandeling van een aardolie-uitgangsstof met waterstof. Bestaat voornamelijk uit koolwaterstoffen, overwegend C9 tot en met C25, met een kooktraject van ongeveer 150 oC tot 400 oC (302 oF tot 752 oF).] |
309-863-0 |
101316-57-8 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-048-00-X |
residuen (aardolie), katalytischereformator-fractioneerder; stookolie; [een complexe verzameling koolwaterstoffen, verkregen als de residufractie bij destillatie van het product van een katalytisch reformingsproces. Bestaat voornamelijk uit aromatische koolwaterstoffen, overwegend C10 tot en met C25, met een kooktraject van ongeveer 160 oC tot 400 oC (320 oF tot 752 oF).] Deze stroom bevat waarschijnlijk 5 of meer gewichtsprocenten aromatische koolwaterstoffen met vier- of zesvoudig gecondenseerde ringen.] |
265-069-3 |
64741-67-9 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-049-00-5 |
aardolie; ruwe aardolie; [een complexe verzameling koolwaterstoffen. Bestaat voornamelijk uit alifatische, alicyclische en aromatische koolwaterstoffen. Kan ook kleine hoeveelheden stikstof-, zuurstof- en zwavelverbindingen bevatten. Deze categorie omvat lichte, middelzware en zware aardoliën, alsmede oliën gewonnen uit teerzand. Koolwaterstofmaterialen die ingrijpende chemische veranderingen vereisen om te worden gewonnen of te worden omgezet in grondstoffen voor aardolieraffinage, zoals ruwe schalieolie, verbeterde schalieolie en vloeibare kolenbrandstof, zijn niet opgenomen in deze definitie.] |
232-298-5 |
8002-05-9 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-050-00-0 |
destillaten (aardolie), lichte paraffinische; niet of licht geraffineerde basisolie; [een complexe verzameling koolwaterstoffen verkregen door vacuümdestillatie van het residu van de atmosferische destillatie van ruwe olie. Bestaat uit koolwaterstoffen, overwegend C15 tot en met C30, en vormt een voltooide olie met een viscositeit die kleiner is dan 100 SUS bij 100 oF (19 cSt bij 40 oC). Bevat een relatief grote hoeveelheid alifatische koolwaterstoffen die normaal aanwezig zijn in dit destillatietraject van ruwe olie.] |
265-051-5 |
64741-50-0 |
Carc. 1A |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-051-00-6 |
destillaten (aardolie), zware paraffinische; niet of licht geraffineerde basisolie; [een complexe verzameling koolwaterstoffen verkregen door vacuümdestillatie van het residu van de atmosferische destillatie van ruwe olie. Bestaat uit koolwaterstoffen, overwegend C15 tot en met C30, en vormt een voltooide olie met een viscositeit die ten minste 100 SUS bij 100 oF (19 cSt bij 40 oC) bedraagt. Bevat een relatief grote hoeveelheid alifatische koolwaterstoffen.] |
265-052-0 |
64741-51-1 |
Carc. 1A |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-052-00-1 |
destillaten (aardolie), lichte naftenische; niet of licht geraffineerde basisolie; [een complexe verzameling koolwaterstoffen verkregen door vacuümdestillatie van het residu van de atmosferische destillatie van ruwe olie. Bestaat uit koolwaterstoffen, overwegend C15 tot en met C30, en vormt een voltooide olie met een viscositeit die kleiner is dan 100 SUS bij 100 oF (19 cSt bij 40 oC). Bevat relatief weinig normale paraffinen.] |
265-053-6 |
64741-52-2 |
Carc. 1A |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-053-00-7 |
destillaten (aardolie), zware naftenische; niet of licht geraffineerde basisolie; [een complexe verzameling koolwaterstoffen verkregen door vacuümdestillatie van het residu van de atmosferische destillatie van ruwe olie. Bestaat uit koolwaterstoffen, overwegend C20 tot en met C50, en vormt een voltooide olie met een viscositeit die ten minste 100 SUS bij 100 oF (19 cSt bij 40 oC) bedraagt. Bevat relatief weinig normale paraffinen.] |
265-054-1 |
64741-53-3 |
Carc. 1A |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-054-00-2 |
destillaten (aardolie), met zuur behandelde zware naftenische; niet of licht geraffineerde basisolie; [een complexe verzameling koolwaterstoffen, verkregen als raffinaat uit een zwavelzuurbehandeling. Bestaat uit koolwaterstoffen, overwegend C20 tot en met C50, en vormt een voltooide olie met een viscositeit die ten minste 100 SUS bij 100 oF (19 cSt bij 40 oC) bedraagt. Bevat relatief weinig normale paraffinen.] |
265-117-3 |
64742-18-3 |
Carc. 1A |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-055-00-8 |
destillaten (aardolie), met zuur behandelde lichte naftenische; niet of licht geraffineerde basisolie; [een complexe verzameling koolwaterstoffen, verkregen als raffinaat uit een zwavelzuurbehandeling. Bestaat uit koolwaterstoffen, overwegend C15 tot en met C30, en vormt een voltooide olie met een viscositeit die kleiner is dan 100 SUS bij 100 oF (19 cSt bij 40 oC). Bevat relatief weinig normale paraffinen.] |
265-118-9 |
64742-19-4 |
Carc. 1A |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-056-00-3 |
destillaten (aardolie), met zuur behandelde zware paraffinische; niet of licht geraffineerde basisolie; [een complexe verzameling koolwaterstoffen die wordt verkregen als het raffinaat uit een zwavelzuurbehandelingsproces. Bestaat voornamelijk uit verzadigde koolwaterstoffen, overwegend C20 tot en met C50, en vormt een voltooide olie met een viscositeit die ten minste 100 SUS bij 100 oF (19 cSt bij 40 oC) bedraagt.] |
265-119-4 |
64742-20-7 |
Carc. 1A |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-057-00-9 |
destillaten (aardolie), met zuur behandelde lichte paraffinische; niet of licht geraffineerde basisolie; [een complexe verzameling koolwaterstoffen, verkregen als raffinaat uit een zwavelzuurbehandeling. Bestaat voornamelijk uit verzadigde koolwaterstoffen, overwegend C15 tot en met C30, en vormt een voltooide olie met een viscositeit die kleiner is dan 100 SUS bij 100 oF (19 cSt bij 40 oC).] |
265-121-5 |
64742-21-8 |
Carc. 1A |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-058-00-4 |
destillaten (aardolie), chemisch geneutraliseerde zware paraffinische; niet of licht geraffineerde basisolie; [een complexe verzameling koolwaterstoffen die wordt verkregen uit een behandelingsproces waarbij zure materialen worden verwijderd. Bestaat voornamelijk uit koolwaterstoffen, overwegend C20 tot en met C50, en vormt een voltooide olie met een viscositeit die ten minste 100 SUS bij 100 oF (19 cSt bij 40 oC) bedraagt. Bevat een relatief grote hoeveelheid alifatische koolwaterstoffen.] |
265-127-8 |
64742-27-4 |
Carc. 1A |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-059-00-X |
destillaten (aardolie), chemisch geneutraliseerde lichte paraffinische; niet of licht geraffineerde basisolie; [een complexe verzameling koolwaterstoffen, verkregen door een behandeling om zure materialen te verwijderen. Bestaat uit koolwaterstoffen, overwegend C15 tot en met C30, en vormt een voltooide olie met een viscositeit die kleiner is dan 100 SUS bij 100 oF (19 cSt bij 40 oC).] |
265-128-3 |
64742-28-5 |
Carc. 1A |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-060-00-5 |
destillaten (aardolie), chemisch geneutraliseerde zware naftenische; niet of licht geraffineerde basisolie; [een complexe verzameling koolwaterstoffen, verkregen door een behandeling om zure materialen te verwijderen. Bestaat uit koolwaterstoffen, overwegend C20 tot en met C50, en vormt een voltooide olie met een viscositeit die ten minste 100 SUS bij 100 oF (19 cSt bij 40 oC) bedraagt. Bevat relatief weinig normale paraffinen.] |
265-135-1 |
64742-34-3 |
Carc. 1A |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-061-00-0 |
destillaten (aardolie), chemisch geneutraliseerde lichte naftenische; niet of licht geraffineerde basisolie; [een complexe verzameling koolwaterstoffen, verkregen door een behandeling om zure materialen te verwijderen. Bestaat uit koolwaterstoffen, overwegend C15 tot en met C30, en vormt een voltooide olie met een viscositeit die kleiner is dan 100 SUS bij 100 oF (19 cSt bij 40 oC). Bevat relatief weinig normale paraffinen.] |
265-136-7 |
64742-35-4 |
Carc. 1A |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-062-00-6 |
gassen (aardolie), katalytisch gekraakte nafta, propaanverwijdering-topproducten, C3-rijke zuurvrije; petroleumgas; [een complexe verzameling koolwaterstoffen, verkregen door fractionering van katalytisch gekraakte koolwaterstoffen en behandeld om zure verontreinigingen te verwijderen. Bestaat uit C2- tot en met C4-koolwaterstoffen, overwegend C3.] |
270-755-0 |
68477-73-6 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-063-00-1 |
gassen (aardolie), katalytische kraker; petroleumgas; [een complexe verzameling koolwaterstoffen die wordt verkregen uit de destillatie van de producten van een katalytisch kraakproces. Bestaat voornamelijk uit alifatische koolwaterstoffen, overwegend C1 tot en met C6.] |
270-756-6 |
68477-74-7 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-064-00-7 |
gassen (aardolie), katalytische kraker, C1-5-rijk; petroleumgas; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van producten van een katalytisch kraakproces. Bestaat uit alifatische koolwaterstoffen, C1 tot en met C6, overwegend C1 tot en met C5.] |
270-757-1 |
68477-75-8 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-065-00-2 |
gassen (aardolie), katalytisch gepolymeriseerde nafta, stabilisator-topfractie, C2-4-rijk; petroleumgas; [een complexe verzameling koolwaterstoffen, verkregen door de fractioneringsstabilisatie van katalytisch gepolymeriseerde nafta. Bestaat uit alifatische koolwaterstoffen, C2 tot en met C6, overwegend C2 tot en met C4.] |
270-758-7 |
68477-76-9 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-066-00-8 |
gassen (aardolie), katalytische reformator, C1-4-rijk; petroleumgas; [een complexe verzameling koolwaterstoffen, gevormd door destillatie van producten uit een katalytisch reformingsproces. Bestaat uit koolwaterstoffen, C1 tot en met C6, overwegend C1 tot en met C4.] |
270-760-8 |
68477-79-2 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-067-00-3 |
gassen (aardolie), C3-5 olefine-paraffine-alkyleringsinvoer; petroleumgas; [een complexe verzameling van olefine- en paraffinekoolwaterstoffen, overwegend C3 tot en met C5, die worden gebruikt als alkyleringsinvoer. Omgevingstemperaturen overtreffen gewoonlijk de kritische temperaturen van deze combinaties.] |
270-765-5 |
68477-83-8 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-068-00-9 |
gassen (aardolie), C4-rijk; petroleumgas; [een complexe verzameling koolwaterstoffen, gevormd door destillatie van producten uit een katalytisch fractioneringsproces. Bestaat uit alifatische koolwaterstoffen, C3 tot en met C5, overwegend C4.] |
270-767-6 |
68477-85-0 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-069-00-4 |
gassen (aardolie), deëthanisator-topproducten; petroleumgas; [een complexe verzameling koolwaterstoffen, verkregen door de destillatie van de gas- en benzinefracties uit een katalytisch kraakproces. Bevat voornamelijk ethaan en ethyleen.] |
270-768-1 |
68477-86-1 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-070-00-X |
gassen (aardolie), deïsobutanisatortoren-topproducten; petroleumgas; [een complexe verzameling koolwaterstoffen, gevormd door de atmosferische destillatie van een butaan-butyleenstroom. Bestaat uit alifatische koolwaterstoffen, overwegend C3 tot en met C4.] |
270-769-7 |
68477-87-2 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-071-00-5 |
Gassen (aardolie), depropanisator droog, propeenrijk; petroleumgas; [een complexe verzameling koolwaterstoffen, gevormd door de destillatie van producten uit de gas- en benzinefracties van een katalytisch kraakproces. Bestaat voornamelijk uit propyleen met wat ethaan en propaan.] |
270-772-3 |
68477-90-7 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-072-00-0 |
gassen (aardolie), topproducten van propaanverwijdering; petroleumgas; [een complexe verzameling koolwaterstoffen, gevormd door destillatie van producten van de gas- en benzinefracties van een katalytisch kraakproces. Bestaat uit alifatische koolwaterstoffen, overwegend C2 tot en met C4.] |
270-773-9 |
68477-91-8 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-073-00-6 |
gassen (aardolie), gasterugwinningsinstallatie depropanisator-topproducten; petroleumgas; [een complexe verzameling koolwaterstoffen, verkregen door de fractionering van verscheidene koolwaterstofstromen. Bestaat voornamelijk uit koolwaterstoffen, C1 tot en met C4, overwegend propaan.] |
270-777-0 |
68477-94-1 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-074-00-1 |
gassen (aardolie), Girbatol-installatiegrondstof; petroleumgas; [een complexe verzameling koolwaterstoffen die wordt gebruikt als grondstof in een Girbatol-installatie om waterstofsulfide te verwijderen. Bestaat uit alifatische koolwaterstoffen, overwegend C2 tot en met C4.] |
270-778-6 |
68477-95-2 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-075-00-7 |
gassen (aardolie), geïsomeriseerde naftafractionator, rijk aan C4, vrij van waterstofsulfide; petroleumgas |
270-782-8 |
68477-99-6 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-076-00-2 |
restgas (aardolie), katalytisch gekraakte geklaarde olie en thermisch gekraakt vacuümresidu, fractioneringsterugloopvat; petroleumgas; [een complexe verzameling koolwaterstoffen, verkregen door fractionering van katalytisch gekraakte geklaarde olie en thermisch gekraakt vacuümresidu. Bestaat voornamelijk uit koolwaterstoffen, overwegend C1 tot en met C6.] |
270-802-5 |
68478-21-7 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-077-00-8 |
restgas (aardolie), katalytisch gekraakte nafta-stabiliseringsabsorbator; petroleumgas; [een complexe verzameling koolwaterstoffen, verkregen door de stabilisatie van katalytisch gekraakte nafta. Bestaat voornamelijk uit koolwaterstoffen, overwegend C1 tot en met C6.] |
270-803-0 |
68478-22-8 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-078-00-3 |
restgas (aardolie), fractionator van gecombineerde producten uit katalytische kraker, katalytische reformator en waterstofontzwavelaar; petroleumgas; [een complexe verzameling koolwaterstoffen, verkregen door de fractionering van producten uit katalytische kraak-, katalytische reformings- en waterstofontzwavelingsprocessen en behandeld om zure onzuiverheden te verwijderen. Bestaat voornamelijk uit koolwaterstoffen, overwegend C1 tot en met C5.] |
270-804-6 |
68478-24-0 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-079-00-9 |
restgas (aardolie), katalytisch gereformde nafta-fractioneringsstabilisator; petroleumgas; [een complexe verzameling koolwaterstoffen, verkregen uit de fractoneringsstabilisatie van katalytisch gereformde nafta. Bestaat voornamelijk uit koolwaterstoffen, overwegend C1 tot en met C4.] |
270-806-7 |
68478-26-2 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-080-00-4 |
restgas (aardolie), verzadigd gas-installatie gemengde stroom, rijk aan C4; petroleumgas; [een complexe verzameling koolwaterstoffen die wordt verkregen uit de fractioneringsstabilisatie van restgas van de destillatie van nafta verkregen door directe fractionering en katalytisch gereformeerd nafta-stabilisator-restgas. Bestaat uit koolwaterstoffen, C3 tot en met C6, overwegend butaan en isobutaan.) |
270-813-5 |
68478-32-0 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-081-00-X |
restgas (aardolie), verzadigd gasterugwinningsinstallatie, rijk aan C1-2; petroleumgas; [een complexe verzameling koolwaterstoffen die wordt verkregen uit de fractionering van destillatie-restgas, door directe fractionering verkregen nafta, katalytisch gereformeerd nafta-stabilisator-restgas. Bestaat voornamelijk uit koolwaterstoffen, C1 tot en met C5, overwegend methaan en ethaan.] |
270-814-0 |
68478-33-1 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-082-00-5 |
restgas (aardolie), thermische vacuümresiduenkraker; petroleumgas; [een complexe verzameling koolwaterstoffen, verkregen uit het thermische kraken van vacuümresiduen. Bestaat uit koolwaterstoffen, overwegend C1 tot en met C5.] |
270-815-6 |
68478-34-2 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-083-00-0 |
koolwaterstoffen, C3-4-rijk, aardoliedestillaat; petroleumgas; [een complexe verzameling koolwaterstoffen, gevormd door destillatie en condensatie van ruwe olie. Bestaat uit koolwaterstoffen, C3 tot en met C5, overwegend C3 tot en met C4.] |
270-990-9 |
68512-91-4 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-084-00-6 |
gassen (aardolie), totaal bereik door directe fractionering verkregen nafta dehexanisatoruitstoot-; petroleumgas; [een complexe verzameling koolwaterstoffen, verkregen door fractionering van het totale bereik van door directe fractionering verkregen nafta. Bestaat uit koolwaterstoffen, overwegend C2 tot en met C6.] |
271-000-8 |
68513-15-5 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-085-00-1 |
gassen (aardolie), waterstofkraken-depropanisator-uitstoot-, koolwaterstofrijk; petroleumgas; [een complexe verzameling koolwaterstoffen, verkregen door de destillatie van producten van een waterstofkraakproces. Bestaat voornamelijk uit koolwaterstoffen, overwegend C1 tot en met C4. Kan ook kleine hoeveelheden waterstof en waterstofsulfide bevatten.] |
271-001-3 |
68513-16-6 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-086-00-7 |
gassen (aardolie), lichte door directe fractionering verkregen naftastabilisatoruitstoot-; petroleumgas; [een complexe verzameling koolwaterstoffen, verkregen door de stabilisering van lichte door directe fractionering verkregen nafta. Bestaat uit verzadigde alifatische koolwaterstoffen, overwegend C2 tot en met C6.] |
271-002-9 |
68513-17-7 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-087-00-2 |
residuen (aardolie), alkyleringssplitter, C4-rijk; petroleumgas; [een complex residu, afkomstig uit de destillatie van stromen uit uiteenlopende zuiveringsbewerkingen. Bestaat uit koolwaterstoffen, C4 en C5, overwegend butaan en met een kooktraject van ongeveer - 11,7 oC tot 27,8 oC (11 oF tot 82 oF).] |
271-010-2 |
68513-66-6 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-088-00-8 |
koolwaterstoffen, C1-4; petroleumgas; [een complexe verzameling koolwaterstoffen, verkregen door thermische kraak- en absorptieprocessen en door destillatie van ruwe olie. Bestaat uit koolwaterstoffen, overwegend C1 tot en met C4, met een kooktraject van ongeveer - 164 oC tot - 0,5 oC (– 263 oF tot 31 oF).] |
271-032-2 |
68514-31-8 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-089-00-3 |
koolwaterstoffen, C1-4-, stankvrij gemaakt; petroleumgas; [een complexe verzameling koolwaterstoffen, verkregen door koolwaterstofgassen te onderwerpen aan een stankverwijderingsproces waarbij mercaptanen worden omgezet of zure verontreinigingen worden verwijderd. Bestaat uit koolwaterstoffen, overwegend C1 tot en met C4, met een kooktraject van ongeveer – 164 oC tot - 0,5 oC (– 263 oF tot 31 oF).] |
271-038-5 |
68514-36-3 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-090-00-9 |
koolwaterstoffen, C1-3; petroleumgas; [een complexe verzameling koolwaterstoffen, overwegend C1 tot en met C3, met een kooktraject van ongeveer - 164 oC tot - 42 oC (– 263 oF tot - 44 oF).] |
271-259-7 |
68527-16-2 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-091-00-4 |
koolwaterstoffen, C1-4, debutanisatorfractie; petroleumgas |
271-261-8 |
68527-19-5 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-092-00-X |
gassen (aardolie), C1-5, nat; petroleumgas; [een complexe verzameling koolwaterstoffen, verkregen door de destillatie van ruwe olie en/of het kraken van gasolie uit een fractioneringstoren. Bestaat uit koolwaterstoffen, overwegend C1 tot en met C5.] |
271-624-0 |
68602-83-5 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-093-00-5 |
koolwaterstoffen, C2-4; petroleumgas |
271-734-9 |
68606-25-7 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-094-00-0 |
koolwaterstoffen, C3-; petroleumgas |
271-735-4 |
68606-26-8 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-095-00-6 |
gassen (aardolie), alkyleringsinvoer; petroleumgas; [een complexe verzameling koolwaterstoffen, verkregen door het katalytisch kraken van gasolie. Bestaat uit koolwaterstoffen, overwegend C3 tot en met C4.] |
271-737-5 |
68606-27-9 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-096-00-1 |
gassen (aardolie), depropanisatorbodemfracties fractioneringsuitstoot-; petroleumgas; [een complexe verzameling koolwaterstoffen, verkregen uit de fractionering van depropanisatorbodemfracties. Bestaat voornamelijk uit butaan, isobutaan en butadieen.] |
271-742-2 |
68606-34-8 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-097-00-7 |
gassen (aardolie), raffinage-meng-; petroleumgas; [een complexe combinatie, verkregen uit verscheidene raffinageprocessen. Bestaat uit waterstof, waterstofsulfide en koolwaterstoffen, overwegend C1 tot en met C5.] |
272-183-7 |
68783-07-3 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-098-00-2 |
gassen (aardolie), katalytisch kraken; petroleumgas; [een complexe verzameling koolwaterstoffen die wordt verkregen uit de destillatie van de producten van een katalytisch kraakproces. Bestaat voornamelijk uit koolwaterstoffen, overwegend C3 tot en met C5.] |
272-203-4 |
68783-64-2 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-099-00-8 |
gassen (aardolie), C2-4-, stankvrij gemaakt; petroleumgas; [een complexe verzameling koolwaterstoffen, verkregen door het onderwerpen van een aardoliedestillaat aan een stankverwijderingsproces om mercaptanen om te zetten of zure verontreinigingen te verwijderen. Bestaat voornamelijk uit verzadigde en onverzadigde koolwaterstoffen, overwegend C2 tot en met C4, met een kooktraject van ongeveer - 51 oC tot 34 oC (– 60 oF tot 30 oF).] |
272-205-5 |
68783-65-3 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-100-00-1 |
gassen (aardolie), ruwe olie-fractioneringuitstoot-; petroleumgas; [een complexe verzameling koolwaterstoffen die wordt gevormd door de fractionering van ruwe olie. Bestaat uit verzadigde alifatische koolwaterstoffen, overwegend C1 tot en met C5.] |
272-871-7 |
68918-99-0 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-101-00-7 |
gassen (aardolie), dehexanisatoruitstoot-; petroleumgas; [een complexe verzameling koolwaterstoffen die wordt verkregen door de fractionering van gecombineerde naftastromen. Bestaat uit verzadigde alifatische koolwaterstoffen, overwegend C1 tot en met C5.] |
272-872-2 |
68919-00-6 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-102-00-2 |
gassen (aardolie), direct door fractionering verkregen lichte benzine, stabilisatoruitstoot; petroleumgas; [een complexe verzameling koolwaterstoffen die wordt verkregen door de fractionering van direct door fractionering verkregen lichte benzine. Bestaat uit verzadigde alifatische koolwaterstoffen, overwegend C1 tot en met C5.] |
272-878-5 |
68919-05-1 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-103-00-8 |
gassen (aardolie), nafta-unifiner-ontzwaveling stripperuitstoot; petroleumgas; [een complexe verzameling koolwaterstoffen die wordt gevormd door een nafta-unifiner-ontzwavelingsproces en gestript van het nafta-product. Bestaat uit verzadigde alifatische koolwaterstoffen, overwegend C1 tot en met C4.] |
272-879-0 |
68919-06-2 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-104-00-3 |
gassen (aardolie), direct door fractionering verkregen nafta, katalytische reforming, uitstoot; petroleumgas; [een complexe verzameling koolwaterstoffen die wordt verkregen door de katalytische reforming van direct door fractionering verkregen nafta en fractionering van de totale uitstroom. Bestaat uit methaan, ethaan en propaan.] |
272-882-7 |
68919-09-5 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-105-00-9 |
gassen (aardolie), katalytische kraker met wervelbed, splittertopproducten; petroleumgas; [een complexe verzameling koolwaterstoffen die wordt verkregen door de fractionering van de invoer van de C3-C4-splitter. Bestaat voornamelijk uit C3-koolwaterstoffen.] |
272-893-7 |
68919-20-0 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-106-00-4 |
gassen (aardolie), directe fractionerings-stabilisatoruitstoot-; petroleumgas; [een complexe verzameling koolwaterstoffen die wordt verkregen uit de fractionering van de vloeistof uit de eerste destillatietoren die wordt gebruikt bij de destillatie van ruwe olie. Bestaat uit verzadigde alifatische koolwaterstoffen, overwegend C1 tot en met C4.] |
272-883-2 |
68919-10-8 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-107-00-X |
gassen (aardolie), katalytisch gekraakte nafta debutanisator-; petroleumgas; [een complexe verzameling koolwaterstoffen die wordt verkregen uit de fractionering van katalytisch gekraakte nafta. Bestaat uit koolwaterstoffen, overwegend C1 tot en met C4.] |
273-169-3 |
68952-76-1 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-108-00-5 |
restgas (aardolie), katalytisch gekraakt destillaat en nafta stabilisator; petroleumgas; [een complexe verzameling koolwaterstoffen die wordt verkregen door de fractionering van katalytisch gekraakt nafta en destillaat. Bestaat voornamelijk uit koolwaterstoffen, overwegend C1 tot en met C4.] |
273-170-9 |
68952-77-2 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-109-00-0 |
restgas (aardolie), thermisch gekraakt destillaat, gasolie en nafta-absorptievat; petroleumgas; [een complexe verzameling koolwaterstoffen die wordt verkregen uit de scheiding van thermisch gekraakte destillaten, nafta en gasolie. Bestaat voornamelijk uit koolwaterstoffen, overwegend C1 tot en met C6.] |
273-175-6 |
68952-81-8 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-110-00-6 |
restgas (aardolie), thermisch gekraakte koolwaterstof-fractioneringsstabilisator-, aardolieverkooksing; petroleumgas; [een complexe verzameling koolwaterstoffen die wordt verkregen uit de fractioneringsstabilisatie van thermisch gekraakte koolwaterstoffen die afkomstig zijn uit het aardolieverkooksingproces. Bestaat uit koolwaterstoffen, overwegend C1 tot en met C6.] |
273-176-1 |
68952-82-9 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-111-00-1 |
gassen (aardolie), lichte stoomgekraakte, butadieenconcentraat; petroleumgas; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van producten van een thermisch kraakproces. Bestaat uit koolwaterstoffen, overwegend C4.] |
273-265-5 |
68955-28-2 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-112-00-7 |
gassen (aardolie), direct door fractionering verkregen nafta, katalytische reformator, stabilisator-topproducten; petroleumgas; [een complexe verzameling koolwaterstoffen die wordt verkregen door de katalytische reforming van direct door fractionering verkregen nafta en de fractionering van de totale uitstroom. Bestaat uit verzadigde alifatische koolwaterstoffen, overwegend C2 tot en met C4.] |
273-270-2 |
68955-34-0 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-113-00-2 |
koolwaterstoffen, C4-; petroleumgas |
289-339-5 |
87741-01-3 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-114-00-8 |
alkanen, C1-4, rijk aan C3; petroleumgas |
292-456-4 |
90622-55-2 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-115-00-3 |
gassen (aardolie), stoomkraker, rijk aan C3; petroleumgas; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van producten uit een stoomkraakproces. Bestaat voornamelijk uit propyleen met wat propaan en heeft een kooktraject van ongeveer - 70 oC tot 0 oC (– 94 oF tot 32 oF).] |
295-404-9 |
92045-22-2 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-116-00-9 |
koolwaterstoffen, C4-, stoomkrakerdestillaat; petroleumgas; [een complexe verzameling koolwaterstoffen die wordt gevormd door de destillatie van de producten uit een stoomkraakproces. Bestaat voornamelijk uit C4-koolwaterstoffen, overwegend 1-buteen en 2-buteen, bevat ook butaan en isobuteen en heeft een kooktraject van ongeveer - 12 oC tot 5 oC (10,4 oF tot 41 oF).) |
295-405-4 |
92045-23-3 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-117-00-4 |
aardoliegassen, vloeibaar gemaakt, stankvrij gemaakt, C4-fractie; petroleumgas; [een complexe verzameling koolwaterstoffen die wordt verkregen door een vloeibaar gemaakt aardolie-gasmengsel aan een stankvrijmakingsproces te onderwerpen om mercaptanen te oxideren of om zure onzuiverheden te verwijderen. Bestaat voornamelijk uit C4- verzadigde en onverzadigde koolwaterstoffen.] |
295-463-0 |
92045-80-2 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K S U |
649-118-00-X |
koolwaterstoffen, C4-, 1,3-butadieen- en isobuteenvrij; petroleumgas |
306-004-1 |
95465-89-7 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-119-00-5 |
raffinaten (aardolie), stoomgekraakte C4-fractie, cuproammoniumacetaatextractie, C3-5- en C3-5-onverzadigd, vrij van butadieen; petroleumgas |
307-769-4 |
97722-19-5 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-120-00-0 |
gassen (aardolie), toevoer aminesysteem; raffinaderijgas; [het voedingsgas naar het aminesysteem voor de verwijdering van waterstofsulfide. Bestaat uit waterstof. Koolmonoxide, kooldioxide, waterstofsulfide en alifatische koolwaterstoffen, voornamelijk C1 tot en met C5, kunnen ook aanwezig zijn.] |
270-746-1 |
68477-65-6 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-121-00-6 |
gassen (aardolie), uitstoot benzeeninstallatie, waterstofontzwavelaar; raffinaderijgas; [afgassen, gevormd door de benzeeninstallatie. Bestaat voornamelijk uit waterstof. Koolmonoxide en koolwaterstoffen, voornamelijk C1 tot en met C6, inclusief benzeen, kunnen ook aanwezig zijn.] |
270-747-7 |
68477-66-7 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-122-00-1 |
gassen (aardolie), terugvoer benzeeninstallatie, rijk aan waterstof; raffinaderijgas; [een complexe verzameling koolwaterstoffen, verkregen door terugvoer van de gassen uit de benzeeninstallatie. Bestaat voornamelijk uit waterstof met verscheidene kleine hoeveelheden koolmonoxide en koolwaterstoffen, C1 tot en met C6.] |
270-748-2 |
68477-67-8 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-123-00-7 |
gassen (aardolie), mengolie, rijk aan waterstof en stikstof; raffinaderijgas; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van een mengolie. Bestaat voornamelijk uit waterstof en stikstof, met verscheidene kleine hoeveelheden koolmonoxide, kooldioxide en alifatische koolwaterstoffen, voornamelijk C1 tot en met C5.] |
270-749-8 |
68477-68-9 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-124-00-2 |
gassen (aardolie), katalytisch gereformde nafta, stripper-topproducten; raffinaderijgas; [een complexe verzameling koolwaterstoffen, verkregen uit de stabilisatie van katalytisch gereformeerde nafta. Bestaat uit waterstof en verzadigde koolwaterstoffen, overwegend C1 tot en met C4.] |
270-759-2 |
68477-77-0 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-125-00-8 |
gassen (aardolie), terugvoer C6-8-katalytische reformator; raffinaderijgas; [een complexe verzameling van koolwaterstoffen, verkregen door destillatie van producten van de katalytische reforming van C6-8-aanvoer en teruggevoerd om waterstof te behouden. Bestaat voornamelijk uit waterstof. Kan ook verscheidene kleine hoeveelheden koolmonoxide, kooldioxide, stikstof en koolwaterstoffen, overwegend C1 tot en met C6, bevatten.] |
270-761-3 |
68477-80-5 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-126-00-3 |
gassen (aardolie), C6-8-katalytische reformator; raffinaderijgas; [een complexe verzameling van koolwaterstoffen, verkregen door destillatie van producten van de katalytische reforming van C6-8-aanvoer. Bestaat uit koolwaterstoffen, C1 tot en met C5, en waterstof.] |
270-762-9 |
68477-81-6 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-127-00-9 |
gassen (aardolie), terugvoer C6-8 katalytische reformator, rijk aan waterstof; raffinaderijgas |
270-763-4 |
68477-82-7 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-128-00-4 |
gassen (aardolie), C2-terugstroom; raffinaderijgas; [een complexe verzameling koolwaterstoffen, verkregen door de extractie van waterstof uit een gasstroom die voornamelijk bestaat uit waterstof met kleine hoeveelheden stikstof, koolmonoxide, methaan, ethaan en ethyleen. Bevat voornamelijk koolwaterstoffen als methaan, ethaan en ethyleen met kleine hoeveelheden waterstof, stikstof en koolmonoxide.] |
270-766-0 |
68477-84-9 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-129-00-X |
gassen (aardolie), droog zwavelhoudend, uitstoot gasconcentratie-installatie; raffinaderijgas; [de complexe verzameling droge gassen die wordt verkregen uit een gasconcentratie-installatie. Bestaat uit waterstof, waterstofsulfide en koolwaterstoffen, overwegend C1 tot en met C3.] |
270-774-4 |
68477-92-9 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-130-00-5 |
gassen (aardolie), destillatie gasconcentratie-herabsorbeerder; raffinaderijgas; [een complexe verzameling koolwaterstoffen die wordt gevormd door destillatie van producten van gecombineerde gasstromen in een gasconcentratie-herabsorbeerder. Bestaat voornamelijk uit waterstof, koolmonoxide, kooldioxide, stikstof, waterstofsulfide en koolwaterstoffen, C1 tot en met C3.] |
270-776-5 |
68477-93-0 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-131-00-0 |
gassen (aardolie), uitstoot waterstofabsorbeerder; raffinaderijgas; [een complexe combinatie die wordt verkregen door het absorberen van waterstof uit een waterstofrijke stroom. Bestaat uit waterstof, koolmonoxide, stikstof en methaan met kleine hoeveelheden C2-koolwaterstoffen.] |
270-779-1 |
68477-96-3 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-132-00-6 |
gassen (aardolie), rijk aan waterstof; raffinaderijgas; [een complexe combinatie die wordt afgescheiden als een gas uit koolwaterstofgassen door koeling. Bestaat voornamelijk uit waterstof met verscheidene kleine hoeveelheden koolmonoxide, stikstof, methaan en C2-koolwaterstoffen.] |
270-780-7 |
68477-97-4 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-133-00-1 |
gassen (aardolie), waterstofbehandelaar-mengolie-terugvoer-, rijk aan waterstof en stikstof; raffinaderijgas; [een complexe combinatie die wordt verkregen uit teruggevoerde met waterstof behandelde mengolie. Bestaat voornamelijk uit waterstof en stikstof, met verscheidene kleine hoeveelheden koolmonoxide, kooldioxide en koolwaterstoffen, voornamelijk C1 tot en met C5.] |
270-781-2 |
68477-98-5 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-134-00-7 |
gassen (aardolie), terugvoer-, rijk aan waterstof; raffinaderijgas; [een complexe combinatie die wordt verkregen uit teruggevoerde reactorgassen. Bestaat voornamelijk uit waterstof met diverse kleine hoeveelheden koolmonoxide, kooldioxide, stikstof, waterstofsulfide en verzadigde alifatische koolwaterstoffen, C1 tot en met C5.] |
270-783-3 |
68478-00-2 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-135-00-2 |
gassen (aardolie), reformator-verzamel-, rijk aan waterstof; raffinaderijgas; [een complexe combinatie die wordt verkregen uit de reformatoren. Bestaat voornamelijk uit waterstof met verscheidene kleine hoeveelheden koolmonoxide en alifatische koolwaterstoffen, overwegend C1 tot en met C5.] |
270-784-9 |
68478-01-3 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-136-00-8 |
gassen (aardolie), reformende waterstofbehandelaar; raffinaderijgas; [een complexe combinatie die wordt verkregen uit het reformende waterstofbehandelingsproces. Bestaat voornamelijk uit waterstof, methaan en ethaan met diverse kleine hoeveelheden waterstofsulfide en alifatische koolwaterstoffen, overwegend C3 tot en met C5.] |
270-785-4 |
68478-02-4 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-137-00-3 |
gassen (aardolie), reformende waterstofbehandelaar, rijk aan waterstof en methaan; raffinaderijgas; [een complexe combinatie die wordt verkregen uit het reformende waterstofbehandelingsproces. Bestaat voornamelijk uit waterstof en methaan, met verscheidene kleine hoeveelheden koolmonoxide, kooldioxide, stikstof en verzadigde alifatische koolwaterstoffen, voornamelijk C2 tot en met C5.] |
270-787-5 |
68478-03-5 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-138-00-9 |
gassen (aardolie), reformende waterstofbehandelaar aanvullings-, rijk aan waterstof; raffinaderijgas; [een complexe combinatie die wordt verkregen uit het reformende waterstofbehandelingsproces. Bestaat voornamelijk uit waterstof met verscheidene kleine hoeveelheden koolmonoxide en alifatische koolwaterstoffen, overwegend C1 tot en met C5.] |
270-788-0 |
68478-04-6 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-139-00-4 |
gassen (aardolie), thermisch kraken-destillatie-; raffinaderijgas; [een complexe combinatie die wordt gevormd door destillatie van producten van een thermisch kraakproces. Bestaat uit waterstof, waterstofsulfide, koolmonoxide, kooldioxide en koolwaterstoffen, overwegend C1 tot en met C6.] |
270-789-6 |
68478-05-7 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-140-00-X |
restgas (aardolie), katalytisch kraken, refractioneringsabsorbeerder; raffinaderijgas; [een complexe verzameling koolwaterstoffen, verkregen door refractionering van producten uit een katalytisch kraakproces. Bestaat uit waterstof en koolwaterstoffen, overwegend C1 tot en met C3.] |
270-805-1 |
68478-25-1 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-141-00-5 |
restgas (aardolie), katalytisch gereformde nafta-afscheider; raffinaderijgas; [een complexe verzameling koolwaterstoffen, verkregen uit de katalytische reforming van door directe fractionering verkregen nafta. Bestaat uit waterstof en koolwaterstoffen, overwegend C1 tot en met C6.] |
270-807-2 |
68478-27-3 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-142-00-0 |
restgas (aardolie), katalytisch gereformde nafta-stabilisator; raffinaderijgas; [een complexe verzameling koolwaterstoffen, verkregen uit de stabilisatie van katalytisch gereformeerde nafta. Bestaat uit waterstof en koolwaterstoffen, overwegend C1 tot en met C6.] |
270-808-8 |
68478-28-4 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-143-00-6 |
restgas (aardolie), gekraakt destillaat, waterstofbehandelaar, afscheider; raffinaderijgas; [een complexe verzameling koolwaterstoffen, verkregen door de behandeling van gekraakte destillaten met waterstof in de aanwezigheid van een katalysator. Bestaat uit waterstof en verzadigde alifatische koolwaterstoffen, overwegend C1 tot en met C5.] |
270-809-3 |
68478-29-5 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-144-00-1 |
restgas (aardolie), waterstofontzwaveling van door directe fractionering verkregen nafta, afscheider; raffinaderijgas; [een complexe verzameling koolwaterstoffen, verkregen uit de waterstofontzwaveling van door directe fractionering verkregen nafta. Bestaat uit waterstof en verzadigde alifatische koolwaterstoffen, overwegend C1 tot en met C6.] |
270-810-9 |
68478-30-8 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-145-00-7 |
gassen (aardolie), katalytische reforming van door directe fractionering verkregen nafta, stabilisator-topproducten; raffinaderijgas; [een complexe verzameling koolwaterstoffen, verkregen door de katalytische reforming van door directe fractionering verkregen nafta, gevolgd door fractionering van de totale uitstroom. Bestaat uit waterstof, methaan, ethaan en propaan.] |
270-999-8 |
68513-14-4 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-146-00-2 |
gassen (aardolie), reformatoruitstroom, uitstoot hogedruk-afdampvat; raffinaderijgas; [een complexe combinatie die wordt verkregen door het afdampen onder hoge druk van de uitstroom uit de reformingsreactor. Bestaat voornamelijk uit waterstof, met uiteenlopende kleine hoeveelheden methaan, ethaan en propaan.] |
271-003-4 |
68513-18-8 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-147-00-8 |
gassen (aardolie), reformatoruitstroom, uitstoot lagedruk-afdampvat; raffinaderijgas; [een complexe combinatie die wordt verkregen door het afdampen onder lage druk van de uitstroom uit de reformingsreactor. Bestaat voornamelijk uit waterstof, met uiteenlopende kleine hoeveelheden methaan, ethaan en propaan.] |
271-005-5 |
68513-19-9 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-148-00-3 |
gassen (aardolie), olieraffinage, uitstoot gasdestillatie; raffinaderijgas; [een complexe combinatie die wordt afgescheiden door distillatie van een gasstroom die waterstof, koolmonoxide, kooldioxide en koolwaterstoffen, C1 tot en met C6 bevat of verkregen door het kraken van ethaan en propaan. Bestaat uit koolwaterstoffen, overwegend C1 tot en met C2, waterstof, stikstof en koolmonoxide.] |
271-258-1 |
68527-15-1 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-149-00-9 |
gassen (aardolie), benzeeninstallatie, waterstofbehandelaar, depentanisator-topproducten; raffinaderijgas; [een complexe combinatie die wordt gevormd door de behandeling van het materiaal uit de benzeeninstallatie met waterstof in de aanwezigheid van een katalysator gevolgd door depentanisering. Bestaat voornamelijk uit waterstof, ethaan en propaan, met verscheidene kleine hoeveelheden stikstof, koolmonoxide, kooldioxide en koolwaterstoffen, voornamelijk C1 tot en met C6. Kan sporen benzeen bevatten.] |
271-623-5 |
68602-82-4 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-150-00-4 |
gassen (aardolie), uitstoot secundaire absorbeerder, fractionering van topproducten uit katalytische kraker met wervelbed; raffinaderijgas; [een complexe combinatie die wordt gevormd door de fractionering van de topproducten uit het katalytisch kraakproces in de katalytische kraker met wervelbed. Bestaat uit waterstof, stikstof en koolwaterstoffen, overwegend C1 tot en met C3.] |
271-625-6 |
68602-84-6 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-151-00-X |
aardolieproducten, raffinaderijgassen; raffinaderijgas; [een complexe combinatie die voornamelijk bestaat uit waterstof, met uiteenlopende kleine hoeveelheden methaan, ethaan en propaan.] |
271-750-6 |
68607-11-4 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-152-00-5 |
gassen (aardolie), waterstofkraken, lagedruk-afscheider; raffinaderijgas; [een complexe combinatie die wordt verkregen door de vloeistofdampscheiding van de uitstroom uit de waterstofkraakprocesreactor. Bestaat voornamelijk uit waterstof en verzadigde koolwaterstoffen, overwegend C1 tot en met C3.] |
272-182-1 |
68783-06-2 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-153-00-0 |
gassen (aardolie), raffinage; raffinaderijgas; [een complexe combinatie die wordt verkregen uit verscheidene aardolieraffinage-operaties. Bestaat uit waterstof en koolwaterstoffen, overwegend C1 tot en met C3.] |
272-338-9 |
68814-67-5 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-154-00-6 |
gassen (aardolie), platinareformatorproducten, afscheideruitstoot; raffinaderijgas; [een complexe combinatie die wordt verkregen uit de chemische reforming van naftenen tot aromaten. Bestaat uit waterstof en verzadigde alifatische koolwaterstoffen, overwegend C2 tot en met C4.] |
272-343-6 |
68814-90-4 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-155-00-1 |
gassen (aardolie), uitstootgassen uit depentanisator-stabilisator van met waterstof behandelde stinkende kerosine; raffinaderijgas; [de complexe combinatie die wordt verkregen uit de depentanisator-stabilisatie van met waterstof behandelde kerosine. Bestaat voornamelijk uit waterstof, methaan, ethaan en propaan, met verscheidene kleine hoeveelheden stikstof, waterstofsulfide, koolmonoxide en koolwaterstoffen, voornamelijk C4 tot en met C5.] |
272-775-5 |
68911-58-0 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-156-00-7 |
gassen (aardolie), met waterstof behandelde stinkende kerosine, afdampvat; raffinaderijgas; [een complexe combinatie die wordt verkregen uit het afdampvat van de installatie waarin stinkende kerosine in de aanwezigheid van een katalysator met waterstof wordt behandeld. Bestaat voornamelijk uit waterstof en methaan, met verscheidene kleine hoeveelheden stikstof, koolmonoxide en koolwaterstoffen, voornamelijk C2 tot en met C5.] |
272-776-0 |
68911-59-1 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-157-00-2 |
gassen (aardolie), destillaat, unifiner-ontzwaveling, stripperuitstoot; raffinaderijgas; [een complexe combinatie, gestript uit het vloeibare product van het unifiner-ontzwavelingsproces. Bestaat uit waterstofsulfide, methaan, ethaan en propaan.] |
272-873-8 |
68919-01-7 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-158-00-8 |
gassen (aardolie), katalytische kraker met wervelbed, fractioneringsuitstoot; raffinaderijgas; [een complexe combinatie die wordt gevormd door de fractionering van het topproduct van het katalytische kraakproces met wervelbed. Bestaat uit waterstof, waterstofsulfide, stikstof en koolwaterstoffen, overwegend C1 tot en met C5.] |
272-874-3 |
68919-02-8 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-159-00-3 |
gassen (aardolie), katalytische kraker met wervelbed, wassing uitstoot secundair absorptievat; raffinaderijgas; [een complexe combinatie die wordt verkregen door het wassen van topgas uit de katalytische kraker met wervelbed. Bestaat uit waterstof, stikstof, methaan, ethaan en propaan.] |
272-875-9 |
68919-03-9 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-160-00-9 |
gassen (aardolie), zwaar destillaat, waterstofbehandeling-ontzwaveling, stripper-uitstoot; raffinaderijgas; [een complexe combinatie die wordt gestript uit het vloeibare product uit het waterstofbehandelings-ontzwavelingsproces van zwaar destillaat. Bestaat uit waterstof, waterstofsulfide en verzadigde alifatische koolwaterstoffen, overwegend C1 tot en met C5.] |
272-876-4 |
68919-04-0 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-161-00-4 |
gassen (aardolie), platinareforming, stabilisatoruitstoot, fractionering van lichte eindfracties; raffinaderijgas; [een complexe combinatie die wordt verkregen door de fractionering van de lichte eindfracties uit de platinareactoren van de platinareformingsinstallatie. Bestaat uit waterstof, methaan, ethaan en propaan. |
272-880-6 |
68919-07-3 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-162-00-X |
gassen (aardolie), uitstoot voor-afdampingstoren, ruwe destillatie; raffinaderijgas; [een complexe combinatie die wordt gevormd in de eerste destillatietoren die wordt gebruikt bij de destillatie van ruwe olie. Bestaat uit stikstof en verzadigde alifatische koolwaterstoffen, overwegend C1 tot en met C5.] |
272-881-1 |
68919-08-4 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-163-00-5 |
gassen (aardolie), uitstoot teerstripper; raffinaderijgas; [een complexe verzameling die wordt verkregen door de fractionering van gereduceerde ruwe olie. Bestaat uit waterstof en koolwaterstoffen, overwegend C1 tot en met C4.] |
272-884-8 |
68919-11-9 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-164-00-0 |
gassen (aardolie), uitstoot unifiner-stripper; raffinaderijgas; [een combinatie van waterstof en methaan die wordt verkregen door fractionering van de producten uit de unifiner-installatie.] |
272-885-3 |
68919-12-0 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-165-00-6 |
restgas (aardolie), katalytisch waterstof-ontzwavelde nafta, afscheider; raffinaderijgas; [een complexe verzameling koolwaterstoffen die wordt verkregen door waterstof-ontzwaveling van nafta. Bestaat uit waterstof, methaan, ethaan en propaan.] |
273-173-5 |
68952-79-4 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-166-00-1 |
restgas (aardolie), direct door fractionering verkregen nafta, waterstofontzwavelaar; raffinaderijgas; [een complexe combinatie die wordt verkregen door de waterstofontzwaveling van nafta die direct door fractionering is verkregen. Bestaat uit waterstof en koolwaterstoffen, overwegend C1 tot en met C5.] |
273-174-0 |
68952-80-7 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-167-00-7 |
gassen (aardolie), uitstoot sponsabsorptievat, katalytische kraker met wervelbed en gasolieontzwavelaar, fractionering topproducten; raffinaderijgas; [een complexe combinatie die wordt verkregen door de fractionering van producten uit de katalytische kraker met wervelbed en gasolie-ontzwavelaar. Bestaat uit waterstof en koolwaterstoffen, overwegend C1 tot en met C4.] |
273-269-7 |
68955-33-9 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-168-00-2 |
gassen (aardolie), ruwe destillatie en katalytisch kraken; raffinaderijgas; [een complexe combinatie die wordt verkregen door middel van ruwe destillatie- en katalytische kraakprocessen. Bestaat uit waterstof, waterstofsulfide, stikstof, koolmonoxide en paraffine- en olefinekoolwaterstoffen, overwegend C1 tot en met C6.] |
273-563-5 |
68989-88-8 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-169-00-8 |
gassen (aardolie), gasolie, uitstoot diëthanolamine-gaswasser; raffinaderijgas; [een complexe combinatie die wordt gevomd door de ontzwaveling van gasoliën met diethanolamine. Bestaat voornamelijk uit waterstofsulfide, waterstof en alifatische koolwaterstoffen, overwegend C1 tot en met C5.] |
295-397-2 |
92045-15-3 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-170-00-3 |
gassen (aardolie), gasolie, uitstroom waterstofontzwaveling; raffinaderijgas; [een complexe combinatie die wordt verkregen door afscheiding van de vloeibare fase uit de uitstroom uit de hydrogeneringsreactie. Bestaat voornamelijk uit waterstof, waterstofsulfide en alifatische koolwaterstoffen, overwegend C1 tot en met C3.] |
295-398-8 |
92045-16-4 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-171-00-9 |
gassen (aardolie), gasolie, ontgassing waterstofontzwaveling; raffinaderijgas; [een complexe verzameling gassen die wordt verkregen uit de reformator en van de ontgassing van de hydrogeneringsreactor. Bestaat voornamelijk uit waterstof en alifatische koolwaterstoffen, overwegend C1 tot en met C4.] |
295-399-3 |
92045-17-5 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-172-00-4 |
gassen (aardolie), hydogenatoruitstroom, uitstoot afdampvat; raffinaderijgas; [een complexe verzameling gassen die wordt verkregen uit afdampen van de uitstroomfracties na de hydrogeneringsreactie. Bestaat voornamelijk uit waterstof en alifatische koolwaterstoffen, overwegend C1 tot en met C6.] |
295-400-7 |
92045-18-6 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-173-00-X |
gassen (aardolie), stoomkraken van nafta, hogedruk-restgassen; raffinaderijgas; [een complexe combinatie die wordt verkregen als een mengsel van de niet-condenseerbare delen uit het product van een naftastoomkraakproces evenals restgassen die worden verkregen tijdens de bereiding van daaruit voortkomende producten. Bestaat voornamelijk uit waterstof en paraffine- en olefinekoolwaterstoffen, overwegend C1 tot en met C5, waarmee ook aardgas kan worden gemengd.] |
295-401-2 |
92045-19-7 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-174-00-5 |
gassen (aardolie), residu-visbreaking-uitstoot; raffinaderijgas; [een complexe combinatie die wordt verkregen uit de viscositeitsreductie van residuen in een oven. Bestaat voornamelijk uit waterstofsulfide en paraffine- en olefinekoolwaterstoffen, overwegend C1 tot en met C5.] |
295-402-8 |
92045-20-0 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-175-00-0 |
bezinkselolie (aardolie), met zuur behandeld; bezinkselolie uit paraffinewas; [een complexe verzameling koolwaterstoffen, verkregen door de behandeling van bezinkselolie met zwavelzuur. Bestaat voornamelijk uit vertakte koolwaterstoffen, overwegend C20 tot en met C50.] |
300-225-7 |
93924-31-3 |
Flam. Gas 1 Press. Gas Carc. 1B |
H220 H350 H340 |
GHS02 GHS04 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-176-00-6 |
bezinkselolie, met klei behandeld; bezinkselolie uit paraffinewas; [een complexe verzameling koolwaterstoffen, verkregen door de behandeling van bezinkselolie met natuurlijke of aangepaste klei in een contact- of een percolatieproces om de aanwezige sporen van polaire verbindingen en onzuiverheden te verwijderen. Bestaat voornamelijk uit vertakte koolwaterstoffen, overwegend C20 tot en met C50.] |
300-226-2 |
93924-32-4 |
Flam. Gas 1 Press. Gas Carc. 1B |
H220 H350 H340 |
GHS02 GHS04 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-177-00-1 |
gassen (aardolie), C3-4; petroleumgas; [een complexe verzameling koolwaterstoffen, verkregen uit de destillatie van producten van het kraken van ruwe olie. Bestaat uit koolwaterstoffen, C3 tot en met C4 en voornamelijk propaan en propyleen, met een kooktraject van ongeveer - 51 oC tot - 1 oC (– 60 oF tot 30 oF).] |
268-629-5 |
68131-75-9 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-178-00-7 |
restgas (aardolie), katalytisch gekraakt destillaat en katalytisch gekraakte nafta, fractioneringsabsorptievat; petroleumgas; [de complexe verzameling koolwaterstoffen, verkregen uit de destillatie van de producten van katalytisch gekraakte destillaten en katalytisch gekraakte nafta. Bestaat voornamelijk uit koolwaterstoffen, C1 tot en met C4.] |
269-617-2 |
68307-98-2 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-179-00-2 |
restgas (aardolie), katalytische polymerisatie van nafta, fractioneringsstabilisator; petroleumgas; [een complexe verzameling koolwaterstoffen, verkregen uit de fractioneringsstabilisatie-producten van geïsomeriseerde nafta. Bestaat voornamelijk uit koolwaterstoffen, C1 tot en met C4.] |
269-618-8 |
68307-99-3 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-180-00-8 |
restgas (aardolie), katalytisch gereformde nafta, fractioneringsstabilisator, waterstofsulfidevrij; petroleumgas; [een complexe verzameling koolwaterstoffen, verkregen uit fractioneringsstabilisatie van katalytisch gereformeerde nafta, waar waterstofsulfide door aminebehandeling uit verwijderd is. Bestaat voornamelijk uit koolwaterstoffen, overwegend C1 tot en met C4.] |
269-619-3 |
68308-00-9 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-181-00-3 |
restgas (aardolie), gekraakt destillaat, waterstofbehandelingsstripper; petroleumgas; [een complexe verzameling koolwaterstoffen, verkregen door behandeling van thermisch gekraakte destillaten met waterstof in de aanwezigheid van een katalysator. Bestaat voornamelijk uit verzadigde koolwaterstoffen, overwegend C1 tot en met C6.] |
269-620-9 |
68308-01-0 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-182-00-9 |
restgas (aardolie), direct uit fractionering verkregen destillaat, waterstofontzwavelaar, waterstofsulfidevrij; petroleumgas; [een complexe verzameling koolwaterstoffen, verkregen door katalytische waterstofontzwaveling van direct uit fractionering verkregen destillaten, waaruit waterstofsulfide door aminebehandeling is verwijderd. Bestaat voornamelijk uit koolwaterstoffen, overwegend C1 tot en met C4.] |
269-630-3 |
68308-10-1 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-183-00-4 |
restgas (aardolie), katalytisch kraken van gasolie, absorptievat; petroleumgas; [een complexe verzameling koolwaterstoffen, verkregen uit de destillatie van producten van het katalytisch kraken van gasolie. Bestaat voornamelijk uit koolwaterstoffen, overwegend C1 tot en met C5.] |
269-623-5 |
68308-03-2 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-184-00-X |
restgas (aardolie), gasterugwinningsinstallatie; petroleumgas; [een complexe verzameling koolwaterstoffen die wordt verkregen door de destillatie van producten uit verschillende koolwaterstofstromen. Bestaat voornamelijk uit koolwaterstoffen, overwegend C1 tot en met C5.] |
269-624-0 |
68308-04-3 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-185-00-5 |
restgas (aardolie), gasterugwinningsinstallatie, deëthanisator; petroleumgas; [een complexe verzameling koolwaterstoffen die wordt verkregen door de destillatie van producten uit verschillende koolwaterstofstromen. Bestaat uit koolwaterstoffen, overwegend C1 tot en met C4.] |
269-625-6 |
68308-05-4 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-186-00-0 |
restgas (aardolie), fractionator van met waterstof ontzwaveld destillaat en met waterstof ontzwavelde nafta, zuurvrij; petroleumgas; [een complexe verzameling koolwaterstoffen, verkregen door fractionering van met waterstof ontzwavelde nafta- en destillaat- koolwaterstofstromen, en behandeld om zure onzuiverheden te verwijderen. Bestaat voornamelijk uit koolwaterstoffen, overwegend C1 tot en met C5.] |
269-626-1 |
68308-06-5 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-187-00-6 |
restgas (aardolie), stripper van met waterstof ontzwavelde gasolie uit vacuümdestillatie, vrij van waterstofsulfide; petroleumgas; [een complexe verzameling koolwaterstoffen, verkregen uit de stabilisatie door strippen van katalytisch met waterstof ontzwavelde gasolie uit vacuümdestillatie, waaruit waterstofsulfide is verwijderd door aminebehandeling. Bestaat voornamelijk uit koolwaterstoffen, overwegend C1 tot en met C6.] |
269-627-7 |
68308-07-6 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-188-00-1 |
restgas (aardolie), stabilisator van lichte direct uit fractionering verkregen nafta, vrij van waterstofsulfide; petroleumgas; [een complexe verzameling koolwaterstoffen, verkregen door fractioneringsstabilisatie van lichte, direct uit fractionering verkregen, nafta, waaruit waterstofsulfide door aminebehandeling is verwijderd. Bestaat voornamelijk uit koolwaterstoffen, overwegend C1 tot en met C5.] |
269-629-8 |
68308-09-8 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-189-00-7 |
restgas (aardolie), propaan-propyleenalkyleringsinvoer, preparatieve deëthanisator; petroleumgas; [een complexe verzameling koolwaterstoffen die wordt verkregen door de destillatie van de reactieproducten van propaan met propyleen. Bestaat uit koolwaterstoffen, overwegend C1 tot en met C4.] |
269-631-9 |
68308-11-2 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-190-00-2 |
restgas (aardolie), waterstofontzwavelaar gasolie uit vacuümdestillatie, waterstofsulfidevrij; petroleumgas; [een complexe verzameling koolwaterstoffen, verkregen uit katalytische waterstofontzwaveling van door vacuümdestillatie verkregen gasolie, waaruit waterstofsulfide door aminebehandeling is verwijderd. Bestaat voornamelijk uit koolwaterstoffen, overwegend C1 tot en met C6.] |
269-632-4 |
68308-12-3 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-191-00-8 |
gassen (aardolie), katalytisch gekraakte topfracties; petroleumgas; [een complexe verzameling koolwaterstoffen, gevormd door de destillatie van producten van een katalytisch kraakproces. Bestaat uit koolwaterstoffen, overwegend C3 tot en met C5, met een kooktraject van ongeveer - 48 oC tot 32 oC (– 54 oF tot 90 oF).] |
270-071-2 |
68409-99-4 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-193-00-9 |
alkanen, C1-2-; petroleumgas |
270-651-5 |
68475-57-0 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-194-00-4 |
alkanen, C2-3-; petroleumgas |
270-652-0 |
68475-58-1 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-195-00-X |
alkanen, C3-4-; petroleumgas |
270-653-6 |
68475-59-2 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-196-00-5 |
alkanen, C4-5-; petroleumgas |
270-654-1 |
68475-60-5 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-197-00-0 |
brandstofgassen; petroleumgas; [een combinatie van lichte gassen. Bestaat voornamelijk uit waterstof en/of laagmoleculaire koolwaterstoffen.] |
270-667-2 |
68476-26-6 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-198-00-6 |
brandstofgassen, destillaten van ruwe olie; petroleumgas; [een complexe verzameling lichte gassen, gevormd door destillatie van ruwe olie en door katalytische reforming van nafta. Bestaat uit waterstof en koolwaterstoffen, overwegend C1 tot en met C4, met een kooktraject van ongeveer - 217 oC tot - 12 oC (– 423 oF tot 10 oF).] |
270-670-9 |
68476-29-9 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-199-00-1 |
koolwaterstoffen, C3-4; petroleumgas |
270-681-9 |
68476-40-4 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-200-00-5 |
koolwaterstoffen, C4-5; petroleumgas |
270-682-4 |
68476-42-6 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-201-00-0 |
koolwaterstoffen, C2-4, rijk aan C3; petroleumgas |
270-689-2 |
68476-49-3 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-202-00-6 |
petroleumgassen, vloeibaar gemaakt; petroleumgas; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van ruwe olie. Bestaat uit koolwaterstoffen, overwegend C3 tot en met C7, met een kooktraject van ongeveer – 40 oC tot 80 oC (– 40 oF tot 176 oF).] |
270-704-2 |
68476-85-7 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K S U |
649-203-00-1 |
petroleumgassen, vloeibaar gemaakt, stankvrij gemaakt; petroleumgas; [een complexe verzameling koolwaterstoffen, verkregen door het onderwerpen van een vloeibaar gemaakt aardoliegasmengsel aan een stankvrijmakingsproces, om mercaptanen om te zetten of zure onzuiverheden te verwijderen. Bestaat uit koolwaterstoffen, overwegend C3 tot en met C7, met een kooktraject van ongeveer - 40 oC tot 80 oC (– 40 oF tot 176 oF).] |
270-705-8 |
68476-86-8 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K S U |
649-204-00-7 |
gassen (aardolie), C3-4, rijk aan isobutaan; petroleumgas; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van verzadigde en onverzadigde koolwaterstoffen, gewoonlijk C3 tot en met C6, overwegend butaan en isobutaan. Bestaat uit verzadigde en onverzadigde koolwaterstoffen, C3 en C4, overwegend isobutaan.] |
270-724-1 |
68477-33-8 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-205-00-2 |
destillaten (aardolie), C3-6, rijk aan piperyleen; petroleumgas; [een complexe verzameling koolwaterstoffen, verkregen uit de destillatie van verzadigde en onverzadigde alifatische koolwaterstoffen, gewoonlijk C3 tot en met C6. Bestaat uit verzadigde en onverzadigde koolwaterstoffen, C3 tot en met C6, overwegend piperylenen.] |
270-726-2 |
68477-35-0 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-206-00-8 |
gassen (aardolie), butaansplittertopproducten; petroleumgas; [een complexe verzameling koolwaterstoffen, verkregen uit de destillatie van de butaanstroom. Bestaat uit alifatische koolwaterstoffen, overwegend C3 tot en met C4.] |
270-750-3 |
68477-69-0 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-207-00-3 |
gassen (aardolie), C2-3; petroleumgas; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van producten van een katalytisch fractioneringsproces. Bevat voornamelijk ethaan, ethyleen, propaan en proplyleen.] |
270-751-9 |
68477-70-3 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-208-00-9 |
gassen (aardolie), bodemfracties uit depropanisator van katalytisch gekraakte gasolie, C4-rijk zuurvrij; petroleumgas; [een complexe verzameling koolwaterstoffen, verkregen door de fractionering van katalytisch gekraakte gasolie-koolwaterstof- stroom en behandeld om waterstofsulfide en andere zure bestanddelen te verwijderen. Bestaat uit koolwaterstoffen, C3 tot en met C5, overwegend C4.] |
270-752-4 |
68477-71-4 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-209-00-4 |
Gassen (aardolie), bodemfracties uit debutanisator van katalytisch gekraakte nafta, C3-5-rijk; petroleumgas; [een complexe verzameling koolwaterstoffen, verkregen door de stabilisatie van katalytisch gekraakte nafta. Bestaat uit alifatische koolwaterstoffen, overwegend C3 tot en met C5.] |
270-754-5 |
68477-72-5 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-210-00-X |
restgas (aardolie), geïsomeriseerde nafta, fractioneringsstabilisator; petroleumgas; [een complexe verzameling koolwaterstoffen, verkregen uit de fractioneringsstabilisatie-producten van geïsomeriseerde nafta. Bestaat voornamelijk uit koolwaterstoffen, overwegend C1 tot en met C4.] |
269-628-2 |
68308-08-7 |
Press. Gas Flam. Gas 1 Carc. 1A Muta. 1B |
H220 H350 H340 |
GHS04 GHS02 GHS08 Dgr |
H220 H350 H340 |
|
|
K U |
649-211-00-5 |
bezinkselolie (aardolie), met koolstof behandeld; bezinkselolie; [een complexe verzameling koolwaterstoffen die wordt verkregen door de behandeling van bezinkselolie met geactiveerde kool voor de verwijdering van sporenbestanddelen en onzuiverheden. Bestaat voornamelijk uit verzadigde niet-vertakte koolwaterstoffen, overwegend groter dan C12.] |
308-126-0 |
97862-76-5 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-212-00-0 |
destillaten (aardolie), stankvrij gemaakte midden fractie; gasolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen door het onderwerpen van een aardoliedestillaat aan een stankverwijderingsproces om mercaptanen om te zetten of zure verontreinigingen te verwijderen. Bestaat uit koolwaterstoffen, overwegend C9 tot en met C20, met een kooktraject van ongeveer 150 oC tot 345 oC (302 oF tot 653 oF).] |
265-088-7 |
64741-86-2 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
N |
649-213-00-6 |
gasoliën (aardolie), oplosmiddelgeraffineerde; gasolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen als raffinaat van een oplosmiddelextractieproces. Bestaat voornamelijk uit alifatische koolwaterstoffen, overwegend C11 tot en met C25, met een kooktraject van ongeveer 205 oC tot 400 oC (401 oF tot 752 oF).] |
265-092-9 |
64741-90-8 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
N |
649-214-00-1 |
destillaten (aardolie), oplosmiddelgeraffineerde middenfractie; gasolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen als raffinaat van een oplosmiddelextractieproces. Bestaat voornamelijk uit alifatische koolwaterstoffen, overwegend C9 tot en met C20, met een kooktraject van ongeveer 150 oC tot 345 oC (302 oF tot 653 oF).] |
265-093-4 |
64741-91-9 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
N |
649-215-00-7 |
gasoliën (aardolie), met zuur behandeld; gasolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen als raffinaat uit een zwavelzuurbehandeling. Bestaat uit koolwaterstoffen, overwegend C13 tot en met C25, met een kooktraject van ongeveer 230 oC tot 400 oC (446 oF tot 752 oF).] |
265-112-6 |
64742-12-7 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
N |
649-216-00-2 |
destillaten (aardolie), met zuur behandelde middenfractie; gasolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen als raffinaat uit een zwavelzuurbehandeling. Bestaat uit koolwaterstoffen, overwegend C11 tot en met C20, met een kooktraject van ongeveer 205 oC tot 345 oC (401 oF tot 653 oF).] |
265-113-1 |
64742-13-8 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
N |
649-217-00-8 |
destillaten (aardolie), met zuur behandelde lichte fractie; gasolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen als raffinaat uit een zwavelzuurbehandeling. Bestaat uit koolwaterstoffen, overwegend C9 tot en met C16, met een kooktraject van ongeveer 150 oC tot 290 oC (302 oF tot 554 oF).] |
265-114-7 |
64742-14-9 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
N |
649-218-00-3 |
gasoliën (aardolie), chemisch geneutraliseerd; gasolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen door een behandeling om zure materialen te verwijderen. Bestaat uit koolwaterstoffen, overwegend C13 tot en met C25, met een kooktraject van ongeveer 230 oC tot 400 oC (446 oF tot 752 oF).] |
265-129-9 |
64742-29-6 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
N |
649-219-00-9 |
destillaten (aardolie), chemisch geneutraliseerd middenfractie; gasolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen door een behandeling om zure materialen te verwijderen. Bestaat uit koolwaterstoffen, overwegend C11 tot en met C20, met een kooktraject van ongeveer 205 oC tot 345 oC (401 oF tot 653 oF).] |
265-130-4 |
64742-30-9 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
N |
649-220-00-4 |
destillaten (aardolie), met klei behandelde middenfractie; gasolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen uit de behandeling van een aardoliefractie met natuurlijke of gemodificeerde klei, gewoonlijk in een percolatieproces om sporen van polaire verbindingen en onzuiverheden te verwijderen. Bestaat uit koolwaterstoffen, overwegend C9 tot en met C20, met een kooktraject van ongeveer 150 oC tot 345 oC (302 oF tot 653 oF).] |
265-139-3 |
64742-38-7 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
N |
649-221-00-X |
destillaten (aardolie), met waterstof behandelde middenfractie; gasolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen door het behandelen van een aardoliefractie met waterstof in aanwezigheid van een katalysator. Bestaat uit koolwaterstoffen, overwegend C11 tot en met C25, met een kooktraject van ongeveer 250 oC tot 400 oC (401 oF tot 752 oF).] |
265-148-2 |
64742-46-7 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
N |
649-222-00-5 |
gasoliën (aardolie), met waterstof ontzwaveld; gasolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt verkregen uit de aardoliegrondstof door behandeling met waterstof om organische zwavel om te zetten in waterstofsulfide dat wordt verwijderd. Bestaat voornamelijk uit koolwaterstoffen, overwegend C13 tot en met C25, met een kooktraject van ongeveer 230 oC tot 400 oC (446 oF tot 752 oF).] |
265-182-8 |
64742-79-6 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
N |
649-223-00-0 |
destillaten (aardolie), met waterstof ontzwavelde middenfractie; gasolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt verkregen uit de aardoliegrondstof door behandeling met waterstof om organische zwavel om te zetten in waterstofsulfide dat wordt verwijderd. Bestaat uit koolwaterstoffen, overwegend C11 tot en met C25, met een kooktraject van ongeveer 205 oC tot 400 oC (401 oF tot 752 oF).] |
265-183-3 |
64742-80-9 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
N |
649-224-00-6 |
brandstoffen, diesel-; gasolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van ruwe olie. Bestaat uit koolwaterstoffen, overwegend C9 tot en met C20, met een kooktraject van ongeveer 163 oC tot 357 oC (325 oF tot 675 oF).] |
269-822-7 |
68334-30-5 |
Carc. 2 |
H351 |
GHS08 Wng |
H351 |
|
|
N |
649-225-00-1 |
brandstofolie, nr. 2; gasolie — niet gespecifieerd; [een stookolie met een minimale viscositeit van 32,6 SUS bij 37,7 oC (100 oF) en een maximale viscositeit van 37,9 SUS bij 37,7 oC (100 oF).] |
270-671-4 |
68476-30-2 |
Carc. 2 |
H351 |
GHS08 Wng |
H351 |
|
|
|
649-226-00-7 |
brandstofolie, nr. 4; gasolie — niet gespecifieerd; [een stookolie met een minimale viscositeit van 45 SUS bij 37,7 oC (100 oF) en een maximale viscositeit van 125 SUS bij 37,7 oC (100 oF).] |
270-673-5 |
68476-31-3 |
Carc. 2 |
H351 |
GHS08 Wng |
H351 |
|
|
|
649-227-00-2 |
brandstoffen, diesel-, nr. 2; gasolie — niet gespecifieerd; [een stookolie met een minimale viscositeit van 32,6 SUS bij 37,7 oC (100 oF).] |
270-676-1 |
68476-34-6 |
Carc. 2 |
H351 |
GHS08 Wng |
H351 |
|
|
|
649-228-00-8 |
destillaten (aardolie), katalytischereformator-fractioneerderresidu, hoogkokend; gasolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen uit de destillatie van katalytischereformator-fractioneerderresidu. Heeft een kooktraject van ongeveer 343 oC tot 399 oC (650 oF tot 842 oF).] |
270-719-4 |
68477-29-2 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
N |
649-229-00-3 |
destillaten (aardolie), katalytischereformator-fractioneerderresidu, bij middentemperaturen kokend; gasolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen uit de destillatie van katalytischereformator-fractioneerderresidu. Heeft een kooktraject van ongeveer 288 oC tot 371 oC (550 oF tot 700 oF).] |
270-721-5 |
68477-30-5 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
N |
649-230-00-9 |
destillaten (aardolie), katalytische reformator-fractioneerderresidu, bij lage temperaturen kokend; gasolie — niet gespecifieerd; [de complexe verzameling koolwaterstoffen, verkregen uit de destillatie van katalytischereformator-fractioneerderresidu. Kookt beneden ongeveer 288 oC (550 oF).] |
270-722-0 |
68477-31-6 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
N |
649-231-00-4 |
destillaten (aardolie), hooggezuiverde midden-; gasolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt verkregen door het onderwerpen van een aardoliefractie aan verscheidene van de volgende stappen: filtratie, centrifugatie, atmosferische destillatie, vacuümdestillatie, verzuring, neutralisatie en behandeling met klei. Bestaat voornamelijk uit koolwaterstoffen, overwegend C10 tot en met C20.] |
292-615-8 |
90640-93-0 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
N |
649-232-00-X |
destillaten (aardolie), katalytische reformator, concentraat van zware aromaten; gasolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt verkregen uit de destillatie van een katalytisch gereformde aardoliefractie. Bestaat voornamelijk uit aromatische koolwaterstoffen, overwegend C10 tot en met C16, met een kooktraject van ongeveer 200 oC tot 300 oC (392 oF tot 572 oF).] |
295-294-2 |
91995-34-5 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
N |
649-233-00-5 |
gasoliën, paraffinisch; gasolie — niet gespecifieerd; [een destillaat, verkregen uit de herdestillatie van een complexe verzameling koolwaterstoffen, verkregen door de destillatie van de vloeistoffen verkregen na een grondige katalytische waterstofbehandeling van paraffinen. Heeft een kooktraject van ongeveer 190 oC tot 330 oC (374 oF tot 594 oF).] |
300-227-8 |
93924-33-5 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
N |
649-234-00-0 |
nafta (aardolie), oplosmiddelgeraffineerde met waterstof ontzwavelde zware; gasolie — niet gespecifieerd |
307-035-3 |
97488-96-5 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
N |
649-235-00-6 |
koolwaterstoffen, C16-20-, met waterstof behandeld middendestillaat, lichte destillatiefracties; gasolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt verkregen als de eerste fracties uit de vacuümdestillatie van de vloeistof die wordt verkregen door de behandeling van een middendestillaat met waterstof. Bestaat voornamelijk uit koolwaterstoffen, overwegend C16 tot en met C20, met een kooktraject van ongeveer 290 oC tot 350 oC (554 oF tot 662 oF). Vormt een voltooide olie met een viscositeit van 2 cSt bij 100 oC (212 oF).] |
307-659-6 |
97675-85-9 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
N |
649-236-00-1 |
koolwaterstoffen, C12-20-, met waterstof behandelde paraffinische, lichte destillatiefracties; gasolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt verkregen als de eerste fracties uit de vacuümdestillatie van de vloeistoffen die worden verkregen bij de behandeling van zware paraffine met waterstof in de aanwezigheid van een katalysator. Bestaat voornamelijk uit koolwaterstoffen, overwegend C12 tot en met C20, met een kooktraject van ongeveer 230 oC tot 350 oC (446 oF tot 662 oF). Vormt een voltooide olie met een viscositeit van 2 cSt bij 100 oC (212 oF).] |
307-660-1 |
97675-86-0 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
N |
649-237-00-7 |
koolwaterstoffen, C11-17-, met oplosmiddel geëxtraheerde naftenische lichte; gasolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt verkregen door extractie van de aromaten uit een naftenisch licht destillaat met een viscositeit van 2,2 cSt bij 40 oC (104 oF). Bestaat voornamelijk uit koolwaterstoffen, overwegend C11 tot en met C17, met een kooktraject van ongeveer 200 oC tot 300 oC (392 oF tot 572 oF).] |
307-757-9 |
97722-08-2 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
N |
649-238-00-2 |
gasoliën, met waterstof behandeld; gasolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt verkregen door herdestillatie van de vloeistoffen die worden verkregen bij de behandeling van paraffinen met waterstof in aanwezigheid van een katalysator. Bestaat voornamelijk uit koolwaterstoffen, overwegend C17 tot en met C27, met een kooktraject van ongeveer 330 oC tot 340 oC (626 oF tot 644 oF).] |
308-128-1 |
97862-78-7 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
N |
649-239-00-8 |
destillaten (aardolie), met koolstof behandelde lichte paraffinische; gasolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die is verkregen door de behandeling van een aardoliefractie met geactiveerde houtskool voor de verwijdering van sporen polaire bestanddelen en onzuiverheden. Bestaat voornamelijk uit koolwaterstoffen, overwegend C12 tot en met C28.] |
309-667-5 |
100683-97-4 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
N |
649-240-00-3 |
destillaten (aardolie), middelste paraffinische, behandeld met koolstof; gasolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die is verkregen door de behandeling van aardolie met geactiveerde houtskool voor de verwijdering van sporen polaire bestanddelen en onzuiverheden. Bestaat voornamelijk uit koolwaterstoffen, overwegend C16 tot en met C36.] |
309-668-0 |
100683-98-5 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
N |
649-241-00-9 |
destillaten (aardolie), middelste paraffinische, behandeld met klei; gasolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die is verkregen door de behandeling van aardolie met bleekaarde voor de verwijdering van sporen van polaire bestanddelen en onzuiverheden. Bestaat voornamelijk uit koolwaterstoffen, overwegend C16 tot en met C36.] |
309-669-6 |
100683-99-6 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
N |
649-242-00-4 |
alkanen, C12-26-vertakte en niet-vertakte |
292-454-3 |
90622-53-0 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
N |
649-243-00-X |
smeervetten; mineraal vet; [een complexe verzameling koolwaterstoffen, overwegend C12 tot en met C50. Kan organische zouten van alkali- en aardalkalimetalen en/of aluminiumverbindingen bevatten.] |
278-011-7 |
74869-21-9 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
N |
649-244-00-5 |
ruwe paraffinewas (aardolie); ruwe paraffinewas; [een complexe verzameling koolwaterstoffen, verkregen uit een aardoliefractie door oplosmiddelkristallisatie (met oplosmiddel van was ontdoen) of als een destillatiefractie uit een zeer wasachtige ruwe olie. Bestaat voornamelijk uit verzadigde vertakte en niet-vertakte koolwaterstoffen, overwegend groter dan C20.] |
265-165-5 |
64742-61-6 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
N |
649-245-00-0 |
ruwe paraffinewas (aardolie), met zuur behandeld; ruwe paraffinewas; [een complexe verzameling koolwaterstoffen die wordt verkregen als een raffinaat door de behandeling van een ruwe paraffinewasfractie uit aardolie in een zwavelzuurbehandelingsproces. Bestaat voornamelijk uit verzadigde vertakte en niet-vertakte koolwaterstoffen, overwegend groter dan C20.] |
292-659-8 |
90669-77-5 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
N |
649-246-00-6 |
ruwe paraffinewas (aardolie), met klei behandeld; ruwe paraffinewas; [een complexe verzameling koolwaterstoffen die wordt verkregen door de behandeling van een ruwe paraffinewasfractie uit aardolie met natuurlijke of gemodificeerde klei in een contact- of een percolatieproces. Bestaat voornamelijk uit verzadigde vertakte en niet-vertakte koolwaterstoffen, overwegend groter dan C20.] |
292-660-3 |
90669-78-6 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
N |
649-247-00-1 |
ruwe paraffine (aardolie), met waterstof behandeld; ruwe paraffinewas; [een complexe verzameling koolwaterstoffen die wordt verkregen door het behandelen van ruwe paraffine met waterstof in de aanwezigheid van een katalysator. Bestaat voornamelijk uit verzadigde vertakte en niet-vertakte koolwaterstoffen, overwegend groter dan C20.] |
295-523-6 |
92062-09-4 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
N |
649-248-00-7 |
ruwe paraffinewas (aardolie), smeltend bij lage temperaturen; ruwe paraffinewas; [een complexe verzameling koolwaterstoffen die wordt verkregen uit een aardoliefractie door deparaffinering met oplosmiddel. Bestaat voornamelijk uit verzadigde vertakte en niet-vertakte koolwaterstoffen, overwegend groter dan C12.] |
295-524-1 |
92062-10-7 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
N |
649-249-00-2 |
ruwe paraffinewas (aardolie), smeltend bij lage temperaturen, met waterstof behandeld; ruwe paraffinewas; [een complexe verzameling koolwaterstoffen die wordt verkregen door de behandeling van bij lage temperaturen smeltende ruwe paraffinewas uit aardolie met waterstof in de aanwezigheid van een katalysator. Bestaat voornamelijk uit verzadigde vertakte en niet-vertakte koolwaterstoffen, overwegend groter dan C12.] |
295-525-7 |
92062-11-8 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
N |
649-250-00-8 |
ruwe paraffinewas (aardolie), smeltend bij lage temperaturen, behandeld met kool; ruwe paraffinewas; [een complexe verzameling koolwaterstoffen die wordt verkregen door de behandeling van bij lage temperaturen smeltende ruwe paraffinewas met geactiveerde kool om sporen van polaire bestanddelen en onzuiverheden te verwijderen. Bestaat voornamelijk uit verzadigde vertakte en niet-vertakte koolwaterstoffen, overwegend groter dan C12.] |
308-155-9 |
97863-04-2 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
N |
649-251-00-3 |
ruwe paraffinewas (aardolie), smeltend bij lage temperaturen, behandeld met klei; ruwe paraffinewas; [een complexe verzameling koolwaterstoffen die wordt verkregen door de behandeling van bij lage temperaturen smeltende ruwe paraffinewas uit aardolie met bentoniet om sporen polaire bestanddelen en onzuiverheden te verwijderen. Bestaat voornamelijk uit verzadigde vertakte en niet-vertakte koolwaterstoffen, overwegend groter dan C12.] |
308-156-4 |
97863-05-3 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
N |
649-252-00-9 |
ruwe paraffinewas (aardolie), smeltend bij lage temperaturen, behandeld met kiezelzuur; ruwe paraffinewas; [een complexe verzameling koolwaterstoffen die wordt verkregen door de behandeling van bij lage temperaturen smeltende ruwe paraffinewas uit aardolie met kiezelzuur om sporen van polaire bestanddelen en onzuiverheden te verwijderen. Bestaat voornamelijk uit verzadigde vertakte en niet-vertakte koolwaterstoffen, overwegend groter dan C12.] |
308-158-5 |
97863-06-4 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
N |
649-253-00-4 |
ruwe paraffinewas (aardolie), behandeld met koolstof; ruwe paraffinewas; [een complexe verzameling koolwaterstoffen die wordt verkregen door de behandeling van ruwe paraffinewas uit aardolie met geactiveerde kool teneinde sporen van polaire bestanddelen en onzuiverheden te verwijderen.] |
309-723-9 |
100684-49-9 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
N |
649-254-00-X |
petrolatum; petrolatum; [een complexe verzameling van koolwaterstoffen, verkregen als een halfvaste stof bij het van was ontdoen van paraffinische residuolie. Het bestaat voornamelijk uit verzadigde kristallijne en vloeibare koolwaterstoffen, overwegend groter dan C25.]; |
232-373-2 |
8009-03-8 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
N |
649-255-00-5 |
petrolatum (aardolie), geoxideerd; petrolatum; [een complexe verzameling organische verbindingen, voornamelijk carbonzuren met hoog molecuulgewicht, verkregen door de oxidatie aan lucht van petrolatum.] |
265-206-7 |
64743-01-7 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
N |
649-256-00-0 |
petrolatum (aardolie), met aluminiumoxide behandeld; petrolatum; [een complexe verzameling koolwaterstoffen, verkregen wanneer petrolatum wordt behandeld met Al2O3 om polaire componenten en onzuiverheden te verwijderen. Het bestaat voornamelijk uit verzadigde kristallijne en vloeibare koolwaterstoffen, overwegend groter dan C25.]; |
285-098-5 |
85029-74-9 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
N |
649-257-00-6 |
petrolatum (aardolie), met waterstof behandeld; petrolatum; [een complexe verzameling koolwaterstoffen die wordt verkregen als een halfvaste stof uit van was ontdane paraffinische residuolie, die in aanwezigheid van een katalysator met waterstof behandeld is. Het bestaat voornamelijk uit verzadigde microkristallijne en vloeibare koolwaterstoffen, overwegend groter dan C20.]; |
295-459-9 |
92045-77-7 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
N |
649-258-00-1 |
petrolatum (aardolie), behandeld met kool; petrolatum; [een complexe verzameling koolwaterstoffen die wordt verkregen door de behandeling van aardoliepetrolatum met geactiveerde kool om sporen van polaire bestanddelen en onzuiverheden te verwijderen. Bestaat voornamelijk uit verzadigde koolwaterstoffen, overwegend groter dan C20.] |
308-149-6 |
97862-97-0 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
N |
649-259-00-7 |
petrolatum (aardolie), behandeld met kiezelzuur; petrolatum; [een complexe verzameling koolwaterstoffen die wordt verkregen door de behandeling van aardoliepetrolatum met geactiveerde kool om sporen van polaire bestanddelen en onzuiverheden te verwijderen. Bestaat voornamelijk uit verzadigde koolwaterstoffen, overwegend groter dan C20.] |
308-150-1 |
97862-98-1 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
N |
649-260-00-2 |
petrolatum (aardolie), behandeld met klei; petrolatum; [een complexe verzameling koolwaterstoffen die wordt verkregen door de behandeling van petrolatum met bleekaarde teneinde sporen van polaire bestanddelen en onzuiverheden te verwijderen. Bestaat voornamelijk uit koolwaterstoffen, overwegend groter dan C25.] |
309-706-6 |
100684-33-1 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
N |
649-261-00-8 |
benzine, natuurlijke; nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, afgescheiden van aardgas door processen als afkoeling en absorptie. Bestaat voornamelijk uit verzadigde alifatische koolwaterstoffen, overwegend C4 tot en met C8, met een kooktraject van ongeveer - 20 oC tot 120 oC (– 4 oF tot 248 oF).] |
232-349-1 |
8006-61-9 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-262-00-3 |
nafta; nafta met laag kookpunt; [geraffineerde, deels geraffineerde of ongeraffineerde aardolieproducten verkregen door destillatie van aardgas. Bestaat uit koolwaterstoffen, overwegend C5 tot en met C6, met een kooktraject van ongeveer 100 oC tot 200 oC (212 oF tot 392 oF).] |
232-443-2 |
8030-30-6 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-263-00-9 |
ligroïne; nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door fractionele destillatie van aardolie. Deze fractie heeft een kooktraject van ongeveer 20 oC tot 135 oC (58 oF tot 275 oF.] |
232-453-7 |
8032-32-4 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-264-00-4 |
nafta (aardolie), zware direct uit fractionering verkregen; nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van ruwe olie. Bestaat uit koolwaterstoffen, overwegend C6 tot en met C12, met een kooktraject van ongeveer 65 oC tot 230 oC (149 oF tot 446 oF).] |
265-041-0 |
64741-41-9 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-265-00-X |
nafta (aardolie), totaalfractie direct uit fractionering verkregen; nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van ruwe olie. Bestaat uit koolwaterstoffen, overwegend C4 tot en met C11, met een kooktraject van ongeveer - 20 oC tot 220 oC (– 4 oF tot 428 oF).] |
265-042-6 |
64741-42-0 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-266-00-5 |
nafta (aardolie), lichte direct uit fractionering verkregen; nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van ruwe olie. Bestaat voornamelijk uit alifatische koolwaterstoffen, overwegend C4 tot en met C10, met een kooktraject van ongeveer - 20 oC tot 180 oC (– 4 oF tot 356 oF).] |
265-046-8 |
64741-46-4 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-267-00-0 |
oplosmiddelnafta (aardolie), lichte alifatische; nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van ruwe olie of natuurlijke benzine. Bestaat voornamelijk uit verzadigde koolwaterstoffen, overwegend C5 tot en met C10, met een kooktraject van ongeveer 35 oC tot 160 oC (95 oF tot 320 oF).] |
265-192-2 |
64742-89-8 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-268-00-6 |
destillaten (aardolie), lichte direct uit fractionering verkregen; nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van ruwe olie. Bestaat uit koolwaterstoffen, overwegend C2 tot en met C7, met een kooktraject van ongeveer - 88 oC tot 99 oC (– 127 oF tot 210 oF).] |
270-077-5 |
68410-05-9 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-269-00-1 |
benzine, dampterugwinning; nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, door afkoeling afgescheiden van de gassen uit dampterugwinningssystemen. Bestaat uit koolwaterstoffen, overwegend C4 tot en met C11, met een kooktraject van ongeveer - 20 oC tot 196 oC (– 4 oF tot 384 oF).] |
271-025-4 |
68514-15-8 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-270-00-7 |
benzine, direct door fractionering verkregen, aftopinrichting; nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, afkomstig uit de aftopinrichting bij de destillatie van ruwe olie. Heeft een kooktraject van ongeveer 36,1 oC tot 193,3 oC (97 oF tot 380 oF).] |
271-727-0 |
68606-11-1 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-271-00-2 |
nafta (aardolie), niet stankvrij gemaakt; nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van naftastromen uit verscheidene raffinageprocessen. Bestaat uit koolwaterstoffen, overwegend C5 tot en met C12, met een kooktraject van ongeveer 0 oC tot 230 oC (25 oF tot 446 oF).] |
272-186-3 |
68783-12-0 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-272-00-8 |
destillaten (aardolie), lichte direct door fractionering verkregen benzine, topproducten uit fractioneringsstabilisator; nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen die wordt verkregen door de fractionering van direct door fractionering verkregen lichte benzine. Bestaat uit verzadigde alifatische koolwaterstoffen, overwegend C3 tot en met C6.] |
272-931-2 |
68921-08-4 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-273-00-3 |
nafta (aardolie), zware direct door fractionering verkregen, aromaathoudend; nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen uit een destillatieproces van ruwe aardolie. Bestaat voornamelijk uit koolwaterstoffen, C8 tot en met C12, met een kooktraject van ongeveer 130 oC tot 210 oC (266 oF tot 410 oF).] |
309-945-6 |
101631-20-3 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-274-00-9 |
nafta (aardolie), totaalfractie, gealkyleerd; gemodificeerde nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van de reactieproducten van isobutaan met enkelvoudig onverzadigde koolwaterstoffen, overwegend C3 tot en met C5. Bestaat voornamelijk uit verzadigde koolwaterstoffen met vertakte keten, overwegend C7 tot en met C12, met een kooktraject van ongeveer 90 oC tot 220 oC (194 oF tot 428 oF).] |
265-066-7 |
64741-64-6 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-275-00-4 |
nafta (aardolie), zwaar, gealkyleerd; gemodificeerde nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van de reactieproducten van isobutaan met enkelvoudig onverzadigde koolwaterstoffen, overwegend C3 tot en met C5. Bestaat voornamelijk uit verzadigde koolwaterstoffen met vertakte keten, overwegend C9 tot en met C12, met een kooktraject van ongeveer 150 oC tot 220 oC (302 oF tot 428 oF).] |
265-067-2 |
64741-65-7 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-276-00-X |
nafta (aardolie), licht, gealkyleerd; gemodificeerde nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van de reactieproducten van isobutaan met enkelvoudig onverzadigde koolwaterstoffen, overwegend C3 tot en met C5. Bestaat voornamelijk uit verzadigde koolwaterstoffen met vertakte keten, overwegend C7 tot en met C10, met een kooktraject van ongeveer 90 oC tot 160 oC (194 oF tot 320 oF).] |
265-068-8 |
64741-66-8 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-277-00-5 |
nafta (aardolie), isomerisatie-; gemodificeerde nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door katalytische isomerisatie van onvertakte paraffinekoolwaterstoffen, C4 tot en met C6. Bestaat voornamelijk uit verzadigde koolwaterstoffen als isobutaan, isopentaan, 2,2-dimethylbutaan, 2-methylpentaan en 3-methylpentaan.] |
265-073-5 |
64741-70-4 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-278-00-0 |
nafta (aardolie), oplosmiddelgeraffineerde lichte; gemodificeerde nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen als raffinaat van een oplosmiddelextractieproces. Bestaat voornamelijk uit alifatische koolwaterstoffen, overwegend C5 tot en met C11, met een kooktraject van ongeveer 35 oC tot 190 oC (95 oF tot 374 oF).] |
265-086-6 |
64741-84-0 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-279-00-6 |
nafta (petroleum), oplosmiddelgeraffineerde zware; gemodificeerde nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen als raffinaat van een oplosmiddelextractieproces. Bestaat voornamelijk uit alifatische koolwaterstoffen, overwegend C7 tot en met C12, met een kooktraject van ongeveer 90 oC tot 230 oC (194 oF tot 446 oF).] |
265-095-5 |
64741-92-0 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-280-00-1 |
raffinaten (aardolie), katalytische reformator, ethyleenglycol-water-tegenstroomextractie; gemodificeerde nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen als raffinaat van een Udex-extractie van de stroom uit de katalytische reformator. Bestaat uit verzadigde koolwaterstoffen, overwegend C6 tot en met C9.] |
270-088-5 |
68410-71-9 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-281-00-7 |
raffinaten (aardolie), reformator, Lurgi-afscheider; gemodificeerde nafta met laag kookpunt; [de complexe verzameling koolwaterstoffen, verkregen als raffinaat uit een Lurgi-afscheider. Bestaat voornamelijk uit niet-aromatische koolwaterstoffen, met uiteenlopende kleine hoeveelheden aromatische koolwaterstoffen, overwegend C6 tot en met C8.] |
270-349-3 |
68425-35-4 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-28-00-2 |
nafta (aardolie), totaalfractie gealkyleerd, butaan bevattend; gemodificeerde nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door de destillatie van de reactieproducten van isobutaan met enkelvoudig onverzadigde koolwaterstoffen, overwegend C3 tot en met C5. Bestaat voornamelijk uit verzadigde koolwaterstoffen met vertakte keten, overwegend C7 tot en met C12, en enkele butanen. Heeft een kooktraject van ongeveer 35 oC tot 200 oC (95 oF tot 428 oF).] |
271-267-0 |
68527-27-5 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-283-00-8 |
destillaten (aardolie), afkomstig van nafta-stoomkraken, oplosmiddelgeraffineerde lichte met waterstof behandelde; gemodificeerde nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen als raffinaten uit de oplosmiddelextractie van met waterstof behandeld licht destillaat uit stoomgekraakte nafta.] |
295-315-5 |
91995-53-8 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-284-00-3 |
nafta (aardolie), C4-12-butaanalkylaat, rijk aan isoöctaan; gemodificeerde nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door alkylering van butanen. Bestaat voornamelijk uit koolwaterstoffen, overwegend C4 tot en met C12, rijk aan isoöctaan, met een kooktraject van ongeveer 35 oC tot 210 oC (95 oF tot 410 oF).] |
295-430-0 |
92045-49-3 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-285-00-9 |
koolwaterstoffen, met waterstof behandelde lichte naftadestillaten, oplosmiddelgeraffineerd; gemodificeerde nafta met laag kookpunt; [een verzameling koolwaterstoffen, verkregen door destillatie van met waterstof behandelde nafta, gevolgd door een oplosmiddelextractie- en destillatieproces. Bestaat voornamelijk uit verzadigde koolwaterstoffen, met een kooktraject van ongeveer 94 oC tot 99 oC (201 oF tot 210 oF).] |
295-436-3 |
92045-55-1 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-286-00-4 |
nafta (aardolie), isomerisatie, C6-fractie; gemodificeerde nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van een katalytisch geïsomeriseerde benzine. Bestaat voornamelijk uit hexaanisomeren met een kooktraject van ongeveer 60 oC tot 66 oC (140 oF tot 151 oF).] |
295-440-5 |
92045-58-4 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-287-00-X |
koolwaterstoffen, C6-7, naftakraken, oplosmiddelgeraffineerd; gemodificeerde nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door sorptie van benzeen uit een katalytisch volledig gehydrogeneerde benzeenrijke koolwaterstoffractie die door destillatie is verkregen uit voorgehydrogeneerde gekraakte nafta. Bestaat voornamelijk uit paraffine- en nafteenkoolwaterstoffen, overwegend C6 tot en met C7, met een kooktraject van ongeveer 70 oC tot 100 oC (158 oF tot 212 oF).] |
295-446-8 |
92045-64-2 |
Carc. 1B muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-288-00-5 |
koolwaterstoffen, rijk aan C6, met waterstof behandelde lichte naftadestillaten, oplosmiddelgeraffineerd; gemodificeerde nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van met waterstof behandelde nafta, gevolgd door oplosmiddelextractie. Bestaat voornamelijk uit verzadigde koolwaterstoffen, met een kooktraject van ongeveer 65 oC tot 70 oC (149 oF tot 158 oF).] |
309-871-4 |
101316-67-0 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-289-00-0 |
nafta (aardolie), zware katalytisch gekraakte; katalytisch gekraakte nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van producten van een katalytisch kraakproces. Bestaat uit koolwaterstoffen, overwegend C6 tot en met C12, met een kooktraject van ongeveer 65 oC tot 230 oC (148 oF tot 446 oF). Bevat een relatief grote hoeveelheid onverzadigde koolwaterstoffen.] |
265-055-7 |
64741-54-4 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-290-00-6 |
nafta (aardolie), lichte katalytisch gekraakte; katalytisch gekraakte nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van producten van een katalytisch kraakproces. Bestaat uit koolwaterstoffen, overwegend C4 tot en met C11, met een kooktraject van ongeveer - 20 oC tot 190 oC (– 4 oF tot 374 oF). Bevat een relatief grote hoeveelheid onverzadigde koolwaterstoffen.] |
265-056-2 |
64741-55-5 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-291-00-1 |
koolwaterstoffen, C3-11-, destillaten uit katalytische kraker; katalytisch gekraakte nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van producten uit een katalytisch kraakproces. Bestaat uit koolwaterstoffen, overwegend C3 tot en met C11, met een kooktraject tot ongeveer 204 oC (400 oF).] |
270-686-6 |
68476-46-0 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-292-00-7 |
nafta (aardolie), katalytisch gekraakte lichte destillaten; katalytisch gekraakte nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van producten van een katalytisch kraakproces. Bestaat uit koolwaterstoffen, overwegend C1 tot en met C5.] |
272-185-8 |
68783-09-5 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-293-00-2 |
Destillaten (aardolie), met waterstof behandelde aromatische lichte, afkomstig van het stoomkraken van nafta; katalytisch gekraakte nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door het behandelen met waterstof van een licht destillaat uit stoomgekraakte nafta. Bestaat voornamelijk uit aromatische koolwaterstoffen.] |
295-311-3 |
91995-50-5 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-294-00-8 |
nafta (aardolie), zware katalytisch gekraakte, stankvrij gemaakt; katalytisch gekraakte nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door het onderwerpen van een katalytisch gekraakt aardoliedestillaat aan een stankverwijderingsproces om mercaptanen om te zetten of zure verontreinigingen te verwijderen. Bestaat voornamelijk uit koolwaterstoffen, overwegend C6 tot en met C12, met een kooktraject van ongeveer 60 oC tot 200 oC (140 oF tot 392 oF).] |
295-431-6 |
92045-50-6 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-295-00-3 |
nafta (aardolie), lichte katalytisch gekraakte, stankvrij gemaakt; katalytisch gekraakte nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door het onderwerpen van katalytisch gekraakte nafta aan een stankverwijderingsproces om mercaptanen om te zetten of zure verontreinigingen te verwijderen. Bestaat voornamelijk uit koolwaterstoffen, met een kooktraject van ongeveer 35 oC tot 210 oC (95 oF tot 410 oF).] |
295-441-0 |
92045-59-5 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-296-00-9 |
koolwaterstoffen, C8-12-, katalytisch gekraakte, chemisch geneutraliseerde; katalytisch gekraakte nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van een fractie uit een katalytisch kraakproces, die alkalisch gewassen is. Bestaat voornamelijk uit koolwaterstoffen, C8 tot en met C12, met een kooktraject van ongeveer 130 oC tot 210 oC (266 oF tot 410 oF).] |
295-794-0 |
92128-94-4 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-297-00-4 |
koolwaterstoffen, C8-12-, destillaten uit katalytische kraker; katalytisch gekraakte nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van producten uit een katalytisch kraakproces. Bestaat voornamelijk uit koolwaterstoffen, overwegend C8 tot en met C12, met een kooktraject van ongeveer 140 oC tot 210 oC (284 oF tot 410 oF).] |
309-974-4 |
101794-97-2 |
Carc. 1B Muta. 1B A Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-298-00-X |
koolwaterstoffen, C8-12-, katalytisch gekraakte, chemisch geneutraliseerde, stankvrij gemaakte; katalytisch gekraakte nafta met laag kookpunt |
309-987-5 |
101896-28-0 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-299-00-5 |
nafta (aardolie), lichte katalytisch gereformde; katalytisch gereformde nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van producten van een katalytisch reformingsproces. Bestaat uit koolwaterstoffen, overwegend C5 tot en met C11, met een kooktraject van ongeveer 35 oC tot 190 oC (95 oF tot 374 oF).] Bevat een relatief grote hoeveelheid aromatische en vertakte koolwaterstoffen. Deze stroom kan 10 of meer volumeprocent benzeen bevatten.] |
265-065-1 |
64741-63-5 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-300-00-9 |
nafta (aardolie), zware katalytisch gereformde; katalytisch gereformde nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van producten van een katalytisch reformingsproces. Bestaat voornamelijk uit koolwaterstoffen, overwegend C7 tot en met C12, met een kooktraject van ongeveer 90 oC tot 230 oC (194 oF tot 446 oF). |
265-070-9 |
64741-68-0 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-301-00-4 |
destillaten (aardolie), katalytisch gereformde pentaanverwijdering-; katalytisch gereformde nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van producten van een katalytisch reformingsproces. Bestaat voornamelijk uit alifatische koolwaterstoffen, overwegend C3 tot en met C6, met een kooktraject van ongeveer - 49 oC tot 63 oC (-57 oF tot 145 oF).] |
270-660-4 |
68475-79-6 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-302-00-X |
Koolwaterstoffen, C2-6-, katalytische reformer C6-8; Katalytisch gereformde nafta met laag kookpunt; |
270-687-1 |
68476-47-1 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-303-00-5 |
residuen (aardolie), C6-8-katalytische reformator; katalytisch gereformde nafta met laag kookpunt; [een complex residu, afkomstig uit de katalytische reforming van C6-8-aanvoer. Bestaat uit koolwaterstoffen, overwegend C2 tot en met C6.] |
270-794-3 |
68478-15-9 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-304-00-0 |
nafta (aardolie), lichte katalytisch gereformde, vrij van aromaten; katalytisch gereformde nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van producten van een katalytisch reformingsproces. Bestaat voornamelijk uit koolwaterstoffen, overwegend C5 tot en met C8, met een kooktraject van ongeveer 35 oC tot 120 oC (95 oF tot 248 oF). Bevat een relatief grote hoeveelheid vertakte koolwaterstoffen en de aromatische bestanddelen zijn verwijderd.] |
270-993-5 |
68513-03-1 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-305-00-6 |
destillaten (aardolie), topproducten van katalytisch gereformde, door directe fractionering verkregen nafta; katalytisch gereformde nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door katalytische reforming van door directe fractionering verkregen nafta, gevolgd door fractionering van de totale uitstroom. Bestaat uit verzadigde alifatische koolwaterstoffen, overwegend C2 tot en met C6.] |
271-008-1 |
68513-63-3 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-306-00-1 |
aardolieproducten, hydrofiner-powerformer-reformaten; katalytisch gereformde nafta met laag kookpunt; [de complexe verzameling koolwaterstoffen, verkregen door een hydrofiner-powerformer-proces, met een kooktraject van ongeveer 27 oC tot 210 oC (80 oF tot 410 oF).] |
271-058-4 |
68514-79-4 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-307-00-7 |
nafta (aardolie), totaalfractie gereformde; katalytisch gereformde nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van producten van een katalytisch reformingsproces. Bestaat uit koolwaterstoffen, overwegend C5 tot en met C12, met een kooktraject van ongeveer 35 oC tot 230 oC (95 oF tot 446 oF). |
272-895-8 |
68919-37-9 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-308-00-2 |
nafta (aardolie), katalytisch gereformde; katalytisch gereformde nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van producten van een katalytisch reformingsproces. Bestaat uit koolwaterstoffen, overwegend C4 tot en met C12, met een kooktraject van ongeveer 30 oC tot 220 oC (90 oF tot 430 oF). Bevat een relatief grote hoeveelheid aromatische en vertakte koolwaterstoffen. Deze stroom kan 10 of meer volumeprocent benzeen bevatten.] |
273-271-8 |
68955-35-1 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-309-00-8 |
Destillaten (aardolie), katalytisch gereformde, met waterstof behandelde, lichte fractie, C8-12- aromatische fractie. Katalytisch gereformde nafta met laag kookpunt; [een complexe verzameling alkylbenzenen, verkregen door katalytische reforming van aardolienafta. Bestaat voornamelijk uit koolwaterstoffen, C8 tot en met C10, met een kooktraject van ongeveer 160 oC tot 180 oC (320 oF tot 356 oF).] |
285-509-8 |
85116-58-1 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-310-00-3 |
aromatische koolwaterstoffen, C8-, afkomstig uit katalytische reforming; Katalytisch gereformde nafta met laag kookpunt; |
295-279-0 |
91995-18-5 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-311-00-9 |
aromatische koolwaterstoffen, C7-12, rijk aan C8; katalytisch gereformde nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door afscheiding uit de platformate-houdende fractie. Bestaat voornamelijk uit aromatische koolwaterstoffen, overwegend C7 tot en met C12 (hoofdzakelijk C8) en kan niet-aromatische koolwaterstoffen bevatten, beide met een kooktraject van ongeveer 130 oC tot 200 oC (266 oF tot 392 oF).] |
297-401-8 |
93571-75-6 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-312-00-4 |
benzine, C5-11-, gestabiliseerde, gereformde, met hoog octaangehalte; katalytisch gereformde nafta met laag kookpunt; - [een complexe verzameling koolwaterstoffen met hoog octaangehalte, verkregen door katalytische dehydrogenering van een overwegend naftenische nafta. Bestaat voornamelijk uit aromaten en niet-aromaten, overwegend C5 tot en met C11, met een kooktraject van ongeveer 45 oC tot 185 oC (113 oF tot 365 oF).] |
297-458-9 |
93572-29-3 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-313-00-X |
koolwaterstoffen, C7-12-, rijk aan C≥9-aromaten, zware fractie uit reforming; katalytisch gereformde nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door afscheiding uit de platformate-houdende fractie. Bestaat voornamelijk uit niet-aromatische koolwaterstoffen, overwegend C7 tot en met C12, met een kooktraject van ongeveer 120 oC tot 210 oC (248 oF tot 380 oF), en uit aromatische koolwaterstoffen, C9 en hoger.] |
297-465-7 |
93572-35-1 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-314-00-5 |
koolwaterstoffen, C5-11-, rijk aan niet-aromaten, lichte fractie uit reforming; katalytisch gereformde nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door afscheiding uit de platformate-houdende fractie. Bestaat voornamelijk uit niet-aromatische koolwaterstoffen, overwegend C5 tot en met C11, met een kooktraject van ongeveer 35 oC tot 125 oC (94 oF tot 257 oF), benzeen en tolueen.] |
297-466-2 |
93572-36-2 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-315-00-0 |
bezinkselolie (aardolie), behandeld met kiezelzuur; bezinkselolie; [een complexe verzameling koolwaterstoffen die wordt verkregen door de behandeling van bezinkselolie met kiezelzuur om sporenbestanddelen en onzuiverheden te verwijderen. Bestaat voornamelijk uit niet-vertakte koolwaterstoffen, overwegend groter dan C12.] |
308-127-6 |
97862-77-6 |
Carc. 1B |
H350 H304 |
GHS08 Dgr |
H350 H304 |
|
|
L |
649-316-00-6 |
nafta (aardolie), lichte thermisch gekraakte; thermisch gekraakte nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van producten van een thermisch kraakproces. Bestaat voornamelijk uit onverzadigde koolwaterstoffen, overwegend C4 tot en met C8, met een kooktraject van ongeveer - 10 oC tot 130 oC (14 oF tot 266 oF).] |
265-075-6 |
64741-74-8 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-317-00-1 |
nafta (aardolie), zware thermisch gekraakte; thermisch gekraakte nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van de producten van een thermisch kraakproces. Bestaat voornamelijk uit onverzadigde koolwaterstoffen, overwegend C6 tot en met C12, met een kooktraject van ongeveer 65 oC tot 220 oC (148 oF tot 428 oF).] |
265-085-0 |
64741-83-9 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-318-00-7 |
destillaten (aardolie), zware aromatische fractie; thermisch gekraakte nafta met laag kookpunt; [de complexe verzameling koolwaterstoffen, verkregen door destillatie van de producten van het thermisch kraken van ethaan en propaan. Deze bij hogere temperaturen kokende fractie bestaat voornamelijk uit C5-7-aromatische koolwaterstoffen met enkele onverzadigde alifatische koolwaterstoffen, overwegend C5. Deze stroom kan benzeen bevatten.] |
267-563-4 |
67891-79-6 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-319-00-2 |
destillaten (aardolie), lichte aromatische fractie; thermisch gekraakte nafta met laag kookpunt; [de complexe verzameling koolwaterstoffen, verkregen door destillatie van de producten van het thermisch kraken van ethaan en propaan. Deze bij lagere temperaturen kokende fractie bestaat voornamelijk uit C5-7-aromatische koolwaterstoffen met enkele onverzadigde alifatische koolwaterstoffen, overwegend C5. Deze stroom kan benzeen bevatten.] |
267-565-5 |
67891-80-9 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
HS08 Dgr |
H350 H340 H304 |
|
|
P |
649-320-00-8 |
destillaten (aardolie), afkomstig van pyrolysaat van naftaraffinaat, benzinemenging; thermisch gekraakte nafta met laag kookpunt; [de complexe verzameling koolwaterstoffen, verkregen door pyrolysefractionering bij 816 oC (1 500 oF) van nafta en raffinaat. Bestaat voornamelijk uit C9-koolwaterstoffen die koken bij ongeveer 204 oC (400 oF).] |
270-344-6 |
68425-29-6 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-321-00-3 |
aromatische koolwaterstoffen, C6-8-, afkomstig van pyrolysaat van naftaraffinaat; thermisch gekraakte nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen uit de fractioneringspyrolyse bij 816 oC (1 500 oF) van nafta en raffinaat. Bestaat voornamelijk uit aromatische koolwaterstoffen, overwegend C6 tot en met C8, inclusief benzeen.] |
270-658-3 |
68475-70-7 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-322-00-9 |
destillaten (aardolie), thermisch gekraakte nafta en gasolie; thermisch gekraakte nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van thermisch gekraakte nafta en/of gasolie. Bestaat voornamelijk uit olefinekoolwaterstoffen (C5), met een kooktraject van ongeveer 33 oC tot 60 oC (91 oF tot 140 oF).] |
271-631-9 |
68603-00-9 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-323-00-4 |
destillaten (aardolie), thermisch gekraakte nafta en gasolie, C5-dimeer bevattend; thermisch gekraakte nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door extractieve destillatie van thermisch gekraakte nafta en/of gasolie. Bestaat voornamelijk uit C5-koolwaterstoffen, met enkele gedimeriseerde C5-olefinen, met een kooktraject van ongeveer 33 oC tot 184 oC (91 oF tot 363 oF).] |
271-632-4 |
68603-01-0 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-324-00-X |
destillaten (aardolie), thermisch gekraakte nafta en gasolie, extractieve; thermisch gekraakte nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door extractieve destillatie van thermisch gekraakte nafta en/of gasolie. Bestaat uit paraffine- en olefinekoolwaterstoffen, overwegend isoamylenen zoals 2-methyl-1-buteen en 2-methyl-2-buteen, met een kooktraject van ongeveer 31 oC tot 40 oC (88 oF tot 104 oF).] |
271-634-5 |
68603-03-2 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-325-00-5 |
destillaten (aardolie), lichte thermisch gekraakte, gedebutaniseerde aromatische; thermisch gekraakte nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van producten van een thermisch kraakproces. Bestaat voornamelijk uit aromatische koolwaterstoffen, overwegend benzeen.] |
273-266-0 |
68955-29-3 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-326-00-0 |
nafta (aardolie), lichte thermisch gekraakte, stankvrij gemaakt; thermisch gekraakte nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door het onderwerpen van een aardoliedestillaat, afkomstig uit het thermisch kraken bij hoge temperatuur van zware oliefracties, aan een stankverwijderingsproces om mercaptanen om te zetten. Bestaat voornamelijk uit aromaten, olefinen en verzadigde koolwaterstoffen en heeft een kooktraject van ongeveer 20 oC tot 100 oC (68 oF tot 212 oF).] |
295-447-3 |
92045-65-3 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-327-00-6 |
nafta (aardolie), met waterstof behandelde zware; gehydrogeneerde nafta met laag kookpunkt; [een complexe verzameling koolwaterstoffen, verkregen door het behandelen van een aardoliefractie met waterstof in aanwezigheid van een katalysator. Bestaat uit koolwaterstoffen, overwegend C6 tot en met C13, met een kooktraject van ongeveer 65 oC tot 230 oC (149 oF tot 446 oF).] |
265-150-3 |
64742-48-9 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-328-00-1 |
nafta (aardolie), met waterstof behandelde lichte; gehydrogeneerde nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door het behandelen van een aardoliefractie met waterstof in aanwezigheid van een katalysator. Bestaat uit koolwaterstoffen, overwegend C4 tot en met C11, met een kooktraject van ongeveer - 20 oC tot 190 oC (– 4 oF tot 374 oF).] |
265-151-9 |
64742-49-0 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-329-00-7 |
nafta (aardolie), met waterstof ontzwavelde lichte; gehydrogeneerde nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door katalytische waterstofontzwaveling. Bestaat uit koolwaterstoffen, overwegend C4 tot en met C11, met een kooktraject van ongeveer - 20 oC tot 190 oC (– 4 oF tot 374 oF).] |
265-178-6 |
64742-73-0 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-330-00-2 |
nafta (aardolie), met waterstof ontzwavelde zware; gehydrogeneerde nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door katalytische waterstofontzwaveling. Bestaat uit koolwaterstoffen, overwegend C7 tot en met C12, met een kooktraject van ongeveer 90 oC tot 230 oC (194 oF tot 446 oF).] |
265-185-4 |
64742-82-1 |
Carc. 1B Muta. 1B STOT RE 1 Asp. Tox. 1 |
H350 H340 H372 (centraal zenuwstelsel) H304 |
GHS08 Dgr |
H350 H340 H372 (centraal zenuwstelsel) H304 |
|
|
P |
649-331-00-8 |
destillaten (aardolie), met waterstof behandelde middenfracties, bij middentemperaturen kokend; gehydrogeneerde nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van producten uit de waterstofbehandeling van middendestillaat. Bestaat uit koolwaterstoffen, overwegend C5 tot en met C10, met een kooktraject van ongeveer 127 oC tot 188 oC (262 oF tot 370 oF).] |
270-092-7 |
68410-96-8 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-332-00-3 |
destillaten (aardolie), met waterstof behandelde lichte fracties, bij lage temperaturen kokend; gehydrogeneerde nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van producten uit de waterstofbehandeling van licht destillaat. Bestaat uit koolwaterstoffen, overwegend C6 tot en met C9, met een kooktraject van ongeveer 3 oC tot 194 oC (37 oF tot 382 oF).] |
270-093-2 |
68410-97-9 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-333-00-9 |
destillaten (aardolie), met waterstof behandelde zware nafta, deïsohexanisator-topproducten; gehydrogeneerde nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van producten uit de waterstofbehandeling van zware nafta. Bestaat uit koolwaterstoffen, overwegend C3 tot en met C6, met een kooktraject van ongeveer - 49 oC tot 68 oC (– 57 oF tot 155 oF).] |
270-094-8 |
68410-98-0 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-334-00-4 |
oplosmiddelnafta (aardolie), lichte aromatische, met waterstof behandeld; gehydrogeneerde nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door het behandelen van een aardoliefractie met waterstof in aanwezigheid van een katalysator. Bestaat voornamelijk uit aromatische koolwaterstoffen, overwegend C8 tot en met C10, met een kooktraject van ongeveer 135 oC tot 210 oC (275 oF tot 410 oF).] |
270-988-8 |
68512-78-7 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-335-00-X |
nafta (aardolie), met waterstof ontzwavelde thermisch gekraakte lichte fractie; gehydrogeneerde nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door fractionering van met waterstof ontzwaveld thermisch gekraakt destillaat. Bestaat voornamelijk uit koolwaterstoffen, overwegend C5 tot en met C11, met een kooktraject van ongeveer 23 oC tot 195 oC (73 oF tot 383 oF). |
285-511-9 |
85116-60-5 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-336-00-5 |
nafta (aardolie), met waterstof behandelde lichte fractie, cycloalkaan bevattend; gehydrogeneerde nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van een aardoliefractie. Bestaat voornamelijk uit alkanen en cycloalkanen, met een kooktraject van ongeveer - 20 oC tot 190 oC (– 4 oF tot 374 oF).] |
285-512-4 |
85116-61-6 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-337-00-0 |
nafta (aardolie), met stoom gekraakte zware fractie, gehydrogeneerd; gehydrogeneerde nafta met laag kookpunt |
295-432-1 |
92045-51-7 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-338-00-6 |
nafta (aardolie), met waterstof ontzwaveld, totaalfractie; gehydrogeneerde nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door katalytische waterstofontzwaveling. Bestaat voornamelijk uit koolwaterstoffen, overwegend C4 tot en met C11, met een kooktraject van ongeveer 30 oC tot 250 oC (86 oF tot 482 oF). |
295-433-7 |
92045-52-8 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-339-00-1 |
nafta (aardolie), met stoom gekraakte lichte fractie, met waterstof behandeld; gehydrogeneerde nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door waterstofbehandeling van een aardoliefractie, afkomstig uit een pyrolyseproces, in aanwezigheid van een katalysator. Bestaat voornamelijk uit onverzadigde koolwaterstoffen, overwegend C5 tot en met C11, met een kooktraject van ongeveer 35 oC tot 190 oC (95 oF tot 374 oF).] |
295-438-4 |
92045-57-3 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-340-00-7 |
koolwaterstoffen, C4-12-, naftakraken, met waterstof behandeld; gehydrogeneerde nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van het product uit een nafta-stoomkraakproces, gevolgd door katalytische selectieve hydrogenering van gomvormers. Bestaat uit koolwaterstoffen, overwegend C4 tot en met C12, met een kooktraject van ongeveer 30 oC tot 230 oC (86 oF tot 446 oF).] |
295-443-1 |
92045-61-9 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-341-00-2 |
oplosmiddelnafta (aardolie), met waterstof behandelde lichte naftenische; gehydrogeneerde nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door het behandelen van een aardoliefractie met waterstof in aanwezigheid van een katalysator. Bestaat voornamelijk uit cycloparaffinekoolwaterstoffen, overwegend C6 tot en met C7, met een kooktraject van ongeveer 73 oC tot 85 oC (163 oF tot 185 oF).] |
295-529-9 |
92062-15-2 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-342-00-8 |
nafta (aardolie), met stoom gekraakte lichte, gehydrogeneerd; gehydrogeneerde nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen door scheiding en daaropvolgende hydrogenering van de producten van een stoomkraakproces om ethyleen te produceren. Bestaat voornamelijk uit verzadigde en onverzadigde paraffinen, cyclische paraffinen en cyclische aromatische koolwaterstoffen, overwegend C4 tot en met C10, met een kooktraject van ongeveer 50 oC tot 200 oC (122 oF tot 392 oF). Het aandeel van benzeenkoolwaterstoffen kan oplopen tot 30 gewichtsprocent en de stroom kan ook kleine hoeveelheden zwavel- en zuurstofverbindingen bevatten.] |
296-942-7 |
93165-55-0 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-343-00-3 |
koolwaterstoffen, C6-11-, met waterstof behandeld, gedearomatiseerd; gehydrogeneerde nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen als oplosmiddelen die zijn onderworpen aan een waterstofbehandeling teneinde aromaten door katalytische hydrogenering om te zetten in naftenen.] |
297-852-0 |
93763-33-8 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-344-00-9 |
koolwaterstoffen, C9-12-, met waterstof behandeld, gedearomatiseerd; gehydrogeneerde nafta met laag kookpunt; [een complexe verzameling koolwaterstoffen, verkregen als oplosmiddelen die zijn onderworpen aan een waterstofbehandeling teneinde aromaten door katalytische hydrogenering om te zetten in naftenen.] |
297-853-6 |
93763-34-9 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-345-00-4 |
Stoddard-oplosmiddel; nafta met laag kookpunt – niet gespecificeerd [een kleurloos, geraffineerd aardoliedestillaat, vrij van ranzige of onaangename geuren, met een kooktraject van ongeveer 148,8 oC tot 204,4 oC (300 oF tot 400 oF).] |
232-489-3 |
8052-41-3 |
Carc. 1B Muta. 1B STOT RE 1 Asp. Tox. 1 |
H350 H340 H372 (centraal zenuwstelsel) H304 |
GHS08 Dgr |
H350 H340 H372 (centraal zenuwstelsel) H304 |
|
|
P |
649-346-00-X |
aardgascondensaten (aardolie); nafta met laag kookpunt — niet gespecificeerd; [een complexe verzameling koolwaterstoffen, in een oppervlakteseparator door middel van retrograde condensatie als vloeistof afgescheiden van aardgas. Bestaat voornamelijk uit koolwaterstoffen, overwegend C2 tot en met C20.] Vloeibaar bij atmosferische temperatuur en druk.] |
265-047-3 |
64741-47-5 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-347-00-5 |
aardgas (aardolie), ruw vloeibaar mengsel; nafta met laag kookpunt — niet gespecificeerd; [een complexe verzameling koolwaterstoffen, in een gasrecyclinginstallatie door processen als afkoeling en absorptie als vloeistof afgescheiden van aardgas. Bestaat voornamelijk uit verzadigde alifatische koolwaterstoffen, C2 tot en met C8.] |
265-048-9 |
64741-48-6 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-348-00-0 |
nafta (aardolie), lichte waterstofgekraakte; nafta met laag kookpunt — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van de producten van een waterstofkraakproces. Bestaat voornamelijk uit verzadigde koolwaterstoffen, overwegend C4 tot en met C10, met een kooktraject van ongeveer - 20 oC tot 180 oC (– 4 oF tot 356 oF).] |
265-071-4 |
64741-69-1 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-349-00-6 |
nafta (aardolie), zware waterstofgekraakte; nafta met laag kookpunt — niet gespecificeerd; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van de producten van een waterstofkraakproces. Bestaat voornamelijk uit verzadigde koolwaterstoffen, overwegend C6 tot en met C12, met een kooktraject van ongeveer 65 oC tot 230 oC (148 oF tot 446 oF).] |
265-079-8 |
64741-78-2 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-350-00-1 |
nafta (aardolie), stankvrij gemaakt; nafta met laag kookpunt — niet gespecificeerd; [een complexe verzameling koolwaterstoffen, verkregen door het onderwerpen van een aardolienafta aan een stankverwijderingsproces om mercaptanen om te zetten of zure verontreinigingen te verwijderen. Bestaat uit koolwaterstoffen, overwegend C4 tot en met C12, met een kooktraject van ongeveer - 10 oC tot 230 oC (14 oF tot 446 oF).] |
265-089-2 |
64741-87-3 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-351-00-7 |
nafta (aardolie), met zuur behandeld; nafta met laag kookpunt — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen als raffinaat uit een zwavelzuurbehandeling. Bestaat uit koolwaterstoffen, overwegend C7 tot en met C12, met een kooktraject van ongeveer 90 oC tot 230 oC (194 oF tot 446 oF).] |
265-115-2 |
64742-15-0 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-352-00-2 |
nafta (aardolie), chemisch geneutraliseerde zware; nafta met laag kookpunt — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen door een behandeling om zure materialen te verwijderen. Bestaat uit koolwaterstoffen, overwegend C6 tot en met C12, met een kooktraject van ongeveer 65 oC tot 230 oC (149 oF tot 446 oF).] |
265-122-0 |
64742-22-9 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-353-00-8 |
nafta (aardolie), chemisch geneutraliseerde lichte; nafta met laag kookpunt — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen door een behandeling om zure materialen te verwijderen. Bestaat uit koolwaterstoffen, overwegend C4 tot en met C11, met een kooktraject van ongeveer - 20 oC tot 190 oC (– 4 oF tot 374 oF).] |
265-123-6 |
64742-23-0 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-354-00-3 |
nafta (aardolie), katalytisch van was ontdaan; nafta met laag kookpunt — niet gespecificeerd; [een complexe verzameling koolwaterstoffen, verkregen door het katalytisch van was ontdoen van een aardoliefractie. Bestaat voornamelijk uit koolwaterstoffen, overwegend C5 tot en met C12, met een kooktraject van ongeveer 35 oC tot 230 oC (95 oF tot 446 oF). |
265-170-2 |
64742-66-1 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-355-00-9 |
nafta (aardolie), lichte stoomgekraakte; nafta met laag kookpunt — niet gespecificeerd; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van de producten van een stoomkraakproces. Bestaat voornamelijk uit onverzadigde alifatische koolwaterstoffen, overwegend C4 tot en met C11, met een kooktraject van ongeveer - 20 oC tot 190 oC (– 4 oF tot 374 oF).] Deze stroom bevat waarschijnlijk 10 of meer volumeprocent benzeen.] |
265-187-5 |
64742-83-2 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-356-00-4 |
oplosmiddelnafta (aardolie), lichte aromatische; nafta met laag kookpunt — niet gespecificeerd; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van aromatische stromen. Bestaat voornamelijk uit aromatische koolwaterstoffen, overwegend C8 tot en met C10, met een kooktraject van ongeveer 135 oC tot 210 oC (275 oF tot 410 oF). |
265-199-0 |
64742-95-6 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-357-00-X |
aromatische koolwaterstoffen, C6-10-, met zuur behandeld, geneutraliseerd; nafta met laag kookpunt — niet gespecifieerd |
268-618-5 |
68131-49-7 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-358-00-5 |
destillaten (aardolie), C3-5-, rijk aan 2-methyl-2-buteen; nafta met laag kookpunt — niet gespecificeerd; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van koolwaterstoffen, meestal C3 tot en met C5, overwegend isopentaan en 3-methyl-1-buteen. Bestaat uit verzadigde en onverzadigde koolwaterstoffen, C3 tot en met C5, overwegend 2-methyl-2-buteen.] |
270-725-7 |
68477-34-9 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-359-00-0 |
destillaten (aardolie), gepolymeriseerde stoomgekraakte aardoliedestillaten, C5-12-fractie; nafta met laag kookpunt — niet gespecificeerd; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van gepolymeriseerd stoomgekraakt aardoliedestillaat. Bestaat voornamelijk uit koolwaterstoffen, overwegend C5 tot en met C12.] |
270-735-1 |
68477-50-9 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-360-00-6 |
destillaten (aardolie), stoomgekraakt, C5-12-fractie; nafta met laag kookpunt — niet gespecificeerd; [een complexe verzameling organische verbindingen, verkregen door destillatie van producten uit een stoomkraakproces. Bestaat uit onverzadigde koolwaterstoffen, overwegend C5 tot en met C12.] |
270-736-7 |
68477-53-2 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-361-00-1 |
destillaten (aardolie), stoomgekraakt, C5-10-fractie, gemengd met lichte stoomgekraakte aardolienafta-C5-fractie; nafta met laag kookpunt — niet gespecificeerd |
270-738-8 |
68477-55-4 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-362-00-7 |
extracten (aardolie), koud zuur, C4-6; nafta met laag kookpunt — niet gespecifieerd; [een complexe verzameling organische verbindingen, gevormd door de extractie met koud zuur van verzadigde en onverzadigde alifatische koolwaterstoffen, meestal C3 tot en met C6, overwegend pentanen en amylenen. Bestaat voornamelijk uit verzadigde en onverzadigde koolwaterstoffen, C4 tot en met C6, overwegend C5.] |
270-741-4 |
68477-61-2 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-363-00-2 |
destillaten (aardolie), pentaanverwijdering, topproducten; nafta met laag kookpunt — niet gespecificeerd; [een complexe verzameling koolwaterstoffen, verkregen uit een katalytisch gekraakte gasstroom. Bestaat uit alifatische koolwaterstoffen, overwegend C4 tot en met C6.] |
270-771-8 |
68477-89-4 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-364-00-8 |
residuen (aardolie), butaansplitter-bodemfracties; nafta met laag kookpunt — niet gespecificeerd; [een complex residu, afkomstig uit de destillatie van een butaanstroom. Bestaat uit alifatische koolwaterstoffen, overwegend C4 tot en met C6.] |
270-791-7 |
68478-12-6 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-365-00-3 |
residuoliën (aardolie), deïsobutanisatortoren; nafta met laag kookpunt — niet gespecificeerd; [een complex residu, afkomstig uit de atmosferische destillatie van de butaan-butyleenstroom. Bestaat uit alifatische koolwaterstoffen, overwegend C4 tot en met C6.] |
270-795-9 |
68478-16-0 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-366-00-9 |
nafta (aardolie), totaalfractie verkookser; nafta met laag kookpunt — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van producten uit een wervelbedverkookser. Bestaat voornamelijk uit onverzadigde koolwaterstoffen, overwegend C4 tot en met C15, met een kooktraject van ongeveer 43 oC tot 250 oC (110 oF tot 500 oF).] |
270-991-4 |
68513-02-0 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-367-00-4 |
nafta (aardolie), stoomgekraakte aromatische middenfracties; nafta met laag kookpunt — niet gespecificeerd; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van producten uit een stoomkraakproces. Bestaat voornamelijk uit aromatische koolwaterstoffen, overwegend C7 tot en met C12, met een kooktraject van ongeveer 130 oC tot 220 oC (266 oF tot 428 oF).] |
271-138-9 |
68516-20-1 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-368-00-X |
nafta (aardolie), met klei behandelde totaalfractie direct door fractionering verkregen; nafta met laag kookpunt — niet gespecificeerd; [een complexe verzameling koolwaterstoffen die wordt verkregen uit de behandeling van de totaalfractie van direct door fractionering verkregen nafta met natuurlijke of gemodificeerde klei, meestal in een percolatieproces, om de aanwezige sporen polaire verbindingen en verontreinigingen te verwijderen. Bestaat uit koolwaterstoffen, overwegend C4 tot en met C11, met een kooktraject van ongeveer - 20 oC tot 220 oC (– 4 oF tot 429 oF).] |
271-262-3 |
68527-21-9 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-369-00-5 |
nafta (aardolie), met klei behandelde lichte direct door fractionering verkregen; nafta met laag kookpunt — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen door de behandeling van lichte direct door fractionering verkregen nafta met natuurlijke of gemodificeerde klei, meestal in een percolatieproces, om de aanwezige sporen polaire verbindingen en verontreinigingen te verwijderen. Bestaat uit koolwaterstoffen, overwegend C7 tot en met C10, met een kooktraject van ongeveer 93 oC tot 180 oC (200 oF tot 356 oF).] |
271-263-9 |
68527-22-0 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-370-00-0 |
nafta (aardolie), lichte stoomgekraakte aromatische; nafta met laag kookpunt — niet gespecificeerd; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van producten uit een stoomkraakproces. Bestaat voornamelijk uit aromatische koolwaterstoffen, overwegend C7 tot en met C9, met een kooktraject van ongeveer 110 oC tot 165 oC (230 oF tot 329 oF).] |
271-264-4 |
68527-23-1 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-371-00-6 |
nafta (aardolie), lichte stoomgekraakte, van benzeen ontdaan; nafta met laag kookpunt — niet gespecificeerd; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van producten uit een stoomkraakproces. Bestaat voornamelijk uit koolwaterstoffen, overwegend C4 tot en met C12, met een kooktraject van ongeveer 80 oC tot 218 oC (176 oF tot 424 oF).] |
271-266-5 |
68527-26-4 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-372-00-1 |
nafta (aardolie), aromaathoudend; nafta met laag kookpunt — niet gespecifieerd; |
271-635-0 |
68603-08-7 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-373-00-7 |
benzine, pyrolyse, butaanverwijdering bodemfracties; nafta met laag kookpunt — niet gespecificeerd; [een complexe verzameling koolwaterstoffen, verkregen door fractionering van propaanverwijdering-bodemfracties. Bestaat uit koolwaterstoffen, overwegend groter dan C5.] |
271-726-5 |
68606-10-0 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-374-00-2 |
nafta (aardolie), lichte, stankvrij gemaakt; nafta met laag kookpunt — niet gespecificeerd; [een complexe verzameling koolwaterstoffen, verkregen door het onderwerpen van een aardoliedestillaat aan een stankverwijderingsproces om mercaptanen om te zetten of zure verontreinigingen te verwijderen. Bestaat voornamelijk uit verzadigde en onverzadigde koolwaterstoffen, overwegend C3 tot en met C6, met een kooktraject van ongeveer - 20 oC tot 100 oC (– 4 oF tot 212 oF).] |
272-206-0 |
68783-66-4 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-375-00-8 |
aardgascondensaten; nafta met laag kookpunt — niet gespecificeerd; [een complexe verzameling koolwaterstoffen, afgescheiden en/of gecondenseerd uit aardgas tijdens het vervoer en verzameld bij de putmond en/of uit de productie-, verzamel-, transport- en distributiepijpleidingen in putten, gaswassers, enz. Bestaat voornamelijk uit koolwaterstoffen, overwegend C2 tot en met C8.] |
272-896-3 |
68919-39-1 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-376-00-3 |
destillaten (aardolie), nafta-unifiner-stripper; nafta met laag kookpunt — niet gespecificeerd; [een complexe verzameling koolwaterstoffen, verkregen door strippen van de producten uit de nafta-unifiner. Bestaat uit verzadigde alifatische koolwaterstoffen, overwegend C2 tot en met C6.] |
272-932-8 |
68921-09-5 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-377-00-9 |
nafta (aardolie), katalytisch gereformde lichte, aromaatvrije fractie; nafta met laag kookpunt — niet gespecificeerd; [een complexe verzameling koolwaterstoffen, overblijvend na de verwijdering van aromatische verbindingen uit katalytisch gereformde lichte nafta bij een selectief absorptieproces. Bestaat voornamelijk uit paraffinische en cyclische verbindingen, overwegend C5 tot en met C8, met een kooktraject van ongeveer 66 oC tot 121 oC (151 oF tot 250 oF).] |
285-510-3 |
85116-59-2 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-378-00-4 |
benzine; nafta met laag kookpunt — niet gespecificeerd; [een complexe verzameling koolwaterstoffen die voornamelijk is samengesteld uit paraffinen, cycloparaffinen, aromaat- en olefinekoolwaterstoffen, overwegend groter dan C3 en met een kooktraject van 30 oC tot 260 oC (86 oF tot 500 oF).] |
289-220-8 |
86290-81-5 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-379-00-X |
aromatische koolwaterstoffen, C7-8-, dealkyleringsproducten, destillatieresiduen; nafta met laag kookpunt — niet gespecifieerd |
292-698-0 |
90989-42-7 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-380-00-5 |
koolwaterstoffen, C4-6-, lichte fracties pentaanverwijdering, aromatische waterstofbehandelaar; nafta met laag kookpunt — niet gespecificeerd; [een complexe verzameling koolwaterstoffen, verkregen als eerste fracties uit de pentaanverwijderingkolom, voorafgaand aan de waterstofbehandeling van de aromatische belading. Bestaat voornamelijk uit koolwaterstoffen, overwegend C4 tot en met C6, vooral pentanen en pentenen, met een kooktraject van ongeveer 25 oC tot 40 oC (77 oF tot 104 oF).] |
295-298-4 |
91995-38-9 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-381-00-0 |
destillaten (aardolie), hitteverzadigde stoomgekraakte nafta, rijk aan C5; nafta met laag kookpunt — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van hitteverzadigde stoomgekraakte nafta. Bestaat voornamelijk uit koolwaterstoffen, C4 tot en met C6, overwegend C5.] |
295-302-4 |
91995-41-4 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-382-00-6 |
extracten (aardolie), oplosmiddel-, katalytisch gereformde lichte nafta; nafta met laag kookpunt — niet gespecificeerd; [een complexe verzameling koolwaterstoffen, verkregen als extract uit de oplosmiddelextractie van een katalytisch gereformde aardoliefractie. Bestaat voornamelijk uit aromatische koolwaterstoffen, overwegend C7 tot en met C8, met een kooktraject van ongeveer 100 oC tot 200 oC (212 oF tot 392 oF). |
295-331-2 |
91995-68-5 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-383-00-1 |
nafta (aardolie), met waterstof ontzwavelde lichte, gedearomatiseerd; nafta met laag kookpunt — niet gespecificeerd; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van met waterstof ontzwavelde en gedearomatiseerde lichte aardoliefracties. Bestaat voornamelijk uit C7-paraffinen en -cycloparaffinen met een kooktraject van ongeveer 90 oC tot 100 oC (194 oF tot 212 oF).] |
295-434-2 |
92045-53-9 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-384-00-7 |
nafta (aardolie), lichte, rijk aan C5, stankvrij gemaakt; nafta met laag kookpunt — niet gespecificeerd; [een complexe verzameling koolwaterstoffen, verkregen door het onderwerpen van een aardolienafta aan een stankverwijderingsproces om mercaptanen om te zetten of zure verontreinigingen te verwijderen. Bestaat uit koolwaterstoffen, overwegend C4 tot en met C5, voornamelijk C5, met een kooktraject van ongeveer - 10 oC tot 35 oC (14 oF tot 95 oF).] |
295-442-6 |
92045-60-8 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-385-00-2 |
koolwaterstoffen, C8-11-, naftakraken, tolueenfractie; nafta met laag kookpunt — niet gespecificeerd; [een complexe verzameling koolwaterstoffen, verkregen door destillatie uit voorgehydrogeneerde gekraakte nafta. Bestaat voornamelijk uit koolwaterstoffen, overwegend C8 tot en met C11, met een kooktraject van ongeveer 130 oC tot 205 oC (266 oF tot 401 oF).] |
295-444-7 |
92045-62-0 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-386-00-8 |
koolwaterstoffen, C4-11-, naftakraken, aromaatvrij; nafta met laag kookpunt — niet gespecificeerd; [een complexe verzameling koolwaterstoffen, verkregen uit voorgehydrogeneerde gekraakte nafta na destillatiescheiding van benzeen- en tolueenhoudende koolwaterstoffracties en een hoger kokende fractie. Bestaat uit koolwaterstoffen, overwegend C4 tot en met C11, met een kooktraject van ongeveer 30 oC tot 205 oC (86 oF tot 401 oF).] |
295-445-2 |
92045-63-1 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-387-00-3 |
nafta (aardolie), lichte hitteverzadigde, stoomgekraakt; nafta met laag kookpunt — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen door fractionering van stoomgekraakte nafta na terugwinning uit een hitteverzadigingsproces. Bestaat voornamelijk uit koolwaterstoffen, overwegend C4 tot en met C6, met een kooktraject van ongeveer 0 oC tot 80 oC (32 oF tot 176 oF).] |
296-028-8 |
92201-97-3 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-388-00-9 |
destillaten (aardolie), rijk aan C6; nafta met laag kookpunt — niet gespecificeerd; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van een aardoliegrondstof. Bestaat voornamelijk uit koolwaterstoffen, C5 tot en met C7, rijk aan C6, met een kooktraject van ongeveer 60 oC tot 70 oC (140 oF tot 158 oF).] |
296-903-4 |
93165-19-6 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-389-00-4 |
benzine, pyrolyse, gehydrogeneerd; nafta met laag kookpunt — niet gespecifieerd; [een destillatiefractie, verkregen door hydrogenering van pyrolysebenzine, met een kooktraject van ongeveer 20 oC tot 200 oC (68 oF tot 392 oF).] |
302-639-3 |
94114-03-1 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-390-00-X |
destillaten (aardolie), stoomgekraakt, gepolymeriseerde C8-12-fractie, lichte destillatiefracties; nafta met laag kookpunt — niet gespecificeerd; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van de gepolymeriseerde C8-12-fractie van stoomgekraakte aardoliedestillaten. Bestaat voornamelijk uit aromatische koolwaterstoffen, overwegend C8 tot en met C12.] |
305-750-5 |
95009-23-7 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-391-00-5 |
extracten (aardolie), zware naftaoplosmiddel-, met klei behandeld; nafta met laag kookpunt — niet gespecificeerd; [een complexe verzameling koolwaterstoffen, verkregen door de behandeling van een zwaar naftaoplosmiddelaardolie-extract met bleekaarde. Bestaat voornamelijk uit koolwaterstoffen, overwegend C6 tot en met C10, met een kooktraject van ongeveer 80 oC tot 180 oC (175 oF tot 356 oF).] |
308-261-5 |
97926-43-7 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-392-00-0 |
nafta (aardolie), lichte stoomgekraakte, van benzeen ontdaan, thermisch behandeld; nafta met laag kookpunt — niet gespecificeerd; [een complexe verzameling koolwaterstoffen, verkregen door behandeling en destillatie van lichte stoomgekraakte aardolienafta, ontdaan van benzeen. Bestaat voornamelijk uit koolwaterstoffen, overwegend C7 tot en met C12, met een kooktraject van ongeveer 95 oC tot 200 oC (203 oF tot 392 oF).] |
308-713-1 |
98219-46-6 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-393-00-6 |
nafta (aardolie), lichte stoomgekraakte, thermisch behandeld; nafta met laag kookpunt — niet gespecificeerd; [een complexe verzameling koolwaterstoffen, verkregen door behandeling en destillatie van lichte stoomgekraakte aardolienafta. Bestaat voornamelijk uit koolwaterstoffen, overwegend C5 tot en met C6, met een kooktraject van ongeveer 35 oC tot 80 oC (95 oF tot 176 oF).] |
308-714-7 |
98219-47-7 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-394-00-1 |
destillaten (aardolie), C7-9-, rijk aan C8, met waterstof ontzwaveld, gedearomatiseerd; nafta met laag kookpunt — niet gespecificeerd; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van een lichte aardoliefractie, met waterstof ontzwaveld en gedearomatiseerd. Bestaat voornamelijk uit koolwaterstoffen, C7 tot en met C9, voornamelijk C8-paraffinen en -cycloparaffinen, met een kooktraject van ongeveer 120 oC tot 130 oC (248 oF tot 266 oF).] |
309-862-5 |
101316-56-7 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-395-00-7 |
koolwaterstoffen, C6-8-, gehydrogeneerde, door sorptie gedearomatiseerde, tolueenraffinage; nafta met laag kookpunt — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen bij de sorptie van tolueen uit een koolwaterstoffractie van gekraakte benzine die in aanwezigheid van een katalysator met waterstof is behandeld. Bestaat voornamelijk uit koolwaterstoffen, overwegend C6 tot en met C8, met een kooktraject van ongeveer 80 oC tot 135 oC (176 oF tot 275 oF).] |
309-870-9 |
101316-66-9 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-396-00-2 |
nafta (aardolie), met waterstof ontzwaveld, totaalfractie uit verkookser; nafta met laag kookpunt — niet gespecificeerd; [een complexe verzameling koolwaterstoffen, verkregen door fractionering van met waterstof ontzwaveld verkookserdestillaat. Bestaat voornamelijk uit koolwaterstoffen, overwegend C5 tot en met C11, met een kooktraject van ongeveer 23 oC tot 196 oC (73 oF tot 385 oF). |
309-879-8 |
101316-76-1 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-397-00-8 |
nafta (aardolie), lichte, stankvrij gemaakt; nafta met laag kookpunt — niet gespecificeerd; [een complexe verzameling koolwaterstoffen, verkregen door het onderwerpen van een aardolienafta aan een stankverwijderingsproces om mercaptanen om te zetten of zure verontreinigingen te verwijderen. Bestaat voornamelijk uit koolwaterstoffen, overwegend C5 tot en met C8, met een kooktraject van ongeveer 20 oC tot 130 oC (68 oF tot 266 oF).] |
309-976-5 |
101795-01-1 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-398-00-3 |
koolwaterstoffen, C3-6-, rijk aan C5, stoomgekraakte nafta; nafta met laag kookpunt — niet gespecificeerd; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van stoomgekraakte nafta. Bestaat voornamelijk uit koolwaterstoffen, C3 tot en met C6, overwegend C5.] |
310-012-0 |
102110-14-5 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-399-00-9 |
koolwaterstoffen, rijk aan C5, dicyclopentadieen bevattend; nafta met laag kookpunt — niet gespecificeerd; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van de producten uit een stoomkraakproces. Bestaat voornamelijk uit C5-koolwaterstoffen en dicyclopentadieen en heeft een kooktraject van ongeveer 30 oC tot 170 oC (86 oF tot 338 oF).] |
310-013-6 |
102110-15-6 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-400-00-2 |
residuen (aardolie), stoomgekraakte lichte, aromatisch; nafta met laag kookpunt — niet gespecificeerd; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van de producten uit stoomkraak- of vergelijkbare processen, na verwijdering van de zeer lichte producten, resulterend in een residu dat begint met koolwaterstoffen groter dan C5. Bestaat voornamelijk uit aromatische koolwaterstoffen groter dan C5 en kookt boven ongeveer 40 oC (104 oF).] |
310-057-6 |
102110-55-4 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-401-00-8 |
koolwaterstoffen, C≥5-, rijk aan C5-6; nafta met laag kookpunt — niet gespecificeerd |
270-690-8 |
68476-50-6 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-402-00-3 |
koolwaterstoffen, rijk aan C5; nafta met laag kookpunt — niet gespecifieerd |
270-695-5 |
68476-55-1 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-403-00-9 |
aromatische koolwaterstoffen, C8-10; nafta met laag kookpunt — niet gespecificeerd |
292-695-4 |
90989-39-2 |
Carc. 1B Muta. 1B Asp. Tox. 1 |
H350 H340 H304 |
GHS08 Dgr |
H350 H340 H304 |
|
|
P |
649-404-00-4 |
kerosine (aardolie); gedestilleerde kerosine; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van ruwe olie. Bestaat uit koolwaterstoffen, overwegend C9 tot en met C16, met een kooktraject van ongeveer 150 oC tot 290 oC (302 oF tot 554 oF).] |
232-366-4 |
8008-20-6 |
Asp. Tox. 1 |
H304 |
GHS08 Dgr |
H304 |
|
|
|
649-405-00-X |
oplosmiddelnafta (aardolie), middenfractie alifatisch; kerosine, uit directe fractionering verkregen; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van ruwe olie of natuurlijke benzine. Bestaat uit koolwaterstoffen, overwegend C9 tot en met C12, met een kooktraject van ongeveer 140 oC tot 220 oC (284 oF tot 428 oF).] |
265-191-7 |
64742-88-7 |
STOT RE 1 Asp. Tox. 1 |
H372 (centraal zenuwstelsel) H304 |
GHS08 Dgr |
H372 (centraal zenuwstelsel) H304 |
|
|
|
649-406-00-5 |
oplosmiddelnafta (aardolie), zware alifatische; gedestilleerde kerosine; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van ruwe olie of natuurlijke benzine. Bestaat voornamelijk uit verzadigde koolwaterstoffen, overwegend C11 tot en met C16, met een kooktraject van ongeveer 190 oC tot 290 oC (374 oF tot 554 oF).] |
265-200-4 |
64742-96-7 |
Asp. Tox. 1 |
H304 |
GHS08 Dgr |
H304 |
|
|
|
649-407-00-0 |
kerosine (aardolie), uit directe fractionering verkregen brede fractie („wide cut”); uit directe fractionering verkregen kerosine; [een complexe verzameling koolwaterstoffen, uit atmosferische destillatie verkregen als een brede-fractie- („wide cut”-)koolwaterstofbrandstof, met een kooktraject van ongeveer 70 oC tot 220 oC (158 oF tot 428 oF).] |
295-418-5 |
92045-37-9 |
Asp. Tox. 1 |
H304 |
GHS08 Dgr |
H304 |
|
|
|
649-408-00-6 |
destillaten (aardolie), stoomgekraakt; gekraakte kerosine; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van de producten van een stoomkraakproces. Bestaat voornamelijk uit onverzadigde koolwaterstoffen, overwegend C7 tot en met C16, met een kooktraject van ongeveer 90 oC tot 290 oC (190 oF tot 554 oF). |
265-194-3 |
64742-91-2 |
Asp. Tox. 1 |
H304 |
GHS08 Dgr |
H304 |
|
|
|
649-409-00-1 |
destillaten (aardolie), gekraakte gestripte stoomgekraakte aardoliedestillaten, C8-10-fractie; gekraakte kerosine; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van stoomgekraakte nafta. Bestaat uit koolwaterstoffen, C8 tot en met C10, met een kooktraject van ongeveer 129 oC tot 194 oC (264 oF tot 382 oF).] |
270-728-3 |
68477-39-4 |
Asp. Tox. 1 |
H304 |
GHS08 Dgr |
H304 |
|
|
|
649-410-00-7 |
destillaten (aardolie), gekraakte gestripte stoomgekraakte aardoliedestillaten, C10-12-fractie; gekraakte kerosine; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van stoomgekraakte nafta. Bestaat voornamelijk uit aromatische koolwaterstoffen, C10 tot en met C12.] |
270-729-9 |
68477-40-7 |
Asp. Tox. 1 |
H304 |
GHS08 Dgr |
H304 |
|
|
|
649-411-00-2 |
destillaten (aardolie), stoomgekraakt, C8-12-fractie; gekraakte kerosine; [een complexe verzameling organische verbindingen, verkregen door destillatie van producten uit een stoomkraakproces. Bestaat voornamelijk uit onverzadigde koolwaterstoffen, overwegend C8 tot en met C12.] |
270-737-2 |
68477-54-3 |
Asp. Tox. 1 |
H304 |
GHS08 Dgr |
H304 |
|
|
|
649-412-00-8 |
kerosine (aardolie), met waterstof ontzwaveld thermisch gekraakt; gekraakte kerosine; [een complexe verzameling koolwaterstoffen, verkregen door fractionering van met waterstof ontzwaveld thermisch gekraakt destillaat. Bestaat voornamelijk uit koolwaterstoffen, overwegend C8 tot en met C16, met een kooktraject van ongeveer 120 oC tot 283 oC (284 oF tot 541 oF).] |
285-507-7 |
85116-55-8 |
Asp. Tox. 1 |
H304 |
GHS08 Dgr |
H304 |
|
|
|
649-413-00-3 |
aromatische koolwaterstoffen, C≥10, stoomkraken, met waterstof behandeld; gekraakte kerosine; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van de producten van een stoomkraakproces, behandeld met waterstof in de aanwezigheid van een katalysator. Bestaat voornamelijk uit aromatische koolwaterstoffen, overwegend groter dan C10, met een kooktraject van ongeveer 150 oC tot 320 oC (302 oF tot 608 oF).] |
292-621-0 |
90640-98-5 |
Asp. Tox. 1 |
H304 |
GHS08 Dgr |
H304 |
|
|
|
649-414-00-9 |
nafta (aardolie), stoomgekraakt, met waterstof behandeld, rijk aan C9-10-aromaten; gekraakte kerosine; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van de producten van een stoomkraakproces, en daarna behandeld met waterstof in de aanwezigheid van een katalysator. Bestaat voornamelijk uit aromatische koolwaterstoffen, C9 tot en met C10, met een kooktraject van ongeveer 140 oC tot 200 oC (284 oF tot 392 oF).] |
292-637-8 |
90641-13-7 |
Asp. Tox. 1 |
H304 |
GHS08 Dgr |
H304 |
|
|
|
649-415-00-4 |
destillaten (aardolie), thermisch gekraakt, rijk aan alkylaromatische koolwaterstoffen; gekraakte kerosine; [een complexe verzameling koolwaterstoffen die wordt verkregen door destillatie van stoomgekraakte zware residuen. Bestaat voornamelijk uit in hoge mate gealkyleerde aromatische koolwaterstoffen met een kooktraject van ongeveer 100 oC tot 250 oC (212 oF tot 482 oF).] |
309-866-7 |
101316-61-4 |
Asp. Tox. 1 |
H304 |
GHS08 Dgr |
H304 |
|
|
|
649-416-00-X |
destillaten (aardolie), lichte uit katalytisch gekraakte zware teer; gekraakte kerosine; [een complexe verzameling koolwaterstoffen die wordt verkregen door destillatie van katalytisch gekraakte zware teer. Bestaat voornamelijk uit in hoge mate gealkyleerde aromatische koolwaterstoffen met een kooktraject van ongeveer 100 oC tot 250 oC (212 oF tot 482 oF).] |
309-938-8 |
101631-13-4 |
Asp. Tox. 1 |
H304 |
GHS08 Dgr |
H304 |
|
|
|
649-417-00-5 |
oplosmiddelnafta (aardolie), waterstofgekraakte zware aromatische; gekraakte kerosine; [een complexe verzameling koolwaterstoffen die wordt verkregen door de destillatie van waterstofgekraakte ruwe aardolie. Bestaat voornamelijk uit koolwaterstoffen, overwegend C9 tot en met C16, met een kooktraject van ongeveer 235 oC tot 290 oC (455 oF tot 554 oF).] |
309-881-9 |
101316-80-7 |
Asp. Tox. 1 |
H304 |
GHS08 Dgr |
H304 |
|
|
|
649-418-00-0 |
destillaten (aardolie), lichte uit stoomgekraakte zware teer; gekraakte kerosine; [een complexe verzameling koolwaterstoffen die wordt verkregen door destillatie van stoomgekraakte zware teer. Bestaat voornamelijk uit in hoge mate gealkyleerde aromatische koolwaterstoffen met een kooktraject van ongeveer 100 oC tot 250 oC (212 oF tot 482 oF).] |
309-940-9 |
101631-15-6 |
Asp. Tox. 1 |
H304 |
GHS08 Dgr |
H304 |
|
|
|
649-419-00-6 |
destillaten (aardolie), gealkyleerd; kerosine — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van de reactieproducten van isobutaan met enkelvoudig onverzadigde koolwaterstoffen, overwegend C3 tot en met C5. Bestaat voornamelijk uit verzadigde koolwaterstoffen met vertakte keten, overwegend C11 tot en met C17, met een kooktraject van ongeveer 205 oC tot 320 oC (401 oF tot 608 oF).] |
265-074-0 |
64741-73-7 |
Asp. Tox. 1 |
H304 |
GHS08 Dgr |
H304 |
|
|
|
649-420-00-1 |
extracten (aardolie), zware nafta-oplosmiddel; kerosine — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen als extract van een oplosmiddelextractieproces. Bestaat voornamelijk uit aromatische koolwaterstoffen, overwegend C7 tot en met C12, met een kooktraject van ongeveer 90 oC tot 220 oC (194 oF tot 428 oF).] |
265-099-7 |
64741-98-6 |
Asp. Tox. 1 |
H304 |
GHS08 Dgr |
H304 |
|
|
|
649-421-00-7 |
destillaten (aardolie), chemisch geneutraliseerd lichte fractie; kerosine — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen door een behandeling om zure materialen te verwijderen. Bestaat uit koolwaterstoffen, overwegend C9 tot en met C16, met een kooktraject van ongeveer 150 oC tot 290 oC (302 oF tot 554 oF).] |
265-132-5 |
64742-31-0 |
Asp. Tox. 1 |
H304 |
GHS08 Dgr |
H304 |
|
|
|
649-422-00-2 |
destillaten (aardolie), met zuur behandelde lichte fractie; kerosine — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen door het behandelen van een aardoliefractie met waterstof in aanwezigheid van een katalysator. Bestaat uit koolwaterstoffen, overwegend C9 tot en met C16, met een kooktraject van ongeveer 150 oC tot 290 oC (302 oF tot 554 oF).] |
265-149-8 |
64742-47-8 |
Asp. Tox. 1 |
H304 |
GHS08 Dgr |
H304 |
|
|
|
649-423-00-8 |
kerosine (aardolie), met waterstof ontzwaveld; kerosine — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt verkregen uit de aardoliegrondstof door behandeling met waterstof om organische zwavel om te zetten in waterstofsulfide dat wordt verwijderd. Bestaat uit koolwaterstoffen, overwegend C9 tot en met C16, met een kooktraject van ongeveer 150 oC tot 290 oC (302 oF tot 554 oF).] |
265-184-9 |
64742-81-0 |
Asp. Tox. 1 |
H304 |
GHS08 Dgr |
H304 |
|
|
|
649-424-00-3 |
oplosmiddelnafta (aardolie), zware aromatische; kerosine — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van aromatische stromen. Bestaat voornamelijk uit aromatische koolwaterstoffen, overwegend C9 tot en met C16, met een kooktraject van ongeveer 165 oC tot 290 oC (330 oF tot 554 oF).] |
265-198-5 |
64742-94-5 |
Asp. Tox. 1 |
H304 |
GHS08 Dgr |
H304 |
|
|
|
649-425-00-9 |
nafta (aardolie), zware verkookser-; kerosine — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van producten uit een wervelbedverkookser. Bestaat voornamelijk uit onverzadigde koolwaterstoffen, overwegend C6 tot en met C15, met een kooktraject van ongeveer 157 oC tot 288 oC (315 oF tot 550 oF).] |
269-778-9 |
68333-23-3 |
Asp. Tox. 1 |
H304 |
GHS08 Dgr |
H304 |
|
|
|
649-426-00-4 |
nafta (aardolie), katalytisch gereformde met waterstof ontzwavelde zware, aromatische fractie; kerosine — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen door fractionering van katalytisch gereformde, met waterstof ontzwavelde nafta. Bestaat voornamelijk uit aromatische koolwaterstoffen, overwegend C7 tot en met C13, met een kooktraject van ongeveer 98 oC tot 218 oC (208 oF tot 424 oF).] |
285-508-2 |
85116-57-0 |
Asp. Tox. 1 |
H304 |
GHS08-Dgr |
H304 |
|
|
|
649-427-00-X |
kerosine (aardolie), stankvrij gemaakt; kerosine — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen door het onderwerpen van een aardoliedestillaat aan een stankverwijderingsproces om mercaptanen om te zetten of zure verontreinigingen te verwijderen. Bestaat voornamelijk uit koolwaterstoffen, overwegend C9 tot en met C16, met een kooktraject van 130 oC tot 290 oC (266 oF tot 554 oF).] |
294-799-5 |
91770-15-9 |
Asp. Tox. 1 |
H304 |
GHS08 Dgr |
H304 |
|
|
|
649-428-00-5 |
kerosine (aardolie), met oplosmiddel geraffineerde stankvrij gemaakte; kerosine — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt verkregen uit de aardoliegrondstof door raffinage met oplosmiddelen en stankverwijdering, met een kooktraject van ongeveer 150 oC tot 260 oC (302 oF tot 500 oF).] |
295-416-4 |
92045-36-8 |
Asp. Tox. 1 |
H304 |
GHS08 Dgr |
H304 |
|
|
|
649-429-00-0 |
koolwaterstoffen, C9-16-, met waterstof behandeld, gedearomatiseerd; kerosine — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen als oplosmiddelen die zijn onderworpen aan een waterstofbehandeling teneinde aromaten door katalytische hydrogenering om te zetten in naftenen.] |
297-854-1 |
93763-35-0 |
Asp. Tox. 1 |
H304 |
GHS08 Dgr |
H304 |
|
|
|
649-430-00-6 |
kerosine (aardolie), met oplosmiddel geraffineerde met waterstof ontzwavelde; kerosine — niet gespecifieerd |
307-033-2 |
97488-94-3 |
Asp. Tox. 1 |
H304 |
GHS08 Dgr |
H304 |
|
|
|
649-431-00-1 |
destillaten (aardolie), met waterstof ontzwavelde totale middenfractie verkookser-; kerosine — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen door fractionering van met waterstof ontzwaveld verkookserdestillaat. Bestaat voornamelijk uit koolwaterstoffen, overwegend C8 tot en met C16, met een kooktraject van ongeveer 120 oC tot 283 oC (248 oF tot 541 oF).] |
309-864-6 |
101316-58-9 |
Asp. Tox. 1 |
H304 |
GHS08 Dgr |
H304 |
|
|
|
649-432-00-7 |
oplosmiddelnafta (aardolie), met waterstof ontzwavelde zware aromatische; kerosine — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen door de katalytische waterstofontzwaveling van een aardoliefractie. Bestaat voornamelijk uit koolwaterstoffen, overwegend C10 tot en met C13, met een kooktraject van ongeveer 180 oC tot 240 oC (356 oF tot 464 oF).] |
309-882-4 |
101316-81-8 |
Asp. Tox. 1 |
H304 |
GHS08 Dgr |
H304 |
|
|
|
649-433-00-2 |
oplosmiddelnafta (aardolie), met waterstof ontzwavelde tussenfractie; kerosine — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen door de katalytische waterstofontzwaveling van een aardoliefractie. Bestaat voornamelijk uit koolwaterstoffen, overwegend C10 tot en met C13, met een kooktraject van ongeveer 175 oC tot 220 oC (347 oF tot 428 oF).] |
309-884-5 |
101316-82-9 |
Asp. Tox. 1 |
H304 |
GHS08 Dgr |
H304 |
|
|
|
649-434-00-8 |
kerosine (aardolie), met waterstof behandeld; kerosine — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van aardolie gevolgd door waterstofbehandeling. Bestaat voornamelijk uit alkanen, cycloalkanen en alkylbenzenen, overwegend C12 tot en met C16, met een kooktraject van ongeveer 230 oC tot 270 oC (446 oF tot 518 oF). |
309-944-0 |
101631-19-0 |
Asp. Tox. 1 |
H304 |
GHS08 Dgr |
H304 |
|
|
|
649-435-00-3 |
destillaten (aardolie), licht katalytisch gekraakte; gekraakte gasolie; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van producten van een katalytisch kraakproces. Bestaat uit koolwaterstoffen, overwegend C9 tot en met C25, met een kooktraject van ongeveer 150 oC tot 400 oC (302 oF tot 752 oF).] Bevat een relatief grote hoeveelheid bicyclische aromatische koolwaterstoffen.] |
265-060-4 |
64741-59-9 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-436-00-9 |
destillaten (aardolie), middenfractie katalytisch gekraakt; gekraakte gasolie; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van producten van een katalytisch kraakproces. Bestaat uit koolwaterstoffen, overwegend C11 tot en met C30, met een kooktraject van ongeveer 205 oC tot 450 oC (401 oF tot 842 oF).] Bevat een relatief grote hoeveelheid tricyclische aromatische koolwaterstoffen.] |
265-062-5 |
64741-60-2 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-437-00-4 |
destillaten (aardolie), lichte waterstofgekraakte; gekraakte gasolie; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van de producten van een waterstofkraakproces. Bestaat voornamelijk uit verzadigde koolwaterstoffen, overwegend C10 tot en met C18, met een kooktraject van ongeveer 160 oC tot 320 oC (320 oF tot 608 oF).] |
265-078-2 |
64741-77-1 |
Carc. 2 |
H351 |
GHS08 Wng |
H351 |
|
|
|
649-438-00-X |
destillaten (aardolie), licht thermisch gekraakt; gekraakte gasolie; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van de producten van een thermisch kraakproces. Bestaat voornamelijk uit onverzadigde koolwaterstoffen, overwegend C10 tot en met C22, met een kooktraject van ongeveer 160 oC tot 370 oC (320 oF tot 698 oF). |
265-084-5 |
64741-82-8 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-439-00-5 |
destillaten (aardolie), met waterstof ontzwavelde katalytisch gekraakte lichte fracties; gekraakte gasolie; [een complexe verzameling koolwaterstoffen die wordt verkregen door de behandeling van de katalytisch gekraakte lichte destillaatfracties met waterstof om organisch zwavel om te zetten in waterstofsulfide dat verwijderd wordt. Bestaat uit koolwaterstoffen, overwegend C9 tot en met C25, met een kooktraject van ongeveer 150 oC tot 400 oC (302 oF tot 752 oF).] Bevat een relatief grote hoeveelheid bicyclische aromatische koolwaterstoffen.] |
269-781-5 |
68333-25-5 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-440-00-0 |
destillaten (aardolie), lichte stoomgekraakte nafta; gekraakte gasolie; [een complexe verzameling koolwaterstoffen, verkregen uit de meervoudige destillatie van producten uit een stoomkraakproces. Bestaat uit koolwaterstoffen, overwegend C10 tot en met C18.] |
270-662-5 |
68475-80-9 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-441-00-6 |
destillaten (aardolie), gekraakte stoomgekraakte aardoliedestillaten; gekraakte gasolie; [een complexe verzameling koolwaterstoffen, verkregen door het destilleren van gekraakt stoomgekraakt destillaat en/of fractioneringsproducten daarvan. Bestaat uit koolwaterstoffen, overwegend C10 tot polymeren met klein molecuulgewicht.] |
270-727-8 |
68477-38-3 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-442-00-1 |
gasoliën (aardolie), stoomgekraakt; gekraakte gasolie; [een complexe verzameling koolwaterstoffen, verkregen uit de destillatie van producten van een stroomkraakproces. Bestaat uit koolwaterstoffen, overwegend groter dan C9, met een kooktraject van ongeveer 205 oC tot 400 oC (400 oF tot 752 oF).] |
271-260-2 |
68527-18-4 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-443-00-7 |
destillaten (aardolie), met waterstof ontzwavelde thermisch gekraakte middenfractie; gekraakte gasolie; [een complexe verzameling koolwaterstoffen, verkregen door fractionering van met waterstof ontzwavelde thermische krakerdestillaatgrondstoffen. Bestaat voornamelijk uit koolwaterstoffen, overwegend C11 tot C25, met een kooktraject van ongeveer 205 oC tot 400 oC (401 oF tot 752 oF).] |
285-505-6 |
85116-53-6 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-444-00-2 |
gasoliën (aardolie), thermisch gekraakt, met water ontzwaveld; gekraakte gasolie |
295-411-7 |
92045-29-9 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-445-00-8 |
residuen (aardolie), gehydrogeneerde met stoom gekraakte nafta-; gekraakte gasolie; [een complexe verzameling koolwaterstoffen die wordt verkregen als een residufractie uit de destillatie van met waterstof behandelde met stoom gekraakte nafta. Bestaat voornamelijk uit koolwaterstoffen met een kooktraject van ongeveer 200 oC tot 350 oC (392 oC tot 662 oC). |
295-514-7 |
92062-00-5 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-446-00-3 |
residuen (aardolie), stoomgekraakte naftadestillatie; gekraakte gasolie; [een complexe verzameling koolwaterstoffen die wordt verkregen als een kolombodemfractie uit de scheiding van uitstromen uit het stoomkraken van nafta bij hoge temperatuur. Heeft een kooktraject van ongeveer 147 oC tot 300 oC (297 oF tot 572 oF) en vormt een voltooide olie met een viscositeit van 18 cSt bij 50 oC.] |
295-517-3 |
92062-04-9 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-447-00-9 |
destillaten (aardolie), katalytisch gekraakte lichte fracties, thermisch gedesintegreerd; gekraakte gasolie; [een complexe verzameling koolwaterstoffen die wordt gevormd door de destillatie van producten uit een katalytisch kraakproces en die is gebruikt als een warmteoverdrachtsvloeistof. Bestaat voornamelijk uit koolwaterstoffen met een kooktraject van ongeveer 190 oC tot 340 oC (374 oC tot 644 oC). Deze stroom bevat waarschijnlijk organische zwavelverbindingen.] |
295-991-1 |
92201-60-0 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-448-00-4 |
residuen (aardolie), stoomgekraakte hitteverzadigde nafta; gekraakte gasolie; [een complexe verzameling koolwaterstoffen die wordt verkregen als residu uit destillatie van stoomgekraakte hitteverzadigde nafta, met een kooktraject van ongeveer 150 oC tot 350 oC (302 oF tot 662 oF).] |
297-905-8 |
93763-85-0 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-449-00-X |
koolwaterstoffen, C16-20-, met oplosmiddel van was ontdaan waterstofgekraakt paraffinisch destillatieresidu; gekraakte gasolie; [een complexe verzameling koolwaterstoffen, verkregen door het met oplosmiddel van was ontdoen van een waterstofgekraakt paraffinisch destillaat. Bestaat voornamelijk uit koolwaterstoffen, overwegend C16 tot en met C20, met een kooktraject van ongeveer 360 oC tot 500 oC (680 oF tot 932 oF). Vormt een voltooide olie met een viscositeit van 4,5 cSt bij ongeveer 100 oC (212 oF).] |
307-662-2 |
97675-88-2 |
Carc. 2 |
H351 |
GHS08 Wng |
H351 |
|
|
|
649-450-00-5 |
gasoliën (aardolie), lichte vacuüm-, thermisch gekraakt met waterstof ontzwaveld; gekraakte gasolie; [een complexe verzameling koolwaterstoffen die wordt verkregen door katalytische verwijdering van zwavelwaterstofgroepen uit thermisch gekraakte lichte vacuümaardoliefracties. Bestaat voornamelijk uit koolwaterstoffen, overwegend C14 tot en met C20, met een kooktraject van ongeveer 270 oC tot 370 oC (518 oF tot 698 oF). |
308-278-8 |
97926-59-5 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-451-00-0 |
destillaten (aardolie), met waterstof ontzwavelde middenfractie verkookser-; gekraakte gasolie; [een complexe verzameling koolwaterstoffen die wordt verkregen door fractionering van met waterstof ontzwavelde verkookserdestillaatuitgangsstoffen. Bestaat uit koolwaterstoffen, overwegend C12 tot en met C21, met een kooktraject van ongeveer 200 oC tot 360 oC (392 oF tot 680 oF).] |
309-865-1 |
101316-59-0 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-452-00-6 |
destillaten (aardolie), zware stoomgekraakte; gekraakte gasolie; [een complexe verzameling koolwaterstoffen die wordt verkregen door destillatie van stoomgekraakte zware residuen. Bestaat voornamelijk uit in hoge mate gealkyleerde zware aromatische koolwaterstoffen met een kooktraject van ongeveer 250 oC tot 400 oC (482 oF tot 752 oF).] |
309-939-3 |
101631-14-5 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
|
649-453-00-1 |
destillaten (aardolie), zware waterstofgekraakte; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen door destillatie van de producten van een waterstofkraakproces. Bestaat voornamelijk uit verzadigde koolwaterstoffen, C15 tot en met C39, met een kooktraject van ongeveer 260 oC tot 600 oC (500 oF tot 1 112 oF).] |
265-077-7 |
64741-76-0 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-454-00-7 |
destillaten (aardolie), oplosmiddelgeraffineerde zware paraffinische; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen als raffinaat van een oplosmiddelextractieproces. Bestaat voornamelijk uit verzadigde koolwaterstoffen, overwegend C20 tot en met C50, en vormt een voltooide olie met een viscositeit die ten minste 100 SUS bij 100 oF (19 cSt bij 40 oC) bedraagt. |
265-090-8 |
64741-88-4 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-455-00-2 |
destillaten (aardolie), oplosmiddelgeraffineerde lichte paraffinische; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen als raffinaat van een oplosmiddelextractieproces. Bestaat voornamelijk uit verzadigde koolwaterstoffen, overwegend C15 tot en met C30, en vormt een voltooide olie met een viscositeit die kleiner is dan 100 SUS bij 100 oF (19 cSt bij 40 oC). |
265-091-3 |
64741-89-5 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-456-00-8 |
residuoliën (aardolie), met oplosmiddel gedeasfalteerd; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen als de in oplosmiddel oplosbase fractie bij het met C3-C4-oplosmiddel deasfalteren van een residu. Bestaat uit koolwaterstoffen, overwegend groter dan C25, kokend boven ongeveer 400 oC (752 oF).] |
265-096-0 |
64741-95-3 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-457-00-3 |
destillaten (aardolie), met oplosmiddel geraffineerde zware naftenische; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen als raffinaat van een oplosmiddelextractieproces. Bestaat uit koolwaterstoffen, overwegend C20 tot en met C50, en vormt een voltooide olie met een viscositeit die ten minste 100 SUS bij 100 oF (19 cSt bij 40 oC) bedraagt. Bevat relatief weinig normale paraffinen.] |
265-097-6 |
64741-96-4 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-458-00-9 |
destillaten (aardolie), met oplosmiddel geraffineerde lichte naftenische; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen als raffinaat van een oplosmiddelextractieproces. Bestaat uit koolwaterstoffen, overwegend C15 tot en met C30, en vormt een voltooide olie met een viscositeit die kleiner is dan 100 SUS bij 100 oF (19 cSt bij 40 oC). Bevat relatief weinig normale paraffinen.] |
265-098-1 |
64741-97-5 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-459-00-4 |
residuoliën (aardolie), met oplosmiddel geraffineerd; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen als de in oplosmiddel onoplosbare fractie van oplosmiddelraffinering van een residu met behulp van een polair organisch oplosmiddel zoals fenol of furfural. Bestaat uit koolwaterstoffen, overwegend groter dan C25, kokend boven ongeveer 400 oC (752 oF).] |
265-101-6 |
64742-01-4 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-460-00-X |
destillaten (aardolie), met klei behandelde zware paraffinische; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt verkregen door behandeling van een aardoliefractie met een natuurlijke of gemodificeerde klei in een contact- of een percolatieproces waarbij sporen van polaire verbindingen en aanwezige onzuiverheden worden verwijderd. Bestaat uit koolwaterstoffen, overwegend C20 tot en met C50, en vormt een voltooide olie met een viscositeit die ten minste 100 SUS bij 100 oF (19 cSt bij 40 oC) bedraagt. Bevat een relatief grote hoeveelheid verzadigde koolwaterstoffen.] |
265-137-2 |
64742-36-5 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-461-00-5 |
destillaten (aardolie), met klei behandelde lichte paraffinische; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt verkregen door behandeling van een aardoliefractie met een natuurlijke of gemodificeerde klei in een contact- of een percolatieproces waarbij sporen van polaire verbindingen en aanwezige onzuiverheden worden verwijderd. Bestaat uit koolwaterstoffen, overwegend C15 tot en met C30, en vormt een voltooide olie met een viscositeit die kleiner is dan 100 SUS bij 100 oF (19 cSt bij 40 oC). Bevat een relatief grote hoeveelheid verzadigde koolwaterstoffen.] |
265-138-8 |
64742-37-6 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-462-00-0 |
residuoliën (aardolie), met klei behandeld; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen door behandeling van een residuolie met een natuurlijke of gemodificeerde klei in een contact- of een percolatieproces om sporen van polaire verbindingen en aanwezige onzuiverheden te verwijderen. Bestaat uit koolwaterstoffen, overwegend groter dan C25, kokend boven ongeveer 400 oC (752 oF).] |
265-143-5 |
64742-41-2 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-463-00-6 |
destillaten (aardolie), met klei behandeld zware naftenische; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt verkregen door behandeling van een aardoliefractie met een natuurlijke of gemodificeerde klei in een contact- of een percolatieproces waarbij sporen van polaire verbindingen en aanwezige onzuiverheden worden verwijderd. Bestaat uit koolwaterstoffen, overwegend C20 tot en met C50, en vormt een voltooide olie met een viscositeit die ten minste 100 SUS bij 100 oF (19 cSt bij 40 oC) bedraagt. Bevat relatief weinig normale paraffinen.] |
265-146-1 |
64742-44-5 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-464-00-1 |
destillaten (aardolie), met klei behandelde lichte naftenische; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt verkregen door behandeling van een aardoliefractie met een natuurlijke of gemodificeerde klei in een contact- of een percolatieproces waarbij sporen van polaire verbindingen en aanwezige onzuiverheden worden verwijderd. Bestaat uit koolwaterstoffen, overwegend C15 tot en met C30, en vormt een voltooide olie met een viscositeit die kleiner is dan 100 SUS bij 100 oF (19 cSt bij 40 oC). Bevat relatief weinig normale paraffinen.] |
265-147-7 |
64742-45-6 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-465-00-7 |
destillaten (aardolie), met waterstof behandelde zware naftenische; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen door het behandelen van een aardoliefractie met waterstof in aanwezigheid van een katalysator. Bestaat uit koolwaterstoffen, overwegend C20 tot en met C50, en vormt een voltooide olie van ten minste 100 SUS bij 100 oF (19 cSt bij 40 oC). Bevat relatief weinig normale paraffinen.] |
265-155-0 |
64742-52-5 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-466-00-2 |
destillaten (aardolie), met waterstof behandelde lichte naftenische; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen door het behandelen van een aardoliefractie met waterstof in aanwezigheid van een katalysator. Bestaat uit koolwaterstoffen, overwegend C15 tot en met C30, en vormt een voltooide olie met een viscositeit die kleiner is dan 100 SUS bij 100 oF (19 cSt bij 40 oC). Bevat relatief weinig normale paraffinen.] |
265-156-6 |
64742-53-6 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-467-00-8 |
destillaten (aardolie), met waterstof behandelde zware paraffinische; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen door het behandelen van een aardoliefractie met waterstof in aanwezigheid van een katalysator. Bestaat uit koolwaterstoffen, overwegend C20 tot en met C50, en vormt een voltooide olie van ten minste 100 SUS bij 100 oF (19 cSt bij 40 oC). Bevat een relatief grote hoeveelheid verzadigde koolwaterstoffen.] |
265-157-1 |
64742-54-7 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-468-00-3 |
destillaten (aardolie), met waterstof behandelde lichte paraffinische; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen door het behandelen van een aardoliefractie met waterstof in aanwezigheid van een katalysator. Bestaat uit koolwaterstoffen, overwegend C15 tot en met C30, en vormt een voltooide olie met een viscositeit die kleiner is dan 100 SUS bij 100 oF (19 cSt bij 40 oC). Bevat een relatief grote hoeveelheid verzadigde koolwaterstoffen.] |
265-158-7 |
64742-55-8 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-469-00-9 |
destillaten (aardolie), met oplosmiddel van was ontdane lichte paraffinische; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt verkregen door verwijdering van normale paraffinen uit een aardoliefractie door oplosmiddelkristallisatie. Bestaat voornamelijk uit koolwaterstoffen, overwegend C15 tot en met C30, en vormt een voltooide olie met een viscositeit die kleiner is dan 100 SUS bij 100 oF (19 cSt bij 40 oC). |
265-159-2 |
64742-56-9 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-470-00-4 |
residuoliën (aardolie), met waterstof behandeld; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen door het behandelen van een aardoliefractie met waterstof in aanwezigheid van een katalysator. Bestaat uit koolwaterstoffen, overwegend groter dan C25, kokend boven ongeveer 400 oC (752 oF).] |
265-160-8 |
64742-57-0 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-471-00-X |
residuoliën (aardolie), met oplosmiddel van was ontdaan; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen door de verwijdering van lange koolwaterstoffen met vertakte ketens uit een residuolie door middel van oplosmiddelkristallisatie. Bestaat uit koolwaterstoffen, overwegend groter dan C25, kokend boven ongeveer 400 oC (752 oF).] |
265-166-0 |
64742-62-7 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-472-00-5 |
destillaten (aardolie), met oplosmiddel van was ontdane zware naftenische; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt verkregen door verwijdering van normale paraffinen uit een aardoliefractie door oplosmiddelkristallisatie. Bestaat uit koolwaterstoffen, overwegend C20 tot en met C50, en vormt een voltooide olie van niet minder dan 100 SUS bij 100 oF (19 cSt bij 40 oC). Bevat relatief weinig normale paraffinen.] |
265-167-6 |
64742-63-8 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-473-00-0 |
destillaten (aardolie), met oplosmiddel van was ontdane lichte naftenische; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt verkregen door verwijdering van normale paraffinen uit een aardoliefractie door oplosmiddelkristallisatie. Bestaat uit koolwaterstoffen, overwegend C15 tot en met C30, en vormt een voltooide olie met een viscositeit die kleiner is dan 100 SUS bij 100 oF (19 cSt bij 40 oC). Bevat relatief weinig normale paraffinen.] |
265-168-1 |
64742-64-9 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-474-00-6 |
destillaten (aardolie), met oplosmiddel van was ontdane paraffinische; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt verkregen door verwijdering van normale paraffinen uit een aardoliefractie door oplosmiddelkristallisatie. Bestaat voornamelijk uit koolwaterstoffen, overwegend C20 tot en met C50, en vormt een voltooide olie met een viscositeit die niet minder is dan 100 SUS bij 100 oF (19 cSt bij 40 oC). |
265-169-7 |
64742-65-0 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-475-00-1 |
naftenische oliën (aardolie), katalytisch van was ontdane zware; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt verkregen uit een katalytisch wasverwijderingsproces. Bestaat voornamelijk uit koolwaterstoffen, overwegend C20 tot en met C50, en vormt een voltooide olie met een viscositeit die ten minste 100 SUS bij 100 oF (19 cSt bij 40 oC) bedraagt. Bevat relatief weinig normale paraffinen.] |
265-172-3 |
64742-68-3 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-476-00-7 |
naftenische oliën (aardolie), katalytisch van was ontdane lichte; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt verkregen uit een katalytisch wasverwijderingsproces. Bestaat uit koolwaterstoffen, overwegend C15 tot en met C30, en vormt een voltooide olie met een viscositeit die kleiner is dan 100 SUS bij 100 oF (19 cSt bij 40 oC). Bevat relatief weinig normale paraffinen.] |
265-173-9 |
64742-69-4 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-477-00-2 |
paraffinehoudende oliën (aardolie), katalytisch van was ontdane zware; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt verkregen uit een katalytisch wasverwijderingsproces. Bestaat voornamelijk uit koolwaterstoffen, overwegend C20 tot en met C50, en vormt een voltooide olie met een viscositeit die ten minste 100 SUS bij 100 oF (19 cSt bij 40 oC) bedraagt.] |
265-174-4 |
64742-70-7 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-478-00-8 |
paraffineoliën (aardolie), katalytisch van was ontdane lichte; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt verkregen uit een katalytisch wasverwijderingsproces. Bestaat voornamelijk uit koolwaterstoffen, overwegend C15 tot en met C30, en vormt een voltooide olie met een viscositeit die kleiner is dan 100 SUS bij 100 oF (19 cSt bij 40 oC). |
265-176-5 |
64742-71-8 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-479-00-3 |
naftenische oliën (aardolie), complexe van was ontdane zware; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt verkregen door verwijdering van niet-vertakte paraffinekoolwaterstoffen als vaste stof door behandeling met een agens zoals ureum. Bestaat uit koolwaterstoffen, overwegend C20 tot en met C50, en vormt een voltooide olie met een viscositeit die ten minste 100 SUS bij 100 oF (19 cSt bij 40 oC) bedraagt. Bevat relatief weinig normale paraffinen.] |
265-179-1 |
64742-75-2 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-480-00-9 |
naftenische oliën (aardolie), complexe van was ontdane lichte; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt verkregen uit een katalytisch wasverwijderingsproces. Bestaat uit koolwaterstoffen, overwegend C15 tot en met C30, en vormt een voltooide olie met een viscositeit die kleiner is dan 100 SUS bij 100 oF (19 cSt bij 40 oC). Bevat relatief weinig normale paraffinen.] |
265-180-7 |
64742-76-3 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-481-00-4 |
smeeroliën (aardolie), C20-50-, met waterstof behandelde uit neutrale olie verkregen, hoge viscositeit; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen door de behandeling van lichte vacuümgasolie, zware vacuümgasolie en met oplosmiddel gedeasfalteerde residuolie met waterstof in de aanwezigheid van een katalysator in een proces met twee fasen met wasverwijdering tussen de fasen in. Bestaat voornamelijk uit koolwaterstoffen, overwegend C20 tot en met C50, en vormt een voltooide olie met een viscositeit van ongeveer 112 cSt bij 40 oC. Bevat een relatief grote hoeveelheid verzadigde koolwaterstoffen.] |
276-736-3 |
72623-85-9 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-482-00-X |
smeeroliën (aardolie), C15-30-, met waterstof behandelde uit neutrale olie verkregen; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen door de behandeling van lichte vacuümgasolie en zware vacuümgasolie met waterstof in de aanwezigheid van een katalysator in een proces met twee fasen met wasverwijdering tussen de fasen in. Bestaat voornamelijk uit koolwaterstoffen, overwegend C15 tot en met C30, en vormt een voltooide olie met een viscositeit van ongeveer 15 cSt bij 40 oC. Bevat een relatief grote hoeveelheid verzadigde koolwaterstoffen.] |
276-737-9 |
72623-86-0 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-483-00-5 |
smeeroliën (aardolie), C20-50-, met waterstof behandelde uit neutrale olie verkregen; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen door de behandeling van lichte vacuümgasolie, zware vacuümgasolie en met oplosmiddel gedeasfalteerde residuolie met waterstof in de aanwezigheid van een katalysator in een proces met twee fasen met wasverwijdering tussen de fasen in. Bestaat voornamelijk uit koolwaterstoffen, overwegend C20 tot en met C50, en vormt een voltooide olie met een viscositeit van ongeveer 32 cSt bij 40 oC. Bevat een relatief grote hoeveelheid verzadigde koolwaterstoffen.] |
276-738-4 |
72623-87-1 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-484-00-0 |
smeeroliën; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt verkregen uit oplosmiddelextractie- en wasverwijderingsprocessen. Bestaat voornamelijk uit verzadigde koolwaterstoffen, C15 tot en met C50.] |
278-012-2 |
74869-22-0 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-485-00-6 |
destillaten (aardolie), complexe van was ontdane zware paraffinehoudende; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt verkregen door het van ontdoen van een paraffinisch zwaar destillaat. Bestaat voornamelijk uit koolwaterstoffen, overwegend C20 tot en met C50, en vormt een voltooide olie met een viscositeit groter dan of gelijk aan 100 SUS bij 100 oF (19 cSt bij 40 oC). Bevat relatief weinig normale paraffinen.] |
292-613-7 |
90640-91-8 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-486-00-1 |
destillaten (aardolie), complexe van was ontdane lichte paraffinische; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt verkregen door het van was ontdoen van een paraffinisch licht destillaat. Bestaat voornamelijk uit koolwaterstoffen, overwegend C12 tot en met C30, en vormt een voltooide olie met een viscositeit die kleiner is dan 100 SUS bij 100 oF (19 cSt bij 40 oC). Bevat relatief weinig normale paraffinen.] |
292-614-2 |
90640-92-9 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-487-00-7 |
destillaten (aardolie), met oplosmiddel van was ontdane zware paraffinische, met klei behandeld; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt verkregen door behandeling van van was ontdaan paraffinisch zwaar destillaat met een neutrale of gemodificeerde klei in een contact- of een percolatieproces. Bestaat voornamelijk uit koolwaterstoffen, overwegend C20 tot en met C50.] |
292-616-3 |
90640-94-1 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-488-00-2 |
koolwaterstoffen, C20-50-, met oplosmiddel van was ontdane zware paraffinische, met waterstof behandeld; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt gevormd door de behandeling van van was ontdaan paraffinisch zwaar destillaat met waterstof in de aanwezigheid van een katalysator. Bestaat voornamelijk uit koolwaterstoffen, overwegend C20 tot en met C50.] |
292-617-9 |
90640-95-2 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-489-00-8 |
destillaten (aardolie), met oplosmiddel van was ontdane lichte paraffinische, met klei behandeld; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die overblijft uit de behandeling van van was ontdaan paraffinisch licht destillaat met natuurlijke of gemodificeerde klei in een contact- of een percolatieproces. Bestaat voornamelijk uit koolwaterstoffen, overwegend C15 tot en met C30.] |
292-618-4 |
90640-96-3 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-490-00-3 |
destillaten (aardolie), met oplosmiddel van was ontdane lichte paraffinische, met waterstof behandeld; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt gevormd door de behandeling van een van was ontdaan paraffinisch licht destillaat met waterstof in de aanwezigheid van een katalysator. Bestaat voornamelijk uit koolwaterstoffen, overwegend C15 tot en met C30.] |
292-620-5 |
90640-97-4 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-491-00-9 |
residueoliën (aardolie), met waterstof behandeld en met oplosmiddel van was ontdaan; basisolie — niet gespecifieerd; |
292-656-1 |
90669-74-2 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-492-00-4 |
residuoliën (aardolie), katalytisch van was ontdaan; basisolie — niet gespecifieerd; |
294-843-3 |
91770-57-9 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-493-00-X |
destillaten (aardolie), van was ontdane zware paraffinische, met waterstof behandeld; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt verkregen uit een intensieve behandeling van een van was ontdaan destillaat door hydrogenering in de aanwezigheid van een katalysator. Bestaat voornamelijk uit verzadigde koolwaterstoffen, overwegend C25 tot en met C39, en vormt een voltooide olie met een viscositeit van ongeveer 44 cSt bij 50 oC.] |
295-300-3 |
91995-39-0 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-494-00-5 |
destillaten (aardolie), van was ontdane lichte paraffinische, met waterstof behandeld; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt verkregen uit een intensieve behandeling van een van was ontdaan destillaat door hydrogenering in de aanwezigheid van een katalysator. Bestaat voornamelijk uit verzadigde koolwaterstoffen, overwegend C21 tot en met C29, en vormt een voltooide olie met een viscositeit van ongeveer 13 cSt bij 50 oC.] |
295-301-9 |
91995-40-3 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-495-00-0 |
destillaten (aardolie), waterstofgekraakte met oplosmiddel geraffineerde, van was ontdaan; basisolie — niet gespecifieerd; [een complexe verzameling vloeibare koolwaterstoffen die wordt verkregen door herkristallisatie van van was ontdane, waterstofgekraakte, met oplosmiddel geraffineerde aardoliedestillaten.] |
295-306-6 |
91995-45-8 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-496-00-6 |
destillaten (aardolie), oplosmiddelgeraffineerde naftenische lichte, met waterstof behandeld; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt verkregen door de behandeling van een aardoliefractie met waterstof in aanwezigheid van een katalysator en verwijdering van de aromatische koolwaterstoffen door oplosmiddelextractie. Bestaat voornamelijk uit nafteenkoolwaterstoffen, overwegend C15 tot en met C30, en vormt een voltooide olie met een viscositeit tussen 13 cSt en 15 cSt bij 40 oC.] |
295-316-0 |
91995-54-9 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-497-00-1 |
smeeroliën (aardolie), C17-35-, met oplosmiddel geëxtraheerd, van was ontdaan, met waterstof behandeld; basisolie — niet gespecifieerd; |
295-423-2 |
92045-42-6 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-498-00-7 |
smeeroliën (aardolie), waterstofgekraakte niet-aromatische met oplosmiddel gedeparaffineerde; basisolie — niet gespecifieerd; |
295-424-8 |
92045-43-7 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-499-00-2 |
residuoliën (aardolie), waterstofgekraakte met zuur behandelde met oplosmiddel van was ontdane; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt verkregen door de verwijdering van paraffinen met oplosmiddel uit het residu van de destillatie van met zuur behandelde, waterstofgekraakte zware paraffinen, kokend ongeveer boven 380 oC (716 oF).] |
295-499-7 |
92061-86-4 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-500-00-6 |
paraffineoliën (aardolie), met oplosmiddel geraffineerde van was ontdane zware; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt verkregen uit zwavelhoudende paraffinische ruwe olie. Bestaat voornamelijk uit een met oplosmiddel geraffineerde gedeparaffineerde smeerolie met een viscositeit van 65 cSt bij 50 oC.] |
295-810-6 |
92129-09-4 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-501-00-1 |
smeeroliën (aardolie), basisoliën, paraffinische; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt verkregen door raffinage van ruwe olie. Bestaat voornamelijk uit aromaten, naftenen en paraffinen en vormt een voltooide olie met een viscositeit van 120 SUS bij 100 oF (23 cSt bij 40 oC).] |
297-474-6 |
93572-43-1 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-502-00-7 |
koolwaterstoffen, waterstofgekraakte paraffinische destillatieresiduen, met oplosmiddel van was ontdaan; basisolie — niet gespecifieerd; |
297-857-8 |
93763-38-3 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-503-00-2 |
koolwaterstoffen, C20-50-, residuolie hydrogenering vacuümdestillaat; basisolie — niet gespecifieerd; |
300-257-1 |
93924-61-9 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-504-00-8 |
destillaten (aardolie), met oplosmiddel geraffineerde met waterstof behandelde zware; gehydrogeneerd; basisolie — niet gespecifieerd; |
305-588-5 |
94733-08-1 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-505-00-3 |
destillaten (aardolie), met oplosmiddel gezuiverde waterstofgekraakte lichte; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen door dearomatisering met oplosmiddel van het residu van waterstofgekraakte aardolie. Bestaat voornamelijk uit koolwaterstoffen, overwegend C18 tot en met C27, met een kooktraject van ongeveer 370 oC tot 450 oC (698 oF tot 842 oF).] |
305-589-0 |
94733-09-2 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-506-00-9 |
smeeroliën (aardolie), C18-40, met oplosmiddel van was ontdane waterstofgekraakte uit destillaat verkregen; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen door deparaffinering met oplosmiddel van het destillatieresidu van waterstofgekraakte aardolie. Bestaat voornamelijk uit koolwaterstoffen, overwegend C18 tot en met C40, met een kooktraject van ongeveer 370 oC tot 550 oC (698 oF tot 1 022 oF).] |
305-594-8 |
94733-15-0 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-507-00-4 |
smeeroliën (aardolie), C18-40-, met oplosmiddel van was ontdane uit gehydrogeneerd raffinaat verkregen; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen, verkregen door deparaffinering met oplosmiddel van het gehydrogeneerde raffinaat dat wordt verkregen door oplosmiddelextractie van een met waterstof behandeld aardoliedestillaat. Bestaat voornamelijk uit koolwaterstoffen, overwegend C18 tot en met C40, met een kooktraject van ongeveer 370 oC tot 550 oC (698 oF tot 1 022 oF).] |
305-595-3 |
94733-16-1 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-508-00-X |
koolwaterstoffen, C13-30-, rijk aan aromaten, met oplosmiddel geëxtraheerd naftenisch destillaat; basisolie — niet gespecifieerd; |
305-971-7 |
95371-04-3 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-509-00-5 |
koolwaterstoffen, C16-32-, rijk aan aromaten, met oplosmiddel geëxtraheerd naftenisch destillaat; basisolie — niet gespecifieerd; |
305-972-2 |
95371-05-4 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-510-00-0 |
koolwaterstoffen, C37-68-, van was ontdane gedeasfalteerde met waterstof behandelde vacuümdestillatieresiduen; basisolie — niet gespecifieerd; |
305-974-3 |
95371-07-6 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-511-00-6 |
koolwaterstoffen, C37-65-, met waterstof behandelde gedeasfalteerde vacuümdestillatieresiduen; basisolie — niet gespecifieerd; |
305-975-9 |
95371-08-7 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-512-00-1 |
destillaten (aardolie), waterstofgekraakte met oplosmiddel geraffineerde lichte; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt verkregen door de behandeling met oplosmiddel van een destillaat van waterstofgekraakte aardoliedestillaten. Bestaat voornamelijk uit koolwaterstoffen, overwegend C18 tot en met C27, met een kooktraject van ongeveer 370 oC tot 450 oC (698 oF tot 842 oF).] |
307-010-7 |
97488-73-8 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-513-00-7 |
destillaten (aardolie), met oplosmiddel geraffineerde gehydrogeneerde zware; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt verkregen door de behandeling van een gehydrogeneerd aardoliedestillaat met een oplosmiddel. Bestaat voornamelijk uit koolwaterstoffen, overwegend C19 tot en met C40, met een kooktraject van ongeveer 390 oC tot 550 oC (734 oF tot 1 022 oF).] |
307-011-2 |
97488-74-9 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-514-00-2 |
smeeroliën (aardolie), C18-27-, waterstofgekraakte met oplosmiddel van was ontdane; basisolie — niet gespecifieerd; |
307-034-8 |
97488-95-4 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-515-00-8 |
koolwaterstoffen, C17-30-, met waterstof behandeld met oplosmiddel gedeasfalteerd residu van de atmosferische destillatie, lichte destillatiefracties; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt verkregen als de eerste fracties uit de vacuümdestillatie van de vloeistoffen die worden verkregen bij de behandeling van een met oplosmiddel gedeasfalteerd kleverig residu met waterstof in aanwezigheid van een katalysator. Bestaat voornamelijk uit koolwaterstoffen, overwegend C17 tot en met C30, met een kooktraject van ongeveer 300 oC tot 400 oC (572 oF tot 752 oF). Vormt een voltooide olie met een viscositeit van 4 cSt bij ongeveer 100 oC (212 oF).] |
307-661-7 |
97675-87-1 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-516-00-3 |
koolwaterstoffen, C17-40-, met waterstof behandeld met oplosmiddel gedeasfalteerd destillatieresidu, lichte vacuümdestillatiefracties; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt verkregen als de eerste fracties uit de vacuümdestillatie van de vloeistoffen die worden verkregen door de katalytische behandeling met waterstof van een met oplosmiddel gedeasfalteerd kleverig residu met een viscositeit van 8 cSt bij ongeveer 100 oC (212 oF). Bestaat voornamelijk uit koolwaterstoffen, overwegend C17 tot en met C40, met een kooktraject van ongeveer 300 oC tot 500 oC (592 oF tot 932 oF).] |
307-755-8 |
97722-06-0 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-517-00-9 |
koolwaterstoffen, C13-27-, met oplosmiddel geëxtraheerde lichte naftenische; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt verkregen door extractie van de aromaten uit een naftenisch licht destillaat met een viscositeit van 9,5 cSt bij 40 oC (104 oF). Bestaat voornamelijk uit koolwaterstoffen, overwegend C13 tot en met C27, met een kooktraject van ongeveer 240 oC tot 400 oC (464 oF tot 752 oF).] |
307-758-4 |
97722-09-3 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-518-00-4 |
koolwaterstoffen, C14-29-, met oplosmiddel geëxtraheerde lichte naftenische; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt verkregen door extractie van de aromaten uit een naftenisch licht destillaat met een viscositeit van 16 cSt bij 40 oC (104 oF). Bestaat voornamelijk uit koolwaterstoffen, overwegend C14 tot en met C29, met een kooktraject van ongeveer 250 oC tot 425 oC (482 oF tot 797 oF).] |
307-760-5 |
97722-10-6 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-519-00-X |
koolwaterstoffen, C27-42-, gedearomatiseerd; basisolie — niet gespecifieerd; |
308-131-8 |
97862-81-2 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-520-00-5 |
koolwaterstoffen, C17-30-, met waterstof behandelde destillaten, lichte destillatiefracties; basisolie — niet gespecifieerd; |
308-132-3 |
97862-82-3 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-521-00-0 |
koolwaterstoffen, C27-45-, naftenische vacuümdestillatie-; basisolie — niet gespecifieerd; |
308-133-9 |
97862-83-4 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-522-00-6 |
koolwaterstoffen, C27-45-, gedearomatiseerd; basisolie — niet gespecifieerd; |
308-287-7 |
97926-68-6 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-523-00-1 |
koolwaterstoffen, C20-58-, met waterstof behandeld; basisolie — niet gespecifieerd; |
308-289-8 |
97926-70-0 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-524-00-7 |
koolwaterstoffen, C27-42-, naftenisch; basisolie — niet gespecifieerd; |
308-290-3 |
97926-71-1 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-525-00-2 |
residuoliën (aardolie), behandeld met koolstof en met oplosmiddel van was ontdaan; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt verkregen door de behandeling van met oplosmiddel van was ontdane residuoliën uit aardolie met geactiveerde kool teneinde sporen van polaire bestanddelen en onzuiverheden te verwijderen.] |
309-710-8 |
100684-37-5 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-526-00-8 |
residuoliën (aardolie), behandeld met klei en met oplosmiddel van was ontdaan; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt verkregen door de behandeling van met oplosmiddel van was ontdane residuoliën uit aardolie met bleekaarde teneinde sporen van polaire bestanddelen en onzuiverheden te verwijderen.] |
309-711-3 |
100684-38-6 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-527-00-3 |
smeeroliën (aardolie), C>25, met oplosmiddel geëxtraheerd, gedeasfalteerd, van was ontdaan, gehydrogeneerd; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt verkregen door oplosmiddelextractie en hydrogenering van vacuümdestillatieresiduen. Bestaat voornamelijk uit koolwaterstoffen, overwegend groter dan C25, en vormt een voltooide olie met een viscositeit van 32 cSt tot 37 cSt bij 100 oC (212 oF).] |
309-874-0 |
101316-69-2 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-528-00-9 |
smeeroliën (aardolie), C17-32-, met oplosmiddel geëxtraheerd, van was ontdaan, gehydrogeneerd; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt verkregen door oplosmiddelextractie en hydrogenering van residuen van atmosferische destillatie. Bestaat voornamelijk uit koolwaterstoffen, overwegend C17 tot en met C32, en vormt een voltooide olie met een viscositeit van 17 cSt tot 23 cSt bij 40 oC (104 oF).] |
309-875-6 |
101316-70-5 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-529-00-4 |
smeeroliën (aardolie), C20-35-, met oplosmiddel geëxtraheerd, van was ontdaan, gehydrogeneerd; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt verkregen door oplosmiddelextractie en hydrogenering van residuen van atmosferische destillatie. Bestaat voornamelijk uit koolwaterstoffen, overwegend C20 tot en met C35, en vormt een voltooide olie met een viscositeit van 37 cSt tot 44 cSt bij 40 oC (104 oF).] |
309-876-1 |
101316-71-6 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-530-00-X |
smeeroliën (aardolie), C24-50-, met oplosmiddel geëxtraheerd, van was ontdaan, gehydrogeneerd; basisolie — niet gespecifieerd; [een complexe verzameling koolwaterstoffen die wordt verkregen door oplosmiddelextractie en hydrogenering van residuen van atmosferische destillatie. Bestaat voornamelijk uit koolwaterstoffen, overwegend C24 tot en met C50, en vormt een voltooide olie met een viscositeit van 16 cSt tot 75 cSt bij 40 oC (104 oF).] |
309-877-7 |
101316-72-7 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-531-00-5 |
extracten (aardolie), naftenisch zwaar destillaat-oplosmiddel-, aromaatconcentraat; aromatisch extract van destillaat (bewerkt); [een aromatisch concentraat, verkregen door het toevoegen van water aan oplosmiddelextract van naftenisch zwaar destillaat en extractieoplosmiddel.] |
272-175-3 |
68783-00-6 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-532-00-0 |
extracten (aardolie), met oplosmiddel geraffineerde paraffinisch zwaar destillaat-oplosmiddel-; aromatisch extract van destillaat (bewerkt); [een complexe verzameling koolwaterstoffen, verkregen als het extract van de herextractie van met oplosmiddel geraffineerd paraffinisch zwaar destillaat. Bestaat uit verzadigde en aromatische koolwaterstoffen, overwegend C20 tot en met C50.] |
272-180-0 |
68783-04-0 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-533-00-6 |
extracten (aardolie), zware paraffinische destillaten, met oplosmiddel gedeasfalteerd; aromatisch extract van destillaat (bewerkt); [een complexe verzameling koolwaterstoffen die wordt verkregen als het extract van een oplosmiddelextractie van paraffinisch zwaar destillaat.] |
272-342-0 |
68814-89-1 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-534-00-1 |
extracten (aardolie), naftenisch zwaar destillaat-oplosmiddel-, met waterstof behandeld; aromatisch extract van destillaat (bewerkt); [een complexe verzameling koolwaterstoffen die wordt verkregen door de behandeling van een oplosmiddelextract van naftenisch zwaar destillaat met waterstof in de aanwezigheid van een katalysator. Bestaat voornamelijk uit aromatische koolwaterstoffen, overwegend C20 tot en met C50, en vormt een voltooide olie van ten minste 19 cSt bij 40 oC (100 SUS bij 100 oF). |
292-631-5 |
90641-07-9 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-535-00-7 |
extracten (aardolie), paraffinisch zwaar destillaat-oplosmiddel-, met waterstof behandeld; aromatisch extract van destillaat (bewerkt); [een complexe verzameling koolwaterstoffen die wordt gevormd door de behandeling van een oplosmiddelextract van paraffinisch zwaar destillaat met waterstof in de aanwezigheid van een katalysator. Bestaat voornamelijk uit koolwaterstoffen, overwegend C21 tot en met C33, met een kooktraject van ongeveer 350 oC tot 480 oC (662 oF tot 896 oF).] |
292-632-0 |
90641-08-0 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-536-00-2 |
extracten (aardolie), licht paraffinisch destillaat oplosmiddel-, met waterstof behandeld; aromatisch extract van destillaat (bewerkt); [een complexe verzameling koolwaterstoffen die wordt gevormd door de behandeling van een oplosmiddelextract van paraffinisch licht destillaat met waterstof in de aanwezigheid van een katalysator. Bestaat voornamelijk uit koolwaterstoffen, overwegend C17 tot en met C26, met een kooktraject van ongeveer 280 oC tot 400 oC (536 oF tot 752 oF).] |
292-633-6 |
90641-09-1 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-537-00-8 |
extracten (aardolie), met waterstof behandeld paraffinisch licht destillaat-oplosmiddel-; aromatisch extract van destillaat (bewerkt); [een complexe verzameling koolwaterstoffen die wordt verkregen als het extract uit oplosmiddelextractie van het middelste paraffinische, bij aftoppen verkregen, oplosmiddeldestillaat dat is behandeld met waterstof in de aanwezigheid van een katalysator. Bestaat voornamelijk uit aromatische koolwaterstoffen, overwegend C16 tot en met C36.] |
295-335-4 |
91995-73-2 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-538-00-3 |
extracten (aardolie), naftenisch licht destillaat-oplosmiddel-, met waterstof ontzwaveld; aromatisch extract van destillaat (bewerkt); [een complexe verzameling koolwaterstoffen die wordt verkregen door behandeling van het, uit een oplosmiddelextractieproces verkregen, extract met waterstof in de aanwezigheid van een katalysator onder omstandigheden die primair gericht zijn op de verwijdering van zwavelverbindingen. Bestaat voornamelijk uit aromatische koolwaterstoffen, overwegend C15 tot en met C30. Deze stroom bevat waarschijnlijk 5 of meer gewichtsprocenten aromatische koolwaterstoffen met vier- tot zesvoudig gecondenseerde ringen.] |
295-338-0 |
91995-75-4 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-539-00-9 |
extracten (aardolie), paraffinisch licht destillaat-oplosmiddel-, zuurbehandeld; aromatisch extract van destillaat (bewerkt); [een complexe verzameling koolwaterstoffen die wordt verkregen als een fractie uit de destillatie van een extract uit de oplosmiddelextractie van lichte paraffinische, bij aftoppen verkregen, destillaten uit aardolie dat is onderworpen aan een zuivering met zwavelzuur. Bestaat voornamelijk uit aromatische koolwaterstoffen, overwegend C16 tot en met C32.] |
295-339-6 |
91995-76-5 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-540-00-4 |
extracten (aardolie), paraffinisch licht destillaat-oplosmiddel-, met waterstof ontzwaveld; aromatisch extract van destillaat (bewerkt); [een complexe verzameling koolwaterstoffen die wordt verkregen door oplosmiddelextractie van een paraffinehoudend licht destillaat en wordt behandeld met waterstof om organische zwavel om te zetten in waterstofsulfide dat wordt verwijderd. Bestaat voornamelijk uit koolwaterstoffen, overwegend C15 tot en met C40, en vormt een voltooide olie met een viscositeit groter dan 10 cSt bij 40 oC.] |
295-340-1 |
91995-77-6 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-541-00-X |
extracten (aardolie), lichte vacuümgasolie oplosmiddel-, met waterstof behandeld; aromatisch extract van destillaat (bewerkt); [een complexe verzameling koolwaterstoffen die wordt verkregen door oplosmiddelextractie uit lichte vacuümgasoliën uit aardolie en behandeld met waterstof in de aanwezigheid van een katalysator. Bestaat voornamelijk uit aromatische koolwaterstoffen, overwegend C13 tot en met C30.] |
295-342-2 |
91995-79-8 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-542-00-5 |
extracten (aardolie), paraffinisch zwaar destillaat-oplosmiddel-, met klei behandeld; aromatisch extract van destillaat (bewerkt); [een complexe verzameling koolwaterstoffen die wordt verkregen door behandeling van een aardoliefractie met een natuurlijke of gemodificeerde klei in een contact- of een percolatieproces waarbij sporen van polaire verbindingen en aanwezige onzuiverheden worden verwijderd. Bestaat voornamelijk uit aromatische koolwaterstoffen, overwegend C20 tot en met C50. Deze stroom bevat waarschijnlijk 5 of meer gewichtsprocenten aromatische koolwaterstoffen met vier- tot zesvoudige ringen.] |
296-437-1 |
92704-08-0 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-543-00-0 |
extracten (aardolie), naftenisch zwaar destillaat-oplosmiddel-, met waterstof ontzwaveld; aromatisch extract van destillaat (bewerkt); [een complexe verzameling koolwaterstoffen die wordt verkregen uit de aardoliegrondstof door behandeling met waterstof om organische zwavel om te zetten in waterstofsulfide dat wordt verwijderd. Bestaat voornamelijk uit koolwaterstoffen, overwegend C15 tot en met C50, en vormt een voltooide olie met een viscositeit groter dan 19 cSt bij 40 oC.] |
297-827-4 |
93763-10-1 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-544-00-6 |
extracten (aardolie), met oplosmiddel van was ontdane paraffinisch zwaar destillaat-oplosmiddel-, met waterstof ontzwaveld; aromatisch extract van destillaat (bewerkt); [een complexe verzameling koolwaterstoffen die wordt verkregen uit de met oplosmiddel van was ontdane aardoliegrondstof door behandeling met waterstof om organische zwavel om te zetten in waterstofsulfide dat wordt verwijderd. Bestaat voornamelijk uit koolwaterstoffen, overwegend C15 tot en met C50, en vormt een voltooide olie met een viscositeit groter dan 19 cSt bij 40 oC.] |
297-829-5 |
93763-11-2 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-545-00-1 |
extracten (aardolie), paraffinisch licht destillaat-oplosmiddel-, met koolstof behandeld; aromatisch extract van destillaat (bewerkt); [een complexe verzameling koolwaterstoffen die wordt verkregen als een fractie uit de destillatie van een extract dat is herwonnen door oplosmiddelextractie van het lichte paraffinische, bij aftoppen verkregen, aardoliedestillaat, behandeld met geactiveerde kool teneinde sporen van polaire bestanddelen en onzuiverheden te verwijderen. Bestaat voornamelijk uit aromatische koolwaterstoffen, overwegend C16 tot en met C32.] |
309-672-2 |
100684-02-4 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-546-00-7 |
extracten (aardolie), licht paraffinisch destillaat-oplosmiddel-, met klei behandeld; aromatisch extract van destillaat (bewerkt); [een complexe verzameling koolwaterstoffen die wordt verkregen als een fractie uit de destillatie van een extract teruggewonnen door oplosmiddelextractie van lichte paraffinische, bij aftoppen verkregen, aardoliedestillaten, behandeld met bleekaarde teneinde sporen van polaire bestanddelen en onzuiverheden te verwijderen. Bestaat voornamelijk uit aromatische koolwaterstoffen, overwegend C16 tot en met C32.] |
309-673-8 |
100684-03-5 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-547-00-2 |
extracten (aardolie), lichte vacuüm-, gasolieoplosmiddel-, behandeld met koolstof; aromatisch extract van destillaat (bewerkt); [een complexe verzameling koolwaterstoffen die wordt verkregen door oplosmiddelextractie van lichte vacuümgasolie uit aardolie, behandeld met geactiveerde kool teneinde sporen van polaire bestanddelen en onzuiverheden te verwijderen. Bestaat voornamelijk uit aromatische koolwaterstoffen, overwegend C13 tot en met C30.] |
309-674-3 |
100684-04-6 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-548-00-8 |
extracten (aardolie), lichte vacuümgasolie oplosmiddel-, behandeld met klei; aromatisch extract van destillaat (bewerkt); [een complexe verzameling koolwaterstoffen die wordt verkregen door oplosmiddelextractie van lichte vacuümgasoliën uit aardolie, behandeld met bleekaarde teneinde sporen van polaire bestanddelen en onzuiverheden te verwijderen. Bestaat voornamelijk uit aromatische koolwaterstoffen, overwegend C13 tot en met C30.] |
309-675-9 |
100684-05-7 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-549-00-3 |
bezinkselolie (aardolie); bezinkselolie; [een complexe verzameling koolwaterstoffen die wordt verkregen als de oliefractie uit een oplosmiddel-olieverwijderings- of een wasuitzwetingsproces. Bestaat voornamelijk uit vertakte koolwaterstoffen, overwegend C20 tot en met C50.] |
265-171-8 |
64742-67-2 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
649-550-00-9 |
bezinkselolie (aardolie), met waterstof behandeld; bezinkselolie |
295-394-6 |
92045-12-0 |
Carc. 1B |
H350 |
GHS08 Dgr |
H350 |
|
|
L |
650-002-00-6 |
terpentijn, olie |
232-350-7 |
8006-64-2 |
Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Asp. Tox. 1 Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2 |
H226 H332 H312 H302 H304 H319 H315 H317 H411 |
GHS02 GHS08 GHS07 GHS09 Dgr |
H226 H332 H312 H302 H304 H319 H315 H317 H411 |
|
|
|
650-003-00-1 |
fenson (ISO); 4-chloorfenylbenzeensulfonaat; |
201-274-6 |
80-38-6 |
Acute Tox. 4 * Eye Irrit. 2 Aquatic Chronic 2 |
H302 H319 H411 |
GHS07 GHS09 Wng |
H302 H319 H411 |
|
|
|
650-004-00-7 |
norbormide (ISO); 5-(α-hydroxy-α-2-pyridylbenzyl)-7-(α-2-pyridylbenzylideen)bicyclo[2.2.1]hept-5-een-2,3-dicarboximide |
213-589-6 |
991-42-4 |
Acute Tox. 4 * |
H302 |
GHS07 Wng |
H302 |
|
|
|
650-005-00-2 |
(2R,6aS,12aS)-1,2,6,6a,12,12a-hexahydro-2-isopropenyl-8,9-dimethoxychromeno[3,4-b]furo[2,3-h]chromeen-6-on, rotenon |
201-501-9 |
83-79-4 |
Acute Tox. 3 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 |
H301 H319 H335 H315 H400 H410 |
GHS06 GHS09 Dgr |
H301 H319 H335 H315 H410 |
|
|
|
650-006-00-8 |
benquinox (ISO); p-benzochinon-1-benzoylhydrazon-4-oxim |
207-807-9 |
495-73-8 |
Acute Tox. 3 * Acute Tox. 4 * |
H301 H312 |
GHS06 Dgr |
H301 H312 |
|
|
|
650-007-00-3 |
chloordimeform (ISO); N2-(4-chloor-o-tolyl)-N 1,N 1-dimethylformamidine |
228-200-5 |
6164-98-3 |
Carc. 2 Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H312 H302 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H312 H302 H410 |
|
|
|
650-008-00-9 |
drazoxolon (ISO); 4-(2-chloorfenylhydrazon)-3-methyl-5-isoxazolon |
227-197-8 |
5707-69-7 |
Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H400 H410 |
GHS06 GHS09 Dgr |
H301 H410 |
|
|
|
650-009-00-4 |
chloordimeform-hydrochloride; N'-(4-chloor-o-tolyl)-N,N-dimethylformamidine-monohydrochloride; N2-(4-chloor-o-tolyl)-N 1,N 1-dimethylformamidine-hydrochloride |
243-269-1 |
19750-95-9 |
Carc. 2 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H302 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H302 H410 |
|
|
|
650-010-00-X |
benzyl violet 4B; α-[4-(4-dimethylamino-α-{4-[ethyl(3-natriosulfonato-benzyl)amino] fenyl}benzylideen)cyclohexa-2,5-diënylideen(ethyl)ammonio]tolueen-3-sulfonaat |
216-901-9 |
1694-09-3 |
Carc. 2 |
H351 |
GHS08 Wng |
H351 |
|
|
|
650-012-00-0 |
erioniet |
— |
12510-42-8 |
Carc. 1A |
H350 |
GHS08 Dgr |
H350 |
|
|
|
650-013-00-6 |
asbest |
— — — — — — — |
12001-28-4 132207-32-0 12172-73-5 77536-66-4 77536-68-6 77536-67-5 12001-29-5 |
Carc. 1A STOT RE 1 |
H350 H372 ** |
GHS08 Dgr |
H350 H372 ** |
|
|
|
650-014-00-1 |
diëthyl-2,4-dihydroxycyclodisiloxaan-2,4-diylbis(trimethyleen)difosfonaat, tetranatriumzout, reactieproducten met dinatriummetasilicaat |
401-770-4 |
— |
Skin Corr. 1B Acute Tox. 4 * |
H314 H302 |
GHS05 GHS07 Dgr |
H314 H302 |
|
|
|
650-015-00-7 |
pijnhars; colofonium |
232-475-7 232-484-6 277-299-1 |
8050-09-7 8052-10-6 73138-82-6 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
650-016-00-2 |
minerale wol, tenzij elders in deze bijlage vermeld; [kunstmatige (silicaat)glasvezels met een willekeurige oriëntatie en een gehalte aan alkali- en aardalkalioxiden (Na2O + K2O + CaO + MgO + BaO) van meer dan 18 gewichtsprocent] |
— |
— |
Carc. 2 |
H351 |
GHS08 Wng |
H351 |
|
|
AQR |
650-017-00-8 |
vuurvaste keramische vezels, vezels voor speciale toepassingen, tenzij elders in deze bijlage vermeld; [kunstmatige (silicaat)glasvezels met een willekeurige oriëntatie en een gehalte aan alkali- en aardalkalioxiden (Na2O + K2O + CaO + MgO + BaO) van ten hoogste 18 gewichtsprocent] |
— |
— |
Carc. 1B |
H350i |
GHS08 Dgr |
H350i |
|
|
AR |
650-018-00-3 |
reactieproduct van: acetofenon, formaldehyde, cyclohexylamine, methanol en azijnzuur |
406-230-1 |
— |
Flam. Liq. 3 Carc. 2 Skin Corr. 1B Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H226 H351 H314 H332 H317 H400 H410 |
GHS02 GHS08 GHS05 GHS07 GHS09 Dgr |
H226 H351 H314 H332 H317 H410 |
|
|
|
650-031-00-4 |
bis(4-hydroxy-N-methylanilinium)sulfaat |
200-237-1 |
55-55-0 |
Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H373 ** H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H302 H373 ** H317 H410 |
|
|
|
650-041-00-9 |
triasulfuron (ISO); 1-[2-(2-chloorethoxy)fenylsulfonyl]-3-(4-methoxy-6-methyl-1,3,5-triazine-2-yl)ureum |
— |
82097-50-5 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|
650-042-00-4 |
reactieproduct van: polyethyleen-polyamine-(C16-C18)-alkylamiden met monothio-(C2)-alkylfosfonaten |
417-450-2 |
— |
Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3 |
H319 H315 H317 H412 |
GHS07 Wng |
H319 H315 H317 H412 |
|
|
|
650-043-00-X |
reactieproduct van: 3,5-bis-tert-butylsalicylzuur en aluminiumsulfaat |
420-310-3 |
— |
Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H302 H400 H410 |
GHS07 GHS09 Wng |
H302 H410 |
|
|
|
650-044-00-5 |
gemengde lineaire en vertakte C14-15-alcoholen, geëthoxyleerd, reactieproduct met epichloorhydrine |
420-480-9 |
158570-99-1 |
Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H317 H400 H410 |
GHS07 GHS09 Wng |
H315 H317 H410 |
|
|
|
650-045-00-0 |
reactieproduct van: 1,2,3-propaantricarbonzuur, 2-hydroxy, diëthylester, 1-propanol en zirkonium-tetra-n-propanolaat |
417-110-3 |
— |
Flam. Liq. 2 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 2 |
H225 H315 H318 H411 |
GHS02 GHS05 GHS09 Dgr |
H225 H315 H318 H411 |
|
|
|
650-046-00-6 |
di(tetramethylammonium)(29H,31H-ftalocyanine-N 29,N 30,N 31,N 32)disulfonamide-disulfonaat, koper(II)complex, derivaten |
416-180-2 |
12222-04-7 |
Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 2 |
H302 H373 ** H411 |
GHS08 GHS07 GHS09 Wng |
H302 H373 ** H411 |
|
|
|
650-047-00-1 |
dibenzylfenylsulfonium-hexafluoroantimonaat |
417-760-8 |
134164-24-2 |
STOT RE 1 Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2 |
H372 ** H302 H318 H317 H411 |
GHS08 GHS05 GHS07 GHS09 Dgr |
H372 ** H302 H318 H317 H411 |
|
|
|
650-048-00-7 |
reactieproduct van: borax, waterstofperoxide, azijnzuuranhydride en azijnzuur |
420-070-1 |
— |
Org. Perox. D **** Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A Aquatic Acute 1 |
H242 H332 H312 H302 H314 H400 |
GHS02 GHS05 GHS07 GHS09 Dgr |
H242 H332 H312 H302 H314 H400 |
|
|
|
650-049-00-2 |
2-alkoyloxyethyl-hydrogeenmaleaat, waarbij alkoyl staat voor 70 tot 85 % onverzadigd octadecoyl, 0,5 tot 10 % verzadigd octadecoyl en 2 tot 18 % verzadigd hexadecoyl (in gewichtsprocenten) |
417-960-5 |
— |
Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H315 H318 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H315 H318 H317 H410 |
|
|
|
650-050-00-8 |
reactiemassa van: 1-methyl-3-hydroxypropyl-3,5-[1,1-dimethylethyl]-4-hydroxydihydro-cinnamaat en/of 3-hydroxybutyl-3,5-[1,1-dimethylethyl]-4-hydroxydihydrocinnamaat; 1,3-butaandiol-bis[3-(3'-(1,1-dimethylethyl)-4'-hydroxyfenyl)propionaat]-isomeren; 1,3-butaandiol-bis[3-(3',5'-(1,1-dimethylethyl)-4'-hydroxyfenyl)propionaat]-isomeren; |
423-600-8 |
— |
Aquatic Chronic 2 |
H411 |
GHS09 |
H411 |
|
|
|
650-055-00-5 |
natriumzilverzirkoniumwaterstoffosfaat |
422-570-3 |
155925-27-2 |
Aquatic Acute 1 Aquatic Chronic 1 |
H400 H410 |
GHS09 Wng |
H410 |
|
|
|